| CAS No. | Saflık | Ürün Adı | BOSTON KODU |
|---|---|---|---|
| Cas.: 13369-74-9 | Purity: 97% | 1-Allyl-3,5-dimethylpyrazole | ESD-869457-5G |
| Cas.: 53678-77-6 | Purity: 98% | N-Acetylmuramyl-L-alanyl-D-isoglutamine hydrate | ESD-890200-100MG |
| Cas.: 102-05-6 | Purity: 97% | Dibemethine | ESD-844647-5G |
| Cas.: 102-05-6 | Purity: 97% | Dibemethine | ESD-844647-25G |
| Cas.: 527-21-9 | Purity: 97% | p-Fluoranil | ESD-832061-5G |
| Cas.: 59-23-4 | Purity: Analysis control | D-Galactose | ESD-810321-100MG |
| Cas.: 320-76-3 | Purity: ≥97% | 4-Bromo-2-fluoro-6-nitrophenol | ESD-857768-5G |
| Cas.: 320-76-3 | Purity: ≥97% | 4-Bromo-2-fluoro-6-nitrophenol | ESD-857768-25G |
| Cas.: 320-76-3 | Purity: ≥97% | 4-Bromo-2-fluoro-6-nitrophenol | ESD-857768-100G |
| Cas.: 767-58-8 | Purity: 95% | 1-Methylindan | ESD-864787-25MG |
| Cas.: 767-58-8 | Purity: 95% | 1-Methylindan | ESD-864787-100MG |
| Cas.: 149022-20-8 | Purity: 99% | Adenosine 5′-monophosphate sodium salt | ESD-800164-100G |
| Cas.: 1318-02-1 | Purity: SiO2/Al2O3 (mole ratio) ≈ 38-40 | Zsm-5 molecular sieve | ESD-875522-500G |
| Cas.: 1318-02-1 | Purity: SiO2/Al2O3 (mole ratio) ≈ 38-40 | Zsm-5 molecular sieve | ESD-875522-2.5KG |
| Cas.: 24038-68-4 | Purity: 98% | 2,2-Bis(2-hydroxy-5-biphenylyl)propane | ESD-803733-1G |
| Cas.: 490-91-5 | Purity: 99% | Thymoquinone | ESD-819813-25G |
| Cas.: 3705-42-8 | Purity: 95% | Cbz-L-Glutamic acid 1-benzyl ester | ESD-822000-100G |
| Cas.: 154057-58-6 | Purity: 98% | ((2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methyl)triphenylphosphonium bromide | ESD-845422-25G |
| Cas.: 154057-58-6 | Purity: 98% | ((2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methyl)triphenylphosphonium bromide | ESD-845422-100G |
| Cas.: 6360-07-2 | Purity: Strength: 200% | disodium 5-((4-acetylamino-2-sulphophenyl)azo)-6-amino-4-hydroxynaphthalene-2-disulphonate | ESD-832646-25G |
| Cas.: 6360-07-2 | Purity: Strength: 200% | disodium 5-((4-acetylamino-2-sulphophenyl)azo)-6-amino-4-hydroxynaphthalene-2-disulphonate | ESD-832646-100G |
| Cas.: 586966-54-3 | Purity: 98% | Tert-buthyl Pitavastatin | ESD-888460-25G |
| Cas.: 166663-25-8 | Purity: 99% | Anidulafungin | ESD-872577-100MG |
| Cas.: 959122-11-3 | Purity: 99% | A922500 | ESD-872310-5MG |
| Cas.: 7783-40-6 | Purity: 99.99% metals basis, crystal particles | Magnesium fluoride | ESD-888726-100G |
| Cas.: 147027-10-9 | Purity: 98% | Menthyl-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1,3]oxathiolane-2-carboxylic acid | ESD-882248-5G |
| Cas.: 90417-95-1 | Purity: ≥95% | 3-(2,4-Dinitrophenyl)propanoic acid | ESD-890258-1G |
| Cas.: 22246-07-7 | Purity: 97% | 7-Amino-3,4-dihydro-2(1H)-quinolinone | ESD-890259-1G |
| Cas.: 22246-07-7 | Purity: 97% | 7-Amino-3,4-dihydro-2(1H)-quinolinone | ESD-890259-5G |
| Cas.: 74-99-7 | Purity: 4% in N, N-dimethylformamide, 1mol/L, MKSeal | Propyne | ESD-867254-100ML |
| Cas.: 326-56-7 | Purity: 97% | methyl 1,3-benzodioxole-5-carboxylate | ESD-890260-1G |
| Cas.: 326-56-7 | Purity: 97% | methyl 1,3-benzodioxole-5-carboxylate | ESD-890260-5G |
| Cas.: 74-99-7 | Purity: 4% in N, N-dimethylformamide, 1mol/L, MKSeal | Propyne | ESD-867254-500ML |
| Cas.: 640768-72-5 | Purity: 97% | N-methoxy-N-methylcyclobutanecarboxamide | ESD-890261-1G |
| Cas.: 640768-72-5 | Purity: 97% | N-methoxy-N-methylcyclobutanecarboxamide | ESD-890261-5G |
| Cas.: 106896-49-5 | Purity: 95% | METHYL 4-AMINO-3-BROMOBENZOATE | ESD-833556-5G |
| Cas.: 106896-49-5 | Purity: 95% | METHYL 4-AMINO-3-BROMOBENZOATE | ESD-833556-25G |
| Cas.: 106896-49-5 | Purity: 95% | METHYL 4-AMINO-3-BROMOBENZOATE | ESD-833556-100G |
| Cas.: 94838-59-2 | Purity: 98% | tert-Butyl 4-aminophenethylcarbamate | ESD-845399-5G |
| Cas.: 1268519-74-9 | Purity: 98% | 2-Amino-9,9-diphenylfluorene | ESD-824330-25G |
| Cas.: 6223-83-2 | Purity: 97% | 9-Fluorenone-4-carboxylic Acid | ESD-834853-5G |
| Cas.: 6223-83-2 | Purity: 97% | 9-Fluorenone-4-carboxylic Acid | ESD-834853-25G |
| Cas.: 6223-83-2 | Purity: 97% | 9-Fluorenone-4-carboxylic Acid | ESD-834853-100G |
| Cas.: 14347-78-5 | Purity: 98% | (R)-(-)-2,2-Dimethyl-1,3-dioxolane-4-methanol | ESD-823681-25G |
| Cas.: 14347-78-5 | Purity: 98% | (R)-(-)-2,2-Dimethyl-1,3-dioxolane-4-methanol | ESD-823681-100G |
| Cas.: 154804-51-0 | Purity: 98% | β-Glycerol phosphate disodium salt hydrate | ESD-859329-500G |
| Cas.: 1113-83-3 | Purity: ≥95% (HPLC) | N-Glycolylneuraminic acid | ESD-810571-25MG |
| Cas.: 1113-83-3 | Purity: ≥95% (HPLC) | N-Glycolylneuraminic acid | ESD-810571-5MG |
| Cas.: 9004-66-4 | Purity: 5%water solution | Iron–Dextran | ESD-875587-2.5KG |
| Cas.: 83411-71-6 | Purity: 90% | DIISOOCTYLPHOSPHINIC ACID | ESD-822208-100G |
| Cas.: 83411-71-6 | Purity: 90% | DIISOOCTYLPHOSPHINIC ACID | ESD-822208-500G |
| Cas.: 404-86-4 | Purity: 97% | Capsaicin | ESD-832245-100MG |
| Cas.: 59-30-3 | Purity: Analysis control, ≥98% | Folic acid | ESD-809519-500MG |
| Cas.: 4331-28-6 | Purity: 97% | 1H-Pyrazol-4-amine hydrochloride | ESD-841796-5G |
| Cas.: 68890-66-4 | Purity: 98% | Piroctone olamine | ESD-890263-5G |
| Cas.: 68890-66-4 | Purity: 98% | Piroctone olamine | ESD-890263-25G |
| Cas.: 68890-66-4 | Purity: 98% | Piroctone olamine | ESD-890263-1G |
| Cas.: 4998-07-6 | Purity: 99% | 4,5-Dimethoxy-2-nitrobenzoic acid | ESD-831248-100G |
| Cas.: 26100-51-6 | Purity: particle size:3 mm, Mw ~110,000 | Polylactic acid | ESD-890264-100G |
| Cas.: 26100-51-6 | Purity: particle size:3 mm, Mw ~110,000 | Polylactic acid | ESD-890264-500G |
| Cas.: 26100-51-6 | Purity: particle size:3 mm, Mw ~110,000 | Polylactic acid | ESD-890264-2.5KG |
| Cas.: NONE201 | Purity: 10% in H2O | Ammonium alcohol polyvinyl phosphate | ESD-890265-100ML |
| Cas.: NONE201 | Purity: 10% in H2O | Ammonium alcohol polyvinyl phosphate | ESD-890265-500ML |
| Cas.: 115939-25-8 | Purity: 98% | Salvianolic acid B | ESD-890266-100MG |
| Cas.: 865-48-5 | Purity: 2 M in THF, Mkseal | Sodium tert-butoxide solution | ESD-822673-100ML |
| Cas.: 865-48-5 | Purity: 2 M in THF, Mkseal | Sodium tert-butoxide solution | ESD-822673-500ML |
| Cas.: 42017-89-0 | Purity: 98% | Fenofibric acid | ESD-843657-100G |
| Cas.: 42017-89-0 | Purity: 98% | Fenofibric acid | ESD-843657-500G |
| Cas.: 13788-72-2 | Purity: 96% | 6-Methoxyquinolin-4(1H)-one | ESD-841504-5G |
| Cas.: 13788-72-2 | Purity: 96% | 6-Methoxyquinolin-4(1H)-one | ESD-841504-25G |
| Cas.: 24672-76-2 | Purity: 98% | 9,10-Bis(4-methoxyphenyl)anthracene | ESD-871218-1G |
| Cas.: 557-48-2 | Purity: ≥95% | trans,cis-2,6-Nonadienal | ESD-865986-5G |
| Cas.: 557-48-2 | Purity: ≥95% | trans,cis-2,6-Nonadienal | ESD-865986-25G |
| Cas.: 147291-66-5 | Purity: ≥98% | α-(Boc-amino)-m-toluidine | ESD-866856-5G |
| Cas.: 34642-77-8 | Purity: 89% | Amoxicillin Sodium | ESD-863593-5G |
| Cas.: 34642-77-8 | Purity: 89% | Amoxicillin Sodium | ESD-863593-25G |
| Cas.: 34642-77-8 | Purity: 89% | Amoxicillin Sodium | ESD-863593-100G |
| Cas.: 78238-14-9 | Purity: ≥97% | 3-HYDROXY-5-NITROBENZOIC ACID | ESD-890268-1G |
| Cas.: 78238-14-9 | Purity: ≥97% | 3-HYDROXY-5-NITROBENZOIC ACID | ESD-890268-5G |
| Cas.: 923595-49-7 | Purity: ≥96% | 6-Chloro-3-iodoimidazo[1,2-b]pyridazine | ESD-890270-5G |
| Cas.: 923595-49-7 | Purity: ≥96% | 6-Chloro-3-iodoimidazo[1,2-b]pyridazine | ESD-890270-1G |
| Cas.: 923595-49-7 | Purity: ≥96% | 6-Chloro-3-iodoimidazo[1,2-b]pyridazine | ESD-890270-250MG |
| Cas.: 35212-22-7 | Purity: 97% | ipriflavone | ESD-838103-25G |
| Cas.: 62667-64-5 | Purity: 99% | Europium(III) acetate hydrate | ESD-861689-100G |
| Cas.: 33659-28-8 | Purity: 98% | Calcium bromolactobionate | ESD-890271-5G |
| Cas.: 4026-27-1 | Purity: 97% | 1,2,3,4-DI-O-ISOPROPYLIDENE-ALPHA-D-FUCOPYRANOSE | ESD-890272-1G |
| Cas.: 3969-59-3 | Purity: ≥95% | (4R,4’R,4”R,5’R)-2,2,2′,2′,2”,2”-Hexamethyl-4,4′:5′,4”-ter (1,3-dioxolane) | ESD-890273-1G |
| Cas.: 13039-75-3 | Purity: ≥95% | 5-Deoxy-D-ribose | ESD-890274-250MG |
| Cas.: 4451-35-8 | Purity: 98% | 2,3,4,6-Tetra-O-acetyl-α-D-glucopyranosyl chloride | ESD-890275-250MG |
| Cas.: 38440-79-8 | Purity: 98% | 2-Deoxy-2-fluoro-D-mannose | ESD-890276-50MG |
| Cas.: 7783-20-2 | Purity: AR, 99% | Ammonium sulfate | ESD-801013-2.5KG |
| Cas.: 7783-20-2 | Purity: AR, 99% | Ammonium sulfate | ESD-801013-10KG |
| Cas.: 7632-00-0 | Purity: 99% metals basis | Sodium nitrite | ESD-818034-10KG |
| Cas.: 631-61-8 | Purity: 98% | Ammonium acetate | ESD-800997-10KG |
| Cas.: 3878-55-5 | Purity: 98% | mono-Methyl hydrogen succinate | ESD-812983-500G |
| Cas.: 91079-42-4 | Purity: BR | Peptone,fish powder | ESD-822644-100G |
| Cas.: 91079-42-4 | Purity: BR | Peptone,fish powder | ESD-822644-500G |
| Cas.: 81403-68-1 | Purity: 98% | Alfuzosin Hydrochloride | ESD-849369-1G |
| Cas.: 81403-68-1 | Purity: 98% | Alfuzosin Hydrochloride | ESD-849369-5G |
| Cas.: 380917-97-5 | Purity: 98% | Perampanel | ESD-824497-5G |
| Cas.: 17397-13-6 | Purity: ≥95% | 2-Cyclopropylpropan-2-Amine Hydrochloride | ESD-890277-250MG |
| Cas.: 17397-13-6 | Purity: ≥95% | 2-Cyclopropylpropan-2-Amine Hydrochloride | ESD-890277-50MG |
| Cas.: 154229-18-2 | Purity: 98% | Abiraterone acetate | ESD-823787-5G |
| Cas.: 16470-24-9 | Purity: Fluorescence intensity 100% | Fluorescent Brightener 220 | ESD-824165-500G |
| Cas.: 32222-06-3 | Purity: 97% | Calcitriol | ESD-805879-5MG |
| Cas.: 32222-06-3 | Purity: 97% | Calcitriol | ESD-805879-25MG |
| Cas.: 12001-26-2 | Purity: 40 Mesh | Synthetic mica | ESD-875301-2.5KG |
| Cas.: 125299-79-8 | Purity: 97% | meso-tetra(3,5-dibromo-4-hydroxyphenyl)porphyrin | ESD-857262-250MG |
| Cas.: 125299-79-8 | Purity: 97% | meso-tetra(3,5-dibromo-4-hydroxyphenyl)porphyrin | ESD-857262-1G |
| Cas.: 40515-89-7 | Purity: 98% | Phenethoxybenzene | ESD-841467-25G |
| Cas.: 40515-89-7 | Purity: 98% | Phenethoxybenzene | ESD-841467-100G |
| Cas.: 1309-36-0 | Purity: About 1.5-4.8mm | Pyrite, naturally occurring minerals, grains, | ESD-849291-25G |
| Cas.: 673-40-5 | Purity: 97% | 4-Bromobenzenediazonium tetrafluoroborate | ESD-838717-25G |
| Cas.: 673-40-5 | Purity: 97% | 4-Bromobenzenediazonium tetrafluoroborate | ESD-838717-100G |
| Cas.: 7789-78-8 | Purity: AR, 97.0% | Calcium hydride | ESD-804980-1KG |
| Cas.: 34598-33-9 | Purity: ≥97%(GC)(T) | 2H,2H,3H,3H-Heptadecafluoroundecanoic Acid | ESD-863131-1G |
| Cas.: 131088-02-3 | Purity: ≥95% | 5-chloro-2,4-dihydroxybenzaldehyde | ESD-890220-1G |
| Cas.: 131088-02-3 | Purity: ≥95% | 5-chloro-2,4-dihydroxybenzaldehyde | ESD-890220-5G |
| Cas.: 37942-07-7 | Purity: 98% | 3,5-Di-|tert|-butyl-2-hydroxybenzaldehyde | ESD-806988-500G |
| Cas.: 93249-44-6 | Purity: 97% | 2-Fluoro-5-methylbenzaldehyde | ESD-810082-25G |
| Cas.: 96426-21-0 | Purity: ≥98% | Gly-Arg-Gly-Asp-Ser | ESD-876111-25MG |
| Cas.: 161796-78-7 | Purity: 98% | Esomeprazole sodium | ESD-843894-25G |
| Cas.: 104810-48-2 | Purity: 98% | [3-[3-(2H-Benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]-1-oxopropyl]-hydroxypoly(oxo-1,2-ethanediyl) | ESD-872066-500G |
| Cas.: 303-97-9 | Purity: 95% | COENZYME Q9 | ESD-855538-25MG |
| Cas.: 8007-47-4 | Purity: BR | Canada balsam | ESD-836780-25G |
| Cas.: 8007-47-4 | Purity: BR | Canada balsam | ESD-836780-5G |
| Cas.: 14017-55-1 | Purity: 99.9% trace metals basis | Erbium perchlorate | ESD-890278-5G |
| Cas.: 14017-55-1 | Purity: 99.9% trace metals basis | Erbium perchlorate | ESD-890278-1G |
| Cas.: 2516-40-7 | Purity: ≥95% | 2-bromobenzo[d]thiazole | ESD-825381-25G |
| Cas.: 146137-80-6 | Purity: 97% | 2-Fluoro-4-methylbenzaldehyde | ESD-810081-25G |
| Cas.: 12124-97-9 | Purity: 99.9% metals basis | Ammonium bromide | ESD-871781-10KG |
| Cas.: 6246-06-6 | Purity: 98% | Oxetan-3-ylmethanol | ESD-839207-5G |
| Cas.: NONE7141 | Endotoxin Erasol(for DNA solution) | ESD-890279-20ML | |
| Cas.: 132866-11-6 | Purity: ≥98% (HPLC) | Lercanidipine hydrochloride hemihydrate | ESD-812677-250MG |
| Cas.: 288246-16-2 | Purity: 97% | 4-BROMO-1H-PYRAZOLE-3-CARBONITRILE | ESD-829713-250MG |
| Cas.: 5736-85-6 | Purity: 97% | 4-Propoxybenzaldehyde | ESD-834905-100G |
| Cas.: 6148-75-0 | Purity: ≥99% | Mesitylenesulfonic Acid Sodium Salt Hemihydrate | ESD-860106-25G |
| Cas.: 6148-75-0 | Purity: ≥99% | Mesitylenesulfonic Acid Sodium Salt Hemihydrate | ESD-860106-100G |
| Cas.: 704-41-6 | Purity: 97% | 2-(Trifluoromethyl)phenylacetylene | ESD-838606-5G |
| Cas.: 104-15-4 | Purity: 1.0 mol/L in H2O | p-Toluenesulfonic acid | ESD-890280-100ML |
| Cas.: 104-15-4 | Purity: 1.0 mol/L in H2O | p-Toluenesulfonic acid | ESD-890280-500ML |
| Cas.: 1291-47-0 | Purity: 93% | 1,1′-Dimethylferrocene | ESD-868850-25G |
| Cas.: 104-15-4 | Purity: 65% in H2O | p-Toluenesulfonic acid | ESD-890281-100ML |
| Cas.: 104-15-4 | Purity: 65% in H2O | p-Toluenesulfonic acid | ESD-890281-250ML |
| Cas.: 17955-67-8 | Purity: ≥90%(GC) | 1,1,3,3,5,5-Hexaethoxy-1,3,5-trisilacyclohexane | ESD-862501-5G |
| Cas.: 13093-04-4 | Purity: 98% | N1,N6-Dimethylhexane-1,6-diamine | ESD-839254-5G |
| Cas.: 517918-95-5 | Purity: 97% | 5-Cyano-7-azindole | ESD-806122-5G |
| Cas.: 4004-05-1 | Purity: Medicinal Reagent grade | 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine | ESD-890282-50MG |
| Cas.: 4635-08-9 | Purity: ≥95% | 5-bromopyridine-3,4-diamine | ESD-825879-5G |
| Cas.: 4635-08-9 | Purity: ≥95% | 5-bromopyridine-3,4-diamine | ESD-825879-1G |
| Cas.: 1645-65-4 | Purity: 97% | 4-(TRIFLUOROMETHYL)PHENYL ISOTHIOCYANATE | ESD-833334-100G |
| Cas.: 1069-79-0 | Purity: ≥99% | 1,2-distearoyl-sn-glycero-3-phosphoethanolamine | ESD-890283-50MG |
| Cas.: 148-87-8 | Purity: 98% | N-(2-Cyanoethyl)-N-ethylaniline | ESD-805447-2.5KG |
| Cas.: 14774-37-9 | Purity: 97% | Tetrahydropyran-4-methanol | ESD-831564-100G |
| Cas.: 1236288-25-7 | Purity: >99% | DSPE-PEG2000-Folate | ESD-833095-1MG |
| Cas.: 475207-59-1 | Purity: 99% | Sorafenib tosylate | ESD-823786-25G |
| Cas.: 127641-86-5 | Purity: Reagent grade | 1,2-DILAUROYL-SN-GLYCERO-3-PHOSPHOCHOLINE | ESD-890285-25MG |
| Cas.: 2208-05-1 | Purity: 96% | 2-(Dimethylamino)ethyl benzoate | ESD-838745-100G |
| Cas.: 448-60-2 | Purity: 97% | 1,3,5-tris(4-fluorophenyl)benzene | ESD-890286-1G |
| Cas.: 448-60-2 | Purity: 97% | 1,3,5-tris(4-fluorophenyl)benzene | ESD-890286-5G |
| Cas.: 50590-07-3 | Purity: 95% | 3-Iodo-4-nitrophenol | ESD-831685-250MG |
| Cas.: 50590-07-3 | Purity: 95% | 3-Iodo-4-nitrophenol | ESD-831685-1G |
| Cas.: 50590-07-3 | Purity: 95% | 3-Iodo-4-nitrophenol | ESD-831685-5G |
| Cas.: 2993-85-3 | Purity: 97%, contains stabilizerTBC | 2,2,3,3,4,4,5,5,6,6,7,7-Dodecafluoroheptyl Acrylate | ESD-871447-5G |
| Cas.: 2993-85-3 | Purity: 97%, contains stabilizerTBC | 2,2,3,3,4,4,5,5,6,6,7,7-Dodecafluoroheptyl Acrylate | ESD-871447-25G |
| Cas.: 7250-94-4 | Purity: ≥98% | 2-Acetoxyacetophenone | ESD-860208-25G |
| Cas.: 7250-94-4 | Purity: ≥98% | 2-Acetoxyacetophenone | ESD-860208-100G |
| Cas.: 107859-98-3 | Purity: 97% | Ethyl 3-(4-(hydroxymethyl)phenyl)propanoate | ESD-890287-1G |
| Cas.: 107859-98-3 | Purity: 97% | Ethyl 3-(4-(hydroxymethyl)phenyl)propanoate | ESD-890287-250MG |
| Cas.: 107859-98-3 | Purity: 97% | Ethyl 3-(4-(hydroxymethyl)phenyl)propanoate | ESD-890287-50MG |
| Cas.: 2152-56-9 | Purity: 97% | DL-Arabitol | ESD-869332-50MG |
| Cas.: 132172-61-3 | Purity: 99% | (2,3-Dioleyl-propyl)-trimethylamine | ESD-890288-25MG |
| Cas.: 502-61-4 | Purity: ≥98% | Farnesene, mixture of isomers | ESD-885947-250MG |
| Cas.: 2999-46-4 | Purity: 99% | Ethyl isocyanoacetate | ESD-822774-100G |
| Cas.: 22890-21-7 | Purity: 98% | 2-Heptylundecanoic Acid | ESD-888981-500G |
| Cas.: 109292-46-8 | Purity: ≥98% | Arg-Gly-Asp-Cys | ESD-884603-25MG |
| Cas.: 109292-46-8 | Purity: ≥98% | Arg-Gly-Asp-Cys | ESD-884603-100MG |
| Cas.: 139717-71-8 | Purity: 97% | 5-methoxy-1-(4-methylbenzenesulfonyl)-1H-indole | ESD-890289-1G |
| Cas.: 139717-71-8 | Purity: 97% | 5-methoxy-1-(4-methylbenzenesulfonyl)-1H-indole | ESD-890289-250MG |
| Cas.: 139717-71-8 | Purity: 97% | 5-methoxy-1-(4-methylbenzenesulfonyl)-1H-indole | ESD-890289-50MG |
| Cas.: 7758-16-9 | Purity: 99% | Disodium pytophosphate | ESD-834667-500G |
| Cas.: 7758-16-9 | Purity: 99% | Disodium pytophosphate | ESD-834667-2.5KG |
| Cas.: 6191-97-5 | Purity: ≥95% | 3,3-Diethoxy-Propionic Acid | ESD-858008-5G |
| Cas.: 10043-52-4 | Purity: 96% | Calcium chloride anhydrous | ESD-805226-25KG |
| Cas.: 1898-66-4 | Purity: ≥98.5%(HPLC) | 2,2-Diphenyl-1-picrylhydrazyl | ESD-861667-5G |
| Cas.: 5177-27-5 | Purity: 97% | 5-Amino-2,4-dichloropyrimidine | ESD-801711-25G |
| Cas.: 518-18-3 | Purity: ≥98%(HPLC)(N) | (±)-Evodiamine | ESD-862499-5G |
| Cas.: 10034-99-8 | Purity: 99.99% metals basis | Magnesium sulfate | ESD-813602-2.5KG |
| Cas.: 21637-25-2 | Purity: 97% | Quercetin 3-β-D-glucoside | ESD-890293-50MG |
| Cas.: 179898-34-1 | Purity: 98% | 3-Bromo-5-fluorobenzonitrile | ESD-804035-10G |
| Cas.: 65992-66-7 | Purity: Epoxy equivalent 98-110Gm/Eq | 1,3-Bis (N,N-diglycidyl aminomethyl)-cyclohexane | ESD-890294-100G |
| Cas.: 65992-66-7 | Purity: Epoxy equivalent 98-110Gm/Eq | 1,3-Bis (N,N-diglycidyl aminomethyl)-cyclohexane | ESD-890294-500G |
| Cas.: 20249-12-1 | Purity: 98% | 1,4-Cyclohexanedimethanol bis(3,4-epoxycyclohexanecarboxylate) | ESD-856278-1KG |
| Cas.: 877-24-7 | Purity: NMR quantitative standard, 99.998% | Potassium hydrogen phthalate | ESD-816395-100G |
| Cas.: 41088-52-2 | Purity: ≥95% | 3,4-Epoxycyclohexanecarboxylic acid, methyl ester | ESD-890296-5G |
| Cas.: 922-68-9 | Purity: ≥95% | Methyl Glyoxylate | ESD-885979-5G |
| Cas.: 101-42-8 | Purity: 97% | Fenuron | ESD-890297-5G |
| Cas.: 101-42-8 | Purity: 97% | Fenuron | ESD-890297-1G |
| Cas.: 632-85-9 | Purity: Analysis control, ≥99% | Wogonin | ESD-820522-50MG |
| Cas.: 7778-77-0 | Purity: 99,5% | Potassium phosphate monobasic | ESD-815663-10KG |
| Cas.: 68-19-9 | Purity: Use For Cell Culture and Insect Cell Culture | Vitamin B12 | ESD-820401-5G |
| Cas.: 37067-30-4 | Purity: 99% | 4-Methylumbelliferyl-2-acetamido-2-deoxy-β-D-glucopyranoside | ESD-813353-50MG |
| Cas.: 103222-11-3 | Purity: BR | Vapreotide,RC160,BMY 41606 | ESD-860483-25MG |
| Cas.: 117-81-7 | Purity: AR | Dioctyl phthalate | ESD-807325-100ML |
| Cas.: 51639-48-6 | Purity: 94% | 1-(4-Piperazin-1-ylphenyl)ethanone | ESD-838783-1G |
| Cas.: NONE7003 | Purity: 0.5M, pH8.0 | Phosphate Buffer (PB Buffer) | ESD-885770-500ML |
| Cas.: 1527-96-4 | Purity: ≥98.0%(HPLC) | Crotonaldehyde 2,4-Dinitrophenylhydrazone | ESD-864067-100MG |
| Cas.: 7772-98-7 | Purity: Analytical Volumetric Solution, 0.01M | Sodium thiosulfate analysis titrant | ESD-890300-1L |
| Cas.: 7772-98-7 | Purity: Analytical Volumetric Solution, 0.05M | Sodium thiosulfate analysis titrant | ESD-890301-1L |
| Cas.: 7772-98-7 | Purity: Analytical Volumetric Solution, 1.0M | Sodium thiosulfate analysis titrant | ESD-890302-1L |
| Cas.: 18934-00-4 | Purity: ≥95% | 3-Ethyl-3[[(3-ethyloxetane-3-yl)methoxy]methyl]oxetane | ESD-890303-5G |
| Cas.: 18934-00-4 | Purity: ≥95% | 3-Ethyl-3[[(3-ethyloxetane-3-yl)methoxy]methyl]oxetane | ESD-890303-25G |
| Cas.: 373-49-9 | Purity: 98,5% | Palmitoleic acid | ESD-816248-1G |
| Cas.: 1185-53-1 | Purity: 1M, pH8.5 | DNA-Grade Tris-HCl Solution | ESD-885214-1L |
| Cas.: 623-53-0 | Purity: 99,9% | Ethyl Methyl Carbonate | ESD-890304-25ML |
| Cas.: 623-53-0 | Purity: 99,9% | Ethyl Methyl Carbonate | ESD-890304-100ML |
| Cas.: 623-53-0 | Purity: 99,9% | Ethyl Methyl Carbonate | ESD-890304-500ML |
| Cas.: 575-03-1 | Purity: 98% | 7-Hydroxy-4-(trifluoromethyl)coumarin | ESD-841236-5G |
| Cas.: 67914-69-6 | Purity: 97% | Elubiol | ESD-873697-5G |
| Cas.: 67914-69-6 | Purity: 97% | Elubiol | ESD-873697-25G |
| Cas.: 67914-69-6 | Purity: 97% | Elubiol | ESD-873697-100G |
| Cas.: 7758-01-2 | Purity: 0.1mol/L, Medium: H2O | Potassium bromate standard solution | ESD-871924-1L |
| Cas.: 128446-33-3 | Purity: average Mw ~1, 180 | (2-Hydroxypropyl)-α-cyclodextrin | ESD-822769-100G |
| Cas.: 84-76-4 | Purity: 97% | Dinonyl Phthalate (mixture of isomers) | ESD-807249-2.5L |
| Cas.: 84-76-4 | Purity: 97% | Dinonyl Phthalate (mixture of isomers) | ESD-807249-10L |
| Cas.: 2177-47-1 | Purity: 98% | 2-Methyl-1H-indene | ESD-839216-5G |
| Cas.: 1070-89-9 | Purity: 2.0 M solution in THF, MKSeal | Sodium bis(trimethylsilyl)amide | ESD-817723-1L |
| Cas.: 9002-98-6 | MW 3000, 25%water solution | Ethylene imine polymer | ESD-890305-2.5KG |
| Cas.: 9002-98-6 | MW 3000, 25%water solution | Ethylene imine polymer | ESD-890305-500G |
| Cas.: 9002-98-6 | MW 3000, 25%water solution | Ethylene imine polymer | ESD-890305-100G |
| Cas.: 9002-98-6 | MW 25, 000, 50%water solution | Ethylene imine polymer | ESD-890306-2.5KG |
| Cas.: 9002-98-6 | MW 25, 000, 50%water solution | Ethylene imine polymer | ESD-890306-500G |
| Cas.: 9002-98-6 | MW 25, 000, 50%water solution | Ethylene imine polymer | ESD-890306-100G |
| Cas.: 13185-00-7 | Purity: ≥98% | (±)-6,6′-Dibromo-1,1′-bi-2-naphthol | ESD-866434-5G |
| Cas.: 106092-09-5 | Purity: 98% | (|S|)-(-)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole | ESD-808526-25G |
| Cas.: 106092-09-5 | Purity: 98% | (|S|)-(-)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole | ESD-808526-100G |
| Cas.: 25293-64-5 | Purity: Epoxy equivalent 117-120Gm/Eq | 4,5-epoxytetrahydrophthalic acid diglycidylester | ESD-890307-100G |
| Cas.: 25293-64-5 | Purity: Epoxy equivalent 117-120Gm/Eq | 4,5-epoxytetrahydrophthalic acid diglycidylester | ESD-890307-500G |
| Cas.: 118427-29-5 | Purity: 98% | 4-Isopropylphenylhydrazine hydrochloride | ESD-812305-100G |
| Cas.: 56512-49-3 | Purity: 98% | 4-Dimethylaminoazobenzene-4′-sulfonyl chloride | ESD-823221-50MG |
| Cas.: 175865-59-5 | Purity: ≥99% | Valganciclovir HCl | ESD-833191-1G |
| Cas.: 159269-48-4 | Purity: 95% | Selectfluor? II reagent | ESD-830328-25G |
| Cas.: 175865-59-5 | Purity: ≥99% | Valganciclovir HCl | ESD-833191-5G |
| Cas.: 175865-59-5 | Purity: ≥99% | Valganciclovir HCl | ESD-833191-25G |
| Cas.: 175865-60-8 | Purity: 98% | Valganciclovir | ESD-873990-1G |
| Cas.: 175865-60-8 | Purity: 98% | Valganciclovir | ESD-873990-250MG |
| Cas.: 71604-74-5 | Purity: Viscosity: 4000~8000 cPs; 105~115 Gm/Eq | 3-Glycidyloxy-N,N-diglycidylaniline | ESD-890310-100G |
| Cas.: 2682-20-4 | Purity: 30% solution in H2O | 2-Methyl-4-isothiazolin-3-one | ESD-890311-1G |
| Cas.: 2682-20-4 | Purity: 30% solution in H2O | 2-Methyl-4-isothiazolin-3-one | ESD-890311-5G |
| Cas.: 2682-20-4 | Purity: 30% solution in H2O | 2-Methyl-4-isothiazolin-3-one | ESD-890311-25G |
| Cas.: 3603-43-8 | Purity: ≥98% | 1-[2-(2-Hydroxyethoxy)Ethyl]Piperidine | ESD-857434-100G |
| Cas.: 4857-44-7 | Purity: 97% | Calcium 2-hydroxy-4-(methylthio)butanoate | ESD-841379-5G |
| Cas.: 4857-44-7 | Purity: 97% | Calcium 2-hydroxy-4-(methylthio)butanoate | ESD-841379-25G |
| Cas.: 4857-44-7 | Purity: 97% | Calcium 2-hydroxy-4-(methylthio)butanoate | ESD-841379-100G |
| Cas.: 66423-62-9 | Purity: 98% | 2,5,5-trimethyl-1,3,2-dioxaborinane | ESD-886356-25G |
| Cas.: 919789-77-8 | Purity: 95% | 4-[1-(4-hydroxyphenyl)-2,2-diphenylehenyl]phenol | ESD-855432-250MG |
| Cas.: 919789-77-8 | Purity: 95% | 4-[1-(4-hydroxyphenyl)-2,2-diphenylehenyl]phenol | ESD-855432-50MG |
| Cas.: 110656-67-2 | Purity: Viscosity: 3000~6000 cPs; 115~135 Gm/Eq | N-[2-Methyl-4-(oxiranylmethoxy)phenyl]-N-(oxiranylmethyl)oxiranemthanamine | ESD-890313-100G |
| Cas.: 161182-73-6 | Purity: 93% solid contains amount, 5%-7% of Toluene | 9,9-Bis[4-(2-acryloyloxyethyloxy)phenyl]fluorene | ESD-890314-5G |
| Cas.: 118399-28-3 | Purity: 98% | Benzyl (R)-5-oxotetrahydrofuran-3-ylcarbamate | ESD-834442-25G |
| Cas.: 12131-44-1 | Purity: 98% | Palladium(II)(π-cinnamyl) Chloride Dimer | ESD-823804-1G |
| Cas.: 186593-42-0 | Purity: 98% | 3-Bromo-2-methyl-5-nitropyridine | ESD-840247-25G |
| Cas.: 1490-25-1 | Purity: 98% | Methyl succinyl chloride | ESD-831978-25G |
| Cas.: 54-05-7 | Purity: 97% | Chloroquine | ESD-843546-5G |
| Cas.: 15366-32-2 | Purity: 95% | Ethyl 2-(1-methylguanidino)acetate hydrochloride | ESD-847550-5G |
| Cas.: 186593-43-1 | Purity: ≥98% | 5-Amino-3-Bromo-2-Methylpyridine | ESD-854776-5G |
| Cas.: 57575-96-9 | Purity: 98% | 1H-Imidazole-2-amine | ESD-890315-1G |
| Cas.: 82428-30-6 | Purity: ≥95% | 3,4-Epoxycyclohexylmethyl methacrylate | ESD-890317-250G |
| Cas.: 82428-30-6 | Purity: ≥95% | 3,4-Epoxycyclohexylmethyl methacrylate | ESD-890317-50G |
| Cas.: 3294-03-9 | Purity: ≥95% | 2,2′-Thiobis(4-tert-octylphenol) | ESD-865795-500G |
| Cas.: 393-79-3 | Purity: 98% | 2,4-Dichloro-3-fluoronitrobenzene | ESD-840432-5G |
| Cas.: 611-33-6 | Purity: 99% | 8-Chloroquinoline | ESD-832491-100G |
| Cas.: 3130-19-6 | Purity: 95% | Bis[(3,4-epoxycyclohexyl)methyl]adipate | ESD-836426-25G |
| Cas.: 3130-19-6 | Purity: 95% | Bis[(3,4-epoxycyclohexyl)methyl]adipate | ESD-836426-100G |
| Cas.: 74420-15-8 | Purity: 97% | 3-Bromo-7-azaindole | ESD-803857-25G |
| Cas.: 33240-96-9 | Purity: ≥98% | 3-Nitroaniline Hydrochloride | ESD-865913-5G |
| Cas.: 138647-49-1 | Purity: 97% | tert-Butyl 4-(((trifluoromethyl)sulfonyl)oxy)-5,6-dihydropyridine-1(2H)-carboxylate | ESD-844462-25G |
| Cas.: 99740-00-8 | Purity: 99% | 3-(N-Tosyl-L-alaninyloxy)-5-phenylpyrrole | ESD-890318-1G |
| Cas.: 99740-00-8 | Purity: 99% | 3-(N-Tosyl-L-alaninyloxy)-5-phenylpyrrole | ESD-890318-250MG |
| Cas.: 1146963-51-0 | Purity: >98% | J-147 | ESD-860938-50MG |
| Cas.: 1146963-51-0 | Purity: >98% | J-147 | ESD-860938-5MG |
| Cas.: 613-33-2 | Purity: 97% | 4,4′-Dimethylbiphenyl | ESD-807535-500G |
| Cas.: 97-64-3 | Purity: Standard for GC, ≥99.0%(GC) | Ethyl lactate | ESD-808942-100ML |
| Cas.: 97-64-3 | Purity: Standard for GC, ≥99.0%(GC) | Ethyl lactate | ESD-808942-500ML |
| Cas.: 75062-54-3 | Purity: 99% | N-Tosyl-L-alanyloxyindole | ESD-890319-1G |
| Cas.: 75062-54-3 | Purity: 99% | N-Tosyl-L-alanyloxyindole | ESD-890319-250MG |
| Cas.: 75062-54-3 | Purity: 99% | N-Tosyl-L-alanyloxyindole | ESD-890319-50MG |
| Cas.: 69408-81-7 | Purity: ≥98% | Amonafide | ESD-863522-50MG |
| Cas.: 69408-81-7 | Purity: ≥98% | Amonafide | ESD-863522-250MG |
| Cas.: 98276-57-4 | Purity: 98% | 2,4-Diaminobenzaldehyde | ESD-846432-1G |
| Cas.: 98276-57-4 | Purity: 98% | 2,4-Diaminobenzaldehyde | ESD-846432-5G |
| Cas.: 4430-25-5 | Purity: 97% | Tetrabromophenol blue | ESD-890320-1G |
| Cas.: 4430-25-5 | Purity: 97% | Tetrabromophenol blue | ESD-890320-5G |
| Cas.: 381-88-4 | Purity: 96% | 1,1,1-Trifluoro-2-butanone | ESD-818723-25G |
| Cas.: 116632-23-6 | Purity: 97% | 3-Bromo-5-nitrophenol | ESD-841212-5G |
| Cas.: 55934-01-5 | Purity: 95% | 2,4,5-Trichloropyridine | ESD-852515-5G |
| Cas.: 595-33-5 | Purity: 98% | Megestrol acetate | ESD-830043-25G |
| Cas.: 13669-42-6 | Purity: 98% | 3-Quinolinecarboxaldehyde | ESD-817188-25G |
| Cas.: 611-05-2 | Purity: 98% | 3-Methyl-4-nitroaniline | ESD-841718-5G |
| Cas.: 611-05-2 | Purity: 98% | 3-Methyl-4-nitroaniline | ESD-841718-25G |
| Cas.: 12068-90-5 | Purity: 99.99% metals basis | Mercury(II) telluride | ESD-860764-5G |
| Cas.: 108321-10-4 | Purity: Dye content 85% | Tetrabromophenol Blue sodium salt | ESD-890323-1G |
| Cas.: 12068-90-5 | Purity: 99.99% metals basis | Mercury(II) telluride | ESD-860764-25G |
| Cas.: 108321-10-4 | Purity: Dye content 85% | Tetrabromophenol Blue sodium salt | ESD-890323-5G |
| Cas.: 108321-10-4 | Purity: 98% | Tetrabromophenol Blue sodium salt | ESD-890322-5G |
| Cas.: 108321-10-4 | Purity: 98% | Tetrabromophenol Blue sodium salt | ESD-890322-1G |
| Cas.: 35704-19-9 | Purity: 97% | N-(4-Cyanophenyl)acetamide | ESD-842875-25G |
| Cas.: 118591-58-5 | Purity: 95% | 2-(2-Hydroxyethoxy)ethyl 4-methylbenzenesulfonate | ESD-888560-1G |
| Cas.: 21872-70-8 | Purity: 98% | 2,4-Dichlorobenzenediazonium tetrafluoroborate | ESD-890324-1G |
| Cas.: 21872-70-8 | Purity: 98% | 2,4-Dichlorobenzenediazonium tetrafluoroborate | ESD-890324-5G |
| Cas.: 346656-34-6 | Purity: 95% | ethyl 2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)benzoate | ESD-890325-250MG |
| Cas.: 346656-34-6 | Purity: 95% | ethyl 2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)benzoate | ESD-890325-1G |
| Cas.: 346656-34-6 | Purity: 95% | ethyl 2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)benzoate | ESD-890325-5G |
| Cas.: 54-25-1 | Purity: 99% | 6-Azauridine | ESD-871286-100MG |
| Cas.: 54-25-1 | Purity: 99% | 6-Azauridine | ESD-871286-500MG |
| Cas.: 85-61-0 | Purity: 85% | Coenzyme A hydrate | ESD-824133-250MG |
| Cas.: 85-61-0 | Purity: 85% | Coenzyme A hydrate | ESD-824133-1G |
| Cas.: 93-69-6 | Purity: 97% | 1-(o-Tolyl)biguanide | ESD-858137-100G |
| Cas.: 93-69-6 | Purity: 97% | 1-(o-Tolyl)biguanide | ESD-858137-500G |
| Cas.: 27407-11-0 | Purity: 98% | 3-Bromo-4-fluorophenol | ESD-828863-100G |
| Cas.: 1001-62-3 | Purity: ≥98% | Dimethanesulfonyl peroroxyde | ESD-890326-250MG |
| Cas.: 1001-62-3 | Purity: ≥98% | Dimethanesulfonyl peroroxyde | ESD-890326-1G |
| Cas.: 1071-23-4 | Purity: >98% | O-Phosphorylethanolamine | ESD-889435-100G |
| Cas.: 15793-77-8 | Purity: ≥98%(HPLC)(T) | 2-Hydrazinoquinoline | ESD-863033-1G |
| Cas.: 15793-77-8 | Purity: ≥98%(HPLC)(T) | 2-Hydrazinoquinoline | ESD-863033-5G |
| Cas.: 132866-11-6 | Purity: ≥98% (HPLC) | Lercanidipine hydrochloride hemihydrate | ESD-812677-1G |
| Cas.: 132866-11-6 | Purity: ≥98% (HPLC) | Lercanidipine hydrochloride hemihydrate | ESD-812677-5G |
| Cas.: 84-19-5 | Purity: 95% | 3,4-Bis(4-acetoxyphenyl)-2,4-hexadiene | ESD-869109-250MG |
| Cas.: 106263-53-0 | Purity: 98% | Ethyl (4-trifluoromethylbenzoyl)acetate | ESD-809363-1G |
| Cas.: 67801-08-5 | Purity: 95% | 2-Methoxy-4-morpholinobenzenediazonium chloride zinc chloride double salt | ESD-890327-25G |
| Cas.: 67801-08-5 | Purity: 95% | 2-Methoxy-4-morpholinobenzenediazonium chloride zinc chloride double salt | ESD-890327-5G |
| Cas.: 53723-88-9 | Purity: >97%(HPLC) | (5-Mercapto-1,3,4-thiadiazol-2-ylthio)acetic Acid | ESD-834941-25G |
| Cas.: 2579-22-8 | Purity: 95% | 3-Phenylpropiolaldehyde | ESD-829431-25G |
| Cas.: 253605-31-1 | Purity: 95% | N-(tert-Butyl)hydroxylamine acetate | ESD-844523-5G |
| Cas.: 2422-91-5 | Purity: 20% in C6H5Cl | METHYLIDYNETRI-P-PHENYLENE TRIISOCYANATE | ESD-890169-500G |
| Cas.: 153719-23-4 | Purity: 95% | Thiamethoxam | ESD-828154-100G |
| Cas.: 63449-39-8 | Purity: CP-70 | Chlorinated paraffin | ESD-875537-2.5KG |
| Cas.: 2602-46-2 | Purity: Reagent grade | Direct Blue 6 | ESD-808266-1G |
| Cas.: 2602-46-2 | Purity: Reagent grade | Direct Blue 6 | ESD-808266-5G |
| Cas.: 2602-46-2 | Purity: Reagent grade | Direct Blue 6 | ESD-808266-25G |
| Cas.: 2602-46-2 | Purity: Reagent grade | Direct Blue 6 | ESD-808266-100G |
| Cas.: 1747-92-8 | Purity: ≥98% | Tribenzylsilane | ESD-865413-25G |
| Cas.: 10138-62-2 | Purity: 99,9% | Holmium(III) chloride | ESD-875721-100G |
| Cas.: 32233-40-2 | Purity: 98% | (-)-Corey lactone diol | ESD-843076-5G |
| Cas.: NONE6755 | Purity: pH8.0 | RNase-Free TE Buffer | ESD-885250-500ML |
| Cas.: 65864-64-4 | Purity: 97% | (Difluoromethyl)trimethylsilane | ESD-857067-25G |
| Cas.: 828934-41-4 | Purity: 99% | Etomoxir (Na salt) | ESD-872870-25MG |
| Cas.: 19829-74-4 | Purity: 98% | 4,6-Dihydroxyisophthalic acid | ESD-887256-5G |
| Cas.: 564-25-0 | Purity: ≥98%(HPLC) | Doxycycline | ESD-861182-100MG |
| Cas.: 564-25-0 | Purity: ≥98%(HPLC) | Doxycycline | ESD-861182-500MG |
| Cas.: 84-60-6 | Purity: 97% | Anthraflavic Acid | ESD-858156-5G |
| Cas.: 84-60-6 | Purity: 97% | Anthraflavic Acid | ESD-858156-25G |
| Cas.: 360-65-6 | Purity: 97% | Glycodeoxycholic acid monohydrate (GDCA) | ESD-810544-5G |
| Cas.: 40665-94-9 | Purity: 98% | Dimethyl 3-(3-chlorophenoxy)-2-oxopropylphosphonate | ESD-890329-1G |
| Cas.: 53848-17-2 | Purity: 95% | 2-Bromo-6-methylaniline | ESD-804072-25G |
| Cas.: 40665-94-9 | Purity: 98% | Dimethyl 3-(3-chlorophenoxy)-2-oxopropylphosphonate | ESD-890329-5G |
| Cas.: 40665-94-9 | Purity: 98% | Dimethyl 3-(3-chlorophenoxy)-2-oxopropylphosphonate | ESD-890329-25G |
| Cas.: 40665-68-7 | Purity: 98% | Dimethyl (2-Oxo-3-phenoxypropyl)phosphonate | ESD-870551-1G |
| Cas.: 271-29-4 | Purity: ≥95% | 1H-pyrrolo[2,3-c]pyridine | ESD-827622-5G |
| Cas.: 619-82-9 | Purity: 97% | |trans|-1,4-Cyclohexanedicarboxylic acid | ESD-805470-500G |
| Cas.: 619-82-9 | Purity: 97% | |trans|-1,4-Cyclohexanedicarboxylic acid | ESD-805470-5G |
| Cas.: 24680-50-0 | Purity: 98% | 4-METHOXYCINNAMALDEHYDE | ESD-831332-25G |
| Cas.: 24680-50-0 | Purity: 98% | 4-METHOXYCINNAMALDEHYDE | ESD-831332-100G |
| Cas.: 603122-41-4 | Purity: 98% | 3-Methoxy-4-(methoxycarbonyl)phenylboronic acid | ESD-833305-5G |
| Cas.: 97-35-8 | Purity: 98% | Fast Red ITR | ESD-810139-5G |
| Cas.: 9028-88-0 | Purity: BR, 2u/mg protein | Aldehyde Dehydrogenase | ESD-875364-100U |
| Cas.: 89331-94-2 | Purity: ≥98% | 2-Anilino-6-dibutylamino-3-methylfluoran | ESD-858099-25G |
| Cas.: 89331-94-2 | Purity: ≥98% | 2-Anilino-6-dibutylamino-3-methylfluoran | ESD-858099-1G |
| Cas.: 89331-94-2 | Purity: ≥98% | 2-Anilino-6-dibutylamino-3-methylfluoran | ESD-858099-100G |
| Cas.: 73568-25-9 | Purity: 98% | 2-Chloro-3-quinolinecarboxaldehyde | ESD-828544-100G |
| Cas.: 65104-06-5 | Purity: 50 wt. % in water | Dihydroxybis(ammonium lactato)titanium(IV) solution | ESD-836671-100G |
| Cas.: 65104-06-5 | Purity: 50 wt. % in water | Dihydroxybis(ammonium lactato)titanium(IV) solution | ESD-836671-25G |
| Cas.: 65104-06-5 | Purity: 50 wt. % in water | Dihydroxybis(ammonium lactato)titanium(IV) solution | ESD-836671-5G |
| Cas.: 521323-11-5 | Purity: 98% | Corey lactone Diol | ESD-890330-250MG |
| Cas.: 521323-11-5 | Purity: 98% | Corey lactone Diol | ESD-890330-1G |
| Cas.: 76704-05-7 | Purity: 98% | (+)-Corey lactone Diol | ESD-850011-250MG |
| Cas.: 76704-05-7 | Purity: 98% | (+)-Corey lactone Diol | ESD-850011-1G |
| Cas.: 91079-42-4 | Purity: BR | Peptone,fish powder | ESD-822644-2.5KG |
| Cas.: 658066-35-4 | Purity: ≥98% | Fluopyram | ESD-877957-250MG |
| Cas.: 2896-60-8 | Purity: 98% | 4-Ethylresorcinol | ESD-808609-1G |
| Cas.: 19883-77-3 | Purity: 98% | H-Phe(3-F)-OH | ESD-834499-25G |
| Cas.: 583-58-4 | Purity: ≥98%(GC) | 3,4-Lutidine | ESD-863200-25ML |
| Cas.: 328-42-7 | Purity: 98% | Oxalacetic acid | ESD-815183-250MG |
| Cas.: 16305-75-2 | Purity: 98% | L-Alanyl-L-tryptophan | ESD-870528-1G |
| Cas.: 160743-62-4 | Purity: ≥99% | 1,2-dimyristoyl-rac-glycero-3-methoxypolyethylene glycol-2000 | ESD-890331-250MG |
| Cas.: 2766-43-0 | Purity: 95% | Boc-Ser-OMe | ESD-803185-250G |
| Cas.: 52025-34-0 | Purity: 98% | 5-Amino-2-ethoxypyridine | ESD-890332-25G |
| Cas.: 52025-34-0 | Purity: 98% | 5-Amino-2-ethoxypyridine | ESD-890332-5G |
| Cas.: 52025-34-0 | Purity: 98% | 5-Amino-2-ethoxypyridine | ESD-890332-1G |
| Cas.: 102625-70-7 | Purity: 97% | Pantoprazole | ESD-871803-1G |
| Cas.: 102625-70-7 | Purity: 97% | Pantoprazole | ESD-871803-5G |
| Cas.: 107-88-0 | Purity: 99,5% | (±)-1,3-Butanediol | ESD-890333-500ML |
| Cas.: 57-85-2 | Purity: 98% | Testosterone propionate | ESD-818616-100G |
| Cas.: 107-88-0 | Purity: 99,5% | (±)-1,3-Butanediol | ESD-890333-2.5L |
| Cas.: 107-88-0 | Purity: 99,5% | (±)-1,3-Butanediol | ESD-890333-10L |
| Cas.: 3160-91-6 | Purity: >98.0% | Moroxydine hydrochloride | ESD-886315-100G |
| Cas.: 5985-28-4 | Purity: 99,5% | Synephrine hydrochloride | ESD-890334-250G |
| Cas.: 5985-28-4 | Purity: 99,5% | Synephrine hydrochloride | ESD-890334-50G |
| Cas.: 5985-28-4 | Purity: 99,5% | Synephrine hydrochloride | ESD-890334-10G |
| Cas.: 610-17-3 | Purity: 95% | N,N-Dimethyl-2-nitroaniline | ESD-845291-5G |
| Cas.: 610-17-3 | Purity: 95% | N,N-Dimethyl-2-nitroaniline | ESD-845291-25G |
| Cas.: 6775-78-6 | Purity: 95% | 6-Chloroimidazo[1,2-b]pyridazine | ESD-890335-5G |
| Cas.: 6775-78-6 | Purity: 95% | 6-Chloroimidazo[1,2-b]pyridazine | ESD-890335-25G |
| Cas.: 6775-78-6 | Purity: 95% | 6-Chloroimidazo[1,2-b]pyridazine | ESD-890335-100G |
| Cas.: 567-61-3 | Purity: 95% | 2-Hydroxy-6-Methylbenzoic acid | ESD-833882-1G |
| Cas.: 567-61-3 | Purity: 95% | 2-Hydroxy-6-Methylbenzoic acid | ESD-833882-5G |
| Cas.: 567-61-3 | Purity: 95% | 2-Hydroxy-6-Methylbenzoic acid | ESD-833882-25G |
| Cas.: 166023-21-8 | Purity: ≥98% | DC-CHO | ESD-890336-25MG |
| Cas.: 9000-90-2 | Purity: 4000U/g | mesotherm α-Amylase | ESD-890337-25G |
| Cas.: 9000-90-2 | Purity: 4000U/g | mesotherm α-Amylase | ESD-890337-100G |
| Cas.: 9000-90-2 | Purity: 4000U/g | mesotherm α-Amylase | ESD-890337-500G |
| Cas.: 9000-90-2 | Purity: 10000U/g | mesotherm α-Amylase | ESD-890338-25G |
| Cas.: 9000-90-2 | Purity: 10000U/g | mesotherm α-Amylase | ESD-890338-100G |
| Cas.: 9000-90-2 | Purity: 10000U/g | mesotherm α-Amylase | ESD-890338-500G |
| Cas.: 169051-60-9 | Purity: medicinal grade | 1,2-dipalmitoyl-sn-glycero-3-phosphate (sodium salt) | ESD-890339-250MG |
| Cas.: 169051-60-9 | Purity: ≥98% | 1,2-dipalmitoyl-sn-glycero-3-phosphate (sodium salt) | ESD-890340-1G |
| Cas.: 1094-61-7 | Purity: 99% | Beta-Nicotinamide Mononucleotide | ESD-886300-25G |
| Cas.: 169051-60-9 | Purity: ≥98% | 1,2-dipalmitoyl-sn-glycero-3-phosphate (sodium salt) | ESD-890340-250MG |
| Cas.: 139893-43-9 | Purity: ≥98% | Simvastatin Ammonium Salt | ESD-859243-1G |
| Cas.: 1384974-37-1 | Purity: ≥95% | N-[(1S,2S)-1,2-Diphenyl-2-(2-(4-methylbenzyloxy)ethylamino)-ethyl]-4-methylbenzene sulfonamide(chloro)ruthenium(II) (S,S)-Ts- DENEB | ESD-868225-1G |
| Cas.: 29703-01-3 | Purity: 99.99% trace metals basis | Cesium hydrogen carbonate | ESD-836404-100G |
| Cas.: 3081-61-6 | Purity: 99% | L-Theanine | ESD-819049-100G |
| Cas.: 18794-84-8 | Purity: 95% | trans-β-Farnesene | ESD-885944-5ML |
| Cas.: 91714-93-1 | Purity: 99% | AHR 10282R | ESD-873782-50MG |
| Cas.: 91714-93-1 | Purity: 99% | AHR 10282R | ESD-873782-250MG |
| Cas.: 52338-87-1 | Purity: 97% | 1,3-Bis(3-(dimethylamino)propyl)urea | ESD-842652-25G |
| Cas.: 52338-87-1 | Purity: 97% | 1,3-Bis(3-(dimethylamino)propyl)urea | ESD-842652-100G |
| Cas.: 52338-87-1 | Purity: 97% | 1,3-Bis(3-(dimethylamino)propyl)urea | ESD-842652-500G |
| Cas.: 80971-60-4 | Purity: 97% | n-Butyl β-D-fructofuranoside | ESD-877279-5MG |
| Cas.: 4651-67-6 | Purity: 98% | 3ALPHA-HYDROXY-7-OXO-5BETA-CHOLANIC ACID | ESD-832269-100G |
| Cas.: 3887-02-3 | Purity: ≥98%(T) | N-Methylmethacrylamide (stabilized with HQ) | ESD-862924-25ML |
| Cas.: 19420-57-6 | Purity: Medicinal injection grade | 1-Stearoyl-sn-glycero-3-phosphocholine | ESD-890341-25MG |
| Cas.: 19420-57-6 | Purity: Medicinal injection grade | 1-Stearoyl-sn-glycero-3-phosphocholine | ESD-890341-100MG |
| Cas.: 58458-11-0 | Purity: ≥97% | 2-Amino-6-(Trifluoromethyl)Benzonitrile | ESD-858695-5G |
| Cas.: 576-15-8 | Purity: 98% | 1-Acetylindole | ESD-864442-5G |
| Cas.: 200880-40-6 | Purity: >99% | 1,2-dimyristoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt) | ESD-863633-100MG |
| Cas.: 20005-42-9 | Purity: >97% | 5-(4-Bromophenyl)furan-2-carbaldehyde | ESD-837385-1G |
| Cas.: 20005-42-9 | Purity: >97% | 5-(4-Bromophenyl)furan-2-carbaldehyde | ESD-837385-25G |
| Cas.: 154-21-2 | Purity: 98% | Lincomycin | ESD-882021-25MG |
| Cas.: 4164-39-0 | Purity: 98% | 1,4-DIFORMYLPIPERAZINE | ESD-831336-25G |
| Cas.: 4164-39-0 | Purity: 98% | 1,4-DIFORMYLPIPERAZINE | ESD-831336-100G |
| Cas.: 4164-39-0 | Purity: 98% | 1,4-DIFORMYLPIPERAZINE | ESD-831336-1G |
| Cas.: 89291-23-6 | Purity: 97% | 2-(Dimethylamine)phenylboronic acid | ESD-845615-1G |
| Cas.: 1955-46-0 | Purity: 98% | Methyl 5-nitroisophthalate | ESD-831146-25G |
| Cas.: 16083-14-0 | Purity: 98% | nickel(2+) trifluoroacetate | ESD-886144-5G |
| Cas.: 1955-46-0 | Purity: 98% | Methyl 5-nitroisophthalate | ESD-831146-100G |
| Cas.: 635-90-5 | Purity: 98% | 1-Phenylpyrrole | ESD-838790-50G |
| Cas.: 5325-43-9 | Purity: Ion pair Chromatography grade, ≥99% | Sodium 1,2-ethanedisulfonate | ESD-818431-25G |
| Cas.: 5325-43-9 | Purity: Ion pair Chromatography grade, ≥99% | Sodium 1,2-ethanedisulfonate | ESD-818431-100G |
| Cas.: 662163-81-7 | Purity: 99% | Importazole | ESD-872607-25MG |
| Cas.: 4221-99-2 | Purity: 98% | (S)-(+)-2-Butanol | ESD-871042-5ML |
| Cas.: 95010-17-6 | Purity: 98% | 2,4,6-Trivinylboroxin – Pyridine Complex | ESD-834688-5G |
| Cas.: 62571-86-2 | Purity: 98% | Captopril | ESD-837214-100G |
| Cas.: 19883-74-0 | Purity: ≥98% | L-3-Nitrophenylalanine | ESD-857694-5G |
| Cas.: 4984-22-9 | Purity: ≥98.5 % sum of enantiomers | (R)-(-)-1-Methoxy-2-propanol | ESD-837979-5G |
| Cas.: 4984-22-9 | Purity: ≥98.5 % sum of enantiomers | (R)-(-)-1-Methoxy-2-propanol | ESD-837979-25G |
| Cas.: 81028-91-3 | Purity: 98% | D-Fructose 1,6-bisphosphate trisodium salt octahydrate (FDP) | ESD-809701-500G |
| Cas.: 69-78-3 | Purity: ≥99%, suitable for determination of sulfhydryl groups | 5,5′-Dithio bis-(2-nitrobenzoic acid) | ESD-890350-25G |
| Cas.: 69-78-3 | Purity: ≥99%, suitable for determination of sulfhydryl groups | 5,5′-Dithio bis-(2-nitrobenzoic acid) | ESD-890350-5G |
| Cas.: 69-78-3 | Purity: ≥99%, suitable for determination of sulfhydryl groups | 5,5′-Dithio bis-(2-nitrobenzoic acid) | ESD-890350-1G |
| Cas.: 72-48-0 | Purity: Analysis control, ≥98% | Alizarin | ESD-800876-20MG |
| Cas.: 72-48-0 | Purity: 97% | Alizarin | ESD-890351-25G |
| Cas.: 72-48-0 | Purity: 97% | Alizarin | ESD-890351-5G |
| Cas.: 75887-54-6 | Purity: ≥97% | Arteether | ESD-890352-25MG |
| Cas.: 75887-54-6 | Purity: ≥97% | Arteether | ESD-890352-100MG |
| Cas.: 5308-63-4 | Purity: ≥95% | 1-(5-methylpyridin-2-yl)ethanone | ESD-827098-1G |
| Cas.: 5308-63-4 | Purity: 97% | 1-(5-methylpyridin-2-yl)ethanone | ESD-890353-5G |
| Cas.: 5308-63-4 | Purity: 97% | 1-(5-methylpyridin-2-yl)ethanone | ESD-890353-1G |
| Cas.: 7400-08-0 | Purity: 99% | p-Coumaric acid | ESD-890354-500G |
| Cas.: 7400-08-0 | Purity: 99% | p-Coumaric acid | ESD-890354-100G |
| Cas.: 7400-08-0 | Purity: 99% | p-Coumaric acid | ESD-890354-25G |
| Cas.: 9011-18-1 | MW 10,000 | Dextran sulfate sodium salt | ESD-808270-100G |
| Cas.: 67874-71-9 | Purity: Usually 92%, soluble in 2-diethylhexanoic acid | Bismuth 2-ethylhexanoate | ESD-890253-100G |
| Cas.: 195044-14-5 | Purity: 97% | 2-Bromo-6-tert-butylpyridine | ESD-890355-1G |
| Cas.: 195044-14-5 | Purity: 97% | 2-Bromo-6-tert-butylpyridine | ESD-890355-250MG |
| Cas.: 195044-14-5 | Purity: 97% | 2-Bromo-6-tert-butylpyridine | ESD-890355-50MG |
| Cas.: 99595-85-4 | Purity: 95% | 3-methoxy-2-nitrobenzamide | ESD-890356-5G |
| Cas.: 99595-85-4 | Purity: 95% | 3-methoxy-2-nitrobenzamide | ESD-890356-1G |
| Cas.: 99595-85-4 | Purity: 95% | 3-methoxy-2-nitrobenzamide | ESD-890356-250MG |
| Cas.: 2150-48-3 | Purity: Dye content 50% | Pyronin B | ESD-816471-25G |
| Cas.: 10025-75-9 | Purity: 99,99% | Erbium chloride hexahydrate | ESD-875718-500G |
| Cas.: 7558-79-4 | Purity: 99%, granular | Sodium phosphate dibasic | ESD-890239-2.5KG |
| Cas.: NONE6993 | Purity: 4%/2.5% | Para-formaldehyde-Glytaraldehyde in PBS | ESD-890357-100ML |
| Cas.: NONE6993 | Purity: 4%/2.5% | Para-formaldehyde-Glytaraldehyde in PBS | ESD-890357-250ML |
| Cas.: NONE6993 | Purity: 4%/1% | Para-formaldehyde-Glytaraldehyde in PBS | ESD-890358-100ML |
| Cas.: NONE6993 | Purity: 4%/1% | Para-formaldehyde-Glytaraldehyde in PBS | ESD-890358-250ML |
| Cas.: NONE6993 | Purity: 4%/0.5% | Para-formaldehyde-Glytaraldehyde in PBS | ESD-890359-100ML |
| Cas.: NONE6993 | Purity: 4%/0.5% | Para-formaldehyde-Glytaraldehyde in PBS | ESD-890359-250ML |
| Cas.: 401916-61-8 | Mw=2000 | mPEG-SH | ESD-890361-200MG |
| Cas.: 401916-61-8 | Mw=2000 | mPEG-SH | ESD-890361-1G |
| Cas.: 401916-61-8 | Mw=2000 | mPEG-SH | ESD-890361-5G |
| Cas.: 401916-61-8 | Mw=1000 | mPEG-SH | ESD-890360-200MG |
| Cas.: 401916-61-8 | Mw=1000 | mPEG-SH | ESD-890360-1G |
| Cas.: 401916-61-8 | Mw=1000 | mPEG-SH | ESD-890360-5G |
| Cas.: 77182-82-2 | Purity: 97% | Glufosinate-ammonium | ESD-890362-1G |
| Cas.: 77182-82-2 | Purity: 97% | Glufosinate-ammonium | ESD-890362-5G |
| Cas.: 77182-82-2 | Purity: 97% | Glufosinate-ammonium | ESD-890362-25G |
| Cas.: 7773-01-5 | Purity: 1M | Manganese Chloride Solution | ESD-885231-1L |
| Cas.: 18437-78-0 | Purity: 98% | Tris(4-fluorophenyl)phosphine | ESD-819851-100G |
| Cas.: 5809-23-4 | Purity: 98% | 2-(4-Diethylamino-2-hydroxybenzoyl)benzoic acid | ESD-830765-500G |
| Cas.: 23076-35-9 | Purity: 98% | Xylazine hydrochloride | ESD-820592-100G |
| Cas.: 382-34-3 | Purity: ≥98%(GC) | 1,1,2,3,3,3-Hexafluoropropyl Methyl Ether | ESD-863133-25G |
| Cas.: 15060-55-6 | Purity: 99.95% trace metal basis | Ammonium tetrathiomolybdate | ESD-828262-25G |
| Cas.: 86831-54-1 | Purity: 97% | Rhodiosin | ESD-890363-25MG |
| Cas.: 86831-54-1 | Purity: 97% | Rhodiosin | ESD-890363-50MG |
| Cas.: 86831-54-1 | Purity: 97% | Rhodiosin | ESD-890363-100MG |
| Cas.: 20347-71-1 | Purity: ≥95% | 2-(3,4-Dihydroxyphenyl)-2-((2-(3,4-dihydroxyphenyl)-5,7-dihydroxychroman-3-yl)oxy)chroman-3,4,5,7-tetraol | ESD-890364-100MG |
| Cas.: 20347-71-1 | Purity: ≥95% | 2-(3,4-Dihydroxyphenyl)-2-((2-(3,4-dihydroxyphenyl)-5,7-dihydroxychroman-3-yl)oxy)chroman-3,4,5,7-tetraol | ESD-890364-250MG |
| Cas.: 20347-71-1 | Purity: ≥95% | 2-(3,4-Dihydroxyphenyl)-2-((2-(3,4-dihydroxyphenyl)-5,7-dihydroxychroman-3-yl)oxy)chroman-3,4,5,7-tetraol | ESD-890364-1G |
| Cas.: 660847-06-3 | Purity: 97% | (S)-6-Acetamido-2-(2-((S)-2-acetamido-4-methylpentanamido)acetamido)-N-(4-methyl-2-oxo-2H-chromen-7-yl)hexanamide | ESD-890365-5MG |
| Cas.: 68906-26-3 | Purity: 97% | (S)-2-Methyl-1-phenylpropan-1-amine | ESD-890366-100MG |
| Cas.: 68906-26-3 | Purity: 97% | (S)-2-Methyl-1-phenylpropan-1-amine | ESD-890366-250MG |
| Cas.: 68906-26-3 | Purity: 97% | (S)-2-Methyl-1-phenylpropan-1-amine | ESD-890366-1G |
| Cas.: 3350-30-9 | Purity: ≥95% | Cyclononanone | ESD-890367-100MG |
| Cas.: 3350-30-9 | Purity: ≥95% | Cyclononanone | ESD-890367-250MG |
| Cas.: 3350-30-9 | Purity: ≥95% | Cyclononanone | ESD-890367-1G |
| Cas.: 1026295-98-6 | Purity: 97% | (S)-2-(2-((S)-2-Acetamido-4-methylpentanamido)acetamido)-N-(4-methyl-2-oxo-2H-chromen-7-yl)-6-(2, 2,2-trifluoroacetamido)hexanamide | ESD-890368-50MG |
| Cas.: 959610-24-3 | Purity: 97% | N2-(1-Oxotetradecyl)-L-lysyl-L-alanyl-L-lysyl-L-alaninamide | ESD-890369-100MG |
| Cas.: 959610-24-3 | Purity: 97% | N2-(1-Oxotetradecyl)-L-lysyl-L-alanyl-L-lysyl-L-alaninamide | ESD-890369-250MG |
| Cas.: 6296-89-5 | Purity: 97% | Methyl 4-hydrazinylbenzoate hydrochloride | ESD-890370-250MG |
| Cas.: 6296-89-5 | Purity: 97% | Methyl 4-hydrazinylbenzoate hydrochloride | ESD-890370-1G |
| Cas.: 6296-89-5 | Purity: 97% | Methyl 4-hydrazinylbenzoate hydrochloride | ESD-890370-5G |
| Cas.: 6296-89-5 | Purity: 97% | Methyl 4-hydrazinylbenzoate hydrochloride | ESD-890370-10G |
| Cas.: 91987-74-5 | Purity: 98% | ((1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayl)tetrakis(methylene))tetraphosphonic acid | ESD-890371-100MG |
| Cas.: 91987-74-5 | Purity: 98% | ((1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayl)tetrakis(methylene))tetraphosphonic acid | ESD-890371-250MG |
| Cas.: 84878-61-5 | Purity: 98% | Maduramicin Ammonium Salt | ESD-890372-5MG |
| Cas.: 84878-61-5 | Purity: 98% | Maduramicin Ammonium Salt | ESD-890372-25MG |
| Cas.: 35095-07-9 | Purity: ≥95% | Methyl bicyclo[4.2.0]octa-1,3,5-triene-7-carboxylate | ESD-890373-100MG |
| Cas.: 35095-07-9 | Purity: ≥95% | Methyl bicyclo[4.2.0]octa-1,3,5-triene-7-carboxylate | ESD-890373-250MG |
| Cas.: 101219-68-5 | Purity: 97% | (R)-1-(4-Fluorophenyl)ethanol | ESD-890374-100MG |
| Cas.: 101219-68-5 | Purity: 97% | (R)-1-(4-Fluorophenyl)ethanol | ESD-890374-250MG |
| Cas.: 101219-68-5 | Purity: 97% | (R)-1-(4-Fluorophenyl)ethanol | ESD-890374-1G |
| Cas.: 101219-68-5 | Purity: 97% | (R)-1-(4-Fluorophenyl)ethanol | ESD-890374-5G |
| Cas.: 577-62-8 | Purity: ≥95% | Ethyl 2-(trifluoromethyl)benzoate | ESD-890375-250MG |
| Cas.: 577-62-8 | Purity: ≥95% | Ethyl 2-(trifluoromethyl)benzoate | ESD-890375-1G |
| Cas.: 577-62-8 | Purity: ≥95% | Ethyl 2-(trifluoromethyl)benzoate | ESD-890375-5G |
| Cas.: 577-62-8 | Purity: ≥95% | Ethyl 2-(trifluoromethyl)benzoate | ESD-890375-10G |
| Cas.: 96036-02-1 | Purity: 98% | Meropenem p-nitrobenzyl diester | ESD-890376-1G |
| Cas.: 96036-02-1 | Purity: 98% | Meropenem p-nitrobenzyl diester | ESD-890376-5G |
| Cas.: 96036-02-1 | Purity: 98% | Meropenem p-nitrobenzyl diester | ESD-890376-10G |
| Cas.: 3154-54-9 | Purity: 97% | Methyl 2-formamidoacetate | ESD-890377-1G |
| Cas.: 3154-54-9 | Purity: 97% | Methyl 2-formamidoacetate | ESD-890377-5G |
| Cas.: 4415-83-2 | Purity: 97% | Cyclobutylmethanamine | ESD-890378-1G |
| Cas.: 4415-83-2 | Purity: 97% | Cyclobutylmethanamine | ESD-890378-5G |
| Cas.: 1007882-23-6 | Purity: ≥95% | BIs(2-methyl-2-propanyl) (2S,2’S)-2,2′-[4,4′-biphenyldiylbis(1H-imidazole-4,2-diyl)]di(1-pyrrolidinecarboxylate) | ESD-890379-1G |
| Cas.: 1007882-23-6 | Purity: ≥95% | BIs(2-methyl-2-propanyl) (2S,2’S)-2,2′-[4,4′-biphenyldiylbis(1H-imidazole-4,2-diyl)]di(1-pyrrolidinecarboxylate) | ESD-890379-5G |
| Cas.: 1007882-23-6 | Purity: ≥95% | BIs(2-methyl-2-propanyl) (2S,2’S)-2,2′-[4,4′-biphenyldiylbis(1H-imidazole-4,2-diyl)]di(1-pyrrolidinecarboxylate) | ESD-890379-10G |
| Cas.: 1007882-23-6 | Purity: ≥95% | BIs(2-methyl-2-propanyl) (2S,2’S)-2,2′-[4,4′-biphenyldiylbis(1H-imidazole-4,2-diyl)]di(1-pyrrolidinecarboxylate) | ESD-890379-25G |
| Cas.: 363-69-9 | Purity: 97% | 2,4-Dibromo-1,3,5-trifluorobenzene | ESD-890380-50MG |
| Cas.: 363-69-9 | Purity: 97% | 2,4-Dibromo-1,3,5-trifluorobenzene | ESD-890380-100MG |
| Cas.: 363-69-9 | Purity: 97% | 2,4-Dibromo-1,3,5-trifluorobenzene | ESD-890380-250MG |
| Cas.: 363-69-9 | Purity: 97% | 2,4-Dibromo-1,3,5-trifluorobenzene | ESD-890380-1G |
| Cas.: 231285-86-2 | Purity: 97% | Ethyl 1-methyl-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate | ESD-890381-100MG |
| Cas.: 231285-86-2 | Purity: 97% | Ethyl 1-methyl-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate | ESD-890381-250MG |
| Cas.: 231285-86-2 | Purity: 97% | Ethyl 1-methyl-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate | ESD-890381-1G |
| Cas.: 13292-22-3 | Purity: 97% | 3-Formylrifamycin SV | ESD-890382-100MG |
| Cas.: 13292-22-3 | Purity: 97% | 3-Formylrifamycin SV | ESD-890382-250MG |
| Cas.: 13292-22-3 | Purity: 97% | 3-Formylrifamycin SV | ESD-890382-1G |
| Cas.: 1448346-63-1 | Purity: 97% | AG-120 Racemate | ESD-890383-1MG |
| Cas.: 1448346-63-1 | Purity: 97% | AG-120 Racemate | ESD-890383-5MG |
| Cas.: 1448346-63-1 | Purity: 97% | AG-120 Racemate | ESD-890383-10MG |
| Cas.: 1448346-63-1 | Purity: 97% | AG-120 Racemate | ESD-890383-50MG |
| Cas.: 1375101-06-6 | Purity: 97% | (E)-6-Bromo-3-(6-bromo-1-(2-octyldodecyl)-2-oxoindolin-3-ylidene)-1-(2-octyldodecyl)indolin-2-one | ESD-890384-100MG |
| Cas.: 1375101-06-6 | Purity: 97% | (E)-6-Bromo-3-(6-bromo-1-(2-octyldodecyl)-2-oxoindolin-3-ylidene)-1-(2-octyldodecyl)indolin-2-one | ESD-890384-250MG |
| Cas.: 556813-39-9 | Purity: ≥95% | CHIR-98024 | ESD-890385-2MG |
| Cas.: 556813-39-9 | Purity: ≥95% | CHIR-98024 | ESD-890385-5MG |
| Cas.: 556813-39-9 | Purity: ≥95% | CHIR-98024 | ESD-890385-10MG |
| Cas.: 556813-39-9 | Purity: ≥95% | CHIR-98024 | ESD-890385-25MG |
| Cas.: 196811-90-2 | Purity: 97% | 2-(4-(Trifluoromethoxy)phenyl)ethanol | ESD-890386-250MG |
| Cas.: 196811-90-2 | Purity: 97% | 2-(4-(Trifluoromethoxy)phenyl)ethanol | ESD-890386-1G |
| Cas.: 196811-90-2 | Purity: 97% | 2-(4-(Trifluoromethoxy)phenyl)ethanol | ESD-890386-5G |
| Cas.: 196811-90-2 | Purity: 97% | 2-(4-(Trifluoromethoxy)phenyl)ethanol | ESD-890386-10G |
| Cas.: 201046-59-5 | Purity: ≥95% | Fmoc-Orn(Fmoc)-OH | ESD-890387-250MG |
| Cas.: 201046-59-5 | Purity: ≥95% | Fmoc-Orn(Fmoc)-OH | ESD-890387-1G |
| Cas.: 201046-59-5 | Purity: ≥95% | Fmoc-Orn(Fmoc)-OH | ESD-890387-5G |
| Cas.: 201046-59-5 | Purity: ≥95% | Fmoc-Orn(Fmoc)-OH | ESD-890387-10G |
| Cas.: 1206524-85-7 | Purity: 99% | 8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-dimethylethyl)-1,1a, 3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, (1ar,5s,8s,10r,22ar)- | ESD-890388-100MG |
| Cas.: 1206524-85-7 | Purity: 99% | 8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-dimethylethyl)-1,1a, 3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, (1ar,5s,8s,10r,22ar)- | ESD-890388-250MG |
| Cas.: 1206524-85-7 | Purity: 99% | 8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-dimethylethyl)-1,1a, 3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, (1ar,5s,8s,10r,22ar)- | ESD-890388-1G |
| Cas.: 1206524-85-7 | Purity: 99% | 8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-dimethylethyl)-1,1a, 3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, (1ar,5s,8s,10r,22ar)- | ESD-890388-5G |
| Cas.: 201473-83-8 | Purity: 97% | Fmoc-Dab(Fmoc)-OH | ESD-890389-1G |
| Cas.: 201473-83-8 | Purity: 97% | Fmoc-Dab(Fmoc)-OH | ESD-890389-5G |
| Cas.: 201473-83-8 | Purity: 97% | Fmoc-Dab(Fmoc)-OH | ESD-890389-10G |
| Cas.: 201473-83-8 | Purity: 97% | Fmoc-Dab(Fmoc)-OH | ESD-890389-25G |
| Cas.: 93249-62-8 | Purity: ≥95% | 2-Hydroxy-5-(trifluoromethoxy)benzaldehyde | ESD-890390-1G |
| Cas.: 93249-62-8 | Purity: ≥95% | 2-Hydroxy-5-(trifluoromethoxy)benzaldehyde | ESD-890390-5G |
| Cas.: 93249-62-8 | Purity: ≥95% | 2-Hydroxy-5-(trifluoromethoxy)benzaldehyde | ESD-890390-10G |
| Cas.: 93249-62-8 | Purity: ≥95% | 2-Hydroxy-5-(trifluoromethoxy)benzaldehyde | ESD-890390-25G |
| Cas.: 1241725-64-3 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-5-fluoropiperidine-3-carboxylic acid | ESD-890391-100MG |
| Cas.: 1241725-64-3 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-5-fluoropiperidine-3-carboxylic acid | ESD-890391-250MG |
| Cas.: 1241725-64-3 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-5-fluoropiperidine-3-carboxylic acid | ESD-890391-1G |
| Cas.: 503614-92-4 | Purity: 97% | 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine -3-carboxylic acid | ESD-890392-100MG |
| Cas.: 503614-92-4 | Purity: 97% | 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine -3-carboxylic acid | ESD-890392-250MG |
| Cas.: 503614-92-4 | Purity: 97% | 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine -3-carboxylic acid | ESD-890392-1G |
| Cas.: 1191064-81-9 | Purity: 97% | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28,31-decaoxa-4-azatetratriacontan-34-oic acid | ESD-890393-100MG |
| Cas.: 1191064-81-9 | Purity: 97% | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28,31-decaoxa-4-azatetratriacontan-34-oic acid | ESD-890393-250MG |
| Cas.: 1191064-81-9 | Purity: 97% | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19,22,25,28,31-decaoxa-4-azatetratriacontan-34-oic acid | ESD-890393-1G |
| Cas.: 74874-09-2 | Purity: ≥95% | Argatroban-5 | ESD-890394-100MG |
| Cas.: 74874-09-2 | Purity: ≥95% | Argatroban-5 | ESD-890394-250MG |
| Cas.: 74874-09-2 | Purity: ≥95% | Argatroban-5 | ESD-890394-1G |
| Cas.: 132388-60-4 | Purity: 97% | Z-Gln(Trt)-OH | ESD-890395-250MG |
| Cas.: 132388-60-4 | Purity: 97% | Z-Gln(Trt)-OH | ESD-890395-1G |
| Cas.: 132388-60-4 | Purity: 97% | Z-Gln(Trt)-OH | ESD-890395-5G |
| Cas.: 132388-60-4 | Purity: 97% | Z-Gln(Trt)-OH | ESD-890395-10G |
| Cas.: 708-64-5 | Purity: 97% | 2,2,2-Trifluoro-1-(3-fluorophenyl)ethanone | ESD-890396-250MG |
| Cas.: 708-64-5 | Purity: 97% | 2,2,2-Trifluoro-1-(3-fluorophenyl)ethanone | ESD-890396-1G |
| Cas.: 708-64-5 | Purity: 97% | 2,2,2-Trifluoro-1-(3-fluorophenyl)ethanone | ESD-890396-5G |
| Cas.: 708-64-5 | Purity: 97% | 2,2,2-Trifluoro-1-(3-fluorophenyl)ethanone | ESD-890396-10G |
| Cas.: 159680-21-4 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(((2-phenylacetamido)methyl)thio)propanoic acid | ESD-890397-250MG |
| Cas.: 159680-21-4 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(((2-phenylacetamido)methyl)thio)propanoic acid | ESD-890397-1G |
| Cas.: 159680-21-4 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(((2-phenylacetamido)methyl)thio)propanoic acid | ESD-890397-5G |
| Cas.: 159680-21-4 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(((2-phenylacetamido)methyl)thio)propanoic acid | ESD-890397-10G |
| Cas.: 167015-23-8 | Purity: 95%(HPLC) | Fmoc-HoCys(Trt)-OH | ESD-890398-250MG |
| Cas.: 167015-23-8 | Purity: 95%(HPLC) | Fmoc-HoCys(Trt)-OH | ESD-890398-1G |
| Cas.: 167015-23-8 | Purity: 95%(HPLC) | Fmoc-HoCys(Trt)-OH | ESD-890398-5G |
| Cas.: 167015-23-8 | Purity: 95%(HPLC) | Fmoc-HoCys(Trt)-OH | ESD-890398-10G |
| Cas.: 132388-57-9 | Purity: 98% | N-Cbz-N’-trityl-L-asparagine | ESD-890399-1G |
| Cas.: 132388-57-9 | Purity: 98% | N-Cbz-N’-trityl-L-asparagine | ESD-890399-5G |
| Cas.: 132388-57-9 | Purity: 98% | N-Cbz-N’-trityl-L-asparagine | ESD-890399-10G |
| Cas.: 132388-57-9 | Purity: 98% | N-Cbz-N’-trityl-L-asparagine | ESD-890399-25G |
| Cas.: 218938-57-9 | Purity: ≥95% | Z-Trp(Boc)-OH.DCHA | ESD-890400-1G |
| Cas.: 218938-57-9 | Purity: ≥95% | Z-Trp(Boc)-OH.DCHA | ESD-890400-5G |
| Cas.: 218938-57-9 | Purity: ≥95% | Z-Trp(Boc)-OH.DCHA | ESD-890400-10G |
| Cas.: 218938-57-9 | Purity: ≥95% | Z-Trp(Boc)-OH.DCHA | ESD-890400-25G |
| Cas.: 3054-47-5 | Purity: ≥95% | S-Acetyl-L-glutathione | ESD-890401-250MG |
| Cas.: 3054-47-5 | Purity: ≥95% | S-Acetyl-L-glutathione | ESD-890401-1G |
| Cas.: 3054-47-5 | Purity: ≥95% | S-Acetyl-L-glutathione | ESD-890401-5G |
| Cas.: 157599-02-5 | Purity: 97% | 2,2′,2”,2”’-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetamide | ESD-890402-100MG |
| Cas.: 157599-02-5 | Purity: 97% | 2,2′,2”,2”’-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetamide | ESD-890402-250MG |
| Cas.: 157599-02-5 | Purity: 97% | 2,2′,2”,2”’-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetamide | ESD-890402-1G |
| Cas.: 866084-31-3 | Purity: 97% | tert-Butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino) pyridin-3-yl)piperazine-1-carboxylate | ESD-890403-100MG |
| Cas.: 866084-31-3 | Purity: 97% | tert-Butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino) pyridin-3-yl)piperazine-1-carboxylate | ESD-890403-250MG |
| Cas.: 866084-31-3 | Purity: 97% | tert-Butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino) pyridin-3-yl)piperazine-1-carboxylate | ESD-890403-1G |
| Cas.: 1206102-11-5 | Purity: ≥95% | (4R,12aS)-7-(Benzyloxy)-N-(2,4-difluorobenzyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[ 1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide | ESD-890404-100MG |
| Cas.: 1206102-11-5 | Purity: ≥95% | (4R,12aS)-7-(Benzyloxy)-N-(2,4-difluorobenzyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[ 1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide | ESD-890404-250MG |
| Cas.: 1206102-11-5 | Purity: ≥95% | (4R,12aS)-7-(Benzyloxy)-N-(2,4-difluorobenzyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[ 1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide | ESD-890404-1G |
| Cas.: 178119-94-3 | Purity: 95% | Fmoc-5-Hydroxy-L-tryptophan | ESD-890405-250MG |
| Cas.: 178119-94-3 | Purity: 95% | Fmoc-5-Hydroxy-L-tryptophan | ESD-890405-1G |
| Cas.: 274693-26-4 | Purity: ≥95% | 2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[ 1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol | ESD-890406-1G |
| Cas.: 274693-26-4 | Purity: ≥95% | 2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[ 1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol | ESD-890406-5G |
| Cas.: 274693-26-4 | Purity: ≥95% | 2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[ 1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol | ESD-890406-10G |
| Cas.: 274693-26-4 | Purity: ≥95% | 2-(((3aR,4S,6R,6aS)-6-(7-(((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[ 1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol | ESD-890406-25G |
| Cas.: 503614-91-3 | Purity: 97% | Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c] pyridine-3-carboxylate | ESD-890407-250MG |
| Cas.: 503614-91-3 | Purity: 97% | Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c] pyridine-3-carboxylate | ESD-890407-1G |
| Cas.: 503614-91-3 | Purity: 97% | Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c] pyridine-3-carboxylate | ESD-890407-5G |
| Cas.: 503614-91-3 | Purity: 97% | Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c] pyridine-3-carboxylate | ESD-890407-10G |
| Cas.: 268734-27-6 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(anthracen-9-yl)propanoic acid | ESD-890408-100MG |
| Cas.: 268734-27-6 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(anthracen-9-yl)propanoic acid | ESD-890408-250MG |
| Cas.: 16196-97-7 | Purity: 97% | 1,1′-(((3,3′-Dimethyl-[1,1′-biphenyl]-4,4′-diyl)bis(azanylylidene))bis(methanylylidene))bis(naphthalen-2-ol) | ESD-890409-100MG |
| Cas.: 16196-97-7 | Purity: 97% | 1,1′-(((3,3′-Dimethyl-[1,1′-biphenyl]-4,4′-diyl)bis(azanylylidene))bis(methanylylidene))bis(naphthalen-2-ol) | ESD-890409-250MG |
| Cas.: 16196-97-7 | Purity: 97% | 1,1′-(((3,3′-Dimethyl-[1,1′-biphenyl]-4,4′-diyl)bis(azanylylidene))bis(methanylylidene))bis(naphthalen-2-ol) | ESD-890409-1G |
| Cas.: 868539-96-2 | Purity: 98% | (6S,9S,12S)-Methyl 12-benzyl-9-isobutyl-2,2-dimethyl-4,7,10-trioxo-6-phenethyl-3-oxa-5,8,11-triazatridecan-13-oate | ESD-890410-100MG |
| Cas.: 868539-96-2 | Purity: 98% | (6S,9S,12S)-Methyl 12-benzyl-9-isobutyl-2,2-dimethyl-4,7,10-trioxo-6-phenethyl-3-oxa-5,8,11-triazatridecan-13-oate | ESD-890410-250MG |
| Cas.: 50292-95-0 | Purity: 97% | 3,3-Bis(2-methyl-1-octyl-1H-indol-3-yl)isobenzofuran-1(3H)-one | ESD-890411-1G |
| Cas.: 50292-95-0 | Purity: 97% | 3,3-Bis(2-methyl-1-octyl-1H-indol-3-yl)isobenzofuran-1(3H)-one | ESD-890411-5G |
| Cas.: 50292-95-0 | Purity: 97% | 3,3-Bis(2-methyl-1-octyl-1H-indol-3-yl)isobenzofuran-1(3H)-one | ESD-890411-10G |
| Cas.: 202467-69-4 | Purity: 97% | 3-((2S,4S)-4-Mercapto-1-(((4-nitrobenzyl)oxy)carbonyl)pyrrolidine-2-carboxamido)benzoic acid | ESD-890412-100MG |
| Cas.: 202467-69-4 | Purity: 97% | 3-((2S,4S)-4-Mercapto-1-(((4-nitrobenzyl)oxy)carbonyl)pyrrolidine-2-carboxamido)benzoic acid | ESD-890412-250MG |
| Cas.: 202467-69-4 | Purity: 97% | 3-((2S,4S)-4-Mercapto-1-(((4-nitrobenzyl)oxy)carbonyl)pyrrolidine-2-carboxamido)benzoic acid | ESD-890412-1G |
| Cas.: 202467-69-4 | Purity: 97% | 3-((2S,4S)-4-Mercapto-1-(((4-nitrobenzyl)oxy)carbonyl)pyrrolidine-2-carboxamido)benzoic acid | ESD-890412-5G |
| Cas.: 187223-15-0 | Purity: 97% | Fmoc-Hyp(Bom)-OH | ESD-890413-1G |
| Cas.: 187223-15-0 | Purity: 97% | Fmoc-Hyp(Bom)-OH | ESD-890413-5G |
| Cas.: 187223-15-0 | Purity: 97% | Fmoc-Hyp(Bom)-OH | ESD-890413-10G |
| Cas.: 272778-12-8 | Purity: 97% | (S)-3-((2R,5S)-5-(4-Fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-((trimethylsilyl)oxy)phenyl)methyl)- 5-((trimethylsilyl)oxy)pentanoyl)-4-phenyloxazolidin-2-one | ESD-890414-100MG |
| Cas.: 272778-12-8 | Purity: 97% | (S)-3-((2R,5S)-5-(4-Fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-((trimethylsilyl)oxy)phenyl)methyl)- 5-((trimethylsilyl)oxy)pentanoyl)-4-phenyloxazolidin-2-one | ESD-890414-250MG |
| Cas.: 272778-12-8 | Purity: 97% | (S)-3-((2R,5S)-5-(4-Fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-((trimethylsilyl)oxy)phenyl)methyl)- 5-((trimethylsilyl)oxy)pentanoyl)-4-phenyloxazolidin-2-one | ESD-890414-1G |
| Cas.: 272778-12-8 | Purity: 97% | (S)-3-((2R,5S)-5-(4-Fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-((trimethylsilyl)oxy)phenyl)methyl)- 5-((trimethylsilyl)oxy)pentanoyl)-4-phenyloxazolidin-2-one | ESD-890414-5G |
| Cas.: 16519-02-1 | Purity: ≥95% | Diethyl 2-fluoro-2-methylmalonate | ESD-890415-250MG |
| Cas.: 16519-02-1 | Purity: ≥95% | Diethyl 2-fluoro-2-methylmalonate | ESD-890415-1G |
| Cas.: 16519-02-1 | Purity: ≥95% | Diethyl 2-fluoro-2-methylmalonate | ESD-890415-5G |
| Cas.: 944797-51-7 | Purity: ≥95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(tritylthio)propanoic acid | ESD-890416-100MG |
| Cas.: 944797-51-7 | Purity: ≥95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(tritylthio)propanoic acid | ESD-890416-250MG |
| Cas.: 944797-51-7 | Purity: ≥95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(tritylthio)propanoic acid | ESD-890416-1G |
| Cas.: 252049-08-4 | Purity: ≥95% | Fmoc-Dab(Z)-OH | ESD-890417-250MG |
| Cas.: 252049-08-4 | Purity: ≥95% | Fmoc-Dab(Z)-OH | ESD-890417-1G |
| Cas.: 252049-08-4 | Purity: ≥95% | Fmoc-Dab(Z)-OH | ESD-890417-5G |
| Cas.: 63013-46-7 | Purity: 95% | (S)-2-(((Benzyloxy)carbonyl)amino)-3-(1-(2,4-dinitrophenyl)-1H-imidazol-4-yl)propanoic acid | ESD-890418-250MG |
| Cas.: 63013-46-7 | Purity: 95% | (S)-2-(((Benzyloxy)carbonyl)amino)-3-(1-(2,4-dinitrophenyl)-1H-imidazol-4-yl)propanoic acid | ESD-890418-1G |
| Cas.: 163277-78-9 | Purity: 97% | Ac-Asn(Trt)-OH | ESD-890419-100MG |
| Cas.: 163277-78-9 | Purity: 97% | Ac-Asn(Trt)-OH | ESD-890419-250MG |
| Cas.: 163277-78-9 | Purity: 97% | Ac-Asn(Trt)-OH | ESD-890419-1G |
| Cas.: 1373156-28-5 | Purity: 95% | 3-(4-(2-(3-(4-Chlorophenyl)-1,2,4-oxadiazol-5-yl)-2-(4-methoxyphenyl)ethyl)phenyl)isoxazole-5-carboxylic acid | ESD-890420-50MG |
| Cas.: 1257849-07-2 | Purity: ≥95% | Fmoc-5-Chloro-L-tryptophan | ESD-890421-100MG |
| Cas.: 1257849-07-2 | Purity: ≥95% | Fmoc-5-Chloro-L-tryptophan | ESD-890421-250MG |
| Cas.: 1257849-07-2 | Purity: ≥95% | Fmoc-5-Chloro-L-tryptophan | ESD-890421-1G |
| Cas.: 1257849-07-2 | Purity: ≥95% | Fmoc-5-Chloro-L-tryptophan | ESD-890421-5G |
| Cas.: 28542-78-1 | Purity: ≥95% | (2R,3R,4S,5R)-2-(6-(((E)-4-Hydroxy-3-methylbut-2-en-1-yl)amino)-9H-purin-9-yl)-5 -(hydroxymethyl)tetrahydrofuran-3,4-diol | ESD-890422-100MG |
| Cas.: 28542-78-1 | Purity: ≥95% | (2R,3R,4S,5R)-2-(6-(((E)-4-Hydroxy-3-methylbut-2-en-1-yl)amino)-9H-purin-9-yl)-5 -(hydroxymethyl)tetrahydrofuran-3,4-diol | ESD-890422-250MG |
| Cas.: 28542-78-1 | Purity: ≥95% | (2R,3R,4S,5R)-2-(6-(((E)-4-Hydroxy-3-methylbut-2-en-1-yl)amino)-9H-purin-9-yl)-5 -(hydroxymethyl)tetrahydrofuran-3,4-diol | ESD-890422-1G |
| Cas.: 117666-96-3 | Purity: ≥95% | Fmoc-Bpa-OH | ESD-890423-250MG |
| Cas.: 117666-96-3 | Purity: ≥95% | Fmoc-Bpa-OH | ESD-890423-1G |
| Cas.: 117666-96-3 | Purity: ≥95% | Fmoc-Bpa-OH | ESD-890423-5G |
| Cas.: 117666-96-3 | Purity: ≥95% | Fmoc-Bpa-OH | ESD-890423-10G |
| Cas.: 887707-95-1 | Purity: ≥95% | Boc-Thr(Fmoc-Val)-OH | ESD-890424-100MG |
| Cas.: 887707-95-1 | Purity: ≥95% | Boc-Thr(Fmoc-Val)-OH | ESD-890424-250MG |
| Cas.: 71337-53-6 | Purity: 97% | (E)-2,2′-(Fumaroylbis(oxy))bis(3,5-dibromobenzoic acid) | ESD-890425-100MG |
| Cas.: 71337-53-6 | Purity: 97% | (E)-2,2′-(Fumaroylbis(oxy))bis(3,5-dibromobenzoic acid) | ESD-890425-250MG |
| Cas.: 71337-53-6 | Purity: 97% | (E)-2,2′-(Fumaroylbis(oxy))bis(3,5-dibromobenzoic acid) | ESD-890425-1G |
| Cas.: 900160-98-7 | Purity: 97% | (1’R,3a’R,8a’S,9’S,9a’S)-1′-Methyl-3′-oxo-N,N-diphenyl-3′,3a’,5′,7′,8′,8a’, 9′,9a’-octahydro-1’H-spiro[[1,3]dioxolane-2,6′-naphtho[2,3-c]furan]-9′-carboxamide | ESD-890426-100MG |
| Cas.: 900160-98-7 | Purity: 97% | (1’R,3a’R,8a’S,9’S,9a’S)-1′-Methyl-3′-oxo-N,N-diphenyl-3′,3a’,5′,7′,8′,8a’, 9′,9a’-octahydro-1’H-spiro[[1,3]dioxolane-2,6′-naphtho[2,3-c]furan]-9′-carboxamide | ESD-890426-250MG |
| Cas.: 16947-89-0 | Purity: 97% | Boc-Dab(Z)-OH.DCHA | ESD-890427-250MG |
| Cas.: 16947-89-0 | Purity: 97% | Boc-Dab(Z)-OH.DCHA | ESD-890427-1G |
| Cas.: 16947-89-0 | Purity: 97% | Boc-Dab(Z)-OH.DCHA | ESD-890427-5G |
| Cas.: 205393-22-2 | Purity: 97% | Bortezomib pinanediol | ESD-890428-100MG |
| Cas.: 205393-22-2 | Purity: 97% | Bortezomib pinanediol | ESD-890428-250MG |
| Cas.: 1597403-48-9 | Purity: 97% | N,N’-(cis-Cyclohexane-1,4-diyl)bis(2-(4-chlorophenoxy)acetamide) | ESD-890429-100MG |
| Cas.: 1597403-48-9 | Purity: 97% | N,N’-(cis-Cyclohexane-1,4-diyl)bis(2-(4-chlorophenoxy)acetamide) | ESD-890429-250MG |
| Cas.: 19213-72-0 | Purity: 97% | Ethyl 1H-imidazole-1-carboxylate | ESD-890430-1G |
| Cas.: 19213-72-0 | Purity: 97% | Ethyl 1H-imidazole-1-carboxylate | ESD-890430-5G |
| Cas.: 19213-72-0 | Purity: 97% | Ethyl 1H-imidazole-1-carboxylate | ESD-890430-10G |
| Cas.: 19213-72-0 | Purity: 97% | Ethyl 1H-imidazole-1-carboxylate | ESD-890430-25G |
| Cas.: 196808-79-4 | Purity: ≥95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-methyl-1H-indol-3-yl)propanoic acid | ESD-890431-250MG |
| Cas.: 196808-79-4 | Purity: ≥95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-methyl-1H-indol-3-yl)propanoic acid | ESD-890431-1G |
| Cas.: 247595-29-5 | Purity: 97% | Fmoc-Cys(Dpm)-OH | ESD-890432-250MG |
| Cas.: 247595-29-5 | Purity: 97% | Fmoc-Cys(Dpm)-OH | ESD-890432-1G |
| Cas.: 247595-29-5 | Purity: 97% | Fmoc-Cys(Dpm)-OH | ESD-890432-5G |
| Cas.: 247595-29-5 | Purity: 97% | Fmoc-Cys(Dpm)-OH | ESD-890432-10G |
| Cas.: 47862-55-5 | Purity: ≥95% | N1,N1-Dibutyl-N4,N4-bis(4-(dibutylamino)phenyl)benzene-1,4-diamine | ESD-890433-100MG |
| Cas.: 47862-55-5 | Purity: ≥95% | N1,N1-Dibutyl-N4,N4-bis(4-(dibutylamino)phenyl)benzene-1,4-diamine | ESD-890433-250MG |
| Cas.: 1956434-65-3 | Purity: 95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(7-fluoro-1H-indol-3-yl)propanoic acid | ESD-890434-100MG |
| Cas.: 1956434-65-3 | Purity: 95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(7-fluoro-1H-indol-3-yl)propanoic acid | ESD-890434-250MG |
| Cas.: 882847-32-7 | Purity: ≥95% | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19-hexaoxa-4-azadocosan-22-oic acid | ESD-890435-100MG |
| Cas.: 882847-32-7 | Purity: ≥95% | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19-hexaoxa-4-azadocosan-22-oic acid | ESD-890435-250MG |
| Cas.: 882847-32-7 | Purity: ≥95% | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19-hexaoxa-4-azadocosan-22-oic acid | ESD-890435-1G |
| Cas.: 882847-32-7 | Purity: ≥95% | 1-(9H-Fluoren-9-yl)-3-oxo-2,7,10,13,16,19-hexaoxa-4-azadocosan-22-oic acid | ESD-890435-5G |
| Cas.: 163437-14-7 | Purity: 95% | Fmoc-Met(O2)-OH | ESD-890436-250MG |
| Cas.: 163437-14-7 | Purity: 95% | Fmoc-Met(O2)-OH | ESD-890436-1G |
| Cas.: 163437-14-7 | Purity: 95% | Fmoc-Met(O2)-OH | ESD-890436-5G |
| Cas.: 163437-14-7 | Purity: 95% | Fmoc-Met(O2)-OH | ESD-890436-10G |
| Cas.: 201531-77-3 | Purity: 97% | Fmoc-D-Pen(Acm)-OH | ESD-890437-250MG |
| Cas.: 201531-77-3 | Purity: 97% | Fmoc-D-Pen(Acm)-OH | ESD-890437-1G |
| Cas.: 201531-77-3 | Purity: 97% | Fmoc-D-Pen(Acm)-OH | ESD-890437-5G |
| Cas.: 7168-85-6 | Purity: 97% | 7-Methoxybenzofuran | ESD-890438-250MG |
| Cas.: 7168-85-6 | Purity: 97% | 7-Methoxybenzofuran | ESD-890438-1G |
| Cas.: 7168-85-6 | Purity: 97% | 7-Methoxybenzofuran | ESD-890438-5G |
| Cas.: 20561-09-5 | Purity: ≥95% | Cyclopropane-1,2-dicarboxylic acid diethyl ester | ESD-890439-100MG |
| Cas.: 20561-09-5 | Purity: ≥95% | Cyclopropane-1,2-dicarboxylic acid diethyl ester | ESD-890439-250MG |
| Cas.: 20561-09-5 | Purity: ≥95% | Cyclopropane-1,2-dicarboxylic acid diethyl ester | ESD-890439-1G |
| Cas.: 20561-09-5 | Purity: ≥95% | Cyclopropane-1,2-dicarboxylic acid diethyl ester | ESD-890439-5G |
| Cas.: 1174132-74-1 | Purity: ≥95% | 5-Bromo-1H-pyrazole | ESD-890440-250MG |
| Cas.: 1174132-74-1 | Purity: ≥95% | 5-Bromo-1H-pyrazole | ESD-890440-1G |
| Cas.: 1174132-74-1 | Purity: ≥95% | 5-Bromo-1H-pyrazole | ESD-890440-5G |
| Cas.: 163222-32-0 | Purity: 97% | (3R,4S)-4-(4-(Benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)azetidin-2-one | ESD-890441-250MG |
| Cas.: 163222-32-0 | Purity: 97% | (3R,4S)-4-(4-(Benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)azetidin-2-one | ESD-890441-1G |
| Cas.: 163222-32-0 | Purity: 97% | (3R,4S)-4-(4-(Benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)azetidin-2-one | ESD-890441-5G |
| Cas.: 269398-78-9 | Purity: ≥95% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(4-nitrophenyl)butanoic acid | ESD-890442-50MG |
| Cas.: 269398-78-9 | Purity: ≥95% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(4-nitrophenyl)butanoic acid | ESD-890442-100MG |
| Cas.: 269398-78-9 | Purity: ≥95% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(4-nitrophenyl)butanoic acid | ESD-890442-250MG |
| Cas.: 205526-38-1 | Purity: 97% | Fmoc-D-Bip(4,4′)-OH | ESD-890443-250MG |
| Cas.: 205526-38-1 | Purity: 97% | Fmoc-D-Bip(4,4′)-OH | ESD-890443-1G |
| Cas.: 205526-38-1 | Purity: 97% | Fmoc-D-Bip(4,4′)-OH | ESD-890443-5G |
| Cas.: 205526-38-1 | Purity: 97% | Fmoc-D-Bip(4,4′)-OH | ESD-890443-10G |
| Cas.: 32117-82-1 | Purity: ≥95% | N-Methoxy-N-methylformamide | ESD-890444-250MG |
| Cas.: 32117-82-1 | Purity: ≥95% | N-Methoxy-N-methylformamide | ESD-890444-1G |
| Cas.: 32117-82-1 | Purity: ≥95% | N-Methoxy-N-methylformamide | ESD-890444-5G |
| Cas.: 42753-80-0 | Purity: 97% | N-(3-(2-Chlorobenzoyl)-5-ethylthiophen-2-yl)-2-(1,3-dioxoisoindolin-2-yl)acetamide | ESD-890445-100MG |
| Cas.: 42753-80-0 | Purity: 97% | N-(3-(2-Chlorobenzoyl)-5-ethylthiophen-2-yl)-2-(1,3-dioxoisoindolin-2-yl)acetamide | ESD-890445-250MG |
| Cas.: 83799-24-0 | Purity: ≥95% | Fexofenadine | ESD-890446-250MG |
| Cas.: 83799-24-0 | Purity: ≥95% | Fexofenadine | ESD-890446-1G |
| Cas.: 83799-24-0 | Purity: ≥95% | Fexofenadine | ESD-890446-5G |
| Cas.: 1253799-29-9 | Purity: 97% | Phenyl 2-(benzyloxy)-3-(dibenzylamino)-5-fluoro-6-methylbenzoate | ESD-890447-100MG |
| Cas.: 1253799-29-9 | Purity: 97% | Phenyl 2-(benzyloxy)-3-(dibenzylamino)-5-fluoro-6-methylbenzoate | ESD-890447-250MG |
| Cas.: 1253799-29-9 | Purity: 97% | Phenyl 2-(benzyloxy)-3-(dibenzylamino)-5-fluoro-6-methylbenzoate | ESD-890447-1G |
| Cas.: 1421372-67-9 | Purity: ≥95% | N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)-2-nitrobenzene-1, 4-diamine | ESD-890448-250MG |
| Cas.: 1421372-67-9 | Purity: ≥95% | N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)-2-nitrobenzene-1, 4-diamine | ESD-890448-1G |
| Cas.: 1421372-67-9 | Purity: ≥95% | N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)-2-nitrobenzene-1, 4-diamine | ESD-890448-5G |
| Cas.: 1421372-67-9 | Purity: ≥95% | N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)-2-nitrobenzene-1, 4-diamine | ESD-890448-10G |
| Cas.: 331987-72-5 | Purity: 97% | N,N’-(1,3-Phenylenebis(methylene))bis(thiophene-2-carboxamide) | ESD-890449-100MG |
| Cas.: 331987-72-5 | Purity: 97% | N,N’-(1,3-Phenylenebis(methylene))bis(thiophene-2-carboxamide) | ESD-890449-250MG |
| Cas.: 147118-40-9 | Purity: ≥95% | Rosuvastatin methyl ester | ESD-890450-250MG |
| Cas.: 147118-40-9 | Purity: ≥95% | Rosuvastatin methyl ester | ESD-890450-1G |
| Cas.: 147118-40-9 | Purity: ≥95% | Rosuvastatin methyl ester | ESD-890450-5G |
| Cas.: 147118-40-9 | Purity: ≥95% | Rosuvastatin methyl ester | ESD-890450-10G |
| Cas.: 177966-61-9 | Purity: ≥95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(benzo[b]thiophen-3-yl)propanoic acid | ESD-890451-1G |
| Cas.: 177966-61-9 | Purity: ≥95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(benzo[b]thiophen-3-yl)propanoic acid | ESD-890451-5G |
| Cas.: 177966-61-9 | Purity: ≥95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(benzo[b]thiophen-3-yl)propanoic acid | ESD-890451-10G |
| Cas.: 35942-94-0 | Purity: 97% | 2-(5-Methylfuran-2-yl)ethanol | ESD-890452-100MG |
| Cas.: 35942-94-0 | Purity: 97% | 2-(5-Methylfuran-2-yl)ethanol | ESD-890452-250MG |
| Cas.: 35942-94-0 | Purity: 97% | 2-(5-Methylfuran-2-yl)ethanol | ESD-890452-1G |
| Cas.: 1135243-19-4 | Purity: ≥95% | VU 0255035 | ESD-890453-25MG |
| Cas.: 1135243-19-4 | Purity: ≥95% | VU 0255035 | ESD-890453-100MG |
| Cas.: 1135243-19-4 | Purity: ≥95% | VU 0255035 | ESD-890453-250MG |
| Cas.: 1135243-19-4 | Purity: ≥95% | VU 0255035 | ESD-890453-1G |
| Cas.: 288149-55-3 | Purity: 97% | (S)-4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-amino-5-oxopentanoic acid | ESD-890454-250MG |
| Cas.: 288149-55-3 | Purity: 97% | (S)-4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-amino-5-oxopentanoic acid | ESD-890454-1G |
| Cas.: 204589-82-2 | Purity: ≥95% | 3-((2S,3R)-2-(4-(Benzyloxy)phenyl)-1-(4-fluorophenyl)-4-oxoazetidin-3-yl)propanoic acid | ESD-890455-100MG |
| Cas.: 204589-82-2 | Purity: ≥95% | 3-((2S,3R)-2-(4-(Benzyloxy)phenyl)-1-(4-fluorophenyl)-4-oxoazetidin-3-yl)propanoic acid | ESD-890455-250MG |
| Cas.: 150009-58-8 | Purity: ≥95% | Fmoc-D-Asp(OBzl)-OH | ESD-890456-100MG |
| Cas.: 150009-58-8 | Purity: ≥95% | Fmoc-D-Asp(OBzl)-OH | ESD-890456-250MG |
| Cas.: 150009-58-8 | Purity: ≥95% | Fmoc-D-Asp(OBzl)-OH | ESD-890456-1G |
| Cas.: 150009-58-8 | Purity: ≥95% | Fmoc-D-Asp(OBzl)-OH | ESD-890456-5G |
| Cas.: 139755-82-1 | Purity: ≥95% | 5-(2-Ethoxy-5-(piperazin-1-ylsulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one | ESD-890457-250MG |
| Cas.: 139755-82-1 | Purity: ≥95% | 5-(2-Ethoxy-5-(piperazin-1-ylsulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one | ESD-890457-1G |
| Cas.: 139755-82-1 | Purity: ≥95% | 5-(2-Ethoxy-5-(piperazin-1-ylsulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one | ESD-890457-5G |
| Cas.: 139755-82-1 | Purity: ≥95% | 5-(2-Ethoxy-5-(piperazin-1-ylsulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one | ESD-890457-10G |
| Cas.: 452105-23-6 | Purity: ≥95% | SU14813 | ESD-890458-5MG |
| Cas.: 114747-44-3 | Purity: 95% | 6′-(Indolin-1-yl)-1,3,3-trimethylspiro[indoline-2,3′-naphtho[2,1-b][1,4]oxazine] | ESD-890459-1G |
| Cas.: 114747-44-3 | Purity: 95% | 6′-(Indolin-1-yl)-1,3,3-trimethylspiro[indoline-2,3′-naphtho[2,1-b][1,4]oxazine] | ESD-890459-5G |
| Cas.: 114747-44-3 | Purity: 95% | 6′-(Indolin-1-yl)-1,3,3-trimethylspiro[indoline-2,3′-naphtho[2,1-b][1,4]oxazine] | ESD-890459-10G |
| Cas.: 1335210-35-9 | Purity: 97% | (4R,12AS)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1′ ,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide | ESD-890460-100MG |
| Cas.: 1335210-35-9 | Purity: 97% | (4R,12AS)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1′ ,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide | ESD-890460-250MG |
| Cas.: 214750-74-0 | Purity: 97% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(((allyloxy)carbonyl)amino)pentanoic acid | ESD-890461-250MG |
| Cas.: 214750-74-0 | Purity: 97% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(((allyloxy)carbonyl)amino)pentanoic acid | ESD-890461-1G |
| Cas.: 214750-74-0 | Purity: 97% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(((allyloxy)carbonyl)amino)pentanoic acid | ESD-890461-5G |
| Cas.: 958293-23-7 | Purity: ≥95% | 5,5-Dioctyl-3,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5H-dibenzo[b,d]silole | ESD-890462-100MG |
| Cas.: 1732-96-3 | Purity: ≥95% | Ethane-1,2-diylbis(1,3-dioxo-1,3-dihydroisobenzofuran-5-carboxylate) | ESD-890463-250MG |
| Cas.: 1732-96-3 | Purity: ≥95% | Ethane-1,2-diylbis(1,3-dioxo-1,3-dihydroisobenzofuran-5-carboxylate) | ESD-890463-1G |
| Cas.: 1732-96-3 | Purity: ≥95% | Ethane-1,2-diylbis(1,3-dioxo-1,3-dihydroisobenzofuran-5-carboxylate) | ESD-890463-5G |
| Cas.: 1732-96-3 | Purity: ≥95% | Ethane-1,2-diylbis(1,3-dioxo-1,3-dihydroisobenzofuran-5-carboxylate) | ESD-890463-10G |
| Cas.: 805245-41-4 | Purity: ≥95% | tert-Butyl(((3aR,4R,6aR)-5-fluoro-2,2-dimethyl-6-((trityloxy)methyl)-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol -4-yl)oxy)diphenylsilane | ESD-890464-100MG |
| Cas.: 805245-41-4 | Purity: ≥95% | tert-Butyl(((3aR,4R,6aR)-5-fluoro-2,2-dimethyl-6-((trityloxy)methyl)-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol -4-yl)oxy)diphenylsilane | ESD-890464-250MG |
| Cas.: 689293-69-4 | Purity: ≥95% | 2-Methyl-3-tritylamino-4-[(2-N-bocamino)ethylaminoacarbonyl]amino-2H-pyrazole | ESD-890465-250MG |
| Cas.: 689293-69-4 | Purity: ≥95% | 2-Methyl-3-tritylamino-4-[(2-N-bocamino)ethylaminoacarbonyl]amino-2H-pyrazole | ESD-890465-1G |
| Cas.: 689293-69-4 | Purity: ≥95% | 2-Methyl-3-tritylamino-4-[(2-N-bocamino)ethylaminoacarbonyl]amino-2H-pyrazole | ESD-890465-5G |
| Cas.: 148515-78-0 | Purity: 97% | Fmoc-N(Hmb)-Gly-OH | ESD-890466-100MG |
| Cas.: 148515-78-0 | Purity: 97% | Fmoc-N(Hmb)-Gly-OH | ESD-890466-250MG |
| Cas.: 148515-78-0 | Purity: 97% | Fmoc-N(Hmb)-Gly-OH | ESD-890466-1G |
| Cas.: 148515-78-0 | Purity: 97% | Fmoc-N(Hmb)-Gly-OH | ESD-890466-5G |
| Cas.: 289042-10-0 | Purity: 97% | N-(5-((Diphenylphosphoryl)methyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide | ESD-890467-250MG |
| Cas.: 289042-10-0 | Purity: 97% | N-(5-((Diphenylphosphoryl)methyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide | ESD-890467-1G |
| Cas.: 289042-10-0 | Purity: 97% | N-(5-((Diphenylphosphoryl)methyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide | ESD-890467-5G |
| Cas.: 289042-10-0 | Purity: 97% | N-(5-((Diphenylphosphoryl)methyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide | ESD-890467-10G |
| Cas.: 201485-38-3 | Purity: 97% | Fmoc-D-HoCit-OH | ESD-890468-100MG |
| Cas.: 201485-38-3 | Purity: 97% | Fmoc-D-HoCit-OH | ESD-890468-250MG |
| Cas.: 201485-38-3 | Purity: 97% | Fmoc-D-HoCit-OH | ESD-890468-1G |
| Cas.: 201485-38-3 | Purity: 97% | Fmoc-D-HoCit-OH | ESD-890468-5G |
| Cas.: 201485-17-8 | Purity: 97% | Fmoc-HoCit-OH | ESD-890469-250MG |
| Cas.: 201485-17-8 | Purity: 97% | Fmoc-HoCit-OH | ESD-890469-1G |
| Cas.: 201485-17-8 | Purity: 97% | Fmoc-HoCit-OH | ESD-890469-5G |
| Cas.: 201485-17-8 | Purity: 97% | Fmoc-HoCit-OH | ESD-890469-10G |
| Cas.: 166881-43-2 | Purity: 97% | Fmoc-N-(2,4,6-trimethoxybenzyl)-glycine | ESD-890470-100MG |
| Cas.: 166881-43-2 | Purity: 97% | Fmoc-N-(2,4,6-trimethoxybenzyl)-glycine | ESD-890470-250MG |
| Cas.: 478183-58-3 | Purity: ≥95% | Fmoc-Tyr(3-Cl)-OH | ESD-890471-250MG |
| Cas.: 478183-58-3 | Purity: ≥95% | Fmoc-Tyr(3-Cl)-OH | ESD-890471-1G |
| Cas.: 478183-58-3 | Purity: ≥95% | Fmoc-Tyr(3-Cl)-OH | ESD-890471-5G |
| Cas.: 478183-58-3 | Purity: ≥95% | Fmoc-Tyr(3-Cl)-OH | ESD-890471-10G |
| Cas.: 849928-23-0 | Purity: ≥95% | 2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-8-(tert-butoxycarbonyl)-2,8-diazaspiro[4.5]decane-3-carboxylic acid | ESD-890472-100MG |
| Cas.: 849928-23-0 | Purity: ≥95% | 2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-8-(tert-butoxycarbonyl)-2,8-diazaspiro[4.5]decane-3-carboxylic acid | ESD-890472-250MG |
| Cas.: 210282-31-8 | Purity: ≥95% | Fmoc-Phe(3-I)-OH | ESD-890473-250MG |
| Cas.: 210282-31-8 | Purity: ≥95% | Fmoc-Phe(3-I)-OH | ESD-890473-1G |
| Cas.: 210282-31-8 | Purity: ≥95% | Fmoc-Phe(3-I)-OH | ESD-890473-5G |
| Cas.: 210282-31-8 | Purity: ≥95% | Fmoc-Phe(3-I)-OH | ESD-890473-10G |
| Cas.: 869199-61-1 | Purity: 97% | N-(3-Chloro-4-fluorophenyl)-N-(7-methoxy-6-nitroquinazolin-4-yl)acetamide | ESD-890474-100MG |
| Cas.: 869199-61-1 | Purity: 97% | N-(3-Chloro-4-fluorophenyl)-N-(7-methoxy-6-nitroquinazolin-4-yl)acetamide | ESD-890474-250MG |
| Cas.: 869199-61-1 | Purity: 97% | N-(3-Chloro-4-fluorophenyl)-N-(7-methoxy-6-nitroquinazolin-4-yl)acetamide | ESD-890474-1G |
| Cas.: 270063-49-5 | Purity: ≥95% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(2,4-dichlorophenyl)butanoic acid | ESD-890475-100MG |
| Cas.: 270063-49-5 | Purity: ≥95% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(2,4-dichlorophenyl)butanoic acid | ESD-890475-250MG |
| Cas.: 270063-49-5 | Purity: ≥95% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(2,4-dichlorophenyl)butanoic acid | ESD-890475-1G |
| Cas.: 269396-54-5 | Purity: 95% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(2,4-dichlorophenyl)butanoic acid | ESD-890476-100MG |
| Cas.: 269396-54-5 | Purity: 95% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(2,4-dichlorophenyl)butanoic acid | ESD-890476-250MG |
| Cas.: 269396-54-5 | Purity: 95% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(2,4-dichlorophenyl)butanoic acid | ESD-890476-1G |
| Cas.: 1351636-18-4 | Purity: ≥98% | ONO-4059 | ESD-890477-1MG |
| Cas.: 1351636-18-4 | Purity: ≥98% | ONO-4059 | ESD-890477-5MG |
| Cas.: 1351636-18-4 | Purity: ≥98% | ONO-4059 | ESD-890477-10MG |
| Cas.: 1351636-18-4 | Purity: ≥98% | ONO-4059 | ESD-890477-25MG |
| Cas.: 200344-33-8 | Purity: 97% | Fmoc-D-Cit-OH | ESD-890478-250MG |
| Cas.: 200344-33-8 | Purity: 97% | Fmoc-D-Cit-OH | ESD-890478-1G |
| Cas.: 200344-33-8 | Purity: 97% | Fmoc-D-Cit-OH | ESD-890478-5G |
| Cas.: 200344-33-8 | Purity: 97% | Fmoc-D-Cit-OH | ESD-890478-10G |
| Cas.: 246539-83-3 | Purity: ≥98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-hydroxyphenyl)-2-methylpropanoic acid | ESD-890479-100MG |
| Cas.: 246539-83-3 | Purity: ≥98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-hydroxyphenyl)-2-methylpropanoic acid | ESD-890479-250MG |
| Cas.: 27589-33-9 | Purity: 97% | 2-Chloro-5-(2H-tetrazol-5-yl)-4-((thiophen-2-ylmethyl)amino)benzenesulfonamide | ESD-890480-250MG |
| Cas.: 27589-33-9 | Purity: 97% | 2-Chloro-5-(2H-tetrazol-5-yl)-4-((thiophen-2-ylmethyl)amino)benzenesulfonamide | ESD-890480-1G |
| Cas.: 27589-33-9 | Purity: 97% | 2-Chloro-5-(2H-tetrazol-5-yl)-4-((thiophen-2-ylmethyl)amino)benzenesulfonamide | ESD-890480-5G |
| Cas.: 27589-33-9 | Purity: 97% | 2-Chloro-5-(2H-tetrazol-5-yl)-4-((thiophen-2-ylmethyl)amino)benzenesulfonamide | ESD-890480-10G |
| Cas.: 114360-56-4 | Purity: ≥95% | Fmoc-D-Dab(Boc)-OH | ESD-890481-100MG |
| Cas.: 114360-56-4 | Purity: ≥95% | Fmoc-D-Dab(Boc)-OH | ESD-890481-250MG |
| Cas.: 114360-56-4 | Purity: ≥95% | Fmoc-D-Dab(Boc)-OH | ESD-890481-1G |
| Cas.: 110351-94-5 | Purity: ≥95% | (S)-4-Ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione | ESD-890482-100MG |
| Cas.: 110351-94-5 | Purity: ≥95% | (S)-4-Ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione | ESD-890482-250MG |
| Cas.: 18814-49-8 | Purity: 97% | Boc-Ala-D-Glu(OBzl)-NH2 | ESD-890483-1G |
| Cas.: 18814-49-8 | Purity: 97% | Boc-Ala-D-Glu(OBzl)-NH2 | ESD-890483-5G |
| Cas.: 2465-59-0 | Purity: 98% | 1H-Pyrazolo[3,4-d]pyrimidine-4,6-diol | ESD-890484-100MG |
| Cas.: 2465-59-0 | Purity: 98% | 1H-Pyrazolo[3,4-d]pyrimidine-4,6-diol | ESD-890484-250MG |
| Cas.: 2465-59-0 | Purity: 98% | 1H-Pyrazolo[3,4-d]pyrimidine-4,6-diol | ESD-890484-1G |
| Cas.: 1800044-75-0 | Purity: ≥95% | (Z)-N-(1-Chloro-1-(2-cyanophenyl)-3-oxo-3-(pipidin-1-yl)prop-1-en-2-yl)benzamide | ESD-890485-100MG |
| Cas.: 1800044-75-0 | Purity: ≥95% | (Z)-N-(1-Chloro-1-(2-cyanophenyl)-3-oxo-3-(pipidin-1-yl)prop-1-en-2-yl)benzamide | ESD-890485-250MG |
| Cas.: 1800044-76-1 | Purity: ≥95% | (Z)-N-(1-Chloro-1-(2-nitrophenyl)-3-oxo-3-(pipidin-1-yl)prop-1-en-2-yl)benzamide | ESD-890486-100MG |
| Cas.: 1800044-76-1 | Purity: ≥95% | (Z)-N-(1-Chloro-1-(2-nitrophenyl)-3-oxo-3-(pipidin-1-yl)prop-1-en-2-yl)benzamide | ESD-890486-250MG |
| Cas.: 70785-61-4 | Purity: ≥95% | (R)-2-(4-Hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetic acid | ESD-890487-250MG |
| Cas.: 70785-61-4 | Purity: ≥95% | (R)-2-(4-Hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetic acid | ESD-890487-1G |
| Cas.: 70785-61-4 | Purity: ≥95% | (R)-2-(4-Hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetic acid | ESD-890487-5G |
| Cas.: 378247-75-7 | Purity: ≥95% | 2-(7-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-oxo-2H-chromen-4-yl)acetic acid | ESD-890488-100MG |
| Cas.: 378247-75-7 | Purity: ≥95% | 2-(7-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-oxo-2H-chromen-4-yl)acetic acid | ESD-890488-250MG |
| Cas.: 55592-85-3 | Purity: 97% | 2,6-Bis(((benzyloxy)carbonyl)amino)hexanoic acid | ESD-890489-1G |
| Cas.: 55592-85-3 | Purity: 97% | 2,6-Bis(((benzyloxy)carbonyl)amino)hexanoic acid | ESD-890489-5G |
| Cas.: 55592-85-3 | Purity: 97% | 2,6-Bis(((benzyloxy)carbonyl)amino)hexanoic acid | ESD-890489-10G |
| Cas.: 55592-85-3 | Purity: 97% | 2,6-Bis(((benzyloxy)carbonyl)amino)hexanoic acid | ESD-890489-25G |
| Cas.: 511272-37-0 | Purity: 96% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,4-dichlorophenyl)propanoic acid | ESD-890490-100MG |
| Cas.: 511272-37-0 | Purity: 96% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,4-dichlorophenyl)propanoic acid | ESD-890490-250MG |
| Cas.: 352351-62-3 | Purity: ≥95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,4-dichlorophenyl)propanoic acid | ESD-890491-250MG |
| Cas.: 352351-62-3 | Purity: ≥95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,4-dichlorophenyl)propanoic acid | ESD-890491-1G |
| Cas.: 352351-62-3 | Purity: ≥95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,4-dichlorophenyl)propanoic acid | ESD-890491-5G |
| Cas.: 352351-62-3 | Purity: ≥95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,4-dichlorophenyl)propanoic acid | ESD-890491-10G |
| Cas.: 501015-34-5 | Purity: 96% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,4-dichlorophenyl)propanoic acid | ESD-890492-100MG |
| Cas.: 501015-34-5 | Purity: 96% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,4-dichlorophenyl)propanoic acid | ESD-890492-250MG |
| Cas.: 135944-08-0 | Purity: 95% | 2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid | ESD-890493-250MG |
| Cas.: 57105-50-7 | Purity: 97% | (S)-2-(2-(1H-Indol-3-yl)acetamido)-3-phenylpropanoic acid | ESD-890494-1G |
| Cas.: 57105-50-7 | Purity: 97% | (S)-2-(2-(1H-Indol-3-yl)acetamido)-3-phenylpropanoic acid | ESD-890494-5G |
| Cas.: 57105-50-7 | Purity: 97% | (S)-2-(2-(1H-Indol-3-yl)acetamido)-3-phenylpropanoic acid | ESD-890494-10G |
| Cas.: 478183-67-4 | Purity: 97% | Fmoc-D-Phe(3-I)-OH | ESD-890495-250MG |
| Cas.: 478183-67-4 | Purity: 97% | Fmoc-D-Phe(3-I)-OH | ESD-890495-1G |
| Cas.: 478183-67-4 | Purity: 97% | Fmoc-D-Phe(3-I)-OH | ESD-890495-5G |
| Cas.: 478183-67-4 | Purity: 97% | Fmoc-D-Phe(3-I)-OH | ESD-890495-10G |
| Cas.: 73630-07-6 | Purity: 98% | Tetraethyl 2,2′,2”,2”’-(((ethane-1,2-diylbis(oxy))bis(2,1-phenylene))bis(azanetriyl))tetraacetate | ESD-890496-250MG |
| Cas.: 73630-07-6 | Purity: 98% | Tetraethyl 2,2′,2”,2”’-(((ethane-1,2-diylbis(oxy))bis(2,1-phenylene))bis(azanetriyl))tetraacetate | ESD-890496-1G |
| Cas.: 73630-07-6 | Purity: 98% | Tetraethyl 2,2′,2”,2”’-(((ethane-1,2-diylbis(oxy))bis(2,1-phenylene))bis(azanetriyl))tetraacetate | ESD-890496-5G |
| Cas.: 73630-07-6 | Purity: 98% | Tetraethyl 2,2′,2”,2”’-(((ethane-1,2-diylbis(oxy))bis(2,1-phenylene))bis(azanetriyl))tetraacetate | ESD-890496-10G |
| Cas.: 154477-55-1 | Purity: ≥95% | Methyl 2-(4-(4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butanoyl)phenyl)-2-methylpropanoate | ESD-890497-1G |
| Cas.: 154477-55-1 | Purity: ≥95% | Methyl 2-(4-(4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butanoyl)phenyl)-2-methylpropanoate | ESD-890497-5G |
| Cas.: 154477-55-1 | Purity: ≥95% | Methyl 2-(4-(4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butanoyl)phenyl)-2-methylpropanoate | ESD-890497-10G |
| Cas.: 154477-55-1 | Purity: ≥95% | Methyl 2-(4-(4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butanoyl)phenyl)-2-methylpropanoate | ESD-890497-25G |
| Cas.: 220497-79-0 | Purity: 98% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-bromophenyl)propanoic acid | ESD-890498-250MG |
| Cas.: 220497-79-0 | Purity: 98% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-bromophenyl)propanoic acid | ESD-890498-1G |
| Cas.: 220497-79-0 | Purity: 98% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-bromophenyl)propanoic acid | ESD-890498-5G |
| Cas.: 220497-79-0 | Purity: 98% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-bromophenyl)propanoic acid | ESD-890498-10G |
| Cas.: 73724-48-8 | Purity: ≥95% | Fmoc-Thr-Obzl | ESD-890499-250MG |
| Cas.: 73724-48-8 | Purity: ≥95% | Fmoc-Thr-Obzl | ESD-890499-1G |
| Cas.: 69876-37-5 | Purity: 97% | Z-Trp-OBzl | ESD-890500-1G |
| Cas.: 69876-37-5 | Purity: 97% | Z-Trp-OBzl | ESD-890500-5G |
| Cas.: 69876-37-5 | Purity: 97% | Z-Trp-OBzl | ESD-890500-10G |
| Cas.: 69876-37-5 | Purity: 97% | Z-Trp-OBzl | ESD-890500-25G |
| Cas.: 144164-11-4 | Purity: 95% | Thiazol-5-ylmethyl ((2S,3S,5S)-5-amino-3-hydroxy-1,6-diphenylhexan-2-yl)carbamate | ESD-890501-250MG |
| Cas.: 144164-11-4 | Purity: 95% | Thiazol-5-ylmethyl ((2S,3S,5S)-5-amino-3-hydroxy-1,6-diphenylhexan-2-yl)carbamate | ESD-890501-1G |
| Cas.: 144164-11-4 | Purity: 95% | Thiazol-5-ylmethyl ((2S,3S,5S)-5-amino-3-hydroxy-1,6-diphenylhexan-2-yl)carbamate | ESD-890501-5G |
| Cas.: 133852-23-0 | Purity: ≥95% | Fmoc-Tyr-OtBu | ESD-890502-1G |
| Cas.: 133852-23-0 | Purity: ≥95% | Fmoc-Tyr-OtBu | ESD-890502-5G |
| Cas.: 501015-35-6 | Purity: ≥95% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,3-dichlorophenyl)propanoic acid | ESD-890503-100MG |
| Cas.: 501015-35-6 | Purity: ≥95% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,3-dichlorophenyl)propanoic acid | ESD-890503-250MG |
| Cas.: 501015-35-6 | Purity: ≥95% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,3-dichlorophenyl)propanoic acid | ESD-890503-1G |
| Cas.: 511272-38-1 | Purity: 97% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,3-dichlorophenyl)propanoic acid | ESD-890504-100MG |
| Cas.: 511272-38-1 | Purity: 97% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,3-dichlorophenyl)propanoic acid | ESD-890504-250MG |
| Cas.: 198544-42-2 | Purity: ≥95% | Fmoc-D-Dap(Boc)-OH | ESD-890505-250MG |
| Cas.: 198544-42-2 | Purity: ≥95% | Fmoc-D-Dap(Boc)-OH | ESD-890505-1G |
| Cas.: 198544-42-2 | Purity: ≥95% | Fmoc-D-Dap(Boc)-OH | ESD-890505-5G |
| Cas.: 198544-42-2 | Purity: ≥95% | Fmoc-D-Dap(Boc)-OH | ESD-890505-10G |
| Cas.: 204251-86-5 | Purity: 97% | (R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(allyloxy)-5-oxopentanoic acid | ESD-890506-250MG |
| Cas.: 204251-86-5 | Purity: 97% | (R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(allyloxy)-5-oxopentanoic acid | ESD-890506-1G |
| Cas.: 204251-86-5 | Purity: 97% | (R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(allyloxy)-5-oxopentanoic acid | ESD-890506-5G |
| Cas.: 148901-69-3 | Purity: 96% | (E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoic acid ethyl esterr | ESD-890186-250MG |
| Cas.: 148901-69-3 | Purity: 96% | (E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoic acid ethyl esterr | ESD-890186-10G |
| Cas.: 327156-92-3 | Purity: ≥95% | Dicyclohexylamine (S)-4-(((allyloxy)carbonyl)amino)-2-((tert-butoxycarbonyl)amino)butanoate | ESD-890507-100MG |
| Cas.: 327156-92-3 | Purity: ≥95% | Dicyclohexylamine (S)-4-(((allyloxy)carbonyl)amino)-2-((tert-butoxycarbonyl)amino)butanoate | ESD-890507-250MG |
| Cas.: 327156-92-3 | Purity: ≥95% | Dicyclohexylamine (S)-4-(((allyloxy)carbonyl)amino)-2-((tert-butoxycarbonyl)amino)butanoate | ESD-890507-1G |
| Cas.: 327156-92-3 | Purity: ≥95% | Dicyclohexylamine (S)-4-(((allyloxy)carbonyl)amino)-2-((tert-butoxycarbonyl)amino)butanoate | ESD-890507-5G |
| Cas.: 273222-06-3 | Purity: 97% | (2S,4R)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4-((tert-butoxycarbonyl)amino)pyrrolidine-2-carboxylic acid | ESD-890508-100MG |
| Cas.: 273222-06-3 | Purity: 97% | (2S,4R)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4-((tert-butoxycarbonyl)amino)pyrrolidine-2-carboxylic acid | ESD-890508-250MG |
| Cas.: 866030-35-5 | Purity: ≥95% | tert-Butyl ((1S,3S)-1-((2S,4S)-4-isopropyl-5-oxotetrahydrofuran-2-yl)-3-(4-methoxy-3-(3-methoxypropoxy)benzyl)-4 -methylpentyl)carbamate | ESD-890509-1G |
| Cas.: 866030-35-5 | Purity: ≥95% | tert-Butyl ((1S,3S)-1-((2S,4S)-4-isopropyl-5-oxotetrahydrofuran-2-yl)-3-(4-methoxy-3-(3-methoxypropoxy)benzyl)-4 -methylpentyl)carbamate | ESD-890509-5G |
| Cas.: 866030-35-5 | Purity: ≥95% | tert-Butyl ((1S,3S)-1-((2S,4S)-4-isopropyl-5-oxotetrahydrofuran-2-yl)-3-(4-methoxy-3-(3-methoxypropoxy)benzyl)-4 -methylpentyl)carbamate | ESD-890509-10G |
| Cas.: 415694-42-7 | Purity: 97% | N,N’-(1,3-Phenylenebis(methylene))bis(furan-2-carboxamide) | ESD-890510-100MG |
| Cas.: 415694-42-7 | Purity: 97% | N,N’-(1,3-Phenylenebis(methylene))bis(furan-2-carboxamide) | ESD-890510-250MG |
| Cas.: 26988-61-4 | Purity: 95% | (R)-2-(2-Amino-3-(tritylthio)propanamido)acetic acid | ESD-890511-1G |
| Cas.: 26988-61-4 | Purity: 95% | (R)-2-(2-Amino-3-(tritylthio)propanamido)acetic acid | ESD-890511-5G |
| Cas.: 26988-61-4 | Purity: 95% | (R)-2-(2-Amino-3-(tritylthio)propanamido)acetic acid | ESD-890511-10G |
| Cas.: 53759-36-7 | Purity: 97% | Boc-Ala-D-Glu(OBzl)-OH | ESD-890512-250MG |
| Cas.: 53759-36-7 | Purity: 97% | Boc-Ala-D-Glu(OBzl)-OH | ESD-890512-1G |
| Cas.: 53759-36-7 | Purity: 97% | Boc-Ala-D-Glu(OBzl)-OH | ESD-890512-5G |
| Cas.: 3243-24-1 | Purity: ≥95% | 1H-Imidazo[4,5-c]pyridin-4-ol | ESD-890513-100MG |
| Cas.: 3243-24-1 | Purity: ≥95% | 1H-Imidazo[4,5-c]pyridin-4-ol | ESD-890513-250MG |
| Cas.: 3243-24-1 | Purity: ≥95% | 1H-Imidazo[4,5-c]pyridin-4-ol | ESD-890513-1G |
| Cas.: 7327-87-9 | Purity: 98% | 1,4-Dihydrazinylphthalazine sulfate | ESD-890514-25MG |
| Cas.: 7327-87-9 | Purity: 98% | 1,4-Dihydrazinylphthalazine sulfate | ESD-890514-100MG |
| Cas.: 7327-87-9 | Purity: 98% | 1,4-Dihydrazinylphthalazine sulfate | ESD-890514-250MG |
| Cas.: 201335-88-8 | Purity: 97% | Fmoc-D-Tyr(Me)-OH | ESD-890515-250MG |
| Cas.: 201335-88-8 | Purity: 97% | Fmoc-D-Tyr(Me)-OH | ESD-890515-1G |
| Cas.: 201335-88-8 | Purity: 97% | Fmoc-D-Tyr(Me)-OH | ESD-890515-5G |
| Cas.: 201335-88-8 | Purity: 97% | Fmoc-D-Tyr(Me)-OH | ESD-890515-10G |
| Cas.: 330785-84-7 | Purity: 98% | (S)-4-((3-Chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxylic acid | ESD-890516-250MG |
| Cas.: 330785-84-7 | Purity: 98% | (S)-4-((3-Chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxylic acid | ESD-890516-1G |
| Cas.: 206060-40-4 | Purity: ≥95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-methoxyphenyl)propanoic acid | ESD-890517-100MG |
| Cas.: 206060-40-4 | Purity: ≥95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-methoxyphenyl)propanoic acid | ESD-890517-250MG |
| Cas.: 206060-40-4 | Purity: ≥95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-methoxyphenyl)propanoic acid | ESD-890517-1G |
| Cas.: 206060-40-4 | Purity: ≥95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-methoxyphenyl)propanoic acid | ESD-890517-5G |
| Cas.: 27948-61-4 | Purity: ≥95% | (R)-1-(Furan-2-yl)ethanol | ESD-890518-100MG |
| Cas.: 27948-61-4 | Purity: ≥95% | (R)-1-(Furan-2-yl)ethanol | ESD-890518-250MG |
| Cas.: 27948-61-4 | Purity: ≥95% | (R)-1-(Furan-2-yl)ethanol | ESD-890518-1G |
| Cas.: 270062-91-4 | Purity: 97% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(o-tolyl)butanoic acid | ESD-890519-100MG |
| Cas.: 270062-91-4 | Purity: 97% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(o-tolyl)butanoic acid | ESD-890519-250MG |
| Cas.: 270062-91-4 | Purity: 97% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(o-tolyl)butanoic acid | ESD-890519-1G |
| Cas.: 131545-63-6 | Purity: ≥95% | (2R,3S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(benzyloxy)butanoic acid | ESD-890520-100MG |
| Cas.: 131545-63-6 | Purity: ≥95% | (2R,3S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(benzyloxy)butanoic acid | ESD-890520-250MG |
| Cas.: 131545-63-6 | Purity: ≥95% | (2R,3S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(benzyloxy)butanoic acid | ESD-890520-1G |
| Cas.: 131545-63-6 | Purity: ≥95% | (2R,3S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(benzyloxy)butanoic acid | ESD-890520-5G |
| Cas.: 1261470-87-4 | Purity: 97% | 4-Bromo-2-iodobenzaldehyde | ESD-890521-100MG |
| Cas.: 1261470-87-4 | Purity: 97% | 4-Bromo-2-iodobenzaldehyde | ESD-890521-250MG |
| Cas.: 1261470-87-4 | Purity: 97% | 4-Bromo-2-iodobenzaldehyde | ESD-890521-1G |
| Cas.: 1261470-87-4 | Purity: 97% | 4-Bromo-2-iodobenzaldehyde | ESD-890521-5G |
| Cas.: 1000980-71-1 | Purity: 95% | 2-Chloro-N-[(3-iodophenyl)methyl]-2′,3′-O-(1-methylethylidene) Adenosine | ESD-890522-100MG |
| Cas.: 1000980-71-1 | Purity: 95% | 2-Chloro-N-[(3-iodophenyl)methyl]-2′,3′-O-(1-methylethylidene) Adenosine | ESD-890522-250MG |
| Cas.: 479064-92-1 | Purity: ≥95% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-chlorophenyl)propanoic acid | ESD-890523-250MG |
| Cas.: 479064-92-1 | Purity: ≥95% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-chlorophenyl)propanoic acid | ESD-890523-1G |
| Cas.: 479064-92-1 | Purity: ≥95% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-chlorophenyl)propanoic acid | ESD-890523-5G |
| Cas.: 151541-15-0 | Purity: ≥95% | Ethyl 3-(4-(benzyloxy)-3,5-dimethoxyphenyl)-3-hydroxy-2-(2-methoxyphenoxy)propanoate | ESD-890524-100MG |
| Cas.: 151541-15-0 | Purity: ≥95% | Ethyl 3-(4-(benzyloxy)-3,5-dimethoxyphenyl)-3-hydroxy-2-(2-methoxyphenoxy)propanoate | ESD-890524-250MG |
| Cas.: 151541-15-0 | Purity: ≥95% | Ethyl 3-(4-(benzyloxy)-3,5-dimethoxyphenyl)-3-hydroxy-2-(2-methoxyphenoxy)propanoate | ESD-890524-1G |
| Cas.: 151541-15-0 | Purity: ≥95% | Ethyl 3-(4-(benzyloxy)-3,5-dimethoxyphenyl)-3-hydroxy-2-(2-methoxyphenoxy)propanoate | ESD-890524-5G |
| Cas.: 198560-44-0 | Purity: 98% | Fmoc-Phe(3-Cl)-OH | ESD-890525-1G |
| Cas.: 198560-44-0 | Purity: 98% | Fmoc-Phe(3-Cl)-OH | ESD-890525-5G |
| Cas.: 198560-44-0 | Purity: 98% | Fmoc-Phe(3-Cl)-OH | ESD-890525-10G |
| Cas.: 198560-44-0 | Purity: 98% | Fmoc-Phe(3-Cl)-OH | ESD-890525-25G |
| Cas.: 24787-87-9 | Purity: 97% | Z-Ser-Ala-OH | ESD-890526-250MG |
| Cas.: 24787-87-9 | Purity: 97% | Z-Ser-Ala-OH | ESD-890526-1G |
| Cas.: 3001-45-4 | Purity: 97% | 6-Amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-7H-purine-8(9H)-thione | ESD-890527-100MG |
| Cas.: 3001-45-4 | Purity: 97% | 6-Amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-7H-purine-8(9H)-thione | ESD-890527-250MG |
| Cas.: 1029721-02-5 | Purity: 97% | 4-Oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxylic acid | ESD-890528-100MG |
| Cas.: 1029721-02-5 | Purity: 97% | 4-Oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxylic acid | ESD-890528-250MG |
| Cas.: 1029721-02-5 | Purity: 97% | 4-Oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxylic acid | ESD-890528-1G |
| Cas.: 1029721-02-5 | Purity: 97% | 4-Oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxylic acid | ESD-890528-5G |
| Cas.: 628316-50-7 | Purity: 97% | 5,12-Bis((triisopropylsilyl)ethynyl)tetracene | ESD-890529-100MG |
| Cas.: 628316-50-7 | Purity: 97% | 5,12-Bis((triisopropylsilyl)ethynyl)tetracene | ESD-890529-250MG |
| Cas.: 141743-15-9 | Purity: 97% | Fmoc-N-(2-Boc-aminoethyl)-Gly-OH | ESD-890530-250MG |
| Cas.: 141743-15-9 | Purity: 97% | Fmoc-N-(2-Boc-aminoethyl)-Gly-OH | ESD-890530-1G |
| Cas.: 141743-15-9 | Purity: 97% | Fmoc-N-(2-Boc-aminoethyl)-Gly-OH | ESD-890530-5G |
| Cas.: 133906-29-3 | Purity: 96% | Boc-Glu-Ofm | ESD-890531-1G |
| Cas.: 133906-29-3 | Purity: 96% | Boc-Glu-Ofm | ESD-890531-5G |
| Cas.: 183742-34-9 | Purity: 97% | 4-Boc-1-Fmoc-2-piperazineacetic acid | ESD-890532-100MG |
| Cas.: 183742-34-9 | Purity: 97% | 4-Boc-1-Fmoc-2-piperazineacetic acid | ESD-890532-250MG |
| Cas.: 183742-34-9 | Purity: 97% | 4-Boc-1-Fmoc-2-piperazineacetic acid | ESD-890532-1G |
| Cas.: 183742-34-9 | Purity: 97% | 4-Boc-1-Fmoc-2-piperazineacetic acid | ESD-890532-5G |
| Cas.: 1800044-79-4 | Purity: ≥95% | (Z)-N-(1-(4-Bromophenyl)-1-chloro-3-oxo-3-(pipidin-1-yl)prop-1-en-2-yl)benzamide | ESD-890533-100MG |
| Cas.: 1800044-79-4 | Purity: ≥95% | (Z)-N-(1-(4-Bromophenyl)-1-chloro-3-oxo-3-(pipidin-1-yl)prop-1-en-2-yl)benzamide | ESD-890533-250MG |
| Cas.: 114747-45-4 | Purity: 97% | 1,3,3-Trimethyl-6′-(pipidin-1-yl)spiro[indoline-2,3′-naphtho[2,1-b][1,4]oxazine] | ESD-890534-100MG |
| Cas.: 114747-45-4 | Purity: 97% | 1,3,3-Trimethyl-6′-(pipidin-1-yl)spiro[indoline-2,3′-naphtho[2,1-b][1,4]oxazine] | ESD-890534-250MG |
| Cas.: 114747-45-4 | Purity: 97% | 1,3,3-Trimethyl-6′-(pipidin-1-yl)spiro[indoline-2,3′-naphtho[2,1-b][1,4]oxazine] | ESD-890534-1G |
| Cas.: 103188-46-1 | Purity: ≥95% | (E)-N-(3,4-Dihydroxyphenethyl)-3-(4-hydroxyphenyl)acrylamide | ESD-890535-100MG |
| Cas.: 103188-46-1 | Purity: ≥95% | (E)-N-(3,4-Dihydroxyphenethyl)-3-(4-hydroxyphenyl)acrylamide | ESD-890535-250MG |
| Cas.: 270063-55-3 | Purity: 98% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(3,4-difluorophenyl)butanoic acid | ESD-890536-100MG |
| Cas.: 270063-55-3 | Purity: 98% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(3,4-difluorophenyl)butanoic acid | ESD-890536-250MG |
| Cas.: 270063-55-3 | Purity: 98% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(3,4-difluorophenyl)butanoic acid | ESD-890536-1G |
| Cas.: 1323140-64-2 | Purity: ≥95% | (Z)-N-(1-Chloro-1-(4-methoxyphenyl)-3-oxo-3-(pipidin-1-yl)prop-1-en-2-yl)benzamide | ESD-890537-100MG |
| Cas.: 1323140-64-2 | Purity: ≥95% | (Z)-N-(1-Chloro-1-(4-methoxyphenyl)-3-oxo-3-(pipidin-1-yl)prop-1-en-2-yl)benzamide | ESD-890537-250MG |
| Cas.: 161109-77-9 | Purity: ≥95% | (2R,3R,4S,5R)-2-(Acetoxymethyl)-5-(6-amino-2-fluoro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate | ESD-890538-250MG |
| Cas.: 161109-77-9 | Purity: ≥95% | (2R,3R,4S,5R)-2-(Acetoxymethyl)-5-(6-amino-2-fluoro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate | ESD-890538-1G |
| Cas.: 201472-68-6 | Purity: 97% | Boc-Dap(Boc)-OH.DCHA | ESD-890539-250MG |
| Cas.: 201472-68-6 | Purity: 97% | Boc-Dap(Boc)-OH.DCHA | ESD-890539-1G |
| Cas.: 201472-68-6 | Purity: 97% | Boc-Dap(Boc)-OH.DCHA | ESD-890539-5G |
| Cas.: 201472-68-6 | Purity: 97% | Boc-Dap(Boc)-OH.DCHA | ESD-890539-10G |
| Cas.: 511272-53-0 | Purity: ≥95% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-chlorophenyl)propanoic acid | ESD-890540-100MG |
| Cas.: 511272-53-0 | Purity: ≥95% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-chlorophenyl)propanoic acid | ESD-890540-250MG |
| Cas.: 511272-53-0 | Purity: ≥95% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-chlorophenyl)propanoic acid | ESD-890540-1G |
| Cas.: 1800044-77-2 | Purity: ≥95% | (Z)-N-(1-(2-Bromophenyl)-1-chloro-3-oxo-3-(pipidin-1-yl)prop-1-en-2-yl)benzamide | ESD-890541-100MG |
| Cas.: 1800044-77-2 | Purity: ≥95% | (Z)-N-(1-(2-Bromophenyl)-1-chloro-3-oxo-3-(pipidin-1-yl)prop-1-en-2-yl)benzamide | ESD-890541-250MG |
| Cas.: 269726-78-5 | Purity: 95% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(4-(trifluoromethyl)phenyl)butanoic acid | ESD-890542-100MG |
| Cas.: 269726-78-5 | Purity: 95% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(4-(trifluoromethyl)phenyl)butanoic acid | ESD-890542-250MG |
| Cas.: 269726-78-5 | Purity: 95% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(4-(trifluoromethyl)phenyl)butanoic acid | ESD-890542-1G |
| Cas.: 269726-78-5 | Purity: 95% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(4-(trifluoromethyl)phenyl)butanoic acid | ESD-890542-5G |
| Cas.: 887127-69-7 | Purity: 95% | 3,6-Dibromo-2,7-diiodophenanthrene-9,10-dione | ESD-890543-100MG |
| Cas.: 887127-69-7 | Purity: 95% | 3,6-Dibromo-2,7-diiodophenanthrene-9,10-dione | ESD-890543-250MG |
| Cas.: 887127-69-7 | Purity: 95% | 3,6-Dibromo-2,7-diiodophenanthrene-9,10-dione | ESD-890543-1G |
| Cas.: 84449-65-0 | Purity: ≥95% | 4-(6-((Methylsulfonyl)oxy)benzo[b]thiophen-2-yl)phenyl methanesulfonate | ESD-890544-100MG |
| Cas.: 84449-65-0 | Purity: ≥95% | 4-(6-((Methylsulfonyl)oxy)benzo[b]thiophen-2-yl)phenyl methanesulfonate | ESD-890544-250MG |
| Cas.: 84449-65-0 | Purity: ≥95% | 4-(6-((Methylsulfonyl)oxy)benzo[b]thiophen-2-yl)phenyl methanesulfonate | ESD-890544-1G |
| Cas.: 203854-62-0 | Purity: 98% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid | ESD-890545-100MG |
| Cas.: 203854-62-0 | Purity: 98% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid | ESD-890545-250MG |
| Cas.: 203854-62-0 | Purity: 98% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid | ESD-890545-1G |
| Cas.: 828254-16-6 | Purity: 97% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-benzylpropanoic acid | ESD-890546-50MG |
| Cas.: 20227-41-2 | Purity: 97% | (2R,3R,4S,5R)-5-(6-Amino-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol | ESD-890547-10MG |
| Cas.: 20227-41-2 | Purity: 97% | (2R,3R,4S,5R)-5-(6-Amino-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol | ESD-890547-100MG |
| Cas.: 64183-27-3 | Purity: 98% | 2′-Fluoro-2′-deoxyadenosine | ESD-890548-100MG |
| Cas.: 64183-27-3 | Purity: 98% | 2′-Fluoro-2′-deoxyadenosine | ESD-890548-250MG |
| Cas.: 64183-27-3 | Purity: 98% | 2′-Fluoro-2′-deoxyadenosine | ESD-890548-1G |
| Cas.: 64183-27-3 | Purity: 98% | 2′-Fluoro-2′-deoxyadenosine | ESD-890548-5G |
| Cas.: 75059-22-2 | Purity: ≥95% | (2R,3S,4S,5R)-2-(6-Amino-9H-purin-9-yl)-4-fluoro-5-(hydroxymethyl)tetrahydrofuran-3-ol | ESD-890549-10MG |
| Cas.: 75059-22-2 | Purity: ≥95% | (2R,3S,4S,5R)-2-(6-Amino-9H-purin-9-yl)-4-fluoro-5-(hydroxymethyl)tetrahydrofuran-3-ol | ESD-890549-100MG |
| Cas.: 54385-49-8 | Purity: ≥95% | 5-Amino-1H-pyrazole-3,4-dicarbonitrile | ESD-890550-100MG |
| Cas.: 54385-49-8 | Purity: ≥95% | 5-Amino-1H-pyrazole-3,4-dicarbonitrile | ESD-890550-250MG |
| Cas.: 54385-49-8 | Purity: ≥95% | 5-Amino-1H-pyrazole-3,4-dicarbonitrile | ESD-890550-1G |
| Cas.: 1034305-23-1 | Purity: ≥95% | (2S,3R,4S,5S,6R)-2-(3-(Benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3, 4,5-triol | ESD-890551-100MG |
| Cas.: 1034305-23-1 | Purity: ≥95% | (2S,3R,4S,5S,6R)-2-(3-(Benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3, 4,5-triol | ESD-890551-250MG |
| Cas.: 82038-34-4 | Purity: 97% | Boc-MeTyr-OH | ESD-890552-250MG |
| Cas.: 82038-34-4 | Purity: 97% | Boc-MeTyr-OH | ESD-890552-1G |
| Cas.: 82038-34-4 | Purity: 97% | Boc-MeTyr-OH | ESD-890552-5G |
| Cas.: 82038-34-4 | Purity: 97% | Boc-MeTyr-OH | ESD-890552-10G |
| Cas.: 6958-39-0 | Purity: ≥95% | 6,7-Dichloroquinazolin-4(3H)-one | ESD-890553-100MG |
| Cas.: 6958-39-0 | Purity: ≥95% | 6,7-Dichloroquinazolin-4(3H)-one | ESD-890553-250MG |
| Cas.: 6958-39-0 | Purity: ≥95% | 6,7-Dichloroquinazolin-4(3H)-one | ESD-890553-1G |
| Cas.: 60660-75-5 | Purity: 97% | (7S,9S)-9-Acetyl-6,7,9,11-tetrahydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione | ESD-890554-100MG |
| Cas.: 60660-75-5 | Purity: 97% | (7S,9S)-9-Acetyl-6,7,9,11-tetrahydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione | ESD-890554-250MG |
| Cas.: 1481642-14-1 | Purity: 97% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-methoxy-5-oxopentanoic acid | ESD-890555-250MG |
| Cas.: 1481642-14-1 | Purity: 97% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-methoxy-5-oxopentanoic acid | ESD-890555-1G |
| Cas.: 1481642-14-1 | Purity: 97% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-methoxy-5-oxopentanoic acid | ESD-890555-5G |
| Cas.: 1609071-04-6 | Purity: ≥95% | 5,6-Bis((4-methoxybenzyl)oxy)isobenzofuran-1,3-dione | ESD-890556-100MG |
| Cas.: 1609071-04-6 | Purity: ≥95% | 5,6-Bis((4-methoxybenzyl)oxy)isobenzofuran-1,3-dione | ESD-890556-250MG |
| Cas.: 1072845-47-6 | Purity: ≥95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(tert-butoxy)-2-methyl-4-oxobutanoic acid | ESD-890557-100MG |
| Cas.: 1072845-47-6 | Purity: ≥95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(tert-butoxy)-2-methyl-4-oxobutanoic acid | ESD-890557-250MG |
| Cas.: 198560-43-9 | Purity: 97% | Fmoc-Phe(3,4-DiF)-OH | ESD-890558-250MG |
| Cas.: 198560-43-9 | Purity: 97% | Fmoc-Phe(3,4-DiF)-OH | ESD-890558-1G |
| Cas.: 198560-43-9 | Purity: 97% | Fmoc-Phe(3,4-DiF)-OH | ESD-890558-5G |
| Cas.: 198560-43-9 | Purity: 97% | Fmoc-Phe(3,4-DiF)-OH | ESD-890558-10G |
| Cas.: 198545-59-4 | Purity: ≥95% | Fmoc-D-Phe(3,4-DiF)-OH | ESD-890559-1G |
| Cas.: 198545-59-4 | Purity: ≥95% | Fmoc-D-Phe(3,4-DiF)-OH | ESD-890559-5G |
| Cas.: 198545-59-4 | Purity: ≥95% | Fmoc-D-Phe(3,4-DiF)-OH | ESD-890559-10G |
| Cas.: 198545-59-4 | Purity: ≥95% | Fmoc-D-Phe(3,4-DiF)-OH | ESD-890559-25G |
| Cas.: 956077-63-7 | Purity: ≥95% | 3-Bromo-1H-pyrazolo[3,4-c]pyridin-7(6H)-one | ESD-890560-25MG |
| Cas.: 956077-63-7 | Purity: ≥95% | 3-Bromo-1H-pyrazolo[3,4-c]pyridin-7(6H)-one | ESD-890560-100MG |
| Cas.: 956077-63-7 | Purity: ≥95% | 3-Bromo-1H-pyrazolo[3,4-c]pyridin-7(6H)-one | ESD-890560-250MG |
| Cas.: 50632-89-8 | Purity: 97% | H-Gly-D-Trp-OH | ESD-890561-100MG |
| Cas.: 50632-89-8 | Purity: 97% | H-Gly-D-Trp-OH | ESD-890561-250MG |
| Cas.: 135944-05-7 | Purity: ≥95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyl-3-phenylpropanoic acid | ESD-890562-100MG |
| Cas.: 135944-05-7 | Purity: ≥95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyl-3-phenylpropanoic acid | ESD-890562-250MG |
| Cas.: 135944-05-7 | Purity: ≥95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyl-3-phenylpropanoic acid | ESD-890562-1G |
| Cas.: 135944-05-7 | Purity: ≥95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyl-3-phenylpropanoic acid | ESD-890562-5G |
| Cas.: 152436-04-9 | Purity: ≥95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyl-3-phenylpropanoic acid | ESD-890563-250MG |
| Cas.: 152436-04-9 | Purity: ≥95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyl-3-phenylpropanoic acid | ESD-890563-1G |
| Cas.: 152436-04-9 | Purity: ≥95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyl-3-phenylpropanoic acid | ESD-890563-5G |
| Cas.: 152436-04-9 | Purity: ≥95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyl-3-phenylpropanoic acid | ESD-890563-10G |
| Cas.: 1170-02-1 | Purity: ≥95% | 2,2′-(Ethane-1,2-diylbis(azanediyl))bis(2-(2-hydroxyphenyl)acetic acid) | ESD-890564-250MG |
| Cas.: 1170-02-1 | Purity: ≥95% | 2,2′-(Ethane-1,2-diylbis(azanediyl))bis(2-(2-hydroxyphenyl)acetic acid) | ESD-890564-1G |
| Cas.: 1640968-91-7 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyldodec-11-enoic acid | ESD-890565-100MG |
| Cas.: 1640968-91-7 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyldodec-11-enoic acid | ESD-890565-250MG |
| Cas.: 27486-87-9 | Purity: 97% | Ac-Cys(Trt)-OH | ESD-890566-250MG |
| Cas.: 27486-87-9 | Purity: 97% | Ac-Cys(Trt)-OH | ESD-890566-1G |
| Cas.: 27486-87-9 | Purity: 97% | Ac-Cys(Trt)-OH | ESD-890566-5G |
| Cas.: 27486-87-9 | Purity: 97% | Ac-Cys(Trt)-OH | ESD-890566-10G |
| Cas.: 201046-57-3 | Purity: 97% | Fmoc-Orn-OH.HCl | ESD-890567-250MG |
| Cas.: 201046-57-3 | Purity: 97% | Fmoc-Orn-OH.HCl | ESD-890567-1G |
| Cas.: 201046-57-3 | Purity: 97% | Fmoc-Orn-OH.HCl | ESD-890567-5G |
| Cas.: 201046-57-3 | Purity: 97% | Fmoc-Orn-OH.HCl | ESD-890567-10G |
| Cas.: 1217722-24-1 | Purity: ≥95% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-phenylpropanoic acid | ESD-890568-100MG |
| Cas.: 1217722-24-1 | Purity: ≥95% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-phenylpropanoic acid | ESD-890568-250MG |
| Cas.: 1217722-24-1 | Purity: ≥95% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-phenylpropanoic acid | ESD-890568-1G |
| Cas.: 1178-24-1 | Purity: ≥95% | 3,3′,4′,5,6,7,8-Heptamethoxyflavone | ESD-890569-5MG |
| Cas.: 1217820-78-4 | Purity: ≥95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,4-difluorophenyl)propanoic acid | ESD-890570-100MG |
| Cas.: 1217820-78-4 | Purity: ≥95% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,4-difluorophenyl)propanoic acid | ESD-890570-250MG |
| Cas.: 269078-73-1 | Purity: ≥95% | Fmoc-L-Homocyclohexylalanine | ESD-890571-250MG |
| Cas.: 269078-73-1 | Purity: ≥95% | Fmoc-L-Homocyclohexylalanine | ESD-890571-1G |
| Cas.: 269078-73-1 | Purity: ≥95% | Fmoc-L-Homocyclohexylalanine | ESD-890571-5G |
| Cas.: 269078-73-1 | Purity: ≥95% | Fmoc-L-Homocyclohexylalanine | ESD-890571-10G |
| Cas.: 198560-68-8 | Purity: 97% | Fmoc-Phe(3-F)-OH | ESD-890572-250MG |
| Cas.: 198560-68-8 | Purity: 97% | Fmoc-Phe(3-F)-OH | ESD-890572-1G |
| Cas.: 198560-68-8 | Purity: 97% | Fmoc-Phe(3-F)-OH | ESD-890572-5G |
| Cas.: 198560-68-8 | Purity: 97% | Fmoc-Phe(3-F)-OH | ESD-890572-10G |
| Cas.: 62679-00-9 | Purity: 97% | N,N’-(1H-Pyrazole-3,5-diyl)diacetamide | ESD-890573-100MG |
| Cas.: 62679-00-9 | Purity: 97% | N,N’-(1H-Pyrazole-3,5-diyl)diacetamide | ESD-890573-250MG |
| Cas.: 62679-00-9 | Purity: 97% | N,N’-(1H-Pyrazole-3,5-diyl)diacetamide | ESD-890573-1G |
| Cas.: 19728-57-5 | Purity: 98% | Z-DL-His-OH | ESD-890574-1G |
| Cas.: 19728-57-5 | Purity: 98% | Z-DL-His-OH | ESD-890574-5G |
| Cas.: 19728-57-5 | Purity: 98% | Z-DL-His-OH | ESD-890574-10G |
| Cas.: 205526-30-3 | Purity: 96% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,4,5-trifluorophenyl)propanoic acid | ESD-890575-250MG |
| Cas.: 205526-30-3 | Purity: 96% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,4,5-trifluorophenyl)propanoic acid | ESD-890575-1G |
| Cas.: 205526-30-3 | Purity: 96% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,4,5-trifluorophenyl)propanoic acid | ESD-890575-5G |
| Cas.: 1450590-76-7 | Purity: 97% | 4,7-Bis(5-bromo-4-hexylthiophen-2-yl)-5,6-difluorobenzo[c][1,2,5]thiadiazole | ESD-890576-50MG |
| Cas.: 182868-72-0 | Purity: 97% | 1-Cyclopropyl-8-ethoxy-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | ESD-890577-100MG |
| Cas.: 182868-72-0 | Purity: 97% | 1-Cyclopropyl-8-ethoxy-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | ESD-890577-250MG |
| Cas.: 1351240-72-6 | Purity: 97% | (E)-6,6′-Dibromo-[3,3′-biindolinylidene]-2,2′-dione | ESD-890578-250MG |
| Cas.: 1351240-72-6 | Purity: 97% | (E)-6,6′-Dibromo-[3,3′-biindolinylidene]-2,2′-dione | ESD-890578-1G |
| Cas.: 99740-00-8 | Purity: ≥95% | (S)-5-Phenyl-1H-pyrrol-3-yl 2-(4-methylphenylsulfonamido)propanoate | ESD-890579-250MG |
| Cas.: 99740-00-8 | Purity: ≥95% | (S)-5-Phenyl-1H-pyrrol-3-yl 2-(4-methylphenylsulfonamido)propanoate | ESD-890579-1G |
| Cas.: 99740-00-8 | Purity: ≥95% | (S)-5-Phenyl-1H-pyrrol-3-yl 2-(4-methylphenylsulfonamido)propanoate | ESD-890579-5G |
| Cas.: 6367-08-4 | Purity: 97% | Ac-Lys(Z)-OH | ESD-890580-100MG |
| Cas.: 6367-08-4 | Purity: 97% | Ac-Lys(Z)-OH | ESD-890580-250MG |
| Cas.: 6367-08-4 | Purity: 97% | Ac-Lys(Z)-OH | ESD-890580-1G |
| Cas.: 316-81-4 | Purity: 97% | Thioproperazine | ESD-890581-100MG |
| Cas.: 494782-69-3 | Purity: 97% | N,N-Dimethyl-2-(piperazin-1-yl)benzamide oxalate | ESD-890582-250MG |
| Cas.: 494782-69-3 | Purity: 97% | N,N-Dimethyl-2-(piperazin-1-yl)benzamide oxalate | ESD-890582-1G |
| Cas.: 584-85-0 | Purity: 97% | L-Anserine | ESD-890583-250MG |
| Cas.: 584-85-0 | Purity: 97% | L-Anserine | ESD-890583-1G |
| Cas.: 584-85-0 | Purity: 97% | L-Anserine | ESD-890583-5G |
| Cas.: 584-85-0 | Purity: 97% | L-Anserine | ESD-890583-10G |
| Cas.: 171778-17-9 | Purity: 97% | Fmoc-Ser(Ac)-OH | ESD-890584-250MG |
| Cas.: 171778-17-9 | Purity: 97% | Fmoc-Ser(Ac)-OH | ESD-890584-1G |
| Cas.: 171778-17-9 | Purity: 97% | Fmoc-Ser(Ac)-OH | ESD-890584-5G |
| Cas.: 5513-40-6 | Purity: 97% | Z-Tyr-OBzl | ESD-890585-250MG |
| Cas.: 5513-40-6 | Purity: 97% | Z-Tyr-OBzl | ESD-890585-1G |
| Cas.: 5513-40-6 | Purity: 97% | Z-Tyr-OBzl | ESD-890585-5G |
| Cas.: 5513-40-6 | Purity: 97% | Z-Tyr-OBzl | ESD-890585-10G |
| Cas.: 205526-24-5 | Purity: ≥95% | Fmoc-Phe(3,5-DiF)-OH | ESD-890586-250MG |
| Cas.: 205526-24-5 | Purity: ≥95% | Fmoc-Phe(3,5-DiF)-OH | ESD-890586-1G |
| Cas.: 205526-24-5 | Purity: ≥95% | Fmoc-Phe(3,5-DiF)-OH | ESD-890586-5G |
| Cas.: 1609073-29-1 | Purity: 97% | 2-Amino-4,5-bis((4-methoxybenzyl)oxy)benzoic acid | ESD-890587-250MG |
| Cas.: 1609073-29-1 | Purity: 97% | 2-Amino-4,5-bis((4-methoxybenzyl)oxy)benzoic acid | ESD-890587-1G |
| Cas.: 285996-72-7 | Purity: ≥95% | 4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)tetrahydro-2H-pyran-4-carboxylic acid | ESD-890588-250MG |
| Cas.: 285996-72-7 | Purity: ≥95% | 4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)tetrahydro-2H-pyran-4-carboxylic acid | ESD-890588-1G |
| Cas.: 285996-72-7 | Purity: ≥95% | 4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)tetrahydro-2H-pyran-4-carboxylic acid | ESD-890588-5G |
| Cas.: 285996-72-7 | Purity: ≥95% | 4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)tetrahydro-2H-pyran-4-carboxylic acid | ESD-890588-10G |
| Cas.: 352523-16-1 | Purity: ≥95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-(trifluoromethyl)phenyl)propanoic acid | ESD-890589-250MG |
| Cas.: 352523-16-1 | Purity: ≥95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-(trifluoromethyl)phenyl)propanoic acid | ESD-890589-1G |
| Cas.: 352523-16-1 | Purity: ≥95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-(trifluoromethyl)phenyl)propanoic acid | ESD-890589-5G |
| Cas.: 212140-39-1 | Purity: ≥95% | HD-Lys(Fmoc)-OH | ESD-890590-100MG |
| Cas.: 212140-39-1 | Purity: ≥95% | HD-Lys(Fmoc)-OH | ESD-890590-250MG |
| Cas.: 46834-56-4 | Purity: ≥95% | (2S,3S)-4-((4-Chlorophenyl)amino)-2,3-dihydroxy-4-oxobutanoic acid | ESD-890591-1G |
| Cas.: 46834-56-4 | Purity: ≥95% | (2S,3S)-4-((4-Chlorophenyl)amino)-2,3-dihydroxy-4-oxobutanoic acid | ESD-890591-5G |
| Cas.: 46834-56-4 | Purity: ≥95% | (2S,3S)-4-((4-Chlorophenyl)amino)-2,3-dihydroxy-4-oxobutanoic acid | ESD-890591-10G |
| Cas.: 15572-30-2 | Purity: ≥95% | 6-Bromo-2-naphthyl bD-galactoside | ESD-890592-250MG |
| Cas.: 15572-30-2 | Purity: ≥95% | 6-Bromo-2-naphthyl bD-galactoside | ESD-890592-1G |
| Cas.: 88110-89-8 | Purity: 97% | Mono-O-AcetylGanciclovir | ESD-890593-250MG |
| Cas.: 88110-89-8 | Purity: 97% | Mono-O-AcetylGanciclovir | ESD-890593-1G |
| Cas.: 88110-89-8 | Purity: 97% | Mono-O-AcetylGanciclovir | ESD-890593-5G |
| Cas.: 88110-89-8 | Purity: 97% | Mono-O-AcetylGanciclovir | ESD-890593-10G |
| Cas.: 1323140-63-1 | Purity: ≥95% | (Z)-N-(1-Chloro-3-oxo-3-(pipidin-1-yl)-1-(p-tolyl)prop-1-en-2-yl)benzamide | ESD-890594-100MG |
| Cas.: 1323140-63-1 | Purity: ≥95% | (Z)-N-(1-Chloro-3-oxo-3-(pipidin-1-yl)-1-(p-tolyl)prop-1-en-2-yl)benzamide | ESD-890594-250MG |
| Cas.: 330785-83-6 | Purity: ≥95% | (S)-Ethyl 4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxylate | ESD-890595-250MG |
| Cas.: 330785-83-6 | Purity: ≥95% | (S)-Ethyl 4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxylate | ESD-890595-1G |
| Cas.: 5621-01-2 | Purity: 97% | 6-Chloro-N,2-dimethylpyrimidin-4-amine | ESD-890596-100MG |
| Cas.: 5621-01-2 | Purity: 97% | 6-Chloro-N,2-dimethylpyrimidin-4-amine | ESD-890596-250MG |
| Cas.: 5621-01-2 | Purity: 97% | 6-Chloro-N,2-dimethylpyrimidin-4-amine | ESD-890596-1G |
| Cas.: 1033201-61-4 | Purity: 98% | 6-Amino-3-bromopicolinic acid | ESD-890597-1G |
| Cas.: 1033201-61-4 | Purity: 98% | 6-Amino-3-bromopicolinic acid | ESD-890597-5G |
| Cas.: 1033201-61-4 | Purity: 98% | 6-Amino-3-bromopicolinic acid | ESD-890597-10G |
| Cas.: 1033201-61-4 | Purity: 98% | 6-Amino-3-bromopicolinic acid | ESD-890597-25G |
| Cas.: 105891-54-1 | Purity: 97% | 1,27-Diphenyl-2,5,8,11,14,17,20,23,26-nonaoxaheptacosane | ESD-890598-100MG |
| Cas.: 105891-54-1 | Purity: 97% | 1,27-Diphenyl-2,5,8,11,14,17,20,23,26-nonaoxaheptacosane | ESD-890598-250MG |
| Cas.: 130406-30-3 | Purity: 97% | Fmoc-D-Phenylalaninol | ESD-890599-250MG |
| Cas.: 130406-30-3 | Purity: 97% | Fmoc-D-Phenylalaninol | ESD-890599-1G |
| Cas.: 130406-30-3 | Purity: 97% | Fmoc-D-Phenylalaninol | ESD-890599-5G |
| Cas.: 130406-30-3 | Purity: 97% | Fmoc-D-Phenylalaninol | ESD-890599-10G |
| Cas.: 1562405-20-2 | Purity: 97% | (2S,4R)-Benzyl 4-amino-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-2-methylpentanoate | ESD-890600-100MG |
| Cas.: 1562405-20-2 | Purity: 97% | (2S,4R)-Benzyl 4-amino-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-2-methylpentanoate | ESD-890600-250MG |
| Cas.: 143322-56-9 | Purity: ≥95% | (R)-Benzyl 2-(5-bromo-1H-indole-3-carbonyl)pyrrolidine-1-carboxylate | ESD-890601-100MG |
| Cas.: 143322-56-9 | Purity: ≥95% | (R)-Benzyl 2-(5-bromo-1H-indole-3-carbonyl)pyrrolidine-1-carboxylate | ESD-890601-250MG |
| Cas.: 143322-56-9 | Purity: ≥95% | (R)-Benzyl 2-(5-bromo-1H-indole-3-carbonyl)pyrrolidine-1-carboxylate | ESD-890601-1G |
| Cas.: 143322-56-9 | Purity: ≥95% | (R)-Benzyl 2-(5-bromo-1H-indole-3-carbonyl)pyrrolidine-1-carboxylate | ESD-890601-5G |
| Cas.: 165393-06-6 | Purity: 97% | 3,8,9-Trihydroxy-6H-benzo[c]chromen-6-one | ESD-890602-100MG |
| Cas.: 165393-06-6 | Purity: 97% | 3,8,9-Trihydroxy-6H-benzo[c]chromen-6-one | ESD-890602-250MG |
| Cas.: 165393-06-6 | Purity: 97% | 3,8,9-Trihydroxy-6H-benzo[c]chromen-6-one | ESD-890602-1G |
| Cas.: 42774-15-2 | Purity: ≥99% | N1,N3-Bis(2,2,6,6-tetramethylpiperidin-4-yl)isophthalamide | ESD-890603-250MG |
| Cas.: 42774-15-2 | Purity: ≥99% | N1,N3-Bis(2,2,6,6-tetramethylpiperidin-4-yl)isophthalamide | ESD-890603-1G |
| Cas.: 42774-15-2 | Purity: ≥99% | N1,N3-Bis(2,2,6,6-tetramethylpiperidin-4-yl)isophthalamide | ESD-890603-5G |
| Cas.: 188715-40-4 | Purity: ≥95% | Fmoc-4-Amc-OH | ESD-890604-250MG |
| Cas.: 188715-40-4 | Purity: ≥95% | Fmoc-4-Amc-OH | ESD-890604-1G |
| Cas.: 188715-40-4 | Purity: ≥95% | Fmoc-4-Amc-OH | ESD-890604-5G |
| Cas.: 53525-65-8 | Purity: ≥95% | Diimidazo[1,5-a:1′,5′-d]pyrazine-5,10-dione | ESD-890605-100MG |
| Cas.: 53525-65-8 | Purity: ≥95% | Diimidazo[1,5-a:1′,5′-d]pyrazine-5,10-dione | ESD-890605-250MG |
| Cas.: 53525-65-8 | Purity: ≥95% | Diimidazo[1,5-a:1′,5′-d]pyrazine-5,10-dione | ESD-890605-1G |
| Cas.: 53525-65-8 | Purity: ≥95% | Diimidazo[1,5-a:1′,5′-d]pyrazine-5,10-dione | ESD-890605-5G |
| Cas.: 147071-84-9 | Purity: ≥95% | H-Orn(Fmoc)-OH | ESD-890606-250MG |
| Cas.: 147071-84-9 | Purity: ≥95% | H-Orn(Fmoc)-OH | ESD-890606-1G |
| Cas.: 147071-84-9 | Purity: ≥95% | H-Orn(Fmoc)-OH | ESD-890606-5G |
| Cas.: 19171-18-7 | Purity: 97% | 2-(2,6-Dioxopiperidin-3-yl)-4-nitroisoindoline-1,3-dione | ESD-890607-100MG |
| Cas.: 19171-18-7 | Purity: 97% | 2-(2,6-Dioxopiperidin-3-yl)-4-nitroisoindoline-1,3-dione | ESD-890607-250MG |
| Cas.: 19171-18-7 | Purity: 97% | 2-(2,6-Dioxopiperidin-3-yl)-4-nitroisoindoline-1,3-dione | ESD-890607-1G |
| Cas.: 131766-22-8 | Purity: 97% | Fmoc-D-Cys(tBu)-OH | ESD-890608-250MG |
| Cas.: 131766-22-8 | Purity: 97% | Fmoc-D-Cys(tBu)-OH | ESD-890608-1G |
| Cas.: 131766-22-8 | Purity: 97% | Fmoc-D-Cys(tBu)-OH | ESD-890608-5G |
| Cas.: 260367-12-2 | Purity: 97% | 2-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethoxy)acetic acid | ESD-890609-250MG |
| Cas.: 260367-12-2 | Purity: 97% | 2-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethoxy)acetic acid | ESD-890609-1G |
| Cas.: 260367-12-2 | Purity: 97% | 2-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethoxy)acetic acid | ESD-890609-5G |
| Cas.: 260367-12-2 | Purity: 97% | 2-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethoxy)acetic acid | ESD-890609-25G |
| Cas.: 1323140-59-5 | Purity: ≥95% | (Z)-N-(1-Chloro-3-oxo-3-(pipidin-1-yl)-1-(o-tolyl)prop-1-en-2-yl)benzamide | ESD-890610-100MG |
| Cas.: 1323140-59-5 | Purity: ≥95% | (Z)-N-(1-Chloro-3-oxo-3-(pipidin-1-yl)-1-(o-tolyl)prop-1-en-2-yl)benzamide | ESD-890610-250MG |
| Cas.: 1103738-30-2 | Purity: 97% | (4-Chloro-3-(4-ethoxybenzyl)phenyl)((3aS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5- yl)methanone | ESD-890611-250MG |
| Cas.: 1103738-30-2 | Purity: 97% | (4-Chloro-3-(4-ethoxybenzyl)phenyl)((3aS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5- yl)methanone | ESD-890611-1G |
| Cas.: 1103738-30-2 | Purity: 97% | (4-Chloro-3-(4-ethoxybenzyl)phenyl)((3aS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5- yl)methanone | ESD-890611-5G |
| Cas.: 1103738-30-2 | Purity: 97% | (4-Chloro-3-(4-ethoxybenzyl)phenyl)((3aS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5- yl)methanone | ESD-890611-10G |
| Cas.: 179174-79-9 | Purity: 97% | (Z)-4-Acetoxy-3-(4-(methylsulfonyl) phenyl)-2-phenylbut-2-enoic acid | ESD-890612-100MG |
| Cas.: 179174-79-9 | Purity: 97% | (Z)-4-Acetoxy-3-(4-(methylsulfonyl) phenyl)-2-phenylbut-2-enoic acid | ESD-890612-250MG |
| Cas.: 119141-89-8 | Purity: 96% | (R)-5-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole | ESD-890613-100MG |
| Cas.: 119141-89-8 | Purity: 96% | (R)-5-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole | ESD-890613-250MG |
| Cas.: 915086-32-7 | Purity: 98% | 4-(3-(4-Hydroxyphenyl)-4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile | ESD-890614-100MG |
| Cas.: 915086-32-7 | Purity: 98% | 4-(3-(4-Hydroxyphenyl)-4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile | ESD-890614-250MG |
| Cas.: 5687-48-9 | Purity: 97% | 2-(2-Acetamidoacetamido)acetic acid | ESD-890615-250MG |
| Cas.: 5687-48-9 | Purity: 97% | 2-(2-Acetamidoacetamido)acetic acid | ESD-890615-1G |
| Cas.: 5687-48-9 | Purity: 97% | 2-(2-Acetamidoacetamido)acetic acid | ESD-890615-5G |
| Cas.: 5687-48-9 | Purity: 97% | 2-(2-Acetamidoacetamido)acetic acid | ESD-890615-10G |
| Cas.: 193885-59-5 | Purity: ≥95% | Fmoc-Octyl-Gly-OH | ESD-890616-250MG |
| Cas.: 193885-59-5 | Purity: ≥95% | Fmoc-Octyl-Gly-OH | ESD-890616-1G |
| Cas.: 193885-59-5 | Purity: ≥95% | Fmoc-Octyl-Gly-OH | ESD-890616-5G |
| Cas.: 193885-59-5 | Purity: ≥95% | Fmoc-Octyl-Gly-OH | ESD-890616-10G |
| Cas.: 203854-51-7 | Purity: ≥95% | Fmoc-β-HoSer(tBu)-OH | ESD-890617-250MG |
| Cas.: 203854-51-7 | Purity: ≥95% | Fmoc-β-HoSer(tBu)-OH | ESD-890617-1G |
| Cas.: 203854-51-7 | Purity: ≥95% | Fmoc-β-HoSer(tBu)-OH | ESD-890617-5G |
| Cas.: 889958-08-1 | Purity: ≥95% | 2-(4-Oxo-6-(piperazin-1-yl)quinazolin-3(4H)-yl)acetic acid | ESD-890618-100MG |
| Cas.: 889958-08-1 | Purity: ≥95% | 2-(4-Oxo-6-(piperazin-1-yl)quinazolin-3(4H)-yl)acetic acid | ESD-890618-250MG |
| Cas.: 889958-08-1 | Purity: ≥95% | 2-(4-Oxo-6-(piperazin-1-yl)quinazolin-3(4H)-yl)acetic acid | ESD-890618-1G |
| Cas.: 1000623-95-9 | Purity: ≥95% | 3,6-Bis(5-bromothiophen-2-yl)-2,5-bis(2-ethylhexyl)pyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione | ESD-890619-100MG |
| Cas.: 1000623-95-9 | Purity: ≥95% | 3,6-Bis(5-bromothiophen-2-yl)-2,5-bis(2-ethylhexyl)pyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione | ESD-890619-250MG |
| Cas.: 1000623-95-9 | Purity: ≥95% | 3,6-Bis(5-bromothiophen-2-yl)-2,5-bis(2-ethylhexyl)pyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione | ESD-890619-1G |
| Cas.: 1462950-10-2 | Purity: 97% | Methyl 7-(5-fluoro-2-methoxyphenyl)-2-(methylsulfonyl)thieno[3,2-d]pyrimidine-6-carboxylate | ESD-890620-100MG |
| Cas.: 1462950-10-2 | Purity: 97% | Methyl 7-(5-fluoro-2-methoxyphenyl)-2-(methylsulfonyl)thieno[3,2-d]pyrimidine-6-carboxylate | ESD-890620-250MG |
| Cas.: 265977-72-8 | Purity: ≥95% | (Z)-N-(1-Chloro-3-oxo-1-phenyl-3-(piperidin-1-yl)prop-1-en-2-yl)benzamide | ESD-890621-100MG |
| Cas.: 265977-72-8 | Purity: ≥95% | (Z)-N-(1-Chloro-3-oxo-1-phenyl-3-(piperidin-1-yl)prop-1-en-2-yl)benzamide | ESD-890621-250MG |
| Cas.: 69125-10-6 | Purity: ≥95% | 6-Chloro-1,3,5-triazine-2,4(1H,3H)-dione | ESD-890622-100MG |
| Cas.: 69125-10-6 | Purity: ≥95% | 6-Chloro-1,3,5-triazine-2,4(1H,3H)-dione | ESD-890622-250MG |
| Cas.: 1219424-59-5 | Purity: 95% | Benzyl (1-benzyl-2,5-dioxopyrrolidin-3-yl)carbamate | ESD-890623-250MG |
| Cas.: 1219424-59-5 | Purity: 95% | Benzyl (1-benzyl-2,5-dioxopyrrolidin-3-yl)carbamate | ESD-890623-1G |
| Cas.: 1219424-59-5 | Purity: 95% | Benzyl (1-benzyl-2,5-dioxopyrrolidin-3-yl)carbamate | ESD-890623-5G |
| Cas.: 71367-28-7 | Purity: 95% | 3,3′-(Anthracene-9,10-diyl)dipropanoic acid | ESD-890624-100MG |
| Cas.: 71367-28-7 | Purity: 95% | 3,3′-(Anthracene-9,10-diyl)dipropanoic acid | ESD-890624-250MG |
| Cas.: 71367-28-7 | Purity: 95% | 3,3′-(Anthracene-9,10-diyl)dipropanoic acid | ESD-890624-1G |
| Cas.: 1323140-60-8 | Purity: 97% | (Z)-N-(1-Chloro-1-(2-fluorophenyl)-3-oxo-3-(pipidin-1-yl)prop-1-en-2-yl)benzamide | ESD-890625-100MG |
| Cas.: 1323140-60-8 | Purity: 97% | (Z)-N-(1-Chloro-1-(2-fluorophenyl)-3-oxo-3-(pipidin-1-yl)prop-1-en-2-yl)benzamide | ESD-890625-250MG |
| Cas.: 530084-79-8 | Purity: 97% | (R)-8-(Benzyloxy)-5-(2-bromo-1-hydroxyethyl)quinolin-2(1H)-one | ESD-890626-100MG |
| Cas.: 530084-79-8 | Purity: 97% | (R)-8-(Benzyloxy)-5-(2-bromo-1-hydroxyethyl)quinolin-2(1H)-one | ESD-890626-250MG |
| Cas.: 530084-79-8 | Purity: 97% | (R)-8-(Benzyloxy)-5-(2-bromo-1-hydroxyethyl)quinolin-2(1H)-one | ESD-890626-1G |
| Cas.: 530084-79-8 | Purity: 97% | (R)-8-(Benzyloxy)-5-(2-bromo-1-hydroxyethyl)quinolin-2(1H)-one | ESD-890626-5G |
| Cas.: 1012341-48-8 | Purity: 97% | (R,E)-5-([1,1′-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid | ESD-890627-1G |
| Cas.: 1012341-48-8 | Purity: 97% | (R,E)-5-([1,1′-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid | ESD-890627-5G |
| Cas.: 1012341-48-8 | Purity: 97% | (R,E)-5-([1,1′-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid | ESD-890627-10G |
| Cas.: 1012341-48-8 | Purity: 97% | (R,E)-5-([1,1′-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid | ESD-890627-25G |
| Cas.: 106133-20-4 | Purity: ≥98% | Tamsulosin | ESD-890628-5MG |
| Cas.: 106133-20-4 | Purity: ≥98% | Tamsulosin | ESD-890628-25MG |
| Cas.: 884880-39-1 | Purity: 97% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-hydroxy-3-methylbutanoic acid | ESD-890629-100MG |
| Cas.: 884880-39-1 | Purity: 97% | (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-hydroxy-3-methylbutanoic acid | ESD-890629-250MG |
| Cas.: 13343-62-9 | Purity: ≥95% | N-((2S,3R,4R,5S,6R)-2-(Benzyloxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide | ESD-890630-100MG |
| Cas.: 13343-62-9 | Purity: ≥95% | N-((2S,3R,4R,5S,6R)-2-(Benzyloxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide | ESD-890630-250MG |
| Cas.: 13343-62-9 | Purity: ≥95% | N-((2S,3R,4R,5S,6R)-2-(Benzyloxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide | ESD-890630-1G |
| Cas.: 13343-62-9 | Purity: ≥95% | N-((2S,3R,4R,5S,6R)-2-(Benzyloxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide | ESD-890630-5G |
| Cas.: 201484-12-0 | Purity: 97% | Fmoc-D-Dab-OH | ESD-890631-250MG |
| Cas.: 201484-12-0 | Purity: 97% | Fmoc-D-Dab-OH | ESD-890631-1G |
| Cas.: 201484-12-0 | Purity: 97% | Fmoc-D-Dab-OH | ESD-890631-5G |
| Cas.: 117402-88-7 | Purity: 97% | ZD-Phe(4-NO2)-OH | ESD-890632-1G |
| Cas.: 117402-88-7 | Purity: 97% | ZD-Phe(4-NO2)-OH | ESD-890632-5G |
| Cas.: 28279-48-3 | Purity: ≥95% | 3,4-Dihydroimidazo[4,5-b]pyridin-5-one | ESD-890633-100MG |
| Cas.: 3260-44-4 | Purity: ≥95% | 4-Oxo-3,4-dihydrophthalazine-1-carboxylic acid | ESD-890634-100MG |
| Cas.: 3260-44-4 | Purity: ≥95% | 4-Oxo-3,4-dihydrophthalazine-1-carboxylic acid | ESD-890634-250MG |
| Cas.: 3260-44-4 | Purity: ≥95% | 4-Oxo-3,4-dihydrophthalazine-1-carboxylic acid | ESD-890634-1G |
| Cas.: 3260-44-4 | Purity: ≥95% | 4-Oxo-3,4-dihydrophthalazine-1-carboxylic acid | ESD-890634-5G |
| Cas.: 65365-16-4 | Purity: 97% | ZL-2-Nal-OH | ESD-890635-250MG |
| Cas.: 65365-16-4 | Purity: 97% | ZL-2-Nal-OH | ESD-890635-1G |
| Cas.: 210644-62-5 | Purity: 97% | SU6668 | ESD-890636-25MG |
| Cas.: 210644-62-5 | Purity: 97% | SU6668 | ESD-890636-100MG |
| Cas.: 210644-62-5 | Purity: 97% | SU6668 | ESD-890636-250MG |
| Cas.: 210644-62-5 | Purity: 97% | SU6668 | ESD-890636-1G |
| Cas.: 153815-59-9 | Purity: ≥95% | Fmoc-Glutamol(OtBu) | ESD-890637-250MG |
| Cas.: 153815-59-9 | Purity: ≥95% | Fmoc-Glutamol(OtBu) | ESD-890637-1G |
| Cas.: 153815-59-9 | Purity: ≥95% | Fmoc-Glutamol(OtBu) | ESD-890637-5G |
| Cas.: 153815-59-9 | Purity: ≥95% | Fmoc-Glutamol(OtBu) | ESD-890637-10G |
| Cas.: 1654740-73-4 | Purity: 97% | 3-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethoxy)propanoic acid | ESD-890638-100MG |
| Cas.: 1654740-73-4 | Purity: 97% | 3-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethoxy)propanoic acid | ESD-890638-250MG |
| Cas.: 1654740-73-4 | Purity: 97% | 3-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethoxy)propanoic acid | ESD-890638-1G |
| Cas.: 878671-99-9 | Purity: 97% | Methyl 2-((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetate | ESD-890640-100MG |
| Cas.: 878671-99-9 | Purity: 97% | Methyl 2-((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetate | ESD-890640-250MG |
| Cas.: 878671-99-9 | Purity: 97% | Methyl 2-((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetate | ESD-890640-1G |
| Cas.: 503614-56-0 | Purity: ≥95% | Ethyl 1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | ESD-890641-100MG |
| Cas.: 503614-56-0 | Purity: ≥95% | Ethyl 1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | ESD-890641-250MG |
| Cas.: 88784-33-2 | Purity: 97% | (S)-5-(Benzyloxy)-2-(1,3-dioxoisoindolin-2-yl)-5-oxopentanoic acid | ESD-890642-250MG |
| Cas.: 88784-33-2 | Purity: 97% | (S)-5-(Benzyloxy)-2-(1,3-dioxoisoindolin-2-yl)-5-oxopentanoic acid | ESD-890642-1G |
| Cas.: 1035229-33-4 | Purity: ≥95% | 5-(Benzyloxy)-8-(2-chloroacetyl)-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-890643-100MG |
| Cas.: 1035229-33-4 | Purity: ≥95% | 5-(Benzyloxy)-8-(2-chloroacetyl)-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-890643-250MG |
| Cas.: 1035229-33-4 | Purity: ≥95% | 5-(Benzyloxy)-8-(2-chloroacetyl)-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-890643-1G |
| Cas.: 1084334-86-0 | Purity: 97% | (4-([1,1′-Biphenyl]-4-yl(phenyl)amino)phenyl)boronic acid | ESD-890644-250MG |
| Cas.: 1084334-86-0 | Purity: 97% | (4-([1,1′-Biphenyl]-4-yl(phenyl)amino)phenyl)boronic acid | ESD-890644-1G |
| Cas.: 1084334-86-0 | Purity: 97% | (4-([1,1′-Biphenyl]-4-yl(phenyl)amino)phenyl)boronic acid | ESD-890644-5G |
| Cas.: 160096-59-3 | Purity: ≥98% | Dimethoxycurcumin | ESD-890645-5MG |
| Cas.: 116169-90-5 | Purity: ≥95% | (S)-2-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-6-(2,2,2-trifluoroacetamido)hexanoic acid | ESD-890646-5G |
| Cas.: 116169-90-5 | Purity: ≥95% | (S)-2-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-6-(2,2,2-trifluoroacetamido)hexanoic acid | ESD-890646-10G |
| Cas.: 116169-90-5 | Purity: ≥95% | (S)-2-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-6-(2,2,2-trifluoroacetamido)hexanoic acid | ESD-890646-25G |
| Cas.: 380844-49-5 | Purity: 97% | 7-(3-Chloropropoxy)-4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxyquinoline-3-carbonitrile | ESD-890647-100MG |
| Cas.: 380844-49-5 | Purity: 97% | 7-(3-Chloropropoxy)-4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxyquinoline-3-carbonitrile | ESD-890647-250MG |
| Cas.: 330792-70-6 | Purity: 97% | 3-Amino-5-(4-phenoxyphenyl)pyrazole-4-carbonitrile | ESD-890648-100MG |
| Cas.: 330792-70-6 | Purity: 97% | 3-Amino-5-(4-phenoxyphenyl)pyrazole-4-carbonitrile | ESD-890648-250MG |
| Cas.: 330792-70-6 | Purity: 97% | 3-Amino-5-(4-phenoxyphenyl)pyrazole-4-carbonitrile | ESD-890648-1G |
| Cas.: 330792-70-6 | Purity: 97% | 3-Amino-5-(4-phenoxyphenyl)pyrazole-4-carbonitrile | ESD-890648-5G |
| Cas.: 149303-38-8 | Purity: 98% | Fmoc-β-Ala-OPfp | ESD-890649-1G |
| Cas.: 149303-38-8 | Purity: 98% | Fmoc-β-Ala-OPfp | ESD-890649-5G |
| Cas.: 149303-38-8 | Purity: 98% | Fmoc-β-Ala-OPfp | ESD-890649-10G |
| Cas.: 632-80-4 | Purity: ≥95% | 4,5,6,7-Tetraiodoisobenzofuran-1,3-dione | ESD-890650-100MG |
| Cas.: 214750-76-2 | Purity: ≥95% | Fmoc-β-cyclopropyl-L-Alanine | ESD-890651-250MG |
| Cas.: 214750-76-2 | Purity: ≥95% | Fmoc-β-cyclopropyl-L-Alanine | ESD-890651-1G |
| Cas.: 214750-76-2 | Purity: ≥95% | Fmoc-β-cyclopropyl-L-Alanine | ESD-890651-5G |
| Cas.: 214750-76-2 | Purity: ≥95% | Fmoc-β-cyclopropyl-L-Alanine | ESD-890651-10G |
| Cas.: 21416-67-1 | Purity: ≥95% | 4,4′-(Propane-1,2-diyl)bis(piperazine-2,6-dione) | ESD-890652-100MG |
| Cas.: 21416-67-1 | Purity: ≥95% | 4,4′-(Propane-1,2-diyl)bis(piperazine-2,6-dione) | ESD-890652-250MG |
| Cas.: 21416-67-1 | Purity: ≥95% | 4,4′-(Propane-1,2-diyl)bis(piperazine-2,6-dione) | ESD-890652-1G |
| Cas.: 91644-13-2 | Purity: 97% | 5-((2-(Methylamino)-5-nitrophenyl)amino)-5-oxopentanoic acid | ESD-890653-250MG |
| Cas.: 91644-13-2 | Purity: 97% | 5-((2-(Methylamino)-5-nitrophenyl)amino)-5-oxopentanoic acid | ESD-890653-1G |
| Cas.: 91644-13-2 | Purity: 97% | 5-((2-(Methylamino)-5-nitrophenyl)amino)-5-oxopentanoic acid | ESD-890653-5G |
| Cas.: 241479-75-4 | Purity: 97% | (2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanamide | ESD-890654-1G |
| Cas.: 241479-75-4 | Purity: 97% | (2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanamide | ESD-890654-5G |
| Cas.: 59969-65-2 | Purity: ≥95% | (2S,3R)-3-(((Benzyloxy)carbonyl)amino)-2-hydroxy-4-phenylbutanoic acid | ESD-890655-100MG |
| Cas.: 59969-65-2 | Purity: ≥95% | (2S,3R)-3-(((Benzyloxy)carbonyl)amino)-2-hydroxy-4-phenylbutanoic acid | ESD-890655-250MG |
| Cas.: 59969-65-2 | Purity: ≥95% | (2S,3R)-3-(((Benzyloxy)carbonyl)amino)-2-hydroxy-4-phenylbutanoic acid | ESD-890655-1G |
| Cas.: 1007881-98-2 | Purity: ≥95% | (S)-tert-Butyl 2-((2-(4-bromophenyl)-2-oxoethyl)carbamoyl)pyrrolidine-1-carboxylate | ESD-890656-250MG |
| Cas.: 1007881-98-2 | Purity: ≥95% | (S)-tert-Butyl 2-((2-(4-bromophenyl)-2-oxoethyl)carbamoyl)pyrrolidine-1-carboxylate | ESD-890656-1G |
| Cas.: 129271-98-3 | Purity: ≥95% | (1-(Phenylsulfonyl)-1H-indol-3-yl)boronic acid | ESD-890657-250MG |
| Cas.: 129271-98-3 | Purity: ≥95% | (1-(Phenylsulfonyl)-1H-indol-3-yl)boronic acid | ESD-890657-1G |
| Cas.: 129271-98-3 | Purity: ≥95% | (1-(Phenylsulfonyl)-1H-indol-3-yl)boronic acid | ESD-890657-5G |
| Cas.: 129271-98-3 | Purity: ≥95% | (1-(Phenylsulfonyl)-1H-indol-3-yl)boronic acid | ESD-890657-10G |
| Cas.: 113028-17-4 | Purity: ≥95% | Ethyl 6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate | ESD-890658-100MG |
| Cas.: 113028-17-4 | Purity: ≥95% | Ethyl 6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate | ESD-890658-250MG |
| Cas.: 113028-17-4 | Purity: ≥95% | Ethyl 6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate | ESD-890658-1G |
| Cas.: 7062-40-0 | Purity: 95% | 2-(5-Bromo-2-methoxyphenyl)acetonitrile | ESD-890659-100MG |
| Cas.: 7062-40-0 | Purity: 95% | 2-(5-Bromo-2-methoxyphenyl)acetonitrile | ESD-890659-250MG |
| Cas.: 7062-40-0 | Purity: 95% | 2-(5-Bromo-2-methoxyphenyl)acetonitrile | ESD-890659-1G |
| Cas.: 7062-40-0 | Purity: 95% | 2-(5-Bromo-2-methoxyphenyl)acetonitrile | ESD-890659-5G |
| Cas.: 1378391-38-8 | Purity: 97% | 3-(2-Bromo-1-hydroxyethyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one | ESD-890660-100MG |
| Cas.: 1378391-38-8 | Purity: 97% | 3-(2-Bromo-1-hydroxyethyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one | ESD-890660-250MG |
| Cas.: 1378391-38-8 | Purity: 97% | 3-(2-Bromo-1-hydroxyethyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one | ESD-890660-1G |
| Cas.: 574739-36-9 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-2-phenylacetic acid | ESD-890661-250MG |
| Cas.: 574739-36-9 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-2-phenylacetic acid | ESD-890661-1G |
| Cas.: 574739-36-9 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-2-phenylacetic acid | ESD-890661-5G |
| Cas.: 574739-36-9 | Purity: 97% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-2-phenylacetic acid | ESD-890661-10G |
| Cas.: 1160-54-9 | Purity: 97% | Z-Gly-Pro-OH | ESD-890662-250MG |
| Cas.: 1160-54-9 | Purity: 97% | Z-Gly-Pro-OH | ESD-890662-1G |
| Cas.: 1160-54-9 | Purity: 97% | Z-Gly-Pro-OH | ESD-890662-5G |
| Cas.: 1160-54-9 | Purity: 97% | Z-Gly-Pro-OH | ESD-890662-10G |
| Cas.: 942153-03-9 | Purity: 97% | (R)-4-(((9H-Fluoren-9-yl)methoxy)carbonyl)morpholine-3-carboxylic acid | ESD-890663-100MG |
| Cas.: 942153-03-9 | Purity: 97% | (R)-4-(((9H-Fluoren-9-yl)methoxy)carbonyl)morpholine-3-carboxylic acid | ESD-890663-250MG |
| Cas.: 7733-29-1 | Purity: ≥98% | (S)-2-(((Benzyloxy)carbonyl)amino)-5-((tert-butoxycarbonyl)amino)pentanoic acid | ESD-890664-1G |
| Cas.: 7733-29-1 | Purity: ≥98% | (S)-2-(((Benzyloxy)carbonyl)amino)-5-((tert-butoxycarbonyl)amino)pentanoic acid | ESD-890664-5G |
| Cas.: 7733-29-1 | Purity: ≥98% | (S)-2-(((Benzyloxy)carbonyl)amino)-5-((tert-butoxycarbonyl)amino)pentanoic acid | ESD-890664-10G |
| Cas.: 4790-08-3 | Purity: ≥95% | 5,6-Dihydroxy-1H-indole-2-carboxylic acid | ESD-890665-100MG |
| Cas.: 4790-08-3 | Purity: ≥95% | 5,6-Dihydroxy-1H-indole-2-carboxylic acid | ESD-890665-250MG |
| Cas.: 1378390-29-4 | Purity: 97% | 3-(2-Bromoacetyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one | ESD-890666-100MG |
| Cas.: 1378390-29-4 | Purity: 97% | 3-(2-Bromoacetyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one | ESD-890666-250MG |
| Cas.: 52071-65-5 | Purity: ≥95% | Boc-Pro-Phe-OH | ESD-890667-250MG |
| Cas.: 52071-65-5 | Purity: ≥95% | Boc-Pro-Phe-OH | ESD-890667-1G |
| Cas.: 195877-90-8 | Purity: ≥95% | 3-(1-((Benzyloxy)carbonyl)piperidin-4-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid | ESD-890668-100MG |
| Cas.: 195877-90-8 | Purity: ≥95% | 3-(1-((Benzyloxy)carbonyl)piperidin-4-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid | ESD-890668-250MG |
| Cas.: 117140-77-9 | Purity: 97% | 1H-Indole-2,5-dicarboxylic acid | ESD-890669-100MG |
| Cas.: 117140-77-9 | Purity: 97% | 1H-Indole-2,5-dicarboxylic acid | ESD-890669-250MG |
| Cas.: 117140-77-9 | Purity: 97% | 1H-Indole-2,5-dicarboxylic acid | ESD-890669-1G |
| Cas.: 916888-64-7 | Purity: ≥95% | 2-(4-(2-(Trifluoromethyl)benzoyl)piperazin-1-yl)thiazole-5-carboxylic acid | ESD-890670-100MG |
| Cas.: 916888-64-7 | Purity: ≥95% | 2-(4-(2-(Trifluoromethyl)benzoyl)piperazin-1-yl)thiazole-5-carboxylic acid | ESD-890670-250MG |
| Cas.: 916177-00-9 | Purity: 97% | (5-(Methoxycarbonyl)-1-tosyl-1H-pyrrol-3-yl)boronic acid | ESD-890671-100MG |
| Cas.: 916177-00-9 | Purity: 97% | (5-(Methoxycarbonyl)-1-tosyl-1H-pyrrol-3-yl)boronic acid | ESD-890671-250MG |
| Cas.: 112984-60-8 | Purity: 97% | 6-Fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid | ESD-890672-1G |
| Cas.: 1212257-18-5 | Purity: ≥95% | Fmoc-L-Cyclopropylglycine | ESD-890673-250MG |
| Cas.: 1212257-18-5 | Purity: ≥95% | Fmoc-L-Cyclopropylglycine | ESD-890673-1G |
| Cas.: 1212257-18-5 | Purity: ≥95% | Fmoc-L-Cyclopropylglycine | ESD-890673-5G |
| Cas.: 1212257-18-5 | Purity: ≥95% | Fmoc-L-Cyclopropylglycine | ESD-890673-10G |
| Cas.: 86455-98-3 | Purity: ≥95% | 1-((2-(Dimethylamino)ethyl)amino)-7-hydroxy-4-(hydroxymethyl)-9H-xanthen-9-one | ESD-890674-100MG |
| Cas.: 86455-98-3 | Purity: ≥95% | 1-((2-(Dimethylamino)ethyl)amino)-7-hydroxy-4-(hydroxymethyl)-9H-xanthen-9-one | ESD-890674-250MG |
| Cas.: 86455-98-3 | Purity: ≥95% | 1-((2-(Dimethylamino)ethyl)amino)-7-hydroxy-4-(hydroxymethyl)-9H-xanthen-9-one | ESD-890674-1G |
| Cas.: 24787-89-1 | Purity: 98% | Z-Val-Ala-OH | ESD-890675-250MG |
| Cas.: 24787-89-1 | Purity: 98% | Z-Val-Ala-OH | ESD-890675-1G |
| Cas.: 24787-89-1 | Purity: 98% | Z-Val-Ala-OH | ESD-890675-5G |
| Cas.: 24787-89-1 | Purity: 98% | Z-Val-Ala-OH | ESD-890675-10G |
| Cas.: 193693-63-9 | Purity: 97% | (R)-2-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperidin-2-yl)acetic acid | ESD-890676-100MG |
| Cas.: 193693-63-9 | Purity: 97% | (R)-2-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperidin-2-yl)acetic acid | ESD-890676-250MG |
| Cas.: 119302-24-8 | Purity: ≥95% | (2b,3a,5a,16b,17b)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane | ESD-890677-250MG |
| Cas.: 119302-24-8 | Purity: ≥95% | (2b,3a,5a,16b,17b)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane | ESD-890677-1G |
| Cas.: 119302-24-8 | Purity: ≥95% | (2b,3a,5a,16b,17b)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane | ESD-890677-5G |
| Cas.: 119302-24-8 | Purity: ≥95% | (2b,3a,5a,16b,17b)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane | ESD-890677-10G |
| Cas.: 71-33-0 | Purity: ≥95% | 1,3,5-Triazine-2,4(1H,3H)-dione | ESD-890678-100MG |
| Cas.: 71-33-0 | Purity: ≥95% | 1,3,5-Triazine-2,4(1H,3H)-dione | ESD-890678-250MG |
| Cas.: 172015-79-1 | Purity: ≥95% | ((1S,4R)-4-(2-Amino-6-chloro-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol hydrochloride | ESD-890679-100MG |
| Cas.: 172015-79-1 | Purity: ≥95% | ((1S,4R)-4-(2-Amino-6-chloro-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol hydrochloride | ESD-890679-250MG |
| Cas.: 172015-79-1 | Purity: ≥95% | ((1S,4R)-4-(2-Amino-6-chloro-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol hydrochloride | ESD-890679-1G |
| Cas.: 889939-26-8 | Purity: ≥95% | 4-Bromo-2-iodo-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine | ESD-890680-100MG |
| Cas.: 889939-26-8 | Purity: ≥95% | 4-Bromo-2-iodo-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine | ESD-890680-250MG |
| Cas.: 889939-26-8 | Purity: ≥95% | 4-Bromo-2-iodo-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine | ESD-890680-1G |
| Cas.: 889939-26-8 | Purity: ≥95% | 4-Bromo-2-iodo-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine | ESD-890680-5G |
| Cas.: 1018899-99-4 | Purity: 97% | (R)-2-(((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid | ESD-890681-50MG |
| Cas.: 1018899-99-4 | Purity: 97% | (R)-2-(((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)methyl)-4-methylpentanoic acid | ESD-890681-100MG |
| Cas.: 1472062-94-4 | Purity: ≥98% | 2-([1,1′-Biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine | ESD-890682-250MG |
| Cas.: 1472062-94-4 | Purity: ≥98% | 2-([1,1′-Biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine | ESD-890682-1G |
| Cas.: 1472062-94-4 | Purity: ≥98% | 2-([1,1′-Biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine | ESD-890682-5G |
| Cas.: 283173-80-8 | Purity: ≥95% | 2-Bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one | ESD-890683-250MG |
| Cas.: 283173-80-8 | Purity: ≥95% | 2-Bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one | ESD-890683-1G |
| Cas.: 283173-80-8 | Purity: ≥95% | 2-Bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one | ESD-890683-5G |
| Cas.: 283173-80-8 | Purity: ≥95% | 2-Bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one | ESD-890683-10G |
| Cas.: 1715032-87-3 | Purity: 97% | tert-Butyl 4-(3-amino-6-((1S,3S,4S)-4-((tert-butyldimethylsilyl)oxy)-3-fluorocyclohexyl)pyrazin-2-yl)-2-fluorobenzoate | ESD-890684-100MG |
| Cas.: 1715032-87-3 | Purity: 97% | tert-Butyl 4-(3-amino-6-((1S,3S,4S)-4-((tert-butyldimethylsilyl)oxy)-3-fluorocyclohexyl)pyrazin-2-yl)-2-fluorobenzoate | ESD-890684-250MG |
| Cas.: 13522-16-2 | Purity: ≥95% | (2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-10,13-Dimethyl-2,16-di(pipidin-1-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene- 3,17-diol | ESD-890685-250MG |
| Cas.: 13522-16-2 | Purity: ≥95% | (2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-10,13-Dimethyl-2,16-di(pipidin-1-yl)hexadecahydro-1H-cyclopenta[a]phenanthrene- 3,17-diol | ESD-890685-1G |
| Cas.: 79315-62-1 | Purity: ≥95% | 4-(Benzyloxy)-1-(phenylsulfonyl)-1H-indole | ESD-890686-100MG |
| Cas.: 79315-62-1 | Purity: ≥95% | 4-(Benzyloxy)-1-(phenylsulfonyl)-1H-indole | ESD-890686-250MG |
| Cas.: 60924-38-1 | Purity: 97% | (3AS,4S,5S,7R,8R,9S,9aR,12R)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen- 5-yl 2-((methylsulfonyl)oxy)acetate | ESD-890687-1G |
| Cas.: 60924-38-1 | Purity: 97% | (3AS,4S,5S,7R,8R,9S,9aR,12R)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen- 5-yl 2-((methylsulfonyl)oxy)acetate | ESD-890687-5G |
| Cas.: 60924-38-1 | Purity: 97% | (3AS,4S,5S,7R,8R,9S,9aR,12R)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen- 5-yl 2-((methylsulfonyl)oxy)acetate | ESD-890687-10G |
| Cas.: 26494-58-6 | Purity: 98% | 2-(6-Chloro-3-oxo-2H-benzo[b][1,4]oxazin-4(3H)-yl)acetic acid | ESD-890688-250MG |
| Cas.: 26494-58-6 | Purity: 98% | 2-(6-Chloro-3-oxo-2H-benzo[b][1,4]oxazin-4(3H)-yl)acetic acid | ESD-890688-1G |
| Cas.: 26494-58-6 | Purity: 98% | 2-(6-Chloro-3-oxo-2H-benzo[b][1,4]oxazin-4(3H)-yl)acetic acid | ESD-890688-5G |
| Cas.: 26494-58-6 | Purity: 98% | 2-(6-Chloro-3-oxo-2H-benzo[b][1,4]oxazin-4(3H)-yl)acetic acid | ESD-890688-10G |
| Cas.: 131707-24-9 | Purity: ≥95% | Ethyl 6-bromo-5-hydroxy-1-methyl-2-((phenylthio)methyl)-1H-Indole-3-carboxylate | ESD-890689-5G |
| Cas.: 131707-24-9 | Purity: ≥95% | Ethyl 6-bromo-5-hydroxy-1-methyl-2-((phenylthio)methyl)-1H-Indole-3-carboxylate | ESD-890689-10G |
| Cas.: 131707-24-9 | Purity: ≥95% | Ethyl 6-bromo-5-hydroxy-1-methyl-2-((phenylthio)methyl)-1H-Indole-3-carboxylate | ESD-890689-25G |
| Cas.: 131707-24-9 | Purity: ≥95% | Ethyl 6-bromo-5-hydroxy-1-methyl-2-((phenylthio)methyl)-1H-Indole-3-carboxylate | ESD-890689-100G |
| Cas.: 84378-44-9 | Purity: ≥98% | Ro 15-3890 | ESD-890690-5MG |
| Cas.: 84378-44-9 | Purity: ≥98% | Ro 15-3890 | ESD-890690-25MG |
| Cas.: 84378-44-9 | Purity: ≥98% | Ro 15-3890 | ESD-890690-50MG |
| Cas.: 84378-44-9 | Purity: ≥98% | Ro 15-3890 | ESD-890690-100MG |
| Cas.: 93609-84-8 | Purity: 97% | 5-Acetyl-8-(benzyloxy)quinolin-2(1H)-one | ESD-890691-100MG |
| Cas.: 93609-84-8 | Purity: 97% | 5-Acetyl-8-(benzyloxy)quinolin-2(1H)-one | ESD-890691-250MG |
| Cas.: 93609-84-8 | Purity: 97% | 5-Acetyl-8-(benzyloxy)quinolin-2(1H)-one | ESD-890691-1G |
| Cas.: 93609-84-8 | Purity: 97% | 5-Acetyl-8-(benzyloxy)quinolin-2(1H)-one | ESD-890691-5G |
| Cas.: 1616114-00-1 | Purity: 97% | 1-(2,7-Dibromospiro[fluorene-9,4′-pipidin]-1′-yl)ethanone | ESD-890692-100MG |
| Cas.: 1616114-00-1 | Purity: 97% | 1-(2,7-Dibromospiro[fluorene-9,4′-pipidin]-1′-yl)ethanone | ESD-890692-250MG |
| Cas.: 345633-76-3 | Purity: 97% | 4,4′-Didodecyl-2,2′-bithiophene | ESD-890693-100MG |
| Cas.: 345633-76-3 | Purity: 97% | 4,4′-Didodecyl-2,2′-bithiophene | ESD-890693-250MG |
| Cas.: 27333-50-2 | Purity: 97% | 5-Chloro-1,3,3-trimethylspiro[indoline-2,3′-naphtho[2,1-b][1,4]oxazine] | ESD-890694-250MG |
| Cas.: 27333-50-2 | Purity: 97% | 5-Chloro-1,3,3-trimethylspiro[indoline-2,3′-naphtho[2,1-b][1,4]oxazine] | ESD-890694-1G |
| Cas.: 27333-50-2 | Purity: 97% | 5-Chloro-1,3,3-trimethylspiro[indoline-2,3′-naphtho[2,1-b][1,4]oxazine] | ESD-890694-5G |
| Cas.: 180414-94-2 | Purity: 97% | Fmoc-HoLeu-OH | ESD-890695-250MG |
| Cas.: 180414-94-2 | Purity: 97% | Fmoc-HoLeu-OH | ESD-890695-1G |
| Cas.: 180414-94-2 | Purity: 97% | Fmoc-HoLeu-OH | ESD-890695-5G |
| Cas.: 180414-94-2 | Purity: 97% | Fmoc-HoLeu-OH | ESD-890695-10G |
| Cas.: 159610-93-2 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methoxypropanoic acid | ESD-890696-250MG |
| Cas.: 159610-93-2 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methoxypropanoic acid | ESD-890696-1G |
| Cas.: 159610-93-2 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methoxypropanoic acid | ESD-890696-5G |
| Cas.: 159610-93-2 | Purity: 98% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methoxypropanoic acid | ESD-890696-10G |
| Cas.: 518048-03-8 | Purity: 97% | 2-(2-Aminopropan-2-yl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide | ESD-890697-250MG |
| Cas.: 518048-03-8 | Purity: 97% | 2-(2-Aminopropan-2-yl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide | ESD-890697-1G |
| Cas.: 518048-03-8 | Purity: 97% | 2-(2-Aminopropan-2-yl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide | ESD-890697-5G |
| Cas.: 518048-03-8 | Purity: 97% | 2-(2-Aminopropan-2-yl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide | ESD-890697-10G |
| Cas.: 13564-70-0 | Purity: ≥95% | Dicyclohexylamine (2S,3R)-2-((tert-butoxycarbonyl)amino)-3-hydroxybutanoate | ESD-890698-250MG |
| Cas.: 13564-70-0 | Purity: ≥95% | Dicyclohexylamine (2S,3R)-2-((tert-butoxycarbonyl)amino)-3-hydroxybutanoate | ESD-890698-1G |
| Cas.: 13564-70-0 | Purity: ≥95% | Dicyclohexylamine (2S,3R)-2-((tert-butoxycarbonyl)amino)-3-hydroxybutanoate | ESD-890698-5G |
| Cas.: 103460-89-5 | Purity: ≥95% | 1-Cyclopropyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | ESD-890699-100MG |
| Cas.: 103460-89-5 | Purity: ≥95% | 1-Cyclopropyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | ESD-890699-250MG |
| Cas.: 1447709-01-4 | Purity: 97% | Benzo[b]naphtho[1,2-d]thiophen-5-ylboronic acid | ESD-890700-100MG |
| Cas.: 1447709-01-4 | Purity: 97% | Benzo[b]naphtho[1,2-d]thiophen-5-ylboronic acid | ESD-890700-250MG |
| Cas.: 1447709-01-4 | Purity: 97% | Benzo[b]naphtho[1,2-d]thiophen-5-ylboronic acid | ESD-890700-1G |
| Cas.: 252049-06-2 | Purity: 98% | Fmoc-N-Me-Thr-OH | ESD-890701-100MG |
| Cas.: 252049-06-2 | Purity: 98% | Fmoc-N-Me-Thr-OH | ESD-890701-250MG |
| Cas.: 252049-06-2 | Purity: 98% | Fmoc-N-Me-Thr-OH | ESD-890701-1G |
| Cas.: 252049-06-2 | Purity: 98% | Fmoc-N-Me-Thr-OH | ESD-890701-5G |
| Cas.: 14905-30-7 | Purity: 97% | Z-Lys(Tfa)-OH | ESD-890702-1G |
| Cas.: 14905-30-7 | Purity: 97% | Z-Lys(Tfa)-OH | ESD-890702-5G |
| Cas.: 14905-30-7 | Purity: 97% | Z-Lys(Tfa)-OH | ESD-890702-10G |
| Cas.: 1616415-40-7 | Purity: 97% | (S)-tert-Butyl 4-(6-amino-1,3-dimethyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-3-methylpiperazine-1-carboxylate | ESD-890703-100MG |
| Cas.: 1616415-40-7 | Purity: 97% | (S)-tert-Butyl 4-(6-amino-1,3-dimethyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-3-methylpiperazine-1-carboxylate | ESD-890703-250MG |
| Cas.: 3957-22-0 | Purity: 97% | (Propane-2,2-diylbis(2-hydroxybenzene-5,3,1-triyl))tetramethanol | ESD-890704-250MG |
| Cas.: 3957-22-0 | Purity: 97% | (Propane-2,2-diylbis(2-hydroxybenzene-5,3,1-triyl))tetramethanol | ESD-890704-1G |
| Cas.: 3957-22-0 | Purity: 97% | (Propane-2,2-diylbis(2-hydroxybenzene-5,3,1-triyl))tetramethanol | ESD-890704-5G |
| Cas.: 80047-24-1 | Purity: ≥98% | 2-Methyl-6-oxo-1,6-dihydro-[3,4′-bipyridine]-5-carboxamide | ESD-890705-100MG |
| Cas.: 80047-24-1 | Purity: ≥98% | 2-Methyl-6-oxo-1,6-dihydro-[3,4′-bipyridine]-5-carboxamide | ESD-890705-250MG |
| Cas.: 80047-24-1 | Purity: ≥98% | 2-Methyl-6-oxo-1,6-dihydro-[3,4′-bipyridine]-5-carboxamide | ESD-890705-1G |
| Cas.: 80047-24-1 | Purity: ≥98% | 2-Methyl-6-oxo-1,6-dihydro-[3,4′-bipyridine]-5-carboxamide | ESD-890705-5G |
| Cas.: 266318-79-0 | Purity: ≥95% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methylpentanoic acid | ESD-890706-250MG |
| Cas.: 266318-79-0 | Purity: ≥95% | (S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methylpentanoic acid | ESD-890706-1G |
| Cas.: 881677-11-8 | Purity: 97% | 5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde | ESD-890707-100MG |
| Cas.: 881677-11-8 | Purity: 97% | 5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde | ESD-890707-250MG |
| Cas.: 881677-11-8 | Purity: 97% | 5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde | ESD-890707-1G |
| Cas.: 13676-49-8 | Purity: 95% | 2-(3-Aminophenyl)-1H-benzo[d]imidazol-6-amine | ESD-890708-250MG |
| Cas.: 13676-49-8 | Purity: 95% | 2-(3-Aminophenyl)-1H-benzo[d]imidazol-6-amine | ESD-890708-1G |
| Cas.: 149709-59-1 | Purity: 97% | (R)-Ethyl 5-([1,1′-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoate | ESD-890709-100MG |
| Cas.: 149709-59-1 | Purity: 97% | (R)-Ethyl 5-([1,1′-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoate | ESD-890709-250MG |
| Cas.: 149709-59-1 | Purity: 97% | (R)-Ethyl 5-([1,1′-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoate | ESD-890709-1G |
| Cas.: 149709-59-1 | Purity: 97% | (R)-Ethyl 5-([1,1′-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoate | ESD-890709-5G |
| Cas.: 83928-76-1 | Purity: ≥95% | 4,4-Dimethyl-1-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)piperidine-2,6-dione | ESD-890710-100MG |
| Cas.: 83928-76-1 | Purity: ≥95% | 4,4-Dimethyl-1-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)piperidine-2,6-dione | ESD-890710-250MG |
| Cas.: 193693-60-6 | Purity: 98% | Fmoc-β-HoPro-OH | ESD-890711-100MG |
| Cas.: 193693-60-6 | Purity: 98% | Fmoc-β-HoPro-OH | ESD-890711-250MG |
| Cas.: 193693-60-6 | Purity: 98% | Fmoc-β-HoPro-OH | ESD-890711-1G |
| Cas.: 193693-60-6 | Purity: 98% | Fmoc-β-HoPro-OH | ESD-890711-5G |
| Cas.: 193693-61-7 | Purity: 98% | (R)-2-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)pyrrolidin-2-yl)acetic acid | ESD-890712-250MG |
| Cas.: 193693-61-7 | Purity: 98% | (R)-2-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)pyrrolidin-2-yl)acetic acid | ESD-890712-1G |
| Cas.: 193693-61-7 | Purity: 98% | (R)-2-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)pyrrolidin-2-yl)acetic acid | ESD-890712-5G |
| Cas.: 193693-61-7 | Purity: 98% | (R)-2-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)pyrrolidin-2-yl)acetic acid | ESD-890712-10G |
| Cas.: 3346-22-3 | Purity: 97% | 6-Amino-5-nitropyrimidine-2,4(1H,3H)-dione | ESD-890713-100MG |
| Cas.: 3346-22-3 | Purity: 97% | 6-Amino-5-nitropyrimidine-2,4(1H,3H)-dione | ESD-890713-250MG |
| Cas.: 3346-22-3 | Purity: 97% | 6-Amino-5-nitropyrimidine-2,4(1H,3H)-dione | ESD-890713-1G |
| Cas.: 3346-22-3 | Purity: 97% | 6-Amino-5-nitropyrimidine-2,4(1H,3H)-dione | ESD-890713-5G |
| Cas.: 193693-68-4 | Purity: 98% | (S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperidine-3-carboxylic acid | ESD-890714-250MG |
| Cas.: 193693-68-4 | Purity: 98% | (S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperidine-3-carboxylic acid | ESD-890714-1G |
| Cas.: 193693-68-4 | Purity: 98% | (S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperidine-3-carboxylic acid | ESD-890714-5G |
| Cas.: 193693-68-4 | Purity: 98% | (S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperidine-3-carboxylic acid | ESD-890714-10G |
| Cas.: 1738-87-0 | Purity: 97% | Z-Leu-ONp | ESD-890715-1G |
| Cas.: 1738-87-0 | Purity: 97% | Z-Leu-ONp | ESD-890715-5G |
| Cas.: 52559-17-8 | Purity: 97% | 6-Chloro-3H-imidazo[4,5-c]pyridin-4-amine | ESD-890716-100MG |
| Cas.: 52559-17-8 | Purity: 97% | 6-Chloro-3H-imidazo[4,5-c]pyridin-4-amine | ESD-890716-250MG |
| Cas.: 52559-17-8 | Purity: 97% | 6-Chloro-3H-imidazo[4,5-c]pyridin-4-amine | ESD-890716-1G |
| Cas.: 5987-73-5 | Purity: ≥95% | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(6-chloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate | ESD-890717-100MG |
| Cas.: 5987-73-5 | Purity: ≥95% | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(6-chloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate | ESD-890717-250MG |
| Cas.: 5987-73-5 | Purity: ≥95% | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(6-chloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate | ESD-890717-1G |
| Cas.: 147118-30-7 | Purity: 98% | Ethyl 4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidine-5-carboxylate | ESD-890718-100MG |
| Cas.: 147118-30-7 | Purity: 98% | Ethyl 4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidine-5-carboxylate | ESD-890718-250MG |
| Cas.: 147118-30-7 | Purity: 98% | Ethyl 4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidine-5-carboxylate | ESD-890718-1G |
| Cas.: 50508-89-9 | Purity: 97% | 2-Chloro-N-(3-(2-chlorobenzoyl)-5-ethylthiophen-2-yl)acetamide | ESD-890719-100MG |
| Cas.: 50508-89-9 | Purity: 97% | 2-Chloro-N-(3-(2-chlorobenzoyl)-5-ethylthiophen-2-yl)acetamide | ESD-890719-250MG |
| Cas.: 50508-89-9 | Purity: 97% | 2-Chloro-N-(3-(2-chlorobenzoyl)-5-ethylthiophen-2-yl)acetamide | ESD-890719-1G |
| Cas.: 201677-59-0 | Purity: ≥95% | (R)-N-[5-(2-Bromo-1-hydroxyethyl)-2-(phenylmethoxy)phenyl]formamide | ESD-890720-100MG |
| Cas.: 201677-59-0 | Purity: ≥95% | (R)-N-[5-(2-Bromo-1-hydroxyethyl)-2-(phenylmethoxy)phenyl]formamide | ESD-890720-250MG |
| Cas.: 201677-59-0 | Purity: ≥95% | (R)-N-[5-(2-Bromo-1-hydroxyethyl)-2-(phenylmethoxy)phenyl]formamide | ESD-890720-1G |
| Cas.: 26493-11-8 | Purity: 97% | 2-Amino-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one | ESD-890721-100MG |
| Cas.: 26493-11-8 | Purity: 97% | 2-Amino-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one | ESD-890721-250MG |
| Cas.: 26493-11-8 | Purity: 97% | 2-Amino-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one | ESD-890721-1G |
| Cas.: 7535-56-0 | Purity: 97% | Boc-Phe-ONp | ESD-890722-5G |
| Cas.: 7535-56-0 | Purity: 97% | Boc-Phe-ONp | ESD-890722-10G |
| Cas.: 7535-56-0 | Purity: 97% | Boc-Phe-ONp | ESD-890722-25G |
| Cas.: 7535-56-0 | Purity: 97% | Boc-Phe-ONp | ESD-890722-100G |
| Cas.: 144701-24-6 | Purity: ≥95% | Fmoc-D-Nva-OH | ESD-890723-250MG |
| Cas.: 144701-24-6 | Purity: ≥95% | Fmoc-D-Nva-OH | ESD-890723-1G |
| Cas.: 144701-24-6 | Purity: ≥95% | Fmoc-D-Nva-OH | ESD-890723-5G |
| Cas.: 144701-24-6 | Purity: ≥95% | Fmoc-D-Nva-OH | ESD-890723-10G |
| Cas.: 183282-45-3 | Purity: 95% | (1H-Benzo[d][1,2,3]triazol-5-yl)boronic acid | ESD-890724-100MG |
| Cas.: 123040-79-9 | Purity: ≥95% | 6-Chloro-4-methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxylic acid | ESD-890725-250MG |
| Cas.: 123040-79-9 | Purity: ≥95% | 6-Chloro-4-methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxylic acid | ESD-890725-1G |
| Cas.: 123040-79-9 | Purity: ≥95% | 6-Chloro-4-methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxylic acid | ESD-890725-5G |
| Cas.: 885270-31-5 | Purity: ≥95% | 1-((Benzyloxy)carbonyl)-3-((tert-butoxycarbonyl)amino)piperidine-3-carboxylic acid | ESD-890726-100MG |
| Cas.: 885270-31-5 | Purity: ≥95% | 1-((Benzyloxy)carbonyl)-3-((tert-butoxycarbonyl)amino)piperidine-3-carboxylic acid | ESD-890726-250MG |
| Cas.: 1335210-24-6 | Purity: 97% | (3S,11AR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine- 8-carboxylic acid | ESD-890727-100MG |
| Cas.: 1335210-24-6 | Purity: 97% | (3S,11AR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine- 8-carboxylic acid | ESD-890727-250MG |
| Cas.: 69876-58-0 | Purity: 97% | Boc-Glu(OtBu)-ONp | ESD-890728-250MG |
| Cas.: 69876-58-0 | Purity: 97% | Boc-Glu(OtBu)-ONp | ESD-890728-1G |
| Cas.: 105404-65-7 | Purity: ≥95% | Ethyl 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylate | ESD-890729-100MG |
| Cas.: 105404-65-7 | Purity: ≥95% | Ethyl 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylate | ESD-890729-250MG |
| Cas.: 201864-71-3 | Purity: 98% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)butanoic acid | ESD-890730-1G |
| Cas.: 201864-71-3 | Purity: 98% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)butanoic acid | ESD-890730-5G |
| Cas.: 201864-71-3 | Purity: 98% | (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)butanoic acid | ESD-890730-10G |
| Cas.: 315203-39-5 | Purity: ≥95% | 1-(2,6-Dichlorobenzyl)-3-(pyrrolidin-1-ylmethyl)-1H-indazol-6-amine | ESD-890731-100MG |
| Cas.: 315203-39-5 | Purity: ≥95% | 1-(2,6-Dichlorobenzyl)-3-(pyrrolidin-1-ylmethyl)-1H-indazol-6-amine | ESD-890731-250MG |
| Cas.: 90101-16-9 | Purity: 98% | Droxicam | ESD-890732-10MG |
| Cas.: 90101-16-9 | Purity: 98% | Droxicam | ESD-890732-100MG |
| Cas.: 3070-86-8 | Purity: 97% | N,N’-(Oxybis(4,1-phenylene))diacetamide | ESD-890733-250MG |
| Cas.: 3070-86-8 | Purity: 97% | N,N’-(Oxybis(4,1-phenylene))diacetamide | ESD-890733-1G |
| Cas.: 1400589-53-8 | Purity: 97% | (R)-tert-Butyl 2-((7-chloropyrido[4,3-b]pyrazin-5-ylamino)methyl)morpholine-4-carboxylate | ESD-890734-100MG |
| Cas.: 1400589-53-8 | Purity: 97% | (R)-tert-Butyl 2-((7-chloropyrido[4,3-b]pyrazin-5-ylamino)methyl)morpholine-4-carboxylate | ESD-890734-250MG |
| Cas.: 916486-06-1 | Purity: 96% | Ethyl 2-(2-(methylamino)pyrimidin-4-yl)-1H-indole-5-carboxylate | ESD-890735-100MG |
| Cas.: 916486-06-1 | Purity: 96% | Ethyl 2-(2-(methylamino)pyrimidin-4-yl)-1H-indole-5-carboxylate | ESD-890735-250MG |
| Cas.: 64363-77-5 | Purity: ≥95% | (2R,3R,4R)-3,4-Bis(benzyloxy)-2-((benzyloxy)methyl)-5-methoxytetrahydrofuran | ESD-890736-100MG |
| Cas.: 64363-77-5 | Purity: ≥95% | (2R,3R,4R)-3,4-Bis(benzyloxy)-2-((benzyloxy)methyl)-5-methoxytetrahydrofuran | ESD-890736-250MG |
| Cas.: 64363-77-5 | Purity: ≥95% | (2R,3R,4R)-3,4-Bis(benzyloxy)-2-((benzyloxy)methyl)-5-methoxytetrahydrofuran | ESD-890736-1G |
| Cas.: 63769-58-4 | Purity: 97% | Boc-D-Tyr(Bzl)-OH | ESD-890737-1G |
| Cas.: 63769-58-4 | Purity: 97% | Boc-D-Tyr(Bzl)-OH | ESD-890737-5G |
| Cas.: 63769-58-4 | Purity: 97% | Boc-D-Tyr(Bzl)-OH | ESD-890737-10G |
| Cas.: 63769-58-4 | Purity: 97% | Boc-D-Tyr(Bzl)-OH | ESD-890737-25G |
| Cas.: 931114-41-9 | Purity: 97% | 2-(Hydroxymethyl)naphtho[1,2-b]thiophene 1,1-dioxide | ESD-890738-100MG |
| Cas.: 931114-41-9 | Purity: 97% | 2-(Hydroxymethyl)naphtho[1,2-b]thiophene 1,1-dioxide | ESD-890738-250MG |
| Cas.: 96201-88-6 | Purity: ≥95% | Brequinar sodium | ESD-890739-25MG |
| Cas.: 96201-88-6 | Purity: ≥95% | Brequinar sodium | ESD-890739-100MG |
| Cas.: 96201-88-6 | Purity: ≥95% | Brequinar sodium | ESD-890739-250MG |
| Cas.: 174879-28-8 | Purity: ≥95% | 2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)butanoic acid | ESD-890740-250MG |
| Cas.: 174879-28-8 | Purity: ≥95% | 2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)butanoic acid | ESD-890740-1G |
| Cas.: 174879-28-8 | Purity: ≥95% | 2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)butanoic acid | ESD-890740-5G |
| Cas.: 1446712-19-1 | Purity: ≥98% | SNG-1153 | ESD-890741-1MG |
| Cas.: 1446712-19-1 | Purity: ≥98% | SNG-1153 | ESD-890741-10MG |
| Cas.: 1446712-19-1 | Purity: ≥98% | SNG-1153 | ESD-890741-25MG |
| Cas.: 913836-16-5 | Purity: ≥95% | 5-Bromo-2-hydroxyisonicotinic acid | ESD-890742-250MG |
| Cas.: 913836-16-5 | Purity: ≥95% | 5-Bromo-2-hydroxyisonicotinic acid | ESD-890742-1G |
| Cas.: 913836-16-5 | Purity: ≥95% | 5-Bromo-2-hydroxyisonicotinic acid | ESD-890742-5G |
| Cas.: 1073269-91-6 | Purity: ≥95% | (R)-3-((tert-Butoxycarbonyl)amino)-4-(1H-indol-3-yl)butanoic acid | ESD-890743-250MG |
| Cas.: 1073269-91-6 | Purity: ≥95% | (R)-3-((tert-Butoxycarbonyl)amino)-4-(1H-indol-3-yl)butanoic acid | ESD-890743-1G |
| Cas.: 21947-97-7 | Purity: 97% | Boc-Cys(Dpm)-OH | ESD-890744-250MG |
| Cas.: 21947-97-7 | Purity: 97% | Boc-Cys(Dpm)-OH | ESD-890744-1G |
| Cas.: 21947-97-7 | Purity: 97% | Boc-Cys(Dpm)-OH | ESD-890744-5G |
| Cas.: 62234-36-0 | Purity: 97% | ZD-Dap(Boc)-OH | ESD-890745-250MG |
| Cas.: 62234-36-0 | Purity: 97% | ZD-Dap(Boc)-OH | ESD-890745-1G |
| Cas.: 62234-36-0 | Purity: 97% | ZD-Dap(Boc)-OH | ESD-890745-5G |
| Cas.: 62234-36-0 | Purity: 97% | ZD-Dap(Boc)-OH | ESD-890745-10G |
| Cas.: 51463-14-0 | Purity: 97% | 6-Methoxyisoquinolin-3(2H)-one | ESD-890746-100MG |
| Cas.: 51463-14-0 | Purity: 97% | 6-Methoxyisoquinolin-3(2H)-one | ESD-890746-250MG |
| Cas.: 871709-84-1 | Purity: 96% | 3-Amino-1H-indazole-5-carboxylic acid | ESD-890747-100MG |
| Cas.: 871709-84-1 | Purity: 96% | 3-Amino-1H-indazole-5-carboxylic acid | ESD-890747-250MG |
| Cas.: 857801-97-9 | Purity: 97% | 6-Nitro-1H-indazole-3-carboxylic acid | ESD-890748-250MG |
| Cas.: 857801-97-9 | Purity: 97% | 6-Nitro-1H-indazole-3-carboxylic acid | ESD-890748-1G |
| Cas.: 857801-97-9 | Purity: 97% | 6-Nitro-1H-indazole-3-carboxylic acid | ESD-890748-5G |
| Cas.: 1671088-98-4 | Purity: 97% | tert-Butyl (4-((3-bromobenzyl)amino)-4-oxobutyl)carbamate | ESD-890749-100MG |
| Cas.: 1671088-98-4 | Purity: 97% | tert-Butyl (4-((3-bromobenzyl)amino)-4-oxobutyl)carbamate | ESD-890749-250MG |
| Cas.: 143832-52-4 | Purity: ≥95% | 2-(5-Amino-1H-1,2,4-triazol-3-yl)acetic acid | ESD-890750-250MG |
| Cas.: 143832-52-4 | Purity: ≥95% | 2-(5-Amino-1H-1,2,4-triazol-3-yl)acetic acid | ESD-890750-1G |
| Cas.: 143832-52-4 | Purity: ≥95% | 2-(5-Amino-1H-1,2,4-triazol-3-yl)acetic acid | ESD-890750-5G |
| Cas.: 155815-92-2 | Purity: 97% | 4-Amino-1H-imidazole-2-carboxylic acid | ESD-890751-100MG |
| Cas.: 155815-92-2 | Purity: 97% | 4-Amino-1H-imidazole-2-carboxylic acid | ESD-890751-250MG |
| Cas.: 641569-97-3 | Purity: 97% | Ethyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate | ESD-890752-1G |
| Cas.: 641569-97-3 | Purity: 97% | Ethyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate | ESD-890752-5G |
| Cas.: 641569-97-3 | Purity: 97% | Ethyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate | ESD-890752-10G |
| Cas.: 1755-04-0 | Purity: 98% | Bicyclo[3.1.0]hexan-3-one | ESD-890753-100MG |
| Cas.: 1755-04-0 | Purity: 98% | Bicyclo[3.1.0]hexan-3-one | ESD-890753-250MG |
| Cas.: 33008-07-0 | Purity: 95% | 2-(3-Methylbut-2-enamido)acetic acid | ESD-890754-100MG |
| Cas.: 33008-07-0 | Purity: 95% | 2-(3-Methylbut-2-enamido)acetic acid | ESD-890754-250MG |
| Cas.: 33008-07-0 | Purity: 95% | 2-(3-Methylbut-2-enamido)acetic acid | ESD-890754-1G |
| Cas.: 33631-02-6 | Purity: 97% | 3,4-Diaminopyridin-2-ol | ESD-890755-100MG |
| Cas.: 33631-02-6 | Purity: 97% | 3,4-Diaminopyridin-2-ol | ESD-890755-250MG |
| Cas.: 33631-02-6 | Purity: 97% | 3,4-Diaminopyridin-2-ol | ESD-890755-1G |
| Cas.: 202189-76-2 | Purity: 97% | 4-(2-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)propan-2-yl)phenethyl 4-methylbenzenesulfonate | ESD-890756-1G |
| Cas.: 202189-76-2 | Purity: 97% | 4-(2-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)propan-2-yl)phenethyl 4-methylbenzenesulfonate | ESD-890756-5G |
| Cas.: 185116-43-2 | Purity: 95% | Fmoc-4-Abz-OH | ESD-890757-1G |
| Cas.: 43157-50-2 | Purity: ≥95% | 2-Thioadenosine | ESD-890758-250MG |
| Cas.: 43157-50-2 | Purity: ≥95% | 2-Thioadenosine | ESD-890758-1G |
| Cas.: 43157-50-2 | Purity: ≥95% | 2-Thioadenosine | ESD-890758-5G |
| Cas.: 43157-50-2 | Purity: ≥95% | 2-Thioadenosine | ESD-890758-10G |
| Cas.: 122520-85-8 | Purity: 98% | AG 99 | ESD-890759-1MG |
| Cas.: 122520-85-8 | Purity: 98% | AG 99 | ESD-890759-5MG |
| Cas.: 122520-85-8 | Purity: 98% | AG 99 | ESD-890759-10MG |
| Cas.: 122520-85-8 | Purity: 98% | AG 99 | ESD-890759-25MG |
| Cas.: 122640-83-9 | Purity: 97% | Dodecahydro-[5,5′-biisobenzofuran]-1,1′,3,3′-tetraone | ESD-890760-100MG |
| Cas.: 122640-83-9 | Purity: 97% | Dodecahydro-[5,5′-biisobenzofuran]-1,1′,3,3′-tetraone | ESD-890760-250MG |
| Cas.: 122640-83-9 | Purity: 97% | Dodecahydro-[5,5′-biisobenzofuran]-1,1′,3,3′-tetraone | ESD-890760-1G |
| Cas.: 122640-83-9 | Purity: 97% | Dodecahydro-[5,5′-biisobenzofuran]-1,1′,3,3′-tetraone | ESD-890760-5G |
| Cas.: 3397-65-7 | Purity: ≥95% | N-Lauroyl-L-glutamic acid | ESD-890761-250MG |
| Cas.: 3397-65-7 | Purity: ≥95% | N-Lauroyl-L-glutamic acid | ESD-890761-1G |
| Cas.: 3397-65-7 | Purity: ≥95% | N-Lauroyl-L-glutamic acid | ESD-890761-5G |
| Cas.: 223673-35-6 | Purity: ≥95% | (R)-tert-Butyl (2-hydroxy-2-phenylethyl)(4-nitrophenethyl)carbamate | ESD-890762-100MG |
| Cas.: 223673-35-6 | Purity: ≥95% | (R)-tert-Butyl (2-hydroxy-2-phenylethyl)(4-nitrophenethyl)carbamate | ESD-890762-250MG |
| Cas.: 57116-45-7 | Purity: Solid content 99% | Pentaerythritol tris(3-(1-aziridinyl)propionate) | ESD-890763-5G |
| Cas.: 57116-45-7 | Purity: Solid content 99% | Pentaerythritol tris(3-(1-aziridinyl)propionate) | ESD-890763-10G |
| Cas.: 57116-45-7 | Purity: Solid content 99% | Pentaerythritol tris(3-(1-aziridinyl)propionate) | ESD-890763-25G |
| Cas.: 374064-01-4 | Purity: 97% | 3-(Pyridin-3-yl)-1H-pyrazole-5-carboxylic acid | ESD-890764-100MG |
| Cas.: 374064-01-4 | Purity: 97% | 3-(Pyridin-3-yl)-1H-pyrazole-5-carboxylic acid | ESD-890764-250MG |
| Cas.: 374064-01-4 | Purity: 97% | 3-(Pyridin-3-yl)-1H-pyrazole-5-carboxylic acid | ESD-890764-1G |
| Cas.: 374064-01-4 | Purity: 97% | 3-(Pyridin-3-yl)-1H-pyrazole-5-carboxylic acid | ESD-890764-5G |
| Cas.: 1206102-07-9 | Purity: 97% | Methyl 3-(benzyloxy)-1-(2,3-dihydroxypropyl)-4-oxo-1,4-dihydropyridine-2-carboxylate | ESD-890765-100MG |
| Cas.: 1206102-07-9 | Purity: 97% | Methyl 3-(benzyloxy)-1-(2,3-dihydroxypropyl)-4-oxo-1,4-dihydropyridine-2-carboxylate | ESD-890765-250MG |
| Cas.: 1206102-07-9 | Purity: 97% | Methyl 3-(benzyloxy)-1-(2,3-dihydroxypropyl)-4-oxo-1,4-dihydropyridine-2-carboxylate | ESD-890765-1G |
| Cas.: 175854-39-4 | Purity: 97% | Tri-tert-Butyl 1,4,7,10-tetraazacyclododecane-1,4,7-tricarboxylate | ESD-890766-250MG |
| Cas.: 175854-39-4 | Purity: 97% | Tri-tert-Butyl 1,4,7,10-tetraazacyclododecane-1,4,7-tricarboxylate | ESD-890766-1G |
| Cas.: 175854-39-4 | Purity: 97% | Tri-tert-Butyl 1,4,7,10-tetraazacyclododecane-1,4,7-tricarboxylate | ESD-890766-5G |
| Cas.: 175854-39-4 | Purity: 97% | Tri-tert-Butyl 1,4,7,10-tetraazacyclododecane-1,4,7-tricarboxylate | ESD-890766-10G |
| Cas.: 768350-54-5 | Purity: ≥95% | 7-(Benzyloxy)-N-(4-bromo-2-fluorophenyl)-6-methoxyquinazolin-4-amine | ESD-890767-100MG |
| Cas.: 768350-54-5 | Purity: ≥95% | 7-(Benzyloxy)-N-(4-bromo-2-fluorophenyl)-6-methoxyquinazolin-4-amine | ESD-890767-250MG |
| Cas.: 768350-54-5 | Purity: ≥95% | 7-(Benzyloxy)-N-(4-bromo-2-fluorophenyl)-6-methoxyquinazolin-4-amine | ESD-890767-1G |
| Cas.: 202197-73-7 | Purity: ≥95% | 4-Oxo-3,4-dihydroquinazoline-7-carboxylic acid | ESD-890768-100MG |
| Cas.: 202197-73-7 | Purity: ≥95% | 4-Oxo-3,4-dihydroquinazoline-7-carboxylic acid | ESD-890768-250MG |
| Cas.: 202197-73-7 | Purity: ≥95% | 4-Oxo-3,4-dihydroquinazoline-7-carboxylic acid | ESD-890768-1G |
| Cas.: 76391-97-4 | Purity: 97% | 2-Amino-1H-benzo[d]imidazole-5-carboxylic acid | ESD-890769-100MG |
| Cas.: 76391-97-4 | Purity: 97% | 2-Amino-1H-benzo[d]imidazole-5-carboxylic acid | ESD-890769-250MG |
| Cas.: 76391-97-4 | Purity: 97% | 2-Amino-1H-benzo[d]imidazole-5-carboxylic acid | ESD-890769-1G |
| Cas.: 175281-76-2 | Purity: ≥95% | 4-(4-(1-Hydroxyethyl)-2-methoxy-5-nitrophenoxy)butanoic acid | ESD-890770-100MG |
| Cas.: 175281-76-2 | Purity: ≥95% | 4-(4-(1-Hydroxyethyl)-2-methoxy-5-nitrophenoxy)butanoic acid | ESD-890770-250MG |
| Cas.: 175281-76-2 | Purity: ≥95% | 4-(4-(1-Hydroxyethyl)-2-methoxy-5-nitrophenoxy)butanoic acid | ESD-890770-1G |
| Cas.: 122194-07-4 | Purity: 97% | Dimethyl n,n-diisopropylphosphoramidite | ESD-890771-1G |
| Cas.: 122350-59-8 | Purity: 97%(HPLC) | (2S,4R)-1-((9H-Fluoren-9-yl)methyl) 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate | ESD-890772-5G |
| Cas.: 122350-59-8 | Purity: 97%(HPLC) | (2S,4R)-1-((9H-Fluoren-9-yl)methyl) 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate | ESD-890772-10G |
| Cas.: 122350-59-8 | Purity: 97%(HPLC) | (2S,4R)-1-((9H-Fluoren-9-yl)methyl) 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate | ESD-890772-25G |
| Cas.: 122350-59-8 | Purity: 97%(HPLC) | (2S,4R)-1-((9H-Fluoren-9-yl)methyl) 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate | ESD-890772-100G |
| Cas.: 63547-24-0 | Purity: 97% | 2-(Benzhydrylsulfinyl)acetic acid | ESD-890773-250MG |
| Cas.: 63547-24-0 | Purity: 97% | 2-(Benzhydrylsulfinyl)acetic acid | ESD-890773-1G |
| Cas.: 63547-24-0 | Purity: 97% | 2-(Benzhydrylsulfinyl)acetic acid | ESD-890773-5G |
| Cas.: 63547-24-0 | Purity: 97% | 2-(Benzhydrylsulfinyl)acetic acid | ESD-890773-10G |
| Cas.: 13512-57-7 | Purity: 97% | (S)-Benzyl 4-amino-2-((tert-butoxycarbonyl)amino)-4-oxobutanoate | ESD-890774-100MG |
| Cas.: 13512-57-7 | Purity: 97% | (S)-Benzyl 4-amino-2-((tert-butoxycarbonyl)amino)-4-oxobutanoate | ESD-890774-250MG |
| Cas.: 13512-57-7 | Purity: 97% | (S)-Benzyl 4-amino-2-((tert-butoxycarbonyl)amino)-4-oxobutanoate | ESD-890774-1G |
| Cas.: 13512-57-7 | Purity: 97% | (S)-Benzyl 4-amino-2-((tert-butoxycarbonyl)amino)-4-oxobutanoate | ESD-890774-5G |
| Cas.: 234442-58-1 | Purity: 96% | Fmoc-n-(butyl)-glycine | ESD-890775-100MG |
| Cas.: 234442-58-1 | Purity: 96% | Fmoc-n-(butyl)-glycine | ESD-890775-250MG |
| Cas.: 234442-58-1 | Purity: 96% | Fmoc-n-(butyl)-glycine | ESD-890775-1G |
| Cas.: 30809-75-7 | Purity: 97% | 4′-((4-Chlorophenyl)sulfonyl)-[1,1′-biphenyl]-4-ol | ESD-890776-250MG |
| Cas.: 30809-75-7 | Purity: 97% | 4′-((4-Chlorophenyl)sulfonyl)-[1,1′-biphenyl]-4-ol | ESD-890776-1G |
| Cas.: 141627-42-1 | Purity: ≥95% | (2-Butyl-5-nitrobenzofuran-3-yl)(4-methoxyphenyl)methanone | ESD-890777-1G |
| Cas.: 132679-61-9 | Purity: 97% | (S)-2-((5-Fluoro-2,4-dinitrophenyl)amino)-3-methylbutanamide | ESD-890778-250MG |
| Cas.: 132679-61-9 | Purity: 97% | (S)-2-((5-Fluoro-2,4-dinitrophenyl)amino)-3-methylbutanamide | ESD-890778-1G |
| Cas.: 132679-61-9 | Purity: 97% | (S)-2-((5-Fluoro-2,4-dinitrophenyl)amino)-3-methylbutanamide | ESD-890778-5G |
| Cas.: 755039-55-5 | Purity: ≥95% | (R)-2-Chloro-8-cyclopentyl-7-ethyl-5-methyl-7,8-dihydropteridin-6(5H)-one | ESD-890779-100MG |
| Cas.: 755039-55-5 | Purity: ≥95% | (R)-2-Chloro-8-cyclopentyl-7-ethyl-5-methyl-7,8-dihydropteridin-6(5H)-one | ESD-890779-250MG |
| Cas.: 755039-55-5 | Purity: ≥95% | (R)-2-Chloro-8-cyclopentyl-7-ethyl-5-methyl-7,8-dihydropteridin-6(5H)-one | ESD-890779-1G |
| Cas.: 1017598-71-8 | Purity: 97% | 1′-Benzyl-6-chloro-3H-spiro[furo[3,4-c]pyridine-1,4′-pipidin]-3-one | ESD-890780-100MG |
| Cas.: 1017598-71-8 | Purity: 97% | 1′-Benzyl-6-chloro-3H-spiro[furo[3,4-c]pyridine-1,4′-pipidin]-3-one | ESD-890780-250MG |
| Cas.: 488787-59-3 | Purity: 98% | (S)-4-(4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile | ESD-890781-100MG |
| Cas.: 488787-59-3 | Purity: 98% | (S)-4-(4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile | ESD-890781-250MG |
| Cas.: 1146629-77-7 | Purity: 97% | (4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate | ESD-890782-250MG |
| Cas.: 1146629-77-7 | Purity: 97% | (4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate | ESD-890782-1G |
| Cas.: 1146629-77-7 | Purity: 97% | (4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate | ESD-890782-5G |
| Cas.: 2873-37-2 | Purity: ≥95% | (S)-Benzyl 2-(((S)-1-methoxy-4-methyl-1-oxopentan-2-yl)carbamoyl)pyrrolidine-1-carboxylate | ESD-890783-250MG |
| Cas.: 2873-37-2 | Purity: ≥95% | (S)-Benzyl 2-(((S)-1-methoxy-4-methyl-1-oxopentan-2-yl)carbamoyl)pyrrolidine-1-carboxylate | ESD-890783-1G |
| Cas.: 2873-37-2 | Purity: ≥95% | (S)-Benzyl 2-(((S)-1-methoxy-4-methyl-1-oxopentan-2-yl)carbamoyl)pyrrolidine-1-carboxylate | ESD-890783-5G |
| Cas.: 1227270-43-0 | Purity: 95% | 1-(Phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine-6-carbonitrile | ESD-890784-100MG |
| Cas.: 1227270-43-0 | Purity: 95% | 1-(Phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine-6-carbonitrile | ESD-890784-250MG |
| Cas.: 1246616-66-9 | Purity: 97% | Dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate | ESD-890785-250MG |
| Cas.: 1246616-66-9 | Purity: 97% | Dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate | ESD-890785-1G |
| Cas.: 1246616-66-9 | Purity: 97% | Dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate | ESD-890785-5G |
| Cas.: 1455091-10-7 | Purity: 97% | Methyl 4-hydroxy-7-phenoxyisoquinoline-3-carboxylate | ESD-890786-250MG |
| Cas.: 1455091-10-7 | Purity: 97% | Methyl 4-hydroxy-7-phenoxyisoquinoline-3-carboxylate | ESD-890786-1G |
| Cas.: 1455091-10-7 | Purity: 97% | Methyl 4-hydroxy-7-phenoxyisoquinoline-3-carboxylate | ESD-890786-5G |
| Cas.: 223673-36-7 | Purity: 98% | (R)-tert-Butyl 4-aminophenethyl(2-hydroxy-2-phenylethyl)carbamate | ESD-890787-100MG |
| Cas.: 223673-36-7 | Purity: 98% | (R)-tert-Butyl 4-aminophenethyl(2-hydroxy-2-phenylethyl)carbamate | ESD-890787-250MG |
| Cas.: 860011-60-5 | Purity: 97% | 2-Amino-1H-imidazole-5-carboxylic acid | ESD-890788-1G |
| Cas.: 351990-51-7 | Purity: ≥95% | 5-Nitro-1H-imidazole-2-carboxylic acid | ESD-890789-100MG |
| Cas.: 351990-51-7 | Purity: ≥95% | 5-Nitro-1H-imidazole-2-carboxylic acid | ESD-890789-250MG |
| Cas.: 30169-25-6 | Purity: 97% | 3,6-Bis(3,5-dimethyl-1H-pyrazol-1-yl)-1,2,4,5-tetrazine | ESD-890790-1G |
| Cas.: 30169-25-6 | Purity: 97% | 3,6-Bis(3,5-dimethyl-1H-pyrazol-1-yl)-1,2,4,5-tetrazine | ESD-890790-5G |
| Cas.: 30169-25-6 | Purity: 97% | 3,6-Bis(3,5-dimethyl-1H-pyrazol-1-yl)-1,2,4,5-tetrazine | ESD-890790-10G |
| Cas.: 30169-25-6 | Purity: 97% | 3,6-Bis(3,5-dimethyl-1H-pyrazol-1-yl)-1,2,4,5-tetrazine | ESD-890790-25G |
| Cas.: 94687-10-2 | Purity: ≥95% | Ethyl 3-(3,4-dimethoxyphenyl)-3-hydroxy-2-(2-methoxyphenoxy)propanoate | ESD-890791-100MG |
| Cas.: 94687-10-2 | Purity: ≥95% | Ethyl 3-(3,4-dimethoxyphenyl)-3-hydroxy-2-(2-methoxyphenoxy)propanoate | ESD-890791-250MG |
| Cas.: 94687-10-2 | Purity: ≥95% | Ethyl 3-(3,4-dimethoxyphenyl)-3-hydroxy-2-(2-methoxyphenoxy)propanoate | ESD-890791-1G |
| Cas.: 949109-36-8 | Purity: 97% | (S)-tert-Butyl 3-methyl-4-((2-nitrophenyl)sulfonyl)-1,4-diazepane-1-carboxylate | ESD-890792-250MG |
| Cas.: 949109-36-8 | Purity: 97% | (S)-tert-Butyl 3-methyl-4-((2-nitrophenyl)sulfonyl)-1,4-diazepane-1-carboxylate | ESD-890792-1G |
| Cas.: 1150114-76-3 | Purity: 96% | (4-(4-(tert-Butoxycarbonyl)piperazine-1-carbonyl)phenyl)boronic acid | ESD-890793-250MG |
| Cas.: 1150114-76-3 | Purity: 96% | (4-(4-(tert-Butoxycarbonyl)piperazine-1-carbonyl)phenyl)boronic acid | ESD-890793-1G |
| Cas.: 1150114-76-3 | Purity: 96% | (4-(4-(tert-Butoxycarbonyl)piperazine-1-carbonyl)phenyl)boronic acid | ESD-890793-5G |
| Cas.: 1150114-76-3 | Purity: 96% | (4-(4-(tert-Butoxycarbonyl)piperazine-1-carbonyl)phenyl)boronic acid | ESD-890793-10G |
| Cas.: 1366067-80-2 | Purity: 97% | 2-(Dipropylamino)-2-oxoethyl 3-(((benzyloxy)carbonyl)amino)propanoate | ESD-890794-100MG |
| Cas.: 1366067-80-2 | Purity: 97% | 2-(Dipropylamino)-2-oxoethyl 3-(((benzyloxy)carbonyl)amino)propanoate | ESD-890794-250MG |
| Cas.: 57796-64-2 | Purity: 97% | 3-Hydroxy-5,6-dimethylpyrazine-2-carboxylic acid | ESD-890795-100MG |
| Cas.: 57796-64-2 | Purity: 97% | 3-Hydroxy-5,6-dimethylpyrazine-2-carboxylic acid | ESD-890795-250MG |
| Cas.: 85342-65-0 | Purity: 97% | 4,5,6,7-Tetrachloro-2-hydroxyisoindoline-1,3-dione | ESD-890796-250MG |
| Cas.: 85342-65-0 | Purity: 97% | 4,5,6,7-Tetrachloro-2-hydroxyisoindoline-1,3-dione | ESD-890796-1G |
| Cas.: 85342-65-0 | Purity: 97% | 4,5,6,7-Tetrachloro-2-hydroxyisoindoline-1,3-dione | ESD-890796-5G |
| Cas.: 85342-65-0 | Purity: 97% | 4,5,6,7-Tetrachloro-2-hydroxyisoindoline-1,3-dione | ESD-890796-10G |
| Cas.: 1172579-62-2 | Purity: ≥95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3,3-dimethylbutanoic acid | ESD-890797-100MG |
| Cas.: 1172579-62-2 | Purity: ≥95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3,3-dimethylbutanoic acid | ESD-890797-250MG |
| Cas.: 1172579-62-2 | Purity: ≥95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3,3-dimethylbutanoic acid | ESD-890797-1G |
| Cas.: 1172579-62-2 | Purity: ≥95% | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3,3-dimethylbutanoic acid | ESD-890797-5G |
| Cas.: 153894-33-8 | Purity: 97% | 5,6-Dihydro-4H-benzo[b]thieno[2,3-d]azepine-2-carboxylic acid | ESD-890798-100MG |
| Cas.: 153894-33-8 | Purity: 97% | 5,6-Dihydro-4H-benzo[b]thieno[2,3-d]azepine-2-carboxylic acid | ESD-890798-250MG |
| Cas.: 153894-33-8 | Purity: 97% | 5,6-Dihydro-4H-benzo[b]thieno[2,3-d]azepine-2-carboxylic acid | ESD-890798-1G |
| Cas.: 799842-07-2 | Purity: 97% | N-[5-Bromomethyl-4-(4-fluorophenyl)-6-isopropylpyrimidine-2-yl]-N-methylmethane sulfonamide | ESD-890800-250MG |
| Cas.: 799842-07-2 | Purity: 97% | N-[5-Bromomethyl-4-(4-fluorophenyl)-6-isopropylpyrimidine-2-yl]-N-methylmethane sulfonamide | ESD-890800-1G |
| Cas.: 799842-07-2 | Purity: 97% | N-[5-Bromomethyl-4-(4-fluorophenyl)-6-isopropylpyrimidine-2-yl]-N-methylmethane sulfonamide | ESD-890800-5G |
| Cas.: 799842-07-2 | Purity: 97% | N-[5-Bromomethyl-4-(4-fluorophenyl)-6-isopropylpyrimidine-2-yl]-N-methylmethane sulfonamide | ESD-890800-10G |
| Cas.: 24370-75-0 | Purity: 97% | 7-(Benzyloxy)-1H-indole-3-carboxylic acid | ESD-890801-100MG |
| Cas.: 24370-75-0 | Purity: 97% | 7-(Benzyloxy)-1H-indole-3-carboxylic acid | ESD-890801-250MG |
| Cas.: 24370-75-0 | Purity: 97% | 7-(Benzyloxy)-1H-indole-3-carboxylic acid | ESD-890801-1G |
| Cas.: 156997-99-8 | Purity: ≥95% | N-(2-(2-Bromo-1H-indol-3-yl)ethyl)acetamide | ESD-890802-100MG |
| Cas.: 156997-99-8 | Purity: ≥95% | N-(2-(2-Bromo-1H-indol-3-yl)ethyl)acetamide | ESD-890802-250MG |
| Cas.: 156997-99-8 | Purity: ≥95% | N-(2-(2-Bromo-1H-indol-3-yl)ethyl)acetamide | ESD-890802-1G |
| Cas.: 1477-57-2 | Purity: ≥95% | N,N’-(Octane-1,8-diyl)bis(2,2-dichloroacetamide) | ESD-890804-250MG |
| Cas.: 1477-57-2 | Purity: ≥95% | N,N’-(Octane-1,8-diyl)bis(2,2-dichloroacetamide) | ESD-890804-1G |
| Cas.: 1477-57-2 | Purity: ≥95% | N,N’-(Octane-1,8-diyl)bis(2,2-dichloroacetamide) | ESD-890804-5G |
| Cas.: 1477-57-2 | Purity: ≥95% | N,N’-(Octane-1,8-diyl)bis(2,2-dichloroacetamide) | ESD-890804-10G |
| Cas.: 14086-90-9 | Purity: ≥95% | (3R,4R,5S,6R)-3-Acetamido-6-(acetoxymethyl)tetrahydro-2H-pyran-2,4,5-triyl triacetate | ESD-890805-100MG |
| Cas.: 14086-90-9 | Purity: ≥95% | (3R,4R,5S,6R)-3-Acetamido-6-(acetoxymethyl)tetrahydro-2H-pyran-2,4,5-triyl triacetate | ESD-890805-250MG |
| Cas.: 14086-90-9 | Purity: ≥95% | (3R,4R,5S,6R)-3-Acetamido-6-(acetoxymethyl)tetrahydro-2H-pyran-2,4,5-triyl triacetate | ESD-890805-1G |
| Cas.: 1799421-04-7 | Purity: ≥95% | 5-Bromo-1H-indazole-3-carboxamide | ESD-890806-100MG |
| Cas.: 1799421-04-7 | Purity: ≥95% | 5-Bromo-1H-indazole-3-carboxamide | ESD-890806-250MG |
| Cas.: 136450-06-1 | Purity: ≥95% | N-(3-Acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide | ESD-890807-250MG |
| Cas.: 136450-06-1 | Purity: ≥95% | N-(3-Acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide | ESD-890807-1G |
| Cas.: 136450-06-1 | Purity: ≥95% | N-(3-Acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide | ESD-890807-5G |
| Cas.: 136450-06-1 | Purity: ≥95% | N-(3-Acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide | ESD-890807-10G |
| Cas.: 52315-75-0 | Purity: 98% | N6-dodecanoyl-L-lysine | ESD-890808-1G |
| Cas.: 52315-75-0 | Purity: 98% | N6-dodecanoyl-L-lysine | ESD-890808-5G |
| Cas.: 52315-75-0 | Purity: 98% | N6-dodecanoyl-L-lysine | ESD-890808-25G |
| Cas.: 1616499-37-6 | Purity: 97% | 2-(2-Chloroquinazolin-4-yl)-9-phenyl-9H-carbazole | ESD-890809-250MG |
| Cas.: 1616499-37-6 | Purity: 97% | 2-(2-Chloroquinazolin-4-yl)-9-phenyl-9H-carbazole | ESD-890809-1G |
| Cas.: 23500-04-1 | Purity: 96% | Ac-Lys(Boc)-OH | ESD-890810-1G |
| Cas.: 23500-04-1 | Purity: 96% | Ac-Lys(Boc)-OH | ESD-890810-5G |
| Cas.: 23500-04-1 | Purity: 96% | Ac-Lys(Boc)-OH | ESD-890810-10G |
| Cas.: 23500-04-1 | Purity: 96% | Ac-Lys(Boc)-OH | ESD-890810-25G |
| Cas.: 937-27-9 | Purity: 97% | 1H-Pyrrole-2,5-dicarboxylic acid | ESD-890811-100MG |
| Cas.: 937-27-9 | Purity: 97% | 1H-Pyrrole-2,5-dicarboxylic acid | ESD-890811-250MG |
| Cas.: 937-27-9 | Purity: 97% | 1H-Pyrrole-2,5-dicarboxylic acid | ESD-890811-1G |
| Cas.: 13512-31-7 | Purity: 97% | Z-Tyr-OMe | ESD-890812-5G |
| Cas.: 13512-31-7 | Purity: 97% | Z-Tyr-OMe | ESD-890812-10G |
| Cas.: 13512-31-7 | Purity: 97% | Z-Tyr-OMe | ESD-890812-25G |
| Cas.: 784194-02-1 | Purity: 97% | (S)-N-(2-(4-(tert-Butyl)-4,5-dihydrooxazol-2-yl)phenyl)-1-phenylmethanesulfonamide | ESD-890813-250MG |
| Cas.: 784194-02-1 | Purity: 97% | (S)-N-(2-(4-(tert-Butyl)-4,5-dihydrooxazol-2-yl)phenyl)-1-phenylmethanesulfonamide | ESD-890813-1G |
| Cas.: 168123-82-8 | Purity: ≥95% | 7-Bromopyrido[2,3-b]pyrazine-2,3(1H,4H)-dione | ESD-890814-250MG |
| Cas.: 168123-82-8 | Purity: ≥95% | 7-Bromopyrido[2,3-b]pyrazine-2,3(1H,4H)-dione | ESD-890814-1G |
| Cas.: 168123-82-8 | Purity: ≥95% | 7-Bromopyrido[2,3-b]pyrazine-2,3(1H,4H)-dione | ESD-890814-5G |
| Cas.: 168123-82-8 | Purity: ≥95% | 7-Bromopyrido[2,3-b]pyrazine-2,3(1H,4H)-dione | ESD-890814-10G |
| Cas.: 408327-92-4 | Purity: 97% | 4,4′,4”-(2-Bromoethene-1,1,2-triyl)tris(bromobenzene) | ESD-890815-100MG |
| Cas.: 408327-92-4 | Purity: 97% | 4,4′,4”-(2-Bromoethene-1,1,2-triyl)tris(bromobenzene) | ESD-890815-250MG |
| Cas.: 915095-87-3 | Purity: 97% | (S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yl)oxy)phenyl)methanone | ESD-890816-100MG |
| Cas.: 915095-87-3 | Purity: 97% | (S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yl)oxy)phenyl)methanone | ESD-890816-250MG |
| Cas.: 915095-87-3 | Purity: 97% | (S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yl)oxy)phenyl)methanone | ESD-890816-1G |
| Cas.: 915095-87-3 | Purity: 97% | (S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yl)oxy)phenyl)methanone | ESD-890816-5G |
| Cas.: 1408282-26-7 | Purity: 97% | 8-Fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one | ESD-890817-100MG |
| Cas.: 1408282-26-7 | Purity: 97% | 8-Fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one | ESD-890817-250MG |
| Cas.: 1408282-26-7 | Purity: 97% | 8-Fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one | ESD-890817-1G |
| Cas.: 1408282-26-7 | Purity: 97% | 8-Fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one | ESD-890817-5G |
| Cas.: 61553-71-7 | Purity: ≥95% | 3H-Pyrimido[5,4-b]indol-4(5H)-one | ESD-890818-100MG |
| Cas.: 61553-71-7 | Purity: ≥95% | 3H-Pyrimido[5,4-b]indol-4(5H)-one | ESD-890818-250MG |
| Cas.: 61553-71-7 | Purity: ≥95% | 3H-Pyrimido[5,4-b]indol-4(5H)-one | ESD-890818-1G |
| Cas.: 61553-71-7 | Purity: ≥95% | 3H-Pyrimido[5,4-b]indol-4(5H)-one | ESD-890818-5G |
| Cas.: 313369-25-4 | Purity: 97% | (6bR,10aS)-Ethyl 3-methyl-2-oxo-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3 -de]quinoxaline-8(9H)-carboxylate | ESD-890819-100MG |
| Cas.: 313369-25-4 | Purity: 97% | (6bR,10aS)-Ethyl 3-methyl-2-oxo-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3 -de]quinoxaline-8(9H)-carboxylate | ESD-890819-250MG |
| Cas.: 313369-25-4 | Purity: 97% | (6bR,10aS)-Ethyl 3-methyl-2-oxo-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3 -de]quinoxaline-8(9H)-carboxylate | ESD-890819-1G |
| Cas.: 133565-46-5 | Purity: 97% | Fmoc-isoleucinol | ESD-890820-250MG |
| Cas.: 133565-46-5 | Purity: 97% | Fmoc-isoleucinol | ESD-890820-1G |
| Cas.: 133565-46-5 | Purity: 97% | Fmoc-isoleucinol | ESD-890820-5G |
| Cas.: 133565-46-5 | Purity: 97% | Fmoc-isoleucinol | ESD-890820-10G |
| Cas.: 215178-41-9 | Purity: 97% | (R)-(9H-Fluoren-9-yl)methyl (1-hydroxy-4-methylpentan-2-yl)carbamate | ESD-890821-100MG |
| Cas.: 215178-41-9 | Purity: 97% | (R)-(9H-Fluoren-9-yl)methyl (1-hydroxy-4-methylpentan-2-yl)carbamate | ESD-890821-250MG |
| Cas.: 215178-41-9 | Purity: 97% | (R)-(9H-Fluoren-9-yl)methyl (1-hydroxy-4-methylpentan-2-yl)carbamate | ESD-890821-1G |
| Cas.: 139551-83-0 | Purity: 97% | Fmoc-Leucinol | ESD-890822-250MG |
| Cas.: 139551-83-0 | Purity: 97% | Fmoc-Leucinol | ESD-890822-1G |
| Cas.: 139551-83-0 | Purity: 97% | Fmoc-Leucinol | ESD-890822-5G |
| Cas.: 139551-83-0 | Purity: 97% | Fmoc-Leucinol | ESD-890822-10G |
| Cas.: 274693-54-8 | Purity: 97% | Benzyl ((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)carbamate | ESD-890823-100MG |
| Cas.: 274693-54-8 | Purity: 97% | Benzyl ((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)carbamate | ESD-890823-250MG |
| Cas.: 274693-54-8 | Purity: 97% | Benzyl ((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)carbamate | ESD-890823-1G |
| Cas.: 444731-75-3 | Purity: 97% | N-(2-Chloropyrimdin-4-yl)-N,2,3-trimethyl-2H-indazol-6-amine | ESD-890824-250MG |
| Cas.: 444731-75-3 | Purity: 97% | N-(2-Chloropyrimdin-4-yl)-N,2,3-trimethyl-2H-indazol-6-amine | ESD-890824-1G |
| Cas.: 444731-75-3 | Purity: 97% | N-(2-Chloropyrimdin-4-yl)-N,2,3-trimethyl-2H-indazol-6-amine | ESD-890824-5G |
| Cas.: 444731-75-3 | Purity: 97% | N-(2-Chloropyrimdin-4-yl)-N,2,3-trimethyl-2H-indazol-6-amine | ESD-890824-10G |
| Cas.: 1000341-77-4 | Purity: ≥95% | 6-Bromo-1H-pyrrolo[3,2-c]pyridine-3-carboxylic acid | ESD-890825-100MG |
| Cas.: 1000341-77-4 | Purity: ≥95% | 6-Bromo-1H-pyrrolo[3,2-c]pyridine-3-carboxylic acid | ESD-890825-250MG |
| Cas.: 1000341-77-4 | Purity: ≥95% | 6-Bromo-1H-pyrrolo[3,2-c]pyridine-3-carboxylic acid | ESD-890825-1G |
| Cas.: 25983-13-5 | Purity: 97% | 6,7-Dichloroquinoxaline-2,3(1H,4H)-dione | ESD-890826-5G |
| Cas.: 25983-13-5 | Purity: 97% | 6,7-Dichloroquinoxaline-2,3(1H,4H)-dione | ESD-890826-10G |
| Cas.: 25983-13-5 | Purity: 97% | 6,7-Dichloroquinoxaline-2,3(1H,4H)-dione | ESD-890826-25G |
| Cas.: 1447606-52-1 | Purity: ≥96% | tert-Butyl 4-(((benzyloxy)carbonyl)amino)-4-(2-methoxy-2-oxoethyl)piperidine-1-carboxylate | ESD-890827-100MG |
| Cas.: 1447606-52-1 | Purity: ≥96% | tert-Butyl 4-(((benzyloxy)carbonyl)amino)-4-(2-methoxy-2-oxoethyl)piperidine-1-carboxylate | ESD-890827-250MG |
| Cas.: 1447606-52-1 | Purity: ≥96% | tert-Butyl 4-(((benzyloxy)carbonyl)amino)-4-(2-methoxy-2-oxoethyl)piperidine-1-carboxylate | ESD-890827-1G |
| Cas.: 313969-31-2 | Purity: ≥95% | N-Benzhydrylthiophene-2-carboxamide | ESD-890828-100MG |
| Cas.: 313969-31-2 | Purity: ≥95% | N-Benzhydrylthiophene-2-carboxamide | ESD-890828-250MG |
| Cas.: 146684-74-4 | Purity: 97% | ZD-Tic-OH | ESD-890829-1G |
| Cas.: 146684-74-4 | Purity: 97% | ZD-Tic-OH | ESD-890829-5G |
| Cas.: 146684-74-4 | Purity: 97% | ZD-Tic-OH | ESD-890829-10G |
| Cas.: 146684-74-4 | Purity: 97% | ZD-Tic-OH | ESD-890829-25G |
| Cas.: 241479-74-3 | Purity: ≥95% | (2S,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanenitrile | ESD-890830-250MG |
| Cas.: 241479-74-3 | Purity: ≥95% | (2S,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanenitrile | ESD-890830-1G |
| Cas.: 241479-74-3 | Purity: ≥95% | (2S,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanenitrile | ESD-890830-5G |
| Cas.: 51792-85-9 | Purity: 97% | (((2-Nitro-1,4-phenylene)bis(oxy))bis(methylene))dibenzene | ESD-890831-250MG |
| Cas.: 51792-85-9 | Purity: 97% | (((2-Nitro-1,4-phenylene)bis(oxy))bis(methylene))dibenzene | ESD-890831-1G |
| Cas.: 51792-85-9 | Purity: 97% | (((2-Nitro-1,4-phenylene)bis(oxy))bis(methylene))dibenzene | ESD-890831-5G |
| Cas.: 51792-85-9 | Purity: 97% | (((2-Nitro-1,4-phenylene)bis(oxy))bis(methylene))dibenzene | ESD-890831-10G |
| Cas.: 63310-10-1 | Purity: 97% | Fluorescent whitening agent KCB | ESD-890832-5G |
| Cas.: 63310-10-1 | Purity: 97% | Fluorescent whitening agent KCB | ESD-890832-25G |
| Cas.: 203787-91-1 | Purity: 99% | Sodium 8-(2-hydroxybenzamido)octanoate | ESD-890833-250MG |
| Cas.: 203787-91-1 | Purity: 99% | Sodium 8-(2-hydroxybenzamido)octanoate | ESD-890833-1G |
| Cas.: 1181267-36-6 | Purity: 97% | tert-Butyl 4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate | ESD-890834-1G |
| Cas.: 1181267-36-6 | Purity: 97% | tert-Butyl 4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate | ESD-890834-5G |
| Cas.: 1181267-36-6 | Purity: 97% | tert-Butyl 4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate | ESD-890834-10G |
| Cas.: 151004-88-5 | Purity: ≥95% | (R)-N-Cbz-3,4-dihydro-1H-isoquinolinecarboxylic acid | ESD-890835-50MG |
| Cas.: 151004-88-5 | Purity: ≥95% | (R)-N-Cbz-3,4-dihydro-1H-isoquinolinecarboxylic acid | ESD-890835-100MG |
| Cas.: 151004-88-5 | Purity: ≥95% | (R)-N-Cbz-3,4-dihydro-1H-isoquinolinecarboxylic acid | ESD-890835-250MG |
| Cas.: 30688-66-5 | Purity: ≥95% | 4,6-O-Benzylidene-D-glucose | ESD-890836-250MG |
| Cas.: 30688-66-5 | Purity: ≥95% | 4,6-O-Benzylidene-D-glucose | ESD-890836-1G |
| Cas.: 1098102-93-2 | Purity: ≥95% | Dodecyl 4,6-dibromothieno[3,4-b]thiophene-2-carboxylate | ESD-890837-100MG |
| Cas.: 1098102-93-2 | Purity: ≥95% | Dodecyl 4,6-dibromothieno[3,4-b]thiophene-2-carboxylate | ESD-890837-250MG |
| Cas.: 13567-14-1 | Purity: ≥95% | (S)-2-Amino-3-(6-hydroxy-1H-indol-3-yl)propanoic acid | ESD-890838-50MG |
| Cas.: 1823879-58-8 | Purity: ≥95% | 2-Aminopyrimidine-4-carboxamide | ESD-890839-100MG |
| Cas.: 1823879-58-8 | Purity: ≥95% | 2-Aminopyrimidine-4-carboxamide | ESD-890839-250MG |
| Cas.: 149490-60-8 | Purity: 97% | (S)-2-(Butylsulfonamido)-3-(4-hydroxyphenyl)propanoic acid | ESD-890840-250MG |
| Cas.: 149490-60-8 | Purity: 97% | (S)-2-(Butylsulfonamido)-3-(4-hydroxyphenyl)propanoic acid | ESD-890840-1G |
| Cas.: 149490-60-8 | Purity: 97% | (S)-2-(Butylsulfonamido)-3-(4-hydroxyphenyl)propanoic acid | ESD-890840-5G |
| Cas.: 149490-60-8 | Purity: 97% | (S)-2-(Butylsulfonamido)-3-(4-hydroxyphenyl)propanoic acid | ESD-890840-10G |
| Cas.: 112889-02-8 | Purity: ≥95% | (S)-Diethyl 2-(5-(methylamino)thiophene-2-carboxamido)pentanedioate | ESD-890841-100MG |
| Cas.: 112889-02-8 | Purity: ≥95% | (S)-Diethyl 2-(5-(methylamino)thiophene-2-carboxamido)pentanedioate | ESD-890841-250MG |
| Cas.: 30880-72-9 | Purity: ≥95% | 3-((2-Chloro-4-nitrophenoxy)methyl)benzoic acid | ESD-890842-100MG |
| Cas.: 30880-72-9 | Purity: ≥95% | 3-((2-Chloro-4-nitrophenoxy)methyl)benzoic acid | ESD-890842-250MG |
| Cas.: 138775-02-7 | Purity: ≥95% | (R)-4-((Benzyloxy)carbonyl)-1-(tert-butoxycarbonyl)piperazine-2-carboxylic acid | ESD-890843-250MG |
| Cas.: 138775-02-7 | Purity: ≥95% | (R)-4-((Benzyloxy)carbonyl)-1-(tert-butoxycarbonyl)piperazine-2-carboxylic acid | ESD-890843-1G |
| Cas.: 138775-02-7 | Purity: ≥95% | (R)-4-((Benzyloxy)carbonyl)-1-(tert-butoxycarbonyl)piperazine-2-carboxylic acid | ESD-890843-5G |
| Cas.: 336182-06-0 | Purity: 97% | Boc-β-HoGln-OH | ESD-890844-100MG |
| Cas.: 336182-06-0 | Purity: 97% | Boc-β-HoGln-OH | ESD-890844-250MG |
| Cas.: 336182-06-0 | Purity: 97% | Boc-β-HoGln-OH | ESD-890844-1G |
| Cas.: 336182-06-0 | Purity: 97% | Boc-β-HoGln-OH | ESD-890844-5G |
| Cas.: 3601-89-6 | Purity: 90% | (2R,3S)-5-Chloro-2-(((4-methylbenzoyl)oxy)methyl)tetrahydrofuran-3-yl 4-methylbenzoate | ESD-890845-250MG |
| Cas.: 3601-89-6 | Purity: 90% | (2R,3S)-5-Chloro-2-(((4-methylbenzoyl)oxy)methyl)tetrahydrofuran-3-yl 4-methylbenzoate | ESD-890845-1G |
| Cas.: 3601-89-6 | Purity: 90% | (2R,3S)-5-Chloro-2-(((4-methylbenzoyl)oxy)methyl)tetrahydrofuran-3-yl 4-methylbenzoate | ESD-890845-5G |
| Cas.: 3601-89-6 | Purity: 90% | (2R,3S)-5-Chloro-2-(((4-methylbenzoyl)oxy)methyl)tetrahydrofuran-3-yl 4-methylbenzoate | ESD-890845-10G |
| Cas.: 29651-54-5 | Purity: 97% | 4,4′-(Cyclododecane-1,1-diyl)diphenol | ESD-890846-250MG |
| Cas.: 29651-54-5 | Purity: 97% | 4,4′-(Cyclododecane-1,1-diyl)diphenol | ESD-890846-1G |
| Cas.: 29651-54-5 | Purity: 97% | 4,4′-(Cyclododecane-1,1-diyl)diphenol | ESD-890846-5G |
| Cas.: 871700-24-2 | Purity: 97% | 3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione | ESD-890847-100MG |
| Cas.: 871700-24-2 | Purity: 97% | 3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione | ESD-890847-250MG |
| Cas.: 871700-24-2 | Purity: 97% | 3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione | ESD-890847-1G |
| Cas.: 871700-24-2 | Purity: 97% | 3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione | ESD-890847-5G |
| Cas.: 13500-53-3 | Purity: 95% | (2S,4R)-Dibenzyl 4-hydroxypyrrolidine-1,2-dicarboxylate | ESD-890848-100MG |
| Cas.: 13500-53-3 | Purity: 95% | (2S,4R)-Dibenzyl 4-hydroxypyrrolidine-1,2-dicarboxylate | ESD-890848-250MG |
| Cas.: 13500-53-3 | Purity: 95% | (2S,4R)-Dibenzyl 4-hydroxypyrrolidine-1,2-dicarboxylate | ESD-890848-1G |
| Cas.: 13500-53-3 | Purity: 95% | (2S,4R)-Dibenzyl 4-hydroxypyrrolidine-1,2-dicarboxylate | ESD-890848-5G |
| Cas.: 923359-38-0 | Purity: ≥98% | SAR407899 | ESD-890849-1MG |
| Cas.: 923359-38-0 | Purity: ≥98% | SAR407899 | ESD-890849-5MG |
| Cas.: 923359-38-0 | Purity: ≥98% | SAR407899 | ESD-890849-10MG |
| Cas.: 923359-38-0 | Purity: ≥98% | SAR407899 | ESD-890849-25MG |
| Cas.: 24639-06-3 | Purity: 97% | ((3AR,4R,6R,6aR)-6-(6-amino-2-chloro-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol- 4-yl)methanol | ESD-890850-250MG |
| Cas.: 24639-06-3 | Purity: 97% | ((3AR,4R,6R,6aR)-6-(6-amino-2-chloro-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol- 4-yl)methanol | ESD-890850-1G |
| Cas.: 24639-06-3 | Purity: 97% | ((3AR,4R,6R,6aR)-6-(6-amino-2-chloro-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol- 4-yl)methanol | ESD-890850-5G |
| Cas.: 24639-06-3 | Purity: 97% | ((3AR,4R,6R,6aR)-6-(6-amino-2-chloro-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol- 4-yl)methanol | ESD-890850-10G |
| Cas.: 26395-99-3 | Purity: ≥95% | 7-Amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | ESD-890851-100MG |
| Cas.: 26395-99-3 | Purity: ≥95% | 7-Amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | ESD-890851-250MG |
| Cas.: 26395-99-3 | Purity: ≥95% | 7-Amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | ESD-890851-1G |
| Cas.: 219834-96-5 | Purity: 98% | (2-(Benzyloxy)naphthalen-1-yl)boronic acid | ESD-890852-250MG |
| Cas.: 219834-96-5 | Purity: 98% | (2-(Benzyloxy)naphthalen-1-yl)boronic acid | ESD-890852-1G |
| Cas.: 7063-21-0 | Purity: ≥95% | Sodium 3-oxo-3-phenylpropanoate | ESD-890853-100MG |
| Cas.: 7063-21-0 | Purity: ≥95% | Sodium 3-oxo-3-phenylpropanoate | ESD-890853-250MG |
| Cas.: 7063-21-0 | Purity: ≥95% | Sodium 3-oxo-3-phenylpropanoate | ESD-890853-1G |
| Cas.: 5628-44-4 | Purity: 97% | 4-Amino-2,3-dimethylbenzoic acid | ESD-890854-100MG |
| Cas.: 5628-44-4 | Purity: 97% | 4-Amino-2,3-dimethylbenzoic acid | ESD-890854-250MG |
| Cas.: 5628-44-4 | Purity: 97% | 4-Amino-2,3-dimethylbenzoic acid | ESD-890854-1G |
| Cas.: 5628-44-4 | Purity: 97% | 4-Amino-2,3-dimethylbenzoic acid | ESD-890854-5G |
| Cas.: 1145678-74-5 | Purity: ≥95% | (1-Tosyl-1H-indol-4-yl)methanamine | ESD-890855-100MG |
| Cas.: 1145678-74-5 | Purity: ≥95% | (1-Tosyl-1H-indol-4-yl)methanamine | ESD-890855-250MG |
| Cas.: 2766-17-8 | Purity: 97% | Z-Val-Gly-OEt | ESD-890856-100MG |
| Cas.: 2766-17-8 | Purity: 97% | Z-Val-Gly-OEt | ESD-890856-250MG |
| Cas.: 402948-37-2 | Purity: 97% | Ethyl 2-(5-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)acetate | ESD-890857-100MG |
| Cas.: 402948-37-2 | Purity: 97% | Ethyl 2-(5-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)acetate | ESD-890857-250MG |
| Cas.: 22123-14-4 | Purity: 95% | 2-Chloro-6-methyl-4-(trifluoromethyl)pyridine | ESD-890858-1G |
| Cas.: 22123-14-4 | Purity: 95% | 2-Chloro-6-methyl-4-(trifluoromethyl)pyridine | ESD-890858-5G |
| Cas.: 22123-14-4 | Purity: 95% | 2-Chloro-6-methyl-4-(trifluoromethyl)pyridine | ESD-890858-10G |
| Cas.: 110683-22-2 | Purity: 97% | 8-Amino-2-(1H-tetrazol-5-yl)-4H-chromen-4-one | ESD-890859-250MG |
| Cas.: 110683-22-2 | Purity: 97% | 8-Amino-2-(1H-tetrazol-5-yl)-4H-chromen-4-one | ESD-890859-1G |
| Cas.: 5626-52-8 | Purity: 97% | 5-Oxopyrrolidine-2-carboxamide | ESD-890860-100MG |
| Cas.: 5626-52-8 | Purity: 97% | 5-Oxopyrrolidine-2-carboxamide | ESD-890860-250MG |
| Cas.: 14466-21-8 | Purity: 97% | 5-Oxopyrrolidine-3-carboxamide | ESD-890861-250MG |
| Cas.: 14466-21-8 | Purity: 97% | 5-Oxopyrrolidine-3-carboxamide | ESD-890861-1G |
| Cas.: 14466-21-8 | Purity: 97% | 5-Oxopyrrolidine-3-carboxamide | ESD-890861-5G |
| Cas.: 14466-21-8 | Purity: 97% | 5-Oxopyrrolidine-3-carboxamide | ESD-890861-10G |
| Cas.: 16395-57-6 | Purity: ≥95% | (S)-5-Oxopyrrolidine-2-carboxamide | ESD-890862-100MG |
| Cas.: 16395-57-6 | Purity: ≥95% | (S)-5-Oxopyrrolidine-2-carboxamide | ESD-890862-250MG |
| Cas.: 16395-57-6 | Purity: ≥95% | (S)-5-Oxopyrrolidine-2-carboxamide | ESD-890862-1G |
| Cas.: 215178-46-4 | Purity: 97% | (R)-(9H-Fluoren-9-yl)methyl (1-hydroxy-3-methylbutan-2-yl)carbamate | ESD-890863-100MG |
| Cas.: 215178-46-4 | Purity: 97% | (R)-(9H-Fluoren-9-yl)methyl (1-hydroxy-3-methylbutan-2-yl)carbamate | ESD-890863-250MG |
| Cas.: 215178-46-4 | Purity: 97% | (R)-(9H-Fluoren-9-yl)methyl (1-hydroxy-3-methylbutan-2-yl)carbamate | ESD-890863-1G |
| Cas.: 179552-74-0 | Purity: 97% | N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine | ESD-890864-1G |
| Cas.: 179552-74-0 | Purity: 97% | N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine | ESD-890864-5G |
| Cas.: 179552-74-0 | Purity: 97% | N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine | ESD-890864-10G |
| Cas.: 60846-91-5 | Purity: 97% | (S)-Benzyl(2,5-dioxopyrrolidin-3-yl)carbamate | ESD-890865-1G |
| Cas.: 60846-91-5 | Purity: 97% | (S)-Benzyl(2,5-dioxopyrrolidin-3-yl)carbamate | ESD-890865-5G |
| Cas.: 96219-87-3 | Purity: ≥95% | (3-Amino-1H-pyrazol-4-yl)(thiophen-2-yl)methanone | ESD-890866-100MG |
| Cas.: 96219-87-3 | Purity: ≥95% | (3-Amino-1H-pyrazol-4-yl)(thiophen-2-yl)methanone | ESD-890866-250MG |
| Cas.: 96219-87-3 | Purity: ≥95% | (3-Amino-1H-pyrazol-4-yl)(thiophen-2-yl)methanone | ESD-890866-1G |
| Cas.: 138774-92-2 | Purity: 97% | Fmoc-N-Me-D-Ala-OH | ESD-890867-100MG |
| Cas.: 138774-92-2 | Purity: 97% | Fmoc-N-Me-D-Ala-OH | ESD-890867-250MG |
| Cas.: 138774-92-2 | Purity: 97% | Fmoc-N-Me-D-Ala-OH | ESD-890867-1G |
| Cas.: 138774-92-2 | Purity: 97% | Fmoc-N-Me-D-Ala-OH | ESD-890867-5G |
| Cas.: 330785-81-4 | Purity: 98% | Ethyl 4-((3-chloro-4-methoxybenzyl)amino)-2-(methylthio)pyrimidine-5-carboxylate | ESD-890868-250MG |
| Cas.: 330785-81-4 | Purity: 98% | Ethyl 4-((3-chloro-4-methoxybenzyl)amino)-2-(methylthio)pyrimidine-5-carboxylate | ESD-890868-1G |
| Cas.: 330785-81-4 | Purity: 98% | Ethyl 4-((3-chloro-4-methoxybenzyl)amino)-2-(methylthio)pyrimidine-5-carboxylate | ESD-890868-5G |
| Cas.: 330785-81-4 | Purity: 98% | Ethyl 4-((3-chloro-4-methoxybenzyl)amino)-2-(methylthio)pyrimidine-5-carboxylate | ESD-890868-10G |
| Cas.: 1362858-88-5 | Purity: 97% | Fmoc-N-Me-DL-Ala-OH | ESD-890869-250MG |
| Cas.: 1362858-88-5 | Purity: 97% | Fmoc-N-Me-DL-Ala-OH | ESD-890869-1G |
| Cas.: 153037-40-2 | Purity: 97% | (S)-tert-Butyl (1-([1,1′-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbamate | ESD-890870-100MG |
| Cas.: 153037-40-2 | Purity: 97% | (S)-tert-Butyl (1-([1,1′-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbamate | ESD-890870-250MG |
| Cas.: 154902-51-9 | Purity: ≥95% | (S)-3-(Benzo[b]thiophen-3-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid | ESD-890871-250MG |
| Cas.: 154902-51-9 | Purity: ≥95% | (S)-3-(Benzo[b]thiophen-3-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid | ESD-890871-1G |
| Cas.: 154902-51-9 | Purity: ≥95% | (S)-3-(Benzo[b]thiophen-3-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid | ESD-890871-5G |
| Cas.: 154902-51-9 | Purity: ≥95% | (S)-3-(Benzo[b]thiophen-3-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid | ESD-890871-10G |
| Cas.: 916603-07-1 | Purity: 95% | N2-(4-(Aminomethyl)phenyl)-5-fluoro-N4-phenylpyrimidine-2,4-diamine | ESD-890872-100MG |
| Cas.: 916603-07-1 | Purity: 95% | N2-(4-(Aminomethyl)phenyl)-5-fluoro-N4-phenylpyrimidine-2,4-diamine | ESD-890872-250MG |
| Cas.: 916603-07-1 | Purity: 95% | N2-(4-(Aminomethyl)phenyl)-5-fluoro-N4-phenylpyrimidine-2,4-diamine | ESD-890872-1G |
| Cas.: 13440-07-8 | Purity: 97% | Di(naphthalen-1-yl)phosphine oxide | ESD-890873-250MG |
| Cas.: 13440-07-8 | Purity: 97% | Di(naphthalen-1-yl)phosphine oxide | ESD-890873-1G |
| Cas.: 13440-07-8 | Purity: 97% | Di(naphthalen-1-yl)phosphine oxide | ESD-890873-5G |
| Cas.: 78871-05-3 | Purity: 97% | Di(naphthalen-2-yl)phosphine oxide | ESD-890874-250MG |
| Cas.: 78871-05-3 | Purity: 97% | Di(naphthalen-2-yl)phosphine oxide | ESD-890874-1G |
| Cas.: 78871-05-3 | Purity: 97% | Di(naphthalen-2-yl)phosphine oxide | ESD-890874-5G |
| Cas.: 733790-97-1 | Purity: 97% | (3-Aminobenzofuran-2-yl)(3,4-dimethoxyphenyl)methanone | ESD-890875-100MG |
| Cas.: 733790-97-1 | Purity: 97% | (3-Aminobenzofuran-2-yl)(3,4-dimethoxyphenyl)methanone | ESD-890875-250MG |
| Cas.: 733790-97-1 | Purity: 97% | (3-Aminobenzofuran-2-yl)(3,4-dimethoxyphenyl)methanone | ESD-890875-1G |
| Cas.: 27663-72-5 | Purity: ≥95% | 3-(1H-Pyrrolo[2,3-b]pyridin-3-yl)propanoic acid | ESD-890876-100MG |
| Cas.: 27663-72-5 | Purity: ≥95% | 3-(1H-Pyrrolo[2,3-b]pyridin-3-yl)propanoic acid | ESD-890876-250MG |
| Cas.: 27663-72-5 | Purity: ≥95% | 3-(1H-Pyrrolo[2,3-b]pyridin-3-yl)propanoic acid | ESD-890876-1G |
| Cas.: 27663-72-5 | Purity: ≥95% | 3-(1H-Pyrrolo[2,3-b]pyridin-3-yl)propanoic acid | ESD-890876-5G |
| Cas.: 54063-52-4 | Purity: ≥98% | Pitofenone | ESD-890877-10MG |
| Cas.: 54063-52-4 | Purity: ≥98% | Pitofenone | ESD-890877-25MG |
| Cas.: 885521-46-0 | Purity: ≥95% | 3-Iodo-1H-indazole-5-carboxylic acid | ESD-890878-100MG |
| Cas.: 885521-46-0 | Purity: ≥95% | 3-Iodo-1H-indazole-5-carboxylic acid | ESD-890878-250MG |
| Cas.: 885521-46-0 | Purity: ≥95% | 3-Iodo-1H-indazole-5-carboxylic acid | ESD-890878-1G |
| Cas.: 885521-46-0 | Purity: ≥95% | 3-Iodo-1H-indazole-5-carboxylic acid | ESD-890878-5G |
| Cas.: 25775-90-0 | Purity: 95% | Zucapsaicin | ESD-890879-10MG |
| Cas.: 25775-90-0 | Purity: 95% | Zucapsaicin | ESD-890879-50MG |
| Cas.: 25775-90-0 | Purity: 95% | Zucapsaicin | ESD-890879-100MG |
| Cas.: 25775-90-0 | Purity: 95% | Zucapsaicin | ESD-890879-250MG |
| Cas.: 501-13-3 | Purity: ≥95% | N-(4-Aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide | ESD-890880-50MG |
| Cas.: 3705-21-3 | Purity: 97% | 5-Hydroxy-1H-indole-3-carboxylic acid | ESD-890881-100MG |
| Cas.: 3705-21-3 | Purity: 97% | 5-Hydroxy-1H-indole-3-carboxylic acid | ESD-890881-250MG |
| Cas.: 252723-16-3 | Purity: 95% | 7-Benzenesulfonyl-4-chloro-6-methyl-7H-pyrrolo[2,3-d]pyrimidine | ESD-890882-1G |
| Cas.: 13880-05-2 | Purity: 97% | N-(1,3-Dihydroxy-2-(hydroxymethyl)propan-2-yl)acrylamide | ESD-890883-5G |
| Cas.: 13880-05-2 | Purity: 97% | N-(1,3-Dihydroxy-2-(hydroxymethyl)propan-2-yl)acrylamide | ESD-890883-10G |
| Cas.: 13880-05-2 | Purity: 97% | N-(1,3-Dihydroxy-2-(hydroxymethyl)propan-2-yl)acrylamide | ESD-890883-25G |
| Cas.: 1198416-32-8 | Purity: 97% | 2-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine | ESD-890884-100MG |
| Cas.: 1198416-32-8 | Purity: 97% | 2-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine | ESD-890884-250MG |
| Cas.: 1198416-32-8 | Purity: 97% | 2-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine | ESD-890884-1G |
| Cas.: 27025-24-7 | Purity: 97% | (R)-2-(((Benzyloxy)carbonyl)amino)-5-methoxy-5-oxopentanoic acid | ESD-890885-100MG |
| Cas.: 27025-24-7 | Purity: 97% | (R)-2-(((Benzyloxy)carbonyl)amino)-5-methoxy-5-oxopentanoic acid | ESD-890885-250MG |
| Cas.: 27025-24-7 | Purity: 97% | (R)-2-(((Benzyloxy)carbonyl)amino)-5-methoxy-5-oxopentanoic acid | ESD-890885-1G |
| Cas.: 27025-24-7 | Purity: 97% | (R)-2-(((Benzyloxy)carbonyl)amino)-5-methoxy-5-oxopentanoic acid | ESD-890885-5G |
| Cas.: 937271-47-1 | Purity: 97% | 3-(2-Chloropyrimdin-4-yl)benzoic acid | ESD-890886-100MG |
| Cas.: 937271-47-1 | Purity: 97% | 3-(2-Chloropyrimdin-4-yl)benzoic acid | ESD-890886-250MG |
| Cas.: 937271-47-1 | Purity: 97% | 3-(2-Chloropyrimdin-4-yl)benzoic acid | ESD-890886-1G |
| Cas.: 918430-49-6 | Purity: 97% | 3,5-Dichloro-N-((1-((2,2-dimethyltetrahydro-2H-pyran-4-yl)methyl)-4-fluoropiperidin-4-yl)methyl)benzamide | ESD-890887-100MG |
| Cas.: 918430-49-6 | Purity: 97% | 3,5-Dichloro-N-((1-((2,2-dimethyltetrahydro-2H-pyran-4-yl)methyl)-4-fluoropiperidin-4-yl)methyl)benzamide | ESD-890887-250MG |
| Cas.: 18620-73-0 | Purity: 98% | 5-Nitropyrimidine-2,4-diamine | ESD-890888-1G |
| Cas.: 18620-73-0 | Purity: 98% | 5-Nitropyrimidine-2,4-diamine | ESD-890888-5G |
| Cas.: 18620-73-0 | Purity: 98% | 5-Nitropyrimidine-2,4-diamine | ESD-890888-10G |
| Cas.: 34805-21-5 | Purity: 96% | Boc-Met(O)-OH | ESD-890889-1G |
| Cas.: 34805-21-5 | Purity: 96% | Boc-Met(O)-OH | ESD-890889-5G |
| Cas.: 34805-21-5 | Purity: 96% | Boc-Met(O)-OH | ESD-890889-10G |
| Cas.: 34805-21-5 | Purity: 96% | Boc-Met(O)-OH | ESD-890889-25G |
| Cas.: 851524-97-5 | Purity: ≥95% | (9H-Carbazol-3-yl)boronic acid | ESD-890890-1G |
| Cas.: 14617-86-8 | Purity: 95% | 4-Nitrophenyl stearate | ESD-890891-1G |
| Cas.: 14617-86-8 | Purity: 95% | 4-Nitrophenyl stearate | ESD-890891-5G |
| Cas.: 540752-87-2 | Purity: 96% | tert-Butyl 4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate | ESD-890892-250MG |
| Cas.: 540752-87-2 | Purity: 96% | tert-Butyl 4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate | ESD-890892-1G |
| Cas.: 540752-87-2 | Purity: 96% | tert-Butyl 4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate | ESD-890892-5G |
| Cas.: 137234-63-0 | Purity: ≥95% | (2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol | ESD-890893-100MG |
| Cas.: 137234-63-0 | Purity: ≥95% | (2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol | ESD-890893-250MG |
| Cas.: 137234-63-0 | Purity: ≥95% | (2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol | ESD-890893-1G |
| Cas.: 764659-72-5 | Purity: ≥95% | (2R,5S)-(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 5-(4-amino-5-fluoro-2-oxopyrimdin-1(2H)-yl)-1,3-oxathiolane- 2-carboxylate | ESD-890894-1G |
| Cas.: 764659-72-5 | Purity: ≥95% | (2R,5S)-(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 5-(4-amino-5-fluoro-2-oxopyrimdin-1(2H)-yl)-1,3-oxathiolane- 2-carboxylate | ESD-890894-5G |
| Cas.: 764659-72-5 | Purity: ≥95% | (2R,5S)-(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 5-(4-amino-5-fluoro-2-oxopyrimdin-1(2H)-yl)-1,3-oxathiolane- 2-carboxylate | ESD-890894-10G |
| Cas.: 7057-92-3 | Purity: 97% | Didodecyl hydrogen phosphate | ESD-890895-100MG |
| Cas.: 7057-92-3 | Purity: 97% | Didodecyl hydrogen phosphate | ESD-890895-250MG |
| Cas.: 7057-92-3 | Purity: 97% | Didodecyl hydrogen phosphate | ESD-890895-1G |
| Cas.: 1227271-03-5 | Purity: 97% | 2-Bromo-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine | ESD-890896-100MG |
| Cas.: 1227271-03-5 | Purity: 97% | 2-Bromo-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine | ESD-890896-250MG |
| Cas.: 393509-23-4 | Purity: ≥95% | 2-(5-Bromo-7-fluoro-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid | ESD-890897-100MG |
| Cas.: 393509-23-4 | Purity: ≥95% | 2-(5-Bromo-7-fluoro-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid | ESD-890897-250MG |
| Cas.: 393509-23-4 | Purity: ≥95% | 2-(5-Bromo-7-fluoro-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid | ESD-890897-1G |
| Cas.: 165454-06-8 | Purity: ≥95% | 3-Oxo-1-phenyl-2,7,10-trioxa-4-azadodecan-12-oic acid | ESD-890898-250MG |
| Cas.: 165454-06-8 | Purity: ≥95% | 3-Oxo-1-phenyl-2,7,10-trioxa-4-azadodecan-12-oic acid | ESD-890898-1G |
| Cas.: 165454-06-8 | Purity: ≥95% | 3-Oxo-1-phenyl-2,7,10-trioxa-4-azadodecan-12-oic acid | ESD-890898-5G |
| Cas.: 75513-35-8 | Purity: ≥95% | 3-(1,3-Dioxo-3,4-dihydroisoquinolin-2(1H)-yl)propanoic acid | ESD-890899-100MG |
| Cas.: 75513-35-8 | Purity: ≥95% | 3-(1,3-Dioxo-3,4-dihydroisoquinolin-2(1H)-yl)propanoic acid | ESD-890899-250MG |
| Cas.: 19542-77-9 | Purity: ≥95% | N-Acetyl-S-benzyl-L-cysteine | ESD-890900-100MG |
| Cas.: 19542-77-9 | Purity: ≥95% | N-Acetyl-S-benzyl-L-cysteine | ESD-890900-250MG |
| Cas.: 76093-33-9 | Purity: ≥95% | (R)-5-(Methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid | ESD-890901-1G |
| Cas.: 76093-33-9 | Purity: ≥95% | (R)-5-(Methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid | ESD-890901-5G |
| Cas.: 76093-33-9 | Purity: ≥95% | (R)-5-(Methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid | ESD-890901-10G |
| Cas.: 4388-22-1 | Purity: 97% | Benzenesulfonic thioanhydride | ESD-890902-250MG |
| Cas.: 4388-22-1 | Purity: 97% | Benzenesulfonic thioanhydride | ESD-890902-1G |
| Cas.: 4388-22-1 | Purity: 97% | Benzenesulfonic thioanhydride | ESD-890902-5G |
| Cas.: 30189-48-1 | Purity: 97% | (S)-tert-Butyl (1-hydrazinyl-1-oxo-3-phenylpropan-2-yl)carbamate | ESD-890903-250MG |
| Cas.: 30189-48-1 | Purity: 97% | (S)-tert-Butyl (1-hydrazinyl-1-oxo-3-phenylpropan-2-yl)carbamate | ESD-890903-1G |
| Cas.: 30189-48-1 | Purity: 97% | (S)-tert-Butyl (1-hydrazinyl-1-oxo-3-phenylpropan-2-yl)carbamate | ESD-890903-5G |
| Cas.: 1017781-49-5 | Purity: ≥95% | tert-Butyl 4-(3-(4-bromophenyl)-3-oxopropanoyl)piperidine-1-carboxylate | ESD-890904-100MG |
| Cas.: 1017781-49-5 | Purity: ≥95% | tert-Butyl 4-(3-(4-bromophenyl)-3-oxopropanoyl)piperidine-1-carboxylate | ESD-890904-250MG |
| Cas.: 1017781-49-5 | Purity: ≥95% | tert-Butyl 4-(3-(4-bromophenyl)-3-oxopropanoyl)piperidine-1-carboxylate | ESD-890904-1G |
| Cas.: 1378388-20-5 | Purity: 97% | 3-Chloro-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one | ESD-890905-100MG |
| Cas.: 1378388-20-5 | Purity: 97% | 3-Chloro-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one | ESD-890905-250MG |
| Cas.: 1378388-20-5 | Purity: 97% | 3-Chloro-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one | ESD-890905-1G |
| Cas.: 215178-45-3 | Purity: ≥95% | (R)-(9H-Fluoren-9-yl)methyl 2-(hydroxymethyl)pyrrolidine-1-carboxylate | ESD-890906-250MG |
| Cas.: 215178-45-3 | Purity: ≥95% | (R)-(9H-Fluoren-9-yl)methyl 2-(hydroxymethyl)pyrrolidine-1-carboxylate | ESD-890906-1G |
| Cas.: 148870-57-9 | Purity: ≥95% | 7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one | ESD-890907-250MG |
| Cas.: 148870-57-9 | Purity: ≥95% | 7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one | ESD-890907-1G |
| Cas.: 148870-57-9 | Purity: ≥95% | 7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one | ESD-890907-5G |
| Cas.: 148870-57-9 | Purity: ≥95% | 7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one | ESD-890907-10G |
| Cas.: 202751-95-9 | Purity: 98% | Fmoc-D-alaninol | ESD-890908-250MG |
| Cas.: 202751-95-9 | Purity: 98% | Fmoc-D-alaninol | ESD-890908-1G |
| Cas.: 202751-95-9 | Purity: 98% | Fmoc-D-alaninol | ESD-890908-5G |
| Cas.: 202751-95-9 | Purity: 98% | Fmoc-D-alaninol | ESD-890908-10G |
| Cas.: 134030-22-1 | Purity: 97% | N1,N2-Bis(2,6-diisopropylphenyl)ethane-1,2-diamine | ESD-890909-250MG |
| Cas.: 134030-22-1 | Purity: 97% | N1,N2-Bis(2,6-diisopropylphenyl)ethane-1,2-diamine | ESD-890909-1G |
| Cas.: 134030-22-1 | Purity: 97% | N1,N2-Bis(2,6-diisopropylphenyl)ethane-1,2-diamine | ESD-890909-5G |
| Cas.: 134030-22-1 | Purity: 97% | N1,N2-Bis(2,6-diisopropylphenyl)ethane-1,2-diamine | ESD-890909-10G |
| Cas.: 179552-73-9 | Purity: 97% | 7-Chloro-N-(3-chloro-4-fluorophenyl)-6-nitroquinazolin-4-amine | ESD-890910-250MG |
| Cas.: 179552-73-9 | Purity: 97% | 7-Chloro-N-(3-chloro-4-fluorophenyl)-6-nitroquinazolin-4-amine | ESD-890910-1G |
| Cas.: 179552-73-9 | Purity: 97% | 7-Chloro-N-(3-chloro-4-fluorophenyl)-6-nitroquinazolin-4-amine | ESD-890910-5G |
| Cas.: 179552-73-9 | Purity: 97% | 7-Chloro-N-(3-chloro-4-fluorophenyl)-6-nitroquinazolin-4-amine | ESD-890910-25G |
| Cas.: 1841081-56-8 | Purity: ≥95% | 3-(4-(Benzyloxy)-2-((dimethylamino)methyl)-1-hydroxycyclohexyl)phenol hydrochloride | ESD-890911-100MG |
| Cas.: 1841081-56-8 | Purity: ≥95% | 3-(4-(Benzyloxy)-2-((dimethylamino)methyl)-1-hydroxycyclohexyl)phenol hydrochloride | ESD-890911-250MG |
| Cas.: 6245-50-7 | Purity: 97% | 4,4′-(Butane-1,4-diylbis(oxy))dianiline | ESD-890912-100MG |
| Cas.: 6245-50-7 | Purity: 97% | 4,4′-(Butane-1,4-diylbis(oxy))dianiline | ESD-890912-250MG |
| Cas.: 6245-50-7 | Purity: 97% | 4,4′-(Butane-1,4-diylbis(oxy))dianiline | ESD-890912-1G |
| Cas.: 886363-18-4 | Purity: 97% | 4-(1H-Indol-5-yl)benzoic acid | ESD-890913-250MG |
| Cas.: 886363-18-4 | Purity: 97% | 4-(1H-Indol-5-yl)benzoic acid | ESD-890913-1G |
| Cas.: 2007044-68-8 | Purity: 97% | 2-(Benzyloxy)-N-(3-bromobenzyl)acetamide | ESD-890914-100MG |
| Cas.: 2007044-68-8 | Purity: 97% | 2-(Benzyloxy)-N-(3-bromobenzyl)acetamide | ESD-890914-250MG |
| Cas.: 2007044-68-8 | Purity: 97% | 2-(Benzyloxy)-N-(3-bromobenzyl)acetamide | ESD-890914-1G |
| Cas.: 98045-13-7 | Purity: ≥95% | 7-Nitrodibenzo[b,d]furan-2-sulfonyl chloride | ESD-890915-100MG |
| Cas.: 98045-13-7 | Purity: ≥95% | 7-Nitrodibenzo[b,d]furan-2-sulfonyl chloride | ESD-890915-250MG |
| Cas.: 98045-13-7 | Purity: ≥95% | 7-Nitrodibenzo[b,d]furan-2-sulfonyl chloride | ESD-890915-1G |
| Cas.: 2103402-31-7 | Purity: 97% | tert-Butyl 5-chloro-2-oxospiro[indoline-3,4′-piperidine]-1′-carboxylate | ESD-890916-100MG |
| Cas.: 2103402-31-7 | Purity: 97% | tert-Butyl 5-chloro-2-oxospiro[indoline-3,4′-piperidine]-1′-carboxylate | ESD-890916-250MG |
| Cas.: 31250-99-4 | Purity: 97% | 1-Trityl-1H-1,2,4-triazole | ESD-890917-250MG |
| Cas.: 31250-99-4 | Purity: 97% | 1-Trityl-1H-1,2,4-triazole | ESD-890917-1G |
| Cas.: 31250-99-4 | Purity: 97% | 1-Trityl-1H-1,2,4-triazole | ESD-890917-5G |
| Cas.: 27313-86-6 | Purity: 97% | (±)-Corypalmine | ESD-890918-100MG |
| Cas.: 27313-86-6 | Purity: 97% | (±)-Corypalmine | ESD-890918-250MG |
| Cas.: 99-26-3 | Purity: 97% | Bismuth subgallate | ESD-890919-1G |
| Cas.: 99-26-3 | Purity: 97% | Bismuth subgallate | ESD-890919-5G |
| Cas.: 924894-85-9 | Purity: 97% | 2,5-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-b]thiophene | ESD-890920-100MG |
| Cas.: 924894-85-9 | Purity: 97% | 2,5-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-b]thiophene | ESD-890920-250MG |
| Cas.: 924894-85-9 | Purity: 97% | 2,5-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-b]thiophene | ESD-890920-1G |
| Cas.: 924894-85-9 | Purity: 97% | 2,5-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[3,2-b]thiophene | ESD-890920-5G |
| Cas.: 800401-68-7 | Purity: 98% | 5-Chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxylic acid | ESD-890921-100MG |
| Cas.: 800401-68-7 | Purity: 98% | 5-Chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxylic acid | ESD-890921-250MG |
| Cas.: 800401-68-7 | Purity: 98% | 5-Chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxylic acid | ESD-890921-1G |
| Cas.: 800401-68-7 | Purity: 98% | 5-Chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxylic acid | ESD-890921-5G |
| Cas.: 92409-15-9 | Purity: 97% | 2-(2-Methoxyphenoxy)-1-(4-methoxyphenyl)propane-1,3-diol | ESD-890922-100MG |
| Cas.: 92409-15-9 | Purity: 97% | 2-(2-Methoxyphenoxy)-1-(4-methoxyphenyl)propane-1,3-diol | ESD-890922-250MG |
| Cas.: 92409-15-9 | Purity: 97% | 2-(2-Methoxyphenoxy)-1-(4-methoxyphenyl)propane-1,3-diol | ESD-890922-1G |
| Cas.: 96-74-2 | Purity: ≥95% | 2-(Methylsulfonyl)-4-nitroaniline | ESD-890923-1G |
| Cas.: 96-74-2 | Purity: ≥95% | 2-(Methylsulfonyl)-4-nitroaniline | ESD-890923-5G |
| Cas.: 96-74-2 | Purity: ≥95% | 2-(Methylsulfonyl)-4-nitroaniline | ESD-890923-10G |
| Cas.: 33288-79-8 | Purity: 98% | 1,2-Bis(4-hydroxyphenyl)ethane-1,2-dione | ESD-890924-100MG |
| Cas.: 33288-79-8 | Purity: 98% | 1,2-Bis(4-hydroxyphenyl)ethane-1,2-dione | ESD-890924-250MG |
| Cas.: 1012057-52-1 | Purity: 97% | N4-(3-Ethynylphenyl)-7-methoxyquinazoline-4,6-diamine | ESD-890925-100MG |
| Cas.: 1012057-52-1 | Purity: 97% | N4-(3-Ethynylphenyl)-7-methoxyquinazoline-4,6-diamine | ESD-890925-250MG |
| Cas.: 1012057-52-1 | Purity: 97% | N4-(3-Ethynylphenyl)-7-methoxyquinazoline-4,6-diamine | ESD-890925-1G |
| Cas.: 56632-83-8 | Purity: ≥95% | 4-Amino-1-((2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one | ESD-890926-100MG |
| Cas.: 56632-83-8 | Purity: ≥95% | 4-Amino-1-((2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one | ESD-890926-250MG |
| Cas.: 17720-60-4 | Purity: ≥95% | 1-(2,4-Dihydroxyphenyl)-2-(4-hydroxyphenyl)ethanone | ESD-890927-100MG |
| Cas.: 17720-60-4 | Purity: ≥95% | 1-(2,4-Dihydroxyphenyl)-2-(4-hydroxyphenyl)ethanone | ESD-890927-250MG |
| Cas.: 17720-60-4 | Purity: ≥95% | 1-(2,4-Dihydroxyphenyl)-2-(4-hydroxyphenyl)ethanone | ESD-890927-1G |
| Cas.: 5757-85-7 | Purity: 98% | 1,3-Dimethyl-1H-indazol-5-amine | ESD-890928-250MG |
| Cas.: 5757-85-7 | Purity: 98% | 1,3-Dimethyl-1H-indazol-5-amine | ESD-890928-1G |
| Cas.: 5757-85-7 | Purity: 98% | 1,3-Dimethyl-1H-indazol-5-amine | ESD-890928-5G |
| Cas.: 5757-85-7 | Purity: 98% | 1,3-Dimethyl-1H-indazol-5-amine | ESD-890928-10G |
| Cas.: 53994-69-7 | Purity: 96% | (6R,7R)-7-Amino-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | ESD-890929-250MG |
| Cas.: 53994-69-7 | Purity: 96% | (6R,7R)-7-Amino-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | ESD-890929-1G |
| Cas.: 53994-69-7 | Purity: 96% | (6R,7R)-7-Amino-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | ESD-890929-5G |
| Cas.: 53994-69-7 | Purity: 96% | (6R,7R)-7-Amino-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | ESD-890929-10G |
| Cas.: 47087-37-6 | Purity: 97% | ZD-Asp-OMe | ESD-890930-250MG |
| Cas.: 47087-37-6 | Purity: 97% | ZD-Asp-OMe | ESD-890930-1G |
| Cas.: 47087-37-6 | Purity: 97% | ZD-Asp-OMe | ESD-890930-5G |
| Cas.: 47087-37-6 | Purity: 97% | ZD-Asp-OMe | ESD-890930-10G |
| Cas.: 570409-85-7 | Purity: ≥95% | 3-Iodo-3H-pyrazolo[3,4-d]pyrimidin-4-amine | ESD-890931-1G |
| Cas.: 570409-85-7 | Purity: ≥95% | 3-Iodo-3H-pyrazolo[3,4-d]pyrimidin-4-amine | ESD-890931-5G |
| Cas.: 342417-01-0 | Purity: ≥95% | 6-(4-Methylpiperazin-1-yl)-4-(o-tolyl)nicotinamide | ESD-890932-100MG |
| Cas.: 342417-01-0 | Purity: ≥95% | 6-(4-Methylpiperazin-1-yl)-4-(o-tolyl)nicotinamide | ESD-890932-250MG |
| Cas.: 342417-01-0 | Purity: ≥95% | 6-(4-Methylpiperazin-1-yl)-4-(o-tolyl)nicotinamide | ESD-890932-1G |
| Cas.: 342417-01-0 | Purity: ≥95% | 6-(4-Methylpiperazin-1-yl)-4-(o-tolyl)nicotinamide | ESD-890932-5G |
| Cas.: 675126-27-9 | Purity: 97% | 2-Amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile | ESD-890933-250MG |
| Cas.: 675126-27-9 | Purity: 97% | 2-Amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile | ESD-890933-1G |
| Cas.: 675126-27-9 | Purity: 97% | 2-Amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile | ESD-890933-5G |
| Cas.: 914348-74-6 | Purity: ≥95% | 2-(Benzo[d]oxazol-2-ylthio)-4-chlorothiazole-5-carbaldehyde | ESD-890934-250MG |
| Cas.: 914348-74-6 | Purity: ≥95% | 2-(Benzo[d]oxazol-2-ylthio)-4-chlorothiazole-5-carbaldehyde | ESD-890934-1G |
| Cas.: 914348-74-6 | Purity: ≥95% | 2-(Benzo[d]oxazol-2-ylthio)-4-chlorothiazole-5-carbaldehyde | ESD-890934-5G |
| Cas.: 10302-78-0 | Purity: 97% | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(4-amino-2-oxo-1,3,5-triazin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate | ESD-890935-100MG |
| Cas.: 10302-78-0 | Purity: 97% | (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(4-amino-2-oxo-1,3,5-triazin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate | ESD-890935-250MG |
| Cas.: 146346-88-5 | Purity: 97% | Fmoc-Ala-OMe | ESD-890936-250MG |
| Cas.: 146346-88-5 | Purity: 97% | Fmoc-Ala-OMe | ESD-890936-1G |
| Cas.: 146346-88-5 | Purity: 97% | Fmoc-Ala-OMe | ESD-890936-5G |
| Cas.: 146346-88-5 | Purity: 97% | Fmoc-Ala-OMe | ESD-890936-10G |
| Cas.: 27018-76-4 | Purity: ≥95% | 1-Benzyl-1H-indole-3-carboxylic acid | ESD-890937-100MG |
| Cas.: 27018-76-4 | Purity: ≥95% | 1-Benzyl-1H-indole-3-carboxylic acid | ESD-890937-250MG |
| Cas.: 27018-76-4 | Purity: ≥95% | 1-Benzyl-1H-indole-3-carboxylic acid | ESD-890937-1G |
| Cas.: 27018-76-4 | Purity: ≥95% | 1-Benzyl-1H-indole-3-carboxylic acid | ESD-890937-5G |
| Cas.: 15992-10-6 | Purity: 97% | 2-(5-Methoxy-2-methyl-1H-indol-3-yl)acetamide | ESD-890938-100MG |
| Cas.: 15992-10-6 | Purity: 97% | 2-(5-Methoxy-2-methyl-1H-indol-3-yl)acetamide | ESD-890938-250MG |
| Cas.: 15992-10-6 | Purity: 97% | 2-(5-Methoxy-2-methyl-1H-indol-3-yl)acetamide | ESD-890938-1G |
| Cas.: 223407-18-9 | Purity: ≥95% | (R)-Benzyl(2-oxopyrrolidin-3-yl)carbamate | ESD-890939-100MG |
| Cas.: 223407-18-9 | Purity: ≥95% | (R)-Benzyl(2-oxopyrrolidin-3-yl)carbamate | ESD-890939-250MG |
| Cas.: 902576-09-4 | Purity: 97% | 2-(Methylthio)pyrido[4,3-d]pyrimidin-5(6H)-one | ESD-890940-100MG |
| Cas.: 902576-09-4 | Purity: 97% | 2-(Methylthio)pyrido[4,3-d]pyrimidin-5(6H)-one | ESD-890940-250MG |
| Cas.: 902576-09-4 | Purity: 97% | 2-(Methylthio)pyrido[4,3-d]pyrimidin-5(6H)-one | ESD-890940-1G |
| Cas.: 902576-09-4 | Purity: 97% | 2-(Methylthio)pyrido[4,3-d]pyrimidin-5(6H)-one | ESD-890940-5G |
| Cas.: 269398-79-0 | Purity: 97% | (R)-3-Amino-4-(o-tolyl)butanoic acid | ESD-890941-100MG |
| Cas.: 269398-79-0 | Purity: 97% | (R)-3-Amino-4-(o-tolyl)butanoic acid | ESD-890941-250MG |
| Cas.: 22387-37-7 | Purity: 98% | 8-Methyl-7H-purin-6-amine | ESD-890942-100MG |
| Cas.: 22387-37-7 | Purity: 98% | 8-Methyl-7H-purin-6-amine | ESD-890942-250MG |
| Cas.: 1224927-63-2 | Purity: 97% | tert-Butyl 2-(6-bromo-2-oxo-3,4-dihydroquinolin-1(2H)-yl)acetate | ESD-890943-100MG |
| Cas.: 1224927-63-2 | Purity: 97% | tert-Butyl 2-(6-bromo-2-oxo-3,4-dihydroquinolin-1(2H)-yl)acetate | ESD-890943-250MG |
| Cas.: 1224927-63-2 | Purity: 97% | tert-Butyl 2-(6-bromo-2-oxo-3,4-dihydroquinolin-1(2H)-yl)acetate | ESD-890943-1G |
| Cas.: 852391-45-8 | Purity: 97% | 2-Amino-3-(7-bromo-1H-indol-3-yl)propanoic acid | ESD-890944-100MG |
| Cas.: 852391-45-8 | Purity: 97% | 2-Amino-3-(7-bromo-1H-indol-3-yl)propanoic acid | ESD-890944-250MG |
| Cas.: 852391-45-8 | Purity: 97% | 2-Amino-3-(7-bromo-1H-indol-3-yl)propanoic acid | ESD-890944-1G |
| Cas.: 25197-99-3 | Purity: 97% | (S)-2-Amino-3-(5-bromo-1H-indol-3-yl)propanoic acid | ESD-890945-100MG |
| Cas.: 25197-99-3 | Purity: 97% | (S)-2-Amino-3-(5-bromo-1H-indol-3-yl)propanoic acid | ESD-890945-250MG |
| Cas.: 25197-99-3 | Purity: 97% | (S)-2-Amino-3-(5-bromo-1H-indol-3-yl)propanoic acid | ESD-890945-1G |
| Cas.: 25197-99-3 | Purity: 97% | (S)-2-Amino-3-(5-bromo-1H-indol-3-yl)propanoic acid | ESD-890945-5G |
| Cas.: 143269-74-3 | Purity: 97% | Hexadecyl 3-amino-4-chlorobenzoate | ESD-890946-5G |
| Cas.: 143269-74-3 | Purity: 97% | Hexadecyl 3-amino-4-chlorobenzoate | ESD-890946-10G |
| Cas.: 143269-74-3 | Purity: 97% | Hexadecyl 3-amino-4-chlorobenzoate | ESD-890946-25G |
| Cas.: 143269-74-3 | Purity: 97% | Hexadecyl 3-amino-4-chlorobenzoate | ESD-890946-100G |
| Cas.: 177793-79-2 | Purity: 97% | (S)-N-((S)-Quinuclidin-3-yl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide | ESD-890947-100MG |
| Cas.: 177793-79-2 | Purity: 97% | (S)-N-((S)-Quinuclidin-3-yl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide | ESD-890947-250MG |
| Cas.: 55490-87-4 | Purity: ≥95% | 2-(Anthracen-9-ylmethylene)malononitrile | ESD-890948-100MG |
| Cas.: 55490-87-4 | Purity: ≥95% | 2-(Anthracen-9-ylmethylene)malononitrile | ESD-890948-250MG |
| Cas.: 92409-23-9 | Purity: ≥95% | 3-Hydroxy-2-(2-methoxyphenoxy)-1-(4-methoxyphenyl)propan-1-one | ESD-890949-100MG |
| Cas.: 92409-23-9 | Purity: ≥95% | 3-Hydroxy-2-(2-methoxyphenoxy)-1-(4-methoxyphenyl)propan-1-one | ESD-890949-250MG |
| Cas.: 92409-23-9 | Purity: ≥95% | 3-Hydroxy-2-(2-methoxyphenoxy)-1-(4-methoxyphenyl)propan-1-one | ESD-890949-1G |
| Cas.: 39861-21-7 | Purity: ≥95% | 4-(5-Chloro-1H-benzo[d]imidazol-2-yl)aniline | ESD-890950-100MG |
| Cas.: 39861-21-7 | Purity: ≥95% | 4-(5-Chloro-1H-benzo[d]imidazol-2-yl)aniline | ESD-890950-250MG |
| Cas.: 952959-39-6 | Purity: 97% | 7-Bromo-5-chloro-1H-indole-2-carboxylic acid | ESD-890951-100MG |
| Cas.: 952959-39-6 | Purity: 97% | 7-Bromo-5-chloro-1H-indole-2-carboxylic acid | ESD-890951-250MG |
| Cas.: 952959-39-6 | Purity: 97% | 7-Bromo-5-chloro-1H-indole-2-carboxylic acid | ESD-890951-1G |
| Cas.: 952959-39-6 | Purity: 97% | 7-Bromo-5-chloro-1H-indole-2-carboxylic acid | ESD-890951-5G |
| Cas.: 383132-31-8 | Purity: 97% | 5-Bromo-7-chloro-1H-indole-2-carboxylic acid | ESD-890952-1G |
| Cas.: 383132-31-8 | Purity: 97% | 5-Bromo-7-chloro-1H-indole-2-carboxylic acid | ESD-890952-5G |
| Cas.: 383132-31-8 | Purity: 97% | 5-Bromo-7-chloro-1H-indole-2-carboxylic acid | ESD-890952-10G |
| Cas.: 61338-13-4 | Purity: 97% | 2-(4-Methyl-2-phenylpiperazin-1-yl)nicotinic acid | ESD-890953-100MG |
| Cas.: 61338-13-4 | Purity: 97% | 2-(4-Methyl-2-phenylpiperazin-1-yl)nicotinic acid | ESD-890953-250MG |
| Cas.: 61338-13-4 | Purity: 97% | 2-(4-Methyl-2-phenylpiperazin-1-yl)nicotinic acid | ESD-890953-1G |
| Cas.: 61338-13-4 | Purity: 97% | 2-(4-Methyl-2-phenylpiperazin-1-yl)nicotinic acid | ESD-890953-5G |
| Cas.: 1259224-11-7 | Purity: ≥95% | 5-Bromo-2,3-diphenyl-1H-indole | ESD-890954-100MG |
| Cas.: 1259224-11-7 | Purity: ≥95% | 5-Bromo-2,3-diphenyl-1H-indole | ESD-890954-250MG |
| Cas.: 1259224-11-7 | Purity: ≥95% | 5-Bromo-2,3-diphenyl-1H-indole | ESD-890954-1G |
| Cas.: 1259224-11-7 | Purity: ≥95% | 5-Bromo-2,3-diphenyl-1H-indole | ESD-890954-5G |
| Cas.: 256431-72-8 | Purity: 97% | (E)-3-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)acrylonitrile | ESD-890955-1G |
| Cas.: 256431-72-8 | Purity: 97% | (E)-3-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)acrylonitrile | ESD-890955-5G |
| Cas.: 256431-72-8 | Purity: 97% | (E)-3-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)acrylonitrile | ESD-890955-10G |
| Cas.: 256431-72-8 | Purity: 97% | (E)-3-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)acrylonitrile | ESD-890955-25G |
| Cas.: 183288-43-9 | Purity: ≥95% | tert-Butyl 4-(2-(ethoxycarbonyl)benzofuran-5-yl)piperazine-1-carboxylate | ESD-890956-250MG |
| Cas.: 183288-43-9 | Purity: ≥95% | tert-Butyl 4-(2-(ethoxycarbonyl)benzofuran-5-yl)piperazine-1-carboxylate | ESD-890956-1G |
| Cas.: 183288-43-9 | Purity: ≥95% | tert-Butyl 4-(2-(ethoxycarbonyl)benzofuran-5-yl)piperazine-1-carboxylate | ESD-890956-5G |
| Cas.: 183288-43-9 | Purity: ≥95% | tert-Butyl 4-(2-(ethoxycarbonyl)benzofuran-5-yl)piperazine-1-carboxylate | ESD-890956-10G |
| Cas.: 1260228-95-2 | Purity: 95% | 11,11-Dimethyl-5,11-dihydroindeno[1,2-b]carbazole | ESD-890957-250MG |
| Cas.: 1260228-95-2 | Purity: 95% | 11,11-Dimethyl-5,11-dihydroindeno[1,2-b]carbazole | ESD-890957-1G |
| Cas.: 1260228-95-2 | Purity: 95% | 11,11-Dimethyl-5,11-dihydroindeno[1,2-b]carbazole | ESD-890957-5G |
| Cas.: 61925-78-8 | Purity: 97% | Boc-D-Cys(pMeBzl)-OH | ESD-890958-250MG |
| Cas.: 61925-78-8 | Purity: 97% | Boc-D-Cys(pMeBzl)-OH | ESD-890958-1G |
| Cas.: 61925-78-8 | Purity: 97% | Boc-D-Cys(pMeBzl)-OH | ESD-890958-5G |
| Cas.: 61925-78-8 | Purity: 97% | Boc-D-Cys(pMeBzl)-OH | ESD-890958-10G |
| Cas.: 926307-99-5 | Purity: ≥95% | 1-Oxoisoindoline-5-carbaldehyde | ESD-890959-100MG |
| Cas.: 926307-99-5 | Purity: ≥95% | 1-Oxoisoindoline-5-carbaldehyde | ESD-890959-250MG |
| Cas.: 926307-99-5 | Purity: ≥95% | 1-Oxoisoindoline-5-carbaldehyde | ESD-890959-1G |
| Cas.: 60480-69-5 | Purity: 97% | N-(2,3,4,9-Tetrahydro-1H-carbazol-3-yl)acetamide | ESD-890960-250MG |
| Cas.: 60480-69-5 | Purity: 97% | N-(2,3,4,9-Tetrahydro-1H-carbazol-3-yl)acetamide | ESD-890960-1G |
| Cas.: 60480-69-5 | Purity: 97% | N-(2,3,4,9-Tetrahydro-1H-carbazol-3-yl)acetamide | ESD-890960-5G |
| Cas.: 211230-35-2 | Purity: ≥95% | Ethyl 4-((4-methoxybenzyl)amino)-2-(methylthio)pyrimidine-5-carboxylate | ESD-890961-100MG |
| Cas.: 211230-35-2 | Purity: ≥95% | Ethyl 4-((4-methoxybenzyl)amino)-2-(methylthio)pyrimidine-5-carboxylate | ESD-890961-250MG |
| Cas.: 211230-35-2 | Purity: ≥95% | Ethyl 4-((4-methoxybenzyl)amino)-2-(methylthio)pyrimidine-5-carboxylate | ESD-890961-1G |
| Cas.: 885521-80-2 | Purity: ≥95% | 4-Bromo-1H-indazole-3-carboxylic acid | ESD-890962-100MG |
| Cas.: 885521-80-2 | Purity: ≥95% | 4-Bromo-1H-indazole-3-carboxylic acid | ESD-890962-250MG |
| Cas.: 885521-80-2 | Purity: ≥95% | 4-Bromo-1H-indazole-3-carboxylic acid | ESD-890962-1G |
| Cas.: 885521-49-3 | Purity: ≥95% | 3-Bromo-1H-indazole-5-carboxylic acid | ESD-890963-250MG |
| Cas.: 885521-49-3 | Purity: ≥95% | 3-Bromo-1H-indazole-5-carboxylic acid | ESD-890963-1G |
| Cas.: 885521-49-3 | Purity: ≥95% | 3-Bromo-1H-indazole-5-carboxylic acid | ESD-890963-5G |
| Cas.: 660823-36-9 | Purity: 97% | 6-Bromo-1H-indazole-3-carboxylic acid | ESD-890964-100MG |
| Cas.: 660823-36-9 | Purity: 97% | 6-Bromo-1H-indazole-3-carboxylic acid | ESD-890964-250MG |
| Cas.: 660823-36-9 | Purity: 97% | 6-Bromo-1H-indazole-3-carboxylic acid | ESD-890964-1G |
| Cas.: 660823-36-9 | Purity: 97% | 6-Bromo-1H-indazole-3-carboxylic acid | ESD-890964-5G |
| Cas.: 201292-99-1 | Purity: 97% | Ac-Tyr(tBu)-OH | ESD-890965-250MG |
| Cas.: 201292-99-1 | Purity: 97% | Ac-Tyr(tBu)-OH | ESD-890965-1G |
| Cas.: 201292-99-1 | Purity: 97% | Ac-Tyr(tBu)-OH | ESD-890965-5G |
| Cas.: 201292-99-1 | Purity: 97% | Ac-Tyr(tBu)-OH | ESD-890965-10G |
| Cas.: 21829-09-4 | Purity: 97% | Dimethyl 2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | ESD-890966-100MG |
| Cas.: 21829-09-4 | Purity: 97% | Dimethyl 2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | ESD-890966-250MG |
| Cas.: 21829-09-4 | Purity: 97% | Dimethyl 2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | ESD-890966-1G |
| Cas.: 177843-26-4 | Purity: 95% | 4-Bromo-1H-benzo[d]imidazol-5-amine | ESD-890967-250MG |
| Cas.: 177843-26-4 | Purity: 95% | 4-Bromo-1H-benzo[d]imidazol-5-amine | ESD-890967-1G |
| Cas.: 177843-26-4 | Purity: 95% | 4-Bromo-1H-benzo[d]imidazol-5-amine | ESD-890967-5G |
| Cas.: 269396-53-4 | Purity: 95% | (R)-3-((tert-Butoxycarbonyl)amino)-4-(2,4-dichlorophenyl)butanoic acid | ESD-890968-250MG |
| Cas.: 269396-53-4 | Purity: 95% | (R)-3-((tert-Butoxycarbonyl)amino)-4-(2,4-dichlorophenyl)butanoic acid | ESD-890968-1G |
| Cas.: 269396-53-4 | Purity: 95% | (R)-3-((tert-Butoxycarbonyl)amino)-4-(2,4-dichlorophenyl)butanoic acid | ESD-890968-5G |
| Cas.: 99584-96-0 | Purity: 95% | 2,5-Dibromohexanediamide | ESD-890969-100MG |
| Cas.: 99584-96-0 | Purity: 95% | 2,5-Dibromohexanediamide | ESD-890969-250MG |
| Cas.: 99584-96-0 | Purity: 95% | 2,5-Dibromohexanediamide | ESD-890969-1G |
| Cas.: 99584-96-0 | Purity: 95% | 2,5-Dibromohexanediamide | ESD-890969-5G |
| Cas.: 1346599-09-4 | Purity: ≥95% | 1-(3-(Methylamino)-1-(thiophen-2-yl)propyl)naphthalen-2-ol | ESD-890970-100MG |
| Cas.: 1346599-09-4 | Purity: ≥95% | 1-(3-(Methylamino)-1-(thiophen-2-yl)propyl)naphthalen-2-ol | ESD-890970-250MG |
| Cas.: 1346599-09-4 | Purity: ≥95% | 1-(3-(Methylamino)-1-(thiophen-2-yl)propyl)naphthalen-2-ol | ESD-890970-1G |
| Cas.: 1824708-16-8 | Purity: 97% | 1-(2-Chloro-4-cyclopropylphenyl)-5-methyl-1H-1,2,3-triazole-4-carboxylic acid | ESD-890971-100MG |
| Cas.: 1824708-16-8 | Purity: 97% | 1-(2-Chloro-4-cyclopropylphenyl)-5-methyl-1H-1,2,3-triazole-4-carboxylic acid | ESD-890971-250MG |
| Cas.: 1824708-16-8 | Purity: 97% | 1-(2-Chloro-4-cyclopropylphenyl)-5-methyl-1H-1,2,3-triazole-4-carboxylic acid | ESD-890971-1G |
| Cas.: 193537-14-3 | Purity: 97% | Ethyl 6-Boc-2-amino-4,7-dihydro-5H-thieno[2,3-c]pyridine-3-carboxylate | ESD-890972-250MG |
| Cas.: 193537-14-3 | Purity: 97% | Ethyl 6-Boc-2-amino-4,7-dihydro-5H-thieno[2,3-c]pyridine-3-carboxylate | ESD-890972-1G |
| Cas.: 193537-14-3 | Purity: 97% | Ethyl 6-Boc-2-amino-4,7-dihydro-5H-thieno[2,3-c]pyridine-3-carboxylate | ESD-890972-5G |
| Cas.: 193537-14-3 | Purity: 97% | Ethyl 6-Boc-2-amino-4,7-dihydro-5H-thieno[2,3-c]pyridine-3-carboxylate | ESD-890972-10G |
| Cas.: 5394-41-2 | Purity: 97% | 5-Amino-1-(4-nitrophenyl)-1H-pyrazole-4-carbonitrile | ESD-890973-250MG |
| Cas.: 5394-41-2 | Purity: 97% | 5-Amino-1-(4-nitrophenyl)-1H-pyrazole-4-carbonitrile | ESD-890973-1G |
| Cas.: 5394-41-2 | Purity: 97% | 5-Amino-1-(4-nitrophenyl)-1H-pyrazole-4-carbonitrile | ESD-890973-5G |
| Cas.: 16937-91-0 | Purity: ≥95% | HD-Orn(Z)-OH | ESD-890974-250MG |
| Cas.: 16937-91-0 | Purity: ≥95% | HD-Orn(Z)-OH | ESD-890974-1G |
| Cas.: 16937-91-0 | Purity: ≥95% | HD-Orn(Z)-OH | ESD-890974-5G |
| Cas.: 16937-91-0 | Purity: ≥95% | HD-Orn(Z)-OH | ESD-890974-10G |
| Cas.: 269396-71-6 | Purity: 95% | (R)-3-((tert-Butoxycarbonyl)amino)-4-(4-iodophenyl)butanoic acid | ESD-890975-100MG |
| Cas.: 269396-71-6 | Purity: 95% | (R)-3-((tert-Butoxycarbonyl)amino)-4-(4-iodophenyl)butanoic acid | ESD-890975-250MG |
| Cas.: 269396-71-6 | Purity: 95% | (R)-3-((tert-Butoxycarbonyl)amino)-4-(4-iodophenyl)butanoic acid | ESD-890975-1G |
| Cas.: 143878-29-9 | Purity: 97% | Methyl 4-acetamido-5-chloro-2,3-dihydrobenzofuran-7-carboxylate | ESD-890976-100MG |
| Cas.: 143878-29-9 | Purity: 97% | Methyl 4-acetamido-5-chloro-2,3-dihydrobenzofuran-7-carboxylate | ESD-890976-250MG |
| Cas.: 143878-29-9 | Purity: 97% | Methyl 4-acetamido-5-chloro-2,3-dihydrobenzofuran-7-carboxylate | ESD-890976-1G |
| Cas.: 340187-12-4 | Purity: ≥95% | (9H-Fluoren-9-yl)methyl (2-bromoethyl)carbamate | ESD-890977-250MG |
| Cas.: 340187-12-4 | Purity: ≥95% | (9H-Fluoren-9-yl)methyl (2-bromoethyl)carbamate | ESD-890977-1G |
| Cas.: 340187-12-4 | Purity: ≥95% | (9H-Fluoren-9-yl)methyl (2-bromoethyl)carbamate | ESD-890977-5G |
| Cas.: 340187-12-4 | Purity: ≥95% | (9H-Fluoren-9-yl)methyl (2-bromoethyl)carbamate | ESD-890977-10G |
| Cas.: 885522-01-0 | Purity: ≥95% | 3-Bromo-6-fluoro-1H-indazole-4-carboxylic acid | ESD-890978-100MG |
| Cas.: 885522-01-0 | Purity: ≥95% | 3-Bromo-6-fluoro-1H-indazole-4-carboxylic acid | ESD-890978-250MG |
| Cas.: 885522-01-0 | Purity: ≥95% | 3-Bromo-6-fluoro-1H-indazole-4-carboxylic acid | ESD-890978-1G |
| Cas.: 33300-72-0 | Purity: 97% | (S)-1-((S)-2-((tert-Butoxycarbonyl)amino)propanoyl)pyrrolidine-2-carboxylic acid | ESD-890979-100MG |
| Cas.: 33300-72-0 | Purity: 97% | (S)-1-((S)-2-((tert-Butoxycarbonyl)amino)propanoyl)pyrrolidine-2-carboxylic acid | ESD-890979-250MG |
| Cas.: 33300-72-0 | Purity: 97% | (S)-1-((S)-2-((tert-Butoxycarbonyl)amino)propanoyl)pyrrolidine-2-carboxylic acid | ESD-890979-1G |
| Cas.: 33300-72-0 | Purity: 97% | (S)-1-((S)-2-((tert-Butoxycarbonyl)amino)propanoyl)pyrrolidine-2-carboxylic acid | ESD-890979-5G |
| Cas.: 27688-86-4 | Purity: 97% | 3,4-Bis(benzyloxy)phenol | ESD-890980-100MG |
| Cas.: 27688-86-4 | Purity: 97% | 3,4-Bis(benzyloxy)phenol | ESD-890980-250MG |
| Cas.: 27688-86-4 | Purity: 97% | 3,4-Bis(benzyloxy)phenol | ESD-890980-1G |
| Cas.: 256414-75-2 | Purity: ≥95% | SEW2871 | ESD-890981-5MG |
| Cas.: 256414-75-2 | Purity: ≥95% | SEW2871 | ESD-890981-10MG |
| Cas.: 256414-75-2 | Purity: ≥95% | SEW2871 | ESD-890981-25MG |
| Cas.: 1428329-80-9 | Purity: ≥95% | 1-(Methylsulfonyl)-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine | ESD-890982-100MG |
| Cas.: 1428329-80-9 | Purity: ≥95% | 1-(Methylsulfonyl)-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine | ESD-890982-250MG |
| Cas.: 24310-36-9 | Purity: 95% | 1-(Toluene-4-sulfonyl)-1,2,3,4-tetrahydrobenzo[b]azepin-5-one | ESD-890983-250MG |
| Cas.: 24310-36-9 | Purity: 95% | 1-(Toluene-4-sulfonyl)-1,2,3,4-tetrahydrobenzo[b]azepin-5-one | ESD-890983-1G |
| Cas.: 24310-36-9 | Purity: 95% | 1-(Toluene-4-sulfonyl)-1,2,3,4-tetrahydrobenzo[b]azepin-5-one | ESD-890983-5G |
| Cas.: 24310-36-9 | Purity: 95% | 1-(Toluene-4-sulfonyl)-1,2,3,4-tetrahydrobenzo[b]azepin-5-one | ESD-890983-25G |
| Cas.: 1316216-05-3 | Purity: 97% | Ethyl 2-(diphenylamino)pyrimidine-5-carboxylate | ESD-890984-100MG |
| Cas.: 1316216-05-3 | Purity: 97% | Ethyl 2-(diphenylamino)pyrimidine-5-carboxylate | ESD-890984-250MG |
| Cas.: 1316216-05-3 | Purity: 97% | Ethyl 2-(diphenylamino)pyrimidine-5-carboxylate | ESD-890984-1G |
| Cas.: 2640-58-6 | Purity: 98% | Z-Orn-OH | ESD-890985-250MG |
| Cas.: 2640-58-6 | Purity: 98% | Z-Orn-OH | ESD-890985-1G |
| Cas.: 2640-58-6 | Purity: 98% | Z-Orn-OH | ESD-890985-5G |
| Cas.: 2640-58-6 | Purity: 98% | Z-Orn-OH | ESD-890985-10G |
| Cas.: 1378388-19-2 | Purity: 97% | 7-((2-Bromo-5-chlorobenzyl)oxy)-3,4-dihydronaphthalen-1(2H)-one | ESD-890986-100MG |
| Cas.: 1378388-19-2 | Purity: 97% | 7-((2-Bromo-5-chlorobenzyl)oxy)-3,4-dihydronaphthalen-1(2H)-one | ESD-890986-250MG |
| Cas.: 1378388-19-2 | Purity: 97% | 7-((2-Bromo-5-chlorobenzyl)oxy)-3,4-dihydronaphthalen-1(2H)-one | ESD-890986-1G |
| Cas.: 1187361-13-2 | Purity: ≥95% | 3-Cyano-1H-pyrazole-5-carboxylic acid | ESD-890987-100MG |
| Cas.: 1187361-13-2 | Purity: ≥95% | 3-Cyano-1H-pyrazole-5-carboxylic acid | ESD-890987-250MG |
| Cas.: 1187361-13-2 | Purity: ≥95% | 3-Cyano-1H-pyrazole-5-carboxylic acid | ESD-890987-1G |
| Cas.: 1227268-62-3 | Purity: 97% | 2-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine | ESD-890988-100MG |
| Cas.: 1227268-62-3 | Purity: 97% | 2-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine | ESD-890988-250MG |
| Cas.: 1227268-62-3 | Purity: 97% | 2-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine | ESD-890988-1G |
| Cas.: 274693-53-7 | Purity: 97% | Benzyl ((3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)carbamate | ESD-890989-250MG |
| Cas.: 274693-53-7 | Purity: 97% | Benzyl ((3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)carbamate | ESD-890989-1G |
| Cas.: 274693-53-7 | Purity: 97% | Benzyl ((3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)carbamate | ESD-890989-5G |
| Cas.: 764667-64-3 | Purity: 97% | 5-(1-Hydroxy-2-(2,4,5-trifluorophenyl)ethylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione | ESD-890990-250MG |
| Cas.: 764667-64-3 | Purity: 97% | 5-(1-Hydroxy-2-(2,4,5-trifluorophenyl)ethylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione | ESD-890990-1G |
| Cas.: 764667-64-3 | Purity: 97% | 5-(1-Hydroxy-2-(2,4,5-trifluorophenyl)ethylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione | ESD-890990-5G |
| Cas.: 185146-84-3 | Purity: 97% | (S)-2-((tert-Butoxycarbonyl)amino)-3-(2-nitrophenyl)propanoic acid | ESD-890991-250MG |
| Cas.: 185146-84-3 | Purity: 97% | (S)-2-((tert-Butoxycarbonyl)amino)-3-(2-nitrophenyl)propanoic acid | ESD-890991-1G |
| Cas.: 185146-84-3 | Purity: 97% | (S)-2-((tert-Butoxycarbonyl)amino)-3-(2-nitrophenyl)propanoic acid | ESD-890991-5G |
| Cas.: 185146-84-3 | Purity: 97% | (S)-2-((tert-Butoxycarbonyl)amino)-3-(2-nitrophenyl)propanoic acid | ESD-890991-10G |
| Cas.: 886510-13-0 | Purity: 97% | (9H-Fluoren-9-yl)methyl 3-hydroxyazetidine-1-carboxylate | ESD-890992-1G |
| Cas.: 886510-13-0 | Purity: 97% | (9H-Fluoren-9-yl)methyl 3-hydroxyazetidine-1-carboxylate | ESD-890992-5G |
| Cas.: 886510-13-0 | Purity: 97% | (9H-Fluoren-9-yl)methyl 3-hydroxyazetidine-1-carboxylate | ESD-890992-10G |
| Cas.: 886510-13-0 | Purity: 97% | (9H-Fluoren-9-yl)methyl 3-hydroxyazetidine-1-carboxylate | ESD-890992-25G |
| Cas.: 896722-50-2 | Purity: ≥95% | 6-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine | ESD-890993-100MG |
| Cas.: 896722-50-2 | Purity: ≥95% | 6-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine | ESD-890993-250MG |
| Cas.: 896722-50-2 | Purity: ≥95% | 6-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine | ESD-890993-1G |
| Cas.: 896722-50-2 | Purity: ≥95% | 6-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine | ESD-890993-5G |
| Cas.: 1035219-96-5 | Purity: ≥95% | 2-Bromo-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one | ESD-890994-100MG |
| Cas.: 1035219-96-5 | Purity: ≥95% | 2-Bromo-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one | ESD-890994-250MG |
| Cas.: 1035219-96-5 | Purity: ≥95% | 2-Bromo-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one | ESD-890994-1G |
| Cas.: 119736-16-2 | Purity: ≥95% | 3-(Benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid | ESD-890995-1G |
| Cas.: 119736-16-2 | Purity: ≥95% | 3-(Benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid | ESD-890995-5G |
| Cas.: 119736-16-2 | Purity: ≥95% | 3-(Benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid | ESD-890995-10G |
| Cas.: 119736-16-2 | Purity: ≥95% | 3-(Benzyloxy)-4-oxo-4H-pyran-2-carboxylic acid | ESD-890995-25G |
| Cas.: 22813-32-7 | Purity: ≥95% | 2-(2-Nitro-1H-imidazol-1-yl)acetic acid | ESD-890996-100MG |
| Cas.: 22813-32-7 | Purity: ≥95% | 2-(2-Nitro-1H-imidazol-1-yl)acetic acid | ESD-890996-250MG |
| Cas.: 240136-69-0 | Purity: 97% | 4-(3-Nitrophenyl)pyrimidin-2-amine | ESD-890997-100MG |
| Cas.: 240136-69-0 | Purity: 97% | 4-(3-Nitrophenyl)pyrimidin-2-amine | ESD-890997-250MG |
| Cas.: 1192711-37-7 | Purity: ≥95% | 2-Chloro-4-(cyclopropylamino)pyrimidine-5-carboxylic acid | ESD-890998-100MG |
| Cas.: 1192711-37-7 | Purity: ≥95% | 2-Chloro-4-(cyclopropylamino)pyrimidine-5-carboxylic acid | ESD-890998-250MG |
| Cas.: 1192711-37-7 | Purity: ≥95% | 2-Chloro-4-(cyclopropylamino)pyrimidine-5-carboxylic acid | ESD-890998-1G |
| Cas.: 13504-86-4 | Purity: 98% | (2S,4S)-1-((Benzyloxy)carbonyl)-4-hydroxypyrrolidine-2-carboxylic acid | ESD-890999-100MG |
| Cas.: 13504-86-4 | Purity: 98% | (2S,4S)-1-((Benzyloxy)carbonyl)-4-hydroxypyrrolidine-2-carboxylic acid | ESD-890999-250MG |
| Cas.: 13504-86-4 | Purity: 98% | (2S,4S)-1-((Benzyloxy)carbonyl)-4-hydroxypyrrolidine-2-carboxylic acid | ESD-890999-1G |
| Cas.: 13504-86-4 | Purity: 98% | (2S,4S)-1-((Benzyloxy)carbonyl)-4-hydroxypyrrolidine-2-carboxylic acid | ESD-890999-5G |
| Cas.: 149246-87-7 | Purity: ≥95% | 5-(Pyridin-3-yl)-1H-pyrazol-3-amine | ESD-891000-250MG |
| Cas.: 149246-87-7 | Purity: ≥95% | 5-(Pyridin-3-yl)-1H-pyrazol-3-amine | ESD-891000-1G |
| Cas.: 149246-87-7 | Purity: ≥95% | 5-(Pyridin-3-yl)-1H-pyrazol-3-amine | ESD-891000-5G |
| Cas.: 149246-87-7 | Purity: ≥95% | 5-(Pyridin-3-yl)-1H-pyrazol-3-amine | ESD-891000-10G |
| Cas.: 1190978-94-9 | Purity: 97% | 4,7-Dibromo-5,6-bis(hexyloxy)benzo[c][1,2,5]thiadiazole | ESD-891001-250MG |
| Cas.: 1190978-94-9 | Purity: 97% | 4,7-Dibromo-5,6-bis(hexyloxy)benzo[c][1,2,5]thiadiazole | ESD-891001-1G |
| Cas.: 178928-70-6 | Purity: 97% | 2-(2-(1-Chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl)-1H-1,2,4-triazole-3(2H)-thione | ESD-891002-250MG |
| Cas.: 178928-70-6 | Purity: 97% | 2-(2-(1-Chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl)-1H-1,2,4-triazole-3(2H)-thione | ESD-891002-1G |
| Cas.: 178928-70-6 | Purity: 97% | 2-(2-(1-Chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl)-1H-1,2,4-triazole-3(2H)-thione | ESD-891002-5G |
| Cas.: 178928-70-6 | Purity: 97% | 2-(2-(1-Chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl)-1H-1,2,4-triazole-3(2H)-thione | ESD-891002-10G |
| Cas.: 6616-56-4 | Purity: ≥95% | MSX-127 | ESD-891003-1MG |
| Cas.: 6616-56-4 | Purity: ≥95% | MSX-127 | ESD-891003-5MG |
| Cas.: 6616-56-4 | Purity: ≥95% | MSX-127 | ESD-891003-10MG |
| Cas.: 4979-32-2 | Purity: ≥95% | S-(Benzo[d]thiazol-2-yl)-N,N-dicyclohexylthiohydroxylamine | ESD-891004-250MG |
| Cas.: 4979-32-2 | Purity: ≥95% | S-(Benzo[d]thiazol-2-yl)-N,N-dicyclohexylthiohydroxylamine | ESD-891004-1G |
| Cas.: 4979-32-2 | Purity: ≥95% | S-(Benzo[d]thiazol-2-yl)-N,N-dicyclohexylthiohydroxylamine | ESD-891004-5G |
| Cas.: 4979-32-2 | Purity: ≥95% | S-(Benzo[d]thiazol-2-yl)-N,N-dicyclohexylthiohydroxylamine | ESD-891004-10G |
| Cas.: 494799-17-6 | Purity: ≥95% | 3-Cyclohexyl-1H-indole-6-carboxylic acid | ESD-891005-100MG |
| Cas.: 494799-17-6 | Purity: ≥95% | 3-Cyclohexyl-1H-indole-6-carboxylic acid | ESD-891005-250MG |
| Cas.: 494799-17-6 | Purity: ≥95% | 3-Cyclohexyl-1H-indole-6-carboxylic acid | ESD-891005-1G |
| Cas.: 494799-17-6 | Purity: ≥95% | 3-Cyclohexyl-1H-indole-6-carboxylic acid | ESD-891005-5G |
| Cas.: 2092-49-1 | Purity: 97% | 6,6′-dihydroxy-5,5′-dimethoxybiphenyl-3,3′-dicarbaldehyde | ESD-891006-250MG |
| Cas.: 2092-49-1 | Purity: 97% | 6,6′-dihydroxy-5,5′-dimethoxybiphenyl-3,3′-dicarbaldehyde | ESD-891006-1G |
| Cas.: 6052-68-2 | Purity: 97% | 2,3,4,9-Tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid | ESD-891007-1G |
| Cas.: 6052-68-2 | Purity: 97% | 2,3,4,9-Tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid | ESD-891007-5G |
| Cas.: 6052-68-2 | Purity: 97% | 2,3,4,9-Tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid | ESD-891007-10G |
| Cas.: 16082-33-0 | Purity: ≥95% | 1H-Pyrazole-3,5-diamine | ESD-891008-100MG |
| Cas.: 16082-33-0 | Purity: ≥95% | 1H-Pyrazole-3,5-diamine | ESD-891008-250MG |
| Cas.: 16082-33-0 | Purity: ≥95% | 1H-Pyrazole-3,5-diamine | ESD-891008-1G |
| Cas.: 2014-58-6 | Purity: 97% | 6-(6-Aminohexanamido)hexanoic acid | ESD-891009-100MG |
| Cas.: 2014-58-6 | Purity: 97% | 6-(6-Aminohexanamido)hexanoic acid | ESD-891009-250MG |
| Cas.: 2605-68-7 | Purity: 95% | Methyl 2-(triphenylphosphoranylidene)propanoate | ESD-891010-100MG |
| Cas.: 2605-68-7 | Purity: 95% | Methyl 2-(triphenylphosphoranylidene)propanoate | ESD-891010-250MG |
| Cas.: 2605-68-7 | Purity: 95% | Methyl 2-(triphenylphosphoranylidene)propanoate | ESD-891010-1G |
| Cas.: 613-56-9 | Purity: 97% | 2,2′-Dinaphthyl ketone | ESD-891011-250MG |
| Cas.: 613-56-9 | Purity: 97% | 2,2′-Dinaphthyl ketone | ESD-891011-1G |
| Cas.: 613-56-9 | Purity: 97% | 2,2′-Dinaphthyl ketone | ESD-891011-5G |
| Cas.: 502764-52-5 | Purity: 97% | Diethyl dithieno[3,2-b:2′,3′-d]thiophene-2,6-dicarboxylate | ESD-891012-100MG |
| Cas.: 502764-52-5 | Purity: 97% | Diethyl dithieno[3,2-b:2′,3′-d]thiophene-2,6-dicarboxylate | ESD-891012-250MG |
| Cas.: 502764-52-5 | Purity: 97% | Diethyl dithieno[3,2-b:2′,3′-d]thiophene-2,6-dicarboxylate | ESD-891012-1G |
| Cas.: 502764-52-5 | Purity: 97% | Diethyl dithieno[3,2-b:2′,3′-d]thiophene-2,6-dicarboxylate | ESD-891012-5G |
| Cas.: 478646-28-5 | Purity: 97% | (R)-Benzyl (1,5-dihydroxypentan-2-yl)carbamate | ESD-891013-250MG |
| Cas.: 478646-28-5 | Purity: 97% | (R)-Benzyl (1,5-dihydroxypentan-2-yl)carbamate | ESD-891013-1G |
| Cas.: 478646-28-5 | Purity: 97% | (R)-Benzyl (1,5-dihydroxypentan-2-yl)carbamate | ESD-891013-5G |
| Cas.: 133775-25-4 | Purity: 97% | (2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol | ESD-891014-100MG |
| Cas.: 133775-25-4 | Purity: 97% | (2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol | ESD-891014-250MG |
| Cas.: 133775-25-4 | Purity: 97% | (2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol | ESD-891014-1G |
| Cas.: 133775-25-4 | Purity: 97% | (2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol | ESD-891014-5G |
| Cas.: 117098-93-8 | Purity: 97% | 6-Aminobenzo[c][1,2]oxaborol-1(3H)-ol hydrochloride | ESD-891015-100MG |
| Cas.: 117098-93-8 | Purity: 97% | 6-Aminobenzo[c][1,2]oxaborol-1(3H)-ol hydrochloride | ESD-891015-250MG |
| Cas.: 117098-93-8 | Purity: 97% | 6-Aminobenzo[c][1,2]oxaborol-1(3H)-ol hydrochloride | ESD-891015-1G |
| Cas.: 878630-96-7 | Purity: 97% | 1-Boc-4-Cbz-aminoazepane | ESD-891016-250MG |
| Cas.: 878630-96-7 | Purity: 97% | 1-Boc-4-Cbz-aminoazepane | ESD-891016-1G |
| Cas.: 878630-96-7 | Purity: 97% | 1-Boc-4-Cbz-aminoazepane | ESD-891016-5G |
| Cas.: 1427502-44-0 | Purity: ≥95% | 4-Cyano-1H-indole-6-carboxylic acid | ESD-891017-100MG |
| Cas.: 1427502-44-0 | Purity: ≥95% | 4-Cyano-1H-indole-6-carboxylic acid | ESD-891017-250MG |
| Cas.: 214630-00-9 | Purity: ≥95% | (R)-2-(tert-Butoxycarbonyl)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | ESD-891018-100MG |
| Cas.: 214630-00-9 | Purity: ≥95% | (R)-2-(tert-Butoxycarbonyl)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | ESD-891018-250MG |
| Cas.: 214630-00-9 | Purity: ≥95% | (R)-2-(tert-Butoxycarbonyl)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | ESD-891018-1G |
| Cas.: 214630-00-9 | Purity: ≥95% | (R)-2-(tert-Butoxycarbonyl)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | ESD-891018-5G |
| Cas.: 160232-08-6 | Purity: ≥96% | tert-Butyl ((2S,3R)-3-hydroxy-4-(isobutylamino)-1-phenylbutan-2-yl)carbamate | ESD-891019-100MG |
| Cas.: 160232-08-6 | Purity: ≥96% | tert-Butyl ((2S,3R)-3-hydroxy-4-(isobutylamino)-1-phenylbutan-2-yl)carbamate | ESD-891019-250MG |
| Cas.: 160232-08-6 | Purity: ≥96% | tert-Butyl ((2S,3R)-3-hydroxy-4-(isobutylamino)-1-phenylbutan-2-yl)carbamate | ESD-891019-1G |
| Cas.: 1072944-52-5 | Purity: ≥95% | Methyl 2-amino-5-(4-bromophenyl)thiazole-4-carboxylate | ESD-891020-250MG |
| Cas.: 1072944-52-5 | Purity: ≥95% | Methyl 2-amino-5-(4-bromophenyl)thiazole-4-carboxylate | ESD-891020-1G |
| Cas.: 1001180-21-7 | Purity: ≥95% | (R)-tert-Butyl 4-(5-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxylate | ESD-891021-100MG |
| Cas.: 1001180-21-7 | Purity: ≥95% | (R)-tert-Butyl 4-(5-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxylate | ESD-891021-250MG |
| Cas.: 1001180-21-7 | Purity: ≥95% | (R)-tert-Butyl 4-(5-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxylate | ESD-891021-1G |
| Cas.: 52062-26-7 | Purity: 95% | 4-Methoxypyridine-2,6-dicarboxylic acid | ESD-891022-250MG |
| Cas.: 52062-26-7 | Purity: 95% | 4-Methoxypyridine-2,6-dicarboxylic acid | ESD-891022-1G |
| Cas.: 284660-86-2 | Purity: 97% | (2-(Methoxycarbonyl)-1H-indol-5-yl)boronic acid | ESD-891023-100MG |
| Cas.: 284660-86-2 | Purity: 97% | (2-(Methoxycarbonyl)-1H-indol-5-yl)boronic acid | ESD-891023-250MG |
| Cas.: 284660-86-2 | Purity: 97% | (2-(Methoxycarbonyl)-1H-indol-5-yl)boronic acid | ESD-891023-1G |
| Cas.: 1228690-37-6 | Purity: 97% | (R)-1-Phenylethyl (5-(4-bromophenyl)-3-methylisoxazol-4-yl)carbamate | ESD-891024-100MG |
| Cas.: 1228690-37-6 | Purity: 97% | (R)-1-Phenylethyl (5-(4-bromophenyl)-3-methylisoxazol-4-yl)carbamate | ESD-891024-250MG |
| Cas.: 1228690-37-6 | Purity: 97% | (R)-1-Phenylethyl (5-(4-bromophenyl)-3-methylisoxazol-4-yl)carbamate | ESD-891024-1G |
| Cas.: 3898-66-6 | Purity: 95% | 2-(Carboxymethyl)-5-nitrobenzoic acid | ESD-891025-100MG |
| Cas.: 3898-66-6 | Purity: 95% | 2-(Carboxymethyl)-5-nitrobenzoic acid | ESD-891025-250MG |
| Cas.: 57446-04-5 | Purity: 97% | Methyl 3-(2-nitrophenyl)-1H-pyrazole-5-carboxylate | ESD-891026-100MG |
| Cas.: 57446-04-5 | Purity: 97% | Methyl 3-(2-nitrophenyl)-1H-pyrazole-5-carboxylate | ESD-891026-250MG |
| Cas.: 57446-04-5 | Purity: 97% | Methyl 3-(2-nitrophenyl)-1H-pyrazole-5-carboxylate | ESD-891026-1G |
| Cas.: 474416-61-0 | Purity: 97% | Bis(2-iodothiophen-3-yl)methanone | ESD-891027-100MG |
| Cas.: 474416-61-0 | Purity: 97% | Bis(2-iodothiophen-3-yl)methanone | ESD-891027-250MG |
| Cas.: 474416-61-0 | Purity: 97% | Bis(2-iodothiophen-3-yl)methanone | ESD-891027-1G |
| Cas.: 150322-38-6 | Purity: 97% | 5-(2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one | ESD-891028-100MG |
| Cas.: 150322-38-6 | Purity: 97% | 5-(2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one | ESD-891028-250MG |
| Cas.: 150322-38-6 | Purity: 97% | 5-(2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one | ESD-891028-1G |
| Cas.: 27317-69-7 | Purity: 97% | Boc-Ala-Ala-OH | ESD-891029-250MG |
| Cas.: 27317-69-7 | Purity: 97% | Boc-Ala-Ala-OH | ESD-891029-1G |
| Cas.: 27317-69-7 | Purity: 97% | Boc-Ala-Ala-OH | ESD-891029-5G |
| Cas.: 27317-69-7 | Purity: 97% | Boc-Ala-Ala-OH | ESD-891029-10G |
| Cas.: 97232-16-1 | Purity: ≥95% | 4,6-O-Benzylidene-D-glucopyranose | ESD-891030-250MG |
| Cas.: 97232-16-1 | Purity: ≥95% | 4,6-O-Benzylidene-D-glucopyranose | ESD-891030-1G |
| Cas.: 97232-16-1 | Purity: ≥95% | 4,6-O-Benzylidene-D-glucopyranose | ESD-891030-5G |
| Cas.: 121080-95-3 | Purity: ≥95% | Boc-D-Cit-OH | ESD-891031-250MG |
| Cas.: 287177-82-6 | Purity: ≥95% | 1H-Pyrazolo[3,4-d]pyrimidin-6-amine | ESD-891032-100MG |
| Cas.: 287177-82-6 | Purity: ≥95% | 1H-Pyrazolo[3,4-d]pyrimidin-6-amine | ESD-891032-250MG |
| Cas.: 287177-82-6 | Purity: ≥95% | 1H-Pyrazolo[3,4-d]pyrimidin-6-amine | ESD-891032-1G |
| Cas.: 287177-82-6 | Purity: ≥95% | 1H-Pyrazolo[3,4-d]pyrimidin-6-amine | ESD-891032-5G |
| Cas.: 63219-70-5 | Purity: ≥95% | (R)-Benzyl (1-oxo-3-phenylpropan-2-yl)carbamate | ESD-891033-100MG |
| Cas.: 63219-70-5 | Purity: ≥95% | (R)-Benzyl (1-oxo-3-phenylpropan-2-yl)carbamate | ESD-891033-250MG |
| Cas.: 63219-70-5 | Purity: ≥95% | (R)-Benzyl (1-oxo-3-phenylpropan-2-yl)carbamate | ESD-891033-1G |
| Cas.: 63219-70-5 | Purity: ≥95% | (R)-Benzyl (1-oxo-3-phenylpropan-2-yl)carbamate | ESD-891033-5G |
| Cas.: 848133-75-5 | Purity: ≥95% | N-(3-Cyano-7-ethoxy-4-hydroxyquinolin-6-yl)acetamide | ESD-891034-100MG |
| Cas.: 848133-75-5 | Purity: ≥95% | N-(3-Cyano-7-ethoxy-4-hydroxyquinolin-6-yl)acetamide | ESD-891034-250MG |
| Cas.: 848133-75-5 | Purity: ≥95% | N-(3-Cyano-7-ethoxy-4-hydroxyquinolin-6-yl)acetamide | ESD-891034-1G |
| Cas.: 489471-87-6 | Purity: 97% | 1,1′-Sulfonylbis(2-methyl-1H-imidazole) | ESD-891035-1G |
| Cas.: 489471-87-6 | Purity: 97% | 1,1′-Sulfonylbis(2-methyl-1H-imidazole) | ESD-891035-5G |
| Cas.: 489471-87-6 | Purity: 97% | 1,1′-Sulfonylbis(2-methyl-1H-imidazole) | ESD-891035-10G |
| Cas.: 489471-87-6 | Purity: 97% | 1,1′-Sulfonylbis(2-methyl-1H-imidazole) | ESD-891035-25G |
| Cas.: 77308-48-6 | Purity: ≥95% | 1,1,4,4,7,7,10,10-Octamethyl-2,3,4,7,8,9,10,12-octahydro-1H-dibenzo[b,h]fluorene | ESD-891036-100MG |
| Cas.: 77308-48-6 | Purity: ≥95% | 1,1,4,4,7,7,10,10-Octamethyl-2,3,4,7,8,9,10,12-octahydro-1H-dibenzo[b,h]fluorene | ESD-891036-250MG |
| Cas.: 77308-48-6 | Purity: ≥95% | 1,1,4,4,7,7,10,10-Octamethyl-2,3,4,7,8,9,10,12-octahydro-1H-dibenzo[b,h]fluorene | ESD-891036-1G |
| Cas.: 2360-19-2 | Purity: ≥95% | 4-Amino-3-nitrobenzenesulfonamide | ESD-891037-250MG |
| Cas.: 2360-19-2 | Purity: ≥95% | 4-Amino-3-nitrobenzenesulfonamide | ESD-891037-1G |
| Cas.: 2360-19-2 | Purity: ≥95% | 4-Amino-3-nitrobenzenesulfonamide | ESD-891037-5G |
| Cas.: 718608-08-3 | Purity: ≥95% | (S)-4-(Benzyloxy)-3-((tert-butoxycarbonyl)amino)butanoic acid | ESD-891038-100MG |
| Cas.: 718608-08-3 | Purity: ≥95% | (S)-4-(Benzyloxy)-3-((tert-butoxycarbonyl)amino)butanoic acid | ESD-891038-250MG |
| Cas.: 1025424-03-6 | Purity: ≥95% | 4-Methoxy-2-tosylisoindoline | ESD-891039-100MG |
| Cas.: 1025424-03-6 | Purity: ≥95% | 4-Methoxy-2-tosylisoindoline | ESD-891039-250MG |
| Cas.: 15686-33-6 | Purity: 97% | 6,6′-Methylenebis(4-chloro-2-isopropyl-5-methylphenol) | ESD-891040-100MG |
| Cas.: 15686-33-6 | Purity: 97% | 6,6′-Methylenebis(4-chloro-2-isopropyl-5-methylphenol) | ESD-891040-250MG |
| Cas.: 15686-33-6 | Purity: 97% | 6,6′-Methylenebis(4-chloro-2-isopropyl-5-methylphenol) | ESD-891040-1G |
| Cas.: 146803-41-0 | Purity: 97% | (S)-(9H-Fluoren-9-yl)methyl (1-oxopropan-2-yl)carbamate | ESD-891041-250MG |
| Cas.: 146803-41-0 | Purity: 97% | (S)-(9H-Fluoren-9-yl)methyl (1-oxopropan-2-yl)carbamate | ESD-891041-1G |
| Cas.: 4273-92-1 | Purity: ≥95% | N-(4-Chloro-2,5-dimethoxyphenyl)-3-hydroxy-2-naphthamide | ESD-891042-1G |
| Cas.: 4273-92-1 | Purity: ≥95% | N-(4-Chloro-2,5-dimethoxyphenyl)-3-hydroxy-2-naphthamide | ESD-891042-5G |
| Cas.: 4273-92-1 | Purity: ≥95% | N-(4-Chloro-2,5-dimethoxyphenyl)-3-hydroxy-2-naphthamide | ESD-891042-10G |
| Cas.: 761440-75-9 | Purity: ≥95% | 2-Methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline | ESD-891043-250MG |
| Cas.: 761440-75-9 | Purity: ≥95% | 2-Methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline | ESD-891043-1G |
| Cas.: 761440-75-9 | Purity: ≥95% | 2-Methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline | ESD-891043-5G |
| Cas.: 761440-75-9 | Purity: ≥95% | 2-Methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)aniline | ESD-891043-10G |
| Cas.: 1103738-19-7 | Purity: 98% | ((3AS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholino)methanone | ESD-891044-100MG |
| Cas.: 1103738-19-7 | Purity: 98% | ((3AS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholino)methanone | ESD-891044-250MG |
| Cas.: 1103738-19-7 | Purity: 98% | ((3AS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholino)methanone | ESD-891044-1G |
| Cas.: 67287-53-0 | Purity: ≥95% | 6-Chloro-7,8-dimethoxy-1-(4-methoxyphenyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepine | ESD-891045-1G |
| Cas.: 67287-53-0 | Purity: ≥95% | 6-Chloro-7,8-dimethoxy-1-(4-methoxyphenyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepine | ESD-891045-5G |
| Cas.: 261165-06-4 | Purity: ≥95% | (S)-3-(4-Bromophenyl)-3-((tert-butoxycarbonyl)amino)propanoic acid | ESD-891046-250MG |
| Cas.: 261165-06-4 | Purity: ≥95% | (S)-3-(4-Bromophenyl)-3-((tert-butoxycarbonyl)amino)propanoic acid | ESD-891046-1G |
| Cas.: 261165-06-4 | Purity: ≥95% | (S)-3-(4-Bromophenyl)-3-((tert-butoxycarbonyl)amino)propanoic acid | ESD-891046-5G |
| Cas.: 261165-06-4 | Purity: ≥95% | (S)-3-(4-Bromophenyl)-3-((tert-butoxycarbonyl)amino)propanoic acid | ESD-891046-10G |
| Cas.: 99226-02-5 | Purity: 97% | trans-2-(2-Methoxyphenyl)-5-oxotetrahydrofuran-3-carboxylic acid | ESD-891047-1G |
| Cas.: 99226-02-5 | Purity: 97% | trans-2-(2-Methoxyphenyl)-5-oxotetrahydrofuran-3-carboxylic acid | ESD-891047-5G |
| Cas.: 99226-02-5 | Purity: 97% | trans-2-(2-Methoxyphenyl)-5-oxotetrahydrofuran-3-carboxylic acid | ESD-891047-10G |
| Cas.: 1361197-82-1 | Purity: ≥95% | 4-Chloro-2-phenylthieno[3,2-c]pyridine-7-carbonitrile | ESD-891048-100MG |
| Cas.: 1361197-82-1 | Purity: ≥95% | 4-Chloro-2-phenylthieno[3,2-c]pyridine-7-carbonitrile | ESD-891048-250MG |
| Cas.: 1361197-82-1 | Purity: ≥95% | 4-Chloro-2-phenylthieno[3,2-c]pyridine-7-carbonitrile | ESD-891048-1G |
| Cas.: 3722-80-3 | Purity: ≥95% | 4,4′-(Propane-1,3-diylbis(oxy))dibenzaldehyde | ESD-891050-100MG |
| Cas.: 3722-80-3 | Purity: ≥95% | 4,4′-(Propane-1,3-diylbis(oxy))dibenzaldehyde | ESD-891050-250MG |
| Cas.: 25197-96-0 | Purity: ≥95% | (S)-2-Amino-3-(5-methoxy-1H-indol-3-yl)propanoic acid | ESD-891051-100MG |
| Cas.: 25197-96-0 | Purity: ≥95% | (S)-2-Amino-3-(5-methoxy-1H-indol-3-yl)propanoic acid | ESD-891051-250MG |
| Cas.: 25197-96-0 | Purity: ≥95% | (S)-2-Amino-3-(5-methoxy-1H-indol-3-yl)propanoic acid | ESD-891051-1G |
| Cas.: 33600-67-8 | Purity: ≥95% | 2-Amino-3-(6-methoxy-1H-indol-3-yl)propanoic acid | ESD-891052-100MG |
| Cas.: 33600-67-8 | Purity: ≥95% | 2-Amino-3-(6-methoxy-1H-indol-3-yl)propanoic acid | ESD-891052-250MG |
| Cas.: 406938-53-2 | Purity: 98% | (S)-2-Amino-3-(4-methoxy-1H-indol-3-yl)propanoic acid | ESD-891053-100MG |
| Cas.: 406938-53-2 | Purity: 98% | (S)-2-Amino-3-(4-methoxy-1H-indol-3-yl)propanoic acid | ESD-891053-250MG |
| Cas.: 957035-10-8 | Purity: 97% | 3-Benzyloxy-6-bromo-2-fluorophenylboronic acid | ESD-891054-1G |
| Cas.: 957035-10-8 | Purity: 97% | 3-Benzyloxy-6-bromo-2-fluorophenylboronic acid | ESD-891054-5G |
| Cas.: 957035-10-8 | Purity: 97% | 3-Benzyloxy-6-bromo-2-fluorophenylboronic acid | ESD-891054-10G |
| Cas.: 957035-10-8 | Purity: 97% | 3-Benzyloxy-6-bromo-2-fluorophenylboronic acid | ESD-891054-25G |
| Cas.: 214470-68-5 | Purity: ≥95% | 4-Chloro-7-(3-chloropropoxy)-6-methoxyquinoline-3-carbonitrile | ESD-891055-100MG |
| Cas.: 214470-68-5 | Purity: ≥95% | 4-Chloro-7-(3-chloropropoxy)-6-methoxyquinoline-3-carbonitrile | ESD-891055-250MG |
| Cas.: 214470-68-5 | Purity: ≥95% | 4-Chloro-7-(3-chloropropoxy)-6-methoxyquinoline-3-carbonitrile | ESD-891055-1G |
| Cas.: 214470-68-5 | Purity: ≥95% | 4-Chloro-7-(3-chloropropoxy)-6-methoxyquinoline-3-carbonitrile | ESD-891055-5G |
| Cas.: 52598-02-4 | Purity: 97% | 5-Chloro-2,3-diphenyl-1H-indole | ESD-891056-250MG |
| Cas.: 52598-02-4 | Purity: 97% | 5-Chloro-2,3-diphenyl-1H-indole | ESD-891056-1G |
| Cas.: 52598-02-4 | Purity: 97% | 5-Chloro-2,3-diphenyl-1H-indole | ESD-891056-5G |
| Cas.: 52598-02-4 | Purity: 97% | 5-Chloro-2,3-diphenyl-1H-indole | ESD-891056-10G |
| Cas.: 7311-93-5 | Purity: 97% | 3-(Piperidin-1-ylsulfonyl)benzoic acid | ESD-891058-100MG |
| Cas.: 7311-93-5 | Purity: 97% | 3-(Piperidin-1-ylsulfonyl)benzoic acid | ESD-891058-250MG |
| Cas.: 7311-93-5 | Purity: 97% | 3-(Piperidin-1-ylsulfonyl)benzoic acid | ESD-891058-1G |
| Cas.: 7311-93-5 | Purity: 97% | 3-(Piperidin-1-ylsulfonyl)benzoic acid | ESD-891058-5G |
| Cas.: 478832-03-0 | Purity: 97% | tert-Butyl (1-benzyl-5-oxopyrrolidin-3-yl)carbamate | ESD-891059-100MG |
| Cas.: 478832-03-0 | Purity: 97% | tert-Butyl (1-benzyl-5-oxopyrrolidin-3-yl)carbamate | ESD-891059-250MG |
| Cas.: 478832-03-0 | Purity: 97% | tert-Butyl (1-benzyl-5-oxopyrrolidin-3-yl)carbamate | ESD-891059-1G |
| Cas.: 89-26-9 | Purity: 97% | 1-(3-Aminophenyl)-5-oxo-4,5-dihydro-1H-pyrazole-3-carboxylic acid | ESD-891060-250MG |
| Cas.: 89-26-9 | Purity: 97% | 1-(3-Aminophenyl)-5-oxo-4,5-dihydro-1H-pyrazole-3-carboxylic acid | ESD-891060-1G |
| Cas.: 17808-21-8 | Purity: ≥95% | 2-Amino-3-(6-chloro-1H-indol-3-yl)propanoic acid | ESD-891061-100MG |
| Cas.: 17808-21-8 | Purity: ≥95% | 2-Amino-3-(6-chloro-1H-indol-3-yl)propanoic acid | ESD-891061-250MG |
| Cas.: 4792-71-6 | Purity: 97% | 5,7-Dichloro-1H-indole-2-carboxylic acid | ESD-891062-100MG |
| Cas.: 4792-71-6 | Purity: 97% | 5,7-Dichloro-1H-indole-2-carboxylic acid | ESD-891062-250MG |
| Cas.: 4792-71-6 | Purity: 97% | 5,7-Dichloro-1H-indole-2-carboxylic acid | ESD-891062-1G |
| Cas.: 4792-71-6 | Purity: 97% | 5,7-Dichloro-1H-indole-2-carboxylic acid | ESD-891062-5G |
| Cas.: 162046-66-4 | Purity: ≥95% | 4-(4-(tert-Butoxycarbonyl)piperazin-1-yl)benzoic acid | ESD-891063-250MG |
| Cas.: 162046-66-4 | Purity: ≥95% | 4-(4-(tert-Butoxycarbonyl)piperazin-1-yl)benzoic acid | ESD-891063-1G |
| Cas.: 162046-66-4 | Purity: ≥95% | 4-(4-(tert-Butoxycarbonyl)piperazin-1-yl)benzoic acid | ESD-891063-5G |
| Cas.: 162046-66-4 | Purity: ≥95% | 4-(4-(tert-Butoxycarbonyl)piperazin-1-yl)benzoic acid | ESD-891063-10G |
| Cas.: 154-07-4 | Purity: 97% | 2-Amino-3-(5-chloro-1H-indol-3-yl)propanoic acid | ESD-891064-250MG |
| Cas.: 154-07-4 | Purity: 97% | 2-Amino-3-(5-chloro-1H-indol-3-yl)propanoic acid | ESD-891064-1G |
| Cas.: 73945-46-7 | Purity: 97% | (S)-2-Amino-3-(7-chloro-1H-indol-3-yl)propanoic acid | ESD-891065-100MG |
| Cas.: 73945-46-7 | Purity: 97% | (S)-2-Amino-3-(7-chloro-1H-indol-3-yl)propanoic acid | ESD-891065-250MG |
| Cas.: 73945-46-7 | Purity: 97% | (S)-2-Amino-3-(7-chloro-1H-indol-3-yl)propanoic acid | ESD-891065-1G |
| Cas.: 75102-74-8 | Purity: 97% | (R)-2-Amino-3-(7-chloro-1H-indol-3-yl)propanoic acid | ESD-891066-50MG |
| Cas.: 99907-84-3 | Purity: ≥95% | 2-Amino-5,8-dimethoxy-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid | ESD-891067-100MG |
| Cas.: 99907-84-3 | Purity: ≥95% | 2-Amino-5,8-dimethoxy-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid | ESD-891067-250MG |
| Cas.: 99907-84-3 | Purity: ≥95% | 2-Amino-5,8-dimethoxy-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid | ESD-891067-1G |
| Cas.: 29103-75-1 | Purity: ≥95% | N1,N1′-(Ethane-1,2-diyl)bis(N1-methylbenzene-1,4-diamine) | ESD-891068-100MG |
| Cas.: 29103-75-1 | Purity: ≥95% | N1,N1′-(Ethane-1,2-diyl)bis(N1-methylbenzene-1,4-diamine) | ESD-891068-250MG |
| Cas.: 1015070-56-0 | Purity: ≥95% | 6-Bromoisoquinolin-4-ol | ESD-891069-100MG |
| Cas.: 1015070-56-0 | Purity: ≥95% | 6-Bromoisoquinolin-4-ol | ESD-891069-250MG |
| Cas.: 1015070-56-0 | Purity: ≥95% | 6-Bromoisoquinolin-4-ol | ESD-891069-1G |
| Cas.: 1160823-85-7 | Purity: 97% | Octyl 4,6-dibromothieno[3,4-b]thiophene-2-carboxylate | ESD-891070-100MG |
| Cas.: 1160823-85-7 | Purity: 97% | Octyl 4,6-dibromothieno[3,4-b]thiophene-2-carboxylate | ESD-891070-250MG |
| Cas.: 3537-14-2 | Purity: ≥95% | 5-Nitro-2,3-pyridinediamine | ESD-891071-100MG |
| Cas.: 3537-14-2 | Purity: ≥95% | 5-Nitro-2,3-pyridinediamine | ESD-891071-250MG |
| Cas.: 3537-14-2 | Purity: ≥95% | 5-Nitro-2,3-pyridinediamine | ESD-891071-1G |
| Cas.: 3537-14-2 | Purity: ≥95% | 5-Nitro-2,3-pyridinediamine | ESD-891071-5G |
| Cas.: 1051934-98-5 | Purity: 97% | Boc-Phe(3,5-Cl)-OH | ESD-891072-100MG |
| Cas.: 1051934-98-5 | Purity: 97% | Boc-Phe(3,5-Cl)-OH | ESD-891072-250MG |
| Cas.: 459423-32-6 | Purity: 96% | (3-(Adamantan-1-yl)-4-methoxyphenyl)boronic acid | ESD-891073-100MG |
| Cas.: 459423-32-6 | Purity: 96% | (3-(Adamantan-1-yl)-4-methoxyphenyl)boronic acid | ESD-891073-250MG |
| Cas.: 459423-32-6 | Purity: 96% | (3-(Adamantan-1-yl)-4-methoxyphenyl)boronic acid | ESD-891073-1G |
| Cas.: 459423-32-6 | Purity: 96% | (3-(Adamantan-1-yl)-4-methoxyphenyl)boronic acid | ESD-891073-5G |
| Cas.: 209128-15-4 | Purity: ≥95% | 1′-(tert-Butoxycarbonyl)spiro[indene-1,4′-piperidine]-3-carboxylic acid | ESD-891074-100MG |
| Cas.: 209128-15-4 | Purity: ≥95% | 1′-(tert-Butoxycarbonyl)spiro[indene-1,4′-piperidine]-3-carboxylic acid | ESD-891074-250MG |
| Cas.: 566169-93-5 | Purity: ≥95% | 2-(4-(Methylamino)phenyl)benzo[d]thiazol-6-ol | ESD-891075-100MG |
| Cas.: 566169-93-5 | Purity: ≥95% | 2-(4-(Methylamino)phenyl)benzo[d]thiazol-6-ol | ESD-891075-250MG |
| Cas.: 1196-30-1 | Purity: ≥95% | 3-Hydroxy-N-methylpicolinamide | ESD-891076-100MG |
| Cas.: 1196-30-1 | Purity: ≥95% | 3-Hydroxy-N-methylpicolinamide | ESD-891076-250MG |
| Cas.: 1260664-94-5 | Purity: ≥95% | 3-Oxoisoindoline-5-carbaldehyde | ESD-891077-100MG |
| Cas.: 1260664-94-5 | Purity: ≥95% | 3-Oxoisoindoline-5-carbaldehyde | ESD-891077-250MG |
| Cas.: 1260664-94-5 | Purity: ≥95% | 3-Oxoisoindoline-5-carbaldehyde | ESD-891077-1G |
| Cas.: 286371-64-0 | Purity: 97% | 6-(Benzyloxy)-7-methoxyquinazolin-4(1H)-one | ESD-891078-100MG |
| Cas.: 286371-64-0 | Purity: 97% | 6-(Benzyloxy)-7-methoxyquinazolin-4(1H)-one | ESD-891078-250MG |
| Cas.: 286371-64-0 | Purity: 97% | 6-(Benzyloxy)-7-methoxyquinazolin-4(1H)-one | ESD-891078-1G |
| Cas.: 286371-64-0 | Purity: 97% | 6-(Benzyloxy)-7-methoxyquinazolin-4(1H)-one | ESD-891078-5G |
| Cas.: 261360-77-4 | Purity: 97% | (R)-3-(3-Bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid | ESD-891079-100MG |
| Cas.: 261360-77-4 | Purity: 97% | (R)-3-(3-Bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid | ESD-891079-250MG |
| Cas.: 261360-77-4 | Purity: 97% | (R)-3-(3-Bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid | ESD-891079-1G |
| Cas.: 261360-77-4 | Purity: 97% | (R)-3-(3-Bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid | ESD-891079-5G |
| Cas.: 203395-59-9 | Purity: ≥95% | 7-(4-Bromobutoxy)quinolin-2(1H)-one | ESD-891080-250MG |
| Cas.: 203395-59-9 | Purity: ≥95% | 7-(4-Bromobutoxy)quinolin-2(1H)-one | ESD-891080-1G |
| Cas.: 203395-59-9 | Purity: ≥95% | 7-(4-Bromobutoxy)quinolin-2(1H)-one | ESD-891080-5G |
| Cas.: 500788-90-9 | Purity: 97% | (R)-3-((tert-Butoxycarbonyl)amino)-3-(2,4-dichlorophenyl)propanoic acid | ESD-891081-100MG |
| Cas.: 500788-90-9 | Purity: 97% | (R)-3-((tert-Butoxycarbonyl)amino)-3-(2,4-dichlorophenyl)propanoic acid | ESD-891081-250MG |
| Cas.: 201214-53-1 | Purity: ≥95% | Methyl 4-acetamido-5-iodo-2-methoxybenzoate | ESD-891082-100MG |
| Cas.: 201214-53-1 | Purity: ≥95% | Methyl 4-acetamido-5-iodo-2-methoxybenzoate | ESD-891082-250MG |
| Cas.: 201214-53-1 | Purity: ≥95% | Methyl 4-acetamido-5-iodo-2-methoxybenzoate | ESD-891082-1G |
| Cas.: 145951-26-4 | Purity: ≥95% | 1H-Indole-6-sulfonamide | ESD-891083-100MG |
| Cas.: 145951-26-4 | Purity: ≥95% | 1H-Indole-6-sulfonamide | ESD-891083-250MG |
| Cas.: 145951-26-4 | Purity: ≥95% | 1H-Indole-6-sulfonamide | ESD-891083-1G |
| Cas.: 10596-23-3 | Purity: 97% | (Dichloromethylene)diphosphonic acid | ESD-891084-5MG |
| Cas.: 1236768-61-8 | Purity: ≥95% | (2-(Benzyloxy)-5-methoxyphenyl)boronic acid | ESD-891085-250MG |
| Cas.: 1236768-61-8 | Purity: ≥95% | (2-(Benzyloxy)-5-methoxyphenyl)boronic acid | ESD-891085-1G |
| Cas.: 1236768-61-8 | Purity: ≥95% | (2-(Benzyloxy)-5-methoxyphenyl)boronic acid | ESD-891085-5G |
| Cas.: 143722-29-6 | Purity: 97% | 1-(4-Bromobenzyl)-2-butyl-4-chloro-1H-imidazole-5-carbaldehyde | ESD-891086-100MG |
| Cas.: 143722-29-6 | Purity: 97% | 1-(4-Bromobenzyl)-2-butyl-4-chloro-1H-imidazole-5-carbaldehyde | ESD-891086-250MG |
| Cas.: 143722-29-6 | Purity: 97% | 1-(4-Bromobenzyl)-2-butyl-4-chloro-1H-imidazole-5-carbaldehyde | ESD-891086-1G |
| Cas.: 143722-29-6 | Purity: 97% | 1-(4-Bromobenzyl)-2-butyl-4-chloro-1H-imidazole-5-carbaldehyde | ESD-891086-5G |
| Cas.: 147269-67-8 | Purity: ≥95% | Benzyl (2-oxo-1,2-dihydropyridin-3-yl)carbamate | ESD-891087-100MG |
| Cas.: 147269-67-8 | Purity: ≥95% | Benzyl (2-oxo-1,2-dihydropyridin-3-yl)carbamate | ESD-891087-250MG |
| Cas.: 147269-67-8 | Purity: ≥95% | Benzyl (2-oxo-1,2-dihydropyridin-3-yl)carbamate | ESD-891087-1G |
| Cas.: 55662-66-3 | Purity: ≥95% | Imidazo[1,2-c]pyrimidin-5(6H)-one | ESD-891088-100MG |
| Cas.: 55662-66-3 | Purity: ≥95% | Imidazo[1,2-c]pyrimidin-5(6H)-one | ESD-891088-250MG |
| Cas.: 55662-66-3 | Purity: ≥95% | Imidazo[1,2-c]pyrimidin-5(6H)-one | ESD-891088-1G |
| Cas.: 209984-30-5 | Purity: 97% | 5-Methyl-5H-dibenzo[b,d]azepin-6(7H)-one | ESD-891089-100MG |
| Cas.: 209984-30-5 | Purity: 97% | 5-Methyl-5H-dibenzo[b,d]azepin-6(7H)-one | ESD-891089-250MG |
| Cas.: 209984-30-5 | Purity: 97% | 5-Methyl-5H-dibenzo[b,d]azepin-6(7H)-one | ESD-891089-1G |
| Cas.: 56469-02-4 | Purity: ≥95% | 3,4-Dihydro-5-hydroxy-1(2H)-isoquinolinone | ESD-891090-50MG |
| Cas.: 56469-02-4 | Purity: ≥95% | 3,4-Dihydro-5-hydroxy-1(2H)-isoquinolinone | ESD-891090-100MG |
| Cas.: 56469-02-4 | Purity: ≥95% | 3,4-Dihydro-5-hydroxy-1(2H)-isoquinolinone | ESD-891090-250MG |
| Cas.: 731810-57-4 | Purity: ≥95% | Methyl 6-((tert-butoxycarbonyl)amino)-3-formyl-1H-indole-4-carboxylate | ESD-891091-100MG |
| Cas.: 731810-57-4 | Purity: ≥95% | Methyl 6-((tert-butoxycarbonyl)amino)-3-formyl-1H-indole-4-carboxylate | ESD-891091-250MG |
| Cas.: 1215107-26-8 | Purity: 97% | (5-Morpholinopyridin-3-yl)boronic acid | ESD-891092-1G |
| Cas.: 61627-58-5 | Purity: ≥95% | N-(3-Cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)propionamide | ESD-891093-100MG |
| Cas.: 61627-58-5 | Purity: ≥95% | N-(3-Cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)propionamide | ESD-891093-250MG |
| Cas.: 61627-58-5 | Purity: ≥95% | N-(3-Cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)propionamide | ESD-891093-1G |
| Cas.: 86776-54-7 | Purity: 97% | 4-Cyano-3-fluorophenyl 4-heptylbenzoate | ESD-891094-250MG |
| Cas.: 86776-54-7 | Purity: 97% | 4-Cyano-3-fluorophenyl 4-heptylbenzoate | ESD-891094-1G |
| Cas.: 316146-27-7 | Purity: 95% | N-(4-Bromophenyl)-3-phenylpropanamide | ESD-891095-1G |
| Cas.: 316146-27-7 | Purity: 95% | N-(4-Bromophenyl)-3-phenylpropanamide | ESD-891095-5G |
| Cas.: 316146-27-7 | Purity: 95% | N-(4-Bromophenyl)-3-phenylpropanamide | ESD-891095-10G |
| Cas.: 316146-27-7 | Purity: 95% | N-(4-Bromophenyl)-3-phenylpropanamide | ESD-891095-25G |
| Cas.: 43156-47-4 | Purity: 97% | 2-Nitro-5-(phenylthio)aniline | ESD-891096-250MG |
| Cas.: 43156-47-4 | Purity: 97% | 2-Nitro-5-(phenylthio)aniline | ESD-891096-1G |
| Cas.: 43156-47-4 | Purity: 97% | 2-Nitro-5-(phenylthio)aniline | ESD-891096-5G |
| Cas.: 43156-47-4 | Purity: 97% | 2-Nitro-5-(phenylthio)aniline | ESD-891096-10G |
| Cas.: 223673-34-5 | Purity: 98% | (R)-2-((4-Nitrophenethyl)amino)-1-phenylethanol | ESD-891097-1G |
| Cas.: 223673-34-5 | Purity: 98% | (R)-2-((4-Nitrophenethyl)amino)-1-phenylethanol | ESD-891097-5G |
| Cas.: 223673-34-5 | Purity: 98% | (R)-2-((4-Nitrophenethyl)amino)-1-phenylethanol | ESD-891097-10G |
| Cas.: 943736-58-1 | Purity: 97% | 4-Chloro-5H-pyrrolo[3,2-d]pyrimidin-2-amine | ESD-891098-250MG |
| Cas.: 943736-58-1 | Purity: 97% | 4-Chloro-5H-pyrrolo[3,2-d]pyrimidin-2-amine | ESD-891098-1G |
| Cas.: 943736-58-1 | Purity: 97% | 4-Chloro-5H-pyrrolo[3,2-d]pyrimidin-2-amine | ESD-891098-5G |
| Cas.: 1073182-87-2 | Purity: ≥95% | 3-Amino-4,6-dichloropicolinic acid | ESD-891099-100MG |
| Cas.: 1073182-87-2 | Purity: ≥95% | 3-Amino-4,6-dichloropicolinic acid | ESD-891099-250MG |
| Cas.: 1073182-87-2 | Purity: ≥95% | 3-Amino-4,6-dichloropicolinic acid | ESD-891099-1G |
| Cas.: 1073182-87-2 | Purity: ≥95% | 3-Amino-4,6-dichloropicolinic acid | ESD-891099-5G |
| Cas.: 876379-22-5 | Purity: 97% | (S)-1-Cbz-3-Boc-Aminopiperidine | ESD-891100-100MG |
| Cas.: 876379-22-5 | Purity: 97% | (S)-1-Cbz-3-Boc-Aminopiperidine | ESD-891100-250MG |
| Cas.: 1799439-14-7 | Purity: ≥95% | 3-(tert-Butoxy)-3-oxo-2-(quinolin-4-ylmethyl)propanoic acid | ESD-891101-100MG |
| Cas.: 1799439-14-7 | Purity: ≥95% | 3-(tert-Butoxy)-3-oxo-2-(quinolin-4-ylmethyl)propanoic acid | ESD-891101-250MG |
| Cas.: 1002360-09-9 | Purity: 95% | (S)-tert-Butyl 3-(((benzyloxy)carbonyl)amino)piperidine-1-carboxylate | ESD-891102-250MG |
| Cas.: 1002360-09-9 | Purity: 95% | (S)-tert-Butyl 3-(((benzyloxy)carbonyl)amino)piperidine-1-carboxylate | ESD-891102-1G |
| Cas.: 134030-21-0 | Purity: 97% | N1,N2-Dimesitylethane-1,2-diamine | ESD-891103-250MG |
| Cas.: 134030-21-0 | Purity: 97% | N1,N2-Dimesitylethane-1,2-diamine | ESD-891103-1G |
| Cas.: 134030-21-0 | Purity: 97% | N1,N2-Dimesitylethane-1,2-diamine | ESD-891103-5G |
| Cas.: 134030-21-0 | Purity: 97% | N1,N2-Dimesitylethane-1,2-diamine | ESD-891103-10G |
| Cas.: 788136-89-0 | Purity: 95% | 4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl acetate | ESD-891104-250MG |
| Cas.: 788136-89-0 | Purity: 95% | 4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl acetate | ESD-891104-1G |
| Cas.: 788136-89-0 | Purity: 95% | 4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl acetate | ESD-891104-5G |
| Cas.: 4770-32-5 | Purity: ≥95% | 1-(5-Hydroxyindolin-1-yl)ethanone | ESD-891105-100MG |
| Cas.: 4770-32-5 | Purity: ≥95% | 1-(5-Hydroxyindolin-1-yl)ethanone | ESD-891105-250MG |
| Cas.: 4770-32-5 | Purity: ≥95% | 1-(5-Hydroxyindolin-1-yl)ethanone | ESD-891105-1G |
| Cas.: 82846-38-6 | Purity: 97% | 2,2′-Oxybis(N,N-dibutylacetamide) | ESD-891106-250MG |
| Cas.: 82846-38-6 | Purity: 97% | 2,2′-Oxybis(N,N-dibutylacetamide) | ESD-891106-1G |
| Cas.: 171047-01-1 | Purity: 97% | 3′-Hydroxy-[1,1′-biphenyl]-3-carboxylic acid | ESD-891107-250MG |
| Cas.: 171047-01-1 | Purity: 97% | 3′-Hydroxy-[1,1′-biphenyl]-3-carboxylic acid | ESD-891107-1G |
| Cas.: 59279-58-2 | Purity: 95% | Boc-Glu(Obzl)-OMe | ESD-891108-1G |
| Cas.: 59279-58-2 | Purity: 95% | Boc-Glu(Obzl)-OMe | ESD-891108-5G |
| Cas.: 59279-58-2 | Purity: 95% | Boc-Glu(Obzl)-OMe | ESD-891108-10G |
| Cas.: 130473-27-7 | Purity: 97% | 1H-Pyrrolo[2,3-c]pyridine-5-carboxylic acid | ESD-891109-100MG |
| Cas.: 130473-27-7 | Purity: 97% | 1H-Pyrrolo[2,3-c]pyridine-5-carboxylic acid | ESD-891109-250MG |
| Cas.: 130473-27-7 | Purity: 97% | 1H-Pyrrolo[2,3-c]pyridine-5-carboxylic acid | ESD-891109-1G |
| Cas.: 945840-82-4 | Purity: ≥95% | 1H-Pyrrolo[2,3-c]pyridine-7-carboxylic acid | ESD-891110-100MG |
| Cas.: 945840-82-4 | Purity: ≥95% | 1H-Pyrrolo[2,3-c]pyridine-7-carboxylic acid | ESD-891110-250MG |
| Cas.: 945840-82-4 | Purity: ≥95% | 1H-Pyrrolo[2,3-c]pyridine-7-carboxylic acid | ESD-891110-1G |
| Cas.: 330792-69-3 | Purity: 97% | 2-(Methoxy(4-phenoxyphenyl)methylene)malononitrile | ESD-891111-250MG |
| Cas.: 330792-69-3 | Purity: 97% | 2-(Methoxy(4-phenoxyphenyl)methylene)malononitrile | ESD-891111-1G |
| Cas.: 330792-69-3 | Purity: 97% | 2-(Methoxy(4-phenoxyphenyl)methylene)malononitrile | ESD-891111-5G |
| Cas.: 330792-69-3 | Purity: 97% | 2-(Methoxy(4-phenoxyphenyl)methylene)malononitrile | ESD-891111-10G |
| Cas.: 4793-24-2 | Purity: 95% | 2-Chloro-4-fluoro-5-sulfamoylbenzoic acid | ESD-891112-250MG |
| Cas.: 4793-24-2 | Purity: 95% | 2-Chloro-4-fluoro-5-sulfamoylbenzoic acid | ESD-891112-1G |
| Cas.: 4793-24-2 | Purity: 95% | 2-Chloro-4-fluoro-5-sulfamoylbenzoic acid | ESD-891112-5G |
| Cas.: 4793-24-2 | Purity: 95% | 2-Chloro-4-fluoro-5-sulfamoylbenzoic acid | ESD-891112-25G |
| Cas.: 138084-65-8 | Purity: 97% | 4-Amino-6-chloropyridin-3-ol | ESD-891113-100MG |
| Cas.: 138084-65-8 | Purity: 97% | 4-Amino-6-chloropyridin-3-ol | ESD-891113-250MG |
| Cas.: 918321-18-3 | Purity: 97% | Methyl 2,4-diamino-3-fluoro-5-nitrobenzoate | ESD-891114-100MG |
| Cas.: 918321-18-3 | Purity: 97% | Methyl 2,4-diamino-3-fluoro-5-nitrobenzoate | ESD-891114-250MG |
| Cas.: 918321-18-3 | Purity: 97% | Methyl 2,4-diamino-3-fluoro-5-nitrobenzoate | ESD-891114-1G |
| Cas.: 1032903-63-1 | Purity: 97% | tert-Butyl 4-(4-amino-5-isopropoxy-2-methylphenyl)piperidine-1-carboxylate | ESD-891115-250MG |
| Cas.: 1032903-63-1 | Purity: 97% | tert-Butyl 4-(4-amino-5-isopropoxy-2-methylphenyl)piperidine-1-carboxylate | ESD-891115-1G |
| Cas.: 1032903-63-1 | Purity: 97% | tert-Butyl 4-(4-amino-5-isopropoxy-2-methylphenyl)piperidine-1-carboxylate | ESD-891115-5G |
| Cas.: 228718-48-7 | Purity: 97% | N,N-Bis(4-chlorophenyl)-2,4-dimethylaniline | ESD-891116-250MG |
| Cas.: 228718-48-7 | Purity: 97% | N,N-Bis(4-chlorophenyl)-2,4-dimethylaniline | ESD-891116-1G |
| Cas.: 348640-02-8 | Purity: 97% | 1-Tosyl-1H-pyrrolo[2,3-b]pyridine | ESD-891117-250MG |
| Cas.: 348640-02-8 | Purity: 97% | 1-Tosyl-1H-pyrrolo[2,3-b]pyridine | ESD-891117-1G |
| Cas.: 348640-02-8 | Purity: 97% | 1-Tosyl-1H-pyrrolo[2,3-b]pyridine | ESD-891117-5G |
| Cas.: 348640-02-8 | Purity: 97% | 1-Tosyl-1H-pyrrolo[2,3-b]pyridine | ESD-891117-10G |
| Cas.: 877060-60-1 | Purity: ≥95% | tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate | ESD-891118-100MG |
| Cas.: 877060-60-1 | Purity: ≥95% | tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate | ESD-891118-250MG |
| Cas.: 877060-60-1 | Purity: ≥95% | tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[3,2-c]pyridine-1-carboxylate | ESD-891118-1G |
| Cas.: 81470-51-1 | Purity: 97% | Z-Pyr-OtBu | ESD-891119-250MG |
| Cas.: 81470-51-1 | Purity: 97% | Z-Pyr-OtBu | ESD-891119-1G |
| Cas.: 81470-51-1 | Purity: 97% | Z-Pyr-OtBu | ESD-891119-5G |
| Cas.: 1083326-26-4 | Purity: 97% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3-sulfonamide | ESD-891120-100MG |
| Cas.: 1083326-26-4 | Purity: 97% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-3-sulfonamide | ESD-891120-250MG |
| Cas.: 357913-53-2 | Purity: ≥95% | 3-(Methylsulfonyl)propyl methanesulfonate | ESD-891121-100MG |
| Cas.: 357913-53-2 | Purity: ≥95% | 3-(Methylsulfonyl)propyl methanesulfonate | ESD-891121-250MG |
| Cas.: 357913-53-2 | Purity: ≥95% | 3-(Methylsulfonyl)propyl methanesulfonate | ESD-891121-1G |
| Cas.: 357913-53-2 | Purity: ≥95% | 3-(Methylsulfonyl)propyl methanesulfonate | ESD-891121-5G |
| Cas.: 10177-08-9 | Purity: ≥95% | 2-Oxo-5-phenyl-1,2-dihydropyridine-3-carboxylic acid | ESD-891122-1G |
| Cas.: 10177-08-9 | Purity: ≥95% | 2-Oxo-5-phenyl-1,2-dihydropyridine-3-carboxylic acid | ESD-891122-5G |
| Cas.: 769069-96-7 | Purity: 97% | (3-(2-Aminophenyl)-1H-pyrazol-5-yl)methanol | ESD-891123-100MG |
| Cas.: 769069-96-7 | Purity: 97% | (3-(2-Aminophenyl)-1H-pyrazol-5-yl)methanol | ESD-891123-250MG |
| Cas.: 769069-96-7 | Purity: 97% | (3-(2-Aminophenyl)-1H-pyrazol-5-yl)methanol | ESD-891123-1G |
| Cas.: 165617-59-4 | Purity: ≥95% | 4,8-Dibromobenzo[1,2-c:4,5-c’]bis([1,2,5]thiadiazole) | ESD-891124-100MG |
| Cas.: 165617-59-4 | Purity: ≥95% | 4,8-Dibromobenzo[1,2-c:4,5-c’]bis([1,2,5]thiadiazole) | ESD-891124-250MG |
| Cas.: 165617-59-4 | Purity: ≥95% | 4,8-Dibromobenzo[1,2-c:4,5-c’]bis([1,2,5]thiadiazole) | ESD-891124-1G |
| Cas.: 131860-97-4 | Purity: 97% | (E)-Methyl 2-(2-((6-chloropyrimidin-4-yl)oxy)phenyl)-3-methoxyacrylate | ESD-891125-5G |
| Cas.: 131860-97-4 | Purity: 97% | (E)-Methyl 2-(2-((6-chloropyrimidin-4-yl)oxy)phenyl)-3-methoxyacrylate | ESD-891125-10G |
| Cas.: 131860-97-4 | Purity: 97% | (E)-Methyl 2-(2-((6-chloropyrimidin-4-yl)oxy)phenyl)-3-methoxyacrylate | ESD-891125-25G |
| Cas.: 148516-11-4 | Purity: 97% | Ethyl 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carboxylate | ESD-891126-250MG |
| Cas.: 148516-11-4 | Purity: 97% | Ethyl 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carboxylate | ESD-891126-1G |
| Cas.: 148516-11-4 | Purity: 97% | Ethyl 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carboxylate | ESD-891126-5G |
| Cas.: 148516-11-4 | Purity: 97% | Ethyl 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carboxylate | ESD-891126-10G |
| Cas.: 13074-06-1 | Purity: 97% | (2R,3S,4R,5S)-Hexane-1,2,3,4,5-pentaol | ESD-891127-100MG |
| Cas.: 13074-06-1 | Purity: 97% | (2R,3S,4R,5S)-Hexane-1,2,3,4,5-pentaol | ESD-891127-250MG |
| Cas.: 13074-06-1 | Purity: 97% | (2R,3S,4R,5S)-Hexane-1,2,3,4,5-pentaol | ESD-891127-1G |
| Cas.: 28721-09-7 | Purity: 97% | 10-Methoxy-5H-dibenzo[b,f]azepine-5-carboxamide | ESD-891128-250MG |
| Cas.: 28721-09-7 | Purity: 97% | 10-Methoxy-5H-dibenzo[b,f]azepine-5-carboxamide | ESD-891128-1G |
| Cas.: 28721-09-7 | Purity: 97% | 10-Methoxy-5H-dibenzo[b,f]azepine-5-carboxamide | ESD-891128-5G |
| Cas.: 1375301-90-8 | Purity: 97% | 3-Bromo-1,7-naphthyridin-8(7H)-one | ESD-891129-100MG |
| Cas.: 1375301-90-8 | Purity: 97% | 3-Bromo-1,7-naphthyridin-8(7H)-one | ESD-891129-250MG |
| Cas.: 1375301-90-8 | Purity: 97% | 3-Bromo-1,7-naphthyridin-8(7H)-one | ESD-891129-1G |
| Cas.: 1375301-90-8 | Purity: 97% | 3-Bromo-1,7-naphthyridin-8(7H)-one | ESD-891129-5G |
| Cas.: 134612-84-3 | Purity: ≥95% | (4-Chlorophenyl)(3,4-dihydroxyphenyl)methanone | ESD-891130-250MG |
| Cas.: 134612-84-3 | Purity: ≥95% | (4-Chlorophenyl)(3,4-dihydroxyphenyl)methanone | ESD-891130-1G |
| Cas.: 134612-84-3 | Purity: ≥95% | (4-Chlorophenyl)(3,4-dihydroxyphenyl)methanone | ESD-891130-5G |
| Cas.: 20303-31-5 | Purity: ≥95% | Benzyl 4-(3-methoxy-3-oxopropyl)-3,5-dimethyl-1H-pyrrole-2-carboxylate | ESD-891131-250MG |
| Cas.: 20303-31-5 | Purity: ≥95% | Benzyl 4-(3-methoxy-3-oxopropyl)-3,5-dimethyl-1H-pyrrole-2-carboxylate | ESD-891131-1G |
| Cas.: 20303-31-5 | Purity: ≥95% | Benzyl 4-(3-methoxy-3-oxopropyl)-3,5-dimethyl-1H-pyrrole-2-carboxylate | ESD-891131-5G |
| Cas.: 141721-97-3 | Purity: 97% | 5-Isopropyl-4-nitro-1H-pyrazole-3-carboxylic acid | ESD-891132-250MG |
| Cas.: 141721-97-3 | Purity: 97% | 5-Isopropyl-4-nitro-1H-pyrazole-3-carboxylic acid | ESD-891132-1G |
| Cas.: 141721-97-3 | Purity: 97% | 5-Isopropyl-4-nitro-1H-pyrazole-3-carboxylic acid | ESD-891132-5G |
| Cas.: 50390-76-6 | Purity: 97% | 2-Methoxy-5-(methylsulfonyl)benzoic acid | ESD-891133-1G |
| Cas.: 50390-76-6 | Purity: 97% | 2-Methoxy-5-(methylsulfonyl)benzoic acid | ESD-891133-5G |
| Cas.: 50390-76-6 | Purity: 97% | 2-Methoxy-5-(methylsulfonyl)benzoic acid | ESD-891133-10G |
| Cas.: 50390-76-6 | Purity: 97% | 2-Methoxy-5-(methylsulfonyl)benzoic acid | ESD-891133-25G |
| Cas.: 6322-07-2 | Purity: 97% | (3R,4S,5S)-5-((R)-1,2-Dihydroxyethyl)-3,4-dihydroxydihydrofuran-2(3H)-one | ESD-891134-1G |
| Cas.: 6322-07-2 | Purity: 97% | (3R,4S,5S)-5-((R)-1,2-Dihydroxyethyl)-3,4-dihydroxydihydrofuran-2(3H)-one | ESD-891134-5G |
| Cas.: 6322-07-2 | Purity: 97% | (3R,4S,5S)-5-((R)-1,2-Dihydroxyethyl)-3,4-dihydroxydihydrofuran-2(3H)-one | ESD-891134-10G |
| Cas.: 6322-07-2 | Purity: 97% | (3R,4S,5S)-5-((R)-1,2-Dihydroxyethyl)-3,4-dihydroxydihydrofuran-2(3H)-one | ESD-891134-25G |
| Cas.: 98589-46-9 | Purity: ≥95% | 5-Aminobenzo[b]thiophene-2-carboxylic acid | ESD-891135-100MG |
| Cas.: 98589-46-9 | Purity: ≥95% | 5-Aminobenzo[b]thiophene-2-carboxylic acid | ESD-891135-250MG |
| Cas.: 98589-46-9 | Purity: ≥95% | 5-Aminobenzo[b]thiophene-2-carboxylic acid | ESD-891135-1G |
| Cas.: 1122660-25-6 | Purity: 97% | 4-(5-(3-Hydroxyphenyl)thiophen-2-yl)-2-methylphenol | ESD-891136-100MG |
| Cas.: 1122660-25-6 | Purity: 97% | 4-(5-(3-Hydroxyphenyl)thiophen-2-yl)-2-methylphenol | ESD-891136-250MG |
| Cas.: 1122660-25-6 | Purity: 97% | 4-(5-(3-Hydroxyphenyl)thiophen-2-yl)-2-methylphenol | ESD-891136-1G |
| Cas.: 416885-42-2 | Purity: 97% | 2-(5-Nitropyridin-2-yl)-1,2,3,4-tetrahydroisoquinoline | ESD-891137-100MG |
| Cas.: 416885-42-2 | Purity: 97% | 2-(5-Nitropyridin-2-yl)-1,2,3,4-tetrahydroisoquinoline | ESD-891137-250MG |
| Cas.: 142770-42-1 | Purity: 97% | 1-Chloro-4-propoxy-9H-thioxanthen-9-one | ESD-891138-250MG |
| Cas.: 142770-42-1 | Purity: 97% | 1-Chloro-4-propoxy-9H-thioxanthen-9-one | ESD-891138-1G |
| Cas.: 142770-42-1 | Purity: 97% | 1-Chloro-4-propoxy-9H-thioxanthen-9-one | ESD-891138-5G |
| Cas.: 142770-42-1 | Purity: 97% | 1-Chloro-4-propoxy-9H-thioxanthen-9-one | ESD-891138-10G |
| Cas.: 376592-58-4 | Purity: 95% | 5′-Chloro-2′-hydroxy-3′-nitro-[1,1′-biphenyl]-3-carboxylic acid | ESD-891139-1G |
| Cas.: 376592-58-4 | Purity: 95% | 5′-Chloro-2′-hydroxy-3′-nitro-[1,1′-biphenyl]-3-carboxylic acid | ESD-891139-5G |
| Cas.: 376592-58-4 | Purity: 95% | 5′-Chloro-2′-hydroxy-3′-nitro-[1,1′-biphenyl]-3-carboxylic acid | ESD-891139-10G |
| Cas.: 1330624-42-4 | Purity: 97% | N-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine | ESD-891140-100MG |
| Cas.: 1330624-42-4 | Purity: 97% | N-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine | ESD-891140-250MG |
| Cas.: 685115-77-9 | Purity: ≥95% | 1-(3,5-Dichloropyridin-4-yl)piperidine-4-carboxamide | ESD-891141-100MG |
| Cas.: 685115-77-9 | Purity: ≥95% | 1-(3,5-Dichloropyridin-4-yl)piperidine-4-carboxamide | ESD-891141-250MG |
| Cas.: 14280-01-4 | Purity: 97% | (S)-Methyl 6-amino-2-benzamidohexanoate hydrochloride | ESD-891142-250MG |
| Cas.: 14280-01-4 | Purity: 97% | (S)-Methyl 6-amino-2-benzamidohexanoate hydrochloride | ESD-891142-1G |
| Cas.: 14280-01-4 | Purity: 97% | (S)-Methyl 6-amino-2-benzamidohexanoate hydrochloride | ESD-891142-5G |
| Cas.: 19152-36-4 | Purity: 97% | 3-(3,4-Dimethoxyphenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one | ESD-891143-1G |
| Cas.: 19152-36-4 | Purity: 97% | 3-(3,4-Dimethoxyphenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one | ESD-891143-5G |
| Cas.: 19152-36-4 | Purity: 97% | 3-(3,4-Dimethoxyphenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one | ESD-891143-10G |
| Cas.: 3670-59-5 | Purity: 97% | 6-Hydroxynicotinamide | ESD-891144-100MG |
| Cas.: 3670-59-5 | Purity: 97% | 6-Hydroxynicotinamide | ESD-891144-250MG |
| Cas.: 3670-59-5 | Purity: 97% | 6-Hydroxynicotinamide | ESD-891144-1G |
| Cas.: 63655-40-3 | Purity: ≥95% | 2-Amino-1H-benzo[d]imidazole-5-carbonitrile | ESD-891145-100MG |
| Cas.: 63655-40-3 | Purity: ≥95% | 2-Amino-1H-benzo[d]imidazole-5-carbonitrile | ESD-891145-250MG |
| Cas.: 63655-40-3 | Purity: ≥95% | 2-Amino-1H-benzo[d]imidazole-5-carbonitrile | ESD-891145-1G |
| Cas.: 1658467-36-7 | Purity: 97% | 4,6-Dichloro-3-iodo-1H-pyrazolo[4,3-c]pyridine | ESD-891146-100MG |
| Cas.: 1658467-36-7 | Purity: 97% | 4,6-Dichloro-3-iodo-1H-pyrazolo[4,3-c]pyridine | ESD-891146-250MG |
| Cas.: 1658467-36-7 | Purity: 97% | 4,6-Dichloro-3-iodo-1H-pyrazolo[4,3-c]pyridine | ESD-891146-1G |
| Cas.: 1658467-36-7 | Purity: 97% | 4,6-Dichloro-3-iodo-1H-pyrazolo[4,3-c]pyridine | ESD-891146-5G |
| Cas.: 889877-77-4 | Purity: 95% | (R)-2-Chloro-7-ethyl-8-isopropyl-7,8-dihydropteridin-6(5H)-one | ESD-891147-250MG |
| Cas.: 889877-77-4 | Purity: 95% | (R)-2-Chloro-7-ethyl-8-isopropyl-7,8-dihydropteridin-6(5H)-one | ESD-891147-1G |
| Cas.: 1352911-89-7 | Purity: ≥95% | (3H-Imidazo[4,5-b]pyridin-5-yl)methanol | ESD-891148-100MG |
| Cas.: 1352911-89-7 | Purity: ≥95% | (3H-Imidazo[4,5-b]pyridin-5-yl)methanol | ESD-891148-250MG |
| Cas.: 1228570-47-5 | Purity: 97% | (R)-2-(4-Bromophenyl)-2-((tert-butoxycarbonyl)amino)acetic acid | ESD-891149-100MG |
| Cas.: 1228570-47-5 | Purity: 97% | (R)-2-(4-Bromophenyl)-2-((tert-butoxycarbonyl)amino)acetic acid | ESD-891149-250MG |
| Cas.: 6258-28-2 | Purity: 97% | 2-(2,6-Dioxopiperidin-4-yl)acetic acid | ESD-891150-250MG |
| Cas.: 6258-28-2 | Purity: 97% | 2-(2,6-Dioxopiperidin-4-yl)acetic acid | ESD-891150-1G |
| Cas.: 6258-28-2 | Purity: 97% | 2-(2,6-Dioxopiperidin-4-yl)acetic acid | ESD-891150-5G |
| Cas.: 59084-72-9 | Purity: 97% | 5,6-Dimethoxyisoindolin-1-one | ESD-891151-100MG |
| Cas.: 59084-72-9 | Purity: 97% | 5,6-Dimethoxyisoindolin-1-one | ESD-891151-250MG |
| Cas.: 59084-72-9 | Purity: 97% | 5,6-Dimethoxyisoindolin-1-one | ESD-891151-1G |
| Cas.: 979-02-2 | Purity: 98% | 16-Dehydropregnenolone Acetate | ESD-891152-5G |
| Cas.: 979-02-2 | Purity: 98% | 16-Dehydropregnenolone Acetate | ESD-891152-25G |
| Cas.: 979-02-2 | Purity: 98% | 16-Dehydropregnenolone Acetate | ESD-891152-100G |
| Cas.: 2050-85-3 | Purity: 97% | N,N’-(1,2-Phenylene)diacetamide | ESD-891153-100MG |
| Cas.: 2050-85-3 | Purity: 97% | N,N’-(1,2-Phenylene)diacetamide | ESD-891153-250MG |
| Cas.: 2050-85-3 | Purity: 97% | N,N’-(1,2-Phenylene)diacetamide | ESD-891153-1G |
| Cas.: 2050-85-3 | Purity: 97% | N,N’-(1,2-Phenylene)diacetamide | ESD-891153-5G |
| Cas.: 1355249-29-4 | Purity: 97% | Ethyl 4-iodo-1-(4-methoxybenzyl)-1H-pyrazole-3-carboxylate | ESD-891154-100MG |
| Cas.: 1355249-29-4 | Purity: 97% | Ethyl 4-iodo-1-(4-methoxybenzyl)-1H-pyrazole-3-carboxylate | ESD-891154-250MG |
| Cas.: 896722-51-3 | Purity: ≥95% | 6-Methyl-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine | ESD-891155-100MG |
| Cas.: 896722-51-3 | Purity: ≥95% | 6-Methyl-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine | ESD-891155-250MG |
| Cas.: 301220-34-8 | Purity: ≥95% | 3-(1-Benzylpiperidin-4-yl)-3H-imidazo[4,5-b]pyridine | ESD-891156-100MG |
| Cas.: 301220-34-8 | Purity: ≥95% | 3-(1-Benzylpiperidin-4-yl)-3H-imidazo[4,5-b]pyridine | ESD-891156-250MG |
| Cas.: 27328-68-3 | Purity: 97% | 2-(5-Chloro-1H-indazol-3-yl)acetic acid | ESD-891157-250MG |
| Cas.: 27328-68-3 | Purity: 97% | 2-(5-Chloro-1H-indazol-3-yl)acetic acid | ESD-891157-1G |
| Cas.: 27328-68-3 | Purity: 97% | 2-(5-Chloro-1H-indazol-3-yl)acetic acid | ESD-891157-5G |
| Cas.: 27328-68-3 | Purity: 97% | 2-(5-Chloro-1H-indazol-3-yl)acetic acid | ESD-891157-10G |
| Cas.: 6270-46-8 | Purity: 97% | 5-Amino-6-methylpyrimidine-2,4-diol | ESD-891158-250MG |
| Cas.: 6270-46-8 | Purity: 97% | 5-Amino-6-methylpyrimidine-2,4-diol | ESD-891158-1G |
| Cas.: 6270-46-8 | Purity: 97% | 5-Amino-6-methylpyrimidine-2,4-diol | ESD-891158-5G |
| Cas.: 6270-46-8 | Purity: 97% | 5-Amino-6-methylpyrimidine-2,4-diol | ESD-891158-10G |
| Cas.: 957120-63-7 | Purity: 97% | 3-Borono-5-bromo-2-fluorobenzoic acid | ESD-891159-250MG |
| Cas.: 957120-63-7 | Purity: 97% | 3-Borono-5-bromo-2-fluorobenzoic acid | ESD-891159-1G |
| Cas.: 957120-63-7 | Purity: 97% | 3-Borono-5-bromo-2-fluorobenzoic acid | ESD-891159-5G |
| Cas.: 957120-63-7 | Purity: 97% | 3-Borono-5-bromo-2-fluorobenzoic acid | ESD-891159-10G |
| Cas.: 69651-48-5 | Purity: 97% | (S)-2-((tert-Butoxycarbonyl)amino)-2-(4-hydroxyphenyl)acetic acid | ESD-891160-250MG |
| Cas.: 69651-48-5 | Purity: 97% | (S)-2-((tert-Butoxycarbonyl)amino)-2-(4-hydroxyphenyl)acetic acid | ESD-891160-1G |
| Cas.: 69651-48-5 | Purity: 97% | (S)-2-((tert-Butoxycarbonyl)amino)-2-(4-hydroxyphenyl)acetic acid | ESD-891160-5G |
| Cas.: 69651-48-5 | Purity: 97% | (S)-2-((tert-Butoxycarbonyl)amino)-2-(4-hydroxyphenyl)acetic acid | ESD-891160-10G |
| Cas.: 1250996-70-3 | Purity: ≥95% | tert-Butyl 2-(hydroxymethyl)-5,6-dihydroimidazo[1,2-a]pyrazine-7(8H)-carboxylate | ESD-891161-100MG |
| Cas.: 1250996-70-3 | Purity: ≥95% | tert-Butyl 2-(hydroxymethyl)-5,6-dihydroimidazo[1,2-a]pyrazine-7(8H)-carboxylate | ESD-891161-250MG |
| Cas.: 112913-94-7 | Purity: ≥95% | N-((4-(4-Fluorobenzyl)morpholin-2-yl)methyl)acetamide | ESD-891162-5G |
| Cas.: 112913-94-7 | Purity: ≥95% | N-((4-(4-Fluorobenzyl)morpholin-2-yl)methyl)acetamide | ESD-891162-10G |
| Cas.: 112913-94-7 | Purity: ≥95% | N-((4-(4-Fluorobenzyl)morpholin-2-yl)methyl)acetamide | ESD-891162-25G |
| Cas.: 155666-33-4 | Purity: ≥98% | 2-Amino-4-(benzyloxy)-5-methoxybenzoic acid | ESD-891163-100MG |
| Cas.: 155666-33-4 | Purity: ≥98% | 2-Amino-4-(benzyloxy)-5-methoxybenzoic acid | ESD-891163-250MG |
| Cas.: 155666-33-4 | Purity: ≥98% | 2-Amino-4-(benzyloxy)-5-methoxybenzoic acid | ESD-891163-1G |
| Cas.: 846023-24-3 | Purity: 97% | 2-Cyano-N-(2,4-dichloro-5-methoxyphenyl)acetamide | ESD-891164-100MG |
| Cas.: 846023-24-3 | Purity: 97% | 2-Cyano-N-(2,4-dichloro-5-methoxyphenyl)acetamide | ESD-891164-250MG |
| Cas.: 846023-24-3 | Purity: 97% | 2-Cyano-N-(2,4-dichloro-5-methoxyphenyl)acetamide | ESD-891164-1G |
| Cas.: 1379324-53-4 | Purity: ≥95% | 5-Bromo-2-(methylsulfonyl)pyrimidin-4-amine | ESD-891165-100MG |
| Cas.: 1379324-53-4 | Purity: ≥95% | 5-Bromo-2-(methylsulfonyl)pyrimidin-4-amine | ESD-891165-1G |
| Cas.: 1380679-97-9 | Purity: ≥95% | 5-tert-Butyl 4-ethyl 3-methyl-6,7-dihydro-3H-imidazo[4,5-c]pyridine-4,5(4H)-dicarboxylate | ESD-891166-100MG |
| Cas.: 1380679-97-9 | Purity: ≥95% | 5-tert-Butyl 4-ethyl 3-methyl-6,7-dihydro-3H-imidazo[4,5-c]pyridine-4,5(4H)-dicarboxylate | ESD-891166-250MG |
| Cas.: 220616-68-2 | Purity: ≥95% | 2,6-Dibromopyridin-4-ol | ESD-891167-250MG |
| Cas.: 959581-21-6 | Purity: ≥95% | (2S,4R)-1-(tert-Butoxycarbonyl)-4-(4-methylbenzyl)pyrrolidine-2-carboxylic acid | ESD-891168-100MG |
| Cas.: 959581-21-6 | Purity: ≥95% | (2S,4R)-1-(tert-Butoxycarbonyl)-4-(4-methylbenzyl)pyrrolidine-2-carboxylic acid | ESD-891168-250MG |
| Cas.: 854382-06-2 | Purity: ≥95% | 2-((Pyridin-4-ylmethyl)amino)nicotinic acid | ESD-891169-250MG |
| Cas.: 854382-06-2 | Purity: ≥95% | 2-((Pyridin-4-ylmethyl)amino)nicotinic acid | ESD-891169-1G |
| Cas.: 864872-05-9 | Purity: ≥95% | 1-(4-Bromophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one | ESD-891170-250MG |
| Cas.: 864872-05-9 | Purity: ≥95% | 1-(4-Bromophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one | ESD-891170-1G |
| Cas.: 309964-23-6 | Purity: ≥95% | 4-(4-Formyl-3-methoxyphenoxy)butanoic acid | ESD-891171-250MG |
| Cas.: 309964-23-6 | Purity: ≥95% | 4-(4-Formyl-3-methoxyphenoxy)butanoic acid | ESD-891171-1G |
| Cas.: 309964-23-6 | Purity: ≥95% | 4-(4-Formyl-3-methoxyphenoxy)butanoic acid | ESD-891171-5G |
| Cas.: 864771-44-8 | Purity: ≥95% | tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole-1-carboxylate | ESD-891172-100MG |
| Cas.: 864771-44-8 | Purity: ≥95% | tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole-1-carboxylate | ESD-891172-250MG |
| Cas.: 864771-44-8 | Purity: ≥95% | tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole-1-carboxylate | ESD-891172-1G |
| Cas.: 864771-44-8 | Purity: ≥95% | tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole-1-carboxylate | ESD-891172-5G |
| Cas.: 1105039-93-7 | Purity: 97% | 1-(4-Methoxybenzyl)-1H-pyrazole-4-carboxylic acid | ESD-891173-100MG |
| Cas.: 1105039-93-7 | Purity: 97% | 1-(4-Methoxybenzyl)-1H-pyrazole-4-carboxylic acid | ESD-891173-250MG |
| Cas.: 1105039-93-7 | Purity: 97% | 1-(4-Methoxybenzyl)-1H-pyrazole-4-carboxylic acid | ESD-891173-1G |
| Cas.: 80076-47-7 | Purity: ≥95% | 8,9-Difluoro-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylic acid | ESD-891174-100MG |
| Cas.: 80076-47-7 | Purity: ≥95% | 8,9-Difluoro-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylic acid | ESD-891174-250MG |
| Cas.: 80076-47-7 | Purity: ≥95% | 8,9-Difluoro-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylic acid | ESD-891174-1G |
| Cas.: 162536-40-5 | Purity: 97% | tert-Butyl ((2S,3R)-4-chloro-3-hydroxy-1-phenylbutan-2-yl)carbamate | ESD-891175-250MG |
| Cas.: 162536-40-5 | Purity: 97% | tert-Butyl ((2S,3R)-4-chloro-3-hydroxy-1-phenylbutan-2-yl)carbamate | ESD-891175-1G |
| Cas.: 162536-40-5 | Purity: 97% | tert-Butyl ((2S,3R)-4-chloro-3-hydroxy-1-phenylbutan-2-yl)carbamate | ESD-891175-5G |
| Cas.: 165727-45-7 | Purity: ≥95% | tert-Butyl ((2S,3S)-4-chloro-3-hydroxy-1-phenylbutan-2-yl)carbamate | ESD-891176-250MG |
| Cas.: 165727-45-7 | Purity: ≥95% | tert-Butyl ((2S,3S)-4-chloro-3-hydroxy-1-phenylbutan-2-yl)carbamate | ESD-891176-1G |
| Cas.: 165727-45-7 | Purity: ≥95% | tert-Butyl ((2S,3S)-4-chloro-3-hydroxy-1-phenylbutan-2-yl)carbamate | ESD-891176-5G |
| Cas.: 65615-90-9 | Purity: 95% | Boc-Phe(4-NH2)-OMe | ESD-891177-100MG |
| Cas.: 65615-90-9 | Purity: 95% | Boc-Phe(4-NH2)-OMe | ESD-891177-250MG |
| Cas.: 462100-06-7 | Purity: 97% | 2,2-Dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azahexadecan-16-oic acid | ESD-891178-100MG |
| Cas.: 462100-06-7 | Purity: 97% | 2,2-Dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azahexadecan-16-oic acid | ESD-891178-250MG |
| Cas.: 462100-06-7 | Purity: 97% | 2,2-Dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azahexadecan-16-oic acid | ESD-891178-1G |
| Cas.: 462100-06-7 | Purity: 97% | 2,2-Dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azahexadecan-16-oic acid | ESD-891178-5G |
| Cas.: 433933-93-8 | Purity: ≥95% | 1-Benzylpyrrolidine-2,5-dicarboxylic acid | ESD-891179-100MG |
| Cas.: 433933-93-8 | Purity: ≥95% | 1-Benzylpyrrolidine-2,5-dicarboxylic acid | ESD-891179-250MG |
| Cas.: 433933-93-8 | Purity: ≥95% | 1-Benzylpyrrolidine-2,5-dicarboxylic acid | ESD-891179-1G |
| Cas.: 77544-68-4 | Purity: 95% | 2-(2-(2-Hydroxyethoxy)ethoxy)ethyl 4-methylbenzenesulfonate | ESD-891180-100MG |
| Cas.: 77544-68-4 | Purity: 95% | 2-(2-(2-Hydroxyethoxy)ethoxy)ethyl 4-methylbenzenesulfonate | ESD-891180-250MG |
| Cas.: 77544-68-4 | Purity: 95% | 2-(2-(2-Hydroxyethoxy)ethoxy)ethyl 4-methylbenzenesulfonate | ESD-891180-1G |
| Cas.: 77544-68-4 | Purity: 95% | 2-(2-(2-Hydroxyethoxy)ethoxy)ethyl 4-methylbenzenesulfonate | ESD-891180-5G |
| Cas.: 131184-89-9 | Purity: 95% | 1-(5-(((2-Cyanoethyl)thio)methyl)thiazol-2-yl)guanidine | ESD-891181-250MG |
| Cas.: 131184-89-9 | Purity: 95% | 1-(5-(((2-Cyanoethyl)thio)methyl)thiazol-2-yl)guanidine | ESD-891181-1G |
| Cas.: 877397-70-1 | Purity: 97% | (R)-3-(1-(2,6-Dichloro-3-fluorophenyl)ethoxy)-2-nitropyridine | ESD-891182-100MG |
| Cas.: 877397-70-1 | Purity: 97% | (R)-3-(1-(2,6-Dichloro-3-fluorophenyl)ethoxy)-2-nitropyridine | ESD-891182-250MG |
| Cas.: 877397-70-1 | Purity: 97% | (R)-3-(1-(2,6-Dichloro-3-fluorophenyl)ethoxy)-2-nitropyridine | ESD-891182-1G |
| Cas.: 1931-44-8 | Purity: 97% | 7-Amino-1,8-naphthyridin-2(8H)-one | ESD-891184-100MG |
| Cas.: 1931-44-8 | Purity: 97% | 7-Amino-1,8-naphthyridin-2(8H)-one | ESD-891184-250MG |
| Cas.: 1931-44-8 | Purity: 97% | 7-Amino-1,8-naphthyridin-2(8H)-one | ESD-891184-1G |
| Cas.: 1931-44-8 | Purity: 97% | 7-Amino-1,8-naphthyridin-2(8H)-one | ESD-891184-5G |
| Cas.: 871700-22-0 | Purity: 97% | 3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-6-(methylamino)pyrimidine-2,4(1H,3H)-dione | ESD-891185-100MG |
| Cas.: 871700-22-0 | Purity: 97% | 3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-6-(methylamino)pyrimidine-2,4(1H,3H)-dione | ESD-891185-250MG |
| Cas.: 871700-22-0 | Purity: 97% | 3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-6-(methylamino)pyrimidine-2,4(1H,3H)-dione | ESD-891185-1G |
| Cas.: 871700-22-0 | Purity: 97% | 3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-6-(methylamino)pyrimidine-2,4(1H,3H)-dione | ESD-891185-5G |
| Cas.: 236750-65-5 | Purity: 97% | 4,5-Bis(2-methoxyethoxy)-2-nitrobenzonitrile | ESD-891186-5G |
| Cas.: 236750-65-5 | Purity: 97% | 4,5-Bis(2-methoxyethoxy)-2-nitrobenzonitrile | ESD-891186-10G |
| Cas.: 236750-65-5 | Purity: 97% | 4,5-Bis(2-methoxyethoxy)-2-nitrobenzonitrile | ESD-891186-25G |
| Cas.: 79098-75-2 | Purity: ≥95% | 3-Piperidin-4-yl-3,4-dihydro-1H-quinazolin-2-one | ESD-891187-100MG |
| Cas.: 79098-75-2 | Purity: ≥95% | 3-Piperidin-4-yl-3,4-dihydro-1H-quinazolin-2-one | ESD-891187-250MG |
| Cas.: 79098-75-2 | Purity: ≥95% | 3-Piperidin-4-yl-3,4-dihydro-1H-quinazolin-2-one | ESD-891187-1G |
| Cas.: 79098-75-2 | Purity: ≥95% | 3-Piperidin-4-yl-3,4-dihydro-1H-quinazolin-2-one | ESD-891187-5G |
| Cas.: 210962-44-0 | Purity: ≥95% | tert-Butyl 4-(4-(ethoxycarbonyl)phenoxy)piperidine-1-carboxylate | ESD-891188-100MG |
| Cas.: 210962-44-0 | Purity: ≥95% | tert-Butyl 4-(4-(ethoxycarbonyl)phenoxy)piperidine-1-carboxylate | ESD-891188-250MG |
| Cas.: 210962-44-0 | Purity: ≥95% | tert-Butyl 4-(4-(ethoxycarbonyl)phenoxy)piperidine-1-carboxylate | ESD-891188-1G |
| Cas.: 1020056-98-7 | Purity: 97% | 2,3-Dibromoisonicotinic acid | ESD-891189-100MG |
| Cas.: 1020056-98-7 | Purity: 97% | 2,3-Dibromoisonicotinic acid | ESD-891189-250MG |
| Cas.: 1020056-98-7 | Purity: 97% | 2,3-Dibromoisonicotinic acid | ESD-891189-1G |
| Cas.: 1020056-98-7 | Purity: 97% | 2,3-Dibromoisonicotinic acid | ESD-891189-5G |
| Cas.: 67073-39-6 | Purity: ≥95% | 4-Chloro-5-nitrobenzene-1,2-diamine | ESD-891190-250MG |
| Cas.: 67073-39-6 | Purity: ≥95% | 4-Chloro-5-nitrobenzene-1,2-diamine | ESD-891190-1G |
| Cas.: 67073-39-6 | Purity: ≥95% | 4-Chloro-5-nitrobenzene-1,2-diamine | ESD-891190-5G |
| Cas.: 67073-39-6 | Purity: ≥95% | 4-Chloro-5-nitrobenzene-1,2-diamine | ESD-891190-10G |
| Cas.: 886366-46-7 | Purity: ≥95% | Methyl 2-(4-bromobenzyl)-3-((tert-butoxycarbonyl)amino)propanoate | ESD-891191-100MG |
| Cas.: 886366-46-7 | Purity: ≥95% | Methyl 2-(4-bromobenzyl)-3-((tert-butoxycarbonyl)amino)propanoate | ESD-891191-250MG |
| Cas.: 1034305-11-7 | Purity: 97% | Benzo[b]thiophen-2-yl(5-bromo-2-fluorophenyl)methanol | ESD-891192-100MG |
| Cas.: 1034305-11-7 | Purity: 97% | Benzo[b]thiophen-2-yl(5-bromo-2-fluorophenyl)methanol | ESD-891192-250MG |
| Cas.: 1034305-11-7 | Purity: 97% | Benzo[b]thiophen-2-yl(5-bromo-2-fluorophenyl)methanol | ESD-891192-1G |
| Cas.: 1034305-11-7 | Purity: 97% | Benzo[b]thiophen-2-yl(5-bromo-2-fluorophenyl)methanol | ESD-891192-5G |
| Cas.: 23148-51-8 | Purity: 97% | 6-(4-Chlorophenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile | ESD-891193-250MG |
| Cas.: 23148-51-8 | Purity: 97% | 6-(4-Chlorophenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile | ESD-891193-1G |
| Cas.: 23148-51-8 | Purity: 97% | 6-(4-Chlorophenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile | ESD-891193-5G |
| Cas.: 23148-51-8 | Purity: 97% | 6-(4-Chlorophenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile | ESD-891193-10G |
| Cas.: 170449-18-0 | Purity: ≥95% | AG 1478 hydrochloride | ESD-891194-100MG |
| Cas.: 170449-18-0 | Purity: ≥95% | AG 1478 hydrochloride | ESD-891194-250MG |
| Cas.: 3655-05-8 | Purity: 98% | Boc-Gly-ONp | ESD-891195-1G |
| Cas.: 3655-05-8 | Purity: 98% | Boc-Gly-ONp | ESD-891195-5G |
| Cas.: 3655-05-8 | Purity: 98% | Boc-Gly-ONp | ESD-891195-10G |
| Cas.: 1375303-15-3 | Purity: ≥95% | 2-(1-Benzhydrylazetidin-3-yl)propane-1,3-diol | ESD-891196-100MG |
| Cas.: 1375303-15-3 | Purity: ≥95% | 2-(1-Benzhydrylazetidin-3-yl)propane-1,3-diol | ESD-891196-250MG |
| Cas.: 1375303-15-3 | Purity: ≥95% | 2-(1-Benzhydrylazetidin-3-yl)propane-1,3-diol | ESD-891196-1G |
| Cas.: 1670-85-5 | Purity: 97% | 1H-Indole-3-carboxamide | ESD-891197-250MG |
| Cas.: 1670-85-5 | Purity: 97% | 1H-Indole-3-carboxamide | ESD-891197-1G |
| Cas.: 1670-85-5 | Purity: 97% | 1H-Indole-3-carboxamide | ESD-891197-5G |
| Cas.: 1670-85-5 | Purity: 97% | 1H-Indole-3-carboxamide | ESD-891197-10G |
| Cas.: 287494-03-5 | Purity: 97% | (5-(Pyridin-3-yl)-1H-pyrazol-3-yl)methanol | ESD-891198-100MG |
| Cas.: 287494-03-5 | Purity: 97% | (5-(Pyridin-3-yl)-1H-pyrazol-3-yl)methanol | ESD-891198-250MG |
| Cas.: 287494-03-5 | Purity: 97% | (5-(Pyridin-3-yl)-1H-pyrazol-3-yl)methanol | ESD-891198-1G |
| Cas.: 13450-77-6 | Purity: ≥95% | 2-(4-Chlorobenzamido)acetic acid | ESD-891199-100MG |
| Cas.: 13450-77-6 | Purity: ≥95% | 2-(4-Chlorobenzamido)acetic acid | ESD-891199-250MG |
| Cas.: 13450-77-6 | Purity: ≥95% | 2-(4-Chlorobenzamido)acetic acid | ESD-891199-1G |
| Cas.: 13450-77-6 | Purity: ≥95% | 2-(4-Chlorobenzamido)acetic acid | ESD-891199-5G |
| Cas.: 775304-60-4 | Purity: 97% | Methyl 3-(5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl)benzoate | ESD-891200-100MG |
| Cas.: 775304-60-4 | Purity: 97% | Methyl 3-(5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl)benzoate | ESD-891200-250MG |
| Cas.: 775304-60-4 | Purity: 97% | Methyl 3-(5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl)benzoate | ESD-891200-1G |
| Cas.: 22958-64-1 | Purity: 97% | 2-(4-Sulfamoylphenyl)acetic acid | ESD-891201-100MG |
| Cas.: 22958-64-1 | Purity: 97% | 2-(4-Sulfamoylphenyl)acetic acid | ESD-891201-250MG |
| Cas.: 22958-64-1 | Purity: 97% | 2-(4-Sulfamoylphenyl)acetic acid | ESD-891201-1G |
| Cas.: 22958-64-1 | Purity: 97% | 2-(4-Sulfamoylphenyl)acetic acid | ESD-891201-5G |
| Cas.: 339539-81-0 | Purity: 97% | (R)-3-Benzyl-1-(tert-butoxycarbonyl)piperidine-3-carboxylic acid | ESD-891202-250MG |
| Cas.: 339539-81-0 | Purity: 97% | (R)-3-Benzyl-1-(tert-butoxycarbonyl)piperidine-3-carboxylic acid | ESD-891202-1G |
| Cas.: 339539-81-0 | Purity: 97% | (R)-3-Benzyl-1-(tert-butoxycarbonyl)piperidine-3-carboxylic acid | ESD-891202-5G |
| Cas.: 339539-81-0 | Purity: 97% | (R)-3-Benzyl-1-(tert-butoxycarbonyl)piperidine-3-carboxylic acid | ESD-891202-10G |
| Cas.: 5434-29-7 | Purity: ≥95% | 3,5-Dimethyl-1H-pyrrole-2,4-dicarboxylic acid | ESD-891203-100MG |
| Cas.: 5434-29-7 | Purity: ≥95% | 3,5-Dimethyl-1H-pyrrole-2,4-dicarboxylic acid | ESD-891203-250MG |
| Cas.: 5434-29-7 | Purity: ≥95% | 3,5-Dimethyl-1H-pyrrole-2,4-dicarboxylic acid | ESD-891203-1G |
| Cas.: 167010-30-2 | Purity: 97% | (S)-N-((3-(3,5-Difluorophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide | ESD-891204-100MG |
| Cas.: 167010-30-2 | Purity: 97% | (S)-N-((3-(3,5-Difluorophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide | ESD-891204-250MG |
| Cas.: 179688-27-8 | Purity: 97% | Ethyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate | ESD-891205-250MG |
| Cas.: 179688-27-8 | Purity: 97% | Ethyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate | ESD-891205-1G |
| Cas.: 179688-27-8 | Purity: 97% | Ethyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate | ESD-891205-5G |
| Cas.: 179688-27-8 | Purity: 97% | Ethyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate | ESD-891205-10G |
| Cas.: 38024-35-0 | Purity: ≥95% | 4-Aminocinnoline-3-carboxamide | ESD-891206-100MG |
| Cas.: 38024-35-0 | Purity: ≥95% | 4-Aminocinnoline-3-carboxamide | ESD-891206-250MG |
| Cas.: 1346674-23-4 | Purity: 95% | 7,7-Dimethyl-2,3,4,6,7,8-hexahydro-1H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1-one | ESD-891207-100MG |
| Cas.: 1346674-23-4 | Purity: 95% | 7,7-Dimethyl-2,3,4,6,7,8-hexahydro-1H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1-one | ESD-891207-250MG |
| Cas.: 1346674-23-4 | Purity: 95% | 7,7-Dimethyl-2,3,4,6,7,8-hexahydro-1H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1-one | ESD-891207-1G |
| Cas.: 1346674-23-4 | Purity: 95% | 7,7-Dimethyl-2,3,4,6,7,8-hexahydro-1H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1-one | ESD-891207-5G |
| Cas.: 1228547-87-2 | Purity: ≥95% | (S)-2-(2-Bromophenyl)-2-((tert-butoxycarbonyl)amino)acetic acid | ESD-891208-100MG |
| Cas.: 1228547-87-2 | Purity: ≥95% | (S)-2-(2-Bromophenyl)-2-((tert-butoxycarbonyl)amino)acetic acid | ESD-891208-250MG |
| Cas.: 36323-92-9 | Purity: 95% | 2-Chloro-9-methyl-3H-purin-6(9H)-one | ESD-891209-100MG |
| Cas.: 36323-92-9 | Purity: 95% | 2-Chloro-9-methyl-3H-purin-6(9H)-one | ESD-891209-250MG |
| Cas.: 243-28-7 | Purity: ≥95% | 5H-Benzo[b]carbazole | ESD-891210-100MG |
| Cas.: 243-28-7 | Purity: ≥95% | 5H-Benzo[b]carbazole | ESD-891210-250MG |
| Cas.: 243-28-7 | Purity: ≥95% | 5H-Benzo[b]carbazole | ESD-891210-1G |
| Cas.: 227940-70-7 | Purity: ≥95% | tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate | ESD-891211-250MG |
| Cas.: 227940-70-7 | Purity: ≥95% | tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate | ESD-891211-1G |
| Cas.: 227940-70-7 | Purity: ≥95% | tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate | ESD-891211-5G |
| Cas.: 227940-70-7 | Purity: ≥95% | tert-Butyl 7-benzyl-9-oxo-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate | ESD-891211-10G |
| Cas.: 860515-97-5 | Purity: 97% | 4-(4-Bromophenoxy)benzenesulfonamide | ESD-891212-100MG |
| Cas.: 860515-97-5 | Purity: 97% | 4-(4-Bromophenoxy)benzenesulfonamide | ESD-891212-250MG |
| Cas.: 860515-97-5 | Purity: 97% | 4-(4-Bromophenoxy)benzenesulfonamide | ESD-891212-1G |
| Cas.: 147266-79-3 | Purity: 97% | (2S,4S)-1-(tert-Butoxycarbonyl)-4-phenoxypyrrolidine-2-carboxylic acid | ESD-891213-250MG |
| Cas.: 147266-79-3 | Purity: 97% | (2S,4S)-1-(tert-Butoxycarbonyl)-4-phenoxypyrrolidine-2-carboxylic acid | ESD-891213-1G |
| Cas.: 147266-79-3 | Purity: 97% | (2S,4S)-1-(tert-Butoxycarbonyl)-4-phenoxypyrrolidine-2-carboxylic acid | ESD-891213-5G |
| Cas.: 1211594-25-0 | Purity: 97% | 4-Bromo-1H-indole-7-carboxylic acid | ESD-891214-100MG |
| Cas.: 1211594-25-0 | Purity: 97% | 4-Bromo-1H-indole-7-carboxylic acid | ESD-891214-250MG |
| Cas.: 1211594-25-0 | Purity: 97% | 4-Bromo-1H-indole-7-carboxylic acid | ESD-891214-1G |
| Cas.: 2050-48-8 | Purity: 97% | 4,4′-Sulfonylbis(bromobenzene) | ESD-891215-250MG |
| Cas.: 2050-48-8 | Purity: 97% | 4,4′-Sulfonylbis(bromobenzene) | ESD-891215-1G |
| Cas.: 2050-48-8 | Purity: 97% | 4,4′-Sulfonylbis(bromobenzene) | ESD-891215-5G |
| Cas.: 2050-48-8 | Purity: 97% | 4,4′-Sulfonylbis(bromobenzene) | ESD-891215-10G |
| Cas.: 29976-82-7 | Purity: 97% | 1-(2-Hydroxy-5-methylphenyl)-3-phenylpropane-1,3-dione | ESD-891216-100MG |
| Cas.: 29976-82-7 | Purity: 97% | 1-(2-Hydroxy-5-methylphenyl)-3-phenylpropane-1,3-dione | ESD-891216-250MG |
| Cas.: 1284966-16-0 | Purity: 97% | Benzyl 3-((tert-butoxycarbonyl)(methyl)amino)piperidine-1-carboxylate | ESD-891217-100MG |
| Cas.: 1284966-16-0 | Purity: 97% | Benzyl 3-((tert-butoxycarbonyl)(methyl)amino)piperidine-1-carboxylate | ESD-891217-250MG |
| Cas.: 870281-86-0 | Purity: ≥95% | (S)-2-(1-Aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one | ESD-891218-100MG |
| Cas.: 870281-86-0 | Purity: ≥95% | (S)-2-(1-Aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one | ESD-891218-250MG |
| Cas.: 870281-86-0 | Purity: ≥95% | (S)-2-(1-Aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one | ESD-891218-1G |
| Cas.: 75903-58-1 | Purity: ≥95% | 6-Aminopyridine-2-sulfonamide | ESD-891219-250MG |
| Cas.: 75903-58-1 | Purity: ≥95% | 6-Aminopyridine-2-sulfonamide | ESD-891219-1G |
| Cas.: 99295-79-1 | Purity: ≥95% | (R)-2-Amino-3-(5-methyl-1H-indol-3-yl)propanoic acid | ESD-891220-100MG |
| Cas.: 99295-79-1 | Purity: ≥95% | (R)-2-Amino-3-(5-methyl-1H-indol-3-yl)propanoic acid | ESD-891220-250MG |
| Cas.: 321983-19-1 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-3-phenylpiperidine-2-carboxylic acid | ESD-891221-100MG |
| Cas.: 321983-19-1 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-3-phenylpiperidine-2-carboxylic acid | ESD-891221-250MG |
| Cas.: 57639-16-4 | Purity: ≥95% | 5-Bromo-3-phenyl-1H-indazole | ESD-891222-100MG |
| Cas.: 57639-16-4 | Purity: ≥95% | 5-Bromo-3-phenyl-1H-indazole | ESD-891222-250MG |
| Cas.: 632-24-6 | Purity: 97% | 2-(Sulfamoylamino)benzoic acid | ESD-891223-100MG |
| Cas.: 632-24-6 | Purity: 97% | 2-(Sulfamoylamino)benzoic acid | ESD-891223-250MG |
| Cas.: 632-24-6 | Purity: 97% | 2-(Sulfamoylamino)benzoic acid | ESD-891223-1G |
| Cas.: 3336-43-4 | Purity: 98% | 1-Chloroisoquinolin-4-ol | ESD-891224-100MG |
| Cas.: 3336-43-4 | Purity: 98% | 1-Chloroisoquinolin-4-ol | ESD-891224-250MG |
| Cas.: 3336-43-4 | Purity: 98% | 1-Chloroisoquinolin-4-ol | ESD-891224-1G |
| Cas.: 893441-86-6 | Purity: ≥95% | tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate | ESD-891225-100MG |
| Cas.: 893441-86-6 | Purity: ≥95% | tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate | ESD-891225-250MG |
| Cas.: 893441-86-6 | Purity: ≥95% | tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate | ESD-891225-1G |
| Cas.: 893441-86-6 | Purity: ≥95% | tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate | ESD-891225-5G |
| Cas.: 914306-50-6 | Purity: ≥95% | 1-(2,6-Diisopropylphenyl)-2-phenyl-1H-imidazole | ESD-891226-100MG |
| Cas.: 914306-50-6 | Purity: ≥95% | 1-(2,6-Diisopropylphenyl)-2-phenyl-1H-imidazole | ESD-891226-250MG |
| Cas.: 217-68-5 | Purity: 97% | Dibenzo[f,h]quinoxaline | ESD-891227-250MG |
| Cas.: 217-68-5 | Purity: 97% | Dibenzo[f,h]quinoxaline | ESD-891227-1G |
| Cas.: 217-68-5 | Purity: 97% | Dibenzo[f,h]quinoxaline | ESD-891227-5G |
| Cas.: 217-68-5 | Purity: 97% | Dibenzo[f,h]quinoxaline | ESD-891227-10G |
| Cas.: 740081-22-5 | Purity: 97% | 4-((3-Chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl acetate | ESD-891228-100MG |
| Cas.: 740081-22-5 | Purity: 97% | 4-((3-Chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl acetate | ESD-891228-250MG |
| Cas.: 740081-22-5 | Purity: 97% | 4-((3-Chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl acetate | ESD-891228-1G |
| Cas.: 1175272-80-6 | Purity: 97% | 7-Chloroisoquinolin-3(2H)-one | ESD-891229-100MG |
| Cas.: 1175272-80-6 | Purity: 97% | 7-Chloroisoquinolin-3(2H)-one | ESD-891229-250MG |
| Cas.: 1175272-80-6 | Purity: 97% | 7-Chloroisoquinolin-3(2H)-one | ESD-891229-1G |
| Cas.: 178388-79-9 | Purity: ≥95% | 3-(1H-Imidazol-2-yl)propanoic acid | ESD-891230-250MG |
| Cas.: 178388-79-9 | Purity: ≥95% | 3-(1H-Imidazol-2-yl)propanoic acid | ESD-891230-1G |
| Cas.: 35317-80-7 | Purity: ≥95% | Thiazolo[4,5-h]isoquinolin-2-amine | ESD-891231-100MG |
| Cas.: 35317-80-7 | Purity: ≥95% | Thiazolo[4,5-h]isoquinolin-2-amine | ESD-891231-250MG |
| Cas.: 35317-80-7 | Purity: ≥95% | Thiazolo[4,5-h]isoquinolin-2-amine | ESD-891231-1G |
| Cas.: 1954-45-6 | Purity: 95% | 2-Amino-3-(4-methyl-1H-indol-3-yl)propanoic acid | ESD-891232-100MG |
| Cas.: 1954-45-6 | Purity: 95% | 2-Amino-3-(4-methyl-1H-indol-3-yl)propanoic acid | ESD-891232-250MG |
| Cas.: 1954-45-6 | Purity: 95% | 2-Amino-3-(4-methyl-1H-indol-3-yl)propanoic acid | ESD-891232-1G |
| Cas.: 1132910-79-2 | Purity: ≥95% | tert-Butyl (2-(5-(trifluoromethyl)-1H-indol-3-yl)ethyl)carbamate | ESD-891233-100MG |
| Cas.: 1132910-79-2 | Purity: ≥95% | tert-Butyl (2-(5-(trifluoromethyl)-1H-indol-3-yl)ethyl)carbamate | ESD-891233-250MG |
| Cas.: 56762-93-7 | Purity: ≥95% | (S)-Methyl 2-(((benzyloxy)carbonyl)amino)-4-(methylthio)butanoate | ESD-891234-250MG |
| Cas.: 56762-93-7 | Purity: ≥95% | (S)-Methyl 2-(((benzyloxy)carbonyl)amino)-4-(methylthio)butanoate | ESD-891234-1G |
| Cas.: 56762-93-7 | Purity: ≥95% | (S)-Methyl 2-(((benzyloxy)carbonyl)amino)-4-(methylthio)butanoate | ESD-891234-5G |
| Cas.: 58327-75-6 | Purity: 95% | 3-Aminothieno[2,3-b]pyridine-2-carboxylic acid | ESD-891235-100MG |
| Cas.: 58327-75-6 | Purity: 95% | 3-Aminothieno[2,3-b]pyridine-2-carboxylic acid | ESD-891235-250MG |
| Cas.: 58327-75-6 | Purity: 95% | 3-Aminothieno[2,3-b]pyridine-2-carboxylic acid | ESD-891235-1G |
| Cas.: 58327-75-6 | Purity: 95% | 3-Aminothieno[2,3-b]pyridine-2-carboxylic acid | ESD-891235-5G |
| Cas.: 6633-36-9 | Purity: 97% | 3,5-Diamino-4-methylbenzoic acid | ESD-891236-250MG |
| Cas.: 6633-36-9 | Purity: 97% | 3,5-Diamino-4-methylbenzoic acid | ESD-891236-1G |
| Cas.: 6633-36-9 | Purity: 97% | 3,5-Diamino-4-methylbenzoic acid | ESD-891236-5G |
| Cas.: 6633-36-9 | Purity: 97% | 3,5-Diamino-4-methylbenzoic acid | ESD-891236-10G |
| Cas.: 1206979-28-3 | Purity: 96% | Methyl 3-bromo-1H-pyrazolo[4,3-c]pyridine-6-carboxylate | ESD-891237-100MG |
| Cas.: 1206979-28-3 | Purity: 96% | Methyl 3-bromo-1H-pyrazolo[4,3-c]pyridine-6-carboxylate | ESD-891237-250MG |
| Cas.: 1206979-28-3 | Purity: 96% | Methyl 3-bromo-1H-pyrazolo[4,3-c]pyridine-6-carboxylate | ESD-891237-1G |
| Cas.: 71856-54-7 | Purity: ≥95% | 5-Amino-1-(2-bromophenyl)-1H-pyrazole-4-carbonitrile | ESD-891238-100MG |
| Cas.: 71856-54-7 | Purity: ≥95% | 5-Amino-1-(2-bromophenyl)-1H-pyrazole-4-carbonitrile | ESD-891238-250MG |
| Cas.: 71856-54-7 | Purity: ≥95% | 5-Amino-1-(2-bromophenyl)-1H-pyrazole-4-carbonitrile | ESD-891238-1G |
| Cas.: 71856-54-7 | Purity: ≥95% | 5-Amino-1-(2-bromophenyl)-1H-pyrazole-4-carbonitrile | ESD-891238-5G |
| Cas.: 23255-59-6 | Purity: 95% | 2-Hydroxy-6-(4-hydroxyphenethyl)benzoic acid | ESD-891239-50MG |
| Cas.: 70015-76-8 | Purity: 97% | Ethyl 4-amino-3-phenyl-1H-pyrazole-5-carboxylate | ESD-891240-100MG |
| Cas.: 70015-76-8 | Purity: 97% | Ethyl 4-amino-3-phenyl-1H-pyrazole-5-carboxylate | ESD-891240-250MG |
| Cas.: 5174-90-3 | Purity: ≥95% | Ethyl 2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylate | ESD-891241-250MG |
| Cas.: 5174-90-3 | Purity: ≥95% | Ethyl 2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylate | ESD-891241-1G |
| Cas.: 5174-90-3 | Purity: ≥95% | Ethyl 2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylate | ESD-891241-5G |
| Cas.: 91371-12-9 | Purity: ≥99% | 4,4′-Dibromo-2,2′-dinitro-1,1′-biphenyl | ESD-891242-250MG |
| Cas.: 91371-12-9 | Purity: ≥99% | 4,4′-Dibromo-2,2′-dinitro-1,1′-biphenyl | ESD-891242-1G |
| Cas.: 91371-12-9 | Purity: ≥99% | 4,4′-Dibromo-2,2′-dinitro-1,1′-biphenyl | ESD-891242-5G |
| Cas.: 91371-12-9 | Purity: ≥99% | 4,4′-Dibromo-2,2′-dinitro-1,1′-biphenyl | ESD-891242-10G |
| Cas.: 65996-58-9 | Purity: 97% | 2-Amino-3H-pyrrolo[3,2-d]pyrimidin-4(5H)-one | ESD-891243-100MG |
| Cas.: 65996-58-9 | Purity: 97% | 2-Amino-3H-pyrrolo[3,2-d]pyrimidin-4(5H)-one | ESD-891243-250MG |
| Cas.: 65996-58-9 | Purity: 97% | 2-Amino-3H-pyrrolo[3,2-d]pyrimidin-4(5H)-one | ESD-891243-1G |
| Cas.: 84547-93-3 | Purity: ≥95% | 4-Bromo-5-nitro-1H-pyrazole-3-carboxylic acid | ESD-891244-100MG |
| Cas.: 84547-93-3 | Purity: ≥95% | 4-Bromo-5-nitro-1H-pyrazole-3-carboxylic acid | ESD-891244-250MG |
| Cas.: 84547-93-3 | Purity: ≥95% | 4-Bromo-5-nitro-1H-pyrazole-3-carboxylic acid | ESD-891244-1G |
| Cas.: 84547-93-3 | Purity: ≥95% | 4-Bromo-5-nitro-1H-pyrazole-3-carboxylic acid | ESD-891244-5G |
| Cas.: 21969-12-0 | Purity: 96% | (4-Bromophenyl)(4-nitrophenyl)sulfane | ESD-891245-100MG |
| Cas.: 21969-12-0 | Purity: 96% | (4-Bromophenyl)(4-nitrophenyl)sulfane | ESD-891245-250MG |
| Cas.: 21969-12-0 | Purity: 96% | (4-Bromophenyl)(4-nitrophenyl)sulfane | ESD-891245-1G |
| Cas.: 21969-12-0 | Purity: 96% | (4-Bromophenyl)(4-nitrophenyl)sulfane | ESD-891245-5G |
| Cas.: 849440-33-1 | Purity: 97% | Boc-Phe(3,5-Me)-OH | ESD-891246-100MG |
| Cas.: 849440-33-1 | Purity: 97% | Boc-Phe(3,5-Me)-OH | ESD-891246-250MG |
| Cas.: 1256789-55-5 | Purity: ≥95% | 2-Bromo-5-methoxyisonicotinic acid | ESD-891247-100MG |
| Cas.: 1256789-55-5 | Purity: ≥95% | 2-Bromo-5-methoxyisonicotinic acid | ESD-891247-250MG |
| Cas.: 330794-35-9 | Purity: 95% | tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzylcarbamate | ESD-891248-250MG |
| Cas.: 330794-35-9 | Purity: 95% | tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzylcarbamate | ESD-891248-1G |
| Cas.: 330794-35-9 | Purity: 95% | tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzylcarbamate | ESD-891248-5G |
| Cas.: 330794-35-9 | Purity: 95% | tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzylcarbamate | ESD-891248-10G |
| Cas.: 1002726-59-1 | Purity: 97% | 2,2-Dimethyl-6-nitro-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one | ESD-891249-100MG |
| Cas.: 1002726-59-1 | Purity: 97% | 2,2-Dimethyl-6-nitro-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one | ESD-891249-250MG |
| Cas.: 1002726-59-1 | Purity: 97% | 2,2-Dimethyl-6-nitro-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one | ESD-891249-1G |
| Cas.: 1002726-59-1 | Purity: 97% | 2,2-Dimethyl-6-nitro-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one | ESD-891249-5G |
| Cas.: 98700-53-9 | Purity: ≥95% | 1,5-Diphenyl-1H-pyrazole-4-carboxylic acid | ESD-891250-100MG |
| Cas.: 98700-53-9 | Purity: ≥95% | 1,5-Diphenyl-1H-pyrazole-4-carboxylic acid | ESD-891250-250MG |
| Cas.: 1227270-79-2 | Purity: ≥95% | Methyl 5-chloro-3-iodo-1H-indazole-6-carboxylate | ESD-891251-100MG |
| Cas.: 1227270-79-2 | Purity: ≥95% | Methyl 5-chloro-3-iodo-1H-indazole-6-carboxylate | ESD-891251-250MG |
| Cas.: 1227270-79-2 | Purity: ≥95% | Methyl 5-chloro-3-iodo-1H-indazole-6-carboxylate | ESD-891251-1G |
| Cas.: 1431-40-9 | Purity: 97% | 2-(Methylthio)pyrimidine-4,5,6-triamine | ESD-891252-100MG |
| Cas.: 1431-40-9 | Purity: 97% | 2-(Methylthio)pyrimidine-4,5,6-triamine | ESD-891252-250MG |
| Cas.: 3469-20-3 | Purity: 97% | 2,3-Diphenyl-1H-indole | ESD-891253-250MG |
| Cas.: 3469-20-3 | Purity: 97% | 2,3-Diphenyl-1H-indole | ESD-891253-1G |
| Cas.: 3469-20-3 | Purity: 97% | 2,3-Diphenyl-1H-indole | ESD-891253-5G |
| Cas.: 3469-20-3 | Purity: 97% | 2,3-Diphenyl-1H-indole | ESD-891253-10G |
| Cas.: 155960-91-1 | Purity: ≥95% | Ethyl 3,4-dihydro-4-oxoquinazoline-6-carboxylate | ESD-891254-100MG |
| Cas.: 155960-91-1 | Purity: ≥95% | Ethyl 3,4-dihydro-4-oxoquinazoline-6-carboxylate | ESD-891254-250MG |
| Cas.: 155960-91-1 | Purity: ≥95% | Ethyl 3,4-dihydro-4-oxoquinazoline-6-carboxylate | ESD-891254-1G |
| Cas.: 155960-91-1 | Purity: ≥95% | Ethyl 3,4-dihydro-4-oxoquinazoline-6-carboxylate | ESD-891254-5G |
| Cas.: 61032-42-6 | Purity: 95% | Methyl 2-amino-4-(benzyloxy)-5-methoxybenzoate | ESD-891255-100MG |
| Cas.: 61032-42-6 | Purity: 95% | Methyl 2-amino-4-(benzyloxy)-5-methoxybenzoate | ESD-891255-250MG |
| Cas.: 61032-42-6 | Purity: 95% | Methyl 2-amino-4-(benzyloxy)-5-methoxybenzoate | ESD-891255-1G |
| Cas.: 61032-42-6 | Purity: 95% | Methyl 2-amino-4-(benzyloxy)-5-methoxybenzoate | ESD-891255-5G |
| Cas.: 7730-20-3 | Purity: ≥95% | 2-Amino-3-(6-fluoro-1H-indol-3-yl)propanoic acid | ESD-891256-100MG |
| Cas.: 7730-20-3 | Purity: ≥95% | 2-Amino-3-(6-fluoro-1H-indol-3-yl)propanoic acid | ESD-891256-250MG |
| Cas.: 7730-20-3 | Purity: ≥95% | 2-Amino-3-(6-fluoro-1H-indol-3-yl)propanoic acid | ESD-891256-1G |
| Cas.: 25631-05-4 | Purity: 97% | 2-Amino-3-(4-fluoro-1H-indol-3-yl)propanoic acid | ESD-891257-100MG |
| Cas.: 25631-05-4 | Purity: 97% | 2-Amino-3-(4-fluoro-1H-indol-3-yl)propanoic acid | ESD-891257-250MG |
| Cas.: 25631-05-4 | Purity: 97% | 2-Amino-3-(4-fluoro-1H-indol-3-yl)propanoic acid | ESD-891257-1G |
| Cas.: 16626-02-1 | Purity: ≥98% | (S)-2-Amino-3-(5-fluoro-1H-indol-3-yl)propanoic acid | ESD-891258-100MG |
| Cas.: 16626-02-1 | Purity: ≥98% | (S)-2-Amino-3-(5-fluoro-1H-indol-3-yl)propanoic acid | ESD-891258-250MG |
| Cas.: 16626-02-1 | Purity: ≥98% | (S)-2-Amino-3-(5-fluoro-1H-indol-3-yl)propanoic acid | ESD-891258-1G |
| Cas.: 53314-95-7 | Purity: 97% | 2-Amino-3-(7-fluoro-1H-indol-3-yl)propanoic acid | ESD-891259-100MG |
| Cas.: 53314-95-7 | Purity: 97% | 2-Amino-3-(7-fluoro-1H-indol-3-yl)propanoic acid | ESD-891259-250MG |
| Cas.: 864754-21-2 | Purity: ≥95% | 3-((4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)methyl)pyridine | ESD-891260-100MG |
| Cas.: 864754-21-2 | Purity: ≥95% | 3-((4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)methyl)pyridine | ESD-891260-250MG |
| Cas.: 864754-21-2 | Purity: ≥95% | 3-((4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)methyl)pyridine | ESD-891260-1G |
| Cas.: 864754-21-2 | Purity: ≥95% | 3-((4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)methyl)pyridine | ESD-891260-5G |
| Cas.: 78892-28-1 | Purity: 95% | (2,6-Dimethylphenyl)(1H-imidazol-4-yl)methanol | ESD-891261-100MG |
| Cas.: 78892-28-1 | Purity: 95% | (2,6-Dimethylphenyl)(1H-imidazol-4-yl)methanol | ESD-891261-250MG |
| Cas.: 19350-66-4 | Purity: 97% | 3,5-Bis(ethoxycarbonyl)-2,6-dimethyl-1,4-dihydropyridine-4-carboxylic acid | ESD-891262-100MG |
| Cas.: 19350-66-4 | Purity: 97% | 3,5-Bis(ethoxycarbonyl)-2,6-dimethyl-1,4-dihydropyridine-4-carboxylic acid | ESD-891262-250MG |
| Cas.: 59830-60-3 | Purity: ≥95% | (S)-Benzyl (1-oxo-3-phenylpropan-2-yl)carbamate | ESD-891263-100MG |
| Cas.: 59830-60-3 | Purity: ≥95% | (S)-Benzyl (1-oxo-3-phenylpropan-2-yl)carbamate | ESD-891263-250MG |
| Cas.: 59830-60-3 | Purity: ≥95% | (S)-Benzyl (1-oxo-3-phenylpropan-2-yl)carbamate | ESD-891263-1G |
| Cas.: 59830-60-3 | Purity: ≥95% | (S)-Benzyl (1-oxo-3-phenylpropan-2-yl)carbamate | ESD-891263-5G |
| Cas.: 885519-92-6 | Purity: ≥95% | 3-Bromo-6-chloro-4-nitro-1H-indazole | ESD-891264-100MG |
| Cas.: 885519-92-6 | Purity: ≥95% | 3-Bromo-6-chloro-4-nitro-1H-indazole | ESD-891264-250MG |
| Cas.: 885519-92-6 | Purity: ≥95% | 3-Bromo-6-chloro-4-nitro-1H-indazole | ESD-891264-1G |
| Cas.: 2001080-85-7 | Purity: 97% | (4-Formyl-3,5-dimethoxyphenyl)boronic acid | ESD-891265-250MG |
| Cas.: 2001080-85-7 | Purity: 97% | (4-Formyl-3,5-dimethoxyphenyl)boronic acid | ESD-891265-1G |
| Cas.: 6322-83-4 | Purity: 97% | 2-(4-Benzoylphenoxy)acetic acid | ESD-891266-100MG |
| Cas.: 6322-83-4 | Purity: 97% | 2-(4-Benzoylphenoxy)acetic acid | ESD-891266-250MG |
| Cas.: 6322-83-4 | Purity: 97% | 2-(4-Benzoylphenoxy)acetic acid | ESD-891266-1G |
| Cas.: 6322-83-4 | Purity: 97% | 2-(4-Benzoylphenoxy)acetic acid | ESD-891266-5G |
| Cas.: 6968-22-5 | Purity: ≥95% | 3-Amino-4-nitrobenzoic acid | ESD-891267-250MG |
| Cas.: 6968-22-5 | Purity: ≥95% | 3-Amino-4-nitrobenzoic acid | ESD-891267-1G |
| Cas.: 6968-22-5 | Purity: ≥95% | 3-Amino-4-nitrobenzoic acid | ESD-891267-5G |
| Cas.: 6968-22-5 | Purity: ≥95% | 3-Amino-4-nitrobenzoic acid | ESD-891267-10G |
| Cas.: 917364-11-5 | Purity: 97% | 5,6,7,8-Tetrahydroimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-891268-250MG |
| Cas.: 28899-75-4 | Purity: ≥95% | 7-Chloro-1H-indole-2-carboxylic acid | ESD-891269-250MG |
| Cas.: 28899-75-4 | Purity: ≥95% | 7-Chloro-1H-indole-2-carboxylic acid | ESD-891269-1G |
| Cas.: 28899-75-4 | Purity: ≥95% | 7-Chloro-1H-indole-2-carboxylic acid | ESD-891269-5G |
| Cas.: 28899-75-4 | Purity: ≥95% | 7-Chloro-1H-indole-2-carboxylic acid | ESD-891269-10G |
| Cas.: 39547-16-5 | Purity: 95% | 3-(5-Methoxy-1H-indol-3-yl)propanoic acid | ESD-891270-100MG |
| Cas.: 39547-16-5 | Purity: 95% | 3-(5-Methoxy-1H-indol-3-yl)propanoic acid | ESD-891270-250MG |
| Cas.: 392326-81-7 | Purity: 97% | 4-(4-Bromophenyl)pyrimidin-2-amine | ESD-891271-100MG |
| Cas.: 392326-81-7 | Purity: 97% | 4-(4-Bromophenyl)pyrimidin-2-amine | ESD-891271-250MG |
| Cas.: 392326-81-7 | Purity: 97% | 4-(4-Bromophenyl)pyrimidin-2-amine | ESD-891271-1G |
| Cas.: 392326-81-7 | Purity: 97% | 4-(4-Bromophenyl)pyrimidin-2-amine | ESD-891271-5G |
| Cas.: 1818217-55-8 | Purity: 97% | 4-((3-Chloro-2,4-difluorophenyl)amino)-7-methoxyquinazolin-6-ol | ESD-891272-100MG |
| Cas.: 1818217-55-8 | Purity: 97% | 4-((3-Chloro-2,4-difluorophenyl)amino)-7-methoxyquinazolin-6-ol | ESD-891272-250MG |
| Cas.: 1818217-55-8 | Purity: 97% | 4-((3-Chloro-2,4-difluorophenyl)amino)-7-methoxyquinazolin-6-ol | ESD-891272-1G |
| Cas.: 190190-47-7 | Purity: 96% | (S)-3-((tert-Butoxycarbonyl)amino)-4-(thiophen-2-yl)butanoic acid | ESD-891273-100MG |
| Cas.: 190190-47-7 | Purity: 96% | (S)-3-((tert-Butoxycarbonyl)amino)-4-(thiophen-2-yl)butanoic acid | ESD-891273-250MG |
| Cas.: 190190-47-7 | Purity: 96% | (S)-3-((tert-Butoxycarbonyl)amino)-4-(thiophen-2-yl)butanoic acid | ESD-891273-1G |
| Cas.: 111669-25-1 | Purity: 97% | 1-Boc-4-(3-Aminopyridin-2-yl)piperazine | ESD-891274-250MG |
| Cas.: 111669-25-1 | Purity: 97% | 1-Boc-4-(3-Aminopyridin-2-yl)piperazine | ESD-891274-1G |
| Cas.: 111669-25-1 | Purity: 97% | 1-Boc-4-(3-Aminopyridin-2-yl)piperazine | ESD-891274-5G |
| Cas.: 111669-25-1 | Purity: 97% | 1-Boc-4-(3-Aminopyridin-2-yl)piperazine | ESD-891274-10G |
| Cas.: 33468-36-9 | Purity: 97% | (S)-2-Amino-3-(7-methyl-1H-indol-3-yl)propanoic acid | ESD-891275-100MG |
| Cas.: 33468-36-9 | Purity: 97% | (S)-2-Amino-3-(7-methyl-1H-indol-3-yl)propanoic acid | ESD-891275-250MG |
| Cas.: 1975-43-5 | Purity: 97% | 4-Nitro-1-naphthoic acid | ESD-891276-100MG |
| Cas.: 1975-43-5 | Purity: 97% | 4-Nitro-1-naphthoic acid | ESD-891276-250MG |
| Cas.: 475271-62-6 | Purity: 98% | 3-(Cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-hydroxybenzamide | ESD-891277-100MG |
| Cas.: 475271-62-6 | Purity: 98% | 3-(Cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-hydroxybenzamide | ESD-891277-250MG |
| Cas.: 475271-62-6 | Purity: 98% | 3-(Cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-hydroxybenzamide | ESD-891277-1G |
| Cas.: 886362-65-8 | Purity: 96% | 1-N-Cbz-Pyrrolidine-3-acetic acid | ESD-891278-100MG |
| Cas.: 886362-65-8 | Purity: 96% | 1-N-Cbz-Pyrrolidine-3-acetic acid | ESD-891278-250MG |
| Cas.: 886362-65-8 | Purity: 96% | 1-N-Cbz-Pyrrolidine-3-acetic acid | ESD-891278-1G |
| Cas.: 73257-49-5 | Purity: 97% | Dimethyl 4-(4-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | ESD-891279-250MG |
| Cas.: 73257-49-5 | Purity: 97% | Dimethyl 4-(4-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | ESD-891279-1G |
| Cas.: 73257-49-5 | Purity: 97% | Dimethyl 4-(4-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | ESD-891279-5G |
| Cas.: 73257-49-5 | Purity: 97% | Dimethyl 4-(4-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | ESD-891279-10G |
| Cas.: 127972-17-2 | Purity: 97% | (2-(Benzyloxy)-5-methylphenyl)boronic acid | ESD-891280-250MG |
| Cas.: 127972-17-2 | Purity: 97% | (2-(Benzyloxy)-5-methylphenyl)boronic acid | ESD-891280-1G |
| Cas.: 127972-17-2 | Purity: 97% | (2-(Benzyloxy)-5-methylphenyl)boronic acid | ESD-891280-5G |
| Cas.: 127972-17-2 | Purity: 97% | (2-(Benzyloxy)-5-methylphenyl)boronic acid | ESD-891280-10G |
| Cas.: 26807-73-8 | Purity: 97% | 1-Benzyl-1H-indol-5-amine | ESD-891281-100MG |
| Cas.: 26807-73-8 | Purity: 97% | 1-Benzyl-1H-indol-5-amine | ESD-891281-250MG |
| Cas.: 26807-73-8 | Purity: 97% | 1-Benzyl-1H-indol-5-amine | ESD-891281-1G |
| Cas.: 26807-73-8 | Purity: 97% | 1-Benzyl-1H-indol-5-amine | ESD-891281-5G |
| Cas.: 1454682-74-6 | Purity: 97% | 1-(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea | ESD-891282-100MG |
| Cas.: 1454682-74-6 | Purity: 97% | 1-(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea | ESD-891282-250MG |
| Cas.: 1454682-74-6 | Purity: 97% | 1-(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea | ESD-891282-1G |
| Cas.: 218451-34-4 | Purity: 97% | tert-Butyl 4-(4-chlorophenyl)-4-cyanopiperidine-1-carboxylate | ESD-891283-100MG |
| Cas.: 218451-34-4 | Purity: 97% | tert-Butyl 4-(4-chlorophenyl)-4-cyanopiperidine-1-carboxylate | ESD-891283-250MG |
| Cas.: 218451-34-4 | Purity: 97% | tert-Butyl 4-(4-chlorophenyl)-4-cyanopiperidine-1-carboxylate | ESD-891283-1G |
| Cas.: 391901-45-4 | Purity: 97% | (R)-2-((4-Aminophenethyl)amino)-1-phenylethanol | ESD-891284-250MG |
| Cas.: 391901-45-4 | Purity: 97% | (R)-2-((4-Aminophenethyl)amino)-1-phenylethanol | ESD-891284-1G |
| Cas.: 391901-45-4 | Purity: 97% | (R)-2-((4-Aminophenethyl)amino)-1-phenylethanol | ESD-891284-5G |
| Cas.: 213745-17-6 | Purity: 97% | 4-Chloro-7-cyclopentyl-5-iodo-7H-pyrrolo[2,3-d]pyrimidine | ESD-891285-250MG |
| Cas.: 213745-17-6 | Purity: 97% | 4-Chloro-7-cyclopentyl-5-iodo-7H-pyrrolo[2,3-d]pyrimidine | ESD-891285-1G |
| Cas.: 213745-17-6 | Purity: 97% | 4-Chloro-7-cyclopentyl-5-iodo-7H-pyrrolo[2,3-d]pyrimidine | ESD-891285-5G |
| Cas.: 213745-17-6 | Purity: 97% | 4-Chloro-7-cyclopentyl-5-iodo-7H-pyrrolo[2,3-d]pyrimidine | ESD-891285-10G |
| Cas.: 875318-46-0 | Purity: ≥95% | Ethyl 2-(4-(hydroxymethyl)piperidin-1-yl)pyrimidine-5-carboxylate | ESD-891286-100MG |
| Cas.: 875318-46-0 | Purity: ≥95% | Ethyl 2-(4-(hydroxymethyl)piperidin-1-yl)pyrimidine-5-carboxylate | ESD-891286-250MG |
| Cas.: 875318-46-0 | Purity: ≥95% | Ethyl 2-(4-(hydroxymethyl)piperidin-1-yl)pyrimidine-5-carboxylate | ESD-891286-1G |
| Cas.: 529508-58-5 | Purity: ≥95% | 1-(3-Fluorobenzyl)-5-nitro-1H-indazole | ESD-891287-250MG |
| Cas.: 529508-58-5 | Purity: ≥95% | 1-(3-Fluorobenzyl)-5-nitro-1H-indazole | ESD-891287-1G |
| Cas.: 24610-33-1 | Purity: ≥95% | 7-Methoxy-1H-indole-2-carboxylic acid | ESD-891288-100MG |
| Cas.: 24610-33-1 | Purity: ≥95% | 7-Methoxy-1H-indole-2-carboxylic acid | ESD-891288-250MG |
| Cas.: 24610-33-1 | Purity: ≥95% | 7-Methoxy-1H-indole-2-carboxylic acid | ESD-891288-1G |
| Cas.: 24610-33-1 | Purity: ≥95% | 7-Methoxy-1H-indole-2-carboxylic acid | ESD-891288-5G |
| Cas.: 60771-18-8 | Purity: ≥95% | 7-(Benzyloxy)-2,4-dichloro-6-methoxyquinazoline | ESD-891289-100MG |
| Cas.: 60771-18-8 | Purity: ≥95% | 7-(Benzyloxy)-2,4-dichloro-6-methoxyquinazoline | ESD-891289-250MG |
| Cas.: 885518-56-9 | Purity: ≥95% | Methyl 6-amino-1H-indazole-4-carboxylate | ESD-891290-100MG |
| Cas.: 885518-56-9 | Purity: ≥95% | Methyl 6-amino-1H-indazole-4-carboxylate | ESD-891290-250MG |
| Cas.: 885518-56-9 | Purity: ≥95% | Methyl 6-amino-1H-indazole-4-carboxylate | ESD-891290-1G |
| Cas.: 159768-57-7 | Purity: 97% | 5-Amino-1H-indole-3-carbonitrile | ESD-891291-100MG |
| Cas.: 159768-57-7 | Purity: 97% | 5-Amino-1H-indole-3-carbonitrile | ESD-891291-250MG |
| Cas.: 1208318-08-4 | Purity: ≥95% | Ethyl 7-(4-bromophenyl)-4,7-dioxoheptanoate | ESD-891292-100MG |
| Cas.: 1208318-08-4 | Purity: ≥95% | Ethyl 7-(4-bromophenyl)-4,7-dioxoheptanoate | ESD-891292-250MG |
| Cas.: 1208318-08-4 | Purity: ≥95% | Ethyl 7-(4-bromophenyl)-4,7-dioxoheptanoate | ESD-891292-1G |
| Cas.: 1208318-08-4 | Purity: ≥95% | Ethyl 7-(4-bromophenyl)-4,7-dioxoheptanoate | ESD-891292-5G |
| Cas.: 4228-66-4 | Purity: 97% | 3-(3,4-Dihydroxyphenyl)-2-oxopropanoic acid | ESD-891293-100MG |
| Cas.: 4228-66-4 | Purity: 97% | 3-(3,4-Dihydroxyphenyl)-2-oxopropanoic acid | ESD-891293-250MG |
| Cas.: 59767-13-4 | Purity: ≥95% | Setastine HCl | ESD-891294-250MG |
| Cas.: 59767-13-4 | Purity: ≥95% | Setastine HCl | ESD-891294-1G |
| Cas.: 17057-04-4 | Purity: 97% | 4-(2,5-Dioxo-2,5-dihydro-pyrrol-1-yl)-benzoicacid | ESD-891295-250MG |
| Cas.: 17057-04-4 | Purity: 97% | 4-(2,5-Dioxo-2,5-dihydro-pyrrol-1-yl)-benzoicacid | ESD-891295-1G |
| Cas.: 17057-04-4 | Purity: 97% | 4-(2,5-Dioxo-2,5-dihydro-pyrrol-1-yl)-benzoicacid | ESD-891295-5G |
| Cas.: 83883-26-5 | Purity: 97% | 4-((6-(Acryloyloxy)hexyl)oxy)benzoic acid | ESD-891296-250MG |
| Cas.: 83883-26-5 | Purity: 97% | 4-((6-(Acryloyloxy)hexyl)oxy)benzoic acid | ESD-891296-1G |
| Cas.: 83883-26-5 | Purity: 97% | 4-((6-(Acryloyloxy)hexyl)oxy)benzoic acid | ESD-891296-5G |
| Cas.: 83883-26-5 | Purity: 97% | 4-((6-(Acryloyloxy)hexyl)oxy)benzoic acid | ESD-891296-10G |
| Cas.: 337909-10-1 | Purity: ≥95% | Ethyl 1-formyl-4-oxo-4H-quinolizine-3-carboxylate | ESD-891297-100MG |
| Cas.: 337909-10-1 | Purity: ≥95% | Ethyl 1-formyl-4-oxo-4H-quinolizine-3-carboxylate | ESD-891297-250MG |
| Cas.: 959579-74-9 | Purity: ≥95% | (2S,4R)-1-(tert-Butoxycarbonyl)-4-(3-fluorobenzyl)pyrrolidine-2-carboxylic acid | ESD-891298-100MG |
| Cas.: 959579-74-9 | Purity: ≥95% | (2S,4R)-1-(tert-Butoxycarbonyl)-4-(3-fluorobenzyl)pyrrolidine-2-carboxylic acid | ESD-891298-250MG |
| Cas.: 959579-74-9 | Purity: ≥95% | (2S,4R)-1-(tert-Butoxycarbonyl)-4-(3-fluorobenzyl)pyrrolidine-2-carboxylic acid | ESD-891298-1G |
| Cas.: 933989-32-3 | Purity: ≥95% | 3-(Morpholine-4-sulfonyl)benzylamine | ESD-891299-100MG |
| Cas.: 933989-32-3 | Purity: ≥95% | 3-(Morpholine-4-sulfonyl)benzylamine | ESD-891299-250MG |
| Cas.: 933989-32-3 | Purity: ≥95% | 3-(Morpholine-4-sulfonyl)benzylamine | ESD-891299-1G |
| Cas.: 200575-16-2 | Purity: ≥95% | 5-(Chlorosulfonyl)-2-ethoxybenzoic acid | ESD-891300-250MG |
| Cas.: 200575-16-2 | Purity: ≥95% | 5-(Chlorosulfonyl)-2-ethoxybenzoic acid | ESD-891300-1G |
| Cas.: 200575-16-2 | Purity: ≥95% | 5-(Chlorosulfonyl)-2-ethoxybenzoic acid | ESD-891300-5G |
| Cas.: 200575-16-2 | Purity: ≥95% | 5-(Chlorosulfonyl)-2-ethoxybenzoic acid | ESD-891300-10G |
| Cas.: 193902-87-3 | Purity: ≥95% | tert-Butyl 4-(4-amino-2-(trifluoromethyl)phenyl)piperazine-1-carboxylate | ESD-891301-250MG |
| Cas.: 193902-87-3 | Purity: ≥95% | tert-Butyl 4-(4-amino-2-(trifluoromethyl)phenyl)piperazine-1-carboxylate | ESD-891301-1G |
| Cas.: 193902-87-3 | Purity: ≥95% | tert-Butyl 4-(4-amino-2-(trifluoromethyl)phenyl)piperazine-1-carboxylate | ESD-891301-5G |
| Cas.: 193902-87-3 | Purity: ≥95% | tert-Butyl 4-(4-amino-2-(trifluoromethyl)phenyl)piperazine-1-carboxylate | ESD-891301-10G |
| Cas.: 1380672-71-8 | Purity: 97% | N-(2-Chlorophenyl)-5-(methylsulfonyl)picolinamide | ESD-891302-100MG |
| Cas.: 1380672-71-8 | Purity: 97% | N-(2-Chlorophenyl)-5-(methylsulfonyl)picolinamide | ESD-891302-250MG |
| Cas.: 1380672-71-8 | Purity: 97% | N-(2-Chlorophenyl)-5-(methylsulfonyl)picolinamide | ESD-891302-1G |
| Cas.: 1072103-29-7 | Purity: ≥95% | 5-Morpholinopicolinic acid | ESD-891303-100MG |
| Cas.: 1072103-29-7 | Purity: ≥95% | 5-Morpholinopicolinic acid | ESD-891303-250MG |
| Cas.: 1072103-29-7 | Purity: ≥95% | 5-Morpholinopicolinic acid | ESD-891303-1G |
| Cas.: 833-47-6 | Purity: ≥95% | 5-(3-Nitrophenyl)-1,3,4-thiadiazol-2-amine | ESD-891304-1G |
| Cas.: 833-47-6 | Purity: ≥95% | 5-(3-Nitrophenyl)-1,3,4-thiadiazol-2-amine | ESD-891304-5G |
| Cas.: 833-47-6 | Purity: ≥95% | 5-(3-Nitrophenyl)-1,3,4-thiadiazol-2-amine | ESD-891304-10G |
| Cas.: 833-47-6 | Purity: ≥95% | 5-(3-Nitrophenyl)-1,3,4-thiadiazol-2-amine | ESD-891304-25G |
| Cas.: 25369-43-1 | Purity: 95% | 2-Oxoindoline-7-carboxylic acid | ESD-891305-100MG |
| Cas.: 25369-43-1 | Purity: 95% | 2-Oxoindoline-7-carboxylic acid | ESD-891305-250MG |
| Cas.: 25369-43-1 | Purity: 95% | 2-Oxoindoline-7-carboxylic acid | ESD-891305-1G |
| Cas.: 103986-22-7 | Purity: 95% | 2-(6-Methoxy-1H-indol-3-yl)acetic acid | ESD-891306-100MG |
| Cas.: 103986-22-7 | Purity: 95% | 2-(6-Methoxy-1H-indol-3-yl)acetic acid | ESD-891306-250MG |
| Cas.: 103986-22-7 | Purity: 95% | 2-(6-Methoxy-1H-indol-3-yl)acetic acid | ESD-891306-1G |
| Cas.: 103986-22-7 | Purity: 95% | 2-(6-Methoxy-1H-indol-3-yl)acetic acid | ESD-891306-5G |
| Cas.: 14771-77-8 | Purity: 97% | 3-Isopropylpiperazine-2,5-dione | ESD-891307-1G |
| Cas.: 14771-77-8 | Purity: 97% | 3-Isopropylpiperazine-2,5-dione | ESD-891307-5G |
| Cas.: 14771-77-8 | Purity: 97% | 3-Isopropylpiperazine-2,5-dione | ESD-891307-10G |
| Cas.: 7234-25-5 | Purity: 97% | Ethyl 4-Methyl-2-(methylthio)-5-pyrimidinecarboxylate | ESD-891308-100MG |
| Cas.: 7234-25-5 | Purity: 97% | Ethyl 4-Methyl-2-(methylthio)-5-pyrimidinecarboxylate | ESD-891308-250MG |
| Cas.: 7234-25-5 | Purity: 97% | Ethyl 4-Methyl-2-(methylthio)-5-pyrimidinecarboxylate | ESD-891308-1G |
| Cas.: 7234-25-5 | Purity: 97% | Ethyl 4-Methyl-2-(methylthio)-5-pyrimidinecarboxylate | ESD-891308-5G |
| Cas.: 1190305-94-2 | Purity: ≥95% | 4-Amino-1-(4-methoxyphenyl)-1H-pyrazole-3-carboxylic acid | ESD-891309-100MG |
| Cas.: 1190305-94-2 | Purity: ≥95% | 4-Amino-1-(4-methoxyphenyl)-1H-pyrazole-3-carboxylic acid | ESD-891309-250MG |
| Cas.: 298217-37-5 | Purity: ≥95% | 2-((5-Phenylpyrimidin-2-yl)amino)ethanol | ESD-891310-50MG |
| Cas.: 80466-56-4 | Purity: 95% | 2-Amino-5-nitropyrimidine-4,6-diol | ESD-891311-250MG |
| Cas.: 80466-56-4 | Purity: 95% | 2-Amino-5-nitropyrimidine-4,6-diol | ESD-891311-1G |
| Cas.: 38664-16-3 | Purity: 97% | 3-(4-(Ethoxycarbonyl)-5-methyl-1H-pyrrol-3-yl)propanoic acid | ESD-891312-100MG |
| Cas.: 38664-16-3 | Purity: 97% | 3-(4-(Ethoxycarbonyl)-5-methyl-1H-pyrrol-3-yl)propanoic acid | ESD-891312-250MG |
| Cas.: 38664-16-3 | Purity: 97% | 3-(4-(Ethoxycarbonyl)-5-methyl-1H-pyrrol-3-yl)propanoic acid | ESD-891312-1G |
| Cas.: 38664-16-3 | Purity: 97% | 3-(4-(Ethoxycarbonyl)-5-methyl-1H-pyrrol-3-yl)propanoic acid | ESD-891312-5G |
| Cas.: 88371-24-8 | Purity: ≥95% | 2-Oxo-1,2,3,4-tetrahydroquinoline-7-carboxylic acid | ESD-891313-100MG |
| Cas.: 88371-24-8 | Purity: ≥95% | 2-Oxo-1,2,3,4-tetrahydroquinoline-7-carboxylic acid | ESD-891313-250MG |
| Cas.: 88371-24-8 | Purity: ≥95% | 2-Oxo-1,2,3,4-tetrahydroquinoline-7-carboxylic acid | ESD-891313-1G |
| Cas.: 41292-43-7 | Purity: ≥95% | N-(6-Hydroxypyridin-3-yl)acetamide | ESD-891314-100MG |
| Cas.: 41292-43-7 | Purity: ≥95% | N-(6-Hydroxypyridin-3-yl)acetamide | ESD-891314-250MG |
| Cas.: 127474-54-8 | Purity: 97% | (R)-2-(((Benzyloxy)carbonyl)amino)pent-4-enoic acid | ESD-891315-100MG |
| Cas.: 127474-54-8 | Purity: 97% | (R)-2-(((Benzyloxy)carbonyl)amino)pent-4-enoic acid | ESD-891315-250MG |
| Cas.: 127474-54-8 | Purity: 97% | (R)-2-(((Benzyloxy)carbonyl)amino)pent-4-enoic acid | ESD-891315-1G |
| Cas.: 127474-54-8 | Purity: 97% | (R)-2-(((Benzyloxy)carbonyl)amino)pent-4-enoic acid | ESD-891315-5G |
| Cas.: 954137-48-5 | Purity: 97% | 5-Bromo-7,7-dimethyl-7H-benzo[c]fluorene | ESD-891316-100MG |
| Cas.: 954137-48-5 | Purity: 97% | 5-Bromo-7,7-dimethyl-7H-benzo[c]fluorene | ESD-891316-250MG |
| Cas.: 954137-48-5 | Purity: 97% | 5-Bromo-7,7-dimethyl-7H-benzo[c]fluorene | ESD-891316-1G |
| Cas.: 266360-56-9 | Purity: 97% | N-Acetyl-3-(2,6-difluorophenyl)-D-alanine | ESD-891317-250MG |
| Cas.: 266360-56-9 | Purity: 97% | N-Acetyl-3-(2,6-difluorophenyl)-D-alanine | ESD-891317-1G |
| Cas.: 266360-56-9 | Purity: 97% | N-Acetyl-3-(2,6-difluorophenyl)-D-alanine | ESD-891317-5G |
| Cas.: 266360-56-9 | Purity: 97% | N-Acetyl-3-(2,6-difluorophenyl)-D-alanine | ESD-891317-10G |
| Cas.: 112257-42-8 | Purity: ≥95% | Benzyl 3-((tert-butoxycarbonyl)amino)azetidine-1-carboxylate | ESD-891318-250MG |
| Cas.: 112257-42-8 | Purity: ≥95% | Benzyl 3-((tert-butoxycarbonyl)amino)azetidine-1-carboxylate | ESD-891318-1G |
| Cas.: 112257-42-8 | Purity: ≥95% | Benzyl 3-((tert-butoxycarbonyl)amino)azetidine-1-carboxylate | ESD-891318-5G |
| Cas.: 129993-47-1 | Purity: 97% | 1-Methyl-1H-imidazole-4-carboxamide | ESD-891319-1G |
| Cas.: 77215-55-5 | Purity: ≥95% | (S)-tert-Butyl 3-amino-2-(((benzyloxy)carbonyl)amino)propanoate | ESD-891320-100MG |
| Cas.: 77215-55-5 | Purity: ≥95% | (S)-tert-Butyl 3-amino-2-(((benzyloxy)carbonyl)amino)propanoate | ESD-891320-250MG |
| Cas.: 77215-55-5 | Purity: ≥95% | (S)-tert-Butyl 3-amino-2-(((benzyloxy)carbonyl)amino)propanoate | ESD-891320-1G |
| Cas.: 77215-55-5 | Purity: ≥95% | (S)-tert-Butyl 3-amino-2-(((benzyloxy)carbonyl)amino)propanoate | ESD-891320-5G |
| Cas.: 1427311-76-9 | Purity: ≥95% | (S)-1-(4-Iodo-5-methoxy-2-nitrophenyl)-2,2-dimethylpropan-1-ol | ESD-891321-100MG |
| Cas.: 1427311-76-9 | Purity: ≥95% | (S)-1-(4-Iodo-5-methoxy-2-nitrophenyl)-2,2-dimethylpropan-1-ol | ESD-891321-250MG |
| Cas.: 1256360-46-9 | Purity: 97% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1,2,3,6-tetrahydropyridine | ESD-891322-100MG |
| Cas.: 1256360-46-9 | Purity: 97% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1,2,3,6-tetrahydropyridine | ESD-891322-250MG |
| Cas.: 1256360-46-9 | Purity: 97% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1,2,3,6-tetrahydropyridine | ESD-891322-1G |
| Cas.: 313225-39-7 | Purity: ≥95% | N-Cyclohexyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | ESD-891323-100MG |
| Cas.: 313225-39-7 | Purity: ≥95% | N-Cyclohexyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | ESD-891323-250MG |
| Cas.: 313225-39-7 | Purity: ≥95% | N-Cyclohexyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | ESD-891323-1G |
| Cas.: 26586-27-6 | Purity: ≥95% | 3-Amino-4-(pipidin-1-yl)benzoic acid | ESD-891324-250MG |
| Cas.: 26586-27-6 | Purity: ≥95% | 3-Amino-4-(pipidin-1-yl)benzoic acid | ESD-891324-1G |
| Cas.: 26586-27-6 | Purity: ≥95% | 3-Amino-4-(pipidin-1-yl)benzoic acid | ESD-891324-5G |
| Cas.: 151378-81-3 | Purity: 97% | ZD-Ala-NH2 | ESD-891325-250MG |
| Cas.: 151378-81-3 | Purity: 97% | ZD-Ala-NH2 | ESD-891325-1G |
| Cas.: 151378-81-3 | Purity: 97% | ZD-Ala-NH2 | ESD-891325-5G |
| Cas.: 84520-67-2 | Purity: 97% | (2S,4R)-1-tert-Butyl 2-methyl 4-((methylsulfonyl)oxy)pyrrolidine-1,2-dicarboxylate | ESD-891326-100MG |
| Cas.: 84520-67-2 | Purity: 97% | (2S,4R)-1-tert-Butyl 2-methyl 4-((methylsulfonyl)oxy)pyrrolidine-1,2-dicarboxylate | ESD-891326-250MG |
| Cas.: 84520-67-2 | Purity: 97% | (2S,4R)-1-tert-Butyl 2-methyl 4-((methylsulfonyl)oxy)pyrrolidine-1,2-dicarboxylate | ESD-891326-1G |
| Cas.: 84520-67-2 | Purity: 97% | (2S,4R)-1-tert-Butyl 2-methyl 4-((methylsulfonyl)oxy)pyrrolidine-1,2-dicarboxylate | ESD-891326-5G |
| Cas.: 1015460-59-9 | Purity: 97% | 7-Bromo-5H-pyrido[4,3-b]indole | ESD-891327-100MG |
| Cas.: 1015460-59-9 | Purity: 97% | 7-Bromo-5H-pyrido[4,3-b]indole | ESD-891327-250MG |
| Cas.: 1015460-59-9 | Purity: 97% | 7-Bromo-5H-pyrido[4,3-b]indole | ESD-891327-1G |
| Cas.: 1015460-62-4 | Purity: 97% | 9-Bromo-5H-pyrido[4,3-b]indole | ESD-891328-100MG |
| Cas.: 1015460-62-4 | Purity: 97% | 9-Bromo-5H-pyrido[4,3-b]indole | ESD-891328-250MG |
| Cas.: 1612184-10-7 | Purity: 97% | 4-Chloro-6-(3-chloro-2-methylphenyl)pyrimidin-2-amine | ESD-891329-100MG |
| Cas.: 1612184-10-7 | Purity: 97% | 4-Chloro-6-(3-chloro-2-methylphenyl)pyrimidin-2-amine | ESD-891329-250MG |
| Cas.: 706806-60-2 | Purity: ≥95% | (R)-2-Benzyl-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid | ESD-891330-100MG |
| Cas.: 706806-60-2 | Purity: ≥95% | (R)-2-Benzyl-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid | ESD-891330-250MG |
| Cas.: 706806-60-2 | Purity: ≥95% | (R)-2-Benzyl-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid | ESD-891330-1G |
| Cas.: 706806-60-2 | Purity: ≥95% | (R)-2-Benzyl-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid | ESD-891330-5G |
| Cas.: 127559-33-5 | Purity: 97% | Boc-D-Serinol(Bzl) | ESD-891331-100MG |
| Cas.: 127559-33-5 | Purity: 97% | Boc-D-Serinol(Bzl) | ESD-891331-250MG |
| Cas.: 127559-33-5 | Purity: 97% | Boc-D-Serinol(Bzl) | ESD-891331-1G |
| Cas.: 127559-33-5 | Purity: 97% | Boc-D-Serinol(Bzl) | ESD-891331-5G |
| Cas.: 1264175-59-8 | Purity: ≥95% | (2-(Benzyloxy)-4-bromo-6-fluorophenyl)boronic acid | ESD-891332-100MG |
| Cas.: 1264175-59-8 | Purity: ≥95% | (2-(Benzyloxy)-4-bromo-6-fluorophenyl)boronic acid | ESD-891332-250MG |
| Cas.: 1264175-59-8 | Purity: ≥95% | (2-(Benzyloxy)-4-bromo-6-fluorophenyl)boronic acid | ESD-891332-1G |
| Cas.: 1231930-37-2 | Purity: ≥95% | 4-Fluoro-1-isopropyl-2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole | ESD-891333-100MG |
| Cas.: 1231930-37-2 | Purity: ≥95% | 4-Fluoro-1-isopropyl-2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole | ESD-891333-250MG |
| Cas.: 1231930-37-2 | Purity: ≥95% | 4-Fluoro-1-isopropyl-2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole | ESD-891333-1G |
| Cas.: 1231930-37-2 | Purity: ≥95% | 4-Fluoro-1-isopropyl-2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole | ESD-891333-5G |
| Cas.: 14464-15-4 | Purity: 97% | Methyl 2-(((benzyloxy)carbonyl)amino)-3-hydroxypropanoate | ESD-891334-1G |
| Cas.: 14464-15-4 | Purity: 97% | Methyl 2-(((benzyloxy)carbonyl)amino)-3-hydroxypropanoate | ESD-891334-5G |
| Cas.: 14464-15-4 | Purity: 97% | Methyl 2-(((benzyloxy)carbonyl)amino)-3-hydroxypropanoate | ESD-891334-10G |
| Cas.: 14464-15-4 | Purity: 97% | Methyl 2-(((benzyloxy)carbonyl)amino)-3-hydroxypropanoate | ESD-891334-25G |
| Cas.: 67592-40-9 | Purity: ≥95% | 3-Hydroxy-2-(pyridin-4-yl)-1H-inden-1-one | ESD-891335-100MG |
| Cas.: 67592-40-9 | Purity: ≥95% | 3-Hydroxy-2-(pyridin-4-yl)-1H-inden-1-one | ESD-891335-250MG |
| Cas.: 67592-40-9 | Purity: ≥95% | 3-Hydroxy-2-(pyridin-4-yl)-1H-inden-1-one | ESD-891335-1G |
| Cas.: 67592-40-9 | Purity: ≥95% | 3-Hydroxy-2-(pyridin-4-yl)-1H-inden-1-one | ESD-891335-5G |
| Cas.: 216955-75-8 | Purity: 97% | 6-(1H-Imidazol-1-yl)nicotinic acid | ESD-891336-250MG |
| Cas.: 216955-75-8 | Purity: 97% | 6-(1H-Imidazol-1-yl)nicotinic acid | ESD-891336-1G |
| Cas.: 216955-75-8 | Purity: 97% | 6-(1H-Imidazol-1-yl)nicotinic acid | ESD-891336-5G |
| Cas.: 848841-48-5 | Purity: 97% | (1-Chloroisoquinolin-4-yl)boronic acid | ESD-891337-100MG |
| Cas.: 848841-48-5 | Purity: 97% | (1-Chloroisoquinolin-4-yl)boronic acid | ESD-891337-250MG |
| Cas.: 848841-48-5 | Purity: 97% | (1-Chloroisoquinolin-4-yl)boronic acid | ESD-891337-1G |
| Cas.: 62176-31-2 | Purity: ≥95% | 2-(Benzyloxy)-5-bromobenzoic acid | ESD-891338-250MG |
| Cas.: 62176-31-2 | Purity: ≥95% | 2-(Benzyloxy)-5-bromobenzoic acid | ESD-891338-1G |
| Cas.: 62176-31-2 | Purity: ≥95% | 2-(Benzyloxy)-5-bromobenzoic acid | ESD-891338-5G |
| Cas.: 603-72-5 | Purity: ≥95% | 2H-Naphtho[1,8-cd]isothiazole 1,1-dioxide | ESD-891339-250MG |
| Cas.: 603-72-5 | Purity: ≥95% | 2H-Naphtho[1,8-cd]isothiazole 1,1-dioxide | ESD-891339-1G |
| Cas.: 82419-34-9 | Purity: 97% | Ethyl 9,10-difluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate | ESD-891340-100MG |
| Cas.: 82419-34-9 | Purity: 97% | Ethyl 9,10-difluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate | ESD-891340-250MG |
| Cas.: 106058-85-9 | Purity: 97% | 1-(1-Tosyl-1H-pyrrol-3-yl)ethanone | ESD-891341-250MG |
| Cas.: 106058-85-9 | Purity: 97% | 1-(1-Tosyl-1H-pyrrol-3-yl)ethanone | ESD-891341-1G |
| Cas.: 106058-85-9 | Purity: 97% | 1-(1-Tosyl-1H-pyrrol-3-yl)ethanone | ESD-891341-5G |
| Cas.: 106058-85-9 | Purity: 97% | 1-(1-Tosyl-1H-pyrrol-3-yl)ethanone | ESD-891341-10G |
| Cas.: 88612-71-9 | Purity: 97% | Ethyl 4-oxo-4H-quinolizine-3-carboxylate | ESD-891342-100MG |
| Cas.: 88612-71-9 | Purity: 97% | Ethyl 4-oxo-4H-quinolizine-3-carboxylate | ESD-891342-250MG |
| Cas.: 88612-71-9 | Purity: 97% | Ethyl 4-oxo-4H-quinolizine-3-carboxylate | ESD-891342-1G |
| Cas.: 906673-54-9 | Purity: 97% | 4-(4-Bromo-3-formylphenoxy)benzonitrile | ESD-891343-250MG |
| Cas.: 906673-54-9 | Purity: 97% | 4-(4-Bromo-3-formylphenoxy)benzonitrile | ESD-891343-1G |
| Cas.: 906673-54-9 | Purity: 97% | 4-(4-Bromo-3-formylphenoxy)benzonitrile | ESD-891343-5G |
| Cas.: 906673-54-9 | Purity: 97% | 4-(4-Bromo-3-formylphenoxy)benzonitrile | ESD-891343-10G |
| Cas.: 64542-91-2 | Purity: 97% | 2-(Benzylthio)-9H-purin-6-amine | ESD-891344-100MG |
| Cas.: 64542-91-2 | Purity: 97% | 2-(Benzylthio)-9H-purin-6-amine | ESD-891344-250MG |
| Cas.: 64542-91-2 | Purity: 97% | 2-(Benzylthio)-9H-purin-6-amine | ESD-891344-1G |
| Cas.: 6600-31-3 | Purity: ≥95% | 3,9-Di(cyclohex-3-en-1-yl)-2,4,8,10-tetraoxaspiro[5.5]undecane | ESD-891345-5G |
| Cas.: 6600-31-3 | Purity: ≥95% | 3,9-Di(cyclohex-3-en-1-yl)-2,4,8,10-tetraoxaspiro[5.5]undecane | ESD-891345-25G |
| Cas.: 17645-17-9 | Purity: 97% | 6-Chloro-N3-methylpyridazine-3,4-diamine | ESD-891346-100MG |
| Cas.: 17645-17-9 | Purity: 97% | 6-Chloro-N3-methylpyridazine-3,4-diamine | ESD-891346-250MG |
| Cas.: 2552-54-7 | Purity: 97% | 3-(Benzyloxy)isoxazole-5-carboxylic acid | ESD-891347-50MG |
| Cas.: 143979-44-6 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-3-phenylpyrrolidine-2-carboxylic acid | ESD-891348-100MG |
| Cas.: 143979-44-6 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-3-phenylpyrrolidine-2-carboxylic acid | ESD-891348-250MG |
| Cas.: 143979-44-6 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-3-phenylpyrrolidine-2-carboxylic acid | ESD-891348-1G |
| Cas.: 96314-29-3 | Purity: ≥95% | (2S,4S)-1-(tert-Butoxycarbonyl)-4-phenylpyrrolidine-2-carboxylic acid | ESD-891349-100MG |
| Cas.: 96314-29-3 | Purity: ≥95% | (2S,4S)-1-(tert-Butoxycarbonyl)-4-phenylpyrrolidine-2-carboxylic acid | ESD-891349-250MG |
| Cas.: 96314-29-3 | Purity: ≥95% | (2S,4S)-1-(tert-Butoxycarbonyl)-4-phenylpyrrolidine-2-carboxylic acid | ESD-891349-1G |
| Cas.: 43156-48-5 | Purity: ≥95% | 4-(Phenylthio)benzene-1,2-diamine | ESD-891350-250MG |
| Cas.: 43156-48-5 | Purity: ≥95% | 4-(Phenylthio)benzene-1,2-diamine | ESD-891350-1G |
| Cas.: 43156-48-5 | Purity: ≥95% | 4-(Phenylthio)benzene-1,2-diamine | ESD-891350-5G |
| Cas.: 1226781-82-3 | Purity: 97% | tert-Butyl 2-(methylsulfonyl)-4,6-dihydropyrrolo[3,4-c]pyrazole-5(2H)-carboxylate | ESD-891351-100MG |
| Cas.: 1226781-82-3 | Purity: 97% | tert-Butyl 2-(methylsulfonyl)-4,6-dihydropyrrolo[3,4-c]pyrazole-5(2H)-carboxylate | ESD-891351-250MG |
| Cas.: 1226781-82-3 | Purity: 97% | tert-Butyl 2-(methylsulfonyl)-4,6-dihydropyrrolo[3,4-c]pyrazole-5(2H)-carboxylate | ESD-891351-1G |
| Cas.: 1226781-82-3 | Purity: 97% | tert-Butyl 2-(methylsulfonyl)-4,6-dihydropyrrolo[3,4-c]pyrazole-5(2H)-carboxylate | ESD-891351-5G |
| Cas.: 52804-26-9 | Purity: ≥95% | [4-(1-adamantyl)phenoxy]acetic acid | ESD-891352-100MG |
| Cas.: 52804-26-9 | Purity: ≥95% | [4-(1-adamantyl)phenoxy]acetic acid | ESD-891352-250MG |
| Cas.: 52804-26-9 | Purity: ≥95% | [4-(1-adamantyl)phenoxy]acetic acid | ESD-891352-1G |
| Cas.: 52804-26-9 | Purity: ≥95% | [4-(1-adamantyl)phenoxy]acetic acid | ESD-891352-5G |
| Cas.: 1086836-82-9 | Purity: ≥95% | 7-Bromo-5-chloro-1H-benzo[d][1,2,3]triazole | ESD-891353-250MG |
| Cas.: 1086836-82-9 | Purity: ≥95% | 7-Bromo-5-chloro-1H-benzo[d][1,2,3]triazole | ESD-891353-1G |
| Cas.: 1086836-82-9 | Purity: ≥95% | 7-Bromo-5-chloro-1H-benzo[d][1,2,3]triazole | ESD-891353-5G |
| Cas.: 195602-17-6 | Purity: ≥95% | 2,2′,3,3′-Tetrahydro-5,5′-bithieno[3,4-b][1,4]dioxine | ESD-891354-250MG |
| Cas.: 195602-17-6 | Purity: ≥95% | 2,2′,3,3′-Tetrahydro-5,5′-bithieno[3,4-b][1,4]dioxine | ESD-891354-1G |
| Cas.: 195602-17-6 | Purity: ≥95% | 2,2′,3,3′-Tetrahydro-5,5′-bithieno[3,4-b][1,4]dioxine | ESD-891354-5G |
| Cas.: 178306-47-3 | Purity: 97% | Methyl 2-hydroxy-3-methoxy-3,3-diphenylpropanoate | ESD-891355-100MG |
| Cas.: 178306-47-3 | Purity: 97% | Methyl 2-hydroxy-3-methoxy-3,3-diphenylpropanoate | ESD-891355-250MG |
| Cas.: 178306-47-3 | Purity: 97% | Methyl 2-hydroxy-3-methoxy-3,3-diphenylpropanoate | ESD-891355-1G |
| Cas.: 178306-47-3 | Purity: 97% | Methyl 2-hydroxy-3-methoxy-3,3-diphenylpropanoate | ESD-891355-5G |
| Cas.: 5334-28-1 | Purity: ≥95% | 5-Amino-1-(4-bromophenyl)-1H-pyrazole-4-carbonitrile | ESD-891356-250MG |
| Cas.: 5334-28-1 | Purity: ≥95% | 5-Amino-1-(4-bromophenyl)-1H-pyrazole-4-carbonitrile | ESD-891356-1G |
| Cas.: 5334-28-1 | Purity: ≥95% | 5-Amino-1-(4-bromophenyl)-1H-pyrazole-4-carbonitrile | ESD-891356-5G |
| Cas.: 5334-28-1 | Purity: ≥95% | 5-Amino-1-(4-bromophenyl)-1H-pyrazole-4-carbonitrile | ESD-891356-10G |
| Cas.: 1368819-46-8 | Purity: 97% | 4-(5-Methyl-1H-1,2,4-triazol-1-yl)benzoic acid | ESD-891357-100MG |
| Cas.: 1368819-46-8 | Purity: 97% | 4-(5-Methyl-1H-1,2,4-triazol-1-yl)benzoic acid | ESD-891357-250MG |
| Cas.: 192997-32-3 | Purity: 97% | Methyl 1-benzyl-1H-indole-5-carboxylate | ESD-891359-100MG |
| Cas.: 192997-32-3 | Purity: 97% | Methyl 1-benzyl-1H-indole-5-carboxylate | ESD-891359-250MG |
| Cas.: 192997-32-3 | Purity: 97% | Methyl 1-benzyl-1H-indole-5-carboxylate | ESD-891359-1G |
| Cas.: 935534-40-0 | Purity: 95% | 2-Bromo-5-fluoro-4-nitropyridine 1-oxide | ESD-891360-100MG |
| Cas.: 935534-40-0 | Purity: 95% | 2-Bromo-5-fluoro-4-nitropyridine 1-oxide | ESD-891360-250MG |
| Cas.: 30081-72-2 | Purity: 97% | 4-Hydroxyisoquinolin-1(2H)-one | ESD-891361-100MG |
| Cas.: 30081-72-2 | Purity: 97% | 4-Hydroxyisoquinolin-1(2H)-one | ESD-891361-250MG |
| Cas.: 1196474-68-6 | Purity: ≥95% | Ethyl 4-(3-bromo-4-formylphenoxy)benzoate | ESD-891362-100MG |
| Cas.: 1196474-68-6 | Purity: ≥95% | Ethyl 4-(3-bromo-4-formylphenoxy)benzoate | ESD-891362-250MG |
| Cas.: 1196474-68-6 | Purity: ≥95% | Ethyl 4-(3-bromo-4-formylphenoxy)benzoate | ESD-891362-1G |
| Cas.: 1448307-66-1 | Purity: ≥95% | 1-(2-Chloropyrimidin-4-yl)-3-methyl-1H-pyrazole-4-carbaldehyde | ESD-891363-100MG |
| Cas.: 1448307-66-1 | Purity: ≥95% | 1-(2-Chloropyrimidin-4-yl)-3-methyl-1H-pyrazole-4-carbaldehyde | ESD-891363-250MG |
| Cas.: 1448307-66-1 | Purity: ≥95% | 1-(2-Chloropyrimidin-4-yl)-3-methyl-1H-pyrazole-4-carbaldehyde | ESD-891363-1G |
| Cas.: 35511-15-0 | Purity: 97% | Methyl 2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide | ESD-891364-250MG |
| Cas.: 35511-15-0 | Purity: 97% | Methyl 2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide | ESD-891364-1G |
| Cas.: 35511-15-0 | Purity: 97% | Methyl 2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide | ESD-891364-5G |
| Cas.: 35511-15-0 | Purity: 97% | Methyl 2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide | ESD-891364-10G |
| Cas.: 19035-79-1 | Purity: 97% | Potassium hexadecyl hydrogenphosphate | ESD-891365-1G |
| Cas.: 19035-79-1 | Purity: 97% | Potassium hexadecyl hydrogenphosphate | ESD-891365-5G |
| Cas.: 19035-79-1 | Purity: 97% | Potassium hexadecyl hydrogenphosphate | ESD-891365-10G |
| Cas.: 19035-79-1 | Purity: 97% | Potassium hexadecyl hydrogenphosphate | ESD-891365-25G |
| Cas.: 129075-49-6 | Purity: ≥95% | 5-Methoxy-3,4-dihydroisoquinolin-1(2H)-one | ESD-891366-100MG |
| Cas.: 129075-49-6 | Purity: ≥95% | 5-Methoxy-3,4-dihydroisoquinolin-1(2H)-one | ESD-891366-250MG |
| Cas.: 129075-49-6 | Purity: ≥95% | 5-Methoxy-3,4-dihydroisoquinolin-1(2H)-one | ESD-891366-1G |
| Cas.: 69454-42-8 | Purity: 97% | Methyl 1-oxo-1,2-dihydroisoquinoline-3-carboxylate | ESD-891367-100MG |
| Cas.: 69454-42-8 | Purity: 97% | Methyl 1-oxo-1,2-dihydroisoquinoline-3-carboxylate | ESD-891367-250MG |
| Cas.: 69454-42-8 | Purity: 97% | Methyl 1-oxo-1,2-dihydroisoquinoline-3-carboxylate | ESD-891367-1G |
| Cas.: 1172623-99-2 | Purity: 98% | tert-Butyl ((2R,3S)-2-(2,5-difluorophenyl)-5-hydroxytetrahydro-2H-pyran-3-yl)carbamate | ESD-891368-100MG |
| Cas.: 1172623-99-2 | Purity: 98% | tert-Butyl ((2R,3S)-2-(2,5-difluorophenyl)-5-hydroxytetrahydro-2H-pyran-3-yl)carbamate | ESD-891368-250MG |
| Cas.: 61990-51-0 | Purity: 97% | 2-Hydroxy-N,N-dimethylpropan-1-aminium 4-acetamidobenzoate | ESD-891369-5G |
| Cas.: 61990-51-0 | Purity: 97% | 2-Hydroxy-N,N-dimethylpropan-1-aminium 4-acetamidobenzoate | ESD-891369-10G |
| Cas.: 61990-51-0 | Purity: 97% | 2-Hydroxy-N,N-dimethylpropan-1-aminium 4-acetamidobenzoate | ESD-891369-25G |
| Cas.: 93012-36-3 | Purity: ≥95% | 5,5′-Dimethyl-[1,1′-biphenyl]-2,2′-dicarboxylic acid | ESD-891370-100MG |
| Cas.: 93012-36-3 | Purity: ≥95% | 5,5′-Dimethyl-[1,1′-biphenyl]-2,2′-dicarboxylic acid | ESD-891370-250MG |
| Cas.: 1217500-68-9 | Purity: 97% | (5-(Benzyloxy)-2-fluorophenyl)boronic acid | ESD-891371-250MG |
| Cas.: 1217500-68-9 | Purity: 97% | (5-(Benzyloxy)-2-fluorophenyl)boronic acid | ESD-891371-1G |
| Cas.: 1217500-68-9 | Purity: 97% | (5-(Benzyloxy)-2-fluorophenyl)boronic acid | ESD-891371-5G |
| Cas.: 313369-26-5 | Purity: 97% | (6bR,10aS)-Ethyl 3-methyl-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxaline -8(9H)-carboxylate | ESD-891372-100MG |
| Cas.: 313369-26-5 | Purity: 97% | (6bR,10aS)-Ethyl 3-methyl-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxaline -8(9H)-carboxylate | ESD-891372-250MG |
| Cas.: 313369-26-5 | Purity: 97% | (6bR,10aS)-Ethyl 3-methyl-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxaline -8(9H)-carboxylate | ESD-891372-1G |
| Cas.: 72816-14-9 | Purity: ≥95% | 5-Amino-1-(pyridin-2-yl)-1H-pyrazole-4-carbonitrile | ESD-891373-100MG |
| Cas.: 72816-14-9 | Purity: ≥95% | 5-Amino-1-(pyridin-2-yl)-1H-pyrazole-4-carbonitrile | ESD-891373-250MG |
| Cas.: 72816-14-9 | Purity: ≥95% | 5-Amino-1-(pyridin-2-yl)-1H-pyrazole-4-carbonitrile | ESD-891373-1G |
| Cas.: 72816-14-9 | Purity: ≥95% | 5-Amino-1-(pyridin-2-yl)-1H-pyrazole-4-carbonitrile | ESD-891373-5G |
| Cas.: 209525-73-5 | Purity: 97% | 2-((tert-Butoxycarbonyl)amino)-2-(4-chlorophenyl)acetic acid | ESD-891374-250MG |
| Cas.: 209525-73-5 | Purity: 97% | 2-((tert-Butoxycarbonyl)amino)-2-(4-chlorophenyl)acetic acid | ESD-891374-1G |
| Cas.: 209525-73-5 | Purity: 97% | 2-((tert-Butoxycarbonyl)amino)-2-(4-chlorophenyl)acetic acid | ESD-891374-5G |
| Cas.: 209525-73-5 | Purity: 97% | 2-((tert-Butoxycarbonyl)amino)-2-(4-chlorophenyl)acetic acid | ESD-891374-10G |
| Cas.: 42406-77-9 | Purity: ≥95% | H-Tyr-OBzl | ESD-891375-1G |
| Cas.: 42406-77-9 | Purity: ≥95% | H-Tyr-OBzl | ESD-891375-5G |
| Cas.: 42406-77-9 | Purity: ≥95% | H-Tyr-OBzl | ESD-891375-10G |
| Cas.: 122024-75-3 | Purity: 97% | 3-(3-(Benzyloxy)phenyl)acrylic acid | ESD-891376-250MG |
| Cas.: 122024-75-3 | Purity: 97% | 3-(3-(Benzyloxy)phenyl)acrylic acid | ESD-891376-1G |
| Cas.: 122024-75-3 | Purity: 97% | 3-(3-(Benzyloxy)phenyl)acrylic acid | ESD-891376-5G |
| Cas.: 122024-75-3 | Purity: 97% | 3-(3-(Benzyloxy)phenyl)acrylic acid | ESD-891376-10G |
| Cas.: 849178-85-4 | Purity: 97% | (R)-tert-Butyl (1-(4-bromophenyl)-2-hydroxyethyl)carbamate | ESD-891377-100MG |
| Cas.: 849178-85-4 | Purity: 97% | (R)-tert-Butyl (1-(4-bromophenyl)-2-hydroxyethyl)carbamate | ESD-891377-250MG |
| Cas.: 1049981-76-1 | Purity: ≥95% | (2S,4R)-4-(2-Cyanobenzyl)pyrrolidine-2-carboxylic acid | ESD-891378-100MG |
| Cas.: 1049981-76-1 | Purity: ≥95% | (2S,4R)-4-(2-Cyanobenzyl)pyrrolidine-2-carboxylic acid | ESD-891378-250MG |
| Cas.: 1211589-13-7 | Purity: ≥95% | 3-Bromo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-5-one | ESD-891379-100MG |
| Cas.: 1211589-13-7 | Purity: ≥95% | 3-Bromo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-5-one | ESD-891379-250MG |
| Cas.: 151838-62-9 | Purity: ≥95% | 2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | ESD-891380-100MG |
| Cas.: 151838-62-9 | Purity: ≥95% | 2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | ESD-891380-250MG |
| Cas.: 151838-62-9 | Purity: ≥95% | 2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | ESD-891380-1G |
| Cas.: 151838-62-9 | Purity: ≥95% | 2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | ESD-891380-5G |
| Cas.: 2875-79-8 | Purity: 97% | N,N-Diphenyl-1H-imidazole-1-carboxamide | ESD-891381-250MG |
| Cas.: 2875-79-8 | Purity: 97% | N,N-Diphenyl-1H-imidazole-1-carboxamide | ESD-891381-1G |
| Cas.: 2875-79-8 | Purity: 97% | N,N-Diphenyl-1H-imidazole-1-carboxamide | ESD-891381-5G |
| Cas.: 122080-99-3 | Purity: 97% | 3-Tosyl-3-azabicyclo[3.2.0]heptan-6-one | ESD-891382-100MG |
| Cas.: 122080-99-3 | Purity: 97% | 3-Tosyl-3-azabicyclo[3.2.0]heptan-6-one | ESD-891382-250MG |
| Cas.: 122080-99-3 | Purity: 97% | 3-Tosyl-3-azabicyclo[3.2.0]heptan-6-one | ESD-891382-1G |
| Cas.: 132906-53-7 | Purity: ≥95% | 8-Bromo-2,3,4,9-tetrahydro-1H-carbazol-1-one | ESD-891383-100MG |
| Cas.: 132906-53-7 | Purity: ≥95% | 8-Bromo-2,3,4,9-tetrahydro-1H-carbazol-1-one | ESD-891383-250MG |
| Cas.: 132906-53-7 | Purity: ≥95% | 8-Bromo-2,3,4,9-tetrahydro-1H-carbazol-1-one | ESD-891383-1G |
| Cas.: 132906-53-7 | Purity: ≥95% | 8-Bromo-2,3,4,9-tetrahydro-1H-carbazol-1-one | ESD-891383-5G |
| Cas.: 1489004-27-4 | Purity: 97% | (E)-3-((tert-Butoxycarbonyl)(isopropyl)amino)-2-(4-chlorophenyl)acrylic acid | ESD-891384-250MG |
| Cas.: 1489004-27-4 | Purity: 97% | (E)-3-((tert-Butoxycarbonyl)(isopropyl)amino)-2-(4-chlorophenyl)acrylic acid | ESD-891384-1G |
| Cas.: 855254-76-1 | Purity: ≥95% | Diethyl 2,2′-dimethylbiphenyl-4,4′-dicarboxylate | ESD-891385-100MG |
| Cas.: 855254-76-1 | Purity: ≥95% | Diethyl 2,2′-dimethylbiphenyl-4,4′-dicarboxylate | ESD-891385-250MG |
| Cas.: 133123-67-8 | Purity: 97% | 1-Ethyl-1H-imidazole-4,5-dicarbonitrile | ESD-891386-250MG |
| Cas.: 133123-67-8 | Purity: 97% | 1-Ethyl-1H-imidazole-4,5-dicarbonitrile | ESD-891386-1G |
| Cas.: 133123-67-8 | Purity: 97% | 1-Ethyl-1H-imidazole-4,5-dicarbonitrile | ESD-891386-5G |
| Cas.: 112835-62-8 | Purity: ≥95% | Ethyl 2-(((1R,2S)-2-hydroxy-1,2-diphenylethyl)amino)acetate | ESD-891387-250MG |
| Cas.: 112835-62-8 | Purity: ≥95% | Ethyl 2-(((1R,2S)-2-hydroxy-1,2-diphenylethyl)amino)acetate | ESD-891387-1G |
| Cas.: 860205-92-1 | Purity: 97% | 7-Bromo-4-hydroxyquinoline-3-carboxylic acid | ESD-891388-1G |
| Cas.: 860205-92-1 | Purity: 97% | 7-Bromo-4-hydroxyquinoline-3-carboxylic acid | ESD-891388-5G |
| Cas.: 91025-05-7 | Purity: 97% | N-(2-Picolinoylphenyl)benzamide | ESD-891389-100MG |
| Cas.: 91025-05-7 | Purity: 97% | N-(2-Picolinoylphenyl)benzamide | ESD-891389-250MG |
| Cas.: 113046-72-3 | Purity: 97% | Ethyl 6,7-difluoro-1-methyl-4-oxo-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate | ESD-891390-1G |
| Cas.: 53623-42-0 | Purity: ≥95% | 2-((((1S,2R,5S)-2-Isopropyl-5-methylcyclohexyl)oxy)carbonyl)benzoic acid | ESD-891391-1G |
| Cas.: 53623-42-0 | Purity: ≥95% | 2-((((1S,2R,5S)-2-Isopropyl-5-methylcyclohexyl)oxy)carbonyl)benzoic acid | ESD-891391-5G |
| Cas.: 53623-42-0 | Purity: ≥95% | 2-((((1S,2R,5S)-2-Isopropyl-5-methylcyclohexyl)oxy)carbonyl)benzoic acid | ESD-891391-10G |
| Cas.: 22976-70-1 | Purity: ≥95% | 4-(2-Amino-2-carboxyethyl)benzoic acid | ESD-891392-100MG |
| Cas.: 22976-70-1 | Purity: ≥95% | 4-(2-Amino-2-carboxyethyl)benzoic acid | ESD-891392-250MG |
| Cas.: 485-61-0 | Purity: 97% | 2-(Benzo[d][1,3]dioxol-5-yl)-1-methylquinolin-4(1H)-one | ESD-891393-100MG |
| Cas.: 485-61-0 | Purity: 97% | 2-(Benzo[d][1,3]dioxol-5-yl)-1-methylquinolin-4(1H)-one | ESD-891393-250MG |
| Cas.: 151004-96-5 | Purity: 97% | (R)-2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid | ESD-891394-100MG |
| Cas.: 151004-96-5 | Purity: 97% | (R)-2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid | ESD-891394-250MG |
| Cas.: 1065114-27-3 | Purity: 97% | tert-Butyl 2,4-dichloro-8,9-dihydro-5H-pyrimido[4,5-d]azepine-7(6H)-carboxylate | ESD-891395-250MG |
| Cas.: 1065114-27-3 | Purity: 97% | tert-Butyl 2,4-dichloro-8,9-dihydro-5H-pyrimido[4,5-d]azepine-7(6H)-carboxylate | ESD-891395-1G |
| Cas.: 53983-15-6 | Purity: 97% | Ethyl 5-amino-4-phenylisoxazole-3-carboxylate | ESD-891396-250MG |
| Cas.: 53983-15-6 | Purity: 97% | Ethyl 5-amino-4-phenylisoxazole-3-carboxylate | ESD-891396-1G |
| Cas.: 53983-15-6 | Purity: 97% | Ethyl 5-amino-4-phenylisoxazole-3-carboxylate | ESD-891396-5G |
| Cas.: 53983-15-6 | Purity: 97% | Ethyl 5-amino-4-phenylisoxazole-3-carboxylate | ESD-891396-10G |
| Cas.: 185669-79-8 | Purity: 97% | N-(4-Methoxybenzyl)-1-(naphthalen-1-yl)methanamine | ESD-891397-100MG |
| Cas.: 185669-79-8 | Purity: 97% | N-(4-Methoxybenzyl)-1-(naphthalen-1-yl)methanamine | ESD-891397-250MG |
| Cas.: 189439-24-5 | Purity: 97% | 4-(Benzyloxy)-2-hydroxybenzonitrile | ESD-891398-100MG |
| Cas.: 189439-24-5 | Purity: 97% | 4-(Benzyloxy)-2-hydroxybenzonitrile | ESD-891398-250MG |
| Cas.: 189439-24-5 | Purity: 97% | 4-(Benzyloxy)-2-hydroxybenzonitrile | ESD-891398-1G |
| Cas.: 143443-23-6 | Purity: ≥95% | (1R,2R)-N1,N2-Dibenzylcyclohexane-1,2-diamine | ESD-891399-250MG |
| Cas.: 143443-23-6 | Purity: ≥95% | (1R,2R)-N1,N2-Dibenzylcyclohexane-1,2-diamine | ESD-891399-1G |
| Cas.: 84656-78-0 | Purity: 97% | (Trans,trans)-4-(4-ethoxyphenyl)-4′-propyl-1,1′-bi(cyclohexane) | ESD-891400-100MG |
| Cas.: 84656-78-0 | Purity: 97% | (Trans,trans)-4-(4-ethoxyphenyl)-4′-propyl-1,1′-bi(cyclohexane) | ESD-891400-250MG |
| Cas.: 847560-49-0 | Purity: ≥97% | 4-Benzyloxy-2-methylphenylboronic acid | ESD-891401-250MG |
| Cas.: 847560-49-0 | Purity: ≥97% | 4-Benzyloxy-2-methylphenylboronic acid | ESD-891401-1G |
| Cas.: 847560-49-0 | Purity: ≥97% | 4-Benzyloxy-2-methylphenylboronic acid | ESD-891401-5G |
| Cas.: 847560-49-0 | Purity: ≥97% | 4-Benzyloxy-2-methylphenylboronic acid | ESD-891401-10G |
| Cas.: 53636-65-0 | Purity: ≥95% | 5-Methylpyridine-2,3-dicarboxylic acid | ESD-891402-250MG |
| Cas.: 53636-65-0 | Purity: ≥95% | 5-Methylpyridine-2,3-dicarboxylic acid | ESD-891402-1G |
| Cas.: 24501-21-1 | Purity: ≥95% | 3-Nitropyridine-2,4-diamine | ESD-891403-100MG |
| Cas.: 24501-21-1 | Purity: ≥95% | 3-Nitropyridine-2,4-diamine | ESD-891403-250MG |
| Cas.: 24501-21-1 | Purity: ≥95% | 3-Nitropyridine-2,4-diamine | ESD-891403-1G |
| Cas.: 872018-40-1 | Purity: ≥95% | 6-Bromo-3-methylisoquinolin-1(2H)-one | ESD-891404-100MG |
| Cas.: 872018-40-1 | Purity: ≥95% | 6-Bromo-3-methylisoquinolin-1(2H)-one | ESD-891404-250MG |
| Cas.: 67843-72-5 | Purity: 97% | Z-β-D-HomoAla-OH | ESD-891405-100MG |
| Cas.: 67843-72-5 | Purity: 97% | Z-β-D-HomoAla-OH | ESD-891405-250MG |
| Cas.: 67843-72-5 | Purity: 97% | Z-β-D-HomoAla-OH | ESD-891405-1G |
| Cas.: 128102-16-9 | Purity: 97% | (R)-4-Benzyl 1-Boc-2-methylpiperazine-4-carboxylate | ESD-891406-100MG |
| Cas.: 128102-16-9 | Purity: 97% | (R)-4-Benzyl 1-Boc-2-methylpiperazine-4-carboxylate | ESD-891406-250MG |
| Cas.: 71420-95-6 | Purity: 96% | 3-[(Boc-amino)methyl]phenylacetic Acid | ESD-891407-250MG |
| Cas.: 71420-95-6 | Purity: 96% | 3-[(Boc-amino)methyl]phenylacetic Acid | ESD-891407-1G |
| Cas.: 71420-95-6 | Purity: 96% | 3-[(Boc-amino)methyl]phenylacetic Acid | ESD-891407-5G |
| Cas.: 955931-76-7 | Purity: 97% | 4-(4-Bromophenethoxy)benzaldehyde | ESD-891408-250MG |
| Cas.: 955931-76-7 | Purity: 97% | 4-(4-Bromophenethoxy)benzaldehyde | ESD-891408-1G |
| Cas.: 34793-28-7 | Purity: ≥95% | 3-(1H-Imidazol-1-yl)propane-1,2-diol | ESD-891409-250MG |
| Cas.: 34793-28-7 | Purity: ≥95% | 3-(1H-Imidazol-1-yl)propane-1,2-diol | ESD-891409-1G |
| Cas.: 763910-07-2 | Purity: ≥95% | 6-(Piperazin-1-yl)-1H-indazole | ESD-891410-250MG |
| Cas.: 763910-07-2 | Purity: ≥95% | 6-(Piperazin-1-yl)-1H-indazole | ESD-891410-1G |
| Cas.: 54143-55-4 | Purity: ≥95% | Flecainide | ESD-891411-10MG |
| Cas.: 54143-55-4 | Purity: ≥95% | Flecainide | ESD-891411-25MG |
| Cas.: 54143-55-4 | Purity: ≥95% | Flecainide | ESD-891411-50MG |
| Cas.: 38398-32-2 | Purity: 95% | 1-((3R,5S,8R,9S,10S,13S,14S,17S)-3-Hydroxy-3,10,13-trimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethanone | ESD-891412-100MG |
| Cas.: 38398-32-2 | Purity: 95% | 1-((3R,5S,8R,9S,10S,13S,14S,17S)-3-Hydroxy-3,10,13-trimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethanone | ESD-891412-250MG |
| Cas.: 38398-32-2 | Purity: 95% | 1-((3R,5S,8R,9S,10S,13S,14S,17S)-3-Hydroxy-3,10,13-trimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethanone | ESD-891412-1G |
| Cas.: 165670-57-5 | Purity: 96% | 5-Phenyl-2-(2-phenylpropan-2-yl)-2H-tetrazole | ESD-891413-1G |
| Cas.: 165670-57-5 | Purity: 96% | 5-Phenyl-2-(2-phenylpropan-2-yl)-2H-tetrazole | ESD-891413-5G |
| Cas.: 165670-57-5 | Purity: 96% | 5-Phenyl-2-(2-phenylpropan-2-yl)-2H-tetrazole | ESD-891413-10G |
| Cas.: 1211515-50-2 | Purity: ≥95% | 2-Bromopyrimidine-4-carboxylic acid | ESD-891414-100MG |
| Cas.: 1211515-50-2 | Purity: ≥95% | 2-Bromopyrimidine-4-carboxylic acid | ESD-891414-250MG |
| Cas.: 22277-01-6 | Purity: ≥95% | 4-Chloro-5-nitro-7H-pyrrolo[2,3-d]pyrimidine | ESD-891415-100MG |
| Cas.: 22277-01-6 | Purity: ≥95% | 4-Chloro-5-nitro-7H-pyrrolo[2,3-d]pyrimidine | ESD-891415-250MG |
| Cas.: 165125-95-1 | Purity: 97% | 2,6-Bis(4,5-dihydrooxazol-2-yl)pyridine | ESD-891416-100MG |
| Cas.: 165125-95-1 | Purity: 97% | 2,6-Bis(4,5-dihydrooxazol-2-yl)pyridine | ESD-891416-250MG |
| Cas.: 319472-78-1 | Purity: 97% | 3,6-Diiodo-1H-indazole | ESD-891417-100MG |
| Cas.: 319472-78-1 | Purity: 97% | 3,6-Diiodo-1H-indazole | ESD-891417-250MG |
| Cas.: 319472-78-1 | Purity: 97% | 3,6-Diiodo-1H-indazole | ESD-891417-1G |
| Cas.: 319472-78-1 | Purity: 97% | 3,6-Diiodo-1H-indazole | ESD-891417-5G |
| Cas.: 256935-86-1 | Purity: ≥95% | 6-Chloro-1H-indole-5-carboxylic acid | ESD-891418-100MG |
| Cas.: 256935-86-1 | Purity: ≥95% | 6-Chloro-1H-indole-5-carboxylic acid | ESD-891418-250MG |
| Cas.: 256935-86-1 | Purity: ≥95% | 6-Chloro-1H-indole-5-carboxylic acid | ESD-891418-1G |
| Cas.: 256935-86-1 | Purity: ≥95% | 6-Chloro-1H-indole-5-carboxylic acid | ESD-891418-5G |
| Cas.: 158001-04-8 | Purity: 97% | Ethyl imidazo[1,2-a]pyridine-6-carboxylate | ESD-891419-250MG |
| Cas.: 158001-04-8 | Purity: 97% | Ethyl imidazo[1,2-a]pyridine-6-carboxylate | ESD-891419-1G |
| Cas.: 158001-04-8 | Purity: 97% | Ethyl imidazo[1,2-a]pyridine-6-carboxylate | ESD-891419-5G |
| Cas.: 945470-53-1 | Purity: ≥95% | 8-Chloroisoquinoline-5-carboxylic acid | ESD-891420-100MG |
| Cas.: 945470-53-1 | Purity: ≥95% | 8-Chloroisoquinoline-5-carboxylic acid | ESD-891420-250MG |
| Cas.: 2113-05-5 | Purity: 97% | m-Chlorophenylbiguanide HCl | ESD-891421-100MG |
| Cas.: 2113-05-5 | Purity: 97% | m-Chlorophenylbiguanide HCl | ESD-891421-250MG |
| Cas.: 2113-05-5 | Purity: 97% | m-Chlorophenylbiguanide HCl | ESD-891421-1G |
| Cas.: 2113-05-5 | Purity: 97% | m-Chlorophenylbiguanide HCl | ESD-891421-5G |
| Cas.: 99844-02-7 | Purity: 97% | 4-(4-Methoxyphenyl)pyrimidin-2-amine | ESD-891422-100MG |
| Cas.: 99844-02-7 | Purity: 97% | 4-(4-Methoxyphenyl)pyrimidin-2-amine | ESD-891422-250MG |
| Cas.: 99844-02-7 | Purity: 97% | 4-(4-Methoxyphenyl)pyrimidin-2-amine | ESD-891422-1G |
| Cas.: 99844-02-7 | Purity: 97% | 4-(4-Methoxyphenyl)pyrimidin-2-amine | ESD-891422-5G |
| Cas.: 51516-68-8 | Purity: 97% | 5-Amino-1-(3-chlorophenyl)-1H-pyrazole-4-carbonitrile | ESD-891423-250MG |
| Cas.: 51516-68-8 | Purity: 97% | 5-Amino-1-(3-chlorophenyl)-1H-pyrazole-4-carbonitrile | ESD-891423-1G |
| Cas.: 51516-68-8 | Purity: 97% | 5-Amino-1-(3-chlorophenyl)-1H-pyrazole-4-carbonitrile | ESD-891423-5G |
| Cas.: 72817-85-7 | Purity: 95% | Ethyl 4-amino-5-cyano-2-hydroxy-3-methylbenzoate | ESD-891424-100MG |
| Cas.: 72817-85-7 | Purity: 95% | Ethyl 4-amino-5-cyano-2-hydroxy-3-methylbenzoate | ESD-891424-250MG |
| Cas.: 72817-85-7 | Purity: 95% | Ethyl 4-amino-5-cyano-2-hydroxy-3-methylbenzoate | ESD-891424-1G |
| Cas.: 72817-85-7 | Purity: 95% | Ethyl 4-amino-5-cyano-2-hydroxy-3-methylbenzoate | ESD-891424-5G |
| Cas.: 1060811-65-5 | Purity: ≥95% | 4-Amino-6-chloronicotinic acid | ESD-891425-100MG |
| Cas.: 1060811-65-5 | Purity: ≥95% | 4-Amino-6-chloronicotinic acid | ESD-891425-250MG |
| Cas.: 1060811-65-5 | Purity: ≥95% | 4-Amino-6-chloronicotinic acid | ESD-891425-1G |
| Cas.: 1060811-65-5 | Purity: ≥95% | 4-Amino-6-chloronicotinic acid | ESD-891425-5G |
| Cas.: 159847-71-9 | Purity: 97% | 3-Amino-4-cyanobenzoic acid | ESD-891426-100MG |
| Cas.: 159847-71-9 | Purity: 97% | 3-Amino-4-cyanobenzoic acid | ESD-891426-250MG |
| Cas.: 159847-71-9 | Purity: 97% | 3-Amino-4-cyanobenzoic acid | ESD-891426-1G |
| Cas.: 159847-71-9 | Purity: 97% | 3-Amino-4-cyanobenzoic acid | ESD-891426-5G |
| Cas.: 1221239-09-3 | Purity: 97% | 2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one | ESD-891427-100MG |
| Cas.: 1221239-09-3 | Purity: 97% | 2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one | ESD-891427-250MG |
| Cas.: 1221239-09-3 | Purity: 97% | 2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one | ESD-891427-1G |
| Cas.: 1369160-12-2 | Purity: 97% | 6,7-Dihydro-5H-pyrrolo[1,2-a]imidazole-6-carboxylic acid | ESD-891428-100MG |
| Cas.: 1369160-12-2 | Purity: 97% | 6,7-Dihydro-5H-pyrrolo[1,2-a]imidazole-6-carboxylic acid | ESD-891428-250MG |
| Cas.: 1369160-12-2 | Purity: 97% | 6,7-Dihydro-5H-pyrrolo[1,2-a]imidazole-6-carboxylic acid | ESD-891428-1G |
| Cas.: 3934-84-7 | Purity: 97% | 3,4-Dihydroxy-5-Methoxy-Benzoic Acid | ESD-891429-250MG |
| Cas.: 3934-84-7 | Purity: 97% | 3,4-Dihydroxy-5-Methoxy-Benzoic Acid | ESD-891429-1G |
| Cas.: 3934-84-7 | Purity: 97% | 3,4-Dihydroxy-5-Methoxy-Benzoic Acid | ESD-891429-5G |
| Cas.: 3934-84-7 | Purity: 97% | 3,4-Dihydroxy-5-Methoxy-Benzoic Acid | ESD-891429-10G |
| Cas.: 871266-80-7 | Purity: 96% | 7-Chloro-N-(p-tolyl)thiazolo[5,4-d]pyrimidin-2-amine | ESD-891430-100MG |
| Cas.: 871266-80-7 | Purity: 96% | 7-Chloro-N-(p-tolyl)thiazolo[5,4-d]pyrimidin-2-amine | ESD-891430-250MG |
| Cas.: 917909-59-2 | Purity: ≥95% | tert-Butyl 3-(2-nitrophenoxy)pyrrolidine-1-carboxylate | ESD-891431-100MG |
| Cas.: 917909-59-2 | Purity: ≥95% | tert-Butyl 3-(2-nitrophenoxy)pyrrolidine-1-carboxylate | ESD-891431-250MG |
| Cas.: 1019009-68-7 | Purity: ≥95% | Ethyl 5-amino-1-(2-bromophenyl)-1H-pyrazole-4-carboxylate | ESD-891432-100MG |
| Cas.: 1019009-68-7 | Purity: ≥95% | Ethyl 5-amino-1-(2-bromophenyl)-1H-pyrazole-4-carboxylate | ESD-891432-250MG |
| Cas.: 1019009-68-7 | Purity: ≥95% | Ethyl 5-amino-1-(2-bromophenyl)-1H-pyrazole-4-carboxylate | ESD-891432-1G |
| Cas.: 1019009-68-7 | Purity: ≥95% | Ethyl 5-amino-1-(2-bromophenyl)-1H-pyrazole-4-carboxylate | ESD-891432-5G |
| Cas.: 951127-25-6 | Purity: ≥95% | tert-Butyl ((2R,3S)-2-(2,5-difluorophenyl)-5-oxotetrahydro-2H-pyran-3-yl)carbamate | ESD-891433-100MG |
| Cas.: 951127-25-6 | Purity: ≥95% | tert-Butyl ((2R,3S)-2-(2,5-difluorophenyl)-5-oxotetrahydro-2H-pyran-3-yl)carbamate | ESD-891433-250MG |
| Cas.: 951127-25-6 | Purity: ≥95% | tert-Butyl ((2R,3S)-2-(2,5-difluorophenyl)-5-oxotetrahydro-2H-pyran-3-yl)carbamate | ESD-891433-1G |
| Cas.: 39562-22-6 | Purity: 95% | 2-Methoxyethyl 2-(3-Nitrobenzylidene)-3-oxobutyrate | ESD-891434-5G |
| Cas.: 39562-22-6 | Purity: 95% | 2-Methoxyethyl 2-(3-Nitrobenzylidene)-3-oxobutyrate | ESD-891434-25G |
| Cas.: 39562-22-6 | Purity: 95% | 2-Methoxyethyl 2-(3-Nitrobenzylidene)-3-oxobutyrate | ESD-891434-100G |
| Cas.: 1211535-73-7 | Purity: ≥95% | Thiazolo[4,5-c]pyridine-6-carboxylic acid | ESD-891435-100MG |
| Cas.: 1211535-73-7 | Purity: ≥95% | Thiazolo[4,5-c]pyridine-6-carboxylic acid | ESD-891435-250MG |
| Cas.: 1211535-73-7 | Purity: ≥95% | Thiazolo[4,5-c]pyridine-6-carboxylic acid | ESD-891435-1G |
| Cas.: 68818-86-0 | Purity: 98% | 9,10-Diethoxyanthracene | ESD-891436-250MG |
| Cas.: 68818-86-0 | Purity: 98% | 9,10-Diethoxyanthracene | ESD-891436-1G |
| Cas.: 68818-86-0 | Purity: 98% | 9,10-Diethoxyanthracene | ESD-891436-5G |
| Cas.: 1458-20-4 | Purity: 95% | Methyl 3,5-diamino-6-bromopyrazine-2-carboxylate | ESD-891437-100MG |
| Cas.: 1458-20-4 | Purity: 95% | Methyl 3,5-diamino-6-bromopyrazine-2-carboxylate | ESD-891437-250MG |
| Cas.: 545445-40-7 | Purity: ≥95% | 3-Morpholino-5,6-dihydropyridin-2(1H)-one | ESD-891438-100MG |
| Cas.: 545445-40-7 | Purity: ≥95% | 3-Morpholino-5,6-dihydropyridin-2(1H)-one | ESD-891438-250MG |
| Cas.: 1139-83-9 | Purity: ≥95% | Urolithin B | ESD-891439-250MG |
| Cas.: 1139-83-9 | Purity: ≥95% | Urolithin B | ESD-891439-1G |
| Cas.: 1139-83-9 | Purity: ≥95% | Urolithin B | ESD-891439-5G |
| Cas.: 155542-33-9 | Purity: 97% | Boc-D-Asp(OtBu)-OH | ESD-891440-250MG |
| Cas.: 155542-33-9 | Purity: 97% | Boc-D-Asp(OtBu)-OH | ESD-891440-1G |
| Cas.: 155542-33-9 | Purity: 97% | Boc-D-Asp(OtBu)-OH | ESD-891440-5G |
| Cas.: 192061-82-8 | Purity: ≥95% | 1-(4-Hydroxyindolin-1-yl)ethanone | ESD-891441-100MG |
| Cas.: 192061-82-8 | Purity: ≥95% | 1-(4-Hydroxyindolin-1-yl)ethanone | ESD-891441-250MG |
| Cas.: 1251009-79-6 | Purity: ≥95% | tert-Butyl (2-bromo-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)carbamate | ESD-891442-100MG |
| Cas.: 1251009-79-6 | Purity: ≥95% | tert-Butyl (2-bromo-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)carbamate | ESD-891442-250MG |
| Cas.: 1251009-79-6 | Purity: ≥95% | tert-Butyl (2-bromo-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)carbamate | ESD-891442-1G |
| Cas.: 156867-56-0 | Purity: ≥95% | 4-((Methylsulfonyl)methyl)benzaldehyde | ESD-891443-100MG |
| Cas.: 156867-56-0 | Purity: ≥95% | 4-((Methylsulfonyl)methyl)benzaldehyde | ESD-891443-250MG |
| Cas.: 5618-96-2 | Purity: 98% | Z-DL-Pro-OH | ESD-891444-250MG |
| Cas.: 5618-96-2 | Purity: 98% | Z-DL-Pro-OH | ESD-891444-1G |
| Cas.: 5618-96-2 | Purity: 98% | Z-DL-Pro-OH | ESD-891444-5G |
| Cas.: 5618-96-2 | Purity: 98% | Z-DL-Pro-OH | ESD-891444-10G |
| Cas.: 192214-00-9 | Purity: 97% | (S)-1-((Benzyloxy)carbonyl)pyrrolidine-3-carboxylic acid | ESD-891445-250MG |
| Cas.: 192214-00-9 | Purity: 97% | (S)-1-((Benzyloxy)carbonyl)pyrrolidine-3-carboxylic acid | ESD-891445-1G |
| Cas.: 192214-00-9 | Purity: 97% | (S)-1-((Benzyloxy)carbonyl)pyrrolidine-3-carboxylic acid | ESD-891445-5G |
| Cas.: 192214-00-9 | Purity: 97% | (S)-1-((Benzyloxy)carbonyl)pyrrolidine-3-carboxylic acid | ESD-891445-10G |
| Cas.: 299443-17-7 | Purity: 97% | 5-(2,3-Dichlorophenyl)-1,3,4-thiadiazol-2-amine | ESD-891446-250MG |
| Cas.: 299443-17-7 | Purity: 97% | 5-(2,3-Dichlorophenyl)-1,3,4-thiadiazol-2-amine | ESD-891446-1G |
| Cas.: 299443-17-7 | Purity: 97% | 5-(2,3-Dichlorophenyl)-1,3,4-thiadiazol-2-amine | ESD-891446-5G |
| Cas.: 79560-18-2 | Purity: ≥95% | 4-(3,4-Dichlorophenyl)-4-phenylbutanoic acid | ESD-891447-100MG |
| Cas.: 79560-18-2 | Purity: ≥95% | 4-(3,4-Dichlorophenyl)-4-phenylbutanoic acid | ESD-891447-250MG |
| Cas.: 41292-66-4 | Purity: ≥95% | 2-Methyl-1H-benzo[d]imidazol-5-ol | ESD-891448-100MG |
| Cas.: 41292-66-4 | Purity: ≥95% | 2-Methyl-1H-benzo[d]imidazol-5-ol | ESD-891448-250MG |
| Cas.: 1324000-40-9 | Purity: ≥95% | Benzyl (1-phenylcyclopropyl)carbamate | ESD-891449-1G |
| Cas.: 1324000-40-9 | Purity: ≥95% | Benzyl (1-phenylcyclopropyl)carbamate | ESD-891449-5G |
| Cas.: 1324000-40-9 | Purity: ≥95% | Benzyl (1-phenylcyclopropyl)carbamate | ESD-891449-10G |
| Cas.: 1324000-40-9 | Purity: ≥95% | Benzyl (1-phenylcyclopropyl)carbamate | ESD-891449-25G |
| Cas.: 288569-60-8 | Purity: 97% | (1-Cyanocyclopropyl)methyl 4-methylbenzenesulfonate | ESD-891450-100MG |
| Cas.: 288569-60-8 | Purity: 97% | (1-Cyanocyclopropyl)methyl 4-methylbenzenesulfonate | ESD-891450-250MG |
| Cas.: 288569-60-8 | Purity: 97% | (1-Cyanocyclopropyl)methyl 4-methylbenzenesulfonate | ESD-891450-1G |
| Cas.: 90800-42-3 | Purity: ≥95% | 8-Hydroxyquinoline-6-carboxylic acid | ESD-891451-100MG |
| Cas.: 530156-90-2 | Purity: ≥95% | 2-Bromo-5-chloroisonicotinic acid | ESD-891452-100MG |
| Cas.: 530156-90-2 | Purity: ≥95% | 2-Bromo-5-chloroisonicotinic acid | ESD-891452-250MG |
| Cas.: 530156-90-2 | Purity: ≥95% | 2-Bromo-5-chloroisonicotinic acid | ESD-891452-1G |
| Cas.: 530156-90-2 | Purity: ≥95% | 2-Bromo-5-chloroisonicotinic acid | ESD-891452-5G |
| Cas.: 1451393-19-3 | Purity: 97% | (6-(Benzyloxy)-2,3-difluorophenyl)boronic acid | ESD-891453-100MG |
| Cas.: 1451393-19-3 | Purity: 97% | (6-(Benzyloxy)-2,3-difluorophenyl)boronic acid | ESD-891453-250MG |
| Cas.: 1451393-19-3 | Purity: 97% | (6-(Benzyloxy)-2,3-difluorophenyl)boronic acid | ESD-891453-1G |
| Cas.: 1451393-19-3 | Purity: 97% | (6-(Benzyloxy)-2,3-difluorophenyl)boronic acid | ESD-891453-5G |
| Cas.: 29331-92-8 | Purity: 97% | 10-Hydroxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide | ESD-891454-250MG |
| Cas.: 29331-92-8 | Purity: 97% | 10-Hydroxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide | ESD-891454-1G |
| Cas.: 29331-92-8 | Purity: 97% | 10-Hydroxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide | ESD-891454-5G |
| Cas.: 29331-92-8 | Purity: 97% | 10-Hydroxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide | ESD-891454-10G |
| Cas.: 914311-50-5 | Purity: 95% | 4-Bromo-1H-indazol-3-amine | ESD-891455-250MG |
| Cas.: 914311-50-5 | Purity: 95% | 4-Bromo-1H-indazol-3-amine | ESD-891455-1G |
| Cas.: 914311-50-5 | Purity: 95% | 4-Bromo-1H-indazol-3-amine | ESD-891455-5G |
| Cas.: 914311-50-5 | Purity: 95% | 4-Bromo-1H-indazol-3-amine | ESD-891455-10G |
| Cas.: 1841081-27-3 | Purity: 97% | Ethyl 2,4-dichloroquinazoline-6-carboxylate | ESD-891456-100MG |
| Cas.: 1841081-27-3 | Purity: 97% | Ethyl 2,4-dichloroquinazoline-6-carboxylate | ESD-891456-250MG |
| Cas.: 1841081-27-3 | Purity: 97% | Ethyl 2,4-dichloroquinazoline-6-carboxylate | ESD-891456-1G |
| Cas.: 885521-25-5 | Purity: ≥95% | 3-Bromo-1H-indazol-4-amine | ESD-891457-100MG |
| Cas.: 885521-25-5 | Purity: ≥95% | 3-Bromo-1H-indazol-4-amine | ESD-891457-250MG |
| Cas.: 885521-25-5 | Purity: ≥95% | 3-Bromo-1H-indazol-4-amine | ESD-891457-1G |
| Cas.: 885521-25-5 | Purity: ≥95% | 3-Bromo-1H-indazol-4-amine | ESD-891457-5G |
| Cas.: 1858252-28-4 | Purity: ≥95% | (1-Methyl-5-phenyl-1H-pyrazol-4-yl)boronic acid | ESD-891458-100MG |
| Cas.: 1858252-28-4 | Purity: ≥95% | (1-Methyl-5-phenyl-1H-pyrazol-4-yl)boronic acid | ESD-891458-250MG |
| Cas.: 6301-60-6 | Purity: 97% | 4-Iodophthalic acid | ESD-891459-100MG |
| Cas.: 6301-60-6 | Purity: 97% | 4-Iodophthalic acid | ESD-891459-250MG |
| Cas.: 6301-60-6 | Purity: 97% | 4-Iodophthalic acid | ESD-891459-1G |
| Cas.: 13877-56-0 | Purity: 97% | 1H-Pyrazolo[4,3-d]pyrimidin-7-amine | ESD-891460-100MG |
| Cas.: 13877-56-0 | Purity: 97% | 1H-Pyrazolo[4,3-d]pyrimidin-7-amine | ESD-891460-250MG |
| Cas.: 13877-56-0 | Purity: 97% | 1H-Pyrazolo[4,3-d]pyrimidin-7-amine | ESD-891460-1G |
| Cas.: 91912-46-8 | Purity: ≥95% | 2-(Carboxymethyl)-5-oxotetrahydrofuran-2-carboxylic acid | ESD-891461-100MG |
| Cas.: 91912-46-8 | Purity: ≥95% | 2-(Carboxymethyl)-5-oxotetrahydrofuran-2-carboxylic acid | ESD-891461-250MG |
| Cas.: 155601-07-3 | Purity: ≥95% | N-Benzyl-3-bromo-1-methyl-4-nitro-1H-pyrazol-5-amine | ESD-891462-100MG |
| Cas.: 155601-07-3 | Purity: ≥95% | N-Benzyl-3-bromo-1-methyl-4-nitro-1H-pyrazol-5-amine | ESD-891462-250MG |
| Cas.: 22433-76-7 | Purity: 97% | N-(Quinolin-6-yl)acetamide | ESD-891464-100MG |
| Cas.: 22433-76-7 | Purity: 97% | N-(Quinolin-6-yl)acetamide | ESD-891464-250MG |
| Cas.: 22433-76-7 | Purity: 97% | N-(Quinolin-6-yl)acetamide | ESD-891464-1G |
| Cas.: 22433-76-7 | Purity: 97% | N-(Quinolin-6-yl)acetamide | ESD-891464-5G |
| Cas.: 2426-59-7 | Purity: 97% | 6-(Benzyloxy)-5-methoxy-1H-indole | ESD-891465-100MG |
| Cas.: 2426-59-7 | Purity: 97% | 6-(Benzyloxy)-5-methoxy-1H-indole | ESD-891465-250MG |
| Cas.: 2426-59-7 | Purity: 97% | 6-(Benzyloxy)-5-methoxy-1H-indole | ESD-891465-1G |
| Cas.: 163831-65-0 | Purity: ≥95% | (R)-N-Benzyl-1-(naphthalen-1-yl)ethanamine hydrochloride | ESD-891466-100MG |
| Cas.: 163831-65-0 | Purity: ≥95% | (R)-N-Benzyl-1-(naphthalen-1-yl)ethanamine hydrochloride | ESD-891466-250MG |
| Cas.: 877399-73-0 | Purity: 97% | 1-Boc-4-(4-Iodo-1H-pyrazol-1-yl)piperidine | ESD-891467-250MG |
| Cas.: 877399-73-0 | Purity: 97% | 1-Boc-4-(4-Iodo-1H-pyrazol-1-yl)piperidine | ESD-891467-1G |
| Cas.: 877399-73-0 | Purity: 97% | 1-Boc-4-(4-Iodo-1H-pyrazol-1-yl)piperidine | ESD-891467-5G |
| Cas.: 877399-73-0 | Purity: 97% | 1-Boc-4-(4-Iodo-1H-pyrazol-1-yl)piperidine | ESD-891467-10G |
| Cas.: 1283095-48-6 | Purity: 97% | tert-Butyl 4′,5′-dihydrospiro[piperidine-4,7′-thieno[2,3-c]pyran]-1-carboxylate | ESD-891468-1G |
| Cas.: 1283095-48-6 | Purity: 97% | tert-Butyl 4′,5′-dihydrospiro[piperidine-4,7′-thieno[2,3-c]pyran]-1-carboxylate | ESD-891468-5G |
| Cas.: 796-77-0 | Purity: 97% | (4-(2-(Diethylamino)ethoxy)phenyl)(phenyl)methanone | ESD-891469-1G |
| Cas.: 796-77-0 | Purity: 97% | (4-(2-(Diethylamino)ethoxy)phenyl)(phenyl)methanone | ESD-891469-5G |
| Cas.: 796-77-0 | Purity: 97% | (4-(2-(Diethylamino)ethoxy)phenyl)(phenyl)methanone | ESD-891469-10G |
| Cas.: 1769-84-2 | Purity: 97% | 6-Methoxy-2-phenyl-3,4-dihydronaphthalen-1(2H)-one | ESD-891470-250MG |
| Cas.: 1769-84-2 | Purity: 97% | 6-Methoxy-2-phenyl-3,4-dihydronaphthalen-1(2H)-one | ESD-891470-1G |
| Cas.: 1769-84-2 | Purity: 97% | 6-Methoxy-2-phenyl-3,4-dihydronaphthalen-1(2H)-one | ESD-891470-5G |
| Cas.: 709665-73-6 | Purity: ≥95% | Methyl 2-(4-bromophenyl)-2-((tert-butoxycarbonyl)amino)acetate | ESD-891471-100MG |
| Cas.: 709665-73-6 | Purity: ≥95% | Methyl 2-(4-bromophenyl)-2-((tert-butoxycarbonyl)amino)acetate | ESD-891471-250MG |
| Cas.: 5194-37-6 | Purity: 98% | 4-Bromobenzo[b]thiophene-2-carboxylic acid | ESD-891472-100MG |
| Cas.: 5194-37-6 | Purity: 98% | 4-Bromobenzo[b]thiophene-2-carboxylic acid | ESD-891472-250MG |
| Cas.: 5194-37-6 | Purity: 98% | 4-Bromobenzo[b]thiophene-2-carboxylic acid | ESD-891472-1G |
| Cas.: 5194-37-6 | Purity: 98% | 4-Bromobenzo[b]thiophene-2-carboxylic acid | ESD-891472-5G |
| Cas.: 7312-10-9 | Purity: 95% | 5-Bromobenzo[b]thiophene-2-carboxylic acid | ESD-891473-250MG |
| Cas.: 7312-10-9 | Purity: 95% | 5-Bromobenzo[b]thiophene-2-carboxylic acid | ESD-891473-1G |
| Cas.: 7312-10-9 | Purity: 95% | 5-Bromobenzo[b]thiophene-2-carboxylic acid | ESD-891473-5G |
| Cas.: 7312-10-9 | Purity: 95% | 5-Bromobenzo[b]thiophene-2-carboxylic acid | ESD-891473-10G |
| Cas.: 32703-82-5 | Purity: ≥95% | 6-(tert-Butyl)naphthalene-2,3-dicarbonitrile | ESD-891474-100MG |
| Cas.: 32703-82-5 | Purity: ≥95% | 6-(tert-Butyl)naphthalene-2,3-dicarbonitrile | ESD-891474-250MG |
| Cas.: 32703-82-5 | Purity: ≥95% | 6-(tert-Butyl)naphthalene-2,3-dicarbonitrile | ESD-891474-1G |
| Cas.: 19075-59-3 | Purity: 98% | 7-Bromobenzo[b]thiophene-2-carboxylic acid | ESD-891475-250MG |
| Cas.: 19075-59-3 | Purity: 98% | 7-Bromobenzo[b]thiophene-2-carboxylic acid | ESD-891475-1G |
| Cas.: 19075-59-3 | Purity: 98% | 7-Bromobenzo[b]thiophene-2-carboxylic acid | ESD-891475-5G |
| Cas.: 1172623-96-9 | Purity: ≥98% | tert-Butyl (1-(2,5-difluorophenyl)-1-oxopent-4-yn-2-yl)carbamate | ESD-891476-100MG |
| Cas.: 1172623-96-9 | Purity: ≥98% | tert-Butyl (1-(2,5-difluorophenyl)-1-oxopent-4-yn-2-yl)carbamate | ESD-891476-250MG |
| Cas.: 1172623-96-9 | Purity: ≥98% | tert-Butyl (1-(2,5-difluorophenyl)-1-oxopent-4-yn-2-yl)carbamate | ESD-891476-1G |
| Cas.: 1172623-96-9 | Purity: ≥98% | tert-Butyl (1-(2,5-difluorophenyl)-1-oxopent-4-yn-2-yl)carbamate | ESD-891476-5G |
| Cas.: 1357946-55-4 | Purity: ≥95% | 6-Bromo-3-iodo-1H-pyrazolo[3,4-b]pyridine | ESD-891477-100MG |
| Cas.: 1357946-55-4 | Purity: ≥95% | 6-Bromo-3-iodo-1H-pyrazolo[3,4-b]pyridine | ESD-891477-250MG |
| Cas.: 83783-33-9 | Purity: ≥95% | 3-Formyl-1H-indole-6-carbonitrile | ESD-891478-250MG |
| Cas.: 83783-33-9 | Purity: ≥95% | 3-Formyl-1H-indole-6-carbonitrile | ESD-891478-1G |
| Cas.: 83783-33-9 | Purity: ≥95% | 3-Formyl-1H-indole-6-carbonitrile | ESD-891478-5G |
| Cas.: 83783-33-9 | Purity: ≥95% | 3-Formyl-1H-indole-6-carbonitrile | ESD-891478-10G |
| Cas.: 5453-07-6 | Purity: 97% | 5-Amino-3-methyl-1H-pyrazole-4-carbonitrile | ESD-891479-250MG |
| Cas.: 5453-07-6 | Purity: 97% | 5-Amino-3-methyl-1H-pyrazole-4-carbonitrile | ESD-891479-1G |
| Cas.: 5453-07-6 | Purity: 97% | 5-Amino-3-methyl-1H-pyrazole-4-carbonitrile | ESD-891479-5G |
| Cas.: 5453-07-6 | Purity: 97% | 5-Amino-3-methyl-1H-pyrazole-4-carbonitrile | ESD-891479-25G |
| Cas.: 930111-10-7 | Purity: 97% | tert-Butyl 4-((4-bromobenzyl)oxy)piperidine-1-carboxylate | ESD-891480-100MG |
| Cas.: 930111-10-7 | Purity: 97% | tert-Butyl 4-((4-bromobenzyl)oxy)piperidine-1-carboxylate | ESD-891480-250MG |
| Cas.: 930111-10-7 | Purity: 97% | tert-Butyl 4-((4-bromobenzyl)oxy)piperidine-1-carboxylate | ESD-891480-1G |
| Cas.: 342417-04-3 | Purity: 97% | N-(tert-Butyl)-6-chloro-4-(o-tolyl)nicotinamide | ESD-891481-100MG |
| Cas.: 342417-04-3 | Purity: 97% | N-(tert-Butyl)-6-chloro-4-(o-tolyl)nicotinamide | ESD-891481-250MG |
| Cas.: 98625-26-4 | Purity: ≥98% | Bay-K-8644 (S)-(-)- | ESD-891482-1MG |
| Cas.: 98625-26-4 | Purity: ≥98% | Bay-K-8644 (S)-(-)- | ESD-891482-5MG |
| Cas.: 98625-26-4 | Purity: ≥98% | Bay-K-8644 (S)-(-)- | ESD-891482-10MG |
| Cas.: 98625-26-4 | Purity: ≥98% | Bay-K-8644 (S)-(-)- | ESD-891482-25MG |
| Cas.: 159589-71-6 | Purity: 97% | 2-(2-Methyl-1H-imidazol-1-yl)benzoic acid | ESD-891483-250MG |
| Cas.: 159589-71-6 | Purity: 97% | 2-(2-Methyl-1H-imidazol-1-yl)benzoic acid | ESD-891483-1G |
| Cas.: 159589-71-6 | Purity: 97% | 2-(2-Methyl-1H-imidazol-1-yl)benzoic acid | ESD-891483-5G |
| Cas.: 132680-54-7 | Purity: 97% | 6-Methoxyisoindolin-1-one | ESD-891484-250MG |
| Cas.: 132680-54-7 | Purity: 97% | 6-Methoxyisoindolin-1-one | ESD-891484-1G |
| Cas.: 132680-54-7 | Purity: 97% | 6-Methoxyisoindolin-1-one | ESD-891484-5G |
| Cas.: 132680-54-7 | Purity: 97% | 6-Methoxyisoindolin-1-one | ESD-891484-10G |
| Cas.: 127838-58-8 | Purity: ≥95% | 4-(Hydroxymethyl)pyridin-2(1H)-one | ESD-891485-250MG |
| Cas.: 127838-58-8 | Purity: ≥95% | 4-(Hydroxymethyl)pyridin-2(1H)-one | ESD-891485-1G |
| Cas.: 127838-58-8 | Purity: ≥95% | 4-(Hydroxymethyl)pyridin-2(1H)-one | ESD-891485-5G |
| Cas.: 19943-16-9 | Purity: ≥95% | (3S,6S)-3,6-Diisopropylpiperazine-2,5-dione | ESD-891486-250MG |
| Cas.: 19943-16-9 | Purity: ≥95% | (3S,6S)-3,6-Diisopropylpiperazine-2,5-dione | ESD-891486-1G |
| Cas.: 19943-16-9 | Purity: ≥95% | (3S,6S)-3,6-Diisopropylpiperazine-2,5-dione | ESD-891486-5G |
| Cas.: 107020-80-4 | Purity: 97% | 2-Acetamido-2-cyclohexylacetic acid | ESD-891487-100MG |
| Cas.: 107020-80-4 | Purity: 97% | 2-Acetamido-2-cyclohexylacetic acid | ESD-891487-250MG |
| Cas.: 107020-80-4 | Purity: 97% | 2-Acetamido-2-cyclohexylacetic acid | ESD-891487-1G |
| Cas.: 893611-67-1 | Purity: ≥95% | 5-Bromo-3-(piperazin-1-yl)pyrazin-2-amine | ESD-891488-1G |
| Cas.: 893611-67-1 | Purity: ≥95% | 5-Bromo-3-(piperazin-1-yl)pyrazin-2-amine | ESD-891488-5G |
| Cas.: 893611-67-1 | Purity: ≥95% | 5-Bromo-3-(piperazin-1-yl)pyrazin-2-amine | ESD-891488-10G |
| Cas.: 919347-16-3 | Purity: 98% | 4-((5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)methyl)morpholine | ESD-891489-100MG |
| Cas.: 919347-16-3 | Purity: 98% | 4-((5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)methyl)morpholine | ESD-891489-250MG |
| Cas.: 18593-44-7 | Purity: 97% | 5,6-Dimethylthieno[2,3-d]pyrimidin-4(3H)-one | ESD-891490-250MG |
| Cas.: 18593-44-7 | Purity: 97% | 5,6-Dimethylthieno[2,3-d]pyrimidin-4(3H)-one | ESD-891490-1G |
| Cas.: 18593-44-7 | Purity: 97% | 5,6-Dimethylthieno[2,3-d]pyrimidin-4(3H)-one | ESD-891490-5G |
| Cas.: 18593-44-7 | Purity: 97% | 5,6-Dimethylthieno[2,3-d]pyrimidin-4(3H)-one | ESD-891490-10G |
| Cas.: 156635-90-4 | Purity: 96% | (4-((4-Methoxybenzyl)oxy)phenyl)boronic acid | ESD-891491-250MG |
| Cas.: 156635-90-4 | Purity: 96% | (4-((4-Methoxybenzyl)oxy)phenyl)boronic acid | ESD-891491-1G |
| Cas.: 156635-90-4 | Purity: 96% | (4-((4-Methoxybenzyl)oxy)phenyl)boronic acid | ESD-891491-5G |
| Cas.: 19418-11-2 | Purity: 97% | Tetrahydrothiophene-2-carboxylic acid | ESD-891492-100MG |
| Cas.: 19418-11-2 | Purity: 97% | Tetrahydrothiophene-2-carboxylic acid | ESD-891492-250MG |
| Cas.: 19418-11-2 | Purity: 97% | Tetrahydrothiophene-2-carboxylic acid | ESD-891492-1G |
| Cas.: 5042-55-7 | Purity: ≥95% | 5-Nitrobenzene-1,3-diamine | ESD-891493-100MG |
| Cas.: 5042-55-7 | Purity: ≥95% | 5-Nitrobenzene-1,3-diamine | ESD-891493-250MG |
| Cas.: 5042-55-7 | Purity: ≥95% | 5-Nitrobenzene-1,3-diamine | ESD-891493-1G |
| Cas.: 4445-43-6 | Purity: 97% | 3-Amino-[1,1′-biphenyl]-4-carboxylic acid | ESD-891494-100MG |
| Cas.: 4445-43-6 | Purity: 97% | 3-Amino-[1,1′-biphenyl]-4-carboxylic acid | ESD-891494-250MG |
| Cas.: 13599-12-7 | Purity: 97% | Ethyl 3-phenyl-1H-pyrazole-5-carboxylate | ESD-891495-250MG |
| Cas.: 13599-12-7 | Purity: 97% | Ethyl 3-phenyl-1H-pyrazole-5-carboxylate | ESD-891495-1G |
| Cas.: 13599-12-7 | Purity: 97% | Ethyl 3-phenyl-1H-pyrazole-5-carboxylate | ESD-891495-5G |
| Cas.: 957034-74-1 | Purity: 97% | 3-Benzyloxy-4-fluorophenylboronic acid | ESD-891496-250MG |
| Cas.: 957034-74-1 | Purity: 97% | 3-Benzyloxy-4-fluorophenylboronic acid | ESD-891496-1G |
| Cas.: 957034-74-1 | Purity: 97% | 3-Benzyloxy-4-fluorophenylboronic acid | ESD-891496-5G |
| Cas.: 957034-74-1 | Purity: 97% | 3-Benzyloxy-4-fluorophenylboronic acid | ESD-891496-10G |
| Cas.: 1799412-23-9 | Purity: ≥95% | (R)-2-((5-Chloro-4-iodopyridin-2-yl)amino)propan-1-ol | ESD-891498-100MG |
| Cas.: 1799412-23-9 | Purity: ≥95% | (R)-2-((5-Chloro-4-iodopyridin-2-yl)amino)propan-1-ol | ESD-891498-250MG |
| Cas.: 1799412-23-9 | Purity: ≥95% | (R)-2-((5-Chloro-4-iodopyridin-2-yl)amino)propan-1-ol | ESD-891498-1G |
| Cas.: 1799434-65-3 | Purity: ≥95% | (S)-2-((5-Chloro-4-iodopyridin-2-yl)amino)propan-1-ol | ESD-891499-100MG |
| Cas.: 1799434-65-3 | Purity: ≥95% | (S)-2-((5-Chloro-4-iodopyridin-2-yl)amino)propan-1-ol | ESD-891499-250MG |
| Cas.: 955406-36-7 | Purity: ≥95% | Benzyl (3-hydroxycyclohexyl)carbamate | ESD-891500-100MG |
| Cas.: 955406-36-7 | Purity: ≥95% | Benzyl (3-hydroxycyclohexyl)carbamate | ESD-891500-250MG |
| Cas.: 955406-36-7 | Purity: ≥95% | Benzyl (3-hydroxycyclohexyl)carbamate | ESD-891500-1G |
| Cas.: 955406-36-7 | Purity: ≥95% | Benzyl (3-hydroxycyclohexyl)carbamate | ESD-891500-5G |
| Cas.: 1279863-38-5 | Purity: 97% | Ethyl 3-iodo-1H-indazole-5-carboxylate | ESD-891501-250MG |
| Cas.: 1279863-38-5 | Purity: 97% | Ethyl 3-iodo-1H-indazole-5-carboxylate | ESD-891501-1G |
| Cas.: 1643141-19-8 | Purity: 97% | tert-Butyl ((5-carbamoyl-1-methyl-1H-pyrazol-3-yl)methyl)(methyl)carbamate | ESD-891502-100MG |
| Cas.: 1643141-19-8 | Purity: 97% | tert-Butyl ((5-carbamoyl-1-methyl-1H-pyrazol-3-yl)methyl)(methyl)carbamate | ESD-891502-250MG |
| Cas.: 1643141-19-8 | Purity: 97% | tert-Butyl ((5-carbamoyl-1-methyl-1H-pyrazol-3-yl)methyl)(methyl)carbamate | ESD-891502-1G |
| Cas.: 57741-46-5 | Purity: 98% | 4,7,10,13-Tetraoxahexadecane-1,16-dinitrile | ESD-891503-100MG |
| Cas.: 57741-46-5 | Purity: 98% | 4,7,10,13-Tetraoxahexadecane-1,16-dinitrile | ESD-891503-250MG |
| Cas.: 57531-38-1 | Purity: ≥95% | 5-Chloro-4-nitro-1H-imidazole | ESD-891504-250MG |
| Cas.: 57531-38-1 | Purity: ≥95% | 5-Chloro-4-nitro-1H-imidazole | ESD-891504-1G |
| Cas.: 57531-38-1 | Purity: ≥95% | 5-Chloro-4-nitro-1H-imidazole | ESD-891504-5G |
| Cas.: 221615-72-1 | Purity: 97% | 1-(6-Methylpyridin-3-yl)-2-(4-(methylthio)phenyl)ethanone | ESD-891505-250MG |
| Cas.: 221615-72-1 | Purity: 97% | 1-(6-Methylpyridin-3-yl)-2-(4-(methylthio)phenyl)ethanone | ESD-891505-1G |
| Cas.: 17999-93-8 | Purity: 97% | 1,1′-Biisoquinoline | ESD-891506-100MG |
| Cas.: 17999-93-8 | Purity: 97% | 1,1′-Biisoquinoline | ESD-891506-250MG |
| Cas.: 4494-16-0 | Purity: ≥95% | Octadec-9-enedioic acid | ESD-891507-50MG |
| Cas.: 6937-34-4 | Purity: ≥95% | 3-Iodophthalic acid | ESD-891508-250MG |
| Cas.: 6937-34-4 | Purity: ≥95% | 3-Iodophthalic acid | ESD-891508-1G |
| Cas.: 6937-34-4 | Purity: ≥95% | 3-Iodophthalic acid | ESD-891508-5G |
| Cas.: 6937-34-4 | Purity: ≥95% | 3-Iodophthalic acid | ESD-891508-10G |
| Cas.: 206763-93-1 | Purity: 97% | (4-Dodecylphenyl)boronic acid | ESD-891509-100MG |
| Cas.: 206763-93-1 | Purity: 97% | (4-Dodecylphenyl)boronic acid | ESD-891509-250MG |
| Cas.: 1774-36-3 | Purity: 97% | 4,4′-Sulfinylbis(methoxybenzene) | ESD-891510-100MG |
| Cas.: 1774-36-3 | Purity: 97% | 4,4′-Sulfinylbis(methoxybenzene) | ESD-891510-250MG |
| Cas.: 1774-36-3 | Purity: 97% | 4,4′-Sulfinylbis(methoxybenzene) | ESD-891510-1G |
| Cas.: 1092579-78-6 | Purity: ≥95% | 5-Bromo-4-chloro-3-iodo-1H-pyrazolo[3,4-b]pyridine | ESD-891511-100MG |
| Cas.: 1092579-78-6 | Purity: ≥95% | 5-Bromo-4-chloro-3-iodo-1H-pyrazolo[3,4-b]pyridine | ESD-891511-250MG |
| Cas.: 192701-73-8 | Purity: ≥95% | Methyl 3-(p-tolyl)-1H-pyrazole-5-carboxylate | ESD-891512-100MG |
| Cas.: 192701-73-8 | Purity: ≥95% | Methyl 3-(p-tolyl)-1H-pyrazole-5-carboxylate | ESD-891512-250MG |
| Cas.: 192701-73-8 | Purity: ≥95% | Methyl 3-(p-tolyl)-1H-pyrazole-5-carboxylate | ESD-891512-1G |
| Cas.: 192701-73-8 | Purity: ≥95% | Methyl 3-(p-tolyl)-1H-pyrazole-5-carboxylate | ESD-891512-5G |
| Cas.: 14579-97-6 | Purity: 97% | N’-(4-Bromophenyl)acetohydrazide | ESD-891513-250MG |
| Cas.: 14579-97-6 | Purity: 97% | N’-(4-Bromophenyl)acetohydrazide | ESD-891513-1G |
| Cas.: 14579-97-6 | Purity: 97% | N’-(4-Bromophenyl)acetohydrazide | ESD-891513-5G |
| Cas.: 2786-05-2 | Purity: 95% | Dibenzo[b,d]furan-4-carboxylic acid | ESD-891514-250MG |
| Cas.: 2786-05-2 | Purity: 95% | Dibenzo[b,d]furan-4-carboxylic acid | ESD-891514-1G |
| Cas.: 2786-05-2 | Purity: 95% | Dibenzo[b,d]furan-4-carboxylic acid | ESD-891514-5G |
| Cas.: 16019-34-4 | Purity: ≥95% | 7-Benzyl-4-chloro-7H-pyrrolo[2,3-d]pyrimidine | ESD-891515-250MG |
| Cas.: 16019-34-4 | Purity: ≥95% | 7-Benzyl-4-chloro-7H-pyrrolo[2,3-d]pyrimidine | ESD-891515-1G |
| Cas.: 16019-34-4 | Purity: ≥95% | 7-Benzyl-4-chloro-7H-pyrrolo[2,3-d]pyrimidine | ESD-891515-5G |
| Cas.: 374104-63-9 | Purity: 97% | 4-Chloro-5-(p-tolyl)thieno[2,3-d]pyrimidine | ESD-891516-250MG |
| Cas.: 374104-63-9 | Purity: 97% | 4-Chloro-5-(p-tolyl)thieno[2,3-d]pyrimidine | ESD-891516-1G |
| Cas.: 374104-63-9 | Purity: 97% | 4-Chloro-5-(p-tolyl)thieno[2,3-d]pyrimidine | ESD-891516-5G |
| Cas.: 59662-47-4 | Purity: ≥95% | 4′-Pentyl-[1,1′-biphenyl]-4-carboxylic acid | ESD-891517-250MG |
| Cas.: 59662-47-4 | Purity: ≥95% | 4′-Pentyl-[1,1′-biphenyl]-4-carboxylic acid | ESD-891517-1G |
| Cas.: 1404192-13-7 | Purity: ≥95% | (1-(6-Ethoxypyrimidin-4-yl)piperidin-3-yl)methanol | ESD-891518-100MG |
| Cas.: 1404192-13-7 | Purity: ≥95% | (1-(6-Ethoxypyrimidin-4-yl)piperidin-3-yl)methanol | ESD-891518-250MG |
| Cas.: 23616-31-1 | Purity: 97% | 1,6-Naphthyridin-5(6H)-one | ESD-891519-100MG |
| Cas.: 23616-31-1 | Purity: 97% | 1,6-Naphthyridin-5(6H)-one | ESD-891519-250MG |
| Cas.: 23616-31-1 | Purity: 97% | 1,6-Naphthyridin-5(6H)-one | ESD-891519-1G |
| Cas.: 23616-31-1 | Purity: 97% | 1,6-Naphthyridin-5(6H)-one | ESD-891519-5G |
| Cas.: 98632-91-8 | Purity: 95% | N-Carbobenzyloxy-D-serine-beta-lactone | ESD-891520-100MG |
| Cas.: 98632-91-8 | Purity: 95% | N-Carbobenzyloxy-D-serine-beta-lactone | ESD-891520-250MG |
| Cas.: 98632-91-8 | Purity: 95% | N-Carbobenzyloxy-D-serine-beta-lactone | ESD-891520-1G |
| Cas.: 98632-91-8 | Purity: 95% | N-Carbobenzyloxy-D-serine-beta-lactone | ESD-891520-5G |
| Cas.: 190274-15-8 | Purity: 97% | 7-Bromoquinazolin-2-amine | ESD-891521-100MG |
| Cas.: 190274-15-8 | Purity: 97% | 7-Bromoquinazolin-2-amine | ESD-891521-250MG |
| Cas.: 190274-15-8 | Purity: 97% | 7-Bromoquinazolin-2-amine | ESD-891521-1G |
| Cas.: 395101-67-4 | Purity: 97% | 3-Bromo-1H-indazole-5-carbonitrile | ESD-891522-100MG |
| Cas.: 395101-67-4 | Purity: 97% | 3-Bromo-1H-indazole-5-carbonitrile | ESD-891522-250MG |
| Cas.: 395101-67-4 | Purity: 97% | 3-Bromo-1H-indazole-5-carbonitrile | ESD-891522-1G |
| Cas.: 395101-67-4 | Purity: 97% | 3-Bromo-1H-indazole-5-carbonitrile | ESD-891522-5G |
| Cas.: 10412-93-8 | Purity: ≥95% | N-Benzyl-2-cyanoacetamide | ESD-891523-250MG |
| Cas.: 10412-93-8 | Purity: ≥95% | N-Benzyl-2-cyanoacetamide | ESD-891523-1G |
| Cas.: 10412-93-8 | Purity: ≥95% | N-Benzyl-2-cyanoacetamide | ESD-891523-5G |
| Cas.: 10412-93-8 | Purity: ≥95% | N-Benzyl-2-cyanoacetamide | ESD-891523-10G |
| Cas.: 870535-27-6 | Purity: 97% | tert-Butyl 4-chloro-2-(hydroxymethyl)-1H-indole-1-carboxylate | ESD-891524-100MG |
| Cas.: 870535-27-6 | Purity: 97% | tert-Butyl 4-chloro-2-(hydroxymethyl)-1H-indole-1-carboxylate | ESD-891524-250MG |
| Cas.: 870535-27-6 | Purity: 97% | tert-Butyl 4-chloro-2-(hydroxymethyl)-1H-indole-1-carboxylate | ESD-891524-1G |
| Cas.: 870535-27-6 | Purity: 97% | tert-Butyl 4-chloro-2-(hydroxymethyl)-1H-indole-1-carboxylate | ESD-891524-5G |
| Cas.: 22860-22-6 | Purity: 97% | (2R,3R,4S,5S,6S)-2-(Acetoxymethyl)-6-hydroxytetrahydro-2H-pyran-3,4,5-triyl triacetate | ESD-891525-100MG |
| Cas.: 22860-22-6 | Purity: 97% | (2R,3R,4S,5S,6S)-2-(Acetoxymethyl)-6-hydroxytetrahydro-2H-pyran-3,4,5-triyl triacetate | ESD-891525-250MG |
| Cas.: 22860-22-6 | Purity: 97% | (2R,3R,4S,5S,6S)-2-(Acetoxymethyl)-6-hydroxytetrahydro-2H-pyran-3,4,5-triyl triacetate | ESD-891525-1G |
| Cas.: 684220-30-2 | Purity: ≥95% | 4,6-Dichloropyrimidine-2-carboxylic acid | ESD-891526-100MG |
| Cas.: 684220-30-2 | Purity: ≥95% | 4,6-Dichloropyrimidine-2-carboxylic acid | ESD-891526-250MG |
| Cas.: 684220-30-2 | Purity: ≥95% | 4,6-Dichloropyrimidine-2-carboxylic acid | ESD-891526-1G |
| Cas.: 33763-20-1 | Purity: 97% | 4-Methyl-2-phenylthiazole-5-carboxylic acid | ESD-891527-1G |
| Cas.: 33763-20-1 | Purity: 97% | 4-Methyl-2-phenylthiazole-5-carboxylic acid | ESD-891527-5G |
| Cas.: 33763-20-1 | Purity: 97% | 4-Methyl-2-phenylthiazole-5-carboxylic acid | ESD-891527-10G |
| Cas.: 531-88-4 | Purity: ≥95% | 5,6-Dimethoxyisobenzofuran-1(3H)-one | ESD-891528-250MG |
| Cas.: 531-88-4 | Purity: ≥95% | 5,6-Dimethoxyisobenzofuran-1(3H)-one | ESD-891528-1G |
| Cas.: 531-88-4 | Purity: ≥95% | 5,6-Dimethoxyisobenzofuran-1(3H)-one | ESD-891528-5G |
| Cas.: 531-88-4 | Purity: ≥95% | 5,6-Dimethoxyisobenzofuran-1(3H)-one | ESD-891528-10G |
| Cas.: 4073-98-7 | Purity: 97% | 4,4-Methylenebis(2,6-dimethylaniline) | ESD-891529-1G |
| Cas.: 4073-98-7 | Purity: 97% | 4,4-Methylenebis(2,6-dimethylaniline) | ESD-891529-5G |
| Cas.: 4073-98-7 | Purity: 97% | 4,4-Methylenebis(2,6-dimethylaniline) | ESD-891529-25G |
| Cas.: 4073-98-7 | Purity: 97% | 4,4-Methylenebis(2,6-dimethylaniline) | ESD-891529-100G |
| Cas.: 1221818-08-1 | Purity: ≥95% | tert-Butyl 1-oxo-2,6-diazaspiro[4.5]decane-6-carboxylate | ESD-891530-100MG |
| Cas.: 1221818-08-1 | Purity: ≥95% | tert-Butyl 1-oxo-2,6-diazaspiro[4.5]decane-6-carboxylate | ESD-891530-250MG |
| Cas.: 1221818-08-1 | Purity: ≥95% | tert-Butyl 1-oxo-2,6-diazaspiro[4.5]decane-6-carboxylate | ESD-891530-1G |
| Cas.: 1221818-08-1 | Purity: ≥95% | tert-Butyl 1-oxo-2,6-diazaspiro[4.5]decane-6-carboxylate | ESD-891530-5G |
| Cas.: 89978-31-4 | Purity: 97% | 5-(2,6-Dichlorophenyl)-1,3,4-thiadiazol-2-amine | ESD-891531-100MG |
| Cas.: 89978-31-4 | Purity: 97% | 5-(2,6-Dichlorophenyl)-1,3,4-thiadiazol-2-amine | ESD-891531-250MG |
| Cas.: 89978-31-4 | Purity: 97% | 5-(2,6-Dichlorophenyl)-1,3,4-thiadiazol-2-amine | ESD-891531-1G |
| Cas.: 1615-53-8 | Purity: 96% | 1-Methyl-2-(methylsulfonyl)-5-nitro-1H-imidazole | ESD-891532-100MG |
| Cas.: 1615-53-8 | Purity: 96% | 1-Methyl-2-(methylsulfonyl)-5-nitro-1H-imidazole | ESD-891532-250MG |
| Cas.: 1615-53-8 | Purity: 96% | 1-Methyl-2-(methylsulfonyl)-5-nitro-1H-imidazole | ESD-891532-1G |
| Cas.: 2236-60-4 | Purity: ≥95% | 2-Amino-1,5-dihydropteridin-4-ol | ESD-891533-250MG |
| Cas.: 2236-60-4 | Purity: ≥95% | 2-Amino-1,5-dihydropteridin-4-ol | ESD-891533-1G |
| Cas.: 2236-60-4 | Purity: ≥95% | 2-Amino-1,5-dihydropteridin-4-ol | ESD-891533-5G |
| Cas.: 2236-60-4 | Purity: ≥95% | 2-Amino-1,5-dihydropteridin-4-ol | ESD-891533-10G |
| Cas.: 284493-72-7 | Purity: 97% | 3-((tert-Butoxycarbonyl)amino)-3-(4-fluorophenyl)propanoic acid | ESD-891534-250MG |
| Cas.: 284493-72-7 | Purity: 97% | 3-((tert-Butoxycarbonyl)amino)-3-(4-fluorophenyl)propanoic acid | ESD-891534-1G |
| Cas.: 284493-72-7 | Purity: 97% | 3-((tert-Butoxycarbonyl)amino)-3-(4-fluorophenyl)propanoic acid | ESD-891534-5G |
| Cas.: 284493-72-7 | Purity: 97% | 3-((tert-Butoxycarbonyl)amino)-3-(4-fluorophenyl)propanoic acid | ESD-891534-10G |
| Cas.: 1420-04-8 | Purity: 97% | 5-Chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide compound with 2-aminoethanol (1:1) | ESD-891535-25G |
| Cas.: 1420-04-8 | Purity: 97% | 5-Chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide compound with 2-aminoethanol (1:1) | ESD-891535-100G |
| Cas.: 1420-04-8 | Purity: 97% | 5-Chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide compound with 2-aminoethanol (1:1) | ESD-891535-500G |
| Cas.: 5803-22-5 | Purity: 97% | 2-(3-Methoxy-4-nitrophenyl)acetic acid | ESD-891536-250MG |
| Cas.: 5803-22-5 | Purity: 97% | 2-(3-Methoxy-4-nitrophenyl)acetic acid | ESD-891536-1G |
| Cas.: 5803-22-5 | Purity: 97% | 2-(3-Methoxy-4-nitrophenyl)acetic acid | ESD-891536-5G |
| Cas.: 135417-65-1 | Purity: 97% | 1-Phenyl-1H-imidazole-5-carboxylic acid | ESD-891537-250MG |
| Cas.: 135417-65-1 | Purity: 97% | 1-Phenyl-1H-imidazole-5-carboxylic acid | ESD-891537-1G |
| Cas.: 878742-33-7 | Purity: ≥95% | 5-(Piperidin-1-yl)nicotinic acid | ESD-891538-100MG |
| Cas.: 878742-33-7 | Purity: ≥95% | 5-(Piperidin-1-yl)nicotinic acid | ESD-891538-250MG |
| Cas.: 1346702-54-2 | Purity: 97% | 6-Bromo-1-isopropyl-1H-indazole-4-carboxylic acid | ESD-891539-100MG |
| Cas.: 1346702-54-2 | Purity: 97% | 6-Bromo-1-isopropyl-1H-indazole-4-carboxylic acid | ESD-891539-250MG |
| Cas.: 1346702-54-2 | Purity: 97% | 6-Bromo-1-isopropyl-1H-indazole-4-carboxylic acid | ESD-891539-1G |
| Cas.: 168824-94-0 | Purity: ≥95% | tert-Butyl 3,4-dihydro-1H-pyrido[3,4-b]indole-2(9H)-carboxylate | ESD-891540-250MG |
| Cas.: 168824-94-0 | Purity: ≥95% | tert-Butyl 3,4-dihydro-1H-pyrido[3,4-b]indole-2(9H)-carboxylate | ESD-891540-1G |
| Cas.: 168824-94-0 | Purity: ≥95% | tert-Butyl 3,4-dihydro-1H-pyrido[3,4-b]indole-2(9H)-carboxylate | ESD-891540-5G |
| Cas.: 1072944-26-3 | Purity: 97% | 4-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole | ESD-891541-250MG |
| Cas.: 1072944-26-3 | Purity: 97% | 4-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole | ESD-891541-1G |
| Cas.: 1072944-26-3 | Purity: 97% | 4-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole | ESD-891541-5G |
| Cas.: 2044703-06-0 | Purity: 97% | 1-(Tetrahydro-2H-pyran-2-yl)-5-(trifluoromethyl)-1H-indazol-4-amine | ESD-891542-100MG |
| Cas.: 2044703-06-0 | Purity: 97% | 1-(Tetrahydro-2H-pyran-2-yl)-5-(trifluoromethyl)-1H-indazol-4-amine | ESD-891542-250MG |
| Cas.: 51516-67-7 | Purity: ≥95% | 5-Amino-1-(4-chlorophenyl)-1H-pyrazole-4-carbonitrile | ESD-891543-100MG |
| Cas.: 51516-67-7 | Purity: ≥95% | 5-Amino-1-(4-chlorophenyl)-1H-pyrazole-4-carbonitrile | ESD-891543-250MG |
| Cas.: 51516-67-7 | Purity: ≥95% | 5-Amino-1-(4-chlorophenyl)-1H-pyrazole-4-carbonitrile | ESD-891543-1G |
| Cas.: 51516-67-7 | Purity: ≥95% | 5-Amino-1-(4-chlorophenyl)-1H-pyrazole-4-carbonitrile | ESD-891543-5G |
| Cas.: 19094-48-5 | Purity: 97% | 3,5-Diiodobenzoic acid | ESD-891544-250MG |
| Cas.: 19094-48-5 | Purity: 97% | 3,5-Diiodobenzoic acid | ESD-891544-1G |
| Cas.: 19094-48-5 | Purity: 97% | 3,5-Diiodobenzoic acid | ESD-891544-5G |
| Cas.: 19094-48-5 | Purity: 97% | 3,5-Diiodobenzoic acid | ESD-891544-10G |
| Cas.: 126030-73-7 | Purity: 97% | 2-(5,6-Difluoro-1H-indol-3-yl)acetic acid | ESD-891545-100MG |
| Cas.: 126030-73-7 | Purity: 97% | 2-(5,6-Difluoro-1H-indol-3-yl)acetic acid | ESD-891545-250MG |
| Cas.: 126030-73-7 | Purity: 97% | 2-(5,6-Difluoro-1H-indol-3-yl)acetic acid | ESD-891545-1G |
| Cas.: 102123-74-0 | Purity: 97% | (S)-tert-Butyl (4-chloro-3-oxo-1-phenylbutan-2-yl)carbamate | ESD-891546-5G |
| Cas.: 102123-74-0 | Purity: 97% | (S)-tert-Butyl (4-chloro-3-oxo-1-phenylbutan-2-yl)carbamate | ESD-891546-10G |
| Cas.: 102123-74-0 | Purity: 97% | (S)-tert-Butyl (4-chloro-3-oxo-1-phenylbutan-2-yl)carbamate | ESD-891546-25G |
| Cas.: 102123-74-0 | Purity: 97% | (S)-tert-Butyl (4-chloro-3-oxo-1-phenylbutan-2-yl)carbamate | ESD-891546-100G |
| Cas.: 52157-82-1 | Purity: ≥95% | 5-Methoxy-3-piperidin-4-yl-1H-indole | ESD-891547-100MG |
| Cas.: 52157-82-1 | Purity: ≥95% | 5-Methoxy-3-piperidin-4-yl-1H-indole | ESD-891547-250MG |
| Cas.: 52157-82-1 | Purity: ≥95% | 5-Methoxy-3-piperidin-4-yl-1H-indole | ESD-891547-1G |
| Cas.: 52157-82-1 | Purity: ≥95% | 5-Methoxy-3-piperidin-4-yl-1H-indole | ESD-891547-5G |
| Cas.: 30762-06-2 | Purity: ≥95% | 4-Phenethoxybenzoic acid | ESD-891548-250MG |
| Cas.: 30762-06-2 | Purity: ≥95% | 4-Phenethoxybenzoic acid | ESD-891548-1G |
| Cas.: 101831-71-4 | Purity: ≥95% | 3-(2-Aminoethyl)-1H-indole-5-carbonitrile hydrochloride | ESD-891549-100MG |
| Cas.: 101831-71-4 | Purity: ≥95% | 3-(2-Aminoethyl)-1H-indole-5-carbonitrile hydrochloride | ESD-891549-250MG |
| Cas.: 711017-85-5 | Purity: 95% | (S)-2-((tert-Butoxycarbonyl)amino)-2-(tetrahydro-2H-pyran-4-yl)acetic acid | ESD-891550-100MG |
| Cas.: 711017-85-5 | Purity: 95% | (S)-2-((tert-Butoxycarbonyl)amino)-2-(tetrahydro-2H-pyran-4-yl)acetic acid | ESD-891550-250MG |
| Cas.: 711017-85-5 | Purity: 95% | (S)-2-((tert-Butoxycarbonyl)amino)-2-(tetrahydro-2H-pyran-4-yl)acetic acid | ESD-891550-1G |
| Cas.: 214483-20-2 | Purity: ≥95% | 4-Chloro-6-iodoquinoline-3-carbonitrile | ESD-891551-100MG |
| Cas.: 214483-20-2 | Purity: ≥95% | 4-Chloro-6-iodoquinoline-3-carbonitrile | ESD-891551-250MG |
| Cas.: 1052114-81-4 | Purity: 97% | 5-(4-Fluorophenyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid | ESD-891552-100MG |
| Cas.: 1052114-81-4 | Purity: 97% | 5-(4-Fluorophenyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid | ESD-891552-250MG |
| Cas.: 62553-86-0 | Purity: 96% | 3-Hydroxy-N-(3-methoxyphenyl)-2-naphthamide | ESD-891553-100MG |
| Cas.: 62553-86-0 | Purity: 96% | 3-Hydroxy-N-(3-methoxyphenyl)-2-naphthamide | ESD-891553-250MG |
| Cas.: 62553-86-0 | Purity: 96% | 3-Hydroxy-N-(3-methoxyphenyl)-2-naphthamide | ESD-891553-1G |
| Cas.: 337463-88-4 | Purity: 97% | 6-Bromo-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one | ESD-891554-100MG |
| Cas.: 337463-88-4 | Purity: 97% | 6-Bromo-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one | ESD-891554-250MG |
| Cas.: 337463-88-4 | Purity: 97% | 6-Bromo-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one | ESD-891554-1G |
| Cas.: 337463-88-4 | Purity: 97% | 6-Bromo-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one | ESD-891554-5G |
| Cas.: 916420-27-4 | Purity: 97% | tert-Butyl 2,4-dichloro-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate | ESD-891555-100MG |
| Cas.: 916420-27-4 | Purity: 97% | tert-Butyl 2,4-dichloro-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate | ESD-891555-250MG |
| Cas.: 916420-27-4 | Purity: 97% | tert-Butyl 2,4-dichloro-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate | ESD-891555-1G |
| Cas.: 916420-27-4 | Purity: 97% | tert-Butyl 2,4-dichloro-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate | ESD-891555-5G |
| Cas.: 56426-35-8 | Purity: ≥95% | Methyl 5-phenyl-1H-pyrazole-3-carboxylate | ESD-891556-250MG |
| Cas.: 56426-35-8 | Purity: ≥95% | Methyl 5-phenyl-1H-pyrazole-3-carboxylate | ESD-891556-1G |
| Cas.: 56426-35-8 | Purity: ≥95% | Methyl 5-phenyl-1H-pyrazole-3-carboxylate | ESD-891556-5G |
| Cas.: 56426-35-8 | Purity: ≥95% | Methyl 5-phenyl-1H-pyrazole-3-carboxylate | ESD-891556-10G |
| Cas.: 227626-60-0 | Purity: 97% | 2-(1-(((tert-Butoxycarbonyl)amino)methyl)cyclohexyl)acetic acid | ESD-891557-250MG |
| Cas.: 227626-60-0 | Purity: 97% | 2-(1-(((tert-Butoxycarbonyl)amino)methyl)cyclohexyl)acetic acid | ESD-891557-1G |
| Cas.: 227626-60-0 | Purity: 97% | 2-(1-(((tert-Butoxycarbonyl)amino)methyl)cyclohexyl)acetic acid | ESD-891557-5G |
| Cas.: 70667-79-7 | Purity: 97% | 2-((1-Cyanoethyl)amino)benzoic acid | ESD-891558-100MG |
| Cas.: 70667-79-7 | Purity: 97% | 2-((1-Cyanoethyl)amino)benzoic acid | ESD-891558-250MG |
| Cas.: 775288-71-6 | Purity: ≥95% | 1-(6-Nitropyridin-3-yl)piperazine | ESD-891559-50MG |
| Cas.: 775288-71-6 | Purity: ≥95% | 1-(6-Nitropyridin-3-yl)piperazine | ESD-891559-100MG |
| Cas.: 775288-71-6 | Purity: ≥95% | 1-(6-Nitropyridin-3-yl)piperazine | ESD-891559-250MG |
| Cas.: 775288-71-6 | Purity: ≥95% | 1-(6-Nitropyridin-3-yl)piperazine | ESD-891559-1G |
| Cas.: 7461-12-3 | Purity: 97% | 8-Nitroquinolin-2(1H)-one | ESD-891560-100MG |
| Cas.: 7461-12-3 | Purity: 97% | 8-Nitroquinolin-2(1H)-one | ESD-891560-250MG |
| Cas.: 7461-12-3 | Purity: 97% | 8-Nitroquinolin-2(1H)-one | ESD-891560-1G |
| Cas.: 7461-12-3 | Purity: 97% | 8-Nitroquinolin-2(1H)-one | ESD-891560-5G |
| Cas.: 57653-35-7 | Purity: 97% | (2S,4S)-1-Benzyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate | ESD-891561-1G |
| Cas.: 57653-35-7 | Purity: 97% | (2S,4S)-1-Benzyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate | ESD-891561-5G |
| Cas.: 57653-35-7 | Purity: 97% | (2S,4S)-1-Benzyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate | ESD-891561-10G |
| Cas.: 57653-35-7 | Purity: 97% | (2S,4S)-1-Benzyl 2-methyl 4-hydroxypyrrolidine-1,2-dicarboxylate | ESD-891561-25G |
| Cas.: 343788-51-2 | Purity: ≥95% | 8-(Benzyloxy)-2-chloroquinoline | ESD-891562-100MG |
| Cas.: 343788-51-2 | Purity: ≥95% | 8-(Benzyloxy)-2-chloroquinoline | ESD-891562-250MG |
| Cas.: 343788-51-2 | Purity: ≥95% | 8-(Benzyloxy)-2-chloroquinoline | ESD-891562-1G |
| Cas.: 343788-51-2 | Purity: ≥95% | 8-(Benzyloxy)-2-chloroquinoline | ESD-891562-5G |
| Cas.: 28004-64-0 | Purity: ≥95% | 5-(3,4-Dichlorophenyl)-1,3,4-thiadiazol-2-amine | ESD-891563-1G |
| Cas.: 28004-64-0 | Purity: ≥95% | 5-(3,4-Dichlorophenyl)-1,3,4-thiadiazol-2-amine | ESD-891563-5G |
| Cas.: 57830-14-5 | Purity: ≥95% | 5-Phenoxyisobenzofuran-1(3H)-one | ESD-891564-100MG |
| Cas.: 57830-14-5 | Purity: ≥95% | 5-Phenoxyisobenzofuran-1(3H)-one | ESD-891564-250MG |
| Cas.: 57830-14-5 | Purity: ≥95% | 5-Phenoxyisobenzofuran-1(3H)-one | ESD-891564-1G |
| Cas.: 889946-17-2 | Purity: ≥95% | Ethyl 4-oxotetrahydro-2H-thiopyran-3-carboxylate 1,1-dioxide | ESD-891565-100MG |
| Cas.: 889946-17-2 | Purity: ≥95% | Ethyl 4-oxotetrahydro-2H-thiopyran-3-carboxylate 1,1-dioxide | ESD-891565-250MG |
| Cas.: 889946-17-2 | Purity: ≥95% | Ethyl 4-oxotetrahydro-2H-thiopyran-3-carboxylate 1,1-dioxide | ESD-891565-1G |
| Cas.: 28312-61-0 | Purity: ≥95% | 1,5-Naphthyridine-4,8-diol | ESD-891566-100MG |
| Cas.: 28312-61-0 | Purity: ≥95% | 1,5-Naphthyridine-4,8-diol | ESD-891566-250MG |
| Cas.: 1217811-51-2 | Purity: 97% | (S)-3-((tert-Butoxycarbonyl)amino)-5-(methylthio)pentanoic acid | ESD-891567-100MG |
| Cas.: 1217811-51-2 | Purity: 97% | (S)-3-((tert-Butoxycarbonyl)amino)-5-(methylthio)pentanoic acid | ESD-891567-250MG |
| Cas.: 23077-43-2 | Purity: 98% | 5-Fluoro-1H-indole-3-carboxylic acid | ESD-891568-100MG |
| Cas.: 23077-43-2 | Purity: 98% | 5-Fluoro-1H-indole-3-carboxylic acid | ESD-891568-250MG |
| Cas.: 23077-43-2 | Purity: 98% | 5-Fluoro-1H-indole-3-carboxylic acid | ESD-891568-1G |
| Cas.: 23077-43-2 | Purity: 98% | 5-Fluoro-1H-indole-3-carboxylic acid | ESD-891568-5G |
| Cas.: 1076199-21-7 | Purity: 97% | tert-Butyl (2-(2-(2-(2-bromoethoxy)ethoxy)ethoxy)ethyl)carbamate | ESD-891569-100MG |
| Cas.: 1076199-21-7 | Purity: 97% | tert-Butyl (2-(2-(2-(2-bromoethoxy)ethoxy)ethoxy)ethyl)carbamate | ESD-891569-250MG |
| Cas.: 799767-82-1 | Purity: 97% | Benzyl 3-bromo-4-hydroxypyrrolidine-1-carboxylate | ESD-891570-100MG |
| Cas.: 799767-82-1 | Purity: 97% | Benzyl 3-bromo-4-hydroxypyrrolidine-1-carboxylate | ESD-891570-250MG |
| Cas.: 1035229-31-2 | Purity: ≥95% | 1-(4-(Benzyloxy)-2-hydroxy-3-nitrophenyl)ethanone | ESD-891571-100MG |
| Cas.: 1035229-31-2 | Purity: ≥95% | 1-(4-(Benzyloxy)-2-hydroxy-3-nitrophenyl)ethanone | ESD-891571-250MG |
| Cas.: 1035229-31-2 | Purity: ≥95% | 1-(4-(Benzyloxy)-2-hydroxy-3-nitrophenyl)ethanone | ESD-891571-1G |
| Cas.: 1035229-31-2 | Purity: ≥95% | 1-(4-(Benzyloxy)-2-hydroxy-3-nitrophenyl)ethanone | ESD-891571-5G |
| Cas.: 71176-55-1 | Purity: ≥95% | (5-Nitro-1,3-phenylene)dimethanol | ESD-891572-250MG |
| Cas.: 71176-55-1 | Purity: ≥95% | (5-Nitro-1,3-phenylene)dimethanol | ESD-891572-1G |
| Cas.: 71176-55-1 | Purity: ≥95% | (5-Nitro-1,3-phenylene)dimethanol | ESD-891572-5G |
| Cas.: 71176-55-1 | Purity: ≥95% | (5-Nitro-1,3-phenylene)dimethanol | ESD-891572-10G |
| Cas.: 13588-95-9 | Purity: 97% | H-Leu-Val-OH | ESD-891573-100MG |
| Cas.: 13588-95-9 | Purity: 97% | H-Leu-Val-OH | ESD-891573-250MG |
| Cas.: 13588-95-9 | Purity: 97% | H-Leu-Val-OH | ESD-891573-1G |
| Cas.: 214699-26-0 | Purity: ≥95% | 6-Benzyl-5,6,7,8-tetrahydro-1,6-naphthyridin-3-amine | ESD-891574-100MG |
| Cas.: 214699-26-0 | Purity: ≥95% | 6-Benzyl-5,6,7,8-tetrahydro-1,6-naphthyridin-3-amine | ESD-891574-250MG |
| Cas.: 214699-26-0 | Purity: ≥95% | 6-Benzyl-5,6,7,8-tetrahydro-1,6-naphthyridin-3-amine | ESD-891574-1G |
| Cas.: 214699-26-0 | Purity: ≥95% | 6-Benzyl-5,6,7,8-tetrahydro-1,6-naphthyridin-3-amine | ESD-891574-5G |
| Cas.: 201594-84-5 | Purity: 98% | (S)-2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine | ESD-891575-100MG |
| Cas.: 201594-84-5 | Purity: 98% | (S)-2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine | ESD-891575-250MG |
| Cas.: 201594-84-5 | Purity: 98% | (S)-2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine | ESD-891575-1G |
| Cas.: 201594-84-5 | Purity: 98% | (S)-2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine | ESD-891575-5G |
| Cas.: 147222-99-9 | Purity: 97% | (4-(Decyloxy)phenyl)boronic acid | ESD-891576-100MG |
| Cas.: 147222-99-9 | Purity: 97% | (4-(Decyloxy)phenyl)boronic acid | ESD-891576-250MG |
| Cas.: 313337-34-7 | Purity: ≥97% | 4-Fluoro-1H-indole-7-carboxylic acid | ESD-891577-100MG |
| Cas.: 313337-34-7 | Purity: ≥97% | 4-Fluoro-1H-indole-7-carboxylic acid | ESD-891577-250MG |
| Cas.: 313337-34-7 | Purity: ≥97% | 4-Fluoro-1H-indole-7-carboxylic acid | ESD-891577-1G |
| Cas.: 423116-18-1 | Purity: 96% | 2-(4-Oxocyclohexylmethyl)isoindole-1,3-dione | ESD-891578-100MG |
| Cas.: 423116-18-1 | Purity: 96% | 2-(4-Oxocyclohexylmethyl)isoindole-1,3-dione | ESD-891578-250MG |
| Cas.: 423116-18-1 | Purity: 96% | 2-(4-Oxocyclohexylmethyl)isoindole-1,3-dione | ESD-891578-1G |
| Cas.: 2974-94-9 | Purity: 98% | 1-Iodo-4-phenoxybenzene | ESD-891579-1G |
| Cas.: 2974-94-9 | Purity: 98% | 1-Iodo-4-phenoxybenzene | ESD-891579-5G |
| Cas.: 2974-94-9 | Purity: 98% | 1-Iodo-4-phenoxybenzene | ESD-891579-25G |
| Cas.: 1729-99-3 | Purity: ≥95% | 8-Bromo-1-naphthoic acid | ESD-891580-250MG |
| Cas.: 1729-99-3 | Purity: ≥95% | 8-Bromo-1-naphthoic acid | ESD-891580-1G |
| Cas.: 1729-99-3 | Purity: ≥95% | 8-Bromo-1-naphthoic acid | ESD-891580-5G |
| Cas.: 1729-99-3 | Purity: ≥95% | 8-Bromo-1-naphthoic acid | ESD-891580-10G |
| Cas.: 1228780-72-0 | Purity: ≥95% | 1-((4′-Chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1′-biphenyl]-2-yl)methyl)piperazine | ESD-891581-100MG |
| Cas.: 1228780-72-0 | Purity: ≥95% | 1-((4′-Chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1′-biphenyl]-2-yl)methyl)piperazine | ESD-891581-250MG |
| Cas.: 1228780-72-0 | Purity: ≥95% | 1-((4′-Chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1′-biphenyl]-2-yl)methyl)piperazine | ESD-891581-1G |
| Cas.: 1228780-72-0 | Purity: ≥95% | 1-((4′-Chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1′-biphenyl]-2-yl)methyl)piperazine | ESD-891581-5G |
| Cas.: 915707-58-3 | Purity: ≥95% | 4-Methyl-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine-7-carboxylic acid | ESD-891582-100MG |
| Cas.: 915707-58-3 | Purity: ≥95% | 4-Methyl-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine-7-carboxylic acid | ESD-891582-250MG |
| Cas.: 915707-58-3 | Purity: ≥95% | 4-Methyl-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine-7-carboxylic acid | ESD-891582-1G |
| Cas.: 5730-78-9 | Purity: ≥95% | 4′-Amino-[1,1′-biphenyl]-4-carboxylic acid | ESD-891583-100MG |
| Cas.: 5730-78-9 | Purity: ≥95% | 4′-Amino-[1,1′-biphenyl]-4-carboxylic acid | ESD-891583-250MG |
| Cas.: 5730-78-9 | Purity: ≥95% | 4′-Amino-[1,1′-biphenyl]-4-carboxylic acid | ESD-891583-1G |
| Cas.: 5730-78-9 | Purity: ≥95% | 4′-Amino-[1,1′-biphenyl]-4-carboxylic acid | ESD-891583-5G |
| Cas.: 14814-17-6 | Purity: 97% | (4-(2-Hydroxyethoxy)phenyl)(phenyl)methanone | ESD-891584-100MG |
| Cas.: 14814-17-6 | Purity: 97% | (4-(2-Hydroxyethoxy)phenyl)(phenyl)methanone | ESD-891584-250MG |
| Cas.: 2548-29-0 | Purity: 98% | 3-Chlorosulfonyl-4-methylbenzoic acid | ESD-891585-1G |
| Cas.: 2548-29-0 | Purity: 98% | 3-Chlorosulfonyl-4-methylbenzoic acid | ESD-891585-5G |
| Cas.: 2548-29-0 | Purity: 98% | 3-Chlorosulfonyl-4-methylbenzoic acid | ESD-891585-10G |
| Cas.: 2548-29-0 | Purity: 98% | 3-Chlorosulfonyl-4-methylbenzoic acid | ESD-891585-25G |
| Cas.: 5176-12-5 | Purity: ≥95% | (2-Nitrophenyl)(phenyl)methanol | ESD-891586-250MG |
| Cas.: 5176-12-5 | Purity: ≥95% | (2-Nitrophenyl)(phenyl)methanol | ESD-891586-1G |
| Cas.: 316810-82-9 | Purity: ≥95% | 5-Bromo-7-nitro-1H-indazole | ESD-891587-100MG |
| Cas.: 316810-82-9 | Purity: ≥95% | 5-Bromo-7-nitro-1H-indazole | ESD-891587-250MG |
| Cas.: 316810-82-9 | Purity: ≥95% | 5-Bromo-7-nitro-1H-indazole | ESD-891587-1G |
| Cas.: 316810-82-9 | Purity: ≥95% | 5-Bromo-7-nitro-1H-indazole | ESD-891587-5G |
| Cas.: 937188-59-5 | Purity: ≥95% | 1-Hydroxy-3,6,9,12-tetraoxapentadecan-15-oic acid | ESD-891588-100MG |
| Cas.: 937188-59-5 | Purity: ≥95% | 1-Hydroxy-3,6,9,12-tetraoxapentadecan-15-oic acid | ESD-891588-250MG |
| Cas.: 145881-74-9 | Purity: ≥95% | [2-(2-Hydroxy-ethoxy)-ethyl]-carbamic acid benzyl ester | ESD-891589-100MG |
| Cas.: 145881-74-9 | Purity: ≥95% | [2-(2-Hydroxy-ethoxy)-ethyl]-carbamic acid benzyl ester | ESD-891589-250MG |
| Cas.: 145881-74-9 | Purity: ≥95% | [2-(2-Hydroxy-ethoxy)-ethyl]-carbamic acid benzyl ester | ESD-891589-1G |
| Cas.: 1214741-19-1 | Purity: 97% | (3R,7aR)-3-(tert-Butyl)-1,5-dioxohexahydropyrrolo[1,2-c]oxazole-7a-carbaldehyde | ESD-891590-100MG |
| Cas.: 1214741-19-1 | Purity: 97% | (3R,7aR)-3-(tert-Butyl)-1,5-dioxohexahydropyrrolo[1,2-c]oxazole-7a-carbaldehyde | ESD-891590-250MG |
| Cas.: 221532-96-3 | Purity: ≥95% | tert-Butyl 4-(4-aminobenzyl)piperidine-1-carboxylate | ESD-891591-100MG |
| Cas.: 221532-96-3 | Purity: ≥95% | tert-Butyl 4-(4-aminobenzyl)piperidine-1-carboxylate | ESD-891591-250MG |
| Cas.: 99185-71-4 | Purity: 97% | 2-Methyl-6-nitroquinolin-4-amine | ESD-891592-100MG |
| Cas.: 99185-71-4 | Purity: 97% | 2-Methyl-6-nitroquinolin-4-amine | ESD-891592-250MG |
| Cas.: 1217677-36-5 | Purity: ≥95% | (S)-2-((tert-Butoxycarbonyl)amino)-2-(m-tolyl)acetic acid | ESD-891593-250MG |
| Cas.: 1217677-36-5 | Purity: ≥95% | (S)-2-((tert-Butoxycarbonyl)amino)-2-(m-tolyl)acetic acid | ESD-891593-1G |
| Cas.: 1211587-01-7 | Purity: 95% | 5-Chloropyridazine-3-carboxylic acid | ESD-891594-100MG |
| Cas.: 1211587-01-7 | Purity: 95% | 5-Chloropyridazine-3-carboxylic acid | ESD-891594-250MG |
| Cas.: 57319-65-0 | Purity: 98% | 6-Aminoisobenzofuran-1(3H)-one | ESD-891595-100MG |
| Cas.: 57319-65-0 | Purity: 98% | 6-Aminoisobenzofuran-1(3H)-one | ESD-891595-250MG |
| Cas.: 57319-65-0 | Purity: 98% | 6-Aminoisobenzofuran-1(3H)-one | ESD-891595-1G |
| Cas.: 57319-65-0 | Purity: 98% | 6-Aminoisobenzofuran-1(3H)-one | ESD-891595-5G |
| Cas.: 884494-83-1 | Purity: ≥95% | 5-Fluoro-2-hydroxynicotinic acid | ESD-891596-100MG |
| Cas.: 884494-83-1 | Purity: ≥95% | 5-Fluoro-2-hydroxynicotinic acid | ESD-891596-250MG |
| Cas.: 884494-83-1 | Purity: ≥95% | 5-Fluoro-2-hydroxynicotinic acid | ESD-891596-1G |
| Cas.: 7478-69-5 | Purity: 97% | 4-Vinylidenebis(N,N-dimethylaniline) | ESD-891597-1G |
| Cas.: 7478-69-5 | Purity: 97% | 4-Vinylidenebis(N,N-dimethylaniline) | ESD-891597-5G |
| Cas.: 7478-69-5 | Purity: 97% | 4-Vinylidenebis(N,N-dimethylaniline) | ESD-891597-10G |
| Cas.: 132521-70-1 | Purity: ≥95% | 6-(4-Methylpiperazin-1-yl)nicotinic acid | ESD-891598-250MG |
| Cas.: 132521-70-1 | Purity: ≥95% | 6-(4-Methylpiperazin-1-yl)nicotinic acid | ESD-891598-1G |
| Cas.: 123240-66-4 | Purity: ≥95% | N-(4,6-Dichloropyrimidin-5-yl)formamide | ESD-891599-250MG |
| Cas.: 123240-66-4 | Purity: ≥95% | N-(4,6-Dichloropyrimidin-5-yl)formamide | ESD-891599-1G |
| Cas.: 221352-46-1 | Purity: 97% | 2-(tert-Butoxycarbonyl)isoindoline-1-carboxylic acid | ESD-891600-100MG |
| Cas.: 221352-46-1 | Purity: 97% | 2-(tert-Butoxycarbonyl)isoindoline-1-carboxylic acid | ESD-891600-250MG |
| Cas.: 221352-46-1 | Purity: 97% | 2-(tert-Butoxycarbonyl)isoindoline-1-carboxylic acid | ESD-891600-1G |
| Cas.: 221352-46-1 | Purity: 97% | 2-(tert-Butoxycarbonyl)isoindoline-1-carboxylic acid | ESD-891600-5G |
| Cas.: 1313399-38-0 | Purity: 97% | 2-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one | ESD-891601-100MG |
| Cas.: 1313399-38-0 | Purity: 97% | 2-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one | ESD-891601-250MG |
| Cas.: 1313399-38-0 | Purity: 97% | 2-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one | ESD-891601-1G |
| Cas.: 910036-98-5 | Purity: 95% | 2-(Tetrahydropyran-4-yloxy)-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)pyridine | ESD-891602-100MG |
| Cas.: 910036-98-5 | Purity: 95% | 2-(Tetrahydropyran-4-yloxy)-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)pyridine | ESD-891602-250MG |
| Cas.: 910036-98-5 | Purity: 95% | 2-(Tetrahydropyran-4-yloxy)-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)pyridine | ESD-891602-1G |
| Cas.: 156941-60-5 | Purity: 98% | 2-(7-Bromo-1H-indol-3-yl)ethanamine hydrochloride | ESD-891603-100MG |
| Cas.: 156941-60-5 | Purity: 98% | 2-(7-Bromo-1H-indol-3-yl)ethanamine hydrochloride | ESD-891603-250MG |
| Cas.: 1965309-05-0 | Purity: 97% | 2-Iodo-4-methoxy-1-(methylsulfonyl)benzene | ESD-891604-100MG |
| Cas.: 1965309-05-0 | Purity: 97% | 2-Iodo-4-methoxy-1-(methylsulfonyl)benzene | ESD-891604-250MG |
| Cas.: 1965309-05-0 | Purity: 97% | 2-Iodo-4-methoxy-1-(methylsulfonyl)benzene | ESD-891604-1G |
| Cas.: 10250-64-3 | Purity: 97% | 1-Methyl-3-phenyl-1H-pyrazole-5-carboxylic acid | ESD-891605-250MG |
| Cas.: 10250-64-3 | Purity: 97% | 1-Methyl-3-phenyl-1H-pyrazole-5-carboxylic acid | ESD-891605-1G |
| Cas.: 10250-64-3 | Purity: 97% | 1-Methyl-3-phenyl-1H-pyrazole-5-carboxylic acid | ESD-891605-5G |
| Cas.: 10250-64-3 | Purity: 97% | 1-Methyl-3-phenyl-1H-pyrazole-5-carboxylic acid | ESD-891605-10G |
| Cas.: 17996-12-2 | Purity: 97% | Benzyl (6-hydroxyhexyl)carbamate | ESD-891606-250MG |
| Cas.: 17996-12-2 | Purity: 97% | Benzyl (6-hydroxyhexyl)carbamate | ESD-891606-1G |
| Cas.: 17996-12-2 | Purity: 97% | Benzyl (6-hydroxyhexyl)carbamate | ESD-891606-5G |
| Cas.: 661458-35-1 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-4-oxopiperidine-2-carboxylic acid | ESD-891607-100MG |
| Cas.: 661458-35-1 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-4-oxopiperidine-2-carboxylic acid | ESD-891607-250MG |
| Cas.: 661458-35-1 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-4-oxopiperidine-2-carboxylic acid | ESD-891607-1G |
| Cas.: 661458-35-1 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-4-oxopiperidine-2-carboxylic acid | ESD-891607-5G |
| Cas.: 849475-89-4 | Purity: 97% | Methyl 5-hydroxy-6-oxo-2-(pyridin-2-yl)-1,6-dihydropyrimidine-4-carboxylate | ESD-891608-100MG |
| Cas.: 849475-89-4 | Purity: 97% | Methyl 5-hydroxy-6-oxo-2-(pyridin-2-yl)-1,6-dihydropyrimidine-4-carboxylate | ESD-891608-250MG |
| Cas.: 65635-85-0 | Purity: 98% | (R)-2-(((Benzyloxy)carbonyl)(methyl)amino)-4-methylpentanoic acid | ESD-891609-250MG |
| Cas.: 65635-85-0 | Purity: 98% | (R)-2-(((Benzyloxy)carbonyl)(methyl)amino)-4-methylpentanoic acid | ESD-891609-1G |
| Cas.: 65635-85-0 | Purity: 98% | (R)-2-(((Benzyloxy)carbonyl)(methyl)amino)-4-methylpentanoic acid | ESD-891609-5G |
| Cas.: 22518-27-0 | Purity: 97% | 4-(4-Chlorophenyl)pyrrolidin-2-one | ESD-891610-100MG |
| Cas.: 22518-27-0 | Purity: 97% | 4-(4-Chlorophenyl)pyrrolidin-2-one | ESD-891610-250MG |
| Cas.: 22518-27-0 | Purity: 97% | 4-(4-Chlorophenyl)pyrrolidin-2-one | ESD-891610-1G |
| Cas.: 1642857-58-6 | Purity: 97% | 3-(Naphthalen-2-yloxy)propyl acrylate | ESD-891611-100MG |
| Cas.: 1642857-58-6 | Purity: 97% | 3-(Naphthalen-2-yloxy)propyl acrylate | ESD-891611-250MG |
| Cas.: 1642857-58-6 | Purity: 97% | 3-(Naphthalen-2-yloxy)propyl acrylate | ESD-891611-1G |
| Cas.: 1216671-97-4 | Purity: ≥95% | 2-Amino-5-bromobenzo[d]thiazole 3-oxide | ESD-891612-250MG |
| Cas.: 1216671-97-4 | Purity: ≥95% | 2-Amino-5-bromobenzo[d]thiazole 3-oxide | ESD-891612-1G |
| Cas.: 1216671-97-4 | Purity: ≥95% | 2-Amino-5-bromobenzo[d]thiazole 3-oxide | ESD-891612-5G |
| Cas.: 117635-21-9 | Purity: 98% | 1,4-Dibromo-2,5-dihexylbenzene | ESD-891613-1G |
| Cas.: 117635-21-9 | Purity: 98% | 1,4-Dibromo-2,5-dihexylbenzene | ESD-891613-5G |
| Cas.: 117635-21-9 | Purity: 98% | 1,4-Dibromo-2,5-dihexylbenzene | ESD-891613-10G |
| Cas.: 198204-16-9 | Purity: ≥95% | Methyl 3-amino-5,6-dimethoxybenzo[b]thiophene-2-carboxylate | ESD-891614-100MG |
| Cas.: 198204-16-9 | Purity: ≥95% | Methyl 3-amino-5,6-dimethoxybenzo[b]thiophene-2-carboxylate | ESD-891614-250MG |
| Cas.: 161975-39-9 | Purity: 95% | tert-Butyl 4-(((methylsulfonyl)oxy)methyl)piperidine-1-carboxylate | ESD-891615-250MG |
| Cas.: 161975-39-9 | Purity: 95% | tert-Butyl 4-(((methylsulfonyl)oxy)methyl)piperidine-1-carboxylate | ESD-891615-1G |
| Cas.: 161975-39-9 | Purity: 95% | tert-Butyl 4-(((methylsulfonyl)oxy)methyl)piperidine-1-carboxylate | ESD-891615-5G |
| Cas.: 823222-03-3 | Purity: 97% | 2-Bromo-5-(trifluoromethyl)isonicotinic acid | ESD-891616-100MG |
| Cas.: 823222-03-3 | Purity: 97% | 2-Bromo-5-(trifluoromethyl)isonicotinic acid | ESD-891616-250MG |
| Cas.: 823222-03-3 | Purity: 97% | 2-Bromo-5-(trifluoromethyl)isonicotinic acid | ESD-891616-1G |
| Cas.: 4922-51-4 | Purity: 96% | 4-(4H-1,2,4-Triazol-3-yl)aniline | ESD-891617-100MG |
| Cas.: 4922-51-4 | Purity: 96% | 4-(4H-1,2,4-Triazol-3-yl)aniline | ESD-891617-250MG |
| Cas.: 86212-34-2 | Purity: ≥95% | 1,2-Bis(4-chlorophenyl)ethane-1,2-diamine | ESD-891618-250MG |
| Cas.: 86212-34-2 | Purity: ≥95% | 1,2-Bis(4-chlorophenyl)ethane-1,2-diamine | ESD-891618-1G |
| Cas.: 86212-34-2 | Purity: ≥95% | 1,2-Bis(4-chlorophenyl)ethane-1,2-diamine | ESD-891618-5G |
| Cas.: 887425-47-0 | Purity: 97% | 1-(5-Bromopyrimidin-2-yl)piperidin-4-ol | ESD-891619-250MG |
| Cas.: 887425-47-0 | Purity: 97% | 1-(5-Bromopyrimidin-2-yl)piperidin-4-ol | ESD-891619-1G |
| Cas.: 887425-47-0 | Purity: 97% | 1-(5-Bromopyrimidin-2-yl)piperidin-4-ol | ESD-891619-5G |
| Cas.: 64483-69-8 | Purity: 97% | 5-Acetylindolin-2-one | ESD-891620-250MG |
| Cas.: 64483-69-8 | Purity: 97% | 5-Acetylindolin-2-one | ESD-891620-1G |
| Cas.: 64483-69-8 | Purity: 97% | 5-Acetylindolin-2-one | ESD-891620-5G |
| Cas.: 64483-69-8 | Purity: 97% | 5-Acetylindolin-2-one | ESD-891620-10G |
| Cas.: 51908-29-3 | Purity: ≥95% | 4-Isothiocyanatobenzenesulfonamide | ESD-891621-250MG |
| Cas.: 51908-29-3 | Purity: ≥95% | 4-Isothiocyanatobenzenesulfonamide | ESD-891621-1G |
| Cas.: 51908-29-3 | Purity: ≥95% | 4-Isothiocyanatobenzenesulfonamide | ESD-891621-5G |
| Cas.: 1000540-60-2 | Purity: 97% | 4-(Cyanomethyl)phthalonitrile | ESD-891622-1G |
| Cas.: 1000540-60-2 | Purity: 97% | 4-(Cyanomethyl)phthalonitrile | ESD-891622-5G |
| Cas.: 1190317-34-0 | Purity: ≥95% | 4-Chloro-1H-pyrrolo[3,2-c]pyridine-3-carbaldehyde | ESD-891623-100MG |
| Cas.: 1190317-34-0 | Purity: ≥95% | 4-Chloro-1H-pyrrolo[3,2-c]pyridine-3-carbaldehyde | ESD-891623-250MG |
| Cas.: 144060-99-1 | Purity: ≥95% | 2-(4-Fluorophenyl)-4-methylthiazole-5-carboxylic acid | ESD-891624-100MG |
| Cas.: 144060-99-1 | Purity: ≥95% | 2-(4-Fluorophenyl)-4-methylthiazole-5-carboxylic acid | ESD-891624-250MG |
| Cas.: 144060-99-1 | Purity: ≥95% | 2-(4-Fluorophenyl)-4-methylthiazole-5-carboxylic acid | ESD-891624-1G |
| Cas.: 60722-67-0 | Purity: ≥95% | 2-(Phenylmethoxy)-4-pyrimidinamine | ESD-891625-100MG |
| Cas.: 60722-67-0 | Purity: ≥95% | 2-(Phenylmethoxy)-4-pyrimidinamine | ESD-891625-250MG |
| Cas.: 60722-67-0 | Purity: ≥95% | 2-(Phenylmethoxy)-4-pyrimidinamine | ESD-891625-1G |
| Cas.: 60722-67-0 | Purity: ≥95% | 2-(Phenylmethoxy)-4-pyrimidinamine | ESD-891625-5G |
| Cas.: 19397-74-1 | Purity: ≥95% | Ethyl 4,5-dihydronaphtho[1,2-b]thiophene-2-carboxylate | ESD-891626-100MG |
| Cas.: 19397-74-1 | Purity: ≥95% | Ethyl 4,5-dihydronaphtho[1,2-b]thiophene-2-carboxylate | ESD-891626-250MG |
| Cas.: 205445-53-0 | Purity: 98% | Boc-D-3,5-Difluorophenylalanine | ESD-891627-250MG |
| Cas.: 205445-53-0 | Purity: 98% | Boc-D-3,5-Difluorophenylalanine | ESD-891627-1G |
| Cas.: 205445-53-0 | Purity: 98% | Boc-D-3,5-Difluorophenylalanine | ESD-891627-5G |
| Cas.: 205445-53-0 | Purity: 98% | Boc-D-3,5-Difluorophenylalanine | ESD-891627-10G |
| Cas.: 1060814-36-9 | Purity: ≥95% | 5-tert-Butyl 2-ethyl 6,7-dihydrofuro[3,2-c]pyridine-2,5(4H)-dicarboxylate | ESD-891628-100MG |
| Cas.: 1060814-36-9 | Purity: ≥95% | 5-tert-Butyl 2-ethyl 6,7-dihydrofuro[3,2-c]pyridine-2,5(4H)-dicarboxylate | ESD-891628-250MG |
| Cas.: 1060814-36-9 | Purity: ≥95% | 5-tert-Butyl 2-ethyl 6,7-dihydrofuro[3,2-c]pyridine-2,5(4H)-dicarboxylate | ESD-891628-1G |
| Cas.: 156635-87-9 | Purity: 97% | (4-(Benzyloxy)-2,3-difluorophenyl)boronic acid | ESD-891629-100MG |
| Cas.: 156635-87-9 | Purity: 97% | (4-(Benzyloxy)-2,3-difluorophenyl)boronic acid | ESD-891629-250MG |
| Cas.: 156635-87-9 | Purity: 97% | (4-(Benzyloxy)-2,3-difluorophenyl)boronic acid | ESD-891629-1G |
| Cas.: 156635-87-9 | Purity: 97% | (4-(Benzyloxy)-2,3-difluorophenyl)boronic acid | ESD-891629-5G |
| Cas.: 7254-29-7 | Purity: ≥95% | 2-Amino-5-nitropyrimidin-4(1H)-one | ESD-891630-100MG |
| Cas.: 7254-29-7 | Purity: ≥95% | 2-Amino-5-nitropyrimidin-4(1H)-one | ESD-891630-250MG |
| Cas.: 7254-29-7 | Purity: ≥95% | 2-Amino-5-nitropyrimidin-4(1H)-one | ESD-891630-1G |
| Cas.: 3541-14-8 | Purity: 97% | S-Phenyl 4-methylbenzenesulfonothioate | ESD-891631-100MG |
| Cas.: 3541-14-8 | Purity: 97% | S-Phenyl 4-methylbenzenesulfonothioate | ESD-891631-250MG |
| Cas.: 3541-14-8 | Purity: 97% | S-Phenyl 4-methylbenzenesulfonothioate | ESD-891631-1G |
| Cas.: 84-73-1 | Purity: ≥95% | Bis(2-hydroxyethyl) phthalate | ESD-891632-100MG |
| Cas.: 84-73-1 | Purity: ≥95% | Bis(2-hydroxyethyl) phthalate | ESD-891632-250MG |
| Cas.: 7326-73-0 | Purity: 97% | 3-(N,N-Dimethylsulfamoyl)benzoic acid | ESD-891633-100MG |
| Cas.: 7326-73-0 | Purity: 97% | 3-(N,N-Dimethylsulfamoyl)benzoic acid | ESD-891633-250MG |
| Cas.: 7326-73-0 | Purity: 97% | 3-(N,N-Dimethylsulfamoyl)benzoic acid | ESD-891633-1G |
| Cas.: 7326-73-0 | Purity: 97% | 3-(N,N-Dimethylsulfamoyl)benzoic acid | ESD-891633-5G |
| Cas.: 90111-58-3 | Purity: 98% | 2-(4-Boronophenyl)acetic acid | ESD-891634-100MG |
| Cas.: 90111-58-3 | Purity: 98% | 2-(4-Boronophenyl)acetic acid | ESD-891634-250MG |
| Cas.: 90111-58-3 | Purity: 98% | 2-(4-Boronophenyl)acetic acid | ESD-891634-1G |
| Cas.: 90111-58-3 | Purity: 98% | 2-(4-Boronophenyl)acetic acid | ESD-891634-5G |
| Cas.: 1218096-48-0 | Purity: ≥95% | 1-(2-Cyanobenzyl)piperidine-2-carboxylic acid | ESD-891635-100MG |
| Cas.: 1218096-48-0 | Purity: ≥95% | 1-(2-Cyanobenzyl)piperidine-2-carboxylic acid | ESD-891635-250MG |
| Cas.: 72120-71-9 | Purity: 97% | (S)-2-Amino-3-(benzo[b]thiophen-3-yl)propanoic acid | ESD-891636-250MG |
| Cas.: 72120-71-9 | Purity: 97% | (S)-2-Amino-3-(benzo[b]thiophen-3-yl)propanoic acid | ESD-891636-1G |
| Cas.: 72120-71-9 | Purity: 97% | (S)-2-Amino-3-(benzo[b]thiophen-3-yl)propanoic acid | ESD-891636-5G |
| Cas.: 186130-62-1 | Purity: 97% | 5-Hydroxy-3-methyl-1-phenyl-1H-pyrazole-4-carboxylic acid | ESD-891637-100MG |
| Cas.: 186130-62-1 | Purity: 97% | 5-Hydroxy-3-methyl-1-phenyl-1H-pyrazole-4-carboxylic acid | ESD-891637-250MG |
| Cas.: 186130-62-1 | Purity: 97% | 5-Hydroxy-3-methyl-1-phenyl-1H-pyrazole-4-carboxylic acid | ESD-891637-1G |
| Cas.: 186130-62-1 | Purity: 97% | 5-Hydroxy-3-methyl-1-phenyl-1H-pyrazole-4-carboxylic acid | ESD-891637-5G |
| Cas.: 885069-22-7 | Purity: 97% | 1-Cbz-3-Cyanopiperidine | ESD-891638-1G |
| Cas.: 885069-22-7 | Purity: 97% | 1-Cbz-3-Cyanopiperidine | ESD-891638-5G |
| Cas.: 885069-22-7 | Purity: 97% | 1-Cbz-3-Cyanopiperidine | ESD-891638-10G |
| Cas.: 885069-22-7 | Purity: 97% | 1-Cbz-3-Cyanopiperidine | ESD-891638-25G |
| Cas.: 40963-62-0 | Purity: ≥95% | 2-(Pyridin-3-yl)pyridin-4-amine | ESD-891639-100MG |
| Cas.: 40963-62-0 | Purity: ≥95% | 2-(Pyridin-3-yl)pyridin-4-amine | ESD-891639-250MG |
| Cas.: 377053-86-6 | Purity: 97% | Methyl 3-(4-bromophenyl)isoxazole-5-carboxylate | ESD-891640-100MG |
| Cas.: 377053-86-6 | Purity: 97% | Methyl 3-(4-bromophenyl)isoxazole-5-carboxylate | ESD-891640-250MG |
| Cas.: 377053-86-6 | Purity: 97% | Methyl 3-(4-bromophenyl)isoxazole-5-carboxylate | ESD-891640-1G |
| Cas.: 20034-02-0 | Purity: ≥95% | (6-Methyl-1H-benzo[d]imidazol-2-yl)methanol | ESD-891641-250MG |
| Cas.: 20034-02-0 | Purity: ≥95% | (6-Methyl-1H-benzo[d]imidazol-2-yl)methanol | ESD-891641-1G |
| Cas.: 20034-02-0 | Purity: ≥95% | (6-Methyl-1H-benzo[d]imidazol-2-yl)methanol | ESD-891641-5G |
| Cas.: 622386-94-1 | Purity: 97% | 4-(4-Bromophenyl)-1-(methylsulfonyl)piperidine | ESD-891642-100MG |
| Cas.: 622386-94-1 | Purity: 97% | 4-(4-Bromophenyl)-1-(methylsulfonyl)piperidine | ESD-891642-250MG |
| Cas.: 1257095-61-6 | Purity: ≥95% | N-(4-Chloro-3-nitrophenyl)-4-(trifluoromethyl)benzothioamide | ESD-891643-100MG |
| Cas.: 1257095-61-6 | Purity: ≥95% | N-(4-Chloro-3-nitrophenyl)-4-(trifluoromethyl)benzothioamide | ESD-891643-250MG |
| Cas.: 17288-54-9 | Purity: ≥95% | 5-(Benzyloxy)-1H-pyrrolo[2,3-c]pyridine | ESD-891644-100MG |
| Cas.: 17288-54-9 | Purity: ≥95% | 5-(Benzyloxy)-1H-pyrrolo[2,3-c]pyridine | ESD-891644-250MG |
| Cas.: 17288-54-9 | Purity: ≥95% | 5-(Benzyloxy)-1H-pyrrolo[2,3-c]pyridine | ESD-891644-1G |
| Cas.: 1545472-15-8 | Purity: 97% | 4-Methyl-1H-indole-6-carboxylic acid | ESD-891645-100MG |
| Cas.: 1545472-15-8 | Purity: 97% | 4-Methyl-1H-indole-6-carboxylic acid | ESD-891645-250MG |
| Cas.: 304664-15-1 | Purity: 97% | N-(4-Bromophenethyl)isobutyramide | ESD-891646-100MG |
| Cas.: 304664-15-1 | Purity: 97% | N-(4-Bromophenethyl)isobutyramide | ESD-891646-250MG |
| Cas.: 304664-15-1 | Purity: 97% | N-(4-Bromophenethyl)isobutyramide | ESD-891646-1G |
| Cas.: 14678-86-5 | Purity: ≥95% | Ethyl 5-amino-1-(2-chlorophenyl)-1H-pyrazole-4-carboxylate | ESD-891647-100MG |
| Cas.: 14678-86-5 | Purity: ≥95% | Ethyl 5-amino-1-(2-chlorophenyl)-1H-pyrazole-4-carboxylate | ESD-891647-250MG |
| Cas.: 119945-11-8 | Purity: 97% | 2-Acetamido-3-(methylamino)propanoic acid | ESD-891648-100MG |
| Cas.: 119945-11-8 | Purity: 97% | 2-Acetamido-3-(methylamino)propanoic acid | ESD-891648-250MG |
| Cas.: 59207-23-7 | Purity: ≥95% | 2-Methylthieno[3,2-c]pyridin-4(5H)-one | ESD-891649-100MG |
| Cas.: 59207-23-7 | Purity: ≥95% | 2-Methylthieno[3,2-c]pyridin-4(5H)-one | ESD-891649-250MG |
| Cas.: 14840-18-7 | Purity: 98% | 3-(1H-Benzo[d]imidazol-1-yl)propanoic acid | ESD-891650-250MG |
| Cas.: 14840-18-7 | Purity: 98% | 3-(1H-Benzo[d]imidazol-1-yl)propanoic acid | ESD-891650-1G |
| Cas.: 14840-18-7 | Purity: 98% | 3-(1H-Benzo[d]imidazol-1-yl)propanoic acid | ESD-891650-5G |
| Cas.: 14840-18-7 | Purity: 98% | 3-(1H-Benzo[d]imidazol-1-yl)propanoic acid | ESD-891650-10G |
| Cas.: 22823-50-3 | Purity: 97% | Dicyclohexylamine (S)-2-((tert-butoxycarbonyl)amino)-4-(methylthio)butanoate | ESD-891651-1G |
| Cas.: 22823-50-3 | Purity: 97% | Dicyclohexylamine (S)-2-((tert-butoxycarbonyl)amino)-4-(methylthio)butanoate | ESD-891651-5G |
| Cas.: 22823-50-3 | Purity: 97% | Dicyclohexylamine (S)-2-((tert-butoxycarbonyl)amino)-4-(methylthio)butanoate | ESD-891651-10G |
| Cas.: 22823-50-3 | Purity: 97% | Dicyclohexylamine (S)-2-((tert-butoxycarbonyl)amino)-4-(methylthio)butanoate | ESD-891651-25G |
| Cas.: 885519-32-4 | Purity: ≥97% | 6-Chloro-1H-indazol-4-amine | ESD-891652-100MG |
| Cas.: 885519-32-4 | Purity: ≥97% | 6-Chloro-1H-indazol-4-amine | ESD-891652-250MG |
| Cas.: 885519-32-4 | Purity: ≥97% | 6-Chloro-1H-indazol-4-amine | ESD-891652-1G |
| Cas.: 64299-26-9 | Purity: 97% | 4-Amino-1-phenyl-1H-pyrazole-3-carboxylic acid | ESD-891653-100MG |
| Cas.: 64299-26-9 | Purity: 97% | 4-Amino-1-phenyl-1H-pyrazole-3-carboxylic acid | ESD-891653-250MG |
| Cas.: 64299-26-9 | Purity: 97% | 4-Amino-1-phenyl-1H-pyrazole-3-carboxylic acid | ESD-891653-1G |
| Cas.: 64299-26-9 | Purity: 97% | 4-Amino-1-phenyl-1H-pyrazole-3-carboxylic acid | ESD-891653-5G |
| Cas.: 1000341-55-8 | Purity: ≥95% | 6-Chloro-3-iodo-1H-pyrrolo[3,2-c]pyridine | ESD-891654-100MG |
| Cas.: 1000341-55-8 | Purity: ≥95% | 6-Chloro-3-iodo-1H-pyrrolo[3,2-c]pyridine | ESD-891654-250MG |
| Cas.: 1000341-55-8 | Purity: ≥95% | 6-Chloro-3-iodo-1H-pyrrolo[3,2-c]pyridine | ESD-891654-1G |
| Cas.: 1000341-55-8 | Purity: ≥95% | 6-Chloro-3-iodo-1H-pyrrolo[3,2-c]pyridine | ESD-891654-5G |
| Cas.: 28004-63-9 | Purity: ≥95% | 5-(2,4-Dichlorophenyl)-1,3,4-thiadiazol-2-amine | ESD-891655-250MG |
| Cas.: 28004-63-9 | Purity: ≥95% | 5-(2,4-Dichlorophenyl)-1,3,4-thiadiazol-2-amine | ESD-891655-1G |
| Cas.: 28004-63-9 | Purity: ≥95% | 5-(2,4-Dichlorophenyl)-1,3,4-thiadiazol-2-amine | ESD-891655-5G |
| Cas.: 28004-63-9 | Purity: ≥95% | 5-(2,4-Dichlorophenyl)-1,3,4-thiadiazol-2-amine | ESD-891655-10G |
| Cas.: 39497-01-3 | Purity: ≥95% | Methyl 2-oxo-1,2-dihydroquinoline-4-carboxylate | ESD-891656-100MG |
| Cas.: 39497-01-3 | Purity: ≥95% | Methyl 2-oxo-1,2-dihydroquinoline-4-carboxylate | ESD-891656-250MG |
| Cas.: 39497-01-3 | Purity: ≥95% | Methyl 2-oxo-1,2-dihydroquinoline-4-carboxylate | ESD-891656-1G |
| Cas.: 39497-01-3 | Purity: ≥95% | Methyl 2-oxo-1,2-dihydroquinoline-4-carboxylate | ESD-891656-5G |
| Cas.: 870837-18-6 | Purity: 95% | 3-Methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde | ESD-891657-100MG |
| Cas.: 870837-18-6 | Purity: 95% | 3-Methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde | ESD-891657-250MG |
| Cas.: 870837-18-6 | Purity: 95% | 3-Methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde | ESD-891657-1G |
| Cas.: 870837-18-6 | Purity: 95% | 3-Methoxy-4-(4-methyl-1H-imidazol-1-yl)benzaldehyde | ESD-891657-5G |
| Cas.: 74230-08-3 | Purity: ≥95% | 4-Hydroxy-2-nitrobenzoic acid | ESD-891658-100MG |
| Cas.: 74230-08-3 | Purity: ≥95% | 4-Hydroxy-2-nitrobenzoic acid | ESD-891658-250MG |
| Cas.: 74230-08-3 | Purity: ≥95% | 4-Hydroxy-2-nitrobenzoic acid | ESD-891658-1G |
| Cas.: 780753-89-1 | Purity: ≥95% | 1-(4-Fluorophenyl)piperazin-2-one | ESD-891659-100MG |
| Cas.: 780753-89-1 | Purity: ≥95% | 1-(4-Fluorophenyl)piperazin-2-one | ESD-891659-250MG |
| Cas.: 6298-03-9 | Purity: ≥95% | H-Lys(Aloc)-OH | ESD-891660-250MG |
| Cas.: 6298-03-9 | Purity: ≥95% | H-Lys(Aloc)-OH | ESD-891660-1G |
| Cas.: 6298-03-9 | Purity: ≥95% | H-Lys(Aloc)-OH | ESD-891660-5G |
| Cas.: 851789-43-0 | Purity: ≥95% | 2-(3-Hydroxy-1-phenylpropyl)-4-methylphenol | ESD-891661-100MG |
| Cas.: 851789-43-0 | Purity: ≥95% | 2-(3-Hydroxy-1-phenylpropyl)-4-methylphenol | ESD-891661-250MG |
| Cas.: 179687-79-7 | Purity: ≥95% | 2-((2-Chloro-4-nitrophenoxy)methyl)pyridine | ESD-891662-100MG |
| Cas.: 179687-79-7 | Purity: ≥95% | 2-((2-Chloro-4-nitrophenoxy)methyl)pyridine | ESD-891662-250MG |
| Cas.: 179687-79-7 | Purity: ≥95% | 2-((2-Chloro-4-nitrophenoxy)methyl)pyridine | ESD-891662-1G |
| Cas.: 179687-79-7 | Purity: ≥95% | 2-((2-Chloro-4-nitrophenoxy)methyl)pyridine | ESD-891662-5G |
| Cas.: 125941-87-9 | Purity: ≥98% | SCH 23390 HCl | ESD-891663-5MG |
| Cas.: 125941-87-9 | Purity: ≥98% | SCH 23390 HCl | ESD-891663-10MG |
| Cas.: 125941-87-9 | Purity: ≥98% | SCH 23390 HCl | ESD-891663-25MG |
| Cas.: 125941-87-9 | Purity: ≥98% | SCH 23390 HCl | ESD-891663-50MG |
| Cas.: 50741-53-2 | Purity: ≥95% | 6-Hydroxy-2-methylquinoline-4-carboxylic acid | ESD-891664-100MG |
| Cas.: 50741-53-2 | Purity: ≥95% | 6-Hydroxy-2-methylquinoline-4-carboxylic acid | ESD-891664-250MG |
| Cas.: 50741-53-2 | Purity: ≥95% | 6-Hydroxy-2-methylquinoline-4-carboxylic acid | ESD-891664-1G |
| Cas.: 1572-97-0 | Purity: 97% | (S)-1-(4-Methoxyphenyl)ethanol | ESD-891665-100MG |
| Cas.: 1572-97-0 | Purity: 97% | (S)-1-(4-Methoxyphenyl)ethanol | ESD-891665-250MG |
| Cas.: 1572-97-0 | Purity: 97% | (S)-1-(4-Methoxyphenyl)ethanol | ESD-891665-1G |
| Cas.: 1572-97-0 | Purity: 97% | (S)-1-(4-Methoxyphenyl)ethanol | ESD-891665-5G |
| Cas.: 53297-68-0 | Purity: 97% | 2-Chloro-4-sulfamoylaniline | ESD-891666-250MG |
| Cas.: 53297-68-0 | Purity: 97% | 2-Chloro-4-sulfamoylaniline | ESD-891666-1G |
| Cas.: 53297-68-0 | Purity: 97% | 2-Chloro-4-sulfamoylaniline | ESD-891666-5G |
| Cas.: 53297-68-0 | Purity: 97% | 2-Chloro-4-sulfamoylaniline | ESD-891666-10G |
| Cas.: 4922-98-9 | Purity: 97% | 5-Phenyl-1H-1,2,4-triazol-3-amine | ESD-891667-250MG |
| Cas.: 4922-98-9 | Purity: 97% | 5-Phenyl-1H-1,2,4-triazol-3-amine | ESD-891667-1G |
| Cas.: 4922-98-9 | Purity: 97% | 5-Phenyl-1H-1,2,4-triazol-3-amine | ESD-891667-5G |
| Cas.: 4922-98-9 | Purity: 97% | 5-Phenyl-1H-1,2,4-triazol-3-amine | ESD-891667-10G |
| Cas.: 6057-60-9 | Purity: 97% | 4-(4-Biphenylyl)butyric acid | ESD-891668-250MG |
| Cas.: 6057-60-9 | Purity: 97% | 4-(4-Biphenylyl)butyric acid | ESD-891668-1G |
| Cas.: 175201-94-2 | Purity: ≥95% | 4-Chloro-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid | ESD-891669-250MG |
| Cas.: 175201-94-2 | Purity: ≥95% | 4-Chloro-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid | ESD-891669-1G |
| Cas.: 175201-94-2 | Purity: ≥95% | 4-Chloro-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid | ESD-891669-5G |
| Cas.: 175201-94-2 | Purity: ≥95% | 4-Chloro-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid | ESD-891669-10G |
| Cas.: 1279200-14-4 | Purity: 97% | (2R,4S)-Benzyl 4-amino-2-(hydroxymethyl)pyrrolidine-1-carboxylate | ESD-891670-100MG |
| Cas.: 1279200-14-4 | Purity: 97% | (2R,4S)-Benzyl 4-amino-2-(hydroxymethyl)pyrrolidine-1-carboxylate | ESD-891670-250MG |
| Cas.: 886853-93-6 | Purity: 97% | 2-Methoxyquinoline-3-boronic acid | ESD-891671-100MG |
| Cas.: 886853-93-6 | Purity: 97% | 2-Methoxyquinoline-3-boronic acid | ESD-891671-250MG |
| Cas.: 886853-93-6 | Purity: 97% | 2-Methoxyquinoline-3-boronic acid | ESD-891671-1G |
| Cas.: 886853-93-6 | Purity: 97% | 2-Methoxyquinoline-3-boronic acid | ESD-891671-5G |
| Cas.: 1008360-84-6 | Purity: 97% | 5-Bromo-6-fluoro-1H-benzo[d]imidazole | ESD-891672-250MG |
| Cas.: 1008360-84-6 | Purity: 97% | 5-Bromo-6-fluoro-1H-benzo[d]imidazole | ESD-891672-1G |
| Cas.: 1008360-84-6 | Purity: 97% | 5-Bromo-6-fluoro-1H-benzo[d]imidazole | ESD-891672-5G |
| Cas.: 1008360-84-6 | Purity: 97% | 5-Bromo-6-fluoro-1H-benzo[d]imidazole | ESD-891672-10G |
| Cas.: 646055-62-1 | Purity: 97% | tert-Butyl 1-benzyl-1,7-diazaspiro[4.4]nonane-7-carboxylate | ESD-891673-100MG |
| Cas.: 646055-62-1 | Purity: 97% | tert-Butyl 1-benzyl-1,7-diazaspiro[4.4]nonane-7-carboxylate | ESD-891673-250MG |
| Cas.: 634905-21-8 | Purity: ≥95% | (3-(Piperidin-1-yl)phenyl)boronic acid | ESD-891674-100MG |
| Cas.: 634905-21-8 | Purity: ≥95% | (3-(Piperidin-1-yl)phenyl)boronic acid | ESD-891674-250MG |
| Cas.: 634905-21-8 | Purity: ≥95% | (3-(Piperidin-1-yl)phenyl)boronic acid | ESD-891674-1G |
| Cas.: 634905-21-8 | Purity: ≥95% | (3-(Piperidin-1-yl)phenyl)boronic acid | ESD-891674-5G |
| Cas.: 18474-60-7 | Purity: 97% | 7-Methyl-1H-indole-2-carboxylic acid | ESD-891675-100MG |
| Cas.: 18474-60-7 | Purity: 97% | 7-Methyl-1H-indole-2-carboxylic acid | ESD-891675-250MG |
| Cas.: 18474-60-7 | Purity: 97% | 7-Methyl-1H-indole-2-carboxylic acid | ESD-891675-1G |
| Cas.: 18474-60-7 | Purity: 97% | 7-Methyl-1H-indole-2-carboxylic acid | ESD-891675-5G |
| Cas.: 1211-19-4 | Purity: 97% | 2-(Phenylamino)benzamide | ESD-891676-250MG |
| Cas.: 1211-19-4 | Purity: 97% | 2-(Phenylamino)benzamide | ESD-891676-1G |
| Cas.: 1354356-24-3 | Purity: ≥95% | tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinate | ESD-891677-100MG |
| Cas.: 1354356-24-3 | Purity: ≥95% | tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinate | ESD-891677-250MG |
| Cas.: 104266-90-2 | Purity: 97% | (S)-4-Benzyl-3-(3-methylbutanoyl)oxazolidin-2-one | ESD-891678-1G |
| Cas.: 104266-90-2 | Purity: 97% | (S)-4-Benzyl-3-(3-methylbutanoyl)oxazolidin-2-one | ESD-891678-5G |
| Cas.: 104266-90-2 | Purity: 97% | (S)-4-Benzyl-3-(3-methylbutanoyl)oxazolidin-2-one | ESD-891678-10G |
| Cas.: 145589-03-3 | Purity: 97% | (R)-4-Benzyl-3-(3-methylbutanoyl)oxazolidin-2-one | ESD-891679-100MG |
| Cas.: 145589-03-3 | Purity: 97% | (R)-4-Benzyl-3-(3-methylbutanoyl)oxazolidin-2-one | ESD-891679-250MG |
| Cas.: 145589-03-3 | Purity: 97% | (R)-4-Benzyl-3-(3-methylbutanoyl)oxazolidin-2-one | ESD-891679-1G |
| Cas.: 145589-03-3 | Purity: 97% | (R)-4-Benzyl-3-(3-methylbutanoyl)oxazolidin-2-one | ESD-891679-5G |
| Cas.: 123715-02-6 | Purity: 97% | (S)-2-Amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoic acid | ESD-891680-100MG |
| Cas.: 123715-02-6 | Purity: 97% | (S)-2-Amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoic acid | ESD-891680-250MG |
| Cas.: 123715-02-6 | Purity: 97% | (S)-2-Amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoic acid | ESD-891680-1G |
| Cas.: 2084-13-1 | Purity: ≥95% | 3-(Carboxymethyl)benzoic acid | ESD-891681-250MG |
| Cas.: 2084-13-1 | Purity: ≥95% | 3-(Carboxymethyl)benzoic acid | ESD-891681-1G |
| Cas.: 53848-00-3 | Purity: ≥95% | 5-(3-Bromophenyl)-1H-imidazole | ESD-891682-100MG |
| Cas.: 53848-00-3 | Purity: ≥95% | 5-(3-Bromophenyl)-1H-imidazole | ESD-891682-250MG |
| Cas.: 72035-46-2 | Purity: ≥95% | 2,3-Bis(4-methoxyphenyl)propanenitrile | ESD-891683-100MG |
| Cas.: 72035-46-2 | Purity: ≥95% | 2,3-Bis(4-methoxyphenyl)propanenitrile | ESD-891683-250MG |
| Cas.: 2450-26-2 | Purity: 95% | 4-Hydroxy-3-methoxy-2-nitrobenzaldehyde | ESD-891684-100MG |
| Cas.: 2450-26-2 | Purity: 95% | 4-Hydroxy-3-methoxy-2-nitrobenzaldehyde | ESD-891684-250MG |
| Cas.: 2450-26-2 | Purity: 95% | 4-Hydroxy-3-methoxy-2-nitrobenzaldehyde | ESD-891684-1G |
| Cas.: 2450-26-2 | Purity: 95% | 4-Hydroxy-3-methoxy-2-nitrobenzaldehyde | ESD-891684-5G |
| Cas.: 612833-37-1 | Purity: ≥95% | (5-Cyano-2-methoxyphenyl)boronic acid | ESD-891685-250MG |
| Cas.: 612833-37-1 | Purity: ≥95% | (5-Cyano-2-methoxyphenyl)boronic acid | ESD-891685-1G |
| Cas.: 612833-37-1 | Purity: ≥95% | (5-Cyano-2-methoxyphenyl)boronic acid | ESD-891685-5G |
| Cas.: 612833-37-1 | Purity: ≥95% | (5-Cyano-2-methoxyphenyl)boronic acid | ESD-891685-25G |
| Cas.: 1262006-62-1 | Purity: 95% | 4′-Methoxy-2-methyl-3′-(trifluoromethyl)-[1,1′-biphenyl]-4-carboxylic acid | ESD-891686-100MG |
| Cas.: 1203578-65-7 | Purity: ≥95% | 7-Bromo-2-phenylquinoline | ESD-891687-250MG |
| Cas.: 1203578-65-7 | Purity: ≥95% | 7-Bromo-2-phenylquinoline | ESD-891687-1G |
| Cas.: 1203578-65-7 | Purity: ≥95% | 7-Bromo-2-phenylquinoline | ESD-891687-5G |
| Cas.: 14108-60-2 | Purity: 97% | H-DL-2-Nal-OH | ESD-891688-250MG |
| Cas.: 14108-60-2 | Purity: 97% | H-DL-2-Nal-OH | ESD-891688-1G |
| Cas.: 14108-60-2 | Purity: 97% | H-DL-2-Nal-OH | ESD-891688-5G |
| Cas.: 14108-60-2 | Purity: 97% | H-DL-2-Nal-OH | ESD-891688-25G |
| Cas.: 863668-07-9 | Purity: 97% | 2-(4-Fluorophenyl)thiazole-4-carboxylic acid | ESD-891689-250MG |
| Cas.: 863668-07-9 | Purity: 97% | 2-(4-Fluorophenyl)thiazole-4-carboxylic acid | ESD-891689-1G |
| Cas.: 863668-07-9 | Purity: 97% | 2-(4-Fluorophenyl)thiazole-4-carboxylic acid | ESD-891689-5G |
| Cas.: 1774893-22-9 | Purity: 97% | 6-(Trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-891690-100MG |
| Cas.: 1774893-22-9 | Purity: 97% | 6-(Trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-2-carboxylic acid | ESD-891690-250MG |
| Cas.: 32884-23-4 | Purity: 97% | 2-(Benzyloxy)-4-methoxybenzaldehyde | ESD-891691-100MG |
| Cas.: 32884-23-4 | Purity: 97% | 2-(Benzyloxy)-4-methoxybenzaldehyde | ESD-891691-250MG |
| Cas.: 32884-23-4 | Purity: 97% | 2-(Benzyloxy)-4-methoxybenzaldehyde | ESD-891691-1G |
| Cas.: 32884-23-4 | Purity: 97% | 2-(Benzyloxy)-4-methoxybenzaldehyde | ESD-891691-5G |
| Cas.: 23088-52-0 | Purity: ≥95% | 5-Phenylisoxazole-3-carboxamide | ESD-891692-100MG |
| Cas.: 23088-52-0 | Purity: ≥95% | 5-Phenylisoxazole-3-carboxamide | ESD-891692-250MG |
| Cas.: 23088-52-0 | Purity: ≥95% | 5-Phenylisoxazole-3-carboxamide | ESD-891692-1G |
| Cas.: 40107-93-5 | Purity: 97% | 6,7-Dihydro-5H-pyrrolo[3,4-b]pyridin-5-one | ESD-891693-100MG |
| Cas.: 40107-93-5 | Purity: 97% | 6,7-Dihydro-5H-pyrrolo[3,4-b]pyridin-5-one | ESD-891693-250MG |
| Cas.: 40107-93-5 | Purity: 97% | 6,7-Dihydro-5H-pyrrolo[3,4-b]pyridin-5-one | ESD-891693-1G |
| Cas.: 1217501-00-2 | Purity: 95% | (4-(1-Cyanocyclopropyl)phenyl)boronic acid | ESD-891694-100MG |
| Cas.: 1217501-00-2 | Purity: 95% | (4-(1-Cyanocyclopropyl)phenyl)boronic acid | ESD-891694-250MG |
| Cas.: 1217501-00-2 | Purity: 95% | (4-(1-Cyanocyclopropyl)phenyl)boronic acid | ESD-891694-1G |
| Cas.: 1217501-00-2 | Purity: 95% | (4-(1-Cyanocyclopropyl)phenyl)boronic acid | ESD-891694-5G |
| Cas.: 870997-82-3 | Purity: ≥95% | 3-((tert-Butoxycarbonyl)amino)-2-methoxyisonicotinic acid | ESD-891695-100MG |
| Cas.: 870997-82-3 | Purity: ≥95% | 3-((tert-Butoxycarbonyl)amino)-2-methoxyisonicotinic acid | ESD-891695-250MG |
| Cas.: 870997-82-3 | Purity: ≥95% | 3-((tert-Butoxycarbonyl)amino)-2-methoxyisonicotinic acid | ESD-891695-1G |
| Cas.: 870997-82-3 | Purity: ≥95% | 3-((tert-Butoxycarbonyl)amino)-2-methoxyisonicotinic acid | ESD-891695-5G |
| Cas.: 155603-50-2 | Purity: 97% | 4-(((2-Ethylhexyl)oxy)carbonyl)benzoic acid | ESD-891696-100MG |
| Cas.: 155603-50-2 | Purity: 97% | 4-(((2-Ethylhexyl)oxy)carbonyl)benzoic acid | ESD-891696-250MG |
| Cas.: 155603-50-2 | Purity: 97% | 4-(((2-Ethylhexyl)oxy)carbonyl)benzoic acid | ESD-891696-1G |
| Cas.: 155603-50-2 | Purity: 97% | 4-(((2-Ethylhexyl)oxy)carbonyl)benzoic acid | ESD-891696-5G |
| Cas.: 28027-16-9 | Purity: 97% | 4-Hydroxy-6-methoxyquinoline-3-carboxylic acid | ESD-891697-250MG |
| Cas.: 28027-16-9 | Purity: 97% | 4-Hydroxy-6-methoxyquinoline-3-carboxylic acid | ESD-891697-1G |
| Cas.: 28027-16-9 | Purity: 97% | 4-Hydroxy-6-methoxyquinoline-3-carboxylic acid | ESD-891697-5G |
| Cas.: 28027-16-9 | Purity: 97% | 4-Hydroxy-6-methoxyquinoline-3-carboxylic acid | ESD-891697-10G |
| Cas.: 59434-19-4 | Purity: 98% | 4-Aminophthalide | ESD-891698-250MG |
| Cas.: 59434-19-4 | Purity: 98% | 4-Aminophthalide | ESD-891698-1G |
| Cas.: 59434-19-4 | Purity: 98% | 4-Aminophthalide | ESD-891698-5G |
| Cas.: 1322091-24-6 | Purity: 97% | 4-Fluoro-2-((4-methoxyphenyl)ethynyl)benzaldehyde | ESD-891699-250MG |
| Cas.: 1322091-24-6 | Purity: 97% | 4-Fluoro-2-((4-methoxyphenyl)ethynyl)benzaldehyde | ESD-891699-1G |
| Cas.: 37901-92-1 | Purity: ≥95% | 4-Acetamido-3-methylbenzoic acid | ESD-891700-1G |
| Cas.: 37901-92-1 | Purity: ≥95% | 4-Acetamido-3-methylbenzoic acid | ESD-891700-5G |
| Cas.: 899809-61-1 | Purity: 95% | (R)-4-Hydroxy-N,N-diphenylpent-2-ynamide | ESD-891701-250MG |
| Cas.: 899809-61-1 | Purity: 95% | (R)-4-Hydroxy-N,N-diphenylpent-2-ynamide | ESD-891701-1G |
| Cas.: 69489-07-2 | Purity: ≥95% | 4-((tert-Butoxycarbonyl)amino)-3-hydroxybutanoic acid | ESD-891702-100MG |
| Cas.: 69489-07-2 | Purity: ≥95% | 4-((tert-Butoxycarbonyl)amino)-3-hydroxybutanoic acid | ESD-891702-250MG |
| Cas.: 69489-07-2 | Purity: ≥95% | 4-((tert-Butoxycarbonyl)amino)-3-hydroxybutanoic acid | ESD-891702-1G |
| Cas.: 5948-71-0 | Purity: 97% | Ethyl 4-(4-chlorophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate | ESD-891703-100MG |
| Cas.: 5948-71-0 | Purity: 97% | Ethyl 4-(4-chlorophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate | ESD-891703-250MG |
| Cas.: 5948-71-0 | Purity: 97% | Ethyl 4-(4-chlorophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate | ESD-891703-1G |
| Cas.: 1536648-98-2 | Purity: 97% | Ethyl 1-(6-bromopyridin-2-yl)-5-methyl-1H-pyrazole-4-carboxylate | ESD-891704-100MG |
| Cas.: 1536648-98-2 | Purity: 97% | Ethyl 1-(6-bromopyridin-2-yl)-5-methyl-1H-pyrazole-4-carboxylate | ESD-891704-250MG |
| Cas.: 1536648-98-2 | Purity: 97% | Ethyl 1-(6-bromopyridin-2-yl)-5-methyl-1H-pyrazole-4-carboxylate | ESD-891704-1G |
| Cas.: 1536648-98-2 | Purity: 97% | Ethyl 1-(6-bromopyridin-2-yl)-5-methyl-1H-pyrazole-4-carboxylate | ESD-891704-5G |
| Cas.: 137088-51-8 | Purity: 96% | 1-(tert-Butoxycarbonyl)indoline-2-carboxylic acid | ESD-891705-1G |
| Cas.: 137088-51-8 | Purity: 96% | 1-(tert-Butoxycarbonyl)indoline-2-carboxylic acid | ESD-891705-5G |
| Cas.: 137088-51-8 | Purity: 96% | 1-(tert-Butoxycarbonyl)indoline-2-carboxylic acid | ESD-891705-25G |
| Cas.: 1347675-92-6 | Purity: ≥95% | (R)-N-(Tetrahydro-2H-pyran-3-yl)benzamide | ESD-891706-100MG |
| Cas.: 1347675-92-6 | Purity: ≥95% | (R)-N-(Tetrahydro-2H-pyran-3-yl)benzamide | ESD-891706-250MG |
| Cas.: 214915-72-7 | Purity: 95% | 2-(6-Bromo-1H-indol-3-yl)ethanol | ESD-891707-100MG |
| Cas.: 214915-72-7 | Purity: 95% | 2-(6-Bromo-1H-indol-3-yl)ethanol | ESD-891707-250MG |
| Cas.: 214915-72-7 | Purity: 95% | 2-(6-Bromo-1H-indol-3-yl)ethanol | ESD-891707-1G |
| Cas.: 5057-12-5 | Purity: 97% | 3,4,7,8-Tetrahydroquinoline-2,5(1H,6H)-dione | ESD-891708-100MG |
| Cas.: 5057-12-5 | Purity: 97% | 3,4,7,8-Tetrahydroquinoline-2,5(1H,6H)-dione | ESD-891708-250MG |
| Cas.: 5057-12-5 | Purity: 97% | 3,4,7,8-Tetrahydroquinoline-2,5(1H,6H)-dione | ESD-891708-1G |
| Cas.: 5057-12-5 | Purity: 97% | 3,4,7,8-Tetrahydroquinoline-2,5(1H,6H)-dione | ESD-891708-5G |
| Cas.: 7152-42-3 | Purity: ≥98% | 10-Phenyl-10H-phenothiazine | ESD-891709-250MG |
| Cas.: 7152-42-3 | Purity: ≥98% | 10-Phenyl-10H-phenothiazine | ESD-891709-1G |
| Cas.: 7152-42-3 | Purity: ≥98% | 10-Phenyl-10H-phenothiazine | ESD-891709-5G |
| Cas.: 7152-42-3 | Purity: ≥98% | 10-Phenyl-10H-phenothiazine | ESD-891709-10G |
| Cas.: 101691-65-0 | Purity: 98% | (Tetrahydro-2H-pyran-4-yl)methyl 4-methylbenzenesulfonate | ESD-891710-1G |
| Cas.: 101691-65-0 | Purity: 98% | (Tetrahydro-2H-pyran-4-yl)methyl 4-methylbenzenesulfonate | ESD-891710-5G |
| Cas.: 101691-65-0 | Purity: 98% | (Tetrahydro-2H-pyran-4-yl)methyl 4-methylbenzenesulfonate | ESD-891710-10G |
| Cas.: 101691-65-0 | Purity: 98% | (Tetrahydro-2H-pyran-4-yl)methyl 4-methylbenzenesulfonate | ESD-891710-25G |
| Cas.: 863604-64-2 | Purity: 97% | 3-Fluoro-N-methoxy-N-methyl-4-nitrobenzamide | ESD-891711-100MG |
| Cas.: 863604-64-2 | Purity: 97% | 3-Fluoro-N-methoxy-N-methyl-4-nitrobenzamide | ESD-891711-250MG |
| Cas.: 863604-64-2 | Purity: 97% | 3-Fluoro-N-methoxy-N-methyl-4-nitrobenzamide | ESD-891711-1G |
| Cas.: 143765-02-0 | Purity: 97% | S-(2-Acetamidoethyl)cyclohexanecarbothioate | ESD-891712-100MG |
| Cas.: 143765-02-0 | Purity: 97% | S-(2-Acetamidoethyl)cyclohexanecarbothioate | ESD-891712-250MG |
| Cas.: 63365-23-1 | Purity: ≥95% | 2-Amino-6-nitrobenzonitrile | ESD-891713-100MG |
| Cas.: 63365-23-1 | Purity: ≥95% | 2-Amino-6-nitrobenzonitrile | ESD-891713-250MG |
| Cas.: 169530-97-6 | Purity: 97% | (R)-2-Amino-3-(3-nitrophenyl)propanoic acid | ESD-891714-100MG |
| Cas.: 169530-97-6 | Purity: 97% | (R)-2-Amino-3-(3-nitrophenyl)propanoic acid | ESD-891714-250MG |
| Cas.: 169530-97-6 | Purity: 97% | (R)-2-Amino-3-(3-nitrophenyl)propanoic acid | ESD-891714-1G |
| Cas.: 169530-97-6 | Purity: 97% | (R)-2-Amino-3-(3-nitrophenyl)propanoic acid | ESD-891714-5G |
| Cas.: 916326-37-9 | Purity: 97% | 5-Bromo-1H-pyrazolo[3,4-b]pyridine-3-carbaldehyde | ESD-891715-100MG |
| Cas.: 916326-37-9 | Purity: 97% | 5-Bromo-1H-pyrazolo[3,4-b]pyridine-3-carbaldehyde | ESD-891715-250MG |
| Cas.: 916326-37-9 | Purity: 97% | 5-Bromo-1H-pyrazolo[3,4-b]pyridine-3-carbaldehyde | ESD-891715-1G |
| Cas.: 16711-71-0 | Purity: ≥95% | 3,5-D-Diiodo-Tyr-OH | ESD-891716-250MG |
| Cas.: 16711-71-0 | Purity: ≥95% | 3,5-D-Diiodo-Tyr-OH | ESD-891716-1G |
| Cas.: 16711-71-0 | Purity: ≥95% | 3,5-D-Diiodo-Tyr-OH | ESD-891716-5G |
| Cas.: 16711-71-0 | Purity: ≥95% | 3,5-D-Diiodo-Tyr-OH | ESD-891716-10G |
| Cas.: 66-02-4 | Purity: ≥95% | 2-Amino-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid | ESD-891717-100MG |
| Cas.: 66-02-4 | Purity: ≥95% | 2-Amino-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid | ESD-891717-250MG |
| Cas.: 66-02-4 | Purity: ≥95% | 2-Amino-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid | ESD-891717-1G |
| Cas.: 1116136-63-0 | Purity: ≥95% | 5-Chloro-3-nitro-1H-pyrrolo[3,2-b]pyridine | ESD-891718-100MG |
| Cas.: 1116136-63-0 | Purity: ≥95% | 5-Chloro-3-nitro-1H-pyrrolo[3,2-b]pyridine | ESD-891718-250MG |
| Cas.: 1116136-63-0 | Purity: ≥95% | 5-Chloro-3-nitro-1H-pyrrolo[3,2-b]pyridine | ESD-891718-1G |
| Cas.: 115185-81-4 | Purity: 97% | 6-Hydroxy-3-methylpicolinic acid | ESD-891719-100MG |
| Cas.: 115185-81-4 | Purity: 97% | 6-Hydroxy-3-methylpicolinic acid | ESD-891719-250MG |
| Cas.: 115185-81-4 | Purity: 97% | 6-Hydroxy-3-methylpicolinic acid | ESD-891719-1G |
| Cas.: 206055-91-6 | Purity: 97% | (3-(4-Bromophenyl)isoxazol-5-yl)methanol | ESD-891720-1G |
| Cas.: 206055-91-6 | Purity: 97% | (3-(4-Bromophenyl)isoxazol-5-yl)methanol | ESD-891720-5G |
| Cas.: 69722-29-8 | Purity: ≥95% | Ethyl 5-amino-1-(pyridin-2-yl)-1H-pyrazole-4-carboxylate | ESD-891721-250MG |
| Cas.: 69722-29-8 | Purity: ≥95% | Ethyl 5-amino-1-(pyridin-2-yl)-1H-pyrazole-4-carboxylate | ESD-891721-1G |
| Cas.: 69722-29-8 | Purity: ≥95% | Ethyl 5-amino-1-(pyridin-2-yl)-1H-pyrazole-4-carboxylate | ESD-891721-5G |
| Cas.: 54400-30-5 | Purity: 97% | 2-Amino-5-iodonicotinic acid | ESD-891722-100MG |
| Cas.: 54400-30-5 | Purity: 97% | 2-Amino-5-iodonicotinic acid | ESD-891722-250MG |
| Cas.: 54400-30-5 | Purity: 97% | 2-Amino-5-iodonicotinic acid | ESD-891722-1G |
| Cas.: 54400-30-5 | Purity: 97% | 2-Amino-5-iodonicotinic acid | ESD-891722-5G |
| Cas.: 393522-78-6 | Purity: 97% | Methyl 4′-(hydroxymethyl)-[1,1′-biphenyl]-4-carboxylate | ESD-891723-100MG |
| Cas.: 393522-78-6 | Purity: 97% | Methyl 4′-(hydroxymethyl)-[1,1′-biphenyl]-4-carboxylate | ESD-891723-250MG |
| Cas.: 393522-78-6 | Purity: 97% | Methyl 4′-(hydroxymethyl)-[1,1′-biphenyl]-4-carboxylate | ESD-891723-1G |
| Cas.: 38335-24-9 | Purity: 97% | 3-(4-Nitrophenyl)-2-oxopropanoic acid | ESD-891724-100MG |
| Cas.: 38335-24-9 | Purity: 97% | 3-(4-Nitrophenyl)-2-oxopropanoic acid | ESD-891724-250MG |
| Cas.: 38335-24-9 | Purity: 97% | 3-(4-Nitrophenyl)-2-oxopropanoic acid | ESD-891724-1G |
| Cas.: 38335-24-9 | Purity: 97% | 3-(4-Nitrophenyl)-2-oxopropanoic acid | ESD-891724-5G |
| Cas.: 645-83-0 | Purity: 98% | 3-(Methylsulfonyl)propanoic acid | ESD-891725-250MG |
| Cas.: 645-83-0 | Purity: 98% | 3-(Methylsulfonyl)propanoic acid | ESD-891725-1G |
| Cas.: 645-83-0 | Purity: 98% | 3-(Methylsulfonyl)propanoic acid | ESD-891725-5G |
| Cas.: 645-83-0 | Purity: 98% | 3-(Methylsulfonyl)propanoic acid | ESD-891725-10G |
| Cas.: 10590-73-5 | Purity: ≥95% | 3-Methyl-1H-indole-2-carboxylic acid | ESD-891726-100MG |
| Cas.: 10590-73-5 | Purity: ≥95% | 3-Methyl-1H-indole-2-carboxylic acid | ESD-891726-250MG |
| Cas.: 10590-73-5 | Purity: ≥95% | 3-Methyl-1H-indole-2-carboxylic acid | ESD-891726-1G |
| Cas.: 10590-73-5 | Purity: ≥95% | 3-Methyl-1H-indole-2-carboxylic acid | ESD-891726-5G |
| Cas.: 944401-55-2 | Purity: ≥95% | 4-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine | ESD-891727-100MG |
| Cas.: 944401-55-2 | Purity: ≥95% | 4-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine | ESD-891727-250MG |
| Cas.: 944401-55-2 | Purity: ≥95% | 4-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine | ESD-891727-1G |
| Cas.: 944401-55-2 | Purity: ≥95% | 4-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine | ESD-891727-5G |
| Cas.: 887589-43-7 | Purity: ≥95% | 6-Bromo-4-chloroquinoline-2-carboxylic acid | ESD-891728-100MG |
| Cas.: 887589-43-7 | Purity: ≥95% | 6-Bromo-4-chloroquinoline-2-carboxylic acid | ESD-891728-250MG |
| Cas.: 887589-43-7 | Purity: ≥95% | 6-Bromo-4-chloroquinoline-2-carboxylic acid | ESD-891728-1G |
| Cas.: 90767-01-4 | Purity: ≥95% | 4-Bromo-2-nitronaphthalen-1-amine | ESD-891729-100MG |
| Cas.: 90767-01-4 | Purity: ≥95% | 4-Bromo-2-nitronaphthalen-1-amine | ESD-891729-250MG |
| Cas.: 1357614-50-6 | Purity: ≥95% | tert-Butyl 3-(4-bromophenyl)-3-hydroxyazetidine-1-carboxylate | ESD-891730-100MG |
| Cas.: 1357614-50-6 | Purity: ≥95% | tert-Butyl 3-(4-bromophenyl)-3-hydroxyazetidine-1-carboxylate | ESD-891730-250MG |
| Cas.: 1357614-50-6 | Purity: ≥95% | tert-Butyl 3-(4-bromophenyl)-3-hydroxyazetidine-1-carboxylate | ESD-891730-1G |
| Cas.: 76315-01-0 | Purity: 97% | 2-(Benzyl(tert-butoxycarbonyl)amino)acetic acid | ESD-891731-250MG |
| Cas.: 76315-01-0 | Purity: 97% | 2-(Benzyl(tert-butoxycarbonyl)amino)acetic acid | ESD-891731-1G |
| Cas.: 76315-01-0 | Purity: 97% | 2-(Benzyl(tert-butoxycarbonyl)amino)acetic acid | ESD-891731-5G |
| Cas.: 76315-01-0 | Purity: 97% | 2-(Benzyl(tert-butoxycarbonyl)amino)acetic acid | ESD-891731-10G |
| Cas.: 18605-26-0 | Purity: ≥95% | tert-Butyl 3-(((benzyloxy)carbonyl)amino)propanoate | ESD-891732-250MG |
| Cas.: 18605-26-0 | Purity: ≥95% | tert-Butyl 3-(((benzyloxy)carbonyl)amino)propanoate | ESD-891732-1G |
| Cas.: 18605-26-0 | Purity: ≥95% | tert-Butyl 3-(((benzyloxy)carbonyl)amino)propanoate | ESD-891732-5G |
| Cas.: 18605-26-0 | Purity: ≥95% | tert-Butyl 3-(((benzyloxy)carbonyl)amino)propanoate | ESD-891732-10G |
| Cas.: 364794-80-9 | Purity: 97% | 4-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)morpholine | ESD-891733-1G |
| Cas.: 364794-80-9 | Purity: 97% | 4-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)morpholine | ESD-891733-5G |
| Cas.: 364794-80-9 | Purity: 97% | 4-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)morpholine | ESD-891733-10G |
| Cas.: 52200-22-3 | Purity: ≥95% | 3-(Dimethylamino)-2-(thiophene-2-carbonyl)acrylonitrile | ESD-891734-100MG |
| Cas.: 52200-22-3 | Purity: ≥95% | 3-(Dimethylamino)-2-(thiophene-2-carbonyl)acrylonitrile | ESD-891734-250MG |
| Cas.: 877060-48-5 | Purity: ≥95% | tert-Butyl 3-iodo-1H-pyrrolo[3,2-c]pyridine-1-carboxylate | ESD-891735-250MG |
| Cas.: 877060-48-5 | Purity: ≥95% | tert-Butyl 3-iodo-1H-pyrrolo[3,2-c]pyridine-1-carboxylate | ESD-891735-1G |
| Cas.: 877060-48-5 | Purity: ≥95% | tert-Butyl 3-iodo-1H-pyrrolo[3,2-c]pyridine-1-carboxylate | ESD-891735-5G |
| Cas.: 877060-48-5 | Purity: ≥95% | tert-Butyl 3-iodo-1H-pyrrolo[3,2-c]pyridine-1-carboxylate | ESD-891735-10G |
| Cas.: 173593-25-4 | Purity: 97% | Dicyclohexyl(o-tolyl)phosphine | ESD-891736-100MG |
| Cas.: 173593-25-4 | Purity: 97% | Dicyclohexyl(o-tolyl)phosphine | ESD-891736-250MG |
| Cas.: 173593-25-4 | Purity: 97% | Dicyclohexyl(o-tolyl)phosphine | ESD-891736-1G |
| Cas.: 173593-25-4 | Purity: 97% | Dicyclohexyl(o-tolyl)phosphine | ESD-891736-5G |
| Cas.: 300543-56-0 | Purity: ≥95% | (R)-1-((4-Chlorophenyl)(phenyl)methyl)piperazine | ESD-891737-250MG |
| Cas.: 300543-56-0 | Purity: ≥95% | (R)-1-((4-Chlorophenyl)(phenyl)methyl)piperazine | ESD-891737-1G |
| Cas.: 300543-56-0 | Purity: ≥95% | (R)-1-((4-Chlorophenyl)(phenyl)methyl)piperazine | ESD-891737-5G |
| Cas.: 300543-56-0 | Purity: ≥95% | (R)-1-((4-Chlorophenyl)(phenyl)methyl)piperazine | ESD-891737-10G |
| Cas.: 227940-71-8 | Purity: ≥95% | tert-Butyl 7-benzyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate | ESD-891738-250MG |
| Cas.: 227940-71-8 | Purity: ≥95% | tert-Butyl 7-benzyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate | ESD-891738-1G |
| Cas.: 227940-71-8 | Purity: ≥95% | tert-Butyl 7-benzyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate | ESD-891738-5G |
| Cas.: 227940-71-8 | Purity: ≥95% | tert-Butyl 7-benzyl-3,7-diazabicyclo[3.3.1]nonane-3-carboxylate | ESD-891738-10G |
| Cas.: 4547-02-8 | Purity: ≥95% | 7-Chloro-5-phenyl-1H-benzo[e][1,4]diazepine-2(3H)-thione | ESD-891739-1G |
| Cas.: 4547-02-8 | Purity: ≥95% | 7-Chloro-5-phenyl-1H-benzo[e][1,4]diazepine-2(3H)-thione | ESD-891739-5G |
| Cas.: 4547-02-8 | Purity: ≥95% | 7-Chloro-5-phenyl-1H-benzo[e][1,4]diazepine-2(3H)-thione | ESD-891739-10G |
| Cas.: 4547-02-8 | Purity: ≥95% | 7-Chloro-5-phenyl-1H-benzo[e][1,4]diazepine-2(3H)-thione | ESD-891739-25G |
| Cas.: 1034305-17-3 | Purity: 97% | 2-(5-Bromo-2-fluorobenzyl)benzo[b]thiophene | ESD-891740-100MG |
| Cas.: 1034305-17-3 | Purity: 97% | 2-(5-Bromo-2-fluorobenzyl)benzo[b]thiophene | ESD-891740-250MG |
| Cas.: 1034305-17-3 | Purity: 97% | 2-(5-Bromo-2-fluorobenzyl)benzo[b]thiophene | ESD-891740-1G |
| Cas.: 1034305-17-3 | Purity: 97% | 2-(5-Bromo-2-fluorobenzyl)benzo[b]thiophene | ESD-891740-5G |
| Cas.: 23612-35-3 | Purity: ≥95% | 3-Nitro-1H-pyrrolo[3,2-c]pyridine | ESD-891741-100MG |
| Cas.: 23612-35-3 | Purity: ≥95% | 3-Nitro-1H-pyrrolo[3,2-c]pyridine | ESD-891741-250MG |
| Cas.: 23612-35-3 | Purity: ≥95% | 3-Nitro-1H-pyrrolo[3,2-c]pyridine | ESD-891741-1G |
| Cas.: 23612-35-3 | Purity: ≥95% | 3-Nitro-1H-pyrrolo[3,2-c]pyridine | ESD-891741-5G |
| Cas.: 116-69-8 | Purity: 97% | 3-Bromophthalic acid | ESD-891742-250MG |
| Cas.: 116-69-8 | Purity: 97% | 3-Bromophthalic acid | ESD-891742-1G |
| Cas.: 116-69-8 | Purity: 97% | 3-Bromophthalic acid | ESD-891742-5G |
| Cas.: 116-69-8 | Purity: 97% | 3-Bromophthalic acid | ESD-891742-10G |
| Cas.: 94838-58-1 | Purity: ≥95% | tert-Butyl 4-nitrobenzylcarbamate | ESD-891743-250MG |
| Cas.: 94838-58-1 | Purity: ≥95% | tert-Butyl 4-nitrobenzylcarbamate | ESD-891743-1G |
| Cas.: 94838-58-1 | Purity: ≥95% | tert-Butyl 4-nitrobenzylcarbamate | ESD-891743-5G |
| Cas.: 1034667-22-5 | Purity: 97% | 5-Fluoro-1H-pyrazolo[3,4-b]pyridin-3-amine | ESD-891744-100MG |
| Cas.: 1034667-22-5 | Purity: 97% | 5-Fluoro-1H-pyrazolo[3,4-b]pyridin-3-amine | ESD-891744-250MG |
| Cas.: 1034667-22-5 | Purity: 97% | 5-Fluoro-1H-pyrazolo[3,4-b]pyridin-3-amine | ESD-891744-1G |
| Cas.: 1034667-22-5 | Purity: 97% | 5-Fluoro-1H-pyrazolo[3,4-b]pyridin-3-amine | ESD-891744-5G |
| Cas.: 90178-72-6 | Purity: 97% | 4-(3-Formylphenoxy)benzonitrile | ESD-891745-1G |
| Cas.: 90178-72-6 | Purity: 97% | 4-(3-Formylphenoxy)benzonitrile | ESD-891745-5G |
| Cas.: 90178-72-6 | Purity: 97% | 4-(3-Formylphenoxy)benzonitrile | ESD-891745-10G |
| Cas.: 26018-73-5 | Purity: 96% | 6-Chlorobenzo[b]thiophene-2-carboxylic acid | ESD-891746-100MG |
| Cas.: 26018-73-5 | Purity: 96% | 6-Chlorobenzo[b]thiophene-2-carboxylic acid | ESD-891746-250MG |
| Cas.: 26018-73-5 | Purity: 96% | 6-Chlorobenzo[b]thiophene-2-carboxylic acid | ESD-891746-1G |
| Cas.: 26018-73-5 | Purity: 96% | 6-Chlorobenzo[b]thiophene-2-carboxylic acid | ESD-891746-5G |
| Cas.: 17083-23-7 | Purity: 97% | H-Tyr(tBu)-OtBu.HCl | ESD-891747-250MG |
| Cas.: 17083-23-7 | Purity: 97% | H-Tyr(tBu)-OtBu.HCl | ESD-891747-1G |
| Cas.: 17083-23-7 | Purity: 97% | H-Tyr(tBu)-OtBu.HCl | ESD-891747-5G |
| Cas.: 17083-23-7 | Purity: 97% | H-Tyr(tBu)-OtBu.HCl | ESD-891747-10G |
| Cas.: 90407-16-2 | Purity: 95% | 7-Chloro-1-benzothiophene-2-carboxylic acid | ESD-891748-250MG |
| Cas.: 90407-16-2 | Purity: 95% | 7-Chloro-1-benzothiophene-2-carboxylic acid | ESD-891748-1G |
| Cas.: 90407-16-2 | Purity: 95% | 7-Chloro-1-benzothiophene-2-carboxylic acid | ESD-891748-5G |
| Cas.: 90407-16-2 | Purity: 95% | 7-Chloro-1-benzothiophene-2-carboxylic acid | ESD-891748-25G |
| Cas.: 66820-95-9 | Purity: 97% | 2-Bromo-10H-phenothiazine | ESD-891749-100MG |
| Cas.: 66820-95-9 | Purity: 97% | 2-Bromo-10H-phenothiazine | ESD-891749-250MG |
| Cas.: 66820-95-9 | Purity: 97% | 2-Bromo-10H-phenothiazine | ESD-891749-1G |
| Cas.: 958030-46-1 | Purity: 98% | (2-Formyl-3-methoxyphenyl)boronic acid | ESD-891750-250MG |
| Cas.: 958030-46-1 | Purity: 98% | (2-Formyl-3-methoxyphenyl)boronic acid | ESD-891750-1G |
| Cas.: 958030-46-1 | Purity: 98% | (2-Formyl-3-methoxyphenyl)boronic acid | ESD-891750-5G |
| Cas.: 135531-92-9 | Purity: ≥95% | 5-Methoxy-4-nitro-1H-indole | ESD-891751-100MG |
| Cas.: 135531-92-9 | Purity: ≥95% | 5-Methoxy-4-nitro-1H-indole | ESD-891751-250MG |
| Cas.: 135531-92-9 | Purity: ≥95% | 5-Methoxy-4-nitro-1H-indole | ESD-891751-1G |
| Cas.: 87905-98-4 | Purity: 96% | Benzyl (5-hydroxypentyl)carbamate | ESD-891752-1G |
| Cas.: 53234-56-3 | Purity: ≥95% | 6-Chloro-5-cyanopicolinic acid | ESD-891753-100MG |
| Cas.: 53234-56-3 | Purity: ≥95% | 6-Chloro-5-cyanopicolinic acid | ESD-891753-250MG |
| Cas.: 53234-56-3 | Purity: ≥95% | 6-Chloro-5-cyanopicolinic acid | ESD-891753-1G |
| Cas.: 53234-56-3 | Purity: ≥95% | 6-Chloro-5-cyanopicolinic acid | ESD-891753-5G |
| Cas.: 24641-31-4 | Purity: ≥95% | 2-(4-Bromophenyl)quinoline | ESD-891754-250MG |
| Cas.: 24641-31-4 | Purity: ≥95% | 2-(4-Bromophenyl)quinoline | ESD-891754-1G |
| Cas.: 24641-31-4 | Purity: ≥95% | 2-(4-Bromophenyl)quinoline | ESD-891754-5G |
| Cas.: 148550-51-0 | Purity: ≥95% | Ethyl 2-(methylsulfonyl)pyrimidine-5-carboxylate | ESD-891755-100MG |
| Cas.: 148550-51-0 | Purity: ≥95% | Ethyl 2-(methylsulfonyl)pyrimidine-5-carboxylate | ESD-891755-250MG |
| Cas.: 148550-51-0 | Purity: ≥95% | Ethyl 2-(methylsulfonyl)pyrimidine-5-carboxylate | ESD-891755-1G |
| Cas.: 872355-55-0 | Purity: 95% | 6-Methyl-1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid | ESD-891756-100MG |
| Cas.: 872355-55-0 | Purity: 95% | 6-Methyl-1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid | ESD-891756-250MG |
| Cas.: 872355-55-0 | Purity: 95% | 6-Methyl-1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid | ESD-891756-1G |
| Cas.: 180624-10-6 | Purity: ≥95% | Methyl 4-amino-3-iodo-5-methoxybenzoate | ESD-891757-1G |
| Cas.: 180624-10-6 | Purity: ≥95% | Methyl 4-amino-3-iodo-5-methoxybenzoate | ESD-891757-5G |
| Cas.: 180624-10-6 | Purity: ≥95% | Methyl 4-amino-3-iodo-5-methoxybenzoate | ESD-891757-10G |
| Cas.: 437707-51-2 | Purity: 97% | Ethyl 4-amino-3-bromo-5-iodobenzoate | ESD-891758-250MG |
| Cas.: 437707-51-2 | Purity: 97% | Ethyl 4-amino-3-bromo-5-iodobenzoate | ESD-891758-1G |
| Cas.: 437707-51-2 | Purity: 97% | Ethyl 4-amino-3-bromo-5-iodobenzoate | ESD-891758-5G |
| Cas.: 437707-51-2 | Purity: 97% | Ethyl 4-amino-3-bromo-5-iodobenzoate | ESD-891758-10G |
| Cas.: 3528-45-8 | Purity: 95% | 1-(4-Methoxybenzyl)-1H-pyrazol-5-amine | ESD-891759-250MG |
| Cas.: 3528-45-8 | Purity: 95% | 1-(4-Methoxybenzyl)-1H-pyrazol-5-amine | ESD-891759-1G |
| Cas.: 3528-45-8 | Purity: 95% | 1-(4-Methoxybenzyl)-1H-pyrazol-5-amine | ESD-891759-5G |
| Cas.: 3528-45-8 | Purity: 95% | 1-(4-Methoxybenzyl)-1H-pyrazol-5-amine | ESD-891759-10G |
| Cas.: 354112-08-6 | Purity: ≥95% | N,N-DiBoc-4-amino-6-chloropyrimidine | ESD-891760-100MG |
| Cas.: 354112-08-6 | Purity: ≥95% | N,N-DiBoc-4-amino-6-chloropyrimidine | ESD-891760-250MG |
| Cas.: 354112-08-6 | Purity: ≥95% | N,N-DiBoc-4-amino-6-chloropyrimidine | ESD-891760-1G |
| Cas.: 354112-08-6 | Purity: ≥95% | N,N-DiBoc-4-amino-6-chloropyrimidine | ESD-891760-5G |
| Cas.: 548457-80-3 | Purity: ≥95% | 2,3-Diamino-6-chlorobenzonitrile | ESD-891761-100MG |
| Cas.: 548457-80-3 | Purity: ≥95% | 2,3-Diamino-6-chlorobenzonitrile | ESD-891761-250MG |
| Cas.: 548457-80-3 | Purity: ≥95% | 2,3-Diamino-6-chlorobenzonitrile | ESD-891761-1G |
| Cas.: 548457-80-3 | Purity: ≥95% | 2,3-Diamino-6-chlorobenzonitrile | ESD-891761-5G |
| Cas.: 914349-66-9 | Purity: ≥95% | 3-(Naphthalen-1-yl)thiomorpholine | ESD-891762-100MG |
| Cas.: 914349-66-9 | Purity: ≥95% | 3-(Naphthalen-1-yl)thiomorpholine | ESD-891762-250MG |
| Cas.: 404577-34-0 | Purity: 98% | (R)-1-N-Boc-3-Methanesulfonyloxypiperidine | ESD-891763-1G |
| Cas.: 404577-34-0 | Purity: 98% | (R)-1-N-Boc-3-Methanesulfonyloxypiperidine | ESD-891763-5G |
| Cas.: 404577-34-0 | Purity: 98% | (R)-1-N-Boc-3-Methanesulfonyloxypiperidine | ESD-891763-10G |
| Cas.: 5912-35-6 | Purity: 97% | 6-Amino-8-bromo-1,7-naphthyridine | ESD-891764-100MG |
| Cas.: 5912-35-6 | Purity: 97% | 6-Amino-8-bromo-1,7-naphthyridine | ESD-891764-250MG |
| Cas.: 5912-35-6 | Purity: 97% | 6-Amino-8-bromo-1,7-naphthyridine | ESD-891764-1G |
| Cas.: 17852-28-7 | Purity: ≥95% | (2-Amino-5-methylphenyl)(phenyl)methanone | ESD-891765-100MG |
| Cas.: 17852-28-7 | Purity: ≥95% | (2-Amino-5-methylphenyl)(phenyl)methanone | ESD-891765-250MG |
| Cas.: 17852-28-7 | Purity: ≥95% | (2-Amino-5-methylphenyl)(phenyl)methanone | ESD-891765-1G |
| Cas.: 761426-65-7 | Purity: 97% | 2-Cyclopropyl-5-iodo-1H-imidazole | ESD-891766-100MG |
| Cas.: 761426-65-7 | Purity: 97% | 2-Cyclopropyl-5-iodo-1H-imidazole | ESD-891766-250MG |
| Cas.: 761426-65-7 | Purity: 97% | 2-Cyclopropyl-5-iodo-1H-imidazole | ESD-891766-1G |
| Cas.: 761426-65-7 | Purity: 97% | 2-Cyclopropyl-5-iodo-1H-imidazole | ESD-891766-5G |
| Cas.: 40107-95-7 | Purity: 97% | 1H-Pyrrolo[3,4-c]pyridin-3(2H)-one | ESD-891767-100MG |
| Cas.: 40107-95-7 | Purity: 97% | 1H-Pyrrolo[3,4-c]pyridin-3(2H)-one | ESD-891767-250MG |
| Cas.: 40107-95-7 | Purity: 97% | 1H-Pyrrolo[3,4-c]pyridin-3(2H)-one | ESD-891767-1G |
| Cas.: 40107-95-7 | Purity: 97% | 1H-Pyrrolo[3,4-c]pyridin-3(2H)-one | ESD-891767-5G |
| Cas.: 800401-67-6 | Purity: 97% | Ethyl 5-chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxylate | ESD-891768-100MG |
| Cas.: 800401-67-6 | Purity: 97% | Ethyl 5-chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxylate | ESD-891768-250MG |
| Cas.: 800401-67-6 | Purity: 97% | Ethyl 5-chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxylate | ESD-891768-1G |
| Cas.: 800401-67-6 | Purity: 97% | Ethyl 5-chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxylate | ESD-891768-5G |
| Cas.: 323-87-5 | Purity: ≥95% | 4-Hydroxy-[1,1′-biphenyl]-3-carboxylic acid | ESD-891769-100MG |
| Cas.: 323-87-5 | Purity: ≥95% | 4-Hydroxy-[1,1′-biphenyl]-3-carboxylic acid | ESD-891769-250MG |
| Cas.: 155370-03-9 | Purity: 97% | 2-(4-Fluorophenyl)-2,3-dihydro-4(1H)-quinolinone | ESD-891770-250MG |
| Cas.: 155370-03-9 | Purity: 97% | 2-(4-Fluorophenyl)-2,3-dihydro-4(1H)-quinolinone | ESD-891770-1G |
| Cas.: 37663-46-0 | Purity: ≥95% | 3H-Spiro[isobenzofuran-1,4′-piperidin]-3-one | ESD-891771-100MG |
| Cas.: 37663-46-0 | Purity: ≥95% | 3H-Spiro[isobenzofuran-1,4′-piperidin]-3-one | ESD-891771-250MG |
| Cas.: 1059630-08-8 | Purity: 97% | (4aS,9bR)-Ethyl 6-bromo-3,4,4a,5-tetrahydro-1H-pyrido[4,3-b]indole-2(9bH)-carboxylate | ESD-891772-250MG |
| Cas.: 1059630-08-8 | Purity: 97% | (4aS,9bR)-Ethyl 6-bromo-3,4,4a,5-tetrahydro-1H-pyrido[4,3-b]indole-2(9bH)-carboxylate | ESD-891772-1G |
| Cas.: 1059630-08-8 | Purity: 97% | (4aS,9bR)-Ethyl 6-bromo-3,4,4a,5-tetrahydro-1H-pyrido[4,3-b]indole-2(9bH)-carboxylate | ESD-891772-5G |
| Cas.: 7750-42-7 | Purity: 98% | (S)-tert-Butyl 6-amino-2-((tert-butoxycarbonyl)amino)hexanoate | ESD-891773-250MG |
| Cas.: 872998-61-3 | Purity: ≥95% | 2,4-Dibromoquinazoline | ESD-891774-1G |
| Cas.: 872998-61-3 | Purity: ≥95% | 2,4-Dibromoquinazoline | ESD-891774-5G |
| Cas.: 872998-61-3 | Purity: ≥95% | 2,4-Dibromoquinazoline | ESD-891774-10G |
| Cas.: 627899-90-5 | Purity: 97% | N,N-Dimethyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propan-1-amine | ESD-891775-1G |
| Cas.: 627899-90-5 | Purity: 97% | N,N-Dimethyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propan-1-amine | ESD-891775-5G |
| Cas.: 627899-90-5 | Purity: 97% | N,N-Dimethyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propan-1-amine | ESD-891775-10G |
| Cas.: 30100-16-4 | Purity: 97% | Boc-8-Aoc-OH | ESD-891776-250MG |
| Cas.: 30100-16-4 | Purity: 97% | Boc-8-Aoc-OH | ESD-891776-1G |
| Cas.: 30100-16-4 | Purity: 97% | Boc-8-Aoc-OH | ESD-891776-5G |
| Cas.: 30100-16-4 | Purity: 97% | Boc-8-Aoc-OH | ESD-891776-10G |
| Cas.: 113225-10-8 | Purity: ≥95% | 1-Methyl-4-(2,4,6-trimethoxyphenyl)piperidin-3-one | ESD-891777-250MG |
| Cas.: 113225-10-8 | Purity: ≥95% | 1-Methyl-4-(2,4,6-trimethoxyphenyl)piperidin-3-one | ESD-891777-1G |
| Cas.: 113225-10-8 | Purity: ≥95% | 1-Methyl-4-(2,4,6-trimethoxyphenyl)piperidin-3-one | ESD-891777-5G |
| Cas.: 113225-10-8 | Purity: ≥95% | 1-Methyl-4-(2,4,6-trimethoxyphenyl)piperidin-3-one | ESD-891777-10G |
| Cas.: 4792-70-5 | Purity: 97% | Ethyl 5,7-dichloro-1H-indole-2-carboxylate | ESD-891778-100MG |
| Cas.: 4792-70-5 | Purity: 97% | Ethyl 5,7-dichloro-1H-indole-2-carboxylate | ESD-891778-250MG |
| Cas.: 4792-70-5 | Purity: 97% | Ethyl 5,7-dichloro-1H-indole-2-carboxylate | ESD-891778-1G |
| Cas.: 224434-83-7 | Purity: 97% | 6-Bromo-1H-indole-3-carbonitrile | ESD-891779-100MG |
| Cas.: 224434-83-7 | Purity: 97% | 6-Bromo-1H-indole-3-carbonitrile | ESD-891779-250MG |
| Cas.: 224434-83-7 | Purity: 97% | 6-Bromo-1H-indole-3-carbonitrile | ESD-891779-1G |
| Cas.: 224434-83-7 | Purity: 97% | 6-Bromo-1H-indole-3-carbonitrile | ESD-891779-5G |
| Cas.: 955978-74-2 | Purity: 97% | 4-Bromo-1H-indole-2-carbonitrile | ESD-891780-100MG |
| Cas.: 955978-74-2 | Purity: 97% | 4-Bromo-1H-indole-2-carbonitrile | ESD-891780-250MG |
| Cas.: 955978-74-2 | Purity: 97% | 4-Bromo-1H-indole-2-carbonitrile | ESD-891780-1G |
| Cas.: 183304-68-9 | Purity: ≥95% | 4-(Hydroxymethyl)-1,2,3-thiadiazole-5-carboxylic acid | ESD-891781-100MG |
| Cas.: 183304-68-9 | Purity: ≥95% | 4-(Hydroxymethyl)-1,2,3-thiadiazole-5-carboxylic acid | ESD-891781-250MG |
| Cas.: 2150-55-2 | Purity: 97% | 2-Amino-4,5-dihydrothiazole-4-carboxylic acid | ESD-891782-1G |
| Cas.: 2150-55-2 | Purity: 97% | 2-Amino-4,5-dihydrothiazole-4-carboxylic acid | ESD-891782-5G |
| Cas.: 2150-55-2 | Purity: 97% | 2-Amino-4,5-dihydrothiazole-4-carboxylic acid | ESD-891782-10G |
| Cas.: 926291-64-7 | Purity: 97% | (R)-tert-Butyl (1-(3-chlorophenyl)-2-hydroxyethyl)carbamate | ESD-891783-100MG |
| Cas.: 926291-64-7 | Purity: 97% | (R)-tert-Butyl (1-(3-chlorophenyl)-2-hydroxyethyl)carbamate | ESD-891783-250MG |
| Cas.: 926291-64-7 | Purity: 97% | (R)-tert-Butyl (1-(3-chlorophenyl)-2-hydroxyethyl)carbamate | ESD-891783-1G |
| Cas.: 926291-64-7 | Purity: 97% | (R)-tert-Butyl (1-(3-chlorophenyl)-2-hydroxyethyl)carbamate | ESD-891783-5G |
| Cas.: 313490-90-3 | Purity: 97% | Ethyl 2-((tert-butoxycarbonyl)amino)-2-(pyridin-2-yl)acetate | ESD-891784-250MG |
| Cas.: 313490-90-3 | Purity: 97% | Ethyl 2-((tert-butoxycarbonyl)amino)-2-(pyridin-2-yl)acetate | ESD-891784-1G |
| Cas.: 380430-67-1 | Purity: ≥95% | (2,3,6-Trimethoxyphenyl)boronic acid | ESD-891785-250MG |
| Cas.: 380430-67-1 | Purity: ≥95% | (2,3,6-Trimethoxyphenyl)boronic acid | ESD-891785-1G |
| Cas.: 380430-67-1 | Purity: ≥95% | (2,3,6-Trimethoxyphenyl)boronic acid | ESD-891785-5G |
| Cas.: 35572-78-2 | Purity: 97% | 2-Methyl-3,5-dinitroaniline | ESD-891786-250MG |
| Cas.: 35572-78-2 | Purity: 97% | 2-Methyl-3,5-dinitroaniline | ESD-891786-1G |
| Cas.: 35572-78-2 | Purity: 97% | 2-Methyl-3,5-dinitroaniline | ESD-891786-5G |
| Cas.: 152942-06-8 | Purity: 97% | Ethyl 4-(4-formyl-3-hydroxyphenoxy)butanoate | ESD-891787-250MG |
| Cas.: 152942-06-8 | Purity: 97% | Ethyl 4-(4-formyl-3-hydroxyphenoxy)butanoate | ESD-891787-1G |
| Cas.: 152942-06-8 | Purity: 97% | Ethyl 4-(4-formyl-3-hydroxyphenoxy)butanoate | ESD-891787-5G |
| Cas.: 7598-70-1 | Purity: 96% | Diethyl 2-(4-nitrobenzyl)malonate | ESD-891788-100MG |
| Cas.: 7598-70-1 | Purity: 96% | Diethyl 2-(4-nitrobenzyl)malonate | ESD-891788-250MG |
| Cas.: 17332-54-6 | Purity: ≥95% | 2-((3-(tert-Butyl)phenyl)amino)benzoic acid | ESD-891789-100MG |
| Cas.: 17332-54-6 | Purity: ≥95% | 2-((3-(tert-Butyl)phenyl)amino)benzoic acid | ESD-891789-250MG |
| Cas.: 112332-97-5 | Purity: ≥95% | Methyl 6-hydroxy-1H-indole-3-carboxylate | ESD-891790-250MG |
| Cas.: 112332-97-5 | Purity: ≥95% | Methyl 6-hydroxy-1H-indole-3-carboxylate | ESD-891790-1G |
| Cas.: 112332-97-5 | Purity: ≥95% | Methyl 6-hydroxy-1H-indole-3-carboxylate | ESD-891790-5G |
| Cas.: 350800-81-6 | Purity: ≥95% | 6-Bromo-1H-indol-4-amine | ESD-891791-100MG |
| Cas.: 350800-81-6 | Purity: ≥95% | 6-Bromo-1H-indol-4-amine | ESD-891791-250MG |
| Cas.: 350800-81-6 | Purity: ≥95% | 6-Bromo-1H-indol-4-amine | ESD-891791-1G |
| Cas.: 1240361-06-1 | Purity: 97% | 2-((tert-Butoxycarbonyl)amino)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid | ESD-891792-100MG |
| Cas.: 1240361-06-1 | Purity: 97% | 2-((tert-Butoxycarbonyl)amino)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid | ESD-891792-250MG |
| Cas.: 1240361-06-1 | Purity: 97% | 2-((tert-Butoxycarbonyl)amino)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid | ESD-891792-1G |
| Cas.: 1240361-06-1 | Purity: 97% | 2-((tert-Butoxycarbonyl)amino)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid | ESD-891792-5G |
| Cas.: 2479-47-2 | Purity: 98% | 4,4′-(Propane-2,2-diyl)dianiline | ESD-891793-250MG |
| Cas.: 2479-47-2 | Purity: 98% | 4,4′-(Propane-2,2-diyl)dianiline | ESD-891793-1G |
| Cas.: 2479-47-2 | Purity: 98% | 4,4′-(Propane-2,2-diyl)dianiline | ESD-891793-5G |
| Cas.: 69322-01-6 | Purity: 98% | Sodium 2-hydroxy-2-(4-hydroxyphenyl)acetate | ESD-891794-100MG |
| Cas.: 69322-01-6 | Purity: 98% | Sodium 2-hydroxy-2-(4-hydroxyphenyl)acetate | ESD-891794-250MG |
| Cas.: 150712-24-6 | Purity: 97% | 5-Benzyl-1H-pyrazol-3-amine | ESD-891795-100MG |
| Cas.: 150712-24-6 | Purity: 97% | 5-Benzyl-1H-pyrazol-3-amine | ESD-891795-250MG |
| Cas.: 150712-24-6 | Purity: 97% | 5-Benzyl-1H-pyrazol-3-amine | ESD-891795-1G |
| Cas.: 1082040-98-9 | Purity: ≥95% | 1H-Pyrrolo[3,2-c]pyridine-6-carbonitrile | ESD-891796-100MG |
| Cas.: 1082040-98-9 | Purity: ≥95% | 1H-Pyrrolo[3,2-c]pyridine-6-carbonitrile | ESD-891796-250MG |
| Cas.: 1082040-98-9 | Purity: ≥95% | 1H-Pyrrolo[3,2-c]pyridine-6-carbonitrile | ESD-891796-1G |
| Cas.: 42164-79-4 | Purity: ≥95% | 2-Hydroxy-2-(3-nitrophenyl)acetic acid | ESD-891797-100MG |
| Cas.: 42164-79-4 | Purity: ≥95% | 2-Hydroxy-2-(3-nitrophenyl)acetic acid | ESD-891797-250MG |
| Cas.: 1040682-68-5 | Purity: ≥95% | 1H-Pyrrolo[3,2-c]pyridine-4-carbonitrile | ESD-891798-100MG |
| Cas.: 1040682-68-5 | Purity: ≥95% | 1H-Pyrrolo[3,2-c]pyridine-4-carbonitrile | ESD-891798-250MG |
| Cas.: 1040682-68-5 | Purity: ≥95% | 1H-Pyrrolo[3,2-c]pyridine-4-carbonitrile | ESD-891798-1G |
| Cas.: 1040682-68-5 | Purity: ≥95% | 1H-Pyrrolo[3,2-c]pyridine-4-carbonitrile | ESD-891798-5G |
| Cas.: 97-10-9 | Purity: ≥95% | 4-(Methylsulfonyl)-2-nitrophenol | ESD-891799-1G |
| Cas.: 97-10-9 | Purity: ≥95% | 4-(Methylsulfonyl)-2-nitrophenol | ESD-891799-5G |
| Cas.: 97-10-9 | Purity: ≥95% | 4-(Methylsulfonyl)-2-nitrophenol | ESD-891799-10G |
| Cas.: 60186-33-6 | Purity: 98% | 4-Benzyloxy-3-ethoxybenzaldehyde | ESD-891800-100MG |
| Cas.: 60186-33-6 | Purity: 98% | 4-Benzyloxy-3-ethoxybenzaldehyde | ESD-891800-250MG |
| Cas.: 60186-33-6 | Purity: 98% | 4-Benzyloxy-3-ethoxybenzaldehyde | ESD-891800-1G |
| Cas.: 60186-33-6 | Purity: 98% | 4-Benzyloxy-3-ethoxybenzaldehyde | ESD-891800-5G |
| Cas.: 22503-72-6 | Purity: 97% | 7-Chloro-3-methyl-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide | ESD-891801-250MG |
| Cas.: 22503-72-6 | Purity: 97% | 7-Chloro-3-methyl-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide | ESD-891801-1G |
| Cas.: 22503-72-6 | Purity: 97% | 7-Chloro-3-methyl-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide | ESD-891801-5G |
| Cas.: 13097-01-3 | Purity: ≥95% | 3-Phenyl-1H-indazole | ESD-891802-100MG |
| Cas.: 13097-01-3 | Purity: ≥95% | 3-Phenyl-1H-indazole | ESD-891802-250MG |
| Cas.: 141519-77-9 | Purity: ≥95% | 1-Chloroisoquinoline-5-sulfonyl chloride | ESD-891803-100MG |
| Cas.: 141519-77-9 | Purity: ≥95% | 1-Chloroisoquinoline-5-sulfonyl chloride | ESD-891803-250MG |
| Cas.: 141519-77-9 | Purity: ≥95% | 1-Chloroisoquinoline-5-sulfonyl chloride | ESD-891803-1G |
| Cas.: 176910-67-1 | Purity: 97% | 2-((4-Methoxyphenyl)ethynyl)benzaldehyde | ESD-891804-100MG |
| Cas.: 176910-67-1 | Purity: 97% | 2-((4-Methoxyphenyl)ethynyl)benzaldehyde | ESD-891804-250MG |
| Cas.: 176910-67-1 | Purity: 97% | 2-((4-Methoxyphenyl)ethynyl)benzaldehyde | ESD-891804-1G |
| Cas.: 4703-15-5 | Purity: 97% | N-(2,6-dimethylphenyl)-4-methylbenzenesulfonamide | ESD-891805-100MG |
| Cas.: 4703-15-5 | Purity: 97% | N-(2,6-dimethylphenyl)-4-methylbenzenesulfonamide | ESD-891805-250MG |
| Cas.: 15944-34-0 | Purity: ≥95% | 7-Chloro-1,8-naphthyridin-2-ol | ESD-891806-100MG |
| Cas.: 15944-34-0 | Purity: ≥95% | 7-Chloro-1,8-naphthyridin-2-ol | ESD-891806-250MG |
| Cas.: 885523-20-6 | Purity: ≥95% | 6-Iodo-4-methoxy-1H-indazole | ESD-891807-100MG |
| Cas.: 885523-20-6 | Purity: ≥95% | 6-Iodo-4-methoxy-1H-indazole | ESD-891807-250MG |
| Cas.: 885523-20-6 | Purity: ≥95% | 6-Iodo-4-methoxy-1H-indazole | ESD-891807-1G |
| Cas.: 718611-17-7 | Purity: 97% | (S)-Boc-3-Amino-3-phenylpropan-1-ol | ESD-891808-250MG |
| Cas.: 718611-17-7 | Purity: 97% | (S)-Boc-3-Amino-3-phenylpropan-1-ol | ESD-891808-1G |
| Cas.: 718611-17-7 | Purity: 97% | (S)-Boc-3-Amino-3-phenylpropan-1-ol | ESD-891808-5G |
| Cas.: 312973-24-3 | Purity: 97% | Methyl 3-formyl-1H-indole-7-carboxylate | ESD-891809-100MG |
| Cas.: 312973-24-3 | Purity: 97% | Methyl 3-formyl-1H-indole-7-carboxylate | ESD-891809-250MG |
| Cas.: 312973-24-3 | Purity: 97% | Methyl 3-formyl-1H-indole-7-carboxylate | ESD-891809-1G |
| Cas.: 58113-36-3 | Purity: ≥95% | 4-(Bis(4-fluorophenyl)methylene)piperidine | ESD-891810-100MG |
| Cas.: 58113-36-3 | Purity: ≥95% | 4-(Bis(4-fluorophenyl)methylene)piperidine | ESD-891810-250MG |
| Cas.: 58113-36-3 | Purity: ≥95% | 4-(Bis(4-fluorophenyl)methylene)piperidine | ESD-891810-1G |
| Cas.: 880360-85-0 | Purity: 97% | Methyl 2-formyl-1H-indole-5-carboxylate | ESD-891811-100MG |
| Cas.: 880360-85-0 | Purity: 97% | Methyl 2-formyl-1H-indole-5-carboxylate | ESD-891811-250MG |
| Cas.: 880360-85-0 | Purity: 97% | Methyl 2-formyl-1H-indole-5-carboxylate | ESD-891811-1G |
| Cas.: 247109-15-5 | Purity: 97% | 5-(3-Methoxyphenyl)-1,3,4-thiadiazol-2-amine | ESD-891812-100MG |
| Cas.: 247109-15-5 | Purity: 97% | 5-(3-Methoxyphenyl)-1,3,4-thiadiazol-2-amine | ESD-891812-250MG |
| Cas.: 247109-15-5 | Purity: 97% | 5-(3-Methoxyphenyl)-1,3,4-thiadiazol-2-amine | ESD-891812-1G |
| Cas.: 247109-15-5 | Purity: 97% | 5-(3-Methoxyphenyl)-1,3,4-thiadiazol-2-amine | ESD-891812-5G |
| Cas.: 917835-93-9 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-4-hydroxypiperidine-2-carboxylic acid | ESD-891813-100MG |
| Cas.: 917835-93-9 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-4-hydroxypiperidine-2-carboxylic acid | ESD-891813-250MG |
| Cas.: 917835-93-9 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-4-hydroxypiperidine-2-carboxylic acid | ESD-891813-1G |
| Cas.: 1203662-37-6 | Purity: 97% | tert-Butyl 4-bromo-1H-indazole-5-carboxylate | ESD-891814-100MG |
| Cas.: 1203662-37-6 | Purity: 97% | tert-Butyl 4-bromo-1H-indazole-5-carboxylate | ESD-891814-250MG |
| Cas.: 1203662-37-6 | Purity: 97% | tert-Butyl 4-bromo-1H-indazole-5-carboxylate | ESD-891814-1G |
| Cas.: 1203662-37-6 | Purity: 97% | tert-Butyl 4-bromo-1H-indazole-5-carboxylate | ESD-891814-5G |
| Cas.: 5472-37-7 | Purity: 95% | N-(2-Amino-4-methoxyphenyl)acetamide | ESD-891815-100MG |
| Cas.: 5472-37-7 | Purity: 95% | N-(2-Amino-4-methoxyphenyl)acetamide | ESD-891815-250MG |
| Cas.: 5472-37-7 | Purity: 95% | N-(2-Amino-4-methoxyphenyl)acetamide | ESD-891815-1G |
| Cas.: 5472-37-7 | Purity: 95% | N-(2-Amino-4-methoxyphenyl)acetamide | ESD-891815-5G |
| Cas.: 223251-16-9 | Purity: 97% | (4-(2-(Azepan-1-yl)ethoxy)phenyl)methanol | ESD-891816-100MG |
| Cas.: 223251-16-9 | Purity: 97% | (4-(2-(Azepan-1-yl)ethoxy)phenyl)methanol | ESD-891816-250MG |
| Cas.: 1214900-52-3 | Purity: ≥95% | (3-Chloro-5-hydroxyphenyl)boronic acid | ESD-891817-100MG |
| Cas.: 1214900-52-3 | Purity: ≥95% | (3-Chloro-5-hydroxyphenyl)boronic acid | ESD-891817-250MG |
| Cas.: 1214900-52-3 | Purity: ≥95% | (3-Chloro-5-hydroxyphenyl)boronic acid | ESD-891817-1G |
| Cas.: 1019558-27-0 | Purity: 97% | 5-(2-Methyl-1H-imidazol-1-yl)pyridin-2-amine | ESD-891818-100MG |
| Cas.: 101078-51-7 | Purity: ≥95% | 6-Methoxy-2-(p-tolyl)benzo[d]thiazole | ESD-891819-100MG |
| Cas.: 101078-51-7 | Purity: ≥95% | 6-Methoxy-2-(p-tolyl)benzo[d]thiazole | ESD-891819-250MG |
| Cas.: 101078-51-7 | Purity: ≥95% | 6-Methoxy-2-(p-tolyl)benzo[d]thiazole | ESD-891819-1G |
| Cas.: 622867-52-1 | Purity: ≥95% | tert-Butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate | ESD-891820-100MG |
| Cas.: 622867-52-1 | Purity: ≥95% | tert-Butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate | ESD-891820-250MG |
| Cas.: 622867-52-1 | Purity: ≥95% | tert-Butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate | ESD-891820-1G |
| Cas.: 77119-84-7 | Purity: 98% | (R)-Methyl 2-((tert-butoxycarbonyl)amino)-3-phenylpropanoate | ESD-891821-250MG |
| Cas.: 77119-84-7 | Purity: 98% | (R)-Methyl 2-((tert-butoxycarbonyl)amino)-3-phenylpropanoate | ESD-891821-1G |
| Cas.: 77119-84-7 | Purity: 98% | (R)-Methyl 2-((tert-butoxycarbonyl)amino)-3-phenylpropanoate | ESD-891821-5G |
| Cas.: 77119-84-7 | Purity: 98% | (R)-Methyl 2-((tert-butoxycarbonyl)amino)-3-phenylpropanoate | ESD-891821-10G |
| Cas.: 4774-24-7 | Purity: 95% | 2-(Piperazin-1-yl)quinoline | ESD-891822-100MG |
| Cas.: 4774-24-7 | Purity: 95% | 2-(Piperazin-1-yl)quinoline | ESD-891822-250MG |
| Cas.: 4774-24-7 | Purity: 95% | 2-(Piperazin-1-yl)quinoline | ESD-891822-1G |
| Cas.: 55580-07-9 | Purity: ≥95% | 4-(4-Bromophenoxy)butanoic acid | ESD-891823-250MG |
| Cas.: 55580-07-9 | Purity: ≥95% | 4-(4-Bromophenoxy)butanoic acid | ESD-891823-1G |
| Cas.: 55580-07-9 | Purity: ≥95% | 4-(4-Bromophenoxy)butanoic acid | ESD-891823-5G |
| Cas.: 55580-07-9 | Purity: ≥95% | 4-(4-Bromophenoxy)butanoic acid | ESD-891823-10G |
| Cas.: 5632-81-5 | Purity: 97% | 2-Chloropyridine-3,5-diamine | ESD-891824-100MG |
| Cas.: 5632-81-5 | Purity: 97% | 2-Chloropyridine-3,5-diamine | ESD-891824-250MG |
| Cas.: 1159825-42-9 | Purity: 97% | 1-N-Boc-3-(4-Bromophenoxy)pyrrolidine | ESD-891825-100MG |
| Cas.: 1159825-42-9 | Purity: 97% | 1-N-Boc-3-(4-Bromophenoxy)pyrrolidine | ESD-891825-250MG |
| Cas.: 1159825-42-9 | Purity: 97% | 1-N-Boc-3-(4-Bromophenoxy)pyrrolidine | ESD-891825-1G |
| Cas.: 1799438-97-3 | Purity: ≥95% | (R)-tert-Butyl (1-(2-bromo-4-chlorophenyl)ethyl)carbamate | ESD-891826-100MG |
| Cas.: 1799438-97-3 | Purity: ≥95% | (R)-tert-Butyl (1-(2-bromo-4-chlorophenyl)ethyl)carbamate | ESD-891826-250MG |
| Cas.: 211235-87-9 | Purity: ≥95% | 2,3-Dihydrothieno[3,4-b][1,4]dioxine-5,7-dicarbaldehyde | ESD-891827-100MG |
| Cas.: 211235-87-9 | Purity: ≥95% | 2,3-Dihydrothieno[3,4-b][1,4]dioxine-5,7-dicarbaldehyde | ESD-891827-250MG |
| Cas.: 4049-39-2 | Purity: 97% | 4-(Benzyloxy)-3-hydroxybenzaldehyde | ESD-891828-100MG |
| Cas.: 4049-39-2 | Purity: 97% | 4-(Benzyloxy)-3-hydroxybenzaldehyde | ESD-891828-250MG |
| Cas.: 4049-39-2 | Purity: 97% | 4-(Benzyloxy)-3-hydroxybenzaldehyde | ESD-891828-1G |
| Cas.: 4049-39-2 | Purity: 97% | 4-(Benzyloxy)-3-hydroxybenzaldehyde | ESD-891828-5G |
| Cas.: 20716-26-1 | Purity: 97% | 3-(2-Nitrophenyl)propan-1-ol | ESD-891829-250MG |
| Cas.: 20716-26-1 | Purity: 97% | 3-(2-Nitrophenyl)propan-1-ol | ESD-891829-1G |
| Cas.: 20716-26-1 | Purity: 97% | 3-(2-Nitrophenyl)propan-1-ol | ESD-891829-5G |
| Cas.: 1349199-60-5 | Purity: 97% | 3-Ethynyl-1-tosylazetidin-3-ol | ESD-891830-100MG |
| Cas.: 1349199-60-5 | Purity: 97% | 3-Ethynyl-1-tosylazetidin-3-ol | ESD-891830-250MG |
| Cas.: 1349199-60-5 | Purity: 97% | 3-Ethynyl-1-tosylazetidin-3-ol | ESD-891830-1G |
| Cas.: 659731-18-7 | Purity: 97% | 3-(Pyrrolidino)phenylboronic acid | ESD-891831-100MG |
| Cas.: 659731-18-7 | Purity: 97% | 3-(Pyrrolidino)phenylboronic acid | ESD-891831-250MG |
| Cas.: 659731-18-7 | Purity: 97% | 3-(Pyrrolidino)phenylboronic acid | ESD-891831-1G |
| Cas.: 659731-18-7 | Purity: 97% | 3-(Pyrrolidino)phenylboronic acid | ESD-891831-5G |
| Cas.: 25195-52-2 | Purity: 97% | 1-Bromo-2-((methylsulfonyl)methyl)benzene | ESD-891832-100MG |
| Cas.: 25195-52-2 | Purity: 97% | 1-Bromo-2-((methylsulfonyl)methyl)benzene | ESD-891832-250MG |
| Cas.: 25195-52-2 | Purity: 97% | 1-Bromo-2-((methylsulfonyl)methyl)benzene | ESD-891832-1G |
| Cas.: 301359-45-5 | Purity: 97% | Ethyl 4-(2-chlorophenyl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate | ESD-891833-100MG |
| Cas.: 301359-45-5 | Purity: 97% | Ethyl 4-(2-chlorophenyl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate | ESD-891833-250MG |
| Cas.: 301359-45-5 | Purity: 97% | Ethyl 4-(2-chlorophenyl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate | ESD-891833-1G |
| Cas.: 892874-34-9 | Purity: ≥95% | 7-Bromoquinoline-3-carboxylic acid | ESD-891834-100MG |
| Cas.: 892874-34-9 | Purity: ≥95% | 7-Bromoquinoline-3-carboxylic acid | ESD-891834-250MG |
| Cas.: 892874-34-9 | Purity: ≥95% | 7-Bromoquinoline-3-carboxylic acid | ESD-891834-1G |
| Cas.: 892874-34-9 | Purity: ≥95% | 7-Bromoquinoline-3-carboxylic acid | ESD-891834-5G |
| Cas.: 22246-07-7 | Purity: 97% | 7-Amino-3,4-dihydro-2(1H)-quinolinone | ESD-890259-250MG |
| Cas.: 22246-07-7 | Purity: 97% | 7-Amino-3,4-dihydro-2(1H)-quinolinone | ESD-890259-10G |
| Cas.: 3073-30-1 | Purity: ≥95% | 3,5-Dinitropyridin-2-amine | ESD-891835-100MG |
| Cas.: 3073-30-1 | Purity: ≥95% | 3,5-Dinitropyridin-2-amine | ESD-891835-250MG |
| Cas.: 3073-30-1 | Purity: ≥95% | 3,5-Dinitropyridin-2-amine | ESD-891835-1G |
| Cas.: 798545-30-9 | Purity: 97% | 6-Bromoquinoline-3-carboxylic acid | ESD-891836-250MG |
| Cas.: 798545-30-9 | Purity: 97% | 6-Bromoquinoline-3-carboxylic acid | ESD-891836-1G |
| Cas.: 798545-30-9 | Purity: 97% | 6-Bromoquinoline-3-carboxylic acid | ESD-891836-5G |
| Cas.: 798545-30-9 | Purity: 97% | 6-Bromoquinoline-3-carboxylic acid | ESD-891836-10G |
| Cas.: 946505-09-5 | Purity: 95% | 2-(4-Fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxylic acid | ESD-891837-100MG |
| Cas.: 946505-09-5 | Purity: 95% | 2-(4-Fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxylic acid | ESD-891837-250MG |
| Cas.: 54788-30-6 | Purity: ≥95% | 2-Amino-3-(3-bromo-4-hydroxyphenyl)propanoic acid | ESD-891838-100MG |
| Cas.: 54788-30-6 | Purity: ≥95% | 2-Amino-3-(3-bromo-4-hydroxyphenyl)propanoic acid | ESD-891838-250MG |
| Cas.: 54788-30-6 | Purity: ≥95% | 2-Amino-3-(3-bromo-4-hydroxyphenyl)propanoic acid | ESD-891838-1G |
| Cas.: 71675-86-0 | Purity: 97% | 4-Amino-5-(ethylthio)-2-methoxybenzoic acid | ESD-891839-5G |
| Cas.: 71675-86-0 | Purity: 97% | 4-Amino-5-(ethylthio)-2-methoxybenzoic acid | ESD-891839-10G |
| Cas.: 71675-86-0 | Purity: 97% | 4-Amino-5-(ethylthio)-2-methoxybenzoic acid | ESD-891839-25G |
| Cas.: 408509-71-7 | Purity: 97% | 2-(Pyridin-3-ylamino)acetic acid | ESD-891840-100MG |
| Cas.: 408509-71-7 | Purity: 97% | 2-(Pyridin-3-ylamino)acetic acid | ESD-891840-250MG |
| Cas.: 260447-04-9 | Purity: 97% | 2,6-Dimethyl-4-(5-nitropyridin-2-yl)morpholine | ESD-891841-100MG |
| Cas.: 260447-04-9 | Purity: 97% | 2,6-Dimethyl-4-(5-nitropyridin-2-yl)morpholine | ESD-891841-250MG |
| Cas.: 260447-04-9 | Purity: 97% | 2,6-Dimethyl-4-(5-nitropyridin-2-yl)morpholine | ESD-891841-1G |
| Cas.: 864772-18-9 | Purity: ≥95% | 4,4,5,5-Tetramethyl-2-(3-phenoxyphenyl)-1,3,2-dioxaborolane | ESD-891842-100MG |
| Cas.: 864772-18-9 | Purity: ≥95% | 4,4,5,5-Tetramethyl-2-(3-phenoxyphenyl)-1,3,2-dioxaborolane | ESD-891842-250MG |
| Cas.: 864772-18-9 | Purity: ≥95% | 4,4,5,5-Tetramethyl-2-(3-phenoxyphenyl)-1,3,2-dioxaborolane | ESD-891842-1G |
| Cas.: 864772-18-9 | Purity: ≥95% | 4,4,5,5-Tetramethyl-2-(3-phenoxyphenyl)-1,3,2-dioxaborolane | ESD-891842-5G |
| Cas.: 104115-70-0 | Purity: 97% | Ethyl 4,7-dichloro-1H-indole-2-carboxylate | ESD-891843-100MG |
| Cas.: 104115-70-0 | Purity: 97% | Ethyl 4,7-dichloro-1H-indole-2-carboxylate | ESD-891843-250MG |
| Cas.: 104115-70-0 | Purity: 97% | Ethyl 4,7-dichloro-1H-indole-2-carboxylate | ESD-891843-1G |
| Cas.: 104115-70-0 | Purity: 97% | Ethyl 4,7-dichloro-1H-indole-2-carboxylate | ESD-891843-5G |
| Cas.: 864266-29-5 | Purity: ≥97% | tert-Butyl ((6-bromopyridin-3-yl)methyl)carbamate | ESD-891844-100MG |
| Cas.: 864266-29-5 | Purity: ≥97% | tert-Butyl ((6-bromopyridin-3-yl)methyl)carbamate | ESD-891844-250MG |
| Cas.: 140927-13-5 | Purity: ≥95% | Benzyl 5-oxo-2-azabicyclo[2.2.1]heptane-2-carboxylate | ESD-891845-250MG |
| Cas.: 140927-13-5 | Purity: ≥95% | Benzyl 5-oxo-2-azabicyclo[2.2.1]heptane-2-carboxylate | ESD-891845-1G |
| Cas.: 140927-13-5 | Purity: ≥95% | Benzyl 5-oxo-2-azabicyclo[2.2.1]heptane-2-carboxylate | ESD-891845-5G |
| Cas.: 496946-78-2 | Purity: ≥95% | 5-(Trifluoromethyl)-1H-indole-2-carboxylic acid | ESD-891846-100MG |
| Cas.: 496946-78-2 | Purity: ≥95% | 5-(Trifluoromethyl)-1H-indole-2-carboxylic acid | ESD-891846-250MG |
| Cas.: 496946-78-2 | Purity: ≥95% | 5-(Trifluoromethyl)-1H-indole-2-carboxylic acid | ESD-891846-1G |
| Cas.: 496946-78-2 | Purity: ≥95% | 5-(Trifluoromethyl)-1H-indole-2-carboxylic acid | ESD-891846-5G |
| Cas.: 885952-26-1 | Purity: ≥95% | 2-Benzyloxy-3-hydroxypyridine | ESD-891847-100MG |
| Cas.: 885952-26-1 | Purity: ≥95% | 2-Benzyloxy-3-hydroxypyridine | ESD-891847-250MG |
| Cas.: 85160-83-4 | Purity: 95% | 2,2-Dimethyl-7-nitro-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-891848-100MG |
| Cas.: 85160-83-4 | Purity: 95% | 2,2-Dimethyl-7-nitro-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-891848-250MG |
| Cas.: 85160-83-4 | Purity: 95% | 2,2-Dimethyl-7-nitro-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-891848-1G |
| Cas.: 85160-83-4 | Purity: 95% | 2,2-Dimethyl-7-nitro-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-891848-5G |
| Cas.: 1000045-93-1 | Purity: ≥95% | Methyl 2-oxo-1,2,3,4-tetrahydroquinoline-7-carboxylate | ESD-891849-100MG |
| Cas.: 1000045-93-1 | Purity: ≥95% | Methyl 2-oxo-1,2,3,4-tetrahydroquinoline-7-carboxylate | ESD-891849-250MG |
| Cas.: 1000045-93-1 | Purity: ≥95% | Methyl 2-oxo-1,2,3,4-tetrahydroquinoline-7-carboxylate | ESD-891849-1G |
| Cas.: 165669-16-9 | Purity: 98% | 5-Bromo-7-nitro-1H-indole | ESD-891850-100MG |
| Cas.: 165669-16-9 | Purity: 98% | 5-Bromo-7-nitro-1H-indole | ESD-891850-250MG |
| Cas.: 165669-16-9 | Purity: 98% | 5-Bromo-7-nitro-1H-indole | ESD-891850-1G |
| Cas.: 165669-16-9 | Purity: 98% | 5-Bromo-7-nitro-1H-indole | ESD-891850-5G |
| Cas.: 87240-07-1 | Purity: ≥95% | 7-Bromo-5-nitro-1H-indole | ESD-891851-250MG |
| Cas.: 87240-07-1 | Purity: ≥95% | 7-Bromo-5-nitro-1H-indole | ESD-891851-1G |
| Cas.: 87240-07-1 | Purity: ≥95% | 7-Bromo-5-nitro-1H-indole | ESD-891851-5G |
| Cas.: 147126-62-3 | Purity: 97% | (2R,5R)-(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 5-hydroxy-1,3-oxathiolane-2-carboxylate | ESD-891852-5G |
| Cas.: 147126-62-3 | Purity: 97% | (2R,5R)-(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 5-hydroxy-1,3-oxathiolane-2-carboxylate | ESD-891852-10G |
| Cas.: 147126-62-3 | Purity: 97% | (2R,5R)-(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 5-hydroxy-1,3-oxathiolane-2-carboxylate | ESD-891852-25G |
| Cas.: 885520-50-3 | Purity: 97% | 6-Bromo-4-nitro-1H-indole | ESD-891853-100MG |
| Cas.: 885520-50-3 | Purity: 97% | 6-Bromo-4-nitro-1H-indole | ESD-891853-250MG |
| Cas.: 885520-50-3 | Purity: 97% | 6-Bromo-4-nitro-1H-indole | ESD-891853-1G |
| Cas.: 374067-94-4 | Purity: 95% | Ethyl 2-methyl-2-(4-sulfamoylphenyl)propanoate | ESD-891854-100MG |
| Cas.: 374067-94-4 | Purity: 95% | Ethyl 2-methyl-2-(4-sulfamoylphenyl)propanoate | ESD-891854-250MG |
| Cas.: 374067-94-4 | Purity: 95% | Ethyl 2-methyl-2-(4-sulfamoylphenyl)propanoate | ESD-891854-1G |
| Cas.: 883898-97-3 | Purity: 97% | 2-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-3-methoxybenzonitrile | ESD-891855-100MG |
| Cas.: 883898-97-3 | Purity: 97% | 2-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-3-methoxybenzonitrile | ESD-891855-250MG |
| Cas.: 883898-97-3 | Purity: 97% | 2-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-3-methoxybenzonitrile | ESD-891855-1G |
| Cas.: 883898-97-3 | Purity: 97% | 2-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-3-methoxybenzonitrile | ESD-891855-5G |
| Cas.: 16382-18-6 | Purity: 95% | Ethyl 5,6-dimethoxy-1H-indole-2-carboxylate | ESD-891856-100MG |
| Cas.: 16382-18-6 | Purity: 95% | Ethyl 5,6-dimethoxy-1H-indole-2-carboxylate | ESD-891856-250MG |
| Cas.: 16382-18-6 | Purity: 95% | Ethyl 5,6-dimethoxy-1H-indole-2-carboxylate | ESD-891856-1G |
| Cas.: 26848-40-8 | Purity: 97% | 3-Hydroxy-N-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)-2-naphthamide | ESD-891857-250MG |
| Cas.: 26848-40-8 | Purity: 97% | 3-Hydroxy-N-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)-2-naphthamide | ESD-891857-1G |
| Cas.: 364793-57-7 | Purity: 97% | 7-Bromo-4-chloroquinoline-3-carbonitrile | ESD-891858-250MG |
| Cas.: 364793-57-7 | Purity: 97% | 7-Bromo-4-chloroquinoline-3-carbonitrile | ESD-891858-1G |
| Cas.: 364793-57-7 | Purity: 97% | 7-Bromo-4-chloroquinoline-3-carbonitrile | ESD-891858-5G |
| Cas.: 85452-79-5 | Purity: ≥95% | (Z)-3-(1H-Indol-3-yl)acrylonitrile | ESD-891859-100MG |
| Cas.: 85452-79-5 | Purity: ≥95% | (Z)-3-(1H-Indol-3-yl)acrylonitrile | ESD-891859-250MG |
| Cas.: 85452-79-5 | Purity: ≥95% | (Z)-3-(1H-Indol-3-yl)acrylonitrile | ESD-891859-1G |
| Cas.: 3515-49-9 | Purity: ≥95% | 3-(Piperidin-4-ylmethyl)-1H-indole | ESD-891860-100MG |
| Cas.: 3515-49-9 | Purity: ≥95% | 3-(Piperidin-4-ylmethyl)-1H-indole | ESD-891860-250MG |
| Cas.: 3515-49-9 | Purity: ≥95% | 3-(Piperidin-4-ylmethyl)-1H-indole | ESD-891860-1G |
| Cas.: 17794-48-8 | Purity: ≥95% | 2-(3-(Trifluoromethyl)benzamido)acetic acid | ESD-891861-100MG |
| Cas.: 17794-48-8 | Purity: ≥95% | 2-(3-(Trifluoromethyl)benzamido)acetic acid | ESD-891861-250MG |
| Cas.: 17794-48-8 | Purity: ≥95% | 2-(3-(Trifluoromethyl)benzamido)acetic acid | ESD-891861-1G |
| Cas.: 2826-91-7 | Purity: 97% | 2-Methyl-3-(2-nitrovinyl)-1H-indole | ESD-891862-1G |
| Cas.: 2826-91-7 | Purity: 97% | 2-Methyl-3-(2-nitrovinyl)-1H-indole | ESD-891862-5G |
| Cas.: 2826-91-7 | Purity: 97% | 2-Methyl-3-(2-nitrovinyl)-1H-indole | ESD-891862-10G |
| Cas.: 116118-98-0 | Purity: 95% | 4,5,6,7-Tetrahydrothieno[3,2-c]pyridine-2-carboxylic acid | ESD-891863-100MG |
| Cas.: 116118-98-0 | Purity: 95% | 4,5,6,7-Tetrahydrothieno[3,2-c]pyridine-2-carboxylic acid | ESD-891863-250MG |
| Cas.: 116118-98-0 | Purity: 95% | 4,5,6,7-Tetrahydrothieno[3,2-c]pyridine-2-carboxylic acid | ESD-891863-1G |
| Cas.: 135875-10-4 | Purity: 97% | 2,3,4,5-Tetrahydro-1H-benzo[4,5]imidazo[1,2-d][1,4]diazepine | ESD-891864-100MG |
| Cas.: 135875-10-4 | Purity: 97% | 2,3,4,5-Tetrahydro-1H-benzo[4,5]imidazo[1,2-d][1,4]diazepine | ESD-891864-250MG |
| Cas.: 374783-78-5 | Purity: ≥95% | (S)-2-Methyl-1-((4-nitrophenyl)sulfonyl)aziridine | ESD-891865-100MG |
| Cas.: 374783-78-5 | Purity: ≥95% | (S)-2-Methyl-1-((4-nitrophenyl)sulfonyl)aziridine | ESD-891865-250MG |
| Cas.: 374783-78-5 | Purity: ≥95% | (S)-2-Methyl-1-((4-nitrophenyl)sulfonyl)aziridine | ESD-891865-1G |
| Cas.: 374783-78-5 | Purity: ≥95% | (S)-2-Methyl-1-((4-nitrophenyl)sulfonyl)aziridine | ESD-891865-5G |
| Cas.: 1431542-21-0 | Purity: 95% | 2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid | ESD-891866-250MG |
| Cas.: 1431542-21-0 | Purity: 95% | 2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid | ESD-891866-1G |
| Cas.: 1431542-21-0 | Purity: 95% | 2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid | ESD-891866-5G |
| Cas.: 72072-06-1 | Purity: ≥95% | 5-((tert-Butoxycarbonyl)amino)-4-oxopentanoic acid | ESD-891867-100MG |
| Cas.: 72072-06-1 | Purity: ≥95% | 5-((tert-Butoxycarbonyl)amino)-4-oxopentanoic acid | ESD-891867-250MG |
| Cas.: 857035-29-1 | Purity: 97% | Ethyl 2-chloro-1H-benzo[d]imidazole-6-carboxylate | ESD-891868-100MG |
| Cas.: 857035-29-1 | Purity: 97% | Ethyl 2-chloro-1H-benzo[d]imidazole-6-carboxylate | ESD-891868-250MG |
| Cas.: 857035-29-1 | Purity: 97% | Ethyl 2-chloro-1H-benzo[d]imidazole-6-carboxylate | ESD-891868-1G |
| Cas.: 864070-18-8 | Purity: 97% | 4-(5-Bromo-2-chlorobenzyl)phenol | ESD-891869-250MG |
| Cas.: 864070-18-8 | Purity: 97% | 4-(5-Bromo-2-chlorobenzyl)phenol | ESD-891869-1G |
| Cas.: 864070-18-8 | Purity: 97% | 4-(5-Bromo-2-chlorobenzyl)phenol | ESD-891869-5G |
| Cas.: 10068-52-7 | Purity: 97% | 2-(((Benzyloxy)carbonyl)amino)-3,3,3-trifluoropropanoic acid | ESD-891870-100MG |
| Cas.: 10068-52-7 | Purity: 97% | 2-(((Benzyloxy)carbonyl)amino)-3,3,3-trifluoropropanoic acid | ESD-891870-250MG |
| Cas.: 502509-10-6 | Purity: 98% | 4-(2-Hydroxyethyl)picolinic acid | ESD-891871-100MG |
| Cas.: 502509-10-6 | Purity: 98% | 4-(2-Hydroxyethyl)picolinic acid | ESD-891871-250MG |
| Cas.: 284030-57-5 | Purity: ≥95% | 4-Amino-2,3-difluoro-5-nitrobenzoic acid | ESD-891872-250MG |
| Cas.: 284030-57-5 | Purity: ≥95% | 4-Amino-2,3-difluoro-5-nitrobenzoic acid | ESD-891872-1G |
| Cas.: 284030-57-5 | Purity: ≥95% | 4-Amino-2,3-difluoro-5-nitrobenzoic acid | ESD-891872-5G |
| Cas.: 284030-57-5 | Purity: ≥95% | 4-Amino-2,3-difluoro-5-nitrobenzoic acid | ESD-891872-10G |
| Cas.: 1033772-26-7 | Purity: 97% | Methyl 1H-pyrazolo[3,4-c]pyridine-5-carboxylate | ESD-891873-100MG |
| Cas.: 1033772-26-7 | Purity: 97% | Methyl 1H-pyrazolo[3,4-c]pyridine-5-carboxylate | ESD-891873-250MG |
| Cas.: 1033772-26-7 | Purity: 97% | Methyl 1H-pyrazolo[3,4-c]pyridine-5-carboxylate | ESD-891873-1G |
| Cas.: 954815-08-8 | Purity: ≥95% | 3-Bromo-4-methoxy-5-nitro-benzoic acid | ESD-891874-100MG |
| Cas.: 954815-08-8 | Purity: ≥95% | 3-Bromo-4-methoxy-5-nitro-benzoic acid | ESD-891874-250MG |
| Cas.: 954815-08-8 | Purity: ≥95% | 3-Bromo-4-methoxy-5-nitro-benzoic acid | ESD-891874-1G |
| Cas.: 954815-08-8 | Purity: ≥95% | 3-Bromo-4-methoxy-5-nitro-benzoic acid | ESD-891874-5G |
| Cas.: 861593-27-3 | Purity: 97% | 3-(Methoxycarbonyl)-2-nitrobenzoic acid | ESD-891875-100MG |
| Cas.: 861593-27-3 | Purity: 97% | 3-(Methoxycarbonyl)-2-nitrobenzoic acid | ESD-891875-250MG |
| Cas.: 861593-27-3 | Purity: 97% | 3-(Methoxycarbonyl)-2-nitrobenzoic acid | ESD-891875-1G |
| Cas.: 861593-27-3 | Purity: 97% | 3-(Methoxycarbonyl)-2-nitrobenzoic acid | ESD-891875-5G |
| Cas.: 1217525-04-6 | Purity: 97% | (2R)-1-(tert-Butoxycarbonyl)octahydro-1H-indole-2-carboxylic acid | ESD-891876-100MG |
| Cas.: 1217525-04-6 | Purity: 97% | (2R)-1-(tert-Butoxycarbonyl)octahydro-1H-indole-2-carboxylic acid | ESD-891876-250MG |
| Cas.: 849928-30-9 | Purity: 97% | 1-Boc-2-Phenyl-4-piperidinone | ESD-891877-100MG |
| Cas.: 849928-30-9 | Purity: 97% | 1-Boc-2-Phenyl-4-piperidinone | ESD-891877-250MG |
| Cas.: 849928-30-9 | Purity: 97% | 1-Boc-2-Phenyl-4-piperidinone | ESD-891877-1G |
| Cas.: 849928-30-9 | Purity: 97% | 1-Boc-2-Phenyl-4-piperidinone | ESD-891877-5G |
| Cas.: 1013-23-6 | Purity: ≥95% | Dibenzo[b,d]thiophene 5-oxide | ESD-891878-50MG |
| Cas.: 1013-23-6 | Purity: ≥95% | Dibenzo[b,d]thiophene 5-oxide | ESD-891878-250MG |
| Cas.: 171178-33-9 | Purity: 95% | 6-Chloropyrido[3,2-d]pyrimidin-4(3H)-one | ESD-891879-100MG |
| Cas.: 171178-33-9 | Purity: 95% | 6-Chloropyrido[3,2-d]pyrimidin-4(3H)-one | ESD-891879-250MG |
| Cas.: 171178-33-9 | Purity: 95% | 6-Chloropyrido[3,2-d]pyrimidin-4(3H)-one | ESD-891879-1G |
| Cas.: 171178-33-9 | Purity: 95% | 6-Chloropyrido[3,2-d]pyrimidin-4(3H)-one | ESD-891879-5G |
| Cas.: 3119-02-6 | Purity: 97% | 4-Cyanobenzenesulphonamide | ESD-891880-250MG |
| Cas.: 3119-02-6 | Purity: 97% | 4-Cyanobenzenesulphonamide | ESD-891880-1G |
| Cas.: 3119-02-6 | Purity: 97% | 4-Cyanobenzenesulphonamide | ESD-891880-5G |
| Cas.: 3119-02-6 | Purity: 97% | 4-Cyanobenzenesulphonamide | ESD-891880-10G |
| Cas.: 1057682-03-7 | Purity: ≥95% | (S)-6-(3-Methylpiperazin-1-yl)nicotinonitrile | ESD-891881-100MG |
| Cas.: 1057682-03-7 | Purity: ≥95% | (S)-6-(3-Methylpiperazin-1-yl)nicotinonitrile | ESD-891881-250MG |
| Cas.: 1057682-05-9 | Purity: ≥95% | (R)-6-(3-Methylpiperazin-1-yl)nicotinonitrile | ESD-891882-100MG |
| Cas.: 1057682-05-9 | Purity: ≥95% | (R)-6-(3-Methylpiperazin-1-yl)nicotinonitrile | ESD-891882-250MG |
| Cas.: 51362-40-4 | Purity: ≥95% | 6-Phenoxypicolinic acid | ESD-891883-100MG |
| Cas.: 51362-40-4 | Purity: ≥95% | 6-Phenoxypicolinic acid | ESD-891883-250MG |
| Cas.: 51362-40-4 | Purity: ≥95% | 6-Phenoxypicolinic acid | ESD-891883-1G |
| Cas.: 1257095-63-8 | Purity: ≥95% | N-(4-Methyl-3-nitrophenyl)-4-(trifluoromethyl)benzothioamide | ESD-891884-100MG |
| Cas.: 1257095-63-8 | Purity: ≥95% | N-(4-Methyl-3-nitrophenyl)-4-(trifluoromethyl)benzothioamide | ESD-891884-250MG |
| Cas.: 684249-99-8 | Purity: 95% | 2-(3,5-Dimethyl-1H-1,2,4-triazol-1-yl)acetic acid | ESD-891885-100MG |
| Cas.: 684249-99-8 | Purity: 95% | 2-(3,5-Dimethyl-1H-1,2,4-triazol-1-yl)acetic acid | ESD-891885-250MG |
| Cas.: 684249-99-8 | Purity: 95% | 2-(3,5-Dimethyl-1H-1,2,4-triazol-1-yl)acetic acid | ESD-891885-1G |
| Cas.: 684249-99-8 | Purity: 95% | 2-(3,5-Dimethyl-1H-1,2,4-triazol-1-yl)acetic acid | ESD-891885-5G |
| Cas.: 35888-99-4 | Purity: ≥95% | 3-([1,1′-Biphenyl]-4-yl)propanoic acid | ESD-891886-250MG |
| Cas.: 35888-99-4 | Purity: ≥95% | 3-([1,1′-Biphenyl]-4-yl)propanoic acid | ESD-891886-1G |
| Cas.: 35888-99-4 | Purity: ≥95% | 3-([1,1′-Biphenyl]-4-yl)propanoic acid | ESD-891886-5G |
| Cas.: 287119-83-9 | Purity: 95% | 2-(2-Methyl-5-nitrophenyl)acetic acid | ESD-891887-250MG |
| Cas.: 287119-83-9 | Purity: 95% | 2-(2-Methyl-5-nitrophenyl)acetic acid | ESD-891887-1G |
| Cas.: 287119-83-9 | Purity: 95% | 2-(2-Methyl-5-nitrophenyl)acetic acid | ESD-891887-5G |
| Cas.: 6303-46-4 | Purity: 97% | 6-Chloro-N-(3,4-dichlorophenyl)pyrimidin-4-amine | ESD-891888-250MG |
| Cas.: 6303-46-4 | Purity: 97% | 6-Chloro-N-(3,4-dichlorophenyl)pyrimidin-4-amine | ESD-891888-1G |
| Cas.: 1026-05-7 | Purity: ≥95% | 2-Methyl-N-phenyl-1,2,3,4-tetrahydroquinolin-4-amine | ESD-891889-100MG |
| Cas.: 1026-05-7 | Purity: ≥95% | 2-Methyl-N-phenyl-1,2,3,4-tetrahydroquinolin-4-amine | ESD-891889-250MG |
| Cas.: 2434-03-9 | Purity: 97% | 4,5-Dibromofuran-2-carboxylic acid | ESD-891890-250MG |
| Cas.: 2434-03-9 | Purity: 97% | 4,5-Dibromofuran-2-carboxylic acid | ESD-891890-1G |
| Cas.: 2434-03-9 | Purity: 97% | 4,5-Dibromofuran-2-carboxylic acid | ESD-891890-5G |
| Cas.: 1261965-53-0 | Purity: 97% | 3′-Chloro-2-fluoro-4′-methyl-[1,1′-biphenyl]-4-carboxylic acid | ESD-891891-50MG |
| Cas.: 155497-10-2 | Purity: 97% | tert-Butyl ((1-benzylpyrrolidin-3-yl)methyl)carbamate | ESD-891892-100MG |
| Cas.: 155497-10-2 | Purity: 97% | tert-Butyl ((1-benzylpyrrolidin-3-yl)methyl)carbamate | ESD-891892-250MG |
| Cas.: 155497-10-2 | Purity: 97% | tert-Butyl ((1-benzylpyrrolidin-3-yl)methyl)carbamate | ESD-891892-1G |
| Cas.: 155497-10-2 | Purity: 97% | tert-Butyl ((1-benzylpyrrolidin-3-yl)methyl)carbamate | ESD-891892-5G |
| Cas.: 1672-58-8 | Purity: ≥95% | N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)formamide | ESD-891893-250MG |
| Cas.: 1672-58-8 | Purity: ≥95% | N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)formamide | ESD-891893-1G |
| Cas.: 1047651-80-8 | Purity: ≥95% | (3R,4S)-4-(3-Chlorophenyl)pyrrolidine-3-carboxylic acid | ESD-891894-100MG |
| Cas.: 1047651-80-8 | Purity: ≥95% | (3R,4S)-4-(3-Chlorophenyl)pyrrolidine-3-carboxylic acid | ESD-891894-250MG |
| Cas.: 1190890-51-7 | Purity: 97% | tert-Butyl (trans-4-phenylcyclohexyl)carbamate | ESD-891895-100MG |
| Cas.: 1190890-51-7 | Purity: 97% | tert-Butyl (trans-4-phenylcyclohexyl)carbamate | ESD-891895-250MG |
| Cas.: 38791-62-7 | Purity: 97% | 4-Phenoxyphthalonitrile | ESD-891896-250MG |
| Cas.: 38791-62-7 | Purity: 97% | 4-Phenoxyphthalonitrile | ESD-891896-1G |
| Cas.: 38791-62-7 | Purity: 97% | 4-Phenoxyphthalonitrile | ESD-891896-5G |
| Cas.: 38791-62-7 | Purity: 97% | 4-Phenoxyphthalonitrile | ESD-891896-10G |
| Cas.: 846036-96-2 | Purity: ≥95% | (4-Amino-6-chloropyridin-3-yl)methanol | ESD-891897-100MG |
| Cas.: 846036-96-2 | Purity: ≥95% | (4-Amino-6-chloropyridin-3-yl)methanol | ESD-891897-250MG |
| Cas.: 846036-96-2 | Purity: ≥95% | (4-Amino-6-chloropyridin-3-yl)methanol | ESD-891897-1G |
| Cas.: 2227-98-7 | Purity: 97% | 4-Aminopyrrolo[3,2-d]pyrimidine | ESD-891898-100MG |
| Cas.: 2227-98-7 | Purity: 97% | 4-Aminopyrrolo[3,2-d]pyrimidine | ESD-891898-250MG |
| Cas.: 2227-98-7 | Purity: 97% | 4-Aminopyrrolo[3,2-d]pyrimidine | ESD-891898-1G |
| Cas.: 952319-70-9 | Purity: ≥95% | (1-Ethyl-1H-indazol-5-yl)boronic acid | ESD-891899-100MG |
| Cas.: 952319-70-9 | Purity: ≥95% | (1-Ethyl-1H-indazol-5-yl)boronic acid | ESD-891899-250MG |
| Cas.: 192945-56-5 | Purity: 97% | Methyl 3-bromo-1H-indazole-6-carboxylate | ESD-891900-1G |
| Cas.: 192945-56-5 | Purity: 97% | Methyl 3-bromo-1H-indazole-6-carboxylate | ESD-891900-5G |
| Cas.: 192945-56-5 | Purity: 97% | Methyl 3-bromo-1H-indazole-6-carboxylate | ESD-891900-10G |
| Cas.: 192945-56-5 | Purity: 97% | Methyl 3-bromo-1H-indazole-6-carboxylate | ESD-891900-25G |
| Cas.: 887000-70-6 | Purity: 97% | 2-(4-oxo-3-Phenyl-1,3-selenazolidin-2-ylidene)malononitrile | ESD-891901-100MG |
| Cas.: 887000-70-6 | Purity: 97% | 2-(4-oxo-3-Phenyl-1,3-selenazolidin-2-ylidene)malononitrile | ESD-891901-250MG |
| Cas.: 20073-19-2 | Purity: 97% | 5-Bromo-6-methoxybenzofuran-2-carboxylic acid | ESD-891902-100MG |
| Cas.: 20073-19-2 | Purity: 97% | 5-Bromo-6-methoxybenzofuran-2-carboxylic acid | ESD-891902-250MG |
| Cas.: 153687-35-5 | Purity: 97% | 1-(4-Methoxybenzyl)-1H-pyrazole-4-carbaldehyde | ESD-891903-250MG |
| Cas.: 153687-35-5 | Purity: 97% | 1-(4-Methoxybenzyl)-1H-pyrazole-4-carbaldehyde | ESD-891903-1G |
| Cas.: 153687-35-5 | Purity: 97% | 1-(4-Methoxybenzyl)-1H-pyrazole-4-carbaldehyde | ESD-891903-5G |
| Cas.: 153687-35-5 | Purity: 97% | 1-(4-Methoxybenzyl)-1H-pyrazole-4-carbaldehyde | ESD-891903-10G |
| Cas.: 1086391-06-1 | Purity: 97% | Methyl 3-bromo-1H-indazole-5-carboxylate | ESD-891904-250MG |
| Cas.: 1086391-06-1 | Purity: 97% | Methyl 3-bromo-1H-indazole-5-carboxylate | ESD-891904-1G |
| Cas.: 1086391-06-1 | Purity: 97% | Methyl 3-bromo-1H-indazole-5-carboxylate | ESD-891904-5G |
| Cas.: 187973-60-0 | Purity: 95% | 6-Iodopyridazin-3-amine | ESD-891905-100MG |
| Cas.: 187973-60-0 | Purity: 95% | 6-Iodopyridazin-3-amine | ESD-891905-250MG |
| Cas.: 187973-60-0 | Purity: 95% | 6-Iodopyridazin-3-amine | ESD-891905-1G |
| Cas.: 187973-60-0 | Purity: 95% | 6-Iodopyridazin-3-amine | ESD-891905-5G |
| Cas.: 873443-66-4 | Purity: 97% | 2,6-Dichloro-4-(o-tolyl)nicotinonitrile | ESD-891906-100MG |
| Cas.: 873443-66-4 | Purity: 97% | 2,6-Dichloro-4-(o-tolyl)nicotinonitrile | ESD-891906-250MG |
| Cas.: 873443-66-4 | Purity: 97% | 2,6-Dichloro-4-(o-tolyl)nicotinonitrile | ESD-891906-1G |
| Cas.: 483324-01-2 | Purity: ≥95% | 2-Chloro-4-(pyridin-3-yl)pyrimidine | ESD-891907-100MG |
| Cas.: 483324-01-2 | Purity: ≥95% | 2-Chloro-4-(pyridin-3-yl)pyrimidine | ESD-891907-250MG |
| Cas.: 483324-01-2 | Purity: ≥95% | 2-Chloro-4-(pyridin-3-yl)pyrimidine | ESD-891907-1G |
| Cas.: 1196154-25-2 | Purity: 97% | tert-Butyl 3-bromo-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxylate | ESD-891908-100MG |
| Cas.: 1196154-25-2 | Purity: 97% | tert-Butyl 3-bromo-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxylate | ESD-891908-250MG |
| Cas.: 1196154-25-2 | Purity: 97% | tert-Butyl 3-bromo-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxylate | ESD-891908-1G |
| Cas.: 1196154-25-2 | Purity: 97% | tert-Butyl 3-bromo-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxylate | ESD-891908-5G |
| Cas.: 2454-72-0 | Purity: 97% | 4-Hydroxy-5-methoxy-2-nitrobenzaldehyde | ESD-891909-250MG |
| Cas.: 2454-72-0 | Purity: 97% | 4-Hydroxy-5-methoxy-2-nitrobenzaldehyde | ESD-891909-1G |
| Cas.: 23405-32-5 | Purity: ≥95% | Methyl 1-oxo-1,3-dihydroisobenzofuran-5-carboxylate | ESD-891910-250MG |
| Cas.: 23405-32-5 | Purity: ≥95% | Methyl 1-oxo-1,3-dihydroisobenzofuran-5-carboxylate | ESD-891910-1G |
| Cas.: 23405-32-5 | Purity: ≥95% | Methyl 1-oxo-1,3-dihydroisobenzofuran-5-carboxylate | ESD-891910-5G |
| Cas.: 23405-32-5 | Purity: ≥95% | Methyl 1-oxo-1,3-dihydroisobenzofuran-5-carboxylate | ESD-891910-10G |
| Cas.: 934560-92-6 | Purity: 97% | 6-Bromo-1H-pyrazolo[3,4-b]pyridine | ESD-891911-100MG |
| Cas.: 934560-92-6 | Purity: 97% | 6-Bromo-1H-pyrazolo[3,4-b]pyridine | ESD-891911-250MG |
| Cas.: 934560-92-6 | Purity: 97% | 6-Bromo-1H-pyrazolo[3,4-b]pyridine | ESD-891911-1G |
| Cas.: 1190319-18-6 | Purity: 97% | 1H-Pyrrolo[3,2-b]pyridine-7-carboxylic acid | ESD-891912-100MG |
| Cas.: 1190319-18-6 | Purity: 97% | 1H-Pyrrolo[3,2-b]pyridine-7-carboxylic acid | ESD-891912-250MG |
| Cas.: 1190319-18-6 | Purity: 97% | 1H-Pyrrolo[3,2-b]pyridine-7-carboxylic acid | ESD-891912-1G |
| Cas.: 1190319-18-6 | Purity: 97% | 1H-Pyrrolo[3,2-b]pyridine-7-carboxylic acid | ESD-891912-5G |
| Cas.: 16462-29-6 | Purity: ≥95% | 4-Amino-2-(ethylthio)-5-pyrimidinecarbonitrile | ESD-891913-100MG |
| Cas.: 16462-29-6 | Purity: ≥95% | 4-Amino-2-(ethylthio)-5-pyrimidinecarbonitrile | ESD-891913-250MG |
| Cas.: 16462-29-6 | Purity: ≥95% | 4-Amino-2-(ethylthio)-5-pyrimidinecarbonitrile | ESD-891913-1G |
| Cas.: 92534-69-5 | Purity: 97% | 1-Methyl-4-nitro-1H-pyrazole-5-carboxylic acid | ESD-891914-250MG |
| Cas.: 92534-69-5 | Purity: 97% | 1-Methyl-4-nitro-1H-pyrazole-5-carboxylic acid | ESD-891914-1G |
| Cas.: 92534-69-5 | Purity: 97% | 1-Methyl-4-nitro-1H-pyrazole-5-carboxylic acid | ESD-891914-5G |
| Cas.: 92534-69-5 | Purity: 97% | 1-Methyl-4-nitro-1H-pyrazole-5-carboxylic acid | ESD-891914-10G |
| Cas.: 27667-34-1 | Purity: ≥95% | 4-Methoxyquinolin-2(1H)-one | ESD-891915-100MG |
| Cas.: 27667-34-1 | Purity: ≥95% | 4-Methoxyquinolin-2(1H)-one | ESD-891915-250MG |
| Cas.: 1159983-30-8 | Purity: ≥95% | 2-(4-Amino-1-(tert-butoxycarbonyl)piperidin-4-yl)acetic acid | ESD-891916-100MG |
| Cas.: 1159983-30-8 | Purity: ≥95% | 2-(4-Amino-1-(tert-butoxycarbonyl)piperidin-4-yl)acetic acid | ESD-891916-250MG |
| Cas.: 1159983-30-8 | Purity: ≥95% | 2-(4-Amino-1-(tert-butoxycarbonyl)piperidin-4-yl)acetic acid | ESD-891916-1G |
| Cas.: 4385-75-5 | Purity: 97% | 4-Pyridin-3-yl-benzoic acid | ESD-891917-250MG |
| Cas.: 4385-75-5 | Purity: 97% | 4-Pyridin-3-yl-benzoic acid | ESD-891917-1G |
| Cas.: 4385-75-5 | Purity: 97% | 4-Pyridin-3-yl-benzoic acid | ESD-891917-5G |
| Cas.: 590417-67-7 | Purity: ≥95% | (2-Methylbenzo[d]thiazol-5-yl)boronic acid | ESD-891918-1G |
| Cas.: 156474-22-5 | Purity: 97% | tert-Butyl ((R)-1-((S)-oxiran-2-yl)-2-phenylethyl)carbamate | ESD-891919-100MG |
| Cas.: 156474-22-5 | Purity: 97% | tert-Butyl ((R)-1-((S)-oxiran-2-yl)-2-phenylethyl)carbamate | ESD-891919-250MG |
| Cas.: 89001-57-0 | Purity: 95% | 5-(Chlorosulfonyl)-2-methylbenzoic acid | ESD-891920-250MG |
| Cas.: 89001-57-0 | Purity: 95% | 5-(Chlorosulfonyl)-2-methylbenzoic acid | ESD-891920-1G |
| Cas.: 89001-57-0 | Purity: 95% | 5-(Chlorosulfonyl)-2-methylbenzoic acid | ESD-891920-5G |
| Cas.: 1241677-76-8 | Purity: 97% | Boc-D-Phg(3,5-F2)-OH | ESD-891921-100MG |
| Cas.: 1241677-76-8 | Purity: 97% | Boc-D-Phg(3,5-F2)-OH | ESD-891921-250MG |
| Cas.: 88912-23-6 | Purity: 97% | 2,6-Difluoroisonicotinic acid | ESD-891922-100MG |
| Cas.: 88912-23-6 | Purity: 97% | 2,6-Difluoroisonicotinic acid | ESD-891922-250MG |
| Cas.: 88912-23-6 | Purity: 97% | 2,6-Difluoroisonicotinic acid | ESD-891922-1G |
| Cas.: 88912-23-6 | Purity: 97% | 2,6-Difluoroisonicotinic acid | ESD-891922-5G |
| Cas.: 134676-67-8 | Purity: ≥95% | N-Boc-2-thiomorpholinecarboxylic Acid | ESD-891923-100MG |
| Cas.: 134676-67-8 | Purity: ≥95% | N-Boc-2-thiomorpholinecarboxylic Acid | ESD-891923-250MG |
| Cas.: 134676-67-8 | Purity: ≥95% | N-Boc-2-thiomorpholinecarboxylic Acid | ESD-891923-1G |
| Cas.: 70057-67-9 | Purity: ≥95% | 5-(3-Chlorophenyl)-1,3,4-thiadiazol-2-amine | ESD-891924-250MG |
| Cas.: 70057-67-9 | Purity: ≥95% | 5-(3-Chlorophenyl)-1,3,4-thiadiazol-2-amine | ESD-891924-1G |
| Cas.: 70057-67-9 | Purity: ≥95% | 5-(3-Chlorophenyl)-1,3,4-thiadiazol-2-amine | ESD-891924-5G |
| Cas.: 114525-81-4 | Purity: 95% | (R)-4-(tert-Butoxycarbonyl)thiomorpholine-3-carboxylic acid | ESD-891925-100MG |
| Cas.: 114525-81-4 | Purity: 95% | (R)-4-(tert-Butoxycarbonyl)thiomorpholine-3-carboxylic acid | ESD-891925-250MG |
| Cas.: 162045-31-0 | Purity: 95% | 1-(4-Piperidinyl)-1,2-dihydro-4H-3,1-benzoxazin-2-one hydrochloride | ESD-891926-100MG |
| Cas.: 146621-92-3 | Purity: 97% | N-Boc-2-(3-trifluoromethylphenyl)-DL-glycine | ESD-891927-250MG |
| Cas.: 146621-92-3 | Purity: 97% | N-Boc-2-(3-trifluoromethylphenyl)-DL-glycine | ESD-891927-1G |
| Cas.: 60956-24-3 | Purity: 97% | 1,2-Dibromo-4-chlorobenzene | ESD-891928-250MG |
| Cas.: 60956-24-3 | Purity: 97% | 1,2-Dibromo-4-chlorobenzene | ESD-891928-1G |
| Cas.: 60956-24-3 | Purity: 97% | 1,2-Dibromo-4-chlorobenzene | ESD-891928-5G |
| Cas.: 60956-24-3 | Purity: 97% | 1,2-Dibromo-4-chlorobenzene | ESD-891928-10G |
| Cas.: 1260883-63-3 | Purity: 97% | Methyl 5,6-dihydroxypicolinate | ESD-891929-100MG |
| Cas.: 1260883-63-3 | Purity: 97% | Methyl 5,6-dihydroxypicolinate | ESD-891929-250MG |
| Cas.: 1260883-63-3 | Purity: 97% | Methyl 5,6-dihydroxypicolinate | ESD-891929-1G |
| Cas.: 870243-94-0 | Purity: 97% | (4-Bromothieno[2,3-c]pyridin-2-yl)methanol | ESD-891930-100MG |
| Cas.: 870243-94-0 | Purity: 97% | (4-Bromothieno[2,3-c]pyridin-2-yl)methanol | ESD-891930-250MG |
| Cas.: 4651-91-6 | Purity: 97% | 2-Amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carbonitrile | ESD-891931-1G |
| Cas.: 4651-91-6 | Purity: 97% | 2-Amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carbonitrile | ESD-891931-5G |
| Cas.: 4651-91-6 | Purity: 97% | 2-Amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carbonitrile | ESD-891931-10G |
| Cas.: 4651-91-6 | Purity: 97% | 2-Amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carbonitrile | ESD-891931-25G |
| Cas.: 22524-35-2 | Purity: ≥95% | 3-Hydroxythietane 1,1-dioxide | ESD-891932-1G |
| Cas.: 22524-35-2 | Purity: ≥95% | 3-Hydroxythietane 1,1-dioxide | ESD-891932-5G |
| Cas.: 22524-35-2 | Purity: ≥95% | 3-Hydroxythietane 1,1-dioxide | ESD-891932-10G |
| Cas.: 1260799-38-9 | Purity: 97% | 1-Chloroisoquinolin-4-amine | ESD-891933-100MG |
| Cas.: 1260799-38-9 | Purity: 97% | 1-Chloroisoquinolin-4-amine | ESD-891933-250MG |
| Cas.: 131986-45-3 | Purity: ≥95% | Xanomeline | ESD-891934-100MG |
| Cas.: 131986-45-3 | Purity: ≥95% | Xanomeline | ESD-891934-250MG |
| Cas.: 7300-91-6 | Purity: 98% | 1-(4-Hydroxyphenyl)-1H-pyrrole-2,5-dione | ESD-891935-1G |
| Cas.: 7300-91-6 | Purity: 98% | 1-(4-Hydroxyphenyl)-1H-pyrrole-2,5-dione | ESD-891935-5G |
| Cas.: 7300-91-6 | Purity: 98% | 1-(4-Hydroxyphenyl)-1H-pyrrole-2,5-dione | ESD-891935-10G |
| Cas.: 131802-60-3 | Purity: 97% | 7-(Benzyloxy)quinoline | ESD-891936-100MG |
| Cas.: 131802-60-3 | Purity: 97% | 7-(Benzyloxy)quinoline | ESD-891936-250MG |
| Cas.: 148990-17-4 | Purity: ≥95% | 4-(4-Methoxyphenyl)-2-(methylthio)pyrimidine | ESD-891937-100MG |
| Cas.: 148990-17-4 | Purity: ≥95% | 4-(4-Methoxyphenyl)-2-(methylthio)pyrimidine | ESD-891937-250MG |
| Cas.: 1124-13-6 | Purity: 97% | trans-Cyclobutane-1,2-dicarboxylic acid | ESD-891938-250MG |
| Cas.: 1124-13-6 | Purity: 97% | trans-Cyclobutane-1,2-dicarboxylic acid | ESD-891938-1G |
| Cas.: 1124-13-6 | Purity: 97% | trans-Cyclobutane-1,2-dicarboxylic acid | ESD-891938-5G |
| Cas.: 1124-13-6 | Purity: 97% | trans-Cyclobutane-1,2-dicarboxylic acid | ESD-891938-10G |
| Cas.: 1951439-41-0 | Purity: ≥95% | Methyl 7-bromo-3-oxo-2,3-dihydro-1H-indene-5-carboxylate | ESD-891939-100MG |
| Cas.: 1951439-41-0 | Purity: ≥95% | Methyl 7-bromo-3-oxo-2,3-dihydro-1H-indene-5-carboxylate | ESD-891939-250MG |
| Cas.: 120205-50-7 | Purity: ≥95% | Boc-Dap | ESD-891940-100MG |
| Cas.: 120205-50-7 | Purity: ≥95% | Boc-Dap | ESD-891940-250MG |
| Cas.: 120205-50-7 | Purity: ≥95% | Boc-Dap | ESD-891940-1G |
| Cas.: 7384-98-7 | Purity: 95% | Propane-1,2-diyl dioctanoate | ESD-891941-100MG |
| Cas.: 7384-98-7 | Purity: 95% | Propane-1,2-diyl dioctanoate | ESD-891941-250MG |
| Cas.: 1263078-12-1 | Purity: 97% | (R)-tert-Butyl 3-((tert-butoxycarbonyl)amino)piperidine-1-carboxylate | ESD-891942-250MG |
| Cas.: 1263078-12-1 | Purity: 97% | (R)-tert-Butyl 3-((tert-butoxycarbonyl)amino)piperidine-1-carboxylate | ESD-891942-1G |
| Cas.: 1263078-12-1 | Purity: 97% | (R)-tert-Butyl 3-((tert-butoxycarbonyl)amino)piperidine-1-carboxylate | ESD-891942-5G |
| Cas.: 1263078-12-1 | Purity: 97% | (R)-tert-Butyl 3-((tert-butoxycarbonyl)amino)piperidine-1-carboxylate | ESD-891942-10G |
| Cas.: 38160-63-3 | Purity: 97% | 2-Amino-4-hydroxybenzoic acid | ESD-891943-100MG |
| Cas.: 38160-63-3 | Purity: 97% | 2-Amino-4-hydroxybenzoic acid | ESD-891943-250MG |
| Cas.: 90725-68-1 | Purity: 96% | Methyl 2-(bromomethyl)-5-nitrobenzoate | ESD-891944-250MG |
| Cas.: 90725-68-1 | Purity: 96% | Methyl 2-(bromomethyl)-5-nitrobenzoate | ESD-891944-1G |
| Cas.: 123986-64-1 | Purity: ≥95% | tert-Butyl 4-(hydroxymethyl)benzylcarbamate | ESD-891945-100MG |
| Cas.: 123986-64-1 | Purity: ≥95% | tert-Butyl 4-(hydroxymethyl)benzylcarbamate | ESD-891945-250MG |
| Cas.: 123986-64-1 | Purity: ≥95% | tert-Butyl 4-(hydroxymethyl)benzylcarbamate | ESD-891945-1G |
| Cas.: 123986-64-1 | Purity: ≥95% | tert-Butyl 4-(hydroxymethyl)benzylcarbamate | ESD-891945-5G |
| Cas.: 50905-10-7 | Purity: 97% | 2-Butyloctanedioic acid | ESD-891946-25G |
| Cas.: 50905-10-7 | Purity: 97% | 2-Butyloctanedioic acid | ESD-891946-100G |
| Cas.: 28890-99-5 | Purity: ≥95% | 5H-Benzo[d]benzo[4,5]imidazo[1,2-a]imidazole | ESD-891947-100MG |
| Cas.: 28890-99-5 | Purity: ≥95% | 5H-Benzo[d]benzo[4,5]imidazo[1,2-a]imidazole | ESD-891947-250MG |
| Cas.: 28890-99-5 | Purity: ≥95% | 5H-Benzo[d]benzo[4,5]imidazo[1,2-a]imidazole | ESD-891947-1G |
| Cas.: 124840-61-5 | Purity: ≥95% | 2-(5-Bromo-2-nitrophenyl)acetic acid | ESD-891948-100MG |
| Cas.: 124840-61-5 | Purity: ≥95% | 2-(5-Bromo-2-nitrophenyl)acetic acid | ESD-891948-250MG |
| Cas.: 124840-61-5 | Purity: ≥95% | 2-(5-Bromo-2-nitrophenyl)acetic acid | ESD-891948-1G |
| Cas.: 124840-61-5 | Purity: ≥95% | 2-(5-Bromo-2-nitrophenyl)acetic acid | ESD-891948-5G |
| Cas.: 209128-50-7 | Purity: 98% | trans-2-((tert-Butoxycarbonyl)amino)cyclohexanecarboxylic acid | ESD-891949-100MG |
| Cas.: 209128-50-7 | Purity: 98% | trans-2-((tert-Butoxycarbonyl)amino)cyclohexanecarboxylic acid | ESD-891949-250MG |
| Cas.: 209128-50-7 | Purity: 98% | trans-2-((tert-Butoxycarbonyl)amino)cyclohexanecarboxylic acid | ESD-891949-1G |
| Cas.: 209128-50-7 | Purity: 98% | trans-2-((tert-Butoxycarbonyl)amino)cyclohexanecarboxylic acid | ESD-891949-5G |
| Cas.: 3449-48-7 | Purity: ≥95% | 6-Methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one | ESD-891950-100MG |
| Cas.: 3449-48-7 | Purity: ≥95% | 6-Methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one | ESD-891950-250MG |
| Cas.: 3449-48-7 | Purity: ≥95% | 6-Methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one | ESD-891950-1G |
| Cas.: 3449-48-7 | Purity: ≥95% | 6-Methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one | ESD-891950-5G |
| Cas.: 151215-34-8 | Purity: ≥98% | (S)-4-Bromo-2-((tert-butoxycarbonyl)amino)pent-4-enoic acid | ESD-891951-100MG |
| Cas.: 151215-34-8 | Purity: ≥98% | (S)-4-Bromo-2-((tert-butoxycarbonyl)amino)pent-4-enoic acid | ESD-891951-250MG |
| Cas.: 151215-34-8 | Purity: ≥98% | (S)-4-Bromo-2-((tert-butoxycarbonyl)amino)pent-4-enoic acid | ESD-891951-1G |
| Cas.: 46322-66-1 | Purity: 97% | 2-(2,4-Dichlorobenzylidene)hydrazinecarboximidamide | ESD-891952-250MG |
| Cas.: 46322-66-1 | Purity: 97% | 2-(2,4-Dichlorobenzylidene)hydrazinecarboximidamide | ESD-891952-1G |
| Cas.: 46322-66-1 | Purity: 97% | 2-(2,4-Dichlorobenzylidene)hydrazinecarboximidamide | ESD-891952-5G |
| Cas.: 122555-04-8 | Purity: 97% | H-Phe(4-Ac)-OH | ESD-891953-250MG |
| Cas.: 122555-04-8 | Purity: 97% | H-Phe(4-Ac)-OH | ESD-891953-1G |
| Cas.: 23428-77-5 | Purity: ≥95% | 1-(3-(Benzyloxy)-4-methoxyphenyl)ethanone | ESD-891954-250MG |
| Cas.: 23428-77-5 | Purity: ≥95% | 1-(3-(Benzyloxy)-4-methoxyphenyl)ethanone | ESD-891954-1G |
| Cas.: 42855-00-5 | Purity: ≥95% | 4,5-Dimethoxy-2-nitrobenzyl carbonochloridate | ESD-891955-100MG |
| Cas.: 42855-00-5 | Purity: ≥95% | 4,5-Dimethoxy-2-nitrobenzyl carbonochloridate | ESD-891955-250MG |
| Cas.: 42855-00-5 | Purity: ≥95% | 4,5-Dimethoxy-2-nitrobenzyl carbonochloridate | ESD-891955-1G |
| Cas.: 69679-30-7 | Purity: ≥95% | Decyl 4-hydroxybenzoate | ESD-891956-250MG |
| Cas.: 69679-30-7 | Purity: ≥95% | Decyl 4-hydroxybenzoate | ESD-891956-1G |
| Cas.: 69679-30-7 | Purity: ≥95% | Decyl 4-hydroxybenzoate | ESD-891956-5G |
| Cas.: 1042369-35-6 | Purity: 97% | 5-Fluoro-2-((4-methoxyphenyl)ethynyl)benzaldehyde | ESD-891957-100MG |
| Cas.: 1042369-35-6 | Purity: 97% | 5-Fluoro-2-((4-methoxyphenyl)ethynyl)benzaldehyde | ESD-891957-250MG |
| Cas.: 1042369-35-6 | Purity: 97% | 5-Fluoro-2-((4-methoxyphenyl)ethynyl)benzaldehyde | ESD-891957-1G |
| Cas.: 56172-36-2 | Purity: ≥95% | 5-Hydroxybenzofuran-2-carboxylic acid | ESD-891958-100MG |
| Cas.: 56172-36-2 | Purity: ≥95% | 5-Hydroxybenzofuran-2-carboxylic acid | ESD-891958-250MG |
| Cas.: 56172-36-2 | Purity: ≥95% | 5-Hydroxybenzofuran-2-carboxylic acid | ESD-891958-1G |
| Cas.: 56172-36-2 | Purity: ≥95% | 5-Hydroxybenzofuran-2-carboxylic acid | ESD-891958-5G |
| Cas.: 558442-96-9 | Purity: ≥95% | tert-Butyl (trans-4-morpholinocyclohexyl)carbamate | ESD-891959-100MG |
| Cas.: 558442-96-9 | Purity: ≥95% | tert-Butyl (trans-4-morpholinocyclohexyl)carbamate | ESD-891959-250MG |
| Cas.: 558442-96-9 | Purity: ≥95% | tert-Butyl (trans-4-morpholinocyclohexyl)carbamate | ESD-891959-1G |
| Cas.: 558442-96-9 | Purity: ≥95% | tert-Butyl (trans-4-morpholinocyclohexyl)carbamate | ESD-891959-5G |
| Cas.: 60080-98-0 | Purity: 97% | (2-Bromo-5-methoxyphenyl)(phenyl)methanone | ESD-891960-250MG |
| Cas.: 60080-98-0 | Purity: 97% | (2-Bromo-5-methoxyphenyl)(phenyl)methanone | ESD-891960-1G |
| Cas.: 1093203-96-3 | Purity: 95% | 4-Hydroxy-2-nitrobenzonitrile | ESD-891961-100MG |
| Cas.: 1093203-96-3 | Purity: 95% | 4-Hydroxy-2-nitrobenzonitrile | ESD-891961-250MG |
| Cas.: 796047-09-1 | Purity: 97% | 2-(Benzyloxy)-5-(tert-butyl)benzaldehyde | ESD-891962-100MG |
| Cas.: 796047-09-1 | Purity: 97% | 2-(Benzyloxy)-5-(tert-butyl)benzaldehyde | ESD-891962-250MG |
| Cas.: 796047-09-1 | Purity: 97% | 2-(Benzyloxy)-5-(tert-butyl)benzaldehyde | ESD-891962-1G |
| Cas.: 796047-09-1 | Purity: 97% | 2-(Benzyloxy)-5-(tert-butyl)benzaldehyde | ESD-891962-5G |
| Cas.: 1260860-64-7 | Purity: ≥95% | 3-Bromoisoquinolin-5-amine | ESD-891963-100MG |
| Cas.: 1260860-64-7 | Purity: ≥95% | 3-Bromoisoquinolin-5-amine | ESD-891963-250MG |
| Cas.: 1260860-64-7 | Purity: ≥95% | 3-Bromoisoquinolin-5-amine | ESD-891963-1G |
| Cas.: 20876-30-6 | Purity: ≥95% | 2-(4-Methoxy-2-nitrophenyl)acetic acid | ESD-891964-100MG |
| Cas.: 20876-30-6 | Purity: ≥95% | 2-(4-Methoxy-2-nitrophenyl)acetic acid | ESD-891964-250MG |
| Cas.: 20876-30-6 | Purity: ≥95% | 2-(4-Methoxy-2-nitrophenyl)acetic acid | ESD-891964-1G |
| Cas.: 20876-30-6 | Purity: ≥95% | 2-(4-Methoxy-2-nitrophenyl)acetic acid | ESD-891964-5G |
| Cas.: 104771-35-9 | Purity: ≥95% | 5-Chloro-1-(pyridin-2-yl)-1H-pyrazole-4-carbonitrile | ESD-891965-100MG |
| Cas.: 104771-35-9 | Purity: ≥95% | 5-Chloro-1-(pyridin-2-yl)-1H-pyrazole-4-carbonitrile | ESD-891965-250MG |
| Cas.: 104771-35-9 | Purity: ≥95% | 5-Chloro-1-(pyridin-2-yl)-1H-pyrazole-4-carbonitrile | ESD-891965-1G |
| Cas.: 184098-19-9 | Purity: 97% | 3-(2-Methyl-1H-imidazol-1-yl)aniline | ESD-891966-100MG |
| Cas.: 184098-19-9 | Purity: 97% | 3-(2-Methyl-1H-imidazol-1-yl)aniline | ESD-891966-250MG |
| Cas.: 184098-19-9 | Purity: 97% | 3-(2-Methyl-1H-imidazol-1-yl)aniline | ESD-891966-1G |
| Cas.: 154698-93-8 | Purity: ≥95% | 2-((tert-Butyldiphenylsilyl)oxy)-N-methoxy-N-methylacetamide | ESD-891967-100MG |
| Cas.: 154698-93-8 | Purity: ≥95% | 2-((tert-Butyldiphenylsilyl)oxy)-N-methoxy-N-methylacetamide | ESD-891967-250MG |
| Cas.: 201932-92-5 | Purity: 97% | Methyl 3-(hydroxymethyl)-4-nitrobenzoate | ESD-891968-100MG |
| Cas.: 201932-92-5 | Purity: 97% | Methyl 3-(hydroxymethyl)-4-nitrobenzoate | ESD-891968-250MG |
| Cas.: 201932-92-5 | Purity: 97% | Methyl 3-(hydroxymethyl)-4-nitrobenzoate | ESD-891968-1G |
| Cas.: 885518-47-8 | Purity: 97% | Methyl 4-bromo-1H-indazole-6-carboxylate | ESD-891969-250MG |
| Cas.: 885518-47-8 | Purity: 97% | Methyl 4-bromo-1H-indazole-6-carboxylate | ESD-891969-1G |
| Cas.: 885518-47-8 | Purity: 97% | Methyl 4-bromo-1H-indazole-6-carboxylate | ESD-891969-5G |
| Cas.: 885518-47-8 | Purity: 97% | Methyl 4-bromo-1H-indazole-6-carboxylate | ESD-891969-10G |
| Cas.: 1427460-96-5 | Purity: ≥95% | Methyl 7-bromo-1H-indazole-5-carboxylate | ESD-891970-100MG |
| Cas.: 1427460-96-5 | Purity: ≥95% | Methyl 7-bromo-1H-indazole-5-carboxylate | ESD-891970-250MG |
| Cas.: 1427460-96-5 | Purity: ≥95% | Methyl 7-bromo-1H-indazole-5-carboxylate | ESD-891970-1G |
| Cas.: 1172623-98-1 | Purity: ≥95% | tert-Butyl ((2R,3S)-2-(2,5-difluorophenyl)-3,4-dihydro-2H-pyran-3-yl)carbamate | ESD-891971-100MG |
| Cas.: 1172623-98-1 | Purity: ≥95% | tert-Butyl ((2R,3S)-2-(2,5-difluorophenyl)-3,4-dihydro-2H-pyran-3-yl)carbamate | ESD-891971-250MG |
| Cas.: 73150-67-1 | Purity: 95% | 2-(2-Aminothiazol-4-yl)-2-oxoacetic acid | ESD-891972-250MG |
| Cas.: 73150-67-1 | Purity: 95% | 2-(2-Aminothiazol-4-yl)-2-oxoacetic acid | ESD-891972-1G |
| Cas.: 73150-67-1 | Purity: 95% | 2-(2-Aminothiazol-4-yl)-2-oxoacetic acid | ESD-891972-5G |
| Cas.: 73150-67-1 | Purity: 95% | 2-(2-Aminothiazol-4-yl)-2-oxoacetic acid | ESD-891972-10G |
| Cas.: 6280-43-9 | Purity: 97% | 4-(4-Chlorobenzyl)benzene-1,3-diol | ESD-891973-100MG |
| Cas.: 6280-43-9 | Purity: 97% | 4-(4-Chlorobenzyl)benzene-1,3-diol | ESD-891973-250MG |
| Cas.: 17360-47-3 | Purity: 97% | 2-(Dibenzylamino)acetic acid | ESD-891974-250MG |
| Cas.: 17360-47-3 | Purity: 97% | 2-(Dibenzylamino)acetic acid | ESD-891974-1G |
| Cas.: 17360-47-3 | Purity: 97% | 2-(Dibenzylamino)acetic acid | ESD-891974-5G |
| Cas.: 17360-47-3 | Purity: 97% | 2-(Dibenzylamino)acetic acid | ESD-891974-10G |
| Cas.: 718596-77-1 | Purity: ≥95% | (S)-3-Amino-3-(4-cyanophenyl)propanoic acid | ESD-891975-250MG |
| Cas.: 718596-77-1 | Purity: ≥95% | (S)-3-Amino-3-(4-cyanophenyl)propanoic acid | ESD-891975-1G |
| Cas.: 718596-77-1 | Purity: ≥95% | (S)-3-Amino-3-(4-cyanophenyl)propanoic acid | ESD-891975-5G |
| Cas.: 718596-77-1 | Purity: ≥95% | (S)-3-Amino-3-(4-cyanophenyl)propanoic acid | ESD-891975-10G |
| Cas.: 738606-24-1 | Purity: ≥95% | (R)-3-Amino-3-(4-cyanophenyl)propanoic acid | ESD-891976-250MG |
| Cas.: 738606-24-1 | Purity: ≥95% | (R)-3-Amino-3-(4-cyanophenyl)propanoic acid | ESD-891976-1G |
| Cas.: 738606-24-1 | Purity: ≥95% | (R)-3-Amino-3-(4-cyanophenyl)propanoic acid | ESD-891976-5G |
| Cas.: 219552-64-4 | Purity: 97% | tert-Butyl 6-nitro-1H-indole-1-carboxylate | ESD-891977-1G |
| Cas.: 219552-64-4 | Purity: 97% | tert-Butyl 6-nitro-1H-indole-1-carboxylate | ESD-891977-5G |
| Cas.: 219552-64-4 | Purity: 97% | tert-Butyl 6-nitro-1H-indole-1-carboxylate | ESD-891977-10G |
| Cas.: 219552-64-4 | Purity: 97% | tert-Butyl 6-nitro-1H-indole-1-carboxylate | ESD-891977-25G |
| Cas.: 176665-09-1 | Purity: 97% | 4,4-Dimethyl-2-pentadecyloxazol-5(4H)-one | ESD-891978-100MG |
| Cas.: 176665-09-1 | Purity: 97% | 4,4-Dimethyl-2-pentadecyloxazol-5(4H)-one | ESD-891978-250MG |
| Cas.: 175592-59-3 | Purity: 97% | 2-Formylthiophene-4-boronic acid | ESD-891979-250MG |
| Cas.: 175592-59-3 | Purity: 97% | 2-Formylthiophene-4-boronic acid | ESD-891979-1G |
| Cas.: 175592-59-3 | Purity: 97% | 2-Formylthiophene-4-boronic acid | ESD-891979-5G |
| Cas.: 175592-59-3 | Purity: 97% | 2-Formylthiophene-4-boronic acid | ESD-891979-10G |
| Cas.: 894807-98-8 | Purity: ≥95% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrazole | ESD-891980-100MG |
| Cas.: 894807-98-8 | Purity: ≥95% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrazole | ESD-891980-250MG |
| Cas.: 894807-98-8 | Purity: ≥95% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrazole | ESD-891980-1G |
| Cas.: 109466-84-4 | Purity: ≥95% | 2-Amino-4-nitrobenzaldehyde | ESD-891981-100MG |
| Cas.: 109466-84-4 | Purity: ≥95% | 2-Amino-4-nitrobenzaldehyde | ESD-891981-250MG |
| Cas.: 1504-16-1 | Purity: 97% | 3-Phenyl-1H-indole | ESD-891982-100MG |
| Cas.: 1504-16-1 | Purity: 97% | 3-Phenyl-1H-indole | ESD-891982-250MG |
| Cas.: 1504-16-1 | Purity: 97% | 3-Phenyl-1H-indole | ESD-891982-1G |
| Cas.: 845826-99-5 | Purity: ≥95% | 5-(4-Fluorophenyl)picolinic acid | ESD-891983-100MG |
| Cas.: 845826-99-5 | Purity: ≥95% | 5-(4-Fluorophenyl)picolinic acid | ESD-891983-250MG |
| Cas.: 845826-99-5 | Purity: ≥95% | 5-(4-Fluorophenyl)picolinic acid | ESD-891983-1G |
| Cas.: 1451392-86-1 | Purity: 97% | (6-Bromo-2,3-dichlorophenyl)boronic acid | ESD-891984-250MG |
| Cas.: 1451392-86-1 | Purity: 97% | (6-Bromo-2,3-dichlorophenyl)boronic acid | ESD-891984-1G |
| Cas.: 1451392-86-1 | Purity: 97% | (6-Bromo-2,3-dichlorophenyl)boronic acid | ESD-891984-5G |
| Cas.: 802826-21-7 | Purity: ≥95% | 1-Benzyl-3-phenylpiperidin-4-amine | ESD-891985-100MG |
| Cas.: 802826-21-7 | Purity: ≥95% | 1-Benzyl-3-phenylpiperidin-4-amine | ESD-891985-250MG |
| Cas.: 53355-29-6 | Purity: ≥95% | Methyl 4-(5-formylfuran-2-yl)benzoate | ESD-891986-250MG |
| Cas.: 53355-29-6 | Purity: ≥95% | Methyl 4-(5-formylfuran-2-yl)benzoate | ESD-891986-1G |
| Cas.: 53355-29-6 | Purity: ≥95% | Methyl 4-(5-formylfuran-2-yl)benzoate | ESD-891986-5G |
| Cas.: 53355-29-6 | Purity: ≥95% | Methyl 4-(5-formylfuran-2-yl)benzoate | ESD-891986-10G |
| Cas.: 211244-81-4 | Purity: 97% | 2-(Methylthio)pyrido[2,3-d]pyrimidin-7(8H)-one | ESD-891987-250MG |
| Cas.: 211244-81-4 | Purity: 97% | 2-(Methylthio)pyrido[2,3-d]pyrimidin-7(8H)-one | ESD-891987-1G |
| Cas.: 211244-81-4 | Purity: 97% | 2-(Methylthio)pyrido[2,3-d]pyrimidin-7(8H)-one | ESD-891987-5G |
| Cas.: 397843-58-2 | Purity: 97% | (3-(Morpholinomethyl)phenyl)boronic acid | ESD-891988-100MG |
| Cas.: 397843-58-2 | Purity: 97% | (3-(Morpholinomethyl)phenyl)boronic acid | ESD-891988-250MG |
| Cas.: 397843-58-2 | Purity: 97% | (3-(Morpholinomethyl)phenyl)boronic acid | ESD-891988-1G |
| Cas.: 397843-58-2 | Purity: 97% | (3-(Morpholinomethyl)phenyl)boronic acid | ESD-891988-5G |
| Cas.: 157869-15-3 | Purity: 97% | 2-((4-Methoxyphenyl)ethynyl)aniline | ESD-891989-250MG |
| Cas.: 157869-15-3 | Purity: 97% | 2-((4-Methoxyphenyl)ethynyl)aniline | ESD-891989-1G |
| Cas.: 185220-68-2 | Purity: 97% | 2-Chloro-6-iodopyridin-3-ol | ESD-891990-100MG |
| Cas.: 185220-68-2 | Purity: 97% | 2-Chloro-6-iodopyridin-3-ol | ESD-891990-250MG |
| Cas.: 185220-68-2 | Purity: 97% | 2-Chloro-6-iodopyridin-3-ol | ESD-891990-1G |
| Cas.: 185220-68-2 | Purity: 97% | 2-Chloro-6-iodopyridin-3-ol | ESD-891990-5G |
| Cas.: 2142-06-5 | Purity: 97% | 1-Benzylpyrrolidine-2,5-dione | ESD-891991-250MG |
| Cas.: 2142-06-5 | Purity: 97% | 1-Benzylpyrrolidine-2,5-dione | ESD-891991-1G |
| Cas.: 2142-06-5 | Purity: 97% | 1-Benzylpyrrolidine-2,5-dione | ESD-891991-5G |
| Cas.: 2142-06-5 | Purity: 97% | 1-Benzylpyrrolidine-2,5-dione | ESD-891991-10G |
| Cas.: 1217501-27-3 | Purity: ≥95% | 1-Boc-3-methyl-1H-pyrazole-5-boronic Acid | ESD-891992-100MG |
| Cas.: 1217501-27-3 | Purity: ≥95% | 1-Boc-3-methyl-1H-pyrazole-5-boronic Acid | ESD-891992-250MG |
| Cas.: 1217501-27-3 | Purity: ≥95% | 1-Boc-3-methyl-1H-pyrazole-5-boronic Acid | ESD-891992-1G |
| Cas.: 1217501-27-3 | Purity: ≥95% | 1-Boc-3-methyl-1H-pyrazole-5-boronic Acid | ESD-891992-5G |
| Cas.: 97804-50-7 | Purity: 97% | (1R,4S,4aR,9aS)-rel-4a-Methyl-1,4,4a,9a-tetrahydro-1,4-methanoanthracene-9,10-dione | ESD-891993-250MG |
| Cas.: 97804-50-7 | Purity: 97% | (1R,4S,4aR,9aS)-rel-4a-Methyl-1,4,4a,9a-tetrahydro-1,4-methanoanthracene-9,10-dione | ESD-891993-1G |
| Cas.: 97804-50-7 | Purity: 97% | (1R,4S,4aR,9aS)-rel-4a-Methyl-1,4,4a,9a-tetrahydro-1,4-methanoanthracene-9,10-dione | ESD-891993-5G |
| Cas.: 86152-46-7 | Purity: 97% | Ethyl 2-(5-amino-4H-1,2,4-triazol-3-yl)acetate | ESD-891994-250MG |
| Cas.: 86152-46-7 | Purity: 97% | Ethyl 2-(5-amino-4H-1,2,4-triazol-3-yl)acetate | ESD-891994-1G |
| Cas.: 19230-50-3 | Purity: 98% | 2-Iodo-5-nitrobenzoic acid | ESD-891995-250MG |
| Cas.: 19230-50-3 | Purity: 98% | 2-Iodo-5-nitrobenzoic acid | ESD-891995-1G |
| Cas.: 19230-50-3 | Purity: 98% | 2-Iodo-5-nitrobenzoic acid | ESD-891995-5G |
| Cas.: 19230-50-3 | Purity: 98% | 2-Iodo-5-nitrobenzoic acid | ESD-891995-10G |
| Cas.: 13838-47-6 | Purity: ≥95% | 5-Methoxy-1H-indol-7-amine | ESD-891996-100MG |
| Cas.: 13838-47-6 | Purity: ≥95% | 5-Methoxy-1H-indol-7-amine | ESD-891996-250MG |
| Cas.: 13838-47-6 | Purity: ≥95% | 5-Methoxy-1H-indol-7-amine | ESD-891996-1G |
| Cas.: 1807209-44-4 | Purity: 97% | 2-Bromo-6-methyl-4-nitrobenzoic acid | ESD-891997-100MG |
| Cas.: 6758-34-5 | Purity: ≥95% | (5-(Trifluoromethyl)-1H-benzo[d]imidazol-2-yl)methanol | ESD-891998-100MG |
| Cas.: 6758-34-5 | Purity: ≥95% | (5-(Trifluoromethyl)-1H-benzo[d]imidazol-2-yl)methanol | ESD-891998-250MG |
| Cas.: 6758-34-5 | Purity: ≥95% | (5-(Trifluoromethyl)-1H-benzo[d]imidazol-2-yl)methanol | ESD-891998-1G |
| Cas.: 99512-09-1 | Purity: 97% | Methyl 3-amino-4-nitrobenzoate | ESD-891999-100MG |
| Cas.: 99512-09-1 | Purity: 97% | Methyl 3-amino-4-nitrobenzoate | ESD-891999-250MG |
| Cas.: 99512-09-1 | Purity: 97% | Methyl 3-amino-4-nitrobenzoate | ESD-891999-1G |
| Cas.: 99512-09-1 | Purity: 97% | Methyl 3-amino-4-nitrobenzoate | ESD-891999-5G |
| Cas.: 51516-70-2 | Purity: 97% | 5-Amino-1-(4-fluorophenyl)-1H-pyrazole-4-carbonitrile | ESD-892000-250MG |
| Cas.: 51516-70-2 | Purity: 97% | 5-Amino-1-(4-fluorophenyl)-1H-pyrazole-4-carbonitrile | ESD-892000-1G |
| Cas.: 51516-70-2 | Purity: 97% | 5-Amino-1-(4-fluorophenyl)-1H-pyrazole-4-carbonitrile | ESD-892000-5G |
| Cas.: 51516-70-2 | Purity: 97% | 5-Amino-1-(4-fluorophenyl)-1H-pyrazole-4-carbonitrile | ESD-892000-10G |
| Cas.: 731742-58-8 | Purity: ≥95% | 2-Thioxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylic acid | ESD-892001-100MG |
| Cas.: 731742-58-8 | Purity: ≥95% | 2-Thioxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylic acid | ESD-892001-250MG |
| Cas.: 731742-58-8 | Purity: ≥95% | 2-Thioxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylic acid | ESD-892001-1G |
| Cas.: 1220968-24-0 | Purity: ≥95% | Ethyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanoate | ESD-892002-100MG |
| Cas.: 1220968-24-0 | Purity: ≥95% | Ethyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanoate | ESD-892002-250MG |
| Cas.: 1220968-24-0 | Purity: ≥95% | Ethyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanoate | ESD-892002-1G |
| Cas.: 31604-30-5 | Purity: 97% | 1,2,4,5-Tetrabromo-3,6-dichlorobenzene | ESD-892003-100MG |
| Cas.: 31604-30-5 | Purity: 97% | 1,2,4,5-Tetrabromo-3,6-dichlorobenzene | ESD-892003-250MG |
| Cas.: 251938-49-5 | Purity: ≥95% | (R)-tert-Butyl(2-oxopyrrolidin-3-yl)carbamate | ESD-892004-100MG |
| Cas.: 251938-49-5 | Purity: ≥95% | (R)-tert-Butyl(2-oxopyrrolidin-3-yl)carbamate | ESD-892004-250MG |
| Cas.: 251938-49-5 | Purity: ≥95% | (R)-tert-Butyl(2-oxopyrrolidin-3-yl)carbamate | ESD-892004-1G |
| Cas.: 220616-39-7 | Purity: 96% | (3-(Cyanomethyl)phenyl)boronic acid | ESD-892005-100MG |
| Cas.: 220616-39-7 | Purity: 96% | (3-(Cyanomethyl)phenyl)boronic acid | ESD-892005-250MG |
| Cas.: 220616-39-7 | Purity: 96% | (3-(Cyanomethyl)phenyl)boronic acid | ESD-892005-1G |
| Cas.: 220616-39-7 | Purity: 96% | (3-(Cyanomethyl)phenyl)boronic acid | ESD-892005-5G |
| Cas.: 59074-26-9 | Purity: ≥95% | 3-(4-Chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole | ESD-892006-100MG |
| Cas.: 59074-26-9 | Purity: ≥95% | 3-(4-Chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole | ESD-892006-250MG |
| Cas.: 59074-26-9 | Purity: ≥95% | 3-(4-Chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole | ESD-892006-1G |
| Cas.: 146552-72-9 | Purity: ≥97% | (S)-tert-Butyl (1-amino-3-phenylpropan-2-yl)carbamate | ESD-892007-100MG |
| Cas.: 146552-72-9 | Purity: ≥97% | (S)-tert-Butyl (1-amino-3-phenylpropan-2-yl)carbamate | ESD-892007-250MG |
| Cas.: 1083168-93-7 | Purity: 97% | Methyl 2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate | ESD-892008-100MG |
| Cas.: 1083168-93-7 | Purity: 97% | Methyl 2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate | ESD-892008-250MG |
| Cas.: 1083168-93-7 | Purity: 97% | Methyl 2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate | ESD-892008-1G |
| Cas.: 1083168-93-7 | Purity: 97% | Methyl 2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate | ESD-892008-5G |
| Cas.: 828-81-9 | Purity: 95% | 5-(2-Chlorophenyl)-1,3,4-thiadiazol-2-amine | ESD-892009-250MG |
| Cas.: 828-81-9 | Purity: 95% | 5-(2-Chlorophenyl)-1,3,4-thiadiazol-2-amine | ESD-892009-1G |
| Cas.: 828-81-9 | Purity: 95% | 5-(2-Chlorophenyl)-1,3,4-thiadiazol-2-amine | ESD-892009-5G |
| Cas.: 828-81-9 | Purity: 95% | 5-(2-Chlorophenyl)-1,3,4-thiadiazol-2-amine | ESD-892009-10G |
| Cas.: 870238-36-1 | Purity: 95% | 5-Chloro-2-formylphenylboronic acid | ESD-892010-250MG |
| Cas.: 870238-36-1 | Purity: 95% | 5-Chloro-2-formylphenylboronic acid | ESD-892010-1G |
| Cas.: 870238-36-1 | Purity: 95% | 5-Chloro-2-formylphenylboronic acid | ESD-892010-5G |
| Cas.: 870238-36-1 | Purity: 95% | 5-Chloro-2-formylphenylboronic acid | ESD-892010-25G |
| Cas.: 1027929-81-2 | Purity: 97% | 7-Fluoro-8-nitroquinazolin-4(3H)-one | ESD-892011-100MG |
| Cas.: 1027929-81-2 | Purity: 97% | 7-Fluoro-8-nitroquinazolin-4(3H)-one | ESD-892011-250MG |
| Cas.: 111042-92-3 | Purity: ≥95% | Methyl 3-aminothieno[3,2-c]pyridine-2-carboxylate | ESD-892012-100MG |
| Cas.: 111042-92-3 | Purity: ≥95% | Methyl 3-aminothieno[3,2-c]pyridine-2-carboxylate | ESD-892012-250MG |
| Cas.: 111042-92-3 | Purity: ≥95% | Methyl 3-aminothieno[3,2-c]pyridine-2-carboxylate | ESD-892012-1G |
| Cas.: 111042-92-3 | Purity: ≥95% | Methyl 3-aminothieno[3,2-c]pyridine-2-carboxylate | ESD-892012-5G |
| Cas.: 111042-91-2 | Purity: 97% | Methyl 3-aminothieno[2,3-c]pyridine-2-carboxylate | ESD-892013-100MG |
| Cas.: 111042-91-2 | Purity: 97% | Methyl 3-aminothieno[2,3-c]pyridine-2-carboxylate | ESD-892013-250MG |
| Cas.: 111042-91-2 | Purity: 97% | Methyl 3-aminothieno[2,3-c]pyridine-2-carboxylate | ESD-892013-1G |
| Cas.: 111042-91-2 | Purity: 97% | Methyl 3-aminothieno[2,3-c]pyridine-2-carboxylate | ESD-892013-5G |
| Cas.: 292636-11-4 | Purity: ≥95% | 5-Chloro-1H-indol-7-amine | ESD-892014-250MG |
| Cas.: 292636-11-4 | Purity: ≥95% | 5-Chloro-1H-indol-7-amine | ESD-892014-1G |
| Cas.: 16234-15-4 | Purity: ≥95% | 4-(2-Chlorothieno[3,2-d]pyrimidin-4-yl)morpholine | ESD-892015-250MG |
| Cas.: 16234-15-4 | Purity: ≥95% | 4-(2-Chlorothieno[3,2-d]pyrimidin-4-yl)morpholine | ESD-892015-1G |
| Cas.: 16234-15-4 | Purity: ≥95% | 4-(2-Chlorothieno[3,2-d]pyrimidin-4-yl)morpholine | ESD-892015-5G |
| Cas.: 259683-56-2 | Purity: ≥95% | Ethyl 1-(2-formylphenyl)piperidine-4-carboxylate | ESD-892016-100MG |
| Cas.: 259683-56-2 | Purity: ≥95% | Ethyl 1-(2-formylphenyl)piperidine-4-carboxylate | ESD-892016-250MG |
| Cas.: 396076-60-1 | Purity: ≥95% | Ethyl 7-bromo-5-fluoro-1H-indole-2-carboxylate | ESD-892017-100MG |
| Cas.: 396076-60-1 | Purity: ≥95% | Ethyl 7-bromo-5-fluoro-1H-indole-2-carboxylate | ESD-892017-250MG |
| Cas.: 396076-60-1 | Purity: ≥95% | Ethyl 7-bromo-5-fluoro-1H-indole-2-carboxylate | ESD-892017-1G |
| Cas.: 396076-60-1 | Purity: ≥95% | Ethyl 7-bromo-5-fluoro-1H-indole-2-carboxylate | ESD-892017-5G |
| Cas.: 1583-65-9 | Purity: 97% | 2-Fluoroisophthalic acid | ESD-892018-250MG |
| Cas.: 1583-65-9 | Purity: 97% | 2-Fluoroisophthalic acid | ESD-892018-1G |
| Cas.: 1583-65-9 | Purity: 97% | 2-Fluoroisophthalic acid | ESD-892018-5G |
| Cas.: 1583-65-9 | Purity: 97% | 2-Fluoroisophthalic acid | ESD-892018-10G |
| Cas.: 87032-82-4 | Purity: 97% | 3-Hydroxyisonicotinonitrile | ESD-892019-250MG |
| Cas.: 1251832-81-1 | Purity: 97% | 2-((4-Chlorophenyl)ethynyl)benzaldehyde | ESD-892020-100MG |
| Cas.: 1251832-81-1 | Purity: 97% | 2-((4-Chlorophenyl)ethynyl)benzaldehyde | ESD-892020-250MG |
| Cas.: 1251832-81-1 | Purity: 97% | 2-((4-Chlorophenyl)ethynyl)benzaldehyde | ESD-892020-1G |
| Cas.: 889660-68-8 | Purity: 97% | 3-Iodoquinolin-6-ol | ESD-892021-100MG |
| Cas.: 889660-68-8 | Purity: 97% | 3-Iodoquinolin-6-ol | ESD-892021-250MG |
| Cas.: 128942-65-4 | Purity: ≥95% | 6,7-Dimethoxy-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline | ESD-892022-100MG |
| Cas.: 128942-65-4 | Purity: ≥95% | 6,7-Dimethoxy-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline | ESD-892022-250MG |
| Cas.: 149771-43-7 | Purity: ≥95% | tert-Butyl 3-benzyl-3,8-diazabicyclo[3.2.1]octane-8-carboxylate | ESD-892023-100MG |
| Cas.: 149771-43-7 | Purity: ≥95% | tert-Butyl 3-benzyl-3,8-diazabicyclo[3.2.1]octane-8-carboxylate | ESD-892023-250MG |
| Cas.: 81323-58-2 | Purity: ≥95% | (S)-tert-Butyl 2-((tert-butoxycarbonyl)amino)-4-hydroxybutanoate | ESD-892024-50MG |
| Cas.: 34084-89-4 | Purity: ≥95% | Methyl 7-nitrobenzo[b]thiophene-2-carboxylate | ESD-892025-100MG |
| Cas.: 34084-89-4 | Purity: ≥95% | Methyl 7-nitrobenzo[b]thiophene-2-carboxylate | ESD-892025-250MG |
| Cas.: 4786-53-2 | Purity: 97% | 4-Hydroxypyrimidine-5-carboxamide | ESD-892026-100MG |
| Cas.: 4786-53-2 | Purity: 97% | 4-Hydroxypyrimidine-5-carboxamide | ESD-892026-250MG |
| Cas.: 4786-53-2 | Purity: 97% | 4-Hydroxypyrimidine-5-carboxamide | ESD-892026-1G |
| Cas.: 4786-53-2 | Purity: 97% | 4-Hydroxypyrimidine-5-carboxamide | ESD-892026-5G |
| Cas.: 936138-17-9 | Purity: 97% | 3-Iodo-6-methoxy-1H-indazole | ESD-892027-250MG |
| Cas.: 936138-17-9 | Purity: 97% | 3-Iodo-6-methoxy-1H-indazole | ESD-892027-1G |
| Cas.: 936138-17-9 | Purity: 97% | 3-Iodo-6-methoxy-1H-indazole | ESD-892027-5G |
| Cas.: 936138-17-9 | Purity: 97% | 3-Iodo-6-methoxy-1H-indazole | ESD-892027-10G |
| Cas.: 1014-25-1 | Purity: ≥95% | 5-(4-Methoxyphenyl)-1,3,4-thiadiazol-2-amine | ESD-892028-250MG |
| Cas.: 1014-25-1 | Purity: ≥95% | 5-(4-Methoxyphenyl)-1,3,4-thiadiazol-2-amine | ESD-892028-1G |
| Cas.: 1014-25-1 | Purity: ≥95% | 5-(4-Methoxyphenyl)-1,3,4-thiadiazol-2-amine | ESD-892028-5G |
| Cas.: 1014-25-1 | Purity: ≥95% | 5-(4-Methoxyphenyl)-1,3,4-thiadiazol-2-amine | ESD-892028-10G |
| Cas.: 619331-71-4 | Purity: 96% | 4,7-Dibromo-1H-pyrrolo[2,3-c]pyridine | ESD-892029-100MG |
| Cas.: 619331-71-4 | Purity: 96% | 4,7-Dibromo-1H-pyrrolo[2,3-c]pyridine | ESD-892029-250MG |
| Cas.: 619331-71-4 | Purity: 96% | 4,7-Dibromo-1H-pyrrolo[2,3-c]pyridine | ESD-892029-1G |
| Cas.: 1201643-70-0 | Purity: 98% | (1-Phenyl-1H-pyrazol-4-yl)boronic acid | ESD-892030-100MG |
| Cas.: 1201643-70-0 | Purity: 98% | (1-Phenyl-1H-pyrazol-4-yl)boronic acid | ESD-892030-250MG |
| Cas.: 1201643-70-0 | Purity: 98% | (1-Phenyl-1H-pyrazol-4-yl)boronic acid | ESD-892030-1G |
| Cas.: 1201643-70-0 | Purity: 98% | (1-Phenyl-1H-pyrazol-4-yl)boronic acid | ESD-892030-5G |
| Cas.: 441784-82-3 | Purity: ≥95% | 1-(((tert-Butyldiphenylsilyl)oxy)methyl)cyclopropanol | ESD-892031-100MG |
| Cas.: 441784-82-3 | Purity: ≥95% | 1-(((tert-Butyldiphenylsilyl)oxy)methyl)cyclopropanol | ESD-892031-250MG |
| Cas.: 441784-82-3 | Purity: ≥95% | 1-(((tert-Butyldiphenylsilyl)oxy)methyl)cyclopropanol | ESD-892031-1G |
| Cas.: 774178-09-5 | Purity: ≥95% | 2-Methyl-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine | ESD-892032-250MG |
| Cas.: 66389-80-8 | Purity: 97% | tert-Butyl 4-cyanobenzylcarbamate | ESD-892033-250MG |
| Cas.: 66389-80-8 | Purity: 97% | tert-Butyl 4-cyanobenzylcarbamate | ESD-892033-1G |
| Cas.: 66389-80-8 | Purity: 97% | tert-Butyl 4-cyanobenzylcarbamate | ESD-892033-5G |
| Cas.: 66389-80-8 | Purity: 97% | tert-Butyl 4-cyanobenzylcarbamate | ESD-892033-10G |
| Cas.: 74165-74-5 | Purity: 97% | 3-Amino-5-methoxybenzoic acid | ESD-892034-100MG |
| Cas.: 74165-74-5 | Purity: 97% | 3-Amino-5-methoxybenzoic acid | ESD-892034-250MG |
| Cas.: 74165-74-5 | Purity: 97% | 3-Amino-5-methoxybenzoic acid | ESD-892034-1G |
| Cas.: 74165-74-5 | Purity: 97% | 3-Amino-5-methoxybenzoic acid | ESD-892034-5G |
| Cas.: 6299-39-4 | Purity: 97% | 4-Nitro-1H-1,2,3-benzotriazole | ESD-892035-100MG |
| Cas.: 6299-39-4 | Purity: 97% | 4-Nitro-1H-1,2,3-benzotriazole | ESD-892035-250MG |
| Cas.: 6299-39-4 | Purity: 97% | 4-Nitro-1H-1,2,3-benzotriazole | ESD-892035-1G |
| Cas.: 6299-39-4 | Purity: 97% | 4-Nitro-1H-1,2,3-benzotriazole | ESD-892035-5G |
| Cas.: 67130-04-5 | Purity: ≥95% | 7-Chloro-1H-benzo[d][1,2,3]triazole | ESD-892036-100MG |
| Cas.: 67130-04-5 | Purity: ≥95% | 7-Chloro-1H-benzo[d][1,2,3]triazole | ESD-892036-250MG |
| Cas.: 710348-63-3 | Purity: ≥95% | 4,4,5,5-Tetramethyl-2-(3-(methylthio)phenyl)-1,3,2-dioxaborolane | ESD-892037-250MG |
| Cas.: 710348-63-3 | Purity: ≥95% | 4,4,5,5-Tetramethyl-2-(3-(methylthio)phenyl)-1,3,2-dioxaborolane | ESD-892037-1G |
| Cas.: 710348-63-3 | Purity: ≥95% | 4,4,5,5-Tetramethyl-2-(3-(methylthio)phenyl)-1,3,2-dioxaborolane | ESD-892037-5G |
| Cas.: 3336-40-1 | Purity: 97% | 3,5-Diiodo-4-methoxybenzonitrile | ESD-892038-100MG |
| Cas.: 3336-40-1 | Purity: 97% | 3,5-Diiodo-4-methoxybenzonitrile | ESD-892038-250MG |
| Cas.: 3336-40-1 | Purity: 97% | 3,5-Diiodo-4-methoxybenzonitrile | ESD-892038-1G |
| Cas.: 3336-40-1 | Purity: 97% | 3,5-Diiodo-4-methoxybenzonitrile | ESD-892038-5G |
| Cas.: 89446-19-5 | Purity: ≥95% | 6-Bromo-4-methylquinolin-2-ol | ESD-892039-250MG |
| Cas.: 89446-19-5 | Purity: ≥95% | 6-Bromo-4-methylquinolin-2-ol | ESD-892039-1G |
| Cas.: 89446-19-5 | Purity: ≥95% | 6-Bromo-4-methylquinolin-2-ol | ESD-892039-5G |
| Cas.: 457957-86-7 | Purity: 97% | N-(3,5-Dibromopyridin-2-yl)formamide | ESD-892040-1G |
| Cas.: 457957-86-7 | Purity: 97% | N-(3,5-Dibromopyridin-2-yl)formamide | ESD-892040-5G |
| Cas.: 874219-46-2 | Purity: 96% | (4-Chloro-3-(ethoxycarbonyl)phenyl)boronic acid | ESD-892041-100MG |
| Cas.: 874219-46-2 | Purity: 96% | (4-Chloro-3-(ethoxycarbonyl)phenyl)boronic acid | ESD-892041-250MG |
| Cas.: 874219-46-2 | Purity: 96% | (4-Chloro-3-(ethoxycarbonyl)phenyl)boronic acid | ESD-892041-1G |
| Cas.: 874219-46-2 | Purity: 96% | (4-Chloro-3-(ethoxycarbonyl)phenyl)boronic acid | ESD-892041-5G |
| Cas.: 1424-51-7 | Purity: 97% | 3-(Phenylsulfonyl)acrylonitrile | ESD-892042-100MG |
| Cas.: 1424-51-7 | Purity: 97% | 3-(Phenylsulfonyl)acrylonitrile | ESD-892042-250MG |
| Cas.: 70829-28-6 | Purity: ≥95% | 3-Cyano-4-hydroxybenzoic acid | ESD-892043-250MG |
| Cas.: 70829-28-6 | Purity: ≥95% | 3-Cyano-4-hydroxybenzoic acid | ESD-892043-1G |
| Cas.: 70829-28-6 | Purity: ≥95% | 3-Cyano-4-hydroxybenzoic acid | ESD-892043-5G |
| Cas.: 956485-60-2 | Purity: ≥95% | 6-Bromo-3-iodo-1H-pyrrolo[3,2-b]pyridine | ESD-892044-100MG |
| Cas.: 956485-60-2 | Purity: ≥95% | 6-Bromo-3-iodo-1H-pyrrolo[3,2-b]pyridine | ESD-892044-250MG |
| Cas.: 956485-60-2 | Purity: ≥95% | 6-Bromo-3-iodo-1H-pyrrolo[3,2-b]pyridine | ESD-892044-1G |
| Cas.: 5437-99-0 | Purity: 97% | 8-Nitroquinolin-6-ol | ESD-892045-100MG |
| Cas.: 5437-99-0 | Purity: 97% | 8-Nitroquinolin-6-ol | ESD-892045-250MG |
| Cas.: 5437-99-0 | Purity: 97% | 8-Nitroquinolin-6-ol | ESD-892045-1G |
| Cas.: 1910-85-6 | Purity: 97% | 1-Chloro-10H-phenothiazine | ESD-892046-250MG |
| Cas.: 1910-85-6 | Purity: 97% | 1-Chloro-10H-phenothiazine | ESD-892046-1G |
| Cas.: 40154-29-8 | Purity: 97% | 2-(6-Methoxy-3,4-dihydronaphthalen-1-yl)acetic acid | ESD-892047-100MG |
| Cas.: 40154-29-8 | Purity: 97% | 2-(6-Methoxy-3,4-dihydronaphthalen-1-yl)acetic acid | ESD-892047-250MG |
| Cas.: 27568-04-3 | Purity: 97% | Ethyl 4-hydroxy-8-methoxyquinoline-3-carboxylate | ESD-892048-250MG |
| Cas.: 27568-04-3 | Purity: 97% | Ethyl 4-hydroxy-8-methoxyquinoline-3-carboxylate | ESD-892048-1G |
| Cas.: 27568-04-3 | Purity: 97% | Ethyl 4-hydroxy-8-methoxyquinoline-3-carboxylate | ESD-892048-5G |
| Cas.: 27568-04-3 | Purity: 97% | Ethyl 4-hydroxy-8-methoxyquinoline-3-carboxylate | ESD-892048-10G |
| Cas.: 3618-96-0 | Purity: 97% | Methyl N-acetyl-L-phenylalaninate | ESD-892049-1G |
| Cas.: 3618-96-0 | Purity: 97% | Methyl N-acetyl-L-phenylalaninate | ESD-892049-5G |
| Cas.: 3618-96-0 | Purity: 97% | Methyl N-acetyl-L-phenylalaninate | ESD-892049-10G |
| Cas.: 3618-96-0 | Purity: 97% | Methyl N-acetyl-L-phenylalaninate | ESD-892049-25G |
| Cas.: 25799-58-0 | Purity: 97% | HD-Tyr(3-I)-OH | ESD-892050-250MG |
| Cas.: 25799-58-0 | Purity: 97% | HD-Tyr(3-I)-OH | ESD-892050-1G |
| Cas.: 1239460-83-3 | Purity: ≥95% | 5-Bromothieno[2,3-d]pyrimidin-4(3H)-one | ESD-892051-100MG |
| Cas.: 1239460-83-3 | Purity: ≥95% | 5-Bromothieno[2,3-d]pyrimidin-4(3H)-one | ESD-892051-250MG |
| Cas.: 1239460-83-3 | Purity: ≥95% | 5-Bromothieno[2,3-d]pyrimidin-4(3H)-one | ESD-892051-1G |
| Cas.: 6216-65-5 | Purity: 97% | Cbz-L-Valinol | ESD-892052-250MG |
| Cas.: 6216-65-5 | Purity: 97% | Cbz-L-Valinol | ESD-892052-1G |
| Cas.: 6216-65-5 | Purity: 97% | Cbz-L-Valinol | ESD-892052-5G |
| Cas.: 253265-97-3 | Purity: ≥95% | 2,5-Dioxopyrrolidin-1-yl ((3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl) carbonate | ESD-892053-100MG |
| Cas.: 253265-97-3 | Purity: ≥95% | 2,5-Dioxopyrrolidin-1-yl ((3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl) carbonate | ESD-892053-250MG |
| Cas.: 253265-97-3 | Purity: ≥95% | 2,5-Dioxopyrrolidin-1-yl ((3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl) carbonate | ESD-892053-1G |
| Cas.: 253265-97-3 | Purity: ≥95% | 2,5-Dioxopyrrolidin-1-yl ((3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl) carbonate | ESD-892053-5G |
| Cas.: 218916-64-4 | Purity: 97% | 3-((tert-Butoxycarbonyl)amino)-2-hydroxypropanoic acid | ESD-892054-250MG |
| Cas.: 218916-64-4 | Purity: 97% | 3-((tert-Butoxycarbonyl)amino)-2-hydroxypropanoic acid | ESD-892054-1G |
| Cas.: 218916-64-4 | Purity: 97% | 3-((tert-Butoxycarbonyl)amino)-2-hydroxypropanoic acid | ESD-892054-5G |
| Cas.: 218916-64-4 | Purity: 97% | 3-((tert-Butoxycarbonyl)amino)-2-hydroxypropanoic acid | ESD-892054-10G |
| Cas.: 87932-49-8 | Purity: ≥95% | 3-Chloro-4,5-dihydroxybenzoic acid | ESD-892055-100MG |
| Cas.: 87932-49-8 | Purity: ≥95% | 3-Chloro-4,5-dihydroxybenzoic acid | ESD-892055-250MG |
| Cas.: 87932-49-8 | Purity: ≥95% | 3-Chloro-4,5-dihydroxybenzoic acid | ESD-892055-1G |
| Cas.: 87932-49-8 | Purity: ≥95% | 3-Chloro-4,5-dihydroxybenzoic acid | ESD-892055-5G |
| Cas.: 102735-84-2 | Purity: ≥95% | 5-Chloro-1H-indazole-3-carbaldehyde | ESD-892056-100MG |
| Cas.: 102735-84-2 | Purity: ≥95% | 5-Chloro-1H-indazole-3-carbaldehyde | ESD-892056-250MG |
| Cas.: 102735-84-2 | Purity: ≥95% | 5-Chloro-1H-indazole-3-carbaldehyde | ESD-892056-1G |
| Cas.: 102735-84-2 | Purity: ≥95% | 5-Chloro-1H-indazole-3-carbaldehyde | ESD-892056-5G |
| Cas.: 885521-37-9 | Purity: ≥95% | 6-Chloro-1H-indazole-3-carbaldehyde | ESD-892057-100MG |
| Cas.: 885521-37-9 | Purity: ≥95% | 6-Chloro-1H-indazole-3-carbaldehyde | ESD-892057-250MG |
| Cas.: 885521-37-9 | Purity: ≥95% | 6-Chloro-1H-indazole-3-carbaldehyde | ESD-892057-1G |
| Cas.: 1190322-81-6 | Purity: ≥95% | 6-Bromo-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | ESD-892058-100MG |
| Cas.: 1190322-81-6 | Purity: ≥95% | 6-Bromo-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | ESD-892058-250MG |
| Cas.: 1190322-81-6 | Purity: ≥95% | 6-Bromo-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | ESD-892058-1G |
| Cas.: 112257-12-2 | Purity: ≥95% | tert-Butyl 4-(2-bromoacetyl)piperazine-1-carboxylate | ESD-892059-250MG |
| Cas.: 112257-12-2 | Purity: ≥95% | tert-Butyl 4-(2-bromoacetyl)piperazine-1-carboxylate | ESD-892059-1G |
| Cas.: 112257-12-2 | Purity: ≥95% | tert-Butyl 4-(2-bromoacetyl)piperazine-1-carboxylate | ESD-892059-5G |
| Cas.: 518990-33-5 | Purity: ≥95% | 4-Chloro-3-iodo-1H-indazole | ESD-892060-100MG |
| Cas.: 518990-33-5 | Purity: ≥95% | 4-Chloro-3-iodo-1H-indazole | ESD-892060-250MG |
| Cas.: 158984-83-9 | Purity: 97% | tert-Butyl 6-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate | ESD-892061-250MG |
| Cas.: 158984-83-9 | Purity: 97% | tert-Butyl 6-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate | ESD-892061-1G |
| Cas.: 158984-83-9 | Purity: 97% | tert-Butyl 6-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate | ESD-892061-5G |
| Cas.: 158984-83-9 | Purity: 97% | tert-Butyl 6-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate | ESD-892061-10G |
| Cas.: 1912400-29-3 | Purity: 97% | 3-(3-((Trifluoromethyl)thio)phenyl)-1H-pyrazol-5-amine | ESD-892062-250MG |
| Cas.: 1912400-29-3 | Purity: 97% | 3-(3-((Trifluoromethyl)thio)phenyl)-1H-pyrazol-5-amine | ESD-892062-1G |
| Cas.: 51440-34-7 | Purity: 97% | 2-(Pyridin-2-ylamino)benzoic acid | ESD-892063-250MG |
| Cas.: 51440-34-7 | Purity: 97% | 2-(Pyridin-2-ylamino)benzoic acid | ESD-892063-1G |
| Cas.: 51440-34-7 | Purity: 97% | 2-(Pyridin-2-ylamino)benzoic acid | ESD-892063-5G |
| Cas.: 51440-34-7 | Purity: 97% | 2-(Pyridin-2-ylamino)benzoic acid | ESD-892063-10G |
| Cas.: 2041-19-2 | Purity: ≥95% | 3-Bromo-9H-fluoren-9-one | ESD-892064-100MG |
| Cas.: 2041-19-2 | Purity: ≥95% | 3-Bromo-9H-fluoren-9-one | ESD-892064-250MG |
| Cas.: 14028-68-3 | Purity: 97% | Ethyl 2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)acetate | ESD-892065-250MG |
| Cas.: 14028-68-3 | Purity: 97% | Ethyl 2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)acetate | ESD-892065-1G |
| Cas.: 14028-68-3 | Purity: 97% | Ethyl 2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)acetate | ESD-892065-5G |
| Cas.: 14028-68-3 | Purity: 97% | Ethyl 2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)acetate | ESD-892065-10G |
| Cas.: 21190-16-9 | Purity: 97% | Ethyl 4-amino-1H-imidazole-5-carboxylate | ESD-892066-100MG |
| Cas.: 21190-16-9 | Purity: 97% | Ethyl 4-amino-1H-imidazole-5-carboxylate | ESD-892066-250MG |
| Cas.: 21190-16-9 | Purity: 97% | Ethyl 4-amino-1H-imidazole-5-carboxylate | ESD-892066-1G |
| Cas.: 21190-16-9 | Purity: 97% | Ethyl 4-amino-1H-imidazole-5-carboxylate | ESD-892066-5G |
| Cas.: 142929-49-5 | Purity: 95% | N-Boc-2-(2-aminoethoxy)acetic Acid | ESD-892067-1G |
| Cas.: 142929-49-5 | Purity: 95% | N-Boc-2-(2-aminoethoxy)acetic Acid | ESD-892067-5G |
| Cas.: 142929-49-5 | Purity: 95% | N-Boc-2-(2-aminoethoxy)acetic Acid | ESD-892067-25G |
| Cas.: 23578-45-2 | Purity: ≥95% | 2-Methacrylamidoacetic acid | ESD-892068-250MG |
| Cas.: 23578-45-2 | Purity: ≥95% | 2-Methacrylamidoacetic acid | ESD-892068-1G |
| Cas.: 97640-15-8 | Purity: ≥95% | 3H-Imidazo[4,5-b]pyridine-2-carboxylic acid | ESD-892069-100MG |
| Cas.: 97640-15-8 | Purity: ≥95% | 3H-Imidazo[4,5-b]pyridine-2-carboxylic acid | ESD-892069-250MG |
| Cas.: 97640-15-8 | Purity: ≥95% | 3H-Imidazo[4,5-b]pyridine-2-carboxylic acid | ESD-892069-1G |
| Cas.: 59782-86-4 | Purity: ≥95% | 2-Chloro-5-iodonicotinic acid | ESD-892070-100MG |
| Cas.: 59782-86-4 | Purity: ≥95% | 2-Chloro-5-iodonicotinic acid | ESD-892070-250MG |
| Cas.: 59782-86-4 | Purity: ≥95% | 2-Chloro-5-iodonicotinic acid | ESD-892070-1G |
| Cas.: 10366-05-9 | Purity: 97%(mix) | 12,43-Dichloro-1,4(1,4)-dibenzenacyclohexaphane | ESD-892071-1G |
| Cas.: 10366-05-9 | Purity: 97%(mix) | 12,43-Dichloro-1,4(1,4)-dibenzenacyclohexaphane | ESD-892071-5G |
| Cas.: 177210-33-2 | Purity: ≥95% | 5-Hydroxy-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-892072-250MG |
| Cas.: 177210-33-2 | Purity: ≥95% | 5-Hydroxy-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-892072-1G |
| Cas.: 177210-33-2 | Purity: ≥95% | 5-Hydroxy-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-892072-5G |
| Cas.: 364077-84-9 | Purity: 97% | (R)-1-(tert-Butoxycarbonyl)-4-oxopyrrolidine-2-carboxylic acid | ESD-892073-100MG |
| Cas.: 364077-84-9 | Purity: 97% | (R)-1-(tert-Butoxycarbonyl)-4-oxopyrrolidine-2-carboxylic acid | ESD-892073-250MG |
| Cas.: 364077-84-9 | Purity: 97% | (R)-1-(tert-Butoxycarbonyl)-4-oxopyrrolidine-2-carboxylic acid | ESD-892073-1G |
| Cas.: 364077-84-9 | Purity: 97% | (R)-1-(tert-Butoxycarbonyl)-4-oxopyrrolidine-2-carboxylic acid | ESD-892073-5G |
| Cas.: 205524-47-6 | Purity: 95% | (R)-Di-tert-butyl 5-oxopyrrolidine-1,2-dicarboxylate | ESD-892074-100MG |
| Cas.: 205524-47-6 | Purity: 95% | (R)-Di-tert-butyl 5-oxopyrrolidine-1,2-dicarboxylate | ESD-892074-250MG |
| Cas.: 205524-47-6 | Purity: 95% | (R)-Di-tert-butyl 5-oxopyrrolidine-1,2-dicarboxylate | ESD-892074-1G |
| Cas.: 1000341-64-9 | Purity: 95% | 6-Chloro-1H-pyrrolo[3,2-c]pyridine-3-carbaldehyde | ESD-892075-100MG |
| Cas.: 1000341-64-9 | Purity: 95% | 6-Chloro-1H-pyrrolo[3,2-c]pyridine-3-carbaldehyde | ESD-892075-250MG |
| Cas.: 1000341-64-9 | Purity: 95% | 6-Chloro-1H-pyrrolo[3,2-c]pyridine-3-carbaldehyde | ESD-892075-1G |
| Cas.: 40232-88-0 | Purity: 97% | 4-(Benzyloxy)-3-methoxyphenol | ESD-892076-100MG |
| Cas.: 40232-88-0 | Purity: 97% | 4-(Benzyloxy)-3-methoxyphenol | ESD-892076-250MG |
| Cas.: 101125-32-0 | Purity: 97% | 3-(4-Fluorophenyl)-1H-indole | ESD-892077-250MG |
| Cas.: 101125-32-0 | Purity: 97% | 3-(4-Fluorophenyl)-1H-indole | ESD-892077-1G |
| Cas.: 101125-32-0 | Purity: 97% | 3-(4-Fluorophenyl)-1H-indole | ESD-892077-5G |
| Cas.: 101125-32-0 | Purity: 97% | 3-(4-Fluorophenyl)-1H-indole | ESD-892077-10G |
| Cas.: 935660-75-6 | Purity: ≥95% | N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide | ESD-892078-100MG |
| Cas.: 935660-75-6 | Purity: ≥95% | N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide | ESD-892078-250MG |
| Cas.: 1375108-46-5 | Purity: ≥95% | 7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinazoline | ESD-892079-100MG |
| Cas.: 1375108-46-5 | Purity: ≥95% | 7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinazoline | ESD-892079-250MG |
| Cas.: 1375108-46-5 | Purity: ≥95% | 7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinazoline | ESD-892079-1G |
| Cas.: 89166-85-8 | Purity: 97% | 5-Chloro-4-nitrothiophene-2-carboxylic acid | ESD-892080-250MG |
| Cas.: 89166-85-8 | Purity: 97% | 5-Chloro-4-nitrothiophene-2-carboxylic acid | ESD-892080-1G |
| Cas.: 89166-85-8 | Purity: 97% | 5-Chloro-4-nitrothiophene-2-carboxylic acid | ESD-892080-5G |
| Cas.: 186435-66-5 | Purity: ≥95% | 6-Amino-2-methoxypyrimidin-4-ol | ESD-892081-1G |
| Cas.: 186435-66-5 | Purity: ≥95% | 6-Amino-2-methoxypyrimidin-4-ol | ESD-892081-5G |
| Cas.: 186435-66-5 | Purity: ≥95% | 6-Amino-2-methoxypyrimidin-4-ol | ESD-892081-10G |
| Cas.: 86770-76-5 | Purity: ≥95% | 1-Phenyl-2,5,8,11-tetraoxatridecan-13-amine | ESD-892082-250MG |
| Cas.: 86770-76-5 | Purity: ≥95% | 1-Phenyl-2,5,8,11-tetraoxatridecan-13-amine | ESD-892082-1G |
| Cas.: 20945-65-7 | Purity: ≥95% | 2-Chloro-4-(methylsulfonyl)phenol | ESD-892083-100MG |
| Cas.: 20945-65-7 | Purity: ≥95% | 2-Chloro-4-(methylsulfonyl)phenol | ESD-892083-250MG |
| Cas.: 169032-03-5 | Purity: ≥95% | 4-Hydroxy-2,3-dihydro-1H-indene-2-carboxylic acid | ESD-892084-100MG |
| Cas.: 169032-03-5 | Purity: ≥95% | 4-Hydroxy-2,3-dihydro-1H-indene-2-carboxylic acid | ESD-892084-250MG |
| Cas.: 1268521-33-0 | Purity: ≥95% | 3-Bromo-2-chloro-5-nitropyridin-4-amine | ESD-892085-100MG |
| Cas.: 1268521-33-0 | Purity: ≥95% | 3-Bromo-2-chloro-5-nitropyridin-4-amine | ESD-892085-250MG |
| Cas.: 1268521-33-0 | Purity: ≥95% | 3-Bromo-2-chloro-5-nitropyridin-4-amine | ESD-892085-1G |
| Cas.: 882188-88-7 | Purity: 97% | tert-Butyl 3-formyl-1H-indazole-1-carboxylate | ESD-892086-250MG |
| Cas.: 882188-88-7 | Purity: 97% | tert-Butyl 3-formyl-1H-indazole-1-carboxylate | ESD-892086-1G |
| Cas.: 882188-88-7 | Purity: 97% | tert-Butyl 3-formyl-1H-indazole-1-carboxylate | ESD-892086-5G |
| Cas.: 1235-74-1 | Purity: 97% | (1R,4aS,10aR)-methyl 7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-carboxylate | ESD-892087-250MG |
| Cas.: 1235-74-1 | Purity: 97% | (1R,4aS,10aR)-methyl 7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-carboxylate | ESD-892087-1G |
| Cas.: 6582-52-1 | Purity: 95% | 2,2′-Methylenedianiline | ESD-892088-10MG |
| Cas.: 6582-52-1 | Purity: 95% | 2,2′-Methylenedianiline | ESD-892088-100MG |
| Cas.: 27080-53-1 | Purity: ≥95% | 7-Methoxy-1H-benzo[d]imidazole | ESD-892089-100MG |
| Cas.: 27080-53-1 | Purity: ≥95% | 7-Methoxy-1H-benzo[d]imidazole | ESD-892089-250MG |
| Cas.: 797060-52-7 | Purity: 96% | Methyl 5-amino-6-bromopicolinate | ESD-892090-100MG |
| Cas.: 797060-52-7 | Purity: 96% | Methyl 5-amino-6-bromopicolinate | ESD-892090-250MG |
| Cas.: 474018-94-5 | Purity: 97% | N,N-Diethyl-4-fluoro-3-nitrobenzamide | ESD-892091-100MG |
| Cas.: 474018-94-5 | Purity: 97% | N,N-Diethyl-4-fluoro-3-nitrobenzamide | ESD-892091-250MG |
| Cas.: 149517-92-0 | Purity: ≥95% | Ethyl 4-bromo-3,5-diethoxybenzoate | ESD-892092-100MG |
| Cas.: 149517-92-0 | Purity: ≥95% | Ethyl 4-bromo-3,5-diethoxybenzoate | ESD-892092-250MG |
| Cas.: 149517-92-0 | Purity: ≥95% | Ethyl 4-bromo-3,5-diethoxybenzoate | ESD-892092-1G |
| Cas.: 1146629-75-5 | Purity: 97% | (4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate | ESD-892093-250MG |
| Cas.: 1146629-75-5 | Purity: 97% | (4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate | ESD-892093-1G |
| Cas.: 1146629-75-5 | Purity: 97% | (4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate | ESD-892093-5G |
| Cas.: 1146629-75-5 | Purity: 97% | (4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate | ESD-892093-10G |
| Cas.: 300576-59-4 | Purity: 98% | (+)-PD 128970 HCl | ESD-892094-50MG |
| Cas.: 300576-59-4 | Purity: 98% | (+)-PD 128970 HCl | ESD-892094-100MG |
| Cas.: 300576-59-4 | Purity: 98% | (+)-PD 128970 HCl | ESD-892094-250MG |
| Cas.: 300576-59-4 | Purity: 98% | (+)-PD 128970 HCl | ESD-892094-1G |
| Cas.: 3803-25-6 | Purity: 95% | 1-(3-(Trifluoromethyl)phenyl)ethanamine hydrochloride | ESD-892095-1G |
| Cas.: 3803-25-6 | Purity: 95% | 1-(3-(Trifluoromethyl)phenyl)ethanamine hydrochloride | ESD-892095-5G |
| Cas.: 73040-66-1 | Purity: 96% | 5-(4-Chlorophenyl)thiazol-2-amine | ESD-892096-100MG |
| Cas.: 73040-66-1 | Purity: 96% | 5-(4-Chlorophenyl)thiazol-2-amine | ESD-892096-250MG |
| Cas.: 73040-66-1 | Purity: 96% | 5-(4-Chlorophenyl)thiazol-2-amine | ESD-892096-1G |
| Cas.: 73040-66-1 | Purity: 96% | 5-(4-Chlorophenyl)thiazol-2-amine | ESD-892096-5G |
| Cas.: 854670-84-1 | Purity: ≥95% | 4-Hydroxyphenylglyoxal hydrate | ESD-892097-1G |
| Cas.: 854670-84-1 | Purity: ≥95% | 4-Hydroxyphenylglyoxal hydrate | ESD-892097-5G |
| Cas.: 197447-05-5 | Purity: ≥95% | 2,2-Dihydroxy-1-(4-hydroxyphenyl)ethanone | ESD-892098-100MG |
| Cas.: 335349-57-0 | Purity: ≥95% | 5-Chloro-4-iodo-2-nitroaniline | ESD-892099-250MG |
| Cas.: 335349-57-0 | Purity: ≥95% | 5-Chloro-4-iodo-2-nitroaniline | ESD-892099-1G |
| Cas.: 335349-57-0 | Purity: ≥95% | 5-Chloro-4-iodo-2-nitroaniline | ESD-892099-5G |
| Cas.: 335349-57-0 | Purity: ≥95% | 5-Chloro-4-iodo-2-nitroaniline | ESD-892099-10G |
| Cas.: 1567641-47-7 | Purity: 97% | 2-Cyano-3-(thiazol-5-yl)acrylic acid | ESD-892100-10MG |
| Cas.: 1567641-47-7 | Purity: 97% | 2-Cyano-3-(thiazol-5-yl)acrylic acid | ESD-892100-100MG |
| Cas.: 144657-66-9 | Purity: 97% | tert-Butyl 3-formyl-1H-pyrrolo[2,3-b]pyridine-1-carboxylate | ESD-892101-250MG |
| Cas.: 144657-66-9 | Purity: 97% | tert-Butyl 3-formyl-1H-pyrrolo[2,3-b]pyridine-1-carboxylate | ESD-892101-1G |
| Cas.: 144657-66-9 | Purity: 97% | tert-Butyl 3-formyl-1H-pyrrolo[2,3-b]pyridine-1-carboxylate | ESD-892101-5G |
| Cas.: 1824050-94-3 | Purity: ≥95% | 3-Fluoroquinoline-5-carboxylic acid | ESD-892102-100MG |
| Cas.: 1824050-94-3 | Purity: ≥95% | 3-Fluoroquinoline-5-carboxylic acid | ESD-892102-250MG |
| Cas.: 1824050-94-3 | Purity: ≥95% | 3-Fluoroquinoline-5-carboxylic acid | ESD-892102-1G |
| Cas.: 434941-55-6 | Purity: ≥95% | 4-(4-Chlorophenyl)-2-(methylthio)pyrimidine | ESD-892103-100MG |
| Cas.: 434941-55-6 | Purity: ≥95% | 4-(4-Chlorophenyl)-2-(methylthio)pyrimidine | ESD-892103-250MG |
| Cas.: 25218-99-9 | Purity: 97% | N-(6-Bromopyridin-2-yl)acetamide | ESD-892104-250MG |
| Cas.: 25218-99-9 | Purity: 97% | N-(6-Bromopyridin-2-yl)acetamide | ESD-892104-1G |
| Cas.: 25218-99-9 | Purity: 97% | N-(6-Bromopyridin-2-yl)acetamide | ESD-892104-5G |
| Cas.: 25218-99-9 | Purity: 97% | N-(6-Bromopyridin-2-yl)acetamide | ESD-892104-10G |
| Cas.: 92346-48-0 | Purity: ≥95% | 2-(2-Bromophenyl)oxazole | ESD-892105-100MG |
| Cas.: 92346-48-0 | Purity: ≥95% | 2-(2-Bromophenyl)oxazole | ESD-892105-250MG |
| Cas.: 92346-48-0 | Purity: ≥95% | 2-(2-Bromophenyl)oxazole | ESD-892105-1G |
| Cas.: 5521-62-0 | Purity: ≥95% | 6-Methylpyrazine-2-carboxamide | ESD-892106-100MG |
| Cas.: 5521-62-0 | Purity: ≥95% | 6-Methylpyrazine-2-carboxamide | ESD-892106-250MG |
| Cas.: 55304-86-4 | Purity: ≥95% | 2,6-Dibromo-5-chloronicotinic acid | ESD-892107-100MG |
| Cas.: 55304-86-4 | Purity: ≥95% | 2,6-Dibromo-5-chloronicotinic acid | ESD-892107-250MG |
| Cas.: 40106-58-9 | Purity: 97% | 4-Chloro-6,7,8,9-tetrahydro-5H-cyclohepta[4,5]thieno[2,3-d]pyrimidine | ESD-892108-100MG |
| Cas.: 40106-58-9 | Purity: 97% | 4-Chloro-6,7,8,9-tetrahydro-5H-cyclohepta[4,5]thieno[2,3-d]pyrimidine | ESD-892108-250MG |
| Cas.: 40106-58-9 | Purity: 97% | 4-Chloro-6,7,8,9-tetrahydro-5H-cyclohepta[4,5]thieno[2,3-d]pyrimidine | ESD-892108-1G |
| Cas.: 40106-58-9 | Purity: 97% | 4-Chloro-6,7,8,9-tetrahydro-5H-cyclohepta[4,5]thieno[2,3-d]pyrimidine | ESD-892108-5G |
| Cas.: 108985-27-9 | Purity: 95% | 2-Heptyl-3-hydroxyquinolin-4(1H)-one | ESD-892109-100MG |
| Cas.: 108985-27-9 | Purity: 95% | 2-Heptyl-3-hydroxyquinolin-4(1H)-one | ESD-892109-250MG |
| Cas.: 108985-27-9 | Purity: 95% | 2-Heptyl-3-hydroxyquinolin-4(1H)-one | ESD-892109-1G |
| Cas.: 31676-54-7 | Purity: 97% | 3-Amino-5-phenylpyridine | ESD-892110-1G |
| Cas.: 869067-01-6 | Purity: ≥95% | Ethyl 4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazine-6-carboxylate | ESD-892111-100MG |
| Cas.: 869067-01-6 | Purity: ≥95% | Ethyl 4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazine-6-carboxylate | ESD-892111-250MG |
| Cas.: 869067-01-6 | Purity: ≥95% | Ethyl 4-oxo-3,4-dihydropyrrolo[2,1-f][1,2,4]triazine-6-carboxylate | ESD-892111-1G |
| Cas.: 23659-88-3 | Purity: 98% | 4,6-Dimethoxyindolin-2-one | ESD-892112-250MG |
| Cas.: 23659-88-3 | Purity: 98% | 4,6-Dimethoxyindolin-2-one | ESD-892112-1G |
| Cas.: 23659-88-3 | Purity: 98% | 4,6-Dimethoxyindolin-2-one | ESD-892112-5G |
| Cas.: 93302-26-2 | Purity: ≥95% | (2R,3R,4S,5R)-2-(Hydroxymethyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triol | ESD-892113-1G |
| Cas.: 93302-26-2 | Purity: ≥95% | (2R,3R,4S,5R)-2-(Hydroxymethyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triol | ESD-892113-5G |
| Cas.: 93302-26-2 | Purity: ≥95% | (2R,3R,4S,5R)-2-(Hydroxymethyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triol | ESD-892113-10G |
| Cas.: 89781-52-2 | Purity: ≥95% | 8-Oxo-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid | ESD-892114-250MG |
| Cas.: 89781-52-2 | Purity: ≥95% | 8-Oxo-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid | ESD-892114-1G |
| Cas.: 89781-52-2 | Purity: ≥95% | 8-Oxo-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid | ESD-892114-5G |
| Cas.: 1167056-36-1 | Purity: ≥95% | Ethyl 1H-pyrrolo[3,2-c]pyridine-4-carboxylate | ESD-892115-100MG |
| Cas.: 1167056-36-1 | Purity: ≥95% | Ethyl 1H-pyrrolo[3,2-c]pyridine-4-carboxylate | ESD-892115-250MG |
| Cas.: 1167056-36-1 | Purity: ≥95% | Ethyl 1H-pyrrolo[3,2-c]pyridine-4-carboxylate | ESD-892115-1G |
| Cas.: 192189-16-5 | Purity: 97% | tert-Butyl 3-bromo-1H-pyrrolo[3,2-c]pyridine-1-carboxylate | ESD-892116-100MG |
| Cas.: 192189-16-5 | Purity: 97% | tert-Butyl 3-bromo-1H-pyrrolo[3,2-c]pyridine-1-carboxylate | ESD-892116-250MG |
| Cas.: 192189-16-5 | Purity: 97% | tert-Butyl 3-bromo-1H-pyrrolo[3,2-c]pyridine-1-carboxylate | ESD-892116-1G |
| Cas.: 192189-16-5 | Purity: 97% | tert-Butyl 3-bromo-1H-pyrrolo[3,2-c]pyridine-1-carboxylate | ESD-892116-5G |
| Cas.: 90111-72-1 | Purity: ≥95% | 3-Cyclohexyl-1H-1,2,4-triazol-5-amine | ESD-892117-100MG |
| Cas.: 90111-72-1 | Purity: ≥95% | 3-Cyclohexyl-1H-1,2,4-triazol-5-amine | ESD-892117-250MG |
| Cas.: 90111-72-1 | Purity: ≥95% | 3-Cyclohexyl-1H-1,2,4-triazol-5-amine | ESD-892117-1G |
| Cas.: 90111-72-1 | Purity: ≥95% | 3-Cyclohexyl-1H-1,2,4-triazol-5-amine | ESD-892117-5G |
| Cas.: 5599-70-2 | Purity: 97% | 1-Chloro-9H-carbazole | ESD-892118-100MG |
| Cas.: 5599-70-2 | Purity: 97% | 1-Chloro-9H-carbazole | ESD-892118-250MG |
| Cas.: 1722-11-8 | Purity: ≥95% | 3-Chloro-6-(pipidin-1-yl)pyridazine | ESD-892119-250MG |
| Cas.: 1722-11-8 | Purity: ≥95% | 3-Chloro-6-(pipidin-1-yl)pyridazine | ESD-892119-1G |
| Cas.: 1722-11-8 | Purity: ≥95% | 3-Chloro-6-(pipidin-1-yl)pyridazine | ESD-892119-5G |
| Cas.: 1722-11-8 | Purity: ≥95% | 3-Chloro-6-(pipidin-1-yl)pyridazine | ESD-892119-10G |
| Cas.: 414910-15-9 | Purity: ≥95% | tert-Butyl 4-(cyclopropanecarbonyl)piperazine-1-carboxylate | ESD-892120-100MG |
| Cas.: 414910-15-9 | Purity: ≥95% | tert-Butyl 4-(cyclopropanecarbonyl)piperazine-1-carboxylate | ESD-892120-250MG |
| Cas.: 414910-15-9 | Purity: ≥95% | tert-Butyl 4-(cyclopropanecarbonyl)piperazine-1-carboxylate | ESD-892120-1G |
| Cas.: 414910-15-9 | Purity: ≥95% | tert-Butyl 4-(cyclopropanecarbonyl)piperazine-1-carboxylate | ESD-892120-5G |
| Cas.: 1186603-47-3 | Purity: 97% | 5-Chloro-2-(phenylethynyl)benzaldehyde | ESD-892121-100MG |
| Cas.: 1186603-47-3 | Purity: 97% | 5-Chloro-2-(phenylethynyl)benzaldehyde | ESD-892121-250MG |
| Cas.: 1186603-47-3 | Purity: 97% | 5-Chloro-2-(phenylethynyl)benzaldehyde | ESD-892121-1G |
| Cas.: 52851-41-9 | Purity: 97% | Quinoline-2,4(1H,3H)-dione | ESD-892122-5G |
| Cas.: 52851-41-9 | Purity: 97% | Quinoline-2,4(1H,3H)-dione | ESD-892122-10G |
| Cas.: 74209-25-9 | Purity: 97% | 3-Bromo-1-methyl-5-nitro-1H-indazole | ESD-892123-250MG |
| Cas.: 74209-25-9 | Purity: 97% | 3-Bromo-1-methyl-5-nitro-1H-indazole | ESD-892123-1G |
| Cas.: 74209-25-9 | Purity: 97% | 3-Bromo-1-methyl-5-nitro-1H-indazole | ESD-892123-5G |
| Cas.: 1220219-36-2 | Purity: 98% | (1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropyl)methanol | ESD-892124-100MG |
| Cas.: 1220219-36-2 | Purity: 98% | (1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropyl)methanol | ESD-892124-250MG |
| Cas.: 3724-26-3 | Purity: 97% | (1H-Imidazol-2-yl)methanol | ESD-892125-100MG |
| Cas.: 3724-26-3 | Purity: 97% | (1H-Imidazol-2-yl)methanol | ESD-892125-250MG |
| Cas.: 3724-26-3 | Purity: 97% | (1H-Imidazol-2-yl)methanol | ESD-892125-1G |
| Cas.: 3724-26-3 | Purity: 97% | (1H-Imidazol-2-yl)methanol | ESD-892125-5G |
| Cas.: 607-58-9 | Purity: ≥95% | 1-(Benzyloxy)naphthalene | ESD-892126-100MG |
| Cas.: 607-58-9 | Purity: ≥95% | 1-(Benzyloxy)naphthalene | ESD-892126-250MG |
| Cas.: 607-58-9 | Purity: ≥95% | 1-(Benzyloxy)naphthalene | ESD-892126-1G |
| Cas.: 13159-88-1 | Purity: ≥95% | 2-((Thiazol-2-ylamino)methyl)phenol | ESD-892127-100MG |
| Cas.: 13159-88-1 | Purity: ≥95% | 2-((Thiazol-2-ylamino)methyl)phenol | ESD-892127-250MG |
| Cas.: 76842-70-1 | Purity: ≥95% | 7-Hydroxy-5-methoxy-2,3-dihydro-1H-inden-1-one | ESD-892128-100MG |
| Cas.: 76842-70-1 | Purity: ≥95% | 7-Hydroxy-5-methoxy-2,3-dihydro-1H-inden-1-one | ESD-892128-250MG |
| Cas.: 76842-70-1 | Purity: ≥95% | 7-Hydroxy-5-methoxy-2,3-dihydro-1H-inden-1-one | ESD-892128-1G |
| Cas.: 307310-72-1 | Purity: 97% | (S)-2-Amino-3-cyclohexylpropanoic acid hydrate | ESD-892129-250MG |
| Cas.: 307310-72-1 | Purity: 97% | (S)-2-Amino-3-cyclohexylpropanoic acid hydrate | ESD-892129-1G |
| Cas.: 307310-72-1 | Purity: 97% | (S)-2-Amino-3-cyclohexylpropanoic acid hydrate | ESD-892129-5G |
| Cas.: 307310-72-1 | Purity: 97% | (S)-2-Amino-3-cyclohexylpropanoic acid hydrate | ESD-892129-10G |
| Cas.: 108381-28-8 | Purity: 97% | 4-(Benzyloxy)-2-chloropyrimidine | ESD-892130-250MG |
| Cas.: 108381-28-8 | Purity: 97% | 4-(Benzyloxy)-2-chloropyrimidine | ESD-892130-1G |
| Cas.: 108381-28-8 | Purity: 97% | 4-(Benzyloxy)-2-chloropyrimidine | ESD-892130-5G |
| Cas.: 1083168-94-8 | Purity: ≥95% | 2-Methoxy-3-nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-892131-250MG |
| Cas.: 1083168-94-8 | Purity: ≥95% | 2-Methoxy-3-nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-892131-1G |
| Cas.: 1083168-94-8 | Purity: ≥95% | 2-Methoxy-3-nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-892131-5G |
| Cas.: 1123661-15-3 | Purity: ≥95% | 8-(Phenylmethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-8-azabicyclo[3.2.1]oct-2-ene | ESD-892132-100MG |
| Cas.: 1123661-15-3 | Purity: ≥95% | 8-(Phenylmethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-8-azabicyclo[3.2.1]oct-2-ene | ESD-892132-250MG |
| Cas.: 1123661-15-3 | Purity: ≥95% | 8-(Phenylmethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-8-azabicyclo[3.2.1]oct-2-ene | ESD-892132-1G |
| Cas.: 405173-97-9 | Purity: ≥95% | 2-(2-Chloroethyl)-1H-benzo[d]imidazole | ESD-892133-100MG |
| Cas.: 405173-97-9 | Purity: ≥95% | 2-(2-Chloroethyl)-1H-benzo[d]imidazole | ESD-892133-250MG |
| Cas.: 405173-97-9 | Purity: ≥95% | 2-(2-Chloroethyl)-1H-benzo[d]imidazole | ESD-892133-1G |
| Cas.: 64037-16-7 | Purity: 97% | 5-Nitrobenzo[d]oxazol-2-amine | ESD-892134-100MG |
| Cas.: 64037-16-7 | Purity: 97% | 5-Nitrobenzo[d]oxazol-2-amine | ESD-892134-250MG |
| Cas.: 64037-16-7 | Purity: 97% | 5-Nitrobenzo[d]oxazol-2-amine | ESD-892134-1G |
| Cas.: 64037-16-7 | Purity: 97% | 5-Nitrobenzo[d]oxazol-2-amine | ESD-892134-5G |
| Cas.: 914348-82-6 | Purity: 98% | 2-(4-Methoxyphenyl)thiazole-5-carbaldehyde | ESD-892135-100MG |
| Cas.: 914348-82-6 | Purity: 98% | 2-(4-Methoxyphenyl)thiazole-5-carbaldehyde | ESD-892135-250MG |
| Cas.: 914348-82-6 | Purity: 98% | 2-(4-Methoxyphenyl)thiazole-5-carbaldehyde | ESD-892135-1G |
| Cas.: 914348-82-6 | Purity: 98% | 2-(4-Methoxyphenyl)thiazole-5-carbaldehyde | ESD-892135-5G |
| Cas.: 57982-78-2 | Purity: 95% | Budipine | ESD-892136-5MG |
| Cas.: 57982-78-2 | Purity: 95% | Budipine | ESD-892136-25MG |
| Cas.: 57982-78-2 | Purity: 95% | Budipine | ESD-892136-100MG |
| Cas.: 276694-19-0 | Purity: ≥95% | 2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1,3,4-oxadiazole | ESD-892137-100MG |
| Cas.: 276694-19-0 | Purity: ≥95% | 2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1,3,4-oxadiazole | ESD-892137-250MG |
| Cas.: 64835-30-9 | Purity: ≥95% | 3-Chloro-4-nitrobenzene-1-sulfonyl chloride | ESD-892138-100MG |
| Cas.: 64835-30-9 | Purity: ≥95% | 3-Chloro-4-nitrobenzene-1-sulfonyl chloride | ESD-892138-250MG |
| Cas.: 64835-30-9 | Purity: ≥95% | 3-Chloro-4-nitrobenzene-1-sulfonyl chloride | ESD-892138-1G |
| Cas.: 64835-30-9 | Purity: ≥95% | 3-Chloro-4-nitrobenzene-1-sulfonyl chloride | ESD-892138-5G |
| Cas.: 1602859-53-9 | Purity: 97% | 4-Chloro-7-fluoro-3-iodo-6-methoxyquinoline | ESD-892139-100MG |
| Cas.: 1602859-53-9 | Purity: 97% | 4-Chloro-7-fluoro-3-iodo-6-methoxyquinoline | ESD-892139-250MG |
| Cas.: 1602859-53-9 | Purity: 97% | 4-Chloro-7-fluoro-3-iodo-6-methoxyquinoline | ESD-892139-1G |
| Cas.: 943735-44-2 | Purity: ≥95% | 2,5-Dibromothiazole-4-carboxylic acid | ESD-892140-100MG |
| Cas.: 943735-44-2 | Purity: ≥95% | 2,5-Dibromothiazole-4-carboxylic acid | ESD-892140-250MG |
| Cas.: 943735-44-2 | Purity: ≥95% | 2,5-Dibromothiazole-4-carboxylic acid | ESD-892140-1G |
| Cas.: 943735-44-2 | Purity: ≥95% | 2,5-Dibromothiazole-4-carboxylic acid | ESD-892140-5G |
| Cas.: 84311-19-3 | Purity: ≥95% | (S)-2-((tert-Butoxycarbonyl)amino)-3-hydroxy-2-methylpropanoic acid | ESD-892141-100MG |
| Cas.: 84311-19-3 | Purity: ≥95% | (S)-2-((tert-Butoxycarbonyl)amino)-3-hydroxy-2-methylpropanoic acid | ESD-892141-250MG |
| Cas.: 84311-19-3 | Purity: ≥95% | (S)-2-((tert-Butoxycarbonyl)amino)-3-hydroxy-2-methylpropanoic acid | ESD-892141-1G |
| Cas.: 2540-30-9 | Purity: ≥95% | 4-Methyl-1-phenylquinolin-2(1H)-one | ESD-892142-100MG |
| Cas.: 2540-30-9 | Purity: ≥95% | 4-Methyl-1-phenylquinolin-2(1H)-one | ESD-892142-250MG |
| Cas.: 2540-30-9 | Purity: ≥95% | 4-Methyl-1-phenylquinolin-2(1H)-one | ESD-892142-1G |
| Cas.: 6242-98-4 | Purity: ≥95% | 4-Bromo-4′-nitro-1,1′-biphenyl | ESD-892143-100MG |
| Cas.: 6242-98-4 | Purity: ≥95% | 4-Bromo-4′-nitro-1,1′-biphenyl | ESD-892143-250MG |
| Cas.: 6242-98-4 | Purity: ≥95% | 4-Bromo-4′-nitro-1,1′-biphenyl | ESD-892143-1G |
| Cas.: 6242-98-4 | Purity: ≥95% | 4-Bromo-4′-nitro-1,1′-biphenyl | ESD-892143-5G |
| Cas.: 7396-44-3 | Purity: 95% | Benzyl 2-(diethoxyphosphoryl)acetate | ESD-892144-250MG |
| Cas.: 7396-44-3 | Purity: 95% | Benzyl 2-(diethoxyphosphoryl)acetate | ESD-892144-1G |
| Cas.: 7396-44-3 | Purity: 95% | Benzyl 2-(diethoxyphosphoryl)acetate | ESD-892144-5G |
| Cas.: 7396-44-3 | Purity: 95% | Benzyl 2-(diethoxyphosphoryl)acetate | ESD-892144-10G |
| Cas.: 1322091-22-4 | Purity: 97% | 4-Fluoro-2-(p-tolylethynyl)benzaldehyde | ESD-892145-250MG |
| Cas.: 1322091-22-4 | Purity: 97% | 4-Fluoro-2-(p-tolylethynyl)benzaldehyde | ESD-892145-1G |
| Cas.: 59803-35-9 | Purity: 96% | Diethyl 2-(2-nitrobenzyl)malonate | ESD-892146-100MG |
| Cas.: 59803-35-9 | Purity: 96% | Diethyl 2-(2-nitrobenzyl)malonate | ESD-892146-250MG |
| Cas.: 23099-72-1 | Purity: ≥95% | 4-Phenethylpiperazin-2-one | ESD-892147-100MG |
| Cas.: 23099-72-1 | Purity: ≥95% | 4-Phenethylpiperazin-2-one | ESD-892147-250MG |
| Cas.: 4815-29-6 | Purity: 96% | Ethyl 2-amino-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylate | ESD-892148-250MG |
| Cas.: 4815-29-6 | Purity: 96% | Ethyl 2-amino-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylate | ESD-892148-1G |
| Cas.: 4815-29-6 | Purity: 96% | Ethyl 2-amino-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylate | ESD-892148-5G |
| Cas.: 4815-29-6 | Purity: 96% | Ethyl 2-amino-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylate | ESD-892148-10G |
| Cas.: 917081-58-4 | Purity: 95% | Di-tert-butyl 5-methyl-2,4-dioxopyrimidine-1,3(2H,4H)-dicarboxylate | ESD-892149-250MG |
| Cas.: 917081-58-4 | Purity: 95% | Di-tert-butyl 5-methyl-2,4-dioxopyrimidine-1,3(2H,4H)-dicarboxylate | ESD-892149-1G |
| Cas.: 917081-58-4 | Purity: 95% | Di-tert-butyl 5-methyl-2,4-dioxopyrimidine-1,3(2H,4H)-dicarboxylate | ESD-892149-5G |
| Cas.: 126501-70-0 | Purity: 97% | 1-(2,2,2-Trifluoroacetyl)piperidine-4-carboxylic acid | ESD-892150-100MG |
| Cas.: 126501-70-0 | Purity: 97% | 1-(2,2,2-Trifluoroacetyl)piperidine-4-carboxylic acid | ESD-892150-250MG |
| Cas.: 126501-70-0 | Purity: 97% | 1-(2,2,2-Trifluoroacetyl)piperidine-4-carboxylic acid | ESD-892150-1G |
| Cas.: 126501-70-0 | Purity: 97% | 1-(2,2,2-Trifluoroacetyl)piperidine-4-carboxylic acid | ESD-892150-5G |
| Cas.: 1190322-13-4 | Purity: ≥95% | 4,6-Dichloro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | ESD-892151-100MG |
| Cas.: 1190322-13-4 | Purity: ≥95% | 4,6-Dichloro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | ESD-892151-250MG |
| Cas.: 1190322-13-4 | Purity: ≥95% | 4,6-Dichloro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | ESD-892151-1G |
| Cas.: 1190322-13-4 | Purity: ≥95% | 4,6-Dichloro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one | ESD-892151-5G |
| Cas.: 618070-65-8 | Purity: ≥95% | Ethyl 5-amino-1-(2-fluorophenyl)-1H-pyrazole-4-carboxylate | ESD-892152-100MG |
| Cas.: 618070-65-8 | Purity: ≥95% | Ethyl 5-amino-1-(2-fluorophenyl)-1H-pyrazole-4-carboxylate | ESD-892152-250MG |
| Cas.: 618070-65-8 | Purity: ≥95% | Ethyl 5-amino-1-(2-fluorophenyl)-1H-pyrazole-4-carboxylate | ESD-892152-1G |
| Cas.: 618070-65-8 | Purity: ≥95% | Ethyl 5-amino-1-(2-fluorophenyl)-1H-pyrazole-4-carboxylate | ESD-892152-5G |
| Cas.: 5434-06-0 | Purity: 98% | 4-Methanesulfonylbenzamidine hydrochloride | ESD-892153-250MG |
| Cas.: 5434-06-0 | Purity: 98% | 4-Methanesulfonylbenzamidine hydrochloride | ESD-892153-1G |
| Cas.: 943757-74-2 | Purity: ≥95% | 2-(4-Methylpiperazin-1-yl)pyrimidin-5-amine | ESD-892154-100MG |
| Cas.: 943757-74-2 | Purity: ≥95% | 2-(4-Methylpiperazin-1-yl)pyrimidin-5-amine | ESD-892154-250MG |
| Cas.: 943757-74-2 | Purity: ≥95% | 2-(4-Methylpiperazin-1-yl)pyrimidin-5-amine | ESD-892154-1G |
| Cas.: 103909-86-0 | Purity: 97% | (E)-Cinnamyl 3-aminobut-2-enoate | ESD-892155-1G |
| Cas.: 103909-86-0 | Purity: 97% | (E)-Cinnamyl 3-aminobut-2-enoate | ESD-892155-5G |
| Cas.: 103909-86-0 | Purity: 97% | (E)-Cinnamyl 3-aminobut-2-enoate | ESD-892155-10G |
| Cas.: 1735-13-3 | Purity: ≥95% | 4-Methylbenzo[b]thiophene-2-carboxylic acid | ESD-892156-100MG |
| Cas.: 1735-13-3 | Purity: ≥95% | 4-Methylbenzo[b]thiophene-2-carboxylic acid | ESD-892156-250MG |
| Cas.: 874766-81-1 | Purity: 97% | 4-(3-Bromophenyl)pyrimidine-2(1H)-thione | ESD-892157-100MG |
| Cas.: 874766-81-1 | Purity: 97% | 4-(3-Bromophenyl)pyrimidine-2(1H)-thione | ESD-892157-250MG |
| Cas.: 4589-66-6 | Purity: 98% | (1,2-Dimethyl-1H-benzo[d]imidazol-5-yl)methanol | ESD-892158-100MG |
| Cas.: 4589-66-6 | Purity: 98% | (1,2-Dimethyl-1H-benzo[d]imidazol-5-yl)methanol | ESD-892158-250MG |
| Cas.: 32203-24-0 | Purity: ≥95% | Ethyl 2-amino-5-nitrobenzoate | ESD-892159-100MG |
| Cas.: 32203-24-0 | Purity: ≥95% | Ethyl 2-amino-5-nitrobenzoate | ESD-892159-250MG |
| Cas.: 32203-24-0 | Purity: ≥95% | Ethyl 2-amino-5-nitrobenzoate | ESD-892159-1G |
| Cas.: 93679-99-3 | Purity: 97% | 3-Aminoisoindolin-1-one | ESD-892160-100MG |
| Cas.: 93679-99-3 | Purity: 97% | 3-Aminoisoindolin-1-one | ESD-892160-250MG |
| Cas.: 93679-99-3 | Purity: 97% | 3-Aminoisoindolin-1-one | ESD-892160-1G |
| Cas.: 197507-59-8 | Purity: 97% | 1,6-Naphthyridine-2-carboxylic acid | ESD-892161-100MG |
| Cas.: 197507-59-8 | Purity: 97% | 1,6-Naphthyridine-2-carboxylic acid | ESD-892161-250MG |
| Cas.: 197507-59-8 | Purity: 97% | 1,6-Naphthyridine-2-carboxylic acid | ESD-892161-1G |
| Cas.: 197507-59-8 | Purity: 97% | 1,6-Naphthyridine-2-carboxylic acid | ESD-892161-5G |
| Cas.: 84-64-0 | Purity: 97% | Butyl cyclohexyl phthalate | ESD-892162-100MG |
| Cas.: 84-64-0 | Purity: 97% | Butyl cyclohexyl phthalate | ESD-892162-250MG |
| Cas.: 84-64-0 | Purity: 97% | Butyl cyclohexyl phthalate | ESD-892162-1G |
| Cas.: 150812-32-1 | Purity: ≥95% | 2-Amino-4-bromo-5-chlorobenzoic acid | ESD-892163-250MG |
| Cas.: 150812-32-1 | Purity: ≥95% | 2-Amino-4-bromo-5-chlorobenzoic acid | ESD-892163-1G |
| Cas.: 150812-32-1 | Purity: ≥95% | 2-Amino-4-bromo-5-chlorobenzoic acid | ESD-892163-5G |
| Cas.: 150812-32-1 | Purity: ≥95% | 2-Amino-4-bromo-5-chlorobenzoic acid | ESD-892163-10G |
| Cas.: 78637-85-1 | Purity: ≥95% | 3,4-Diaminothiophene | ESD-892164-100MG |
| Cas.: 78637-85-1 | Purity: ≥95% | 3,4-Diaminothiophene | ESD-892164-250MG |
| Cas.: 78637-85-1 | Purity: ≥95% | 3,4-Diaminothiophene | ESD-892164-1G |
| Cas.: 127915-50-8 | Purity: ≥95% | 4-Amino-6-methylnicotinic acid | ESD-892165-1G |
| Cas.: 127915-50-8 | Purity: ≥95% | 4-Amino-6-methylnicotinic acid | ESD-892165-5G |
| Cas.: 127915-50-8 | Purity: ≥95% | 4-Amino-6-methylnicotinic acid | ESD-892165-10G |
| Cas.: 87932-50-1 | Purity: ≥95% | 2-Chloro-3,4-dihydroxybenzoic acid | ESD-892166-100MG |
| Cas.: 87932-50-1 | Purity: ≥95% | 2-Chloro-3,4-dihydroxybenzoic acid | ESD-892166-250MG |
| Cas.: 87932-50-1 | Purity: ≥95% | 2-Chloro-3,4-dihydroxybenzoic acid | ESD-892166-1G |
| Cas.: 87932-50-1 | Purity: ≥95% | 2-Chloro-3,4-dihydroxybenzoic acid | ESD-892166-5G |
| Cas.: 35975-57-6 | Purity: 97% | Ethyl 8-bromo-4-hydroxyquinoline-3-carboxylate | ESD-892167-100MG |
| Cas.: 35975-57-6 | Purity: 97% | Ethyl 8-bromo-4-hydroxyquinoline-3-carboxylate | ESD-892167-250MG |
| Cas.: 35975-57-6 | Purity: 97% | Ethyl 8-bromo-4-hydroxyquinoline-3-carboxylate | ESD-892167-1G |
| Cas.: 25391-59-7 | Purity: 97% | 5-Iodo-3-nitropyridin-2-ol | ESD-892168-100MG |
| Cas.: 25391-59-7 | Purity: 97% | 5-Iodo-3-nitropyridin-2-ol | ESD-892168-250MG |
| Cas.: 25391-59-7 | Purity: 97% | 5-Iodo-3-nitropyridin-2-ol | ESD-892168-1G |
| Cas.: 25391-59-7 | Purity: 97% | 5-Iodo-3-nitropyridin-2-ol | ESD-892168-5G |
| Cas.: 21419-48-7 | Purity: 98% | 6-Bromoquinazolin-4-amine | ESD-892169-250MG |
| Cas.: 21419-48-7 | Purity: 98% | 6-Bromoquinazolin-4-amine | ESD-892169-1G |
| Cas.: 21419-48-7 | Purity: 98% | 6-Bromoquinazolin-4-amine | ESD-892169-5G |
| Cas.: 21419-48-7 | Purity: 98% | 6-Bromoquinazolin-4-amine | ESD-892169-10G |
| Cas.: 19883-75-1 | Purity: ≥95% | (S)-2-Amino-3-(2-nitrophenyl)propanoic acid | ESD-892170-1G |
| Cas.: 1201784-87-3 | Purity: 97% | 5-Bromoquinazolin-4-amine | ESD-892171-100MG |
| Cas.: 1201784-87-3 | Purity: 97% | 5-Bromoquinazolin-4-amine | ESD-892171-250MG |
| Cas.: 89524-99-2 | Purity: 97% | Methyl 2-acetamido-2-(dimethoxyphosphoryl)acetate | ESD-892172-250MG |
| Cas.: 89524-99-2 | Purity: 97% | Methyl 2-acetamido-2-(dimethoxyphosphoryl)acetate | ESD-892172-1G |
| Cas.: 89524-99-2 | Purity: 97% | Methyl 2-acetamido-2-(dimethoxyphosphoryl)acetate | ESD-892172-5G |
| Cas.: 89524-99-2 | Purity: 97% | Methyl 2-acetamido-2-(dimethoxyphosphoryl)acetate | ESD-892172-10G |
| Cas.: 129487-92-9 | Purity: ≥95% | tert-Butyl 5-aminoindoline-1-carboxylate | ESD-892173-100MG |
| Cas.: 129487-92-9 | Purity: ≥95% | tert-Butyl 5-aminoindoline-1-carboxylate | ESD-892173-250MG |
| Cas.: 129487-92-9 | Purity: ≥95% | tert-Butyl 5-aminoindoline-1-carboxylate | ESD-892173-1G |
| Cas.: 129487-92-9 | Purity: ≥95% | tert-Butyl 5-aminoindoline-1-carboxylate | ESD-892173-5G |
| Cas.: 1255208-34-4 | Purity: 95% | 5-Bromo-7-fluoroisobenzofuran-1(3H)-one | ESD-892174-100MG |
| Cas.: 1255208-34-4 | Purity: 95% | 5-Bromo-7-fluoroisobenzofuran-1(3H)-one | ESD-892174-250MG |
| Cas.: 1415960-54-1 | Purity: 97% | Methyl 2-(2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate | ESD-892175-100MG |
| Cas.: 1415960-54-1 | Purity: 97% | Methyl 2-(2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate | ESD-892175-250MG |
| Cas.: 1415960-54-1 | Purity: 97% | Methyl 2-(2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate | ESD-892175-1G |
| Cas.: 1246633-53-3 | Purity: 97% | (5-Fluoro-2-(hydroxymethyl)phenyl)boronic acid | ESD-892176-250MG |
| Cas.: 1246633-53-3 | Purity: 97% | (5-Fluoro-2-(hydroxymethyl)phenyl)boronic acid | ESD-892176-1G |
| Cas.: 1246633-53-3 | Purity: 97% | (5-Fluoro-2-(hydroxymethyl)phenyl)boronic acid | ESD-892176-5G |
| Cas.: 1246633-53-3 | Purity: 97% | (5-Fluoro-2-(hydroxymethyl)phenyl)boronic acid | ESD-892176-10G |
| Cas.: 1256359-09-7 | Purity: 97% | 1-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole | ESD-892177-100MG |
| Cas.: 1256359-09-7 | Purity: 97% | 1-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole | ESD-892177-250MG |
| Cas.: 1256359-09-7 | Purity: 97% | 1-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole | ESD-892177-1G |
| Cas.: 63914-81-8 | Purity: 90% | 2-(Chlorosulfonyl)benzoic acid | ESD-892179-100MG |
| Cas.: 63914-81-8 | Purity: 90% | 2-(Chlorosulfonyl)benzoic acid | ESD-892179-250MG |
| Cas.: 26218-04-2 | Purity: 97% | 2-Ethylhexyl 4-aminobenzoate | ESD-892180-250MG |
| Cas.: 26218-04-2 | Purity: 97% | 2-Ethylhexyl 4-aminobenzoate | ESD-892180-1G |
| Cas.: 26218-04-2 | Purity: 97% | 2-Ethylhexyl 4-aminobenzoate | ESD-892180-5G |
| Cas.: 26218-04-2 | Purity: 97% | 2-Ethylhexyl 4-aminobenzoate | ESD-892180-10G |
| Cas.: 7470-50-0 | Purity: 97% | N-(3-Nitrophenyl)propionamide | ESD-892181-250MG |
| Cas.: 7470-50-0 | Purity: 97% | N-(3-Nitrophenyl)propionamide | ESD-892181-1G |
| Cas.: 7470-50-0 | Purity: 97% | N-(3-Nitrophenyl)propionamide | ESD-892181-5G |
| Cas.: 7470-50-0 | Purity: 97% | N-(3-Nitrophenyl)propionamide | ESD-892181-10G |
| Cas.: 220131-57-7 | Purity: ≥95% | Methyl 5-amino-4-cyano-1H-pyrazole-1-carboxylate | ESD-892182-100MG |
| Cas.: 220131-57-7 | Purity: ≥95% | Methyl 5-amino-4-cyano-1H-pyrazole-1-carboxylate | ESD-892182-250MG |
| Cas.: 220131-57-7 | Purity: ≥95% | Methyl 5-amino-4-cyano-1H-pyrazole-1-carboxylate | ESD-892182-1G |
| Cas.: 100858-34-2 | Purity: 97% | (R)-Benzyl 3-hydroxypiperidine-1-carboxylate | ESD-892183-100MG |
| Cas.: 100858-34-2 | Purity: 97% | (R)-Benzyl 3-hydroxypiperidine-1-carboxylate | ESD-892183-250MG |
| Cas.: 100858-34-2 | Purity: 97% | (R)-Benzyl 3-hydroxypiperidine-1-carboxylate | ESD-892183-1G |
| Cas.: 100858-34-2 | Purity: 97% | (R)-Benzyl 3-hydroxypiperidine-1-carboxylate | ESD-892183-5G |
| Cas.: 163395-24-2 | Purity: ≥95% | 2-(3-Fluoro-4-nitrophenyl)acetic acid | ESD-892184-100MG |
| Cas.: 163395-24-2 | Purity: ≥95% | 2-(3-Fluoro-4-nitrophenyl)acetic acid | ESD-892184-250MG |
| Cas.: 163395-24-2 | Purity: ≥95% | 2-(3-Fluoro-4-nitrophenyl)acetic acid | ESD-892184-1G |
| Cas.: 79173-38-9 | Purity: 97% | 6-Methyl-1H-pyrazolo[3,4-b]pyridin-3-amine | ESD-892185-250MG |
| Cas.: 79173-38-9 | Purity: 97% | 6-Methyl-1H-pyrazolo[3,4-b]pyridin-3-amine | ESD-892185-1G |
| Cas.: 79173-38-9 | Purity: 97% | 6-Methyl-1H-pyrazolo[3,4-b]pyridin-3-amine | ESD-892185-5G |
| Cas.: 79173-38-9 | Purity: 97% | 6-Methyl-1H-pyrazolo[3,4-b]pyridin-3-amine | ESD-892185-10G |
| Cas.: 380629-73-2 | Purity: ≥95% | tert-Butyl (5-aminobenzo[d]isoxazol-3-yl)carbamate | ESD-892186-1G |
| Cas.: 1339890-99-1 | Purity: ≥95% | 1-(Oxetan-3-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-892187-100MG |
| Cas.: 1339890-99-1 | Purity: ≥95% | 1-(Oxetan-3-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-892187-250MG |
| Cas.: 1339890-99-1 | Purity: ≥95% | 1-(Oxetan-3-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-892187-1G |
| Cas.: 1339890-99-1 | Purity: ≥95% | 1-(Oxetan-3-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ESD-892187-5G |
| Cas.: 6425-66-7 | Purity: 97% | 1,2-Bis(bromomethyl)-4-nitrobenzene | ESD-892188-100MG |
| Cas.: 6425-66-7 | Purity: 97% | 1,2-Bis(bromomethyl)-4-nitrobenzene | ESD-892188-250MG |
| Cas.: 6425-66-7 | Purity: 97% | 1,2-Bis(bromomethyl)-4-nitrobenzene | ESD-892188-1G |
| Cas.: 6425-66-7 | Purity: 97% | 1,2-Bis(bromomethyl)-4-nitrobenzene | ESD-892188-5G |
| Cas.: 50477-28-6 | Purity: ≥95% | 5,7-Dibromo-1H-indazole | ESD-892189-100MG |
| Cas.: 50477-28-6 | Purity: ≥95% | 5,7-Dibromo-1H-indazole | ESD-892189-250MG |
| Cas.: 50477-28-6 | Purity: ≥95% | 5,7-Dibromo-1H-indazole | ESD-892189-1G |
| Cas.: 447430-07-1 | Purity: ≥95% | 4,6-Dibromo-1H-indazole | ESD-892190-100MG |
| Cas.: 447430-07-1 | Purity: ≥95% | 4,6-Dibromo-1H-indazole | ESD-892190-250MG |
| Cas.: 787544-61-0 | Purity: 97% | (R)-3-Amino-3-(3-nitrophenyl)propionic acid | ESD-892191-250MG |
| Cas.: 787544-61-0 | Purity: 97% | (R)-3-Amino-3-(3-nitrophenyl)propionic acid | ESD-892191-1G |
| Cas.: 787544-61-0 | Purity: 97% | (R)-3-Amino-3-(3-nitrophenyl)propionic acid | ESD-892191-5G |
| Cas.: 787544-61-0 | Purity: 97% | (R)-3-Amino-3-(3-nitrophenyl)propionic acid | ESD-892191-10G |
| Cas.: 734529-57-8 | Purity: 97% | (S)-3-Amino-3-(3-nitrophenyl)propanoic acid | ESD-892192-250MG |
| Cas.: 734529-57-8 | Purity: 97% | (S)-3-Amino-3-(3-nitrophenyl)propanoic acid | ESD-892192-1G |
| Cas.: 734529-57-8 | Purity: 97% | (S)-3-Amino-3-(3-nitrophenyl)propanoic acid | ESD-892192-5G |
| Cas.: 734529-57-8 | Purity: 97% | (S)-3-Amino-3-(3-nitrophenyl)propanoic acid | ESD-892192-10G |
| Cas.: 435275-28-8 | Purity: ≥95% | (R)-Benzyl 3-formylpiperidine-1-carboxylate | ESD-892193-100MG |
| Cas.: 435275-28-8 | Purity: ≥95% | (R)-Benzyl 3-formylpiperidine-1-carboxylate | ESD-892193-250MG |
| Cas.: 405063-39-0 | Purity: ≥95% | (S)-Benzyl 3-formylpiperidine-1-carboxylate | ESD-892194-100MG |
| Cas.: 405063-39-0 | Purity: ≥95% | (S)-Benzyl 3-formylpiperidine-1-carboxylate | ESD-892194-250MG |
| Cas.: 52334-38-0 | Purity: 97% | 2-Phenylthiazolo[5,4-c]pyridine | ESD-892195-100MG |
| Cas.: 52334-38-0 | Purity: 97% | 2-Phenylthiazolo[5,4-c]pyridine | ESD-892195-250MG |
| Cas.: 775305-12-9 | Purity: ≥95% | 1-Boc-3-Bromo-2-methylindole | ESD-892196-100MG |
| Cas.: 775305-12-9 | Purity: ≥95% | 1-Boc-3-Bromo-2-methylindole | ESD-892196-250MG |
| Cas.: 775305-12-9 | Purity: ≥95% | 1-Boc-3-Bromo-2-methylindole | ESD-892196-1G |
| Cas.: 775305-12-9 | Purity: ≥95% | 1-Boc-3-Bromo-2-methylindole | ESD-892196-5G |
| Cas.: 50899-03-1 | Purity: 97% | 4-(Ethylsulfonyl)benzaldehyde | ESD-892197-250MG |
| Cas.: 50899-03-1 | Purity: 97% | 4-(Ethylsulfonyl)benzaldehyde | ESD-892197-1G |
| Cas.: 50899-03-1 | Purity: 97% | 4-(Ethylsulfonyl)benzaldehyde | ESD-892197-5G |
| Cas.: 50899-03-1 | Purity: 97% | 4-(Ethylsulfonyl)benzaldehyde | ESD-892197-10G |
| Cas.: 1211536-93-4 | Purity: ≥95% | 6-Bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine | ESD-892198-100MG |
| Cas.: 1211536-93-4 | Purity: ≥95% | 6-Bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine | ESD-892198-250MG |
| Cas.: 1211536-93-4 | Purity: ≥95% | 6-Bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine | ESD-892198-1G |
| Cas.: 1032650-41-1 | Purity: 97% | 7-Bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine | ESD-892199-250MG |
| Cas.: 1032650-41-1 | Purity: 97% | 7-Bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine | ESD-892199-1G |
| Cas.: 1032650-41-1 | Purity: 97% | 7-Bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine | ESD-892199-5G |
| Cas.: 43050-39-1 | Purity: ≥95% | 1-(3-Methoxyphenyl)cyclopentanecarboxylic acid | ESD-892200-100MG |
| Cas.: 43050-39-1 | Purity: ≥95% | 1-(3-Methoxyphenyl)cyclopentanecarboxylic acid | ESD-892200-250MG |
| Cas.: 43050-39-1 | Purity: ≥95% | 1-(3-Methoxyphenyl)cyclopentanecarboxylic acid | ESD-892200-1G |
| Cas.: 4344-84-7 | Purity: ≥95% | 5-Oxotetrahydrofuran-2-carboxylic acid | ESD-892201-250MG |
| Cas.: 4344-84-7 | Purity: ≥95% | 5-Oxotetrahydrofuran-2-carboxylic acid | ESD-892201-1G |
| Cas.: 4344-84-7 | Purity: ≥95% | 5-Oxotetrahydrofuran-2-carboxylic acid | ESD-892201-5G |
| Cas.: 4344-84-7 | Purity: ≥95% | 5-Oxotetrahydrofuran-2-carboxylic acid | ESD-892201-10G |
| Cas.: 38692-72-7 | Purity: 97% | 2-(5-Bromo-2-hydroxyphenyl)acetic acid | ESD-892202-250MG |
| Cas.: 38692-72-7 | Purity: 97% | 2-(5-Bromo-2-hydroxyphenyl)acetic acid | ESD-892202-1G |
| Cas.: 38692-72-7 | Purity: 97% | 2-(5-Bromo-2-hydroxyphenyl)acetic acid | ESD-892202-5G |
| Cas.: 38692-72-7 | Purity: 97% | 2-(5-Bromo-2-hydroxyphenyl)acetic acid | ESD-892202-10G |
| Cas.: 957065-99-5 | Purity: 97% | Methyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinate | ESD-892203-100MG |
| Cas.: 957065-99-5 | Purity: 97% | Methyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinate | ESD-892203-250MG |
| Cas.: 957065-99-5 | Purity: 97% | Methyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinate | ESD-892203-1G |
| Cas.: 957065-99-5 | Purity: 97% | Methyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinate | ESD-892203-5G |
| Cas.: 847818-72-8 | Purity: 97% | N,N-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-propanamine | ESD-892204-100MG |
| Cas.: 847818-72-8 | Purity: 97% | N,N-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-propanamine | ESD-892204-250MG |
| Cas.: 847818-72-8 | Purity: 97% | N,N-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-propanamine | ESD-892204-1G |
| Cas.: 199872-29-2 | Purity: ≥95% | 8-Methoxy-2-(trifluoromethyl)quinoline-5-carboxylic acid | ESD-892205-100MG |
| Cas.: 199872-29-2 | Purity: ≥95% | 8-Methoxy-2-(trifluoromethyl)quinoline-5-carboxylic acid | ESD-892205-250MG |
| Cas.: 1395417-57-8 | Purity: ≥95% | Oxetan-3-ylmethyl 4-methylbenzenesulfonate | ESD-892206-100MG |
| Cas.: 1395417-57-8 | Purity: ≥95% | Oxetan-3-ylmethyl 4-methylbenzenesulfonate | ESD-892206-250MG |
| Cas.: 1395417-57-8 | Purity: ≥95% | Oxetan-3-ylmethyl 4-methylbenzenesulfonate | ESD-892206-1G |
| Cas.: 915107-30-1 | Purity: ≥95% | Methyl 6-chloro-5-hydroxynicotinate | ESD-892207-100MG |
| Cas.: 915107-30-1 | Purity: ≥95% | Methyl 6-chloro-5-hydroxynicotinate | ESD-892207-250MG |
| Cas.: 915107-30-1 | Purity: ≥95% | Methyl 6-chloro-5-hydroxynicotinate | ESD-892207-1G |
| Cas.: 65461-91-8 | Purity: ≥95% | 3,3′-Azanediyldiphenol | ESD-892208-100MG |
| Cas.: 65461-91-8 | Purity: ≥95% | 3,3′-Azanediyldiphenol | ESD-892208-250MG |
| Cas.: 65461-91-8 | Purity: ≥95% | 3,3′-Azanediyldiphenol | ESD-892208-1G |
| Cas.: 65461-91-8 | Purity: ≥95% | 3,3′-Azanediyldiphenol | ESD-892208-5G |
| Cas.: 30235-26-8 | Purity: 97% | 4-(Pyridin-2-yl)thiazol-2-amine | ESD-892209-100MG |
| Cas.: 30235-26-8 | Purity: 97% | 4-(Pyridin-2-yl)thiazol-2-amine | ESD-892209-250MG |
| Cas.: 30235-26-8 | Purity: 97% | 4-(Pyridin-2-yl)thiazol-2-amine | ESD-892209-1G |
| Cas.: 30235-26-8 | Purity: 97% | 4-(Pyridin-2-yl)thiazol-2-amine | ESD-892209-5G |
| Cas.: 514854-12-7 | Purity: 97% | 6-Ethylpyrimidine-2,4-diamine | ESD-892210-250MG |
| Cas.: 514854-12-7 | Purity: 97% | 6-Ethylpyrimidine-2,4-diamine | ESD-892210-1G |
| Cas.: 514854-12-7 | Purity: 97% | 6-Ethylpyrimidine-2,4-diamine | ESD-892210-5G |
| Cas.: 514854-12-7 | Purity: 97% | 6-Ethylpyrimidine-2,4-diamine | ESD-892210-10G |
| Cas.: 32275-62-0 | Purity: 97% | 2-Ethyl-4,5,6,7-tetrahydro-2H-indazole-3-carboxylic acid | ESD-892211-100MG |
| Cas.: 32275-62-0 | Purity: 97% | 2-Ethyl-4,5,6,7-tetrahydro-2H-indazole-3-carboxylic acid | ESD-892211-250MG |
| Cas.: 7709-13-9 | Purity: 95% | 4-Chloro-1,3,5-triazin-2-amine | ESD-892212-100MG |
| Cas.: 7709-13-9 | Purity: 95% | 4-Chloro-1,3,5-triazin-2-amine | ESD-892212-250MG |
| Cas.: 7709-13-9 | Purity: 95% | 4-Chloro-1,3,5-triazin-2-amine | ESD-892212-1G |
| Cas.: 7709-13-9 | Purity: 95% | 4-Chloro-1,3,5-triazin-2-amine | ESD-892212-5G |
| Cas.: 116332-64-0 | Purity: 95% | 4-Cyano-N-methoxy-N-methylbenzamide | ESD-892213-250MG |
| Cas.: 116332-64-0 | Purity: 95% | 4-Cyano-N-methoxy-N-methylbenzamide | ESD-892213-1G |
| Cas.: 116332-64-0 | Purity: 95% | 4-Cyano-N-methoxy-N-methylbenzamide | ESD-892213-5G |
| Cas.: 148366-28-3 | Purity: ≥95% | 2-(5-Bromo-1H-indol-1-yl)ethanol | ESD-892214-250MG |
| Cas.: 148366-28-3 | Purity: ≥95% | 2-(5-Bromo-1H-indol-1-yl)ethanol | ESD-892214-1G |
| Cas.: 2598-30-3 | Purity: ≥95% | 8-Hydroxyquinoline-5-carbaldehyde | ESD-892215-100MG |
| Cas.: 2598-30-3 | Purity: ≥95% | 8-Hydroxyquinoline-5-carbaldehyde | ESD-892215-250MG |
| Cas.: 2598-30-3 | Purity: ≥95% | 8-Hydroxyquinoline-5-carbaldehyde | ESD-892215-1G |
| Cas.: 2598-30-3 | Purity: ≥95% | 8-Hydroxyquinoline-5-carbaldehyde | ESD-892215-5G |
| Cas.: 3547-07-7 | Purity: ≥95% | 4-(4-Chlorophenoxy)butanoic acid | ESD-892216-250MG |
| Cas.: 3547-07-7 | Purity: ≥95% | 4-(4-Chlorophenoxy)butanoic acid | ESD-892216-1G |
| Cas.: 3547-07-7 | Purity: ≥95% | 4-(4-Chlorophenoxy)butanoic acid | ESD-892216-5G |
| Cas.: 3547-07-7 | Purity: ≥95% | 4-(4-Chlorophenoxy)butanoic acid | ESD-892216-10G |
| Cas.: 1352394-18-3 | Purity: ≥95% | Methyl 1H-pyrrolo[3,2-c]pyridine-6-carboxylate | ESD-892217-250MG |
| Cas.: 1352394-18-3 | Purity: ≥95% | Methyl 1H-pyrrolo[3,2-c]pyridine-6-carboxylate | ESD-892217-1G |
| Cas.: 1060808-94-7 | Purity: 97% | 6-Amino-4-chloronicotinic acid | ESD-892218-100MG |
| Cas.: 1060808-94-7 | Purity: 97% | 6-Amino-4-chloronicotinic acid | ESD-892218-250MG |
| Cas.: 1060808-94-7 | Purity: 97% | 6-Amino-4-chloronicotinic acid | ESD-892218-1G |
| Cas.: 885520-07-0 | Purity: ≥95% | 4-Fluoro-1H-indazol-6-amine | ESD-892219-100MG |
| Cas.: 885520-07-0 | Purity: ≥95% | 4-Fluoro-1H-indazol-6-amine | ESD-892219-250MG |
| Cas.: 885520-07-0 | Purity: ≥95% | 4-Fluoro-1H-indazol-6-amine | ESD-892219-1G |
| Cas.: 37116-80-6 | Purity: 97% | 3-(4-Hydroxyphenethyl)phenol | ESD-892221-100MG |
| Cas.: 37116-80-6 | Purity: 97% | 3-(4-Hydroxyphenethyl)phenol | ESD-892221-250MG |
| Cas.: 179692-09-2 | Purity: 97% | Ethyl 4-formyl-1H-pyrazole-3-carboxylate | ESD-892222-100MG |
| Cas.: 179692-09-2 | Purity: 97% | Ethyl 4-formyl-1H-pyrazole-3-carboxylate | ESD-892222-250MG |
| Cas.: 179692-09-2 | Purity: 97% | Ethyl 4-formyl-1H-pyrazole-3-carboxylate | ESD-892222-1G |
| Cas.: 179692-09-2 | Purity: 97% | Ethyl 4-formyl-1H-pyrazole-3-carboxylate | ESD-892222-5G |
| Cas.: 481038-63-5 | Purity: 96% | 1-Boc-2-Benzylpiperazine | ESD-892223-250MG |
| Cas.: 481038-63-5 | Purity: 96% | 1-Boc-2-Benzylpiperazine | ESD-892223-1G |
| Cas.: 481038-63-5 | Purity: 96% | 1-Boc-2-Benzylpiperazine | ESD-892223-5G |
| Cas.: 481038-63-5 | Purity: 96% | 1-Boc-2-Benzylpiperazine | ESD-892223-10G |
| Cas.: 13040-21-6 | Purity: 97% | N-(3-Hydroxyphenyl)acrylamide | ESD-892224-100MG |
| Cas.: 13040-21-6 | Purity: 97% | N-(3-Hydroxyphenyl)acrylamide | ESD-892224-250MG |
| Cas.: 13040-21-6 | Purity: 97% | N-(3-Hydroxyphenyl)acrylamide | ESD-892224-1G |
| Cas.: 1260855-51-3 | Purity: 98% | 1-(2-(Trifluoromethyl)phenyl)-1H-pyrazole-4-carboxylic acid | ESD-892225-100MG |
| Cas.: 1260855-51-3 | Purity: 98% | 1-(2-(Trifluoromethyl)phenyl)-1H-pyrazole-4-carboxylic acid | ESD-892225-250MG |
| Cas.: 5693-27-6 | Purity: ≥95% | Isochroman-1,4-dione | ESD-892226-250MG |
| Cas.: 5693-27-6 | Purity: ≥95% | Isochroman-1,4-dione | ESD-892226-1G |
| Cas.: 73285-50-4 | Purity: 97% | 1-Deoxynojirimycin hydrochloride | ESD-892227-25MG |
| Cas.: 73285-50-4 | Purity: 97% | 1-Deoxynojirimycin hydrochloride | ESD-892227-100MG |
| Cas.: 53910-10-4 | Purity: ≥95% | 6-Iodoisobenzofuran-1(3H)-one | ESD-892228-100MG |
| Cas.: 53910-10-4 | Purity: ≥95% | 6-Iodoisobenzofuran-1(3H)-one | ESD-892228-250MG |
| Cas.: 53910-10-4 | Purity: ≥95% | 6-Iodoisobenzofuran-1(3H)-one | ESD-892228-1G |
| Cas.: 116529-60-3 | Purity: 98% | 2-Bromo-3,5-dinitrobenzoic acid | ESD-892229-250MG |
| Cas.: 116529-60-3 | Purity: 98% | 2-Bromo-3,5-dinitrobenzoic acid | ESD-892229-1G |
| Cas.: 116529-60-3 | Purity: 98% | 2-Bromo-3,5-dinitrobenzoic acid | ESD-892229-5G |
| Cas.: 116529-60-3 | Purity: 98% | 2-Bromo-3,5-dinitrobenzoic acid | ESD-892229-10G |
| Cas.: 1809004-78-1 | Purity: 97% | Ethyl 4-bromothieno[2,3-c]pyridine-2-carboxylate | ESD-892230-100MG |
| Cas.: 1809004-78-1 | Purity: 97% | Ethyl 4-bromothieno[2,3-c]pyridine-2-carboxylate | ESD-892230-250MG |
| Cas.: 1809004-78-1 | Purity: 97% | Ethyl 4-bromothieno[2,3-c]pyridine-2-carboxylate | ESD-892230-1G |
| Cas.: 6311-47-3 | Purity: 97% | 5-Bromo-2-nitro-N-phenylaniline | ESD-892231-100MG |
| Cas.: 6311-47-3 | Purity: 97% | 5-Bromo-2-nitro-N-phenylaniline | ESD-892231-250MG |
| Cas.: 6311-47-3 | Purity: 97% | 5-Bromo-2-nitro-N-phenylaniline | ESD-892231-1G |
| Cas.: 934266-82-7 | Purity: 98% | 5-Bromothiazolo[5,4-b]pyridin-2-amine | ESD-892232-100MG |
| Cas.: 934266-82-7 | Purity: 98% | 5-Bromothiazolo[5,4-b]pyridin-2-amine | ESD-892232-250MG |
| Cas.: 934266-82-7 | Purity: 98% | 5-Bromothiazolo[5,4-b]pyridin-2-amine | ESD-892232-1G |
| Cas.: 263396-43-6 | Purity: 97% | HD-Phe(3-CN)-OH | ESD-892233-250MG |
| Cas.: 263396-43-6 | Purity: 97% | HD-Phe(3-CN)-OH | ESD-892233-1G |
| Cas.: 263396-43-6 | Purity: 97% | HD-Phe(3-CN)-OH | ESD-892233-5G |
| Cas.: 263396-43-6 | Purity: 97% | HD-Phe(3-CN)-OH | ESD-892233-10G |
| Cas.: 115551-46-7 | Purity: 97% | 3-Cbz-Aminopyrrolidine | ESD-892234-250MG |
| Cas.: 115551-46-7 | Purity: 97% | 3-Cbz-Aminopyrrolidine | ESD-892234-1G |
| Cas.: 161601-29-2 | Purity: 95% | (1S,3S)-3-((tert-Butoxycarbonyl)amino)cyclopentanecarboxylic acid | ESD-892235-10MG |
| Cas.: 161601-29-2 | Purity: 95% | (1S,3S)-3-((tert-Butoxycarbonyl)amino)cyclopentanecarboxylic acid | ESD-892235-100MG |
| Cas.: 245115-25-7 | Purity: ≥95% | (1R,2R)-2-((tert-Butoxycarbonyl)amino)cyclopentanecarboxylic acid | ESD-892236-100MG |
| Cas.: 245115-25-7 | Purity: ≥95% | (1R,2R)-2-((tert-Butoxycarbonyl)amino)cyclopentanecarboxylic acid | ESD-892236-250MG |
| Cas.: 245115-25-7 | Purity: ≥95% | (1R,2R)-2-((tert-Butoxycarbonyl)amino)cyclopentanecarboxylic acid | ESD-892236-1G |
| Cas.: 245115-25-7 | Purity: ≥95% | (1R,2R)-2-((tert-Butoxycarbonyl)amino)cyclopentanecarboxylic acid | ESD-892236-5G |
| Cas.: 957065-85-9 | Purity: 97% | 2-Ethoxy-5-methoxyphenylboronic acid | ESD-892237-250MG |
| Cas.: 957065-85-9 | Purity: 97% | 2-Ethoxy-5-methoxyphenylboronic acid | ESD-892237-1G |
| Cas.: 957065-85-9 | Purity: 97% | 2-Ethoxy-5-methoxyphenylboronic acid | ESD-892237-5G |
| Cas.: 957065-85-9 | Purity: 97% | 2-Ethoxy-5-methoxyphenylboronic acid | ESD-892237-10G |
| Cas.: 65971-76-8 | Purity: ≥95% | 6-Amino-2-bromo-3-chlorobenzoic acid | ESD-892238-100MG |
| Cas.: 65971-76-8 | Purity: ≥95% | 6-Amino-2-bromo-3-chlorobenzoic acid | ESD-892238-250MG |
| Cas.: 15108-18-6 | Purity: ≥95% | 2-Hydrazinyl-1H-benzo[d]imidazole | ESD-892239-250MG |
| Cas.: 15108-18-6 | Purity: ≥95% | 2-Hydrazinyl-1H-benzo[d]imidazole | ESD-892239-1G |
| Cas.: 15108-18-6 | Purity: ≥95% | 2-Hydrazinyl-1H-benzo[d]imidazole | ESD-892239-5G |
| Cas.: 15108-18-6 | Purity: ≥95% | 2-Hydrazinyl-1H-benzo[d]imidazole | ESD-892239-10G |
| Cas.: 5729-06-6 | Purity: 97% | N-Benzyl-2-nitroaniline | ESD-892240-250MG |
| Cas.: 5729-06-6 | Purity: 97% | N-Benzyl-2-nitroaniline | ESD-892240-1G |
| Cas.: 151907-80-1 | Purity: 97% | (1R,4S)-4-((tert-Butoxycarbonyl)amino)cyclopent-2-enecarboxylic acid | ESD-892241-250MG |
| Cas.: 151907-80-1 | Purity: 97% | (1R,4S)-4-((tert-Butoxycarbonyl)amino)cyclopent-2-enecarboxylic acid | ESD-892241-1G |
| Cas.: 151907-80-1 | Purity: 97% | (1R,4S)-4-((tert-Butoxycarbonyl)amino)cyclopent-2-enecarboxylic acid | ESD-892241-5G |
| Cas.: 185847-84-1 | Purity: ≥95% | Benzyl 4-oxo-3,4-dihydropyridine-1(2H)-carboxylate | ESD-892242-100MG |
| Cas.: 185847-84-1 | Purity: ≥95% | Benzyl 4-oxo-3,4-dihydropyridine-1(2H)-carboxylate | ESD-892242-250MG |
| Cas.: 185847-84-1 | Purity: ≥95% | Benzyl 4-oxo-3,4-dihydropyridine-1(2H)-carboxylate | ESD-892242-1G |
| Cas.: 185847-84-1 | Purity: ≥95% | Benzyl 4-oxo-3,4-dihydropyridine-1(2H)-carboxylate | ESD-892242-5G |
| Cas.: 51411-81-5 | Purity: 97% | 3-Amino-4-iodobenzoic acid | ESD-892243-250MG |
| Cas.: 51411-81-5 | Purity: 97% | 3-Amino-4-iodobenzoic acid | ESD-892243-1G |
| Cas.: 51411-81-5 | Purity: 97% | 3-Amino-4-iodobenzoic acid | ESD-892243-5G |
| Cas.: 51411-81-5 | Purity: 97% | 3-Amino-4-iodobenzoic acid | ESD-892243-10G |
| Cas.: 37067-96-2 | Purity: 98% | 4,5-Diiodo-1-methyl-1H-imidazole | ESD-892244-1G |
| Cas.: 37067-96-2 | Purity: 98% | 4,5-Diiodo-1-methyl-1H-imidazole | ESD-892244-5G |
| Cas.: 62482-29-5 | Purity: ≥95% | 6-Chloroquinoline-4-carboxylic acid | ESD-892245-100MG |
| Cas.: 62482-29-5 | Purity: ≥95% | 6-Chloroquinoline-4-carboxylic acid | ESD-892245-250MG |
| Cas.: 62482-29-5 | Purity: ≥95% | 6-Chloroquinoline-4-carboxylic acid | ESD-892245-1G |
| Cas.: 62482-29-5 | Purity: ≥95% | 6-Chloroquinoline-4-carboxylic acid | ESD-892245-5G |
| Cas.: 201933-03-1 | Purity: 97% | Methyl 3-(acetoxymethyl)-4-nitrobenzoate | ESD-892246-100MG |
| Cas.: 201933-03-1 | Purity: 97% | Methyl 3-(acetoxymethyl)-4-nitrobenzoate | ESD-892246-250MG |
| Cas.: 201933-03-1 | Purity: 97% | Methyl 3-(acetoxymethyl)-4-nitrobenzoate | ESD-892246-1G |
| Cas.: 201933-03-1 | Purity: 97% | Methyl 3-(acetoxymethyl)-4-nitrobenzoate | ESD-892246-5G |
| Cas.: 1215310-75-0 | Purity: 97% | 2-Formyl-5-(methylsulphonyl)benzotrifluoride | ESD-892247-100MG |
| Cas.: 1215310-75-0 | Purity: 97% | 2-Formyl-5-(methylsulphonyl)benzotrifluoride | ESD-892247-250MG |
| Cas.: 1215310-75-0 | Purity: 97% | 2-Formyl-5-(methylsulphonyl)benzotrifluoride | ESD-892247-1G |
| Cas.: 7738-22-9 | Purity: 95% | Boc-Ser-OtBu | ESD-892248-250MG |
| Cas.: 7738-22-9 | Purity: 95% | Boc-Ser-OtBu | ESD-892248-1G |
| Cas.: 7738-22-9 | Purity: 95% | Boc-Ser-OtBu | ESD-892248-5G |
| Cas.: 100960-35-8 | Purity: ≥95% | 5-Chloro-1H-indazol-6-amine | ESD-892249-100MG |
| Cas.: 100960-35-8 | Purity: ≥95% | 5-Chloro-1H-indazol-6-amine | ESD-892249-250MG |
| Cas.: 67589-38-2 | Purity: 97% | 4-Methoxyphenyl 4-propylcyclohexanecarboxylate | ESD-892250-1G |
| Cas.: 67589-38-2 | Purity: 97% | 4-Methoxyphenyl 4-propylcyclohexanecarboxylate | ESD-892250-5G |
| Cas.: 67589-38-2 | Purity: 97% | 4-Methoxyphenyl 4-propylcyclohexanecarboxylate | ESD-892250-25G |
| Cas.: 67589-38-2 | Purity: 97% | 4-Methoxyphenyl 4-propylcyclohexanecarboxylate | ESD-892250-100G |
| Cas.: 7094-34-0 | Purity: ≥95% | Bis(3-chlorophenyl)methanone | ESD-892251-250MG |
| Cas.: 7094-34-0 | Purity: ≥95% | Bis(3-chlorophenyl)methanone | ESD-892251-1G |
| Cas.: 82437-64-7 | Purity: ≥95% | Methyl 3-amino-4-phenylthiophene-2-carboxylate | ESD-892252-100MG |
| Cas.: 82437-64-7 | Purity: ≥95% | Methyl 3-amino-4-phenylthiophene-2-carboxylate | ESD-892252-250MG |
| Cas.: 82437-64-7 | Purity: ≥95% | Methyl 3-amino-4-phenylthiophene-2-carboxylate | ESD-892252-1G |
| Cas.: 65695-05-8 | Purity: 97% | Methyl 4-(N-hydroxycarbamimidoyl)benzoate | ESD-892253-250MG |
| Cas.: 65695-05-8 | Purity: 97% | Methyl 4-(N-hydroxycarbamimidoyl)benzoate | ESD-892253-1G |
| Cas.: 65695-05-8 | Purity: 97% | Methyl 4-(N-hydroxycarbamimidoyl)benzoate | ESD-892253-5G |
| Cas.: 938-39-6 | Purity: ≥95% | 4-Bromoquinolin-2-one | ESD-892254-100MG |
| Cas.: 938-39-6 | Purity: ≥95% | 4-Bromoquinolin-2-one | ESD-892254-250MG |
| Cas.: 938-39-6 | Purity: ≥95% | 4-Bromoquinolin-2-one | ESD-892254-1G |
| Cas.: 851895-20-0 | Purity: 98% | (4-Ethynylphenyl)(morpholino)methanone | ESD-892255-100MG |
| Cas.: 851895-20-0 | Purity: 98% | (4-Ethynylphenyl)(morpholino)methanone | ESD-892255-250MG |
| Cas.: 213130-43-9 | Purity: ≥95% | 3-Chloro-4-cyanobenzene-1-sulfonyl chloride | ESD-892256-100MG |
| Cas.: 213130-43-9 | Purity: ≥95% | 3-Chloro-4-cyanobenzene-1-sulfonyl chloride | ESD-892256-250MG |
| Cas.: 146137-85-1 | Purity: 97% | Methyl 4-iodobenzo[b]thiophene-2-carboxylate | ESD-892257-250MG |
| Cas.: 146137-85-1 | Purity: 97% | Methyl 4-iodobenzo[b]thiophene-2-carboxylate | ESD-892257-1G |
| Cas.: 146137-85-1 | Purity: 97% | Methyl 4-iodobenzo[b]thiophene-2-carboxylate | ESD-892257-5G |
| Cas.: 1219741-53-3 | Purity: 97% | 1-Ethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole | ESD-892258-100MG |
| Cas.: 1219741-53-3 | Purity: 97% | 1-Ethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole | ESD-892258-250MG |
| Cas.: 4038-14-6 | Purity: 98% | (3,4-Dimethoxyphenyl)(phenyl)methanone | ESD-892259-5G |
| Cas.: 4038-14-6 | Purity: 98% | (3,4-Dimethoxyphenyl)(phenyl)methanone | ESD-892259-10G |
| Cas.: 4038-14-6 | Purity: 98% | (3,4-Dimethoxyphenyl)(phenyl)methanone | ESD-892259-25G |
| Cas.: 4038-14-6 | Purity: 98% | (3,4-Dimethoxyphenyl)(phenyl)methanone | ESD-892259-100G |
| Cas.: 446263-96-3 | Purity: 98% | 3-(6-Aminopyridin-3-yl)propanoic acid | ESD-892260-100MG |
| Cas.: 446263-96-3 | Purity: 98% | 3-(6-Aminopyridin-3-yl)propanoic acid | ESD-892260-250MG |
| Cas.: 446263-96-3 | Purity: 98% | 3-(6-Aminopyridin-3-yl)propanoic acid | ESD-892260-1G |
| Cas.: 1073354-91-2 | Purity: 97% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazole | ESD-892261-100MG |
| Cas.: 1073354-91-2 | Purity: 97% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazole | ESD-892261-250MG |
| Cas.: 1073354-91-2 | Purity: 97% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazole | ESD-892261-1G |
| Cas.: 1073354-91-2 | Purity: 97% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazole | ESD-892261-5G |
| Cas.: 1227269-14-8 | Purity: ≥95% | 2-Iodo-1H-pyrrolo[3,2-c]pyridine | ESD-892262-100MG |
| Cas.: 1227269-14-8 | Purity: ≥95% | 2-Iodo-1H-pyrrolo[3,2-c]pyridine | ESD-892262-250MG |
| Cas.: 1227269-14-8 | Purity: ≥95% | 2-Iodo-1H-pyrrolo[3,2-c]pyridine | ESD-892262-1G |
| Cas.: 340702-10-5 | Purity: ≥95% | 6-Fluoroisoindolin-1-one | ESD-892263-250MG |
| Cas.: 340702-10-5 | Purity: ≥95% | 6-Fluoroisoindolin-1-one | ESD-892263-1G |
| Cas.: 340702-10-5 | Purity: ≥95% | 6-Fluoroisoindolin-1-one | ESD-892263-5G |
| Cas.: 340702-10-5 | Purity: ≥95% | 6-Fluoroisoindolin-1-one | ESD-892263-10G |
| Cas.: 15268-07-2 | Purity: 95% | 3,3′-Oxydianiline | ESD-892264-100MG |
| Cas.: 15268-07-2 | Purity: 95% | 3,3′-Oxydianiline | ESD-892264-250MG |
| Cas.: 15268-07-2 | Purity: 95% | 3,3′-Oxydianiline | ESD-892264-1G |
| Cas.: 173731-96-9 | Purity: ≥95% | 4-Guanidino-2-methoxybenzoic acid | ESD-892265-100MG |
| Cas.: 173731-96-9 | Purity: ≥95% | 4-Guanidino-2-methoxybenzoic acid | ESD-892265-250MG |
| Cas.: 173731-96-9 | Purity: ≥95% | 4-Guanidino-2-methoxybenzoic acid | ESD-892265-1G |
| Cas.: 745048-63-9 | Purity: ≥95% | 5-Amino-2-bromo-4-methylbenzoic acid | ESD-892266-1G |
| Cas.: 745048-63-9 | Purity: ≥95% | 5-Amino-2-bromo-4-methylbenzoic acid | ESD-892266-5G |
| Cas.: 745048-63-9 | Purity: ≥95% | 5-Amino-2-bromo-4-methylbenzoic acid | ESD-892266-10G |
| Cas.: 745048-63-9 | Purity: ≥95% | 5-Amino-2-bromo-4-methylbenzoic acid | ESD-892266-25G |
| Cas.: 639807-18-4 | Purity: 97% | 2-(Cyclopropylamino)nicotinic acid | ESD-892267-250MG |
| Cas.: 639807-18-4 | Purity: 97% | 2-(Cyclopropylamino)nicotinic acid | ESD-892267-1G |
| Cas.: 639807-18-4 | Purity: 97% | 2-(Cyclopropylamino)nicotinic acid | ESD-892267-5G |
| Cas.: 2622-63-1 | Purity: 97% | 1-Methyl-2-phenyl-1H-benzo[d]imidazole | ESD-892268-100MG |
| Cas.: 2622-63-1 | Purity: 97% | 1-Methyl-2-phenyl-1H-benzo[d]imidazole | ESD-892268-250MG |
| Cas.: 1310403-98-5 | Purity: ≥95% | (6-Bromo-2-ethoxy-3-fluorophenyl)boronic acid | ESD-892269-100MG |
| Cas.: 1310403-98-5 | Purity: ≥95% | (6-Bromo-2-ethoxy-3-fluorophenyl)boronic acid | ESD-892269-250MG |
| Cas.: 1310403-98-5 | Purity: ≥95% | (6-Bromo-2-ethoxy-3-fluorophenyl)boronic acid | ESD-892269-1G |
| Cas.: 1020635-54-4 | Purity: 95% | 2-Methoxy-5-nitronicotinic acid | ESD-892270-100MG |
| Cas.: 1020635-54-4 | Purity: 95% | 2-Methoxy-5-nitronicotinic acid | ESD-892270-250MG |
| Cas.: 1020635-54-4 | Purity: 95% | 2-Methoxy-5-nitronicotinic acid | ESD-892270-1G |
| Cas.: 887757-25-7 | Purity: 97% | 4-Bromo-3-cyanobenzoic acid | ESD-892271-100MG |
| Cas.: 887757-25-7 | Purity: 97% | 4-Bromo-3-cyanobenzoic acid | ESD-892271-250MG |
| Cas.: 887757-25-7 | Purity: 97% | 4-Bromo-3-cyanobenzoic acid | ESD-892271-1G |
| Cas.: 887757-25-7 | Purity: 97% | 4-Bromo-3-cyanobenzoic acid | ESD-892271-5G |
| Cas.: 1001756-21-3 | Purity: 97% | 4-Amino-6-chloronicotinaldehyde | ESD-892272-250MG |
| Cas.: 1001756-21-3 | Purity: 97% | 4-Amino-6-chloronicotinaldehyde | ESD-892272-1G |
| Cas.: 1001756-21-3 | Purity: 97% | 4-Amino-6-chloronicotinaldehyde | ESD-892272-5G |
| Cas.: 1001756-21-3 | Purity: 97% | 4-Amino-6-chloronicotinaldehyde | ESD-892272-10G |
| Cas.: 163452-78-6 | Purity: 97% | 5-Bromo-2-chloropyridine-3,4-diamine | ESD-892273-250MG |
| Cas.: 163452-78-6 | Purity: 97% | 5-Bromo-2-chloropyridine-3,4-diamine | ESD-892273-1G |
| Cas.: 163452-78-6 | Purity: 97% | 5-Bromo-2-chloropyridine-3,4-diamine | ESD-892273-5G |
| Cas.: 163452-78-6 | Purity: 97% | 5-Bromo-2-chloropyridine-3,4-diamine | ESD-892273-10G |
| Cas.: 76074-47-0 | Purity: ≥95% | 5-(m-tolyl)-1,3,4-Thiadiazol-2-amine | ESD-892274-1G |
| Cas.: 76074-47-0 | Purity: ≥95% | 5-(m-tolyl)-1,3,4-Thiadiazol-2-amine | ESD-892274-5G |
| Cas.: 76074-47-0 | Purity: ≥95% | 5-(m-tolyl)-1,3,4-Thiadiazol-2-amine | ESD-892274-10G |
| Cas.: 76074-47-0 | Purity: ≥95% | 5-(m-tolyl)-1,3,4-Thiadiazol-2-amine | ESD-892274-25G |
| Cas.: 27148-03-4 | Purity: ≥95% | Benzo[d]isothiazole-3(2H)-thione 1,1-dioxide | ESD-892275-100MG |
| Cas.: 27148-03-4 | Purity: ≥95% | Benzo[d]isothiazole-3(2H)-thione 1,1-dioxide | ESD-892275-250MG |
| Cas.: 103755-58-4 | Purity: ≥95% | (1-Phenyl-1H-1,2,3-triazol-4-yl)methanol | ESD-892276-250MG |
| Cas.: 103755-58-4 | Purity: ≥95% | (1-Phenyl-1H-1,2,3-triazol-4-yl)methanol | ESD-892276-1G |
| Cas.: 103755-58-4 | Purity: ≥95% | (1-Phenyl-1H-1,2,3-triazol-4-yl)methanol | ESD-892276-5G |
| Cas.: 103755-58-4 | Purity: ≥95% | (1-Phenyl-1H-1,2,3-triazol-4-yl)methanol | ESD-892276-10G |
| Cas.: 88095-61-8 | Purity: 97% | 1-Benzyl-4-nitro-1H-pyrazole | ESD-892277-250MG |
| Cas.: 88095-61-8 | Purity: 97% | 1-Benzyl-4-nitro-1H-pyrazole | ESD-892277-1G |
| Cas.: 88095-61-8 | Purity: 97% | 1-Benzyl-4-nitro-1H-pyrazole | ESD-892277-5G |
| Cas.: 88095-61-8 | Purity: 97% | 1-Benzyl-4-nitro-1H-pyrazole | ESD-892277-10G |
| Cas.: 19815-17-9 | Purity: 96% | 4-Chloro-7-nitroquinazoline | ESD-892278-1G |
| Cas.: 502649-29-8 | Purity: 97% | 1-Boc-3-Benzylpiperazine | ESD-892279-100MG |
| Cas.: 502649-29-8 | Purity: 97% | 1-Boc-3-Benzylpiperazine | ESD-892279-250MG |
| Cas.: 502649-29-8 | Purity: 97% | 1-Boc-3-Benzylpiperazine | ESD-892279-1G |
| Cas.: 502649-29-8 | Purity: 97% | 1-Boc-3-Benzylpiperazine | ESD-892279-5G |
| Cas.: 16563-41-0 | Purity: ≥95% | 3-(Naphthalen-1-yloxy)propanoic acid | ESD-892280-100MG |
| Cas.: 16563-41-0 | Purity: ≥95% | 3-(Naphthalen-1-yloxy)propanoic acid | ESD-892280-250MG |
| Cas.: 13599-24-1 | Purity: 97% | Ethyl 3-phenylisoxazole-5-carboxylate | ESD-892281-250MG |
| Cas.: 13599-24-1 | Purity: 97% | Ethyl 3-phenylisoxazole-5-carboxylate | ESD-892281-1G |
| Cas.: 13599-24-1 | Purity: 97% | Ethyl 3-phenylisoxazole-5-carboxylate | ESD-892281-5G |
| Cas.: 13599-24-1 | Purity: 97% | Ethyl 3-phenylisoxazole-5-carboxylate | ESD-892281-10G |
| Cas.: 24072-75-1 | Purity: ≥95% | 5,6-Dichlorobenzo[d]thiazol-2-amine | ESD-892282-100MG |
| Cas.: 24072-75-1 | Purity: ≥95% | 5,6-Dichlorobenzo[d]thiazol-2-amine | ESD-892282-250MG |
| Cas.: 24072-75-1 | Purity: ≥95% | 5,6-Dichlorobenzo[d]thiazol-2-amine | ESD-892282-1G |
| Cas.: 24072-75-1 | Purity: ≥95% | 5,6-Dichlorobenzo[d]thiazol-2-amine | ESD-892282-5G |
| Cas.: 25150-27-0 | Purity: 95% | 6,7-Dichlorobenzo[d]thiazol-2-amine | ESD-892283-100MG |
| Cas.: 25150-27-0 | Purity: 95% | 6,7-Dichlorobenzo[d]thiazol-2-amine | ESD-892283-250MG |
| Cas.: 25150-27-0 | Purity: 95% | 6,7-Dichlorobenzo[d]thiazol-2-amine | ESD-892283-1G |
| Cas.: 681246-49-1 | Purity: ≥95% | 6-Amino-7-bromo-2,3-dihydro-1H-inden-1-one | ESD-892284-100MG |
| Cas.: 681246-49-1 | Purity: ≥95% | 6-Amino-7-bromo-2,3-dihydro-1H-inden-1-one | ESD-892284-250MG |
| Cas.: 681246-49-1 | Purity: ≥95% | 6-Amino-7-bromo-2,3-dihydro-1H-inden-1-one | ESD-892284-1G |
| Cas.: 208457-81-2 | Purity: ≥95% | 7-Methyl-6-nitro-1H-indazole | ESD-892285-100MG |
| Cas.: 208457-81-2 | Purity: ≥95% | 7-Methyl-6-nitro-1H-indazole | ESD-892285-250MG |
| Cas.: 208457-81-2 | Purity: ≥95% | 7-Methyl-6-nitro-1H-indazole | ESD-892285-1G |
| Cas.: 56910-99-7 | Purity: ≥95% | Benzo[c]isothiazole-4-carboxylic acid | ESD-892286-100MG |
| Cas.: 56910-99-7 | Purity: ≥95% | Benzo[c]isothiazole-4-carboxylic acid | ESD-892286-250MG |
| Cas.: 56910-99-7 | Purity: ≥95% | Benzo[c]isothiazole-4-carboxylic acid | ESD-892286-1G |
| Cas.: 94201-40-8 | Purity: 97% | 1-Phenylpiperidine-4-carboxylic acid | ESD-892287-100MG |
| Cas.: 94201-40-8 | Purity: 97% | 1-Phenylpiperidine-4-carboxylic acid | ESD-892287-250MG |
| Cas.: 94201-40-8 | Purity: 97% | 1-Phenylpiperidine-4-carboxylic acid | ESD-892287-1G |
| Cas.: 94201-40-8 | Purity: 97% | 1-Phenylpiperidine-4-carboxylic acid | ESD-892287-5G |
| Cas.: 5410-97-9 | Purity: ≥95% | 3-Nitrodibenzo[b,d]furan | ESD-892288-100MG |
| Cas.: 5410-97-9 | Purity: ≥95% | 3-Nitrodibenzo[b,d]furan | ESD-892288-250MG |
| Cas.: 5410-97-9 | Purity: ≥95% | 3-Nitrodibenzo[b,d]furan | ESD-892288-1G |
| Cas.: 5410-97-9 | Purity: ≥95% | 3-Nitrodibenzo[b,d]furan | ESD-892288-5G |
| Cas.: 1197181-29-5 | Purity: 97% | 5-Chloro-7-nitro-1H-indole | ESD-892289-100MG |
| Cas.: 1197181-29-5 | Purity: 97% | 5-Chloro-7-nitro-1H-indole | ESD-892289-250MG |
| Cas.: 1197181-29-5 | Purity: 97% | 5-Chloro-7-nitro-1H-indole | ESD-892289-1G |
| Cas.: 1197181-29-5 | Purity: 97% | 5-Chloro-7-nitro-1H-indole | ESD-892289-5G |
| Cas.: 792180-52-0 | Purity: 97% | 5-Bromo-2-(pipidin-4-yloxy)pyrimidine | ESD-892290-250MG |
| Cas.: 792180-52-0 | Purity: 97% | 5-Bromo-2-(pipidin-4-yloxy)pyrimidine | ESD-892290-1G |
| Cas.: 792180-52-0 | Purity: 97% | 5-Bromo-2-(pipidin-4-yloxy)pyrimidine | ESD-892290-5G |
| Cas.: 946002-90-0 | Purity: ≥95% | (S)-1-(5-Bromopyridin-2-yl)pyrrolidin-3-ol | ESD-892291-100MG |
| Cas.: 946002-90-0 | Purity: ≥95% | (S)-1-(5-Bromopyridin-2-yl)pyrrolidin-3-ol | ESD-892291-250MG |
| Cas.: 265654-77-1 | Purity: 98% | 1-(2-(4-Nitrophenoxy)ethyl)pyrrolidine | ESD-892292-1G |
| Cas.: 265654-77-1 | Purity: 98% | 1-(2-(4-Nitrophenoxy)ethyl)pyrrolidine | ESD-892292-5G |
| Cas.: 1263214-75-0 | Purity: 97% | N-(3-Bromo-5-chloropyridin-2-yl)formamide | ESD-892293-100MG |
| Cas.: 1263214-75-0 | Purity: 97% | N-(3-Bromo-5-chloropyridin-2-yl)formamide | ESD-892293-250MG |
| Cas.: 1263214-75-0 | Purity: 97% | N-(3-Bromo-5-chloropyridin-2-yl)formamide | ESD-892293-1G |
| Cas.: 2510-37-4 | Purity: ≥95% | 2,4-Dimethyloxazole-5-carboxylic acid | ESD-892294-250MG |
| Cas.: 2510-37-4 | Purity: ≥95% | 2,4-Dimethyloxazole-5-carboxylic acid | ESD-892294-1G |
| Cas.: 2510-37-4 | Purity: ≥95% | 2,4-Dimethyloxazole-5-carboxylic acid | ESD-892294-5G |
| Cas.: 2510-37-4 | Purity: ≥95% | 2,4-Dimethyloxazole-5-carboxylic acid | ESD-892294-10G |
| Cas.: 195202-08-5 | Purity: 97% | (S)-2-(3,4,5-Trimethoxyphenyl)butanoic acid | ESD-892295-100MG |
| Cas.: 195202-08-5 | Purity: 97% | (S)-2-(3,4,5-Trimethoxyphenyl)butanoic acid | ESD-892295-250MG |
| Cas.: 195202-08-5 | Purity: 97% | (S)-2-(3,4,5-Trimethoxyphenyl)butanoic acid | ESD-892295-1G |
| Cas.: 195202-08-5 | Purity: 97% | (S)-2-(3,4,5-Trimethoxyphenyl)butanoic acid | ESD-892295-5G |
| Cas.: 81411-68-9 | Purity: 95% | 3-Bromo-1H-pyrazolo[3,4-b]pyrazine | ESD-892296-100MG |
| Cas.: 81411-68-9 | Purity: 95% | 3-Bromo-1H-pyrazolo[3,4-b]pyrazine | ESD-892296-250MG |
| Cas.: 81411-68-9 | Purity: 95% | 3-Bromo-1H-pyrazolo[3,4-b]pyrazine | ESD-892296-1G |
| Cas.: 51765-51-6 | Purity: 97% | N-(2-Phenoxyphenyl)methanesulfonamide | ESD-892297-250MG |
| Cas.: 51765-51-6 | Purity: 97% | N-(2-Phenoxyphenyl)methanesulfonamide | ESD-892297-1G |
| Cas.: 51765-51-6 | Purity: 97% | N-(2-Phenoxyphenyl)methanesulfonamide | ESD-892297-5G |
| Cas.: 30235-28-0 | Purity: 97% | 4-(Pyridin-4-yl)thiazol-2-amine | ESD-892298-250MG |
| Cas.: 30235-28-0 | Purity: 97% | 4-(Pyridin-4-yl)thiazol-2-amine | ESD-892298-1G |
| Cas.: 30235-28-0 | Purity: 97% | 4-(Pyridin-4-yl)thiazol-2-amine | ESD-892298-5G |
| Cas.: 134-52-1 | Purity: 97% | [1,1′-Biphenyl]-2,4-diol | ESD-892299-100MG |
| Cas.: 134-52-1 | Purity: 97% | [1,1′-Biphenyl]-2,4-diol | ESD-892299-250MG |
| Cas.: 134-52-1 | Purity: 97% | [1,1′-Biphenyl]-2,4-diol | ESD-892299-1G |
| Cas.: 134-52-1 | Purity: 97% | [1,1′-Biphenyl]-2,4-diol | ESD-892299-5G |
| Cas.: 217314-45-9 | Purity: ≥95% | Methyl 3-amino-5-iodobenzoate | ESD-892300-100MG |
| Cas.: 217314-45-9 | Purity: ≥95% | Methyl 3-amino-5-iodobenzoate | ESD-892300-250MG |
| Cas.: 39658-45-2 | Purity: ≥95% | 2-(6-Aminopyridin-3-yl)acetic acid | ESD-892301-100MG |
| Cas.: 39658-45-2 | Purity: ≥95% | 2-(6-Aminopyridin-3-yl)acetic acid | ESD-892301-250MG |
| Cas.: 39658-45-2 | Purity: ≥95% | 2-(6-Aminopyridin-3-yl)acetic acid | ESD-892301-1G |
| Cas.: 17295-12-4 | Purity: ≥95% | Ethyl 6-hydroxy-2-naphthoate | ESD-892302-1G |
| Cas.: 17295-12-4 | Purity: ≥95% | Ethyl 6-hydroxy-2-naphthoate | ESD-892302-5G |
| Cas.: 159803-52-8 | Purity: 98% | Ethyl 2-(9H-fluoren-9-yl)acetate | ESD-892303-100MG |
| Cas.: 159803-52-8 | Purity: 98% | Ethyl 2-(9H-fluoren-9-yl)acetate | ESD-892303-250MG |
| Cas.: 239075-26-4 | Purity: ≥95% | Methyl 1-acetyl-1H-indazole-5-carboxylate | ESD-892304-250MG |
| Cas.: 239075-26-4 | Purity: ≥95% | Methyl 1-acetyl-1H-indazole-5-carboxylate | ESD-892304-1G |
| Cas.: 239075-26-4 | Purity: ≥95% | Methyl 1-acetyl-1H-indazole-5-carboxylate | ESD-892304-5G |
| Cas.: 23530-40-7 | Purity: 97% | N-Methyl-2-nitrobenzenesulfonamide | ESD-892305-250MG |
| Cas.: 23530-40-7 | Purity: 97% | N-Methyl-2-nitrobenzenesulfonamide | ESD-892305-1G |
| Cas.: 23530-40-7 | Purity: 97% | N-Methyl-2-nitrobenzenesulfonamide | ESD-892305-5G |
| Cas.: 23530-40-7 | Purity: 97% | N-Methyl-2-nitrobenzenesulfonamide | ESD-892305-10G |
| Cas.: 143426-48-6 | Purity: 97% | Ethyl 4-(1H-1,2,4-triazol-1-yl)benzoate | ESD-892306-100MG |
| Cas.: 143426-48-6 | Purity: 97% | Ethyl 4-(1H-1,2,4-triazol-1-yl)benzoate | ESD-892306-250MG |
| Cas.: 143426-48-6 | Purity: 97% | Ethyl 4-(1H-1,2,4-triazol-1-yl)benzoate | ESD-892306-1G |
| Cas.: 143426-48-6 | Purity: 97% | Ethyl 4-(1H-1,2,4-triazol-1-yl)benzoate | ESD-892306-5G |
| Cas.: 15936-83-1 | Purity: 97% | 5-Chloro-7-methyl-1H-indole-3-carbaldehyde | ESD-892307-100MG |
| Cas.: 15936-83-1 | Purity: 97% | 5-Chloro-7-methyl-1H-indole-3-carbaldehyde | ESD-892307-250MG |
| Cas.: 15936-83-1 | Purity: 97% | 5-Chloro-7-methyl-1H-indole-3-carbaldehyde | ESD-892307-1G |
| Cas.: 15891-49-3 | Purity: 97% | (S)-2-Acetamidohexanoic acid | ESD-892308-1G |
| Cas.: 15891-49-3 | Purity: 97% | (S)-2-Acetamidohexanoic acid | ESD-892308-5G |
| Cas.: 15891-49-3 | Purity: 97% | (S)-2-Acetamidohexanoic acid | ESD-892308-10G |
| Cas.: 1246633-55-5 | Purity: 97% | (3-Fluoro-2-(hydroxymethyl)phenyl)boronic acid | ESD-892309-250MG |
| Cas.: 1246633-55-5 | Purity: 97% | (3-Fluoro-2-(hydroxymethyl)phenyl)boronic acid | ESD-892309-1G |
| Cas.: 1246633-55-5 | Purity: 97% | (3-Fluoro-2-(hydroxymethyl)phenyl)boronic acid | ESD-892309-5G |
| Cas.: 1246633-55-5 | Purity: 97% | (3-Fluoro-2-(hydroxymethyl)phenyl)boronic acid | ESD-892309-10G |
| Cas.: 924287-65-0 | Purity: ≥95% | Methyl 2-bromo-4-fluorobenzo[d]thiazole-6-carboxylate | ESD-892310-100MG |
| Cas.: 924287-65-0 | Purity: ≥95% | Methyl 2-bromo-4-fluorobenzo[d]thiazole-6-carboxylate | ESD-892310-250MG |
| Cas.: 924287-65-0 | Purity: ≥95% | Methyl 2-bromo-4-fluorobenzo[d]thiazole-6-carboxylate | ESD-892310-1G |
| Cas.: 29194-04-5 | Purity: ≥95% | 2-(Benzyl(methyl)amino)-1-phenylethanol | ESD-892311-100MG |
| Cas.: 29194-04-5 | Purity: ≥95% | 2-(Benzyl(methyl)amino)-1-phenylethanol | ESD-892311-250MG |
| Cas.: 70173-54-5 | Purity: 95% | 9-Bromo-1,2,3,5,6,7-hexahydropyrido[3,2,1-ij]quinoline | ESD-892312-250MG |
| Cas.: 70173-54-5 | Purity: 95% | 9-Bromo-1,2,3,5,6,7-hexahydropyrido[3,2,1-ij]quinoline | ESD-892312-1G |
| Cas.: 32286-99-0 | Purity: 97% | 1-Methyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxylic acid | ESD-892313-100MG |
| Cas.: 32286-99-0 | Purity: 97% | 1-Methyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxylic acid | ESD-892313-250MG |
| Cas.: 32286-99-0 | Purity: 97% | 1-Methyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxylic acid | ESD-892313-1G |
| Cas.: 32286-99-0 | Purity: 97% | 1-Methyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxylic acid | ESD-892313-5G |
| Cas.: 1089330-68-6 | Purity: ≥95% | 5-Methyl-3-nitropicolinonitrile | ESD-892314-100MG |
| Cas.: 1089330-68-6 | Purity: ≥95% | 5-Methyl-3-nitropicolinonitrile | ESD-892314-250MG |
| Cas.: 1089330-68-6 | Purity: ≥95% | 5-Methyl-3-nitropicolinonitrile | ESD-892314-1G |
| Cas.: 1089330-68-6 | Purity: ≥95% | 5-Methyl-3-nitropicolinonitrile | ESD-892314-5G |
| Cas.: 898537-77-4 | Purity: 97% | 3-(tert-Butyl)-1-(m-tolyl)-1H-pyrazol-5-amine | ESD-892315-250MG |
| Cas.: 898537-77-4 | Purity: 97% | 3-(tert-Butyl)-1-(m-tolyl)-1H-pyrazol-5-amine | ESD-892315-1G |
| Cas.: 13065-93-5 | Purity: ≥95% | N1-(4-Chlorophenyl)benzene-1,4-diamine | ESD-892316-100MG |
| Cas.: 13065-93-5 | Purity: ≥95% | N1-(4-Chlorophenyl)benzene-1,4-diamine | ESD-892316-250MG |
| Cas.: 13065-93-5 | Purity: ≥95% | N1-(4-Chlorophenyl)benzene-1,4-diamine | ESD-892316-1G |
| Cas.: 1503-49-7 | Purity: ≥95% | 4-Benzoylbenzonitrile | ESD-892317-100MG |
| Cas.: 1503-49-7 | Purity: ≥95% | 4-Benzoylbenzonitrile | ESD-892317-250MG |
| Cas.: 1503-49-7 | Purity: ≥95% | 4-Benzoylbenzonitrile | ESD-892317-1G |
| Cas.: 1503-49-7 | Purity: ≥95% | 4-Benzoylbenzonitrile | ESD-892317-5G |
| Cas.: 871125-81-4 | Purity: 97% | (3-Bromo-5-isopropoxyphenyl)boronic acid | ESD-892318-100MG |
| Cas.: 871125-81-4 | Purity: 97% | (3-Bromo-5-isopropoxyphenyl)boronic acid | ESD-892318-250MG |
| Cas.: 871125-81-4 | Purity: 97% | (3-Bromo-5-isopropoxyphenyl)boronic acid | ESD-892318-1G |
| Cas.: 871125-81-4 | Purity: 97% | (3-Bromo-5-isopropoxyphenyl)boronic acid | ESD-892318-5G |
| Cas.: 884507-39-5 | Purity: 97% | 1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)pyrrolidine | ESD-892319-1G |
| Cas.: 884507-39-5 | Purity: 97% | 1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)pyrrolidine | ESD-892319-5G |
| Cas.: 884507-39-5 | Purity: 97% | 1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)pyrrolidine | ESD-892319-10G |
| Cas.: 884507-39-5 | Purity: 97% | 1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)pyrrolidine | ESD-892319-25G |
| Cas.: 501945-71-7 | Purity: 97% | 2-(Benzo[b]thiophen-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-892320-100MG |
| Cas.: 501945-71-7 | Purity: 97% | 2-(Benzo[b]thiophen-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-892320-250MG |
| Cas.: 501945-71-7 | Purity: 97% | 2-(Benzo[b]thiophen-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-892320-1G |
| Cas.: 501945-71-7 | Purity: 97% | 2-(Benzo[b]thiophen-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-892320-5G |
| Cas.: 15679-03-5 | Purity: ≥95% | 6-Chlorophenanthridine | ESD-892321-250MG |
| Cas.: 15679-03-5 | Purity: ≥95% | 6-Chlorophenanthridine | ESD-892321-1G |
| Cas.: 15679-03-5 | Purity: ≥95% | 6-Chlorophenanthridine | ESD-892321-5G |
| Cas.: 15679-03-5 | Purity: ≥95% | 6-Chlorophenanthridine | ESD-892321-10G |
| Cas.: 103873-80-9 | Purity: 97% | 5-Bromo-4-methylbenzo[d]thiazol-2-amine | ESD-892322-250MG |
| Cas.: 103873-80-9 | Purity: 97% | 5-Bromo-4-methylbenzo[d]thiazol-2-amine | ESD-892322-1G |
| Cas.: 52368-18-0 | Purity: ≥95% | 6-Cyanopicolinamide | ESD-892323-100MG |
| Cas.: 52368-18-0 | Purity: ≥95% | 6-Cyanopicolinamide | ESD-892323-250MG |
| Cas.: 86499-35-6 | Purity: 95% | 3-Amino-2,3,4,5-tetrahydro-1H-benzazepin-2-one | ESD-892324-1G |
| Cas.: 86499-35-6 | Purity: 95% | 3-Amino-2,3,4,5-tetrahydro-1H-benzazepin-2-one | ESD-892324-5G |
| Cas.: 205448-66-4 | Purity: 97% | Methyl 4-chloro-7-methoxyquinoline-6-carboxylate | ESD-892325-250MG |
| Cas.: 205448-66-4 | Purity: 97% | Methyl 4-chloro-7-methoxyquinoline-6-carboxylate | ESD-892325-1G |
| Cas.: 205448-66-4 | Purity: 97% | Methyl 4-chloro-7-methoxyquinoline-6-carboxylate | ESD-892325-5G |
| Cas.: 205448-66-4 | Purity: 97% | Methyl 4-chloro-7-methoxyquinoline-6-carboxylate | ESD-892325-10G |
| Cas.: 1092352-37-8 | Purity: 98% | tert-Butyl 7-bromo-1H-indazole-1-carboxylate | ESD-892326-100MG |
| Cas.: 1092352-37-8 | Purity: 98% | tert-Butyl 7-bromo-1H-indazole-1-carboxylate | ESD-892326-250MG |
| Cas.: 1092352-37-8 | Purity: 98% | tert-Butyl 7-bromo-1H-indazole-1-carboxylate | ESD-892326-1G |
| Cas.: 959585-44-5 | Purity: ≥95% | Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-acetate | ESD-892327-100MG |
| Cas.: 959585-44-5 | Purity: ≥95% | Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-acetate | ESD-892327-250MG |
| Cas.: 959585-44-5 | Purity: ≥95% | Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-acetate | ESD-892327-1G |
| Cas.: 959585-44-5 | Purity: ≥95% | Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-acetate | ESD-892327-5G |
| Cas.: 7160-22-7 | Purity: ≥95% | N-(3,4-Dichlorophenyl)pivalamide | ESD-892328-100MG |
| Cas.: 7160-22-7 | Purity: ≥95% | N-(3,4-Dichlorophenyl)pivalamide | ESD-892328-250MG |
| Cas.: 7160-22-7 | Purity: ≥95% | N-(3,4-Dichlorophenyl)pivalamide | ESD-892328-1G |
| Cas.: 7160-22-7 | Purity: ≥95% | N-(3,4-Dichlorophenyl)pivalamide | ESD-892328-5G |
| Cas.: 1189207-30-4 | Purity: 97% | 4-Fluoro-2-(phenylethynyl)benzaldehyde | ESD-892329-250MG |
| Cas.: 1189207-30-4 | Purity: 97% | 4-Fluoro-2-(phenylethynyl)benzaldehyde | ESD-892329-1G |
| Cas.: 362703-34-2 | Purity: 97% | 1-tert-Butyl 4-methyl 4-cyanopiperidine-1,4-dicarboxylate | ESD-892330-100MG |
| Cas.: 362703-34-2 | Purity: 97% | 1-tert-Butyl 4-methyl 4-cyanopiperidine-1,4-dicarboxylate | ESD-892330-250MG |
| Cas.: 362703-34-2 | Purity: 97% | 1-tert-Butyl 4-methyl 4-cyanopiperidine-1,4-dicarboxylate | ESD-892330-1G |
| Cas.: 85392-01-4 | Purity: 98% | Methyl 4-chloro-2-(chlorosulfonyl)benzoate | ESD-892331-250MG |
| Cas.: 85392-01-4 | Purity: 98% | Methyl 4-chloro-2-(chlorosulfonyl)benzoate | ESD-892331-1G |
| Cas.: 85392-01-4 | Purity: 98% | Methyl 4-chloro-2-(chlorosulfonyl)benzoate | ESD-892331-5G |
| Cas.: 53458-16-5 | Purity: 95% | 1,2-Bis(4-fluorophenyl)-2-hydroxyethanone | ESD-892332-100MG |
| Cas.: 53458-16-5 | Purity: 95% | 1,2-Bis(4-fluorophenyl)-2-hydroxyethanone | ESD-892332-250MG |
| Cas.: 1778-74-1 | Purity: ≥95% | 2-(1H-Pyrrolo[3,2-c]pyridin-3-yl)ethanamine | ESD-892333-100MG |
| Cas.: 1778-74-1 | Purity: ≥95% | 2-(1H-Pyrrolo[3,2-c]pyridin-3-yl)ethanamine | ESD-892333-250MG |
| Cas.: 887571-32-6 | Purity: ≥95% | N-Methyl-1-(5-methyl-1H-benzo[d]imidazol-2-yl)methanamine | ESD-892334-100MG |
| Cas.: 887571-32-6 | Purity: ≥95% | N-Methyl-1-(5-methyl-1H-benzo[d]imidazol-2-yl)methanamine | ESD-892334-250MG |
| Cas.: 100987-04-0 | Purity: ≥95% | 5-(4-(tert-Butyl)phenyl)-1,3,4-thiadiazol-2-amine | ESD-892335-250MG |
| Cas.: 100987-04-0 | Purity: ≥95% | 5-(4-(tert-Butyl)phenyl)-1,3,4-thiadiazol-2-amine | ESD-892335-1G |
| Cas.: 100987-04-0 | Purity: ≥95% | 5-(4-(tert-Butyl)phenyl)-1,3,4-thiadiazol-2-amine | ESD-892335-5G |
| Cas.: 100987-04-0 | Purity: ≥95% | 5-(4-(tert-Butyl)phenyl)-1,3,4-thiadiazol-2-amine | ESD-892335-10G |
| Cas.: 72791-76-5 | Purity: ≥95% | Benzyl bis(2-chloroethyl)carbamate | ESD-892336-1G |
| Cas.: 72791-76-5 | Purity: ≥95% | Benzyl bis(2-chloroethyl)carbamate | ESD-892336-5G |
| Cas.: 72791-76-5 | Purity: ≥95% | Benzyl bis(2-chloroethyl)carbamate | ESD-892336-10G |
| Cas.: 1211581-22-4 | Purity: ≥95% | 2-Methoxy-3-methylisonicotinic acid | ESD-892337-100MG |
| Cas.: 1211581-22-4 | Purity: ≥95% | 2-Methoxy-3-methylisonicotinic acid | ESD-892337-250MG |
| Cas.: 158205-19-7 | Purity: 96% | 5-Amino-6-bromo-2,3-dihydro-1H-inden-1-one | ESD-892338-100MG |
| Cas.: 158205-19-7 | Purity: 96% | 5-Amino-6-bromo-2,3-dihydro-1H-inden-1-one | ESD-892338-250MG |
| Cas.: 158205-19-7 | Purity: 96% | 5-Amino-6-bromo-2,3-dihydro-1H-inden-1-one | ESD-892338-1G |
| Cas.: 41882-44-4 | Purity: 97% | 2,2-Dimethylmalonamide | ESD-892339-250MG |
| Cas.: 41882-44-4 | Purity: 97% | 2,2-Dimethylmalonamide | ESD-892339-1G |
| Cas.: 41882-44-4 | Purity: 97% | 2,2-Dimethylmalonamide | ESD-892339-5G |
| Cas.: 89694-44-0 | Purity: 97% | 2-Bromo-5-methoxybenzene boronic acid | ESD-892340-100MG |
| Cas.: 89694-44-0 | Purity: 97% | 2-Bromo-5-methoxybenzene boronic acid | ESD-892340-250MG |
| Cas.: 89694-44-0 | Purity: 97% | 2-Bromo-5-methoxybenzene boronic acid | ESD-892340-1G |
| Cas.: 89694-44-0 | Purity: 97% | 2-Bromo-5-methoxybenzene boronic acid | ESD-892340-5G |
| Cas.: 3376-59-8 | Purity: ≥95% | 2,3-Dihydroxypropyl benzoate | ESD-892341-100MG |
| Cas.: 3376-59-8 | Purity: ≥95% | 2,3-Dihydroxypropyl benzoate | ESD-892341-250MG |
| Cas.: 1206487-35-5 | Purity: ≥95% | 4,6-Dibromopyridazin-3-amine | ESD-892342-100MG |
| Cas.: 1206487-35-5 | Purity: ≥95% | 4,6-Dibromopyridazin-3-amine | ESD-892342-250MG |
| Cas.: 1206487-35-5 | Purity: ≥95% | 4,6-Dibromopyridazin-3-amine | ESD-892342-1G |
| Cas.: 1206487-35-5 | Purity: ≥95% | 4,6-Dibromopyridazin-3-amine | ESD-892342-5G |
| Cas.: 217073-76-2 | Purity: ≥95% | 1-(4-Fluorophenyl)-5-methyl-1H-pyrazole-4-carboxylic acid | ESD-892343-100MG |
| Cas.: 217073-76-2 | Purity: ≥95% | 1-(4-Fluorophenyl)-5-methyl-1H-pyrazole-4-carboxylic acid | ESD-892343-250MG |
| Cas.: 217073-76-2 | Purity: ≥95% | 1-(4-Fluorophenyl)-5-methyl-1H-pyrazole-4-carboxylic acid | ESD-892343-1G |
| Cas.: 217073-76-2 | Purity: ≥95% | 1-(4-Fluorophenyl)-5-methyl-1H-pyrazole-4-carboxylic acid | ESD-892343-5G |
| Cas.: 2386-37-0 | Purity: ≥95% | Ethyl 4-(3-methoxy-3-oxopropyl)-3,5-dimethyl-1H-pyrrole-2-carboxylate | ESD-892344-250MG |
| Cas.: 2386-37-0 | Purity: ≥95% | Ethyl 4-(3-methoxy-3-oxopropyl)-3,5-dimethyl-1H-pyrrole-2-carboxylate | ESD-892344-1G |
| Cas.: 1000339-10-5 | Purity: 97% | 2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-892345-100MG |
| Cas.: 1000339-10-5 | Purity: 97% | 2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-892345-250MG |
| Cas.: 1000339-10-5 | Purity: 97% | 2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-892345-1G |
| Cas.: 859518-32-4 | Purity: 97% | (R)-tert-Butyl 2-phenylpiperazine-1-carboxylate | ESD-892346-100MG |
| Cas.: 859518-32-4 | Purity: 97% | (R)-tert-Butyl 2-phenylpiperazine-1-carboxylate | ESD-892346-250MG |
| Cas.: 859518-32-4 | Purity: 97% | (R)-tert-Butyl 2-phenylpiperazine-1-carboxylate | ESD-892346-1G |
| Cas.: 859518-32-4 | Purity: 97% | (R)-tert-Butyl 2-phenylpiperazine-1-carboxylate | ESD-892346-5G |
| Cas.: 103860-60-2 | Purity: 97% | 2,3-Dihydroxynaphthalene-1,4-dicarbaldehyde | ESD-892347-100MG |
| Cas.: 103860-60-2 | Purity: 97% | 2,3-Dihydroxynaphthalene-1,4-dicarbaldehyde | ESD-892347-250MG |
| Cas.: 103860-60-2 | Purity: 97% | 2,3-Dihydroxynaphthalene-1,4-dicarbaldehyde | ESD-892347-1G |
| Cas.: 67608-58-6 | Purity: ≥95% | 4-Amino-2-hydroxybenzonitrile | ESD-892348-100MG |
| Cas.: 67608-58-6 | Purity: ≥95% | 4-Amino-2-hydroxybenzonitrile | ESD-892348-250MG |
| Cas.: 67608-58-6 | Purity: ≥95% | 4-Amino-2-hydroxybenzonitrile | ESD-892348-1G |
| Cas.: 174799-52-1 | Purity: ≥95% | tert-Butyl (2-(benzylamino)ethyl)carbamate | ESD-892349-1G |
| Cas.: 174799-52-1 | Purity: ≥95% | tert-Butyl (2-(benzylamino)ethyl)carbamate | ESD-892349-5G |
| Cas.: 174799-52-1 | Purity: ≥95% | tert-Butyl (2-(benzylamino)ethyl)carbamate | ESD-892349-10G |
| Cas.: 15366-65-1 | Purity: ≥95% | 5-Iodonicotinic acid | ESD-892350-100MG |
| Cas.: 15366-65-1 | Purity: ≥95% | 5-Iodonicotinic acid | ESD-892350-250MG |
| Cas.: 5755-07-7 | Purity: 98% | 1,3,4,5-Tetrahydro-2H-1,5-benzodiazepin-2-one | ESD-892351-100MG |
| Cas.: 5755-07-7 | Purity: 98% | 1,3,4,5-Tetrahydro-2H-1,5-benzodiazepin-2-one | ESD-892351-250MG |
| Cas.: 5755-07-7 | Purity: 98% | 1,3,4,5-Tetrahydro-2H-1,5-benzodiazepin-2-one | ESD-892351-1G |
| Cas.: 5755-07-7 | Purity: 98% | 1,3,4,5-Tetrahydro-2H-1,5-benzodiazepin-2-one | ESD-892351-5G |
| Cas.: 28544-83-4 | Purity: 97% | 3,4-Dihydro-1H-benzo[e][1,4]diazepin-5(2H)-one | ESD-892352-100MG |
| Cas.: 28544-83-4 | Purity: 97% | 3,4-Dihydro-1H-benzo[e][1,4]diazepin-5(2H)-one | ESD-892352-250MG |
| Cas.: 28544-83-4 | Purity: 97% | 3,4-Dihydro-1H-benzo[e][1,4]diazepin-5(2H)-one | ESD-892352-1G |
| Cas.: 313546-18-8 | Purity: ≥95% | (4-Cyano-2-methylphenyl)boronic acid | ESD-892353-250MG |
| Cas.: 313546-18-8 | Purity: ≥95% | (4-Cyano-2-methylphenyl)boronic acid | ESD-892353-1G |
| Cas.: 313546-18-8 | Purity: ≥95% | (4-Cyano-2-methylphenyl)boronic acid | ESD-892353-5G |
| Cas.: 313546-18-8 | Purity: ≥95% | (4-Cyano-2-methylphenyl)boronic acid | ESD-892353-10G |
| Cas.: 849996-80-1 | Purity: 96% | 2-Chloroquinoline-6-carboxylic acid | ESD-892354-250MG |
| Cas.: 849996-80-1 | Purity: 96% | 2-Chloroquinoline-6-carboxylic acid | ESD-892354-1G |
| Cas.: 849996-80-1 | Purity: 96% | 2-Chloroquinoline-6-carboxylic acid | ESD-892354-5G |
| Cas.: 5211-23-4 | Purity: 95% | (S)-1-Benzyl 2-methyl pyrrolidine-1,2-dicarboxylate | ESD-892355-1G |
| Cas.: 5211-23-4 | Purity: 95% | (S)-1-Benzyl 2-methyl pyrrolidine-1,2-dicarboxylate | ESD-892355-5G |
| Cas.: 5211-23-4 | Purity: 95% | (S)-1-Benzyl 2-methyl pyrrolidine-1,2-dicarboxylate | ESD-892355-10G |
| Cas.: 5211-23-4 | Purity: 95% | (S)-1-Benzyl 2-methyl pyrrolidine-1,2-dicarboxylate | ESD-892355-25G |
| Cas.: 37102-74-2 | Purity: ≥95% | 3-Methylphthalic acid | ESD-892356-100MG |
| Cas.: 37102-74-2 | Purity: ≥95% | 3-Methylphthalic acid | ESD-892356-250MG |
| Cas.: 37102-74-2 | Purity: ≥95% | 3-Methylphthalic acid | ESD-892356-1G |
| Cas.: 62128-38-5 | Purity: 97% | (4-Chlorophenyl)(1H-pyrrol-3-yl)methanone | ESD-892357-100MG |
| Cas.: 62128-38-5 | Purity: 97% | (4-Chlorophenyl)(1H-pyrrol-3-yl)methanone | ESD-892357-250MG |
| Cas.: 62128-38-5 | Purity: 97% | (4-Chlorophenyl)(1H-pyrrol-3-yl)methanone | ESD-892357-1G |
| Cas.: 32587-10-3 | Purity: ≥95% | 3-Aminopyrazine-2-carboxamide | ESD-892358-250MG |
| Cas.: 32587-10-3 | Purity: ≥95% | 3-Aminopyrazine-2-carboxamide | ESD-892358-1G |
| Cas.: 32587-10-3 | Purity: ≥95% | 3-Aminopyrazine-2-carboxamide | ESD-892358-5G |
| Cas.: 32587-10-3 | Purity: ≥95% | 3-Aminopyrazine-2-carboxamide | ESD-892358-10G |
| Cas.: 459434-40-3 | Purity: 97% | 3-Amino-N-methylbenzenesulfonamide | ESD-892359-1G |
| Cas.: 459434-40-3 | Purity: 97% | 3-Amino-N-methylbenzenesulfonamide | ESD-892359-5G |
| Cas.: 57764-50-8 | Purity: 95% | Ethyl 6-hydroxybenzo[d]isoxazole-3-carboxylate | ESD-892360-100MG |
| Cas.: 57764-50-8 | Purity: 95% | Ethyl 6-hydroxybenzo[d]isoxazole-3-carboxylate | ESD-892360-250MG |
| Cas.: 57764-50-8 | Purity: 95% | Ethyl 6-hydroxybenzo[d]isoxazole-3-carboxylate | ESD-892360-1G |
| Cas.: 5874-61-3 | Purity: 97% | 4-Benzyl-2-phenyloxazol-5(4H)-one | ESD-892361-250MG |
| Cas.: 5874-61-3 | Purity: 97% | 4-Benzyl-2-phenyloxazol-5(4H)-one | ESD-892361-1G |
| Cas.: 27224-09-5 | Purity: ≥95% | 4-Bromoisoquinoline-1-carbonitrile | ESD-892362-100MG |
| Cas.: 27224-09-5 | Purity: ≥95% | 4-Bromoisoquinoline-1-carbonitrile | ESD-892362-250MG |
| Cas.: 27224-09-5 | Purity: ≥95% | 4-Bromoisoquinoline-1-carbonitrile | ESD-892362-1G |
| Cas.: 53681-51-9 | Purity: ≥95% | 6-Amino-1-benzyl-3-methylpyrimidine-2,4(1H,3H)-dione | ESD-892363-100MG |
| Cas.: 53681-51-9 | Purity: ≥95% | 6-Amino-1-benzyl-3-methylpyrimidine-2,4(1H,3H)-dione | ESD-892363-250MG |
| Cas.: 53681-51-9 | Purity: ≥95% | 6-Amino-1-benzyl-3-methylpyrimidine-2,4(1H,3H)-dione | ESD-892363-1G |
| Cas.: 127958-10-5 | Purity: ≥95% | 2-Methyl-4-phenylpyrimidine-5-carboxylic acid | ESD-892364-100MG |
| Cas.: 127958-10-5 | Purity: ≥95% | 2-Methyl-4-phenylpyrimidine-5-carboxylic acid | ESD-892364-250MG |
| Cas.: 127958-10-5 | Purity: ≥95% | 2-Methyl-4-phenylpyrimidine-5-carboxylic acid | ESD-892364-1G |
| Cas.: 127958-10-5 | Purity: ≥95% | 2-Methyl-4-phenylpyrimidine-5-carboxylic acid | ESD-892364-5G |
| Cas.: 34993-02-7 | Purity: 97% | 2-Amino-5-phenylpentanoic acid | ESD-892365-250MG |
| Cas.: 34993-02-7 | Purity: 97% | 2-Amino-5-phenylpentanoic acid | ESD-892365-1G |
| Cas.: 34993-02-7 | Purity: 97% | 2-Amino-5-phenylpentanoic acid | ESD-892365-5G |
| Cas.: 1187932-11-1 | Purity: ≥95% | (S)-tert-Butyl (1-(2-bromophenyl)ethyl)carbamate | ESD-892366-100MG |
| Cas.: 1187932-11-1 | Purity: ≥95% | (S)-tert-Butyl (1-(2-bromophenyl)ethyl)carbamate | ESD-892366-250MG |
| Cas.: 1187932-11-1 | Purity: ≥95% | (S)-tert-Butyl (1-(2-bromophenyl)ethyl)carbamate | ESD-892366-1G |
| Cas.: 1086600-12-5 | Purity: 97% | (R)-tert-Butyl (1-(2-bromophenyl)ethyl)carbamate | ESD-892367-100MG |
| Cas.: 1086600-12-5 | Purity: 97% | (R)-tert-Butyl (1-(2-bromophenyl)ethyl)carbamate | ESD-892367-250MG |
| Cas.: 120321-72-4 | Purity: ≥95% | (1-Methyl-1H-benzo[d][1,2,3]triazol-5-yl)methanol | ESD-892368-100MG |
| Cas.: 120321-72-4 | Purity: ≥95% | (1-Methyl-1H-benzo[d][1,2,3]triazol-5-yl)methanol | ESD-892368-250MG |
| Cas.: 120321-72-4 | Purity: ≥95% | (1-Methyl-1H-benzo[d][1,2,3]triazol-5-yl)methanol | ESD-892368-1G |
| Cas.: 54660-08-1 | Purity: ≥95% | 1-(4-Fluorophenyl)pyrrolidin-2-one | ESD-892369-250MG |
| Cas.: 54660-08-1 | Purity: ≥95% | 1-(4-Fluorophenyl)pyrrolidin-2-one | ESD-892369-1G |
| Cas.: 54660-08-1 | Purity: ≥95% | 1-(4-Fluorophenyl)pyrrolidin-2-one | ESD-892369-5G |
| Cas.: 43142-64-9 | Purity: ≥95% | Ethyl 7-chloro-1H-indole-2-carboxylate | ESD-892370-100MG |
| Cas.: 43142-64-9 | Purity: ≥95% | Ethyl 7-chloro-1H-indole-2-carboxylate | ESD-892370-250MG |
| Cas.: 43142-64-9 | Purity: ≥95% | Ethyl 7-chloro-1H-indole-2-carboxylate | ESD-892370-1G |
| Cas.: 43142-64-9 | Purity: ≥95% | Ethyl 7-chloro-1H-indole-2-carboxylate | ESD-892370-5G |
| Cas.: 81115-45-9 | Purity: ≥95% | 5-Amino-6-methyl-1H-indazole | ESD-892371-100MG |
| Cas.: 81115-45-9 | Purity: ≥95% | 5-Amino-6-methyl-1H-indazole | ESD-892371-250MG |
| Cas.: 81115-45-9 | Purity: ≥95% | 5-Amino-6-methyl-1H-indazole | ESD-892371-1G |
| Cas.: 81115-45-9 | Purity: ≥95% | 5-Amino-6-methyl-1H-indazole | ESD-892371-5G |
| Cas.: 179555-11-4 | Purity: ≥95% | 6-Amino-4-methylnicotinic acid | ESD-892372-100MG |
| Cas.: 179555-11-4 | Purity: ≥95% | 6-Amino-4-methylnicotinic acid | ESD-892372-250MG |
| Cas.: 179555-11-4 | Purity: ≥95% | 6-Amino-4-methylnicotinic acid | ESD-892372-1G |
| Cas.: 23584-85-2 | Purity: 97% | 5-Phenyl-2-(trifluoromethyl)furan-3-carboxylic acid | ESD-892373-100MG |
| Cas.: 23584-85-2 | Purity: 97% | 5-Phenyl-2-(trifluoromethyl)furan-3-carboxylic acid | ESD-892373-250MG |
| Cas.: 23584-85-2 | Purity: 97% | 5-Phenyl-2-(trifluoromethyl)furan-3-carboxylic acid | ESD-892373-1G |
| Cas.: 23584-85-2 | Purity: 97% | 5-Phenyl-2-(trifluoromethyl)furan-3-carboxylic acid | ESD-892373-5G |
| Cas.: 186593-54-4 | Purity: ≥95% | 5-Bromo-6-fluoropyridin-3-ol | ESD-892374-250MG |
| Cas.: 100751-63-1 | Purity: 97% | 6-Bromo-2-naphthylmethanol | ESD-892375-100MG |
| Cas.: 100751-63-1 | Purity: 97% | 6-Bromo-2-naphthylmethanol | ESD-892375-250MG |
| Cas.: 100751-63-1 | Purity: 97% | 6-Bromo-2-naphthylmethanol | ESD-892375-1G |
| Cas.: 100751-63-1 | Purity: 97% | 6-Bromo-2-naphthylmethanol | ESD-892375-5G |
| Cas.: 709648-80-6 | Purity: ≥95% | methyl4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carboxylate | ESD-892376-100MG |
| Cas.: 709648-80-6 | Purity: ≥95% | methyl4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carboxylate | ESD-892376-250MG |
| Cas.: 709648-80-6 | Purity: ≥95% | methyl4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carboxylate | ESD-892376-1G |
| Cas.: 41384-83-2 | Purity: ≥95% | 4-Nitro-1-phenyl-1H-imidazole | ESD-892377-250MG |
| Cas.: 41384-83-2 | Purity: ≥95% | 4-Nitro-1-phenyl-1H-imidazole | ESD-892377-1G |
| Cas.: 43077-77-6 | Purity: ≥95% | 5-Hydroxy-4-oxo-1,4-dihydropyridine-2-carboxylic acid | ESD-892378-100MG |
| Cas.: 43077-77-6 | Purity: ≥95% | 5-Hydroxy-4-oxo-1,4-dihydropyridine-2-carboxylic acid | ESD-892378-250MG |
| Cas.: 405057-75-2 | Purity: 97% | 1-Cbz-4-Methylaminopieridine | ESD-892379-100MG |
| Cas.: 405057-75-2 | Purity: 97% | 1-Cbz-4-Methylaminopieridine | ESD-892379-250MG |
| Cas.: 405057-75-2 | Purity: 97% | 1-Cbz-4-Methylaminopieridine | ESD-892379-1G |
| Cas.: 405057-75-2 | Purity: 97% | 1-Cbz-4-Methylaminopieridine | ESD-892379-5G |
| Cas.: 186698-58-8 | Purity: 97% | HD-Tyr(tBu)-OH | ESD-892380-250MG |
| Cas.: 186698-58-8 | Purity: 97% | HD-Tyr(tBu)-OH | ESD-892380-1G |
| Cas.: 186698-58-8 | Purity: 97% | HD-Tyr(tBu)-OH | ESD-892380-5G |
| Cas.: 186698-58-8 | Purity: 97% | HD-Tyr(tBu)-OH | ESD-892380-10G |
| Cas.: 7013-05-0 | Purity: ≥95% | (S)-4-Amino-3-hydroxybutanoic acid | ESD-892381-250MG |
| Cas.: 7013-05-0 | Purity: ≥95% | (S)-4-Amino-3-hydroxybutanoic acid | ESD-892381-1G |
| Cas.: 7013-05-0 | Purity: ≥95% | (S)-4-Amino-3-hydroxybutanoic acid | ESD-892381-5G |
| Cas.: 16504-56-6 | Purity: 98% | (R)-3-Amino-4-hydroxybutanoic acid | ESD-892382-1G |
| Cas.: 16504-56-6 | Purity: 98% | (R)-3-Amino-4-hydroxybutanoic acid | ESD-892382-5G |
| Cas.: 16504-56-6 | Purity: 98% | (R)-3-Amino-4-hydroxybutanoic acid | ESD-892382-10G |
| Cas.: 313368-85-3 | Purity: 95% | (6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3- de]quinoxaline | ESD-892383-100MG |
| Cas.: 313368-85-3 | Purity: 95% | (6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3- de]quinoxaline | ESD-892383-250MG |
| Cas.: 313368-85-3 | Purity: 95% | (6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3- de]quinoxaline | ESD-892383-1G |
| Cas.: 74339-45-0 | Purity: ≥95% | Methyl 2-(5-chloro-1H-indol-3-yl)acetate | ESD-892384-250MG |
| Cas.: 74339-45-0 | Purity: ≥95% | Methyl 2-(5-chloro-1H-indol-3-yl)acetate | ESD-892384-1G |
| Cas.: 74339-45-0 | Purity: ≥95% | Methyl 2-(5-chloro-1H-indol-3-yl)acetate | ESD-892384-5G |
| Cas.: 848821-06-7 | Purity: 97% | 4-Cyanotetrahydro-2H-pyran-4-carboxylic acid | ESD-892385-100MG |
| Cas.: 848821-06-7 | Purity: 97% | 4-Cyanotetrahydro-2H-pyran-4-carboxylic acid | ESD-892385-250MG |
| Cas.: 848821-06-7 | Purity: 97% | 4-Cyanotetrahydro-2H-pyran-4-carboxylic acid | ESD-892385-1G |
| Cas.: 848821-06-7 | Purity: 97% | 4-Cyanotetrahydro-2H-pyran-4-carboxylic acid | ESD-892385-5G |
| Cas.: 132549-43-0 | Purity: 98% | (S)-3-((tert-Butoxycarbonyl)amino)-5-methylhexanoic acid | ESD-892386-100MG |
| Cas.: 132549-43-0 | Purity: 98% | (S)-3-((tert-Butoxycarbonyl)amino)-5-methylhexanoic acid | ESD-892386-250MG |
| Cas.: 132549-43-0 | Purity: 98% | (S)-3-((tert-Butoxycarbonyl)amino)-5-methylhexanoic acid | ESD-892386-1G |
| Cas.: 132549-43-0 | Purity: 98% | (S)-3-((tert-Butoxycarbonyl)amino)-5-methylhexanoic acid | ESD-892386-5G |
| Cas.: 10102-94-0 | Purity: 97% | 5-Bromo-1-methyl-1H-indole-3-carbaldehyde | ESD-892387-250MG |
| Cas.: 10102-94-0 | Purity: 97% | 5-Bromo-1-methyl-1H-indole-3-carbaldehyde | ESD-892387-1G |
| Cas.: 10102-94-0 | Purity: 97% | 5-Bromo-1-methyl-1H-indole-3-carbaldehyde | ESD-892387-5G |
| Cas.: 183483-29-6 | Purity: ≥95% | 2-(2-Bromopyridin-4-yl)acetic acid | ESD-892388-250MG |
| Cas.: 183483-29-6 | Purity: ≥95% | 2-(2-Bromopyridin-4-yl)acetic acid | ESD-892388-1G |
| Cas.: 183483-29-6 | Purity: ≥95% | 2-(2-Bromopyridin-4-yl)acetic acid | ESD-892388-5G |
| Cas.: 183483-29-6 | Purity: ≥95% | 2-(2-Bromopyridin-4-yl)acetic acid | ESD-892388-10G |
| Cas.: 23690-49-5 | Purity: 95% | 2-(1H-Indol-5-yl)acetonitrile | ESD-892389-100MG |
| Cas.: 23690-49-5 | Purity: 95% | 2-(1H-Indol-5-yl)acetonitrile | ESD-892389-250MG |
| Cas.: 23690-49-5 | Purity: 95% | 2-(1H-Indol-5-yl)acetonitrile | ESD-892389-1G |
| Cas.: 1190318-10-5 | Purity: ≥95% | 7-Chloro-3-iodo-1H-pyrrolo[3,2-b]pyridine | ESD-892390-100MG |
| Cas.: 1190318-10-5 | Purity: ≥95% | 7-Chloro-3-iodo-1H-pyrrolo[3,2-b]pyridine | ESD-892390-250MG |
| Cas.: 944937-79-5 | Purity: 95% | 1H-Pyrrolo[3,2-b]pyridine-6-carbonitrile | ESD-892391-100MG |
| Cas.: 944937-79-5 | Purity: 95% | 1H-Pyrrolo[3,2-b]pyridine-6-carbonitrile | ESD-892391-250MG |
| Cas.: 944937-79-5 | Purity: 95% | 1H-Pyrrolo[3,2-b]pyridine-6-carbonitrile | ESD-892391-1G |
| Cas.: 944937-79-5 | Purity: 95% | 1H-Pyrrolo[3,2-b]pyridine-6-carbonitrile | ESD-892391-5G |
| Cas.: 53590-59-3 | Purity: 97% | 6-Chloro-1H-indole-2-carbaldehyde | ESD-892392-100MG |
| Cas.: 53590-59-3 | Purity: 97% | 6-Chloro-1H-indole-2-carbaldehyde | ESD-892392-250MG |
| Cas.: 53590-59-3 | Purity: 97% | 6-Chloro-1H-indole-2-carbaldehyde | ESD-892392-1G |
| Cas.: 1213876-98-2 | Purity: 97% | (S)-2-Amino-2-(3-ethoxy-4-methoxyphenyl)ethanol | ESD-892393-250MG |
| Cas.: 1213876-98-2 | Purity: 97% | (S)-2-Amino-2-(3-ethoxy-4-methoxyphenyl)ethanol | ESD-892393-1G |
| Cas.: 1213876-98-2 | Purity: 97% | (S)-2-Amino-2-(3-ethoxy-4-methoxyphenyl)ethanol | ESD-892393-5G |
| Cas.: 95331-56-9 | Purity: ≥95% | 4-(Oxazolo[4,5-b]pyridin-2-yl)aniline | ESD-892394-100MG |
| Cas.: 95331-56-9 | Purity: ≥95% | 4-(Oxazolo[4,5-b]pyridin-2-yl)aniline | ESD-892394-250MG |
| Cas.: 35325-02-1 | Purity: 97% | N-(2-Hydroxypropyl)benzenesulfonamide | ESD-892395-1G |
| Cas.: 35325-02-1 | Purity: 97% | N-(2-Hydroxypropyl)benzenesulfonamide | ESD-892395-5G |
| Cas.: 35325-02-1 | Purity: 97% | N-(2-Hydroxypropyl)benzenesulfonamide | ESD-892395-10G |
| Cas.: 24309-97-5 | Purity: ≥95% | N-(2-Hydroxyethyl)-3-oxobutanamide | ESD-892396-100MG |
| Cas.: 24309-97-5 | Purity: ≥95% | N-(2-Hydroxyethyl)-3-oxobutanamide | ESD-892396-250MG |
| Cas.: 24309-97-5 | Purity: ≥95% | N-(2-Hydroxyethyl)-3-oxobutanamide | ESD-892396-1G |
| Cas.: 439134-78-8 | Purity: ≥95% | 5-(Bromomethyl)-4-methyl-2-(4-(trifluoromethyl)phenyl)thiazole | ESD-892397-100MG |
| Cas.: 439134-78-8 | Purity: ≥95% | 5-(Bromomethyl)-4-methyl-2-(4-(trifluoromethyl)phenyl)thiazole | ESD-892397-250MG |
| Cas.: 439134-78-8 | Purity: ≥95% | 5-(Bromomethyl)-4-methyl-2-(4-(trifluoromethyl)phenyl)thiazole | ESD-892397-1G |
| Cas.: 325744-41-0 | Purity: ≥95% | 5-(Chloromethyl)-3-(4-methoxyphenyl)isoxazole | ESD-892398-100MG |
| Cas.: 325744-41-0 | Purity: ≥95% | 5-(Chloromethyl)-3-(4-methoxyphenyl)isoxazole | ESD-892398-250MG |
| Cas.: 325744-41-0 | Purity: ≥95% | 5-(Chloromethyl)-3-(4-methoxyphenyl)isoxazole | ESD-892398-1G |
| Cas.: 53590-49-1 | Purity: 97% | 5-Chloro-1H-indole-2-carbaldehyde | ESD-892399-100MG |
| Cas.: 53590-49-1 | Purity: 97% | 5-Chloro-1H-indole-2-carbaldehyde | ESD-892399-250MG |
| Cas.: 53590-49-1 | Purity: 97% | 5-Chloro-1H-indole-2-carbaldehyde | ESD-892399-1G |
| Cas.: 53590-49-1 | Purity: 97% | 5-Chloro-1H-indole-2-carbaldehyde | ESD-892399-5G |
| Cas.: 23981-25-1 | Purity: 97% | 8-Chloroquinolin-2-ol | ESD-892400-1G |
| Cas.: 23981-25-1 | Purity: 97% | 8-Chloroquinolin-2-ol | ESD-892400-5G |
| Cas.: 23981-25-1 | Purity: 97% | 8-Chloroquinolin-2-ol | ESD-892400-10G |
| Cas.: 23981-25-1 | Purity: 97% | 8-Chloroquinolin-2-ol | ESD-892400-25G |
| Cas.: 92926-60-8 | Purity: ≥95% | 6-Bromospiro[benzo[d][1,3]oxazine-4,4′-piperidin]-2(1H)-one | ESD-892401-100MG |
| Cas.: 885278-33-1 | Purity: ≥95% | 6-Fluoro-1H-indazole-3-carbonitrile | ESD-892402-100MG |
| Cas.: 885278-33-1 | Purity: ≥95% | 6-Fluoro-1H-indazole-3-carbonitrile | ESD-892402-250MG |
| Cas.: 885278-33-1 | Purity: ≥95% | 6-Fluoro-1H-indazole-3-carbonitrile | ESD-892402-1G |
| Cas.: 885278-33-1 | Purity: ≥95% | 6-Fluoro-1H-indazole-3-carbonitrile | ESD-892402-5G |
| Cas.: 870997-87-8 | Purity: ≥95% | 2-Amino-N-methylnicotinamide | ESD-892403-100MG |
| Cas.: 870997-87-8 | Purity: ≥95% | 2-Amino-N-methylnicotinamide | ESD-892403-250MG |
| Cas.: 870997-87-8 | Purity: ≥95% | 2-Amino-N-methylnicotinamide | ESD-892403-1G |
| Cas.: 870997-87-8 | Purity: ≥95% | 2-Amino-N-methylnicotinamide | ESD-892403-5G |
| Cas.: 461699-81-0 | Purity: 98% | 2-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-892404-1G |
| Cas.: 461699-81-0 | Purity: 98% | 2-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-892404-5G |
| Cas.: 461699-81-0 | Purity: 98% | 2-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-892404-10G |
| Cas.: 54904-38-0 | Purity: ≥95% | 8-Chloro-4-methylquinolin-2(1H)-one | ESD-892405-100MG |
| Cas.: 54904-38-0 | Purity: ≥95% | 8-Chloro-4-methylquinolin-2(1H)-one | ESD-892405-250MG |
| Cas.: 54904-38-0 | Purity: ≥95% | 8-Chloro-4-methylquinolin-2(1H)-one | ESD-892405-1G |
| Cas.: 944559-46-0 | Purity: 97% | Ethyl 2-(4-methylpent-2-enoyl)thiazole-4-carboxylate | ESD-892406-100MG |
| Cas.: 944559-46-0 | Purity: 97% | Ethyl 2-(4-methylpent-2-enoyl)thiazole-4-carboxylate | ESD-892406-250MG |
| Cas.: 944559-46-0 | Purity: 97% | Ethyl 2-(4-methylpent-2-enoyl)thiazole-4-carboxylate | ESD-892406-1G |
| Cas.: 884495-30-1 | Purity: ≥95% | 5-Fluoro-2-methoxyisonicotinic acid | ESD-892407-100MG |
| Cas.: 884495-30-1 | Purity: ≥95% | 5-Fluoro-2-methoxyisonicotinic acid | ESD-892407-250MG |
| Cas.: 884495-30-1 | Purity: ≥95% | 5-Fluoro-2-methoxyisonicotinic acid | ESD-892407-1G |
| Cas.: 884495-30-1 | Purity: ≥95% | 5-Fluoro-2-methoxyisonicotinic acid | ESD-892407-5G |
| Cas.: 1208-87-3 | Purity: 95% | (4-(Chloromethyl)phenyl)(phenyl)sulfane | ESD-892408-1G |
| Cas.: 1208-87-3 | Purity: 95% | (4-(Chloromethyl)phenyl)(phenyl)sulfane | ESD-892408-5G |
| Cas.: 1208-87-3 | Purity: 95% | (4-(Chloromethyl)phenyl)(phenyl)sulfane | ESD-892408-10G |
| Cas.: 1117-52-8 | Purity: ≥95% | (5E,9E)-6,10,14-Trimethylpentadeca-5,9,13-trien-2-one | ESD-892409-1G |
| Cas.: 1117-52-8 | Purity: ≥95% | (5E,9E)-6,10,14-Trimethylpentadeca-5,9,13-trien-2-one | ESD-892409-5G |
| Cas.: 1117-52-8 | Purity: ≥95% | (5E,9E)-6,10,14-Trimethylpentadeca-5,9,13-trien-2-one | ESD-892409-10G |
| Cas.: 1303588-27-3 | Purity: ≥95% | 7-Chloro-1,2,3,4-tetrahydro-1,8-naphthyridine | ESD-892410-100MG |
| Cas.: 1303588-27-3 | Purity: ≥95% | 7-Chloro-1,2,3,4-tetrahydro-1,8-naphthyridine | ESD-892410-250MG |
| Cas.: 793-19-1 | Purity: 97% | Dimethyl 3,3′-(benzylazanediyl)dipropanoate | ESD-892411-250MG |
| Cas.: 793-19-1 | Purity: 97% | Dimethyl 3,3′-(benzylazanediyl)dipropanoate | ESD-892411-1G |
| Cas.: 793-19-1 | Purity: 97% | Dimethyl 3,3′-(benzylazanediyl)dipropanoate | ESD-892411-5G |
| Cas.: 33371-00-5 | Purity: ≥95% | 4-Chloro-6,7,8-trimethoxyquinazoline | ESD-892412-50MG |
| Cas.: 724422-42-8 | Purity: 97% | 6-Bromo-2-methyl-3,4-dihydroisoquinolin-1(2H)-one | ESD-892413-100MG |
| Cas.: 724422-42-8 | Purity: 97% | 6-Bromo-2-methyl-3,4-dihydroisoquinolin-1(2H)-one | ESD-892413-250MG |
| Cas.: 59565-54-7 | Purity: ≥95% | 5-(o-Tolyl)-1,3,4-thiadiazol-2-amine | ESD-892414-250MG |
| Cas.: 59565-54-7 | Purity: ≥95% | 5-(o-Tolyl)-1,3,4-thiadiazol-2-amine | ESD-892414-1G |
| Cas.: 59565-54-7 | Purity: ≥95% | 5-(o-Tolyl)-1,3,4-thiadiazol-2-amine | ESD-892414-5G |
| Cas.: 59565-54-7 | Purity: ≥95% | 5-(o-Tolyl)-1,3,4-thiadiazol-2-amine | ESD-892414-10G |
| Cas.: 88312-64-5 | Purity: 97% | Methyl 2-amino-5-nitronicotinate | ESD-892415-100MG |
| Cas.: 88312-64-5 | Purity: 97% | Methyl 2-amino-5-nitronicotinate | ESD-892415-250MG |
| Cas.: 88312-64-5 | Purity: 97% | Methyl 2-amino-5-nitronicotinate | ESD-892415-1G |
| Cas.: 88312-64-5 | Purity: 97% | Methyl 2-amino-5-nitronicotinate | ESD-892415-5G |
| Cas.: 299162-83-7 | Purity: ≥95% | 1-(4-Fluorophenyl)-5-phenyl-1H-pyrazole | ESD-892416-100MG |
| Cas.: 299162-83-7 | Purity: ≥95% | 1-(4-Fluorophenyl)-5-phenyl-1H-pyrazole | ESD-892416-250MG |
| Cas.: 299162-83-7 | Purity: ≥95% | 1-(4-Fluorophenyl)-5-phenyl-1H-pyrazole | ESD-892416-1G |
| Cas.: 299162-83-7 | Purity: ≥95% | 1-(4-Fluorophenyl)-5-phenyl-1H-pyrazole | ESD-892416-5G |
| Cas.: 957035-08-4 | Purity: 97% | (6-Bromo-3-fluoro-2-methoxyphenyl)boronic acid | ESD-892417-100MG |
| Cas.: 957035-08-4 | Purity: 97% | (6-Bromo-3-fluoro-2-methoxyphenyl)boronic acid | ESD-892417-250MG |
| Cas.: 957035-08-4 | Purity: 97% | (6-Bromo-3-fluoro-2-methoxyphenyl)boronic acid | ESD-892417-1G |
| Cas.: 957035-08-4 | Purity: 97% | (6-Bromo-3-fluoro-2-methoxyphenyl)boronic acid | ESD-892417-5G |
| Cas.: 10087-64-6 | Purity: 97% | 1H,1’H-2,2′-Bipyrrole | ESD-892418-100MG |
| Cas.: 10087-64-6 | Purity: 97% | 1H,1’H-2,2′-Bipyrrole | ESD-892418-250MG |
| Cas.: 10087-64-6 | Purity: 97% | 1H,1’H-2,2′-Bipyrrole | ESD-892418-1G |
| Cas.: 478375-42-7 | Purity: ≥95% | Methyl 2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate | ESD-892419-100MG |
| Cas.: 478375-42-7 | Purity: ≥95% | Methyl 2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate | ESD-892419-250MG |
| Cas.: 478375-42-7 | Purity: ≥95% | Methyl 2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate | ESD-892419-1G |
| Cas.: 478375-42-7 | Purity: ≥95% | Methyl 2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate | ESD-892419-5G |
| Cas.: 14346-13-5 | Purity: 97% | 2,5-Diaminobenzonitrile | ESD-892420-250MG |
| Cas.: 14346-13-5 | Purity: 97% | 2,5-Diaminobenzonitrile | ESD-892420-1G |
| Cas.: 14346-13-5 | Purity: 97% | 2,5-Diaminobenzonitrile | ESD-892420-5G |
| Cas.: 14346-13-5 | Purity: 97% | 2,5-Diaminobenzonitrile | ESD-892420-10G |
| Cas.: 865604-20-2 | Purity: ≥95% | 3,4′-Bipyridin-2′-amine | ESD-892421-100MG |
| Cas.: 865604-20-2 | Purity: ≥95% | 3,4′-Bipyridin-2′-amine | ESD-892421-250MG |
| Cas.: 865604-20-2 | Purity: ≥95% | 3,4′-Bipyridin-2′-amine | ESD-892421-1G |
| Cas.: 865604-20-2 | Purity: ≥95% | 3,4′-Bipyridin-2′-amine | ESD-892421-5G |
| Cas.: 800401-64-3 | Purity: 97% | Ethyl 1H-pyrrolo[3,2-c]pyridine-2-carboxylate | ESD-892422-100MG |
| Cas.: 800401-64-3 | Purity: 97% | Ethyl 1H-pyrrolo[3,2-c]pyridine-2-carboxylate | ESD-892422-250MG |
| Cas.: 800401-64-3 | Purity: 97% | Ethyl 1H-pyrrolo[3,2-c]pyridine-2-carboxylate | ESD-892422-1G |
| Cas.: 800401-64-3 | Purity: 97% | Ethyl 1H-pyrrolo[3,2-c]pyridine-2-carboxylate | ESD-892422-5G |
| Cas.: 159532-59-9 | Purity: 97% | (S)-1-(tert-Butoxycarbonyl)piperazine-2-carboxylic acid | ESD-892423-100MG |
| Cas.: 159532-59-9 | Purity: 97% | (S)-1-(tert-Butoxycarbonyl)piperazine-2-carboxylic acid | ESD-892423-250MG |
| Cas.: 159532-59-9 | Purity: 97% | (S)-1-(tert-Butoxycarbonyl)piperazine-2-carboxylic acid | ESD-892423-1G |
| Cas.: 159532-59-9 | Purity: 97% | (S)-1-(tert-Butoxycarbonyl)piperazine-2-carboxylic acid | ESD-892423-5G |
| Cas.: 20736-25-8 | Purity: ≥95% | 4-(3-Hydroxypropyl)-2,6-dimethoxyphenol | ESD-892424-100MG |
| Cas.: 20736-25-8 | Purity: ≥95% | 4-(3-Hydroxypropyl)-2,6-dimethoxyphenol | ESD-892424-250MG |
| Cas.: 1567534-28-4 | Purity: 97% | 2-Cyano-3-(thiazol-2-yl)acrylic acid | ESD-892425-100MG |
| Cas.: 1567534-28-4 | Purity: 97% | 2-Cyano-3-(thiazol-2-yl)acrylic acid | ESD-892425-250MG |
| Cas.: 67139-79-1 | Purity: 97% | 4,6-Dichloro-1H-pyrrolo[3,2-c]pyridine | ESD-892426-100MG |
| Cas.: 67139-79-1 | Purity: 97% | 4,6-Dichloro-1H-pyrrolo[3,2-c]pyridine | ESD-892426-250MG |
| Cas.: 67139-79-1 | Purity: 97% | 4,6-Dichloro-1H-pyrrolo[3,2-c]pyridine | ESD-892426-1G |
| Cas.: 67139-79-1 | Purity: 97% | 4,6-Dichloro-1H-pyrrolo[3,2-c]pyridine | ESD-892426-5G |
| Cas.: 383130-78-7 | Purity: 95% | 5-(4-Ethylphenyl)-1,3,4-thiadiazol-2-amine | ESD-892427-100MG |
| Cas.: 383130-78-7 | Purity: 95% | 5-(4-Ethylphenyl)-1,3,4-thiadiazol-2-amine | ESD-892427-250MG |
| Cas.: 850198-02-6 | Purity: ≥95% | 6-Bromoisoquinolin-5-amine | ESD-892428-100MG |
| Cas.: 850198-02-6 | Purity: ≥95% | 6-Bromoisoquinolin-5-amine | ESD-892428-250MG |
| Cas.: 850198-02-6 | Purity: ≥95% | 6-Bromoisoquinolin-5-amine | ESD-892428-1G |
| Cas.: 14548-45-9 | Purity: ≥95% | (4-Bromophenyl)(pyridin-3-yl)methanone | ESD-892429-100MG |
| Cas.: 14548-45-9 | Purity: ≥95% | (4-Bromophenyl)(pyridin-3-yl)methanone | ESD-892429-250MG |
| Cas.: 14548-45-9 | Purity: ≥95% | (4-Bromophenyl)(pyridin-3-yl)methanone | ESD-892429-1G |
| Cas.: 14548-45-9 | Purity: ≥95% | (4-Bromophenyl)(pyridin-3-yl)methanone | ESD-892429-5G |
| Cas.: 89180-50-7 | Purity: 97% | 5,6-Dichloropyridazin-4-amine | ESD-892430-100MG |
| Cas.: 89180-50-7 | Purity: 97% | 5,6-Dichloropyridazin-4-amine | ESD-892430-250MG |
| Cas.: 89180-50-7 | Purity: 97% | 5,6-Dichloropyridazin-4-amine | ESD-892430-1G |
| Cas.: 133997-05-4 | Purity: 97% | (4-Octylphenyl)boronic acid | ESD-892431-100MG |
| Cas.: 133997-05-4 | Purity: 97% | (4-Octylphenyl)boronic acid | ESD-892431-250MG |
| Cas.: 1073371-77-3 | Purity: 96% | 4-Chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-892432-100MG |
| Cas.: 1073371-77-3 | Purity: 96% | 4-Chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-892432-250MG |
| Cas.: 1073371-77-3 | Purity: 96% | 4-Chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-892432-1G |
| Cas.: 1073371-77-3 | Purity: 96% | 4-Chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-892432-5G |
| Cas.: 23039-94-3 | Purity: 97% | Tris(3-fluorophenyl)phosphine | ESD-892433-1G |
| Cas.: 23039-94-3 | Purity: 97% | Tris(3-fluorophenyl)phosphine | ESD-892433-5G |
| Cas.: 23039-94-3 | Purity: 97% | Tris(3-fluorophenyl)phosphine | ESD-892433-25G |
| Cas.: 132622-78-7 | Purity: ≥95% | (2R,4S)-4-Amino-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid | ESD-892434-100MG |
| Cas.: 132622-78-7 | Purity: ≥95% | (2R,4S)-4-Amino-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid | ESD-892434-250MG |
| Cas.: 132622-78-7 | Purity: ≥95% | (2R,4S)-4-Amino-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid | ESD-892434-1G |
| Cas.: 132622-78-7 | Purity: ≥95% | (2R,4S)-4-Amino-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid | ESD-892434-5G |
| Cas.: 1150114-28-5 | Purity: 95% | (2,6-Difluoro-3-nitrophenyl)boronic acid | ESD-892435-250MG |
| Cas.: 1150114-28-5 | Purity: 95% | (2,6-Difluoro-3-nitrophenyl)boronic acid | ESD-892435-1G |
| Cas.: 1150114-28-5 | Purity: 95% | (2,6-Difluoro-3-nitrophenyl)boronic acid | ESD-892435-5G |
| Cas.: 1150114-28-5 | Purity: 95% | (2,6-Difluoro-3-nitrophenyl)boronic acid | ESD-892435-10G |
| Cas.: 352525-80-5 | Purity: 96% | (3-Bromo-2-methoxyphenyl)boronic acid | ESD-892436-250MG |
| Cas.: 352525-80-5 | Purity: 96% | (3-Bromo-2-methoxyphenyl)boronic acid | ESD-892436-1G |
| Cas.: 352525-80-5 | Purity: 96% | (3-Bromo-2-methoxyphenyl)boronic acid | ESD-892436-5G |
| Cas.: 124643-45-4 | Purity: 97% | 2-(p-Tolylethynyl)aniline | ESD-892437-100MG |
| Cas.: 124643-45-4 | Purity: 97% | 2-(p-Tolylethynyl)aniline | ESD-892437-250MG |
| Cas.: 124643-45-4 | Purity: 97% | 2-(p-Tolylethynyl)aniline | ESD-892437-1G |
| Cas.: 550998-59-9 | Purity: 96% | 7-Bromobenzofuran-2-carboxylic acid | ESD-892438-100MG |
| Cas.: 550998-59-9 | Purity: 96% | 7-Bromobenzofuran-2-carboxylic acid | ESD-892438-250MG |
| Cas.: 550998-59-9 | Purity: 96% | 7-Bromobenzofuran-2-carboxylic acid | ESD-892438-1G |
| Cas.: 550998-59-9 | Purity: 96% | 7-Bromobenzofuran-2-carboxylic acid | ESD-892438-5G |
| Cas.: 128811-37-0 | Purity: 97% | Boc-D-Pyroglutaminol | ESD-892439-250MG |
| Cas.: 128811-37-0 | Purity: 97% | Boc-D-Pyroglutaminol | ESD-892439-1G |
| Cas.: 6297-93-4 | Purity: 95% | tert-Butyl 2-(1,3-dioxoisoindolin-2-yl)acetate | ESD-892440-250MG |
| Cas.: 6297-93-4 | Purity: 95% | tert-Butyl 2-(1,3-dioxoisoindolin-2-yl)acetate | ESD-892440-1G |
| Cas.: 6297-93-4 | Purity: 95% | tert-Butyl 2-(1,3-dioxoisoindolin-2-yl)acetate | ESD-892440-5G |
| Cas.: 6297-93-4 | Purity: 95% | tert-Butyl 2-(1,3-dioxoisoindolin-2-yl)acetate | ESD-892440-10G |
| Cas.: 13402-55-6 | Purity: 97% | 4-Hydroxyindolin-2-one | ESD-892441-100MG |
| Cas.: 13402-55-6 | Purity: 97% | 4-Hydroxyindolin-2-one | ESD-892441-250MG |
| Cas.: 13402-55-6 | Purity: 97% | 4-Hydroxyindolin-2-one | ESD-892441-1G |
| Cas.: 66319-09-3 | Purity: ≥95% | 4-Amino-5-methylthiophene-3-carboxylic acid | ESD-892442-100MG |
| Cas.: 66319-09-3 | Purity: ≥95% | 4-Amino-5-methylthiophene-3-carboxylic acid | ESD-892442-250MG |
| Cas.: 121816-79-3 | Purity: 97% | 4-Bromo-1-methyl-2-nitro-1H-imidazole | ESD-892443-100MG |
| Cas.: 121816-79-3 | Purity: 97% | 4-Bromo-1-methyl-2-nitro-1H-imidazole | ESD-892443-250MG |
| Cas.: 121816-79-3 | Purity: 97% | 4-Bromo-1-methyl-2-nitro-1H-imidazole | ESD-892443-1G |
| Cas.: 34547-28-9 | Purity: 97% | 2-(4-Fluorophenyl)acetohydrazide | ESD-892444-100MG |
| Cas.: 34547-28-9 | Purity: 97% | 2-(4-Fluorophenyl)acetohydrazide | ESD-892444-250MG |
| Cas.: 34547-28-9 | Purity: 97% | 2-(4-Fluorophenyl)acetohydrazide | ESD-892444-1G |
| Cas.: 34547-28-9 | Purity: 97% | 2-(4-Fluorophenyl)acetohydrazide | ESD-892444-5G |
| Cas.: 4741-62-2 | Purity: 97% | 5-Methoxyisobenzofuran-1(3H)-one | ESD-892445-100MG |
| Cas.: 4741-62-2 | Purity: 97% | 5-Methoxyisobenzofuran-1(3H)-one | ESD-892445-250MG |
| Cas.: 873429-57-3 | Purity: ≥95% | (S)-2-Amino-3-(2,3-dichlorophenyl)propanoic acid | ESD-892446-100MG |
| Cas.: 873429-57-3 | Purity: ≥95% | (S)-2-Amino-3-(2,3-dichlorophenyl)propanoic acid | ESD-892446-250MG |
| Cas.: 873429-57-3 | Purity: ≥95% | (S)-2-Amino-3-(2,3-dichlorophenyl)propanoic acid | ESD-892446-1G |
| Cas.: 1211581-51-9 | Purity: ≥95% | 2-(Difluoromethoxy)isonicotinic acid | ESD-892447-100MG |
| Cas.: 1211581-51-9 | Purity: ≥95% | 2-(Difluoromethoxy)isonicotinic acid | ESD-892447-250MG |
| Cas.: 1211581-51-9 | Purity: ≥95% | 2-(Difluoromethoxy)isonicotinic acid | ESD-892447-1G |
| Cas.: 176967-80-9 | Purity: ≥95% | 5-Bromo-8-nitroquinoline | ESD-892448-100MG |
| Cas.: 176967-80-9 | Purity: ≥95% | 5-Bromo-8-nitroquinoline | ESD-892448-250MG |
| Cas.: 176967-80-9 | Purity: ≥95% | 5-Bromo-8-nitroquinoline | ESD-892448-1G |
| Cas.: 176967-80-9 | Purity: ≥95% | 5-Bromo-8-nitroquinoline | ESD-892448-5G |
| Cas.: 147769-93-5 | Purity: 97% | (S)-3-Methyl-1-(2-(pipidin-1-yl)phenyl)butan-1-amine | ESD-892449-1G |
| Cas.: 147769-93-5 | Purity: 97% | (S)-3-Methyl-1-(2-(pipidin-1-yl)phenyl)butan-1-amine | ESD-892449-5G |
| Cas.: 84594-78-5 | Purity: 97% | 6-Nitro-2,3-dihydrobenzofuran-5-amine | ESD-892450-250MG |
| Cas.: 84594-78-5 | Purity: 97% | 6-Nitro-2,3-dihydrobenzofuran-5-amine | ESD-892450-1G |
| Cas.: 84594-78-5 | Purity: 97% | 6-Nitro-2,3-dihydrobenzofuran-5-amine | ESD-892450-5G |
| Cas.: 84594-78-5 | Purity: 97% | 6-Nitro-2,3-dihydrobenzofuran-5-amine | ESD-892450-10G |
| Cas.: 1367986-07-9 | Purity: ≥95% | 2-Chloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine | ESD-892451-100MG |
| Cas.: 1367986-07-9 | Purity: ≥95% | 2-Chloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine | ESD-892451-250MG |
| Cas.: 57339-57-8 | Purity: ≥95% | 6-Bromoquinolin-8-amine | ESD-892452-250MG |
| Cas.: 57339-57-8 | Purity: ≥95% | 6-Bromoquinolin-8-amine | ESD-892452-1G |
| Cas.: 57339-57-8 | Purity: ≥95% | 6-Bromoquinolin-8-amine | ESD-892452-5G |
| Cas.: 6836-21-1 | Purity: 97% | Ethyl 2-(7-methoxynaphthalen-1-yl)acetate | ESD-892453-1G |
| Cas.: 6836-21-1 | Purity: 97% | Ethyl 2-(7-methoxynaphthalen-1-yl)acetate | ESD-892453-5G |
| Cas.: 6836-21-1 | Purity: 97% | Ethyl 2-(7-methoxynaphthalen-1-yl)acetate | ESD-892453-10G |
| Cas.: 65938-79-6 | Purity: 95% | 3-Methylpyridine-2-sulfonamide | ESD-892454-100MG |
| Cas.: 65938-79-6 | Purity: 95% | 3-Methylpyridine-2-sulfonamide | ESD-892454-250MG |
| Cas.: 6972-86-7 | Purity: ≥95% | Ethyl 6-hydroxyquinoline-3-carboxylate | ESD-892455-100MG |
| Cas.: 6972-86-7 | Purity: ≥95% | Ethyl 6-hydroxyquinoline-3-carboxylate | ESD-892455-250MG |
| Cas.: 1435806-78-2 | Purity: ≥95% | 5-Fluoro-2-methoxy-4-nitroaniline | ESD-892456-1G |
| Cas.: 1435806-78-2 | Purity: ≥95% | 5-Fluoro-2-methoxy-4-nitroaniline | ESD-892456-5G |
| Cas.: 1435806-78-2 | Purity: ≥95% | 5-Fluoro-2-methoxy-4-nitroaniline | ESD-892456-10G |
| Cas.: 316808-11-4 | Purity: 97% | Dimethyl 3-bromopyridine-2,6-dicarboxylate | ESD-892457-100MG |
| Cas.: 316808-11-4 | Purity: 97% | Dimethyl 3-bromopyridine-2,6-dicarboxylate | ESD-892457-250MG |
| Cas.: 159639-61-9 | Purity: ≥95% | 5,7-Dibromo-3,4-dihydronaphthalen-1(2H)-one | ESD-892458-100MG |
| Cas.: 159639-61-9 | Purity: ≥95% | 5,7-Dibromo-3,4-dihydronaphthalen-1(2H)-one | ESD-892458-250MG |
| Cas.: 64001-11-2 | Purity: ≥95% | 4-(1H-Tetrazol-1-yl)phenol | ESD-892459-100MG |
| Cas.: 64001-11-2 | Purity: ≥95% | 4-(1H-Tetrazol-1-yl)phenol | ESD-892459-250MG |
| Cas.: 64001-11-2 | Purity: ≥95% | 4-(1H-Tetrazol-1-yl)phenol | ESD-892459-1G |
| Cas.: 64001-11-2 | Purity: ≥95% | 4-(1H-Tetrazol-1-yl)phenol | ESD-892459-5G |
| Cas.: 885326-88-5 | Purity: 97% | Methyl 6-amino-4-bromopicolinate | ESD-892460-100MG |
| Cas.: 885326-88-5 | Purity: 97% | Methyl 6-amino-4-bromopicolinate | ESD-892460-250MG |
| Cas.: 54503-10-5 | Purity: ≥95% | tert-Butyl 2-carbamoylpyrrolidine-1-carboxylate | ESD-892461-250MG |
| Cas.: 54503-10-5 | Purity: ≥95% | tert-Butyl 2-carbamoylpyrrolidine-1-carboxylate | ESD-892461-1G |
| Cas.: 54503-10-5 | Purity: ≥95% | tert-Butyl 2-carbamoylpyrrolidine-1-carboxylate | ESD-892461-5G |
| Cas.: 54503-10-5 | Purity: ≥95% | tert-Butyl 2-carbamoylpyrrolidine-1-carboxylate | ESD-892461-10G |
| Cas.: 716-53-0 | Purity: 95% | 9-Chloroanthracene | ESD-892462-1G |
| Cas.: 716-53-0 | Purity: 95% | 9-Chloroanthracene | ESD-892462-5G |
| Cas.: 716-53-0 | Purity: 95% | 9-Chloroanthracene | ESD-892462-25G |
| Cas.: 98549-92-9 | Purity: ≥95% | 4-Hydroxy-2-aminobenzoxazol | ESD-892463-100MG |
| Cas.: 98549-92-9 | Purity: ≥95% | 4-Hydroxy-2-aminobenzoxazol | ESD-892463-250MG |
| Cas.: 196106-96-4 | Purity: 97% | 4-Bromo-1H-pyrrole-2-carboxamide | ESD-892464-250MG |
| Cas.: 196106-96-4 | Purity: 97% | 4-Bromo-1H-pyrrole-2-carboxamide | ESD-892464-1G |
| Cas.: 196106-96-4 | Purity: 97% | 4-Bromo-1H-pyrrole-2-carboxamide | ESD-892464-5G |
| Cas.: 208522-10-5 | Purity: ≥95% | (S)-2-((tert-Butoxycarbonyl)amino)-5-methylhexanoic acid | ESD-892465-1G |
| Cas.: 208522-10-5 | Purity: ≥95% | (S)-2-((tert-Butoxycarbonyl)amino)-5-methylhexanoic acid | ESD-892465-5G |
| Cas.: 130892-40-9 | Purity: 97% | tert-Butyl 2-((tert-butoxycarbonyl)amino)-2-cyanoacetate | ESD-892466-100MG |
| Cas.: 130892-40-9 | Purity: 97% | tert-Butyl 2-((tert-butoxycarbonyl)amino)-2-cyanoacetate | ESD-892466-250MG |
| Cas.: 727-99-1 | Purity: 98% | Phenyl(2-(trifluoromethyl)phenyl)methanone | ESD-892467-1G |
| Cas.: 727-99-1 | Purity: 98% | Phenyl(2-(trifluoromethyl)phenyl)methanone | ESD-892467-5G |
| Cas.: 727-99-1 | Purity: 98% | Phenyl(2-(trifluoromethyl)phenyl)methanone | ESD-892467-10G |
| Cas.: 727-99-1 | Purity: 98% | Phenyl(2-(trifluoromethyl)phenyl)methanone | ESD-892467-25G |
| Cas.: 365996-71-0 | Purity: ≥95% | Methyl 2-bromo-4-(2-methoxy-2-oxoethyl)thiazole-5-carboxylate | ESD-892468-100MG |
| Cas.: 365996-71-0 | Purity: ≥95% | Methyl 2-bromo-4-(2-methoxy-2-oxoethyl)thiazole-5-carboxylate | ESD-892468-250MG |
| Cas.: 365996-71-0 | Purity: ≥95% | Methyl 2-bromo-4-(2-methoxy-2-oxoethyl)thiazole-5-carboxylate | ESD-892468-1G |
| Cas.: 1234616-14-8 | Purity: 97% | Ethyl 1H-pyrazolo[4,3-b]pyridine-3-carboxylate | ESD-892469-100MG |
| Cas.: 1234616-14-8 | Purity: 97% | Ethyl 1H-pyrazolo[4,3-b]pyridine-3-carboxylate | ESD-892469-250MG |
| Cas.: 1234616-14-8 | Purity: 97% | Ethyl 1H-pyrazolo[4,3-b]pyridine-3-carboxylate | ESD-892469-1G |
| Cas.: 5851-46-7 | Purity: 97% | 2-Pentyl-1H-benzo[d]imidazole | ESD-892470-250MG |
| Cas.: 5851-46-7 | Purity: 97% | 2-Pentyl-1H-benzo[d]imidazole | ESD-892470-1G |
| Cas.: 5851-46-7 | Purity: 97% | 2-Pentyl-1H-benzo[d]imidazole | ESD-892470-5G |
| Cas.: 22536-62-5 | Purity: 97% | 2-Chloro-5-phenylpyrimidine | ESD-892471-100MG |
| Cas.: 22536-62-5 | Purity: 97% | 2-Chloro-5-phenylpyrimidine | ESD-892471-250MG |
| Cas.: 22536-62-5 | Purity: 97% | 2-Chloro-5-phenylpyrimidine | ESD-892471-1G |
| Cas.: 22536-62-5 | Purity: 97% | 2-Chloro-5-phenylpyrimidine | ESD-892471-5G |
| Cas.: 58333-72-5 | Purity: ≥95% | Ethyl 5-phenylthiazole-2-carboxylate | ESD-892472-100MG |
| Cas.: 58333-72-5 | Purity: ≥95% | Ethyl 5-phenylthiazole-2-carboxylate | ESD-892472-250MG |
| Cas.: 58333-72-5 | Purity: ≥95% | Ethyl 5-phenylthiazole-2-carboxylate | ESD-892472-1G |
| Cas.: 58333-72-5 | Purity: ≥95% | Ethyl 5-phenylthiazole-2-carboxylate | ESD-892472-5G |
| Cas.: 21109-27-3 | Purity: ≥95% | (5-Chloro-1H-indol-2-yl)methanamine | ESD-892473-100MG |
| Cas.: 21109-27-3 | Purity: ≥95% | (5-Chloro-1H-indol-2-yl)methanamine | ESD-892473-250MG |
| Cas.: 21109-27-3 | Purity: ≥95% | (5-Chloro-1H-indol-2-yl)methanamine | ESD-892473-1G |
| Cas.: 21109-27-3 | Purity: ≥95% | (5-Chloro-1H-indol-2-yl)methanamine | ESD-892473-5G |
| Cas.: 247068-82-2 | Purity: ≥95% | tert-Butyl ((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)carbamate | ESD-892474-250MG |
| Cas.: 247068-82-2 | Purity: ≥95% | tert-Butyl ((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)carbamate | ESD-892474-1G |
| Cas.: 247068-82-2 | Purity: ≥95% | tert-Butyl ((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)carbamate | ESD-892474-5G |
| Cas.: 247068-82-2 | Purity: ≥95% | tert-Butyl ((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)carbamate | ESD-892474-10G |
| Cas.: 20191-76-8 | Purity: 97% | 2,4-Dibromonaphthalen-1-amine | ESD-892475-250MG |
| Cas.: 20191-76-8 | Purity: 97% | 2,4-Dibromonaphthalen-1-amine | ESD-892475-1G |
| Cas.: 20191-76-8 | Purity: 97% | 2,4-Dibromonaphthalen-1-amine | ESD-892475-5G |
| Cas.: 20191-76-8 | Purity: 97% | 2,4-Dibromonaphthalen-1-amine | ESD-892475-10G |
| Cas.: 18453-32-2 | Purity: 97% | 2-(4-Bromobenzoyl)pyridine | ESD-892476-100MG |
| Cas.: 18453-32-2 | Purity: 97% | 2-(4-Bromobenzoyl)pyridine | ESD-892476-250MG |
| Cas.: 7101-95-3 | Purity: 95% | 3-Bromo-6-nitroquinoline | ESD-892477-100MG |
| Cas.: 7101-95-3 | Purity: 95% | 3-Bromo-6-nitroquinoline | ESD-892477-250MG |
| Cas.: 7101-95-3 | Purity: 95% | 3-Bromo-6-nitroquinoline | ESD-892477-1G |
| Cas.: 7101-95-3 | Purity: 95% | 3-Bromo-6-nitroquinoline | ESD-892477-5G |
| Cas.: 23056-10-2 | Purity: ≥95% | 5-Thiocyanatothiazol-2-amine | ESD-892478-250MG |
| Cas.: 23056-10-2 | Purity: ≥95% | 5-Thiocyanatothiazol-2-amine | ESD-892478-1G |
| Cas.: 23056-10-2 | Purity: ≥95% | 5-Thiocyanatothiazol-2-amine | ESD-892478-5G |
| Cas.: 23056-10-2 | Purity: ≥95% | 5-Thiocyanatothiazol-2-amine | ESD-892478-10G |
| Cas.: 815588-93-3 | Purity: 97% | 1-Methyl-1H-1,2,4-triazole-5-carboxylic acid | ESD-892479-100MG |
| Cas.: 815588-93-3 | Purity: 97% | 1-Methyl-1H-1,2,4-triazole-5-carboxylic acid | ESD-892479-250MG |
| Cas.: 815588-93-3 | Purity: 97% | 1-Methyl-1H-1,2,4-triazole-5-carboxylic acid | ESD-892479-1G |
| Cas.: 815588-93-3 | Purity: 97% | 1-Methyl-1H-1,2,4-triazole-5-carboxylic acid | ESD-892479-5G |
| Cas.: 28466-62-8 | Purity: 97% | 1-Benzyl-1H-pyrazol-4-amine | ESD-892480-250MG |
| Cas.: 28466-62-8 | Purity: 97% | 1-Benzyl-1H-pyrazol-4-amine | ESD-892480-1G |
| Cas.: 28466-62-8 | Purity: 97% | 1-Benzyl-1H-pyrazol-4-amine | ESD-892480-5G |
| Cas.: 28466-62-8 | Purity: 97% | 1-Benzyl-1H-pyrazol-4-amine | ESD-892480-10G |
| Cas.: 100987-89-1 | Purity: ≥95% | 5-(4-Isopropylphenyl)-1,3,4-thiadiazol-2-amine | ESD-892481-250MG |
| Cas.: 100987-89-1 | Purity: ≥95% | 5-(4-Isopropylphenyl)-1,3,4-thiadiazol-2-amine | ESD-892481-1G |
| Cas.: 100987-89-1 | Purity: ≥95% | 5-(4-Isopropylphenyl)-1,3,4-thiadiazol-2-amine | ESD-892481-5G |
| Cas.: 1256353-15-7 | Purity: 97% | 8-Bromopyrido[4,3-d]pyrimidin-4(3H)-one | ESD-892482-100MG |
| Cas.: 1256353-15-7 | Purity: 97% | 8-Bromopyrido[4,3-d]pyrimidin-4(3H)-one | ESD-892482-250MG |
| Cas.: 199850-56-1 | Purity: 97% | Methyl 2-amino-4-chloro-5-iodobenzoate | ESD-892483-100MG |
| Cas.: 199850-56-1 | Purity: 97% | Methyl 2-amino-4-chloro-5-iodobenzoate | ESD-892483-250MG |
| Cas.: 199850-56-1 | Purity: 97% | Methyl 2-amino-4-chloro-5-iodobenzoate | ESD-892483-1G |
| Cas.: 199850-56-1 | Purity: 97% | Methyl 2-amino-4-chloro-5-iodobenzoate | ESD-892483-5G |
| Cas.: 2277-23-8 | Purity: ≥95% | 2,3-Dihydroxypropyl decanoate | ESD-892484-250MG |
| Cas.: 2277-23-8 | Purity: ≥95% | 2,3-Dihydroxypropyl decanoate | ESD-892484-1G |
| Cas.: 2277-23-8 | Purity: ≥95% | 2,3-Dihydroxypropyl decanoate | ESD-892484-5G |
| Cas.: 2277-23-8 | Purity: ≥95% | 2,3-Dihydroxypropyl decanoate | ESD-892484-10G |
| Cas.: 635712-99-1 | Purity: ≥95% | 6-(Benzyloxy)nicotinaldehyde | ESD-892485-250MG |
| Cas.: 635712-99-1 | Purity: ≥95% | 6-(Benzyloxy)nicotinaldehyde | ESD-892485-1G |
| Cas.: 635712-99-1 | Purity: ≥95% | 6-(Benzyloxy)nicotinaldehyde | ESD-892485-5G |
| Cas.: 1256345-69-3 | Purity: ≥95% | (3-(2-Ethoxy-2-oxoethyl)phenyl)boronic acid | ESD-892486-250MG |
| Cas.: 1256345-69-3 | Purity: ≥95% | (3-(2-Ethoxy-2-oxoethyl)phenyl)boronic acid | ESD-892486-1G |
| Cas.: 1256345-69-3 | Purity: ≥95% | (3-(2-Ethoxy-2-oxoethyl)phenyl)boronic acid | ESD-892486-5G |
| Cas.: 1256345-69-3 | Purity: ≥95% | (3-(2-Ethoxy-2-oxoethyl)phenyl)boronic acid | ESD-892486-10G |
| Cas.: 77215-54-4 | Purity: ≥95% | (S)-tert-Butyl 3-amino-2-((tert-butoxycarbonyl)amino)propanoate | ESD-892487-100MG |
| Cas.: 77215-54-4 | Purity: ≥95% | (S)-tert-Butyl 3-amino-2-((tert-butoxycarbonyl)amino)propanoate | ESD-892487-250MG |
| Cas.: 51760-22-6 | Purity: ≥95% | (5-Bromo-1,3-phenylene)dimethanol | ESD-892488-100MG |
| Cas.: 51760-22-6 | Purity: ≥95% | (5-Bromo-1,3-phenylene)dimethanol | ESD-892488-250MG |
| Cas.: 51760-22-6 | Purity: ≥95% | (5-Bromo-1,3-phenylene)dimethanol | ESD-892488-1G |
| Cas.: 1000577-78-5 | Purity: ≥95% | tert-Butyl (1-benzylazetidin-3-yl)carbamate | ESD-892489-100MG |
| Cas.: 1000577-78-5 | Purity: ≥95% | tert-Butyl (1-benzylazetidin-3-yl)carbamate | ESD-892489-250MG |
| Cas.: 1000577-78-5 | Purity: ≥95% | tert-Butyl (1-benzylazetidin-3-yl)carbamate | ESD-892489-1G |
| Cas.: 5802-65-3 | Purity: ≥95% | Cyclopentane-1,1-dicarboxylic acid | ESD-892490-250MG |
| Cas.: 5802-65-3 | Purity: ≥95% | Cyclopentane-1,1-dicarboxylic acid | ESD-892490-1G |
| Cas.: 5802-65-3 | Purity: ≥95% | Cyclopentane-1,1-dicarboxylic acid | ESD-892490-5G |
| Cas.: 5802-65-3 | Purity: ≥95% | Cyclopentane-1,1-dicarboxylic acid | ESD-892490-10G |
| Cas.: 859522-19-3 | Purity: ≥95% | Ethyl 2-((2-aminothiazol-5-yl)thio)acetate | ESD-892491-100MG |
| Cas.: 859522-19-3 | Purity: ≥95% | Ethyl 2-((2-aminothiazol-5-yl)thio)acetate | ESD-892491-250MG |
| Cas.: 34263-51-9 | Purity: ≥95% | 4-Amino-2,3-dichlorobenzoic acid | ESD-892492-50MG |
| Cas.: 34263-51-9 | Purity: ≥95% | 4-Amino-2,3-dichlorobenzoic acid | ESD-892492-100MG |
| Cas.: 34263-51-9 | Purity: ≥95% | 4-Amino-2,3-dichlorobenzoic acid | ESD-892492-250MG |
| Cas.: 34263-51-9 | Purity: ≥95% | 4-Amino-2,3-dichlorobenzoic acid | ESD-892492-1G |
| Cas.: 1823368-22-4 | Purity: 97% | 5-Bromoisothiazolo[3,4-b]pyridin-3-amine | ESD-892493-100MG |
| Cas.: 1823368-22-4 | Purity: 97% | 5-Bromoisothiazolo[3,4-b]pyridin-3-amine | ESD-892493-250MG |
| Cas.: 1823368-22-4 | Purity: 97% | 5-Bromoisothiazolo[3,4-b]pyridin-3-amine | ESD-892493-1G |
| Cas.: 220210-55-9 | Purity: 97% | 2,4,5-Trichlorophenylboronic acid | ESD-892494-100MG |
| Cas.: 220210-55-9 | Purity: 97% | 2,4,5-Trichlorophenylboronic acid | ESD-892494-250MG |
| Cas.: 220210-55-9 | Purity: 97% | 2,4,5-Trichlorophenylboronic acid | ESD-892494-1G |
| Cas.: 220210-55-9 | Purity: 97% | 2,4,5-Trichlorophenylboronic acid | ESD-892494-5G |
| Cas.: 57976-57-5 | Purity: ≥95% | 3-(Pyridin-3-yl)benzenamine | ESD-892495-100MG |
| Cas.: 57976-57-5 | Purity: ≥95% | 3-(Pyridin-3-yl)benzenamine | ESD-892495-250MG |
| Cas.: 57976-57-5 | Purity: ≥95% | 3-(Pyridin-3-yl)benzenamine | ESD-892495-1G |
| Cas.: 57976-57-5 | Purity: ≥95% | 3-(Pyridin-3-yl)benzenamine | ESD-892495-5G |
| Cas.: 885271-78-3 | Purity: ≥95% | 6-Bromo-3-chloro-1H-indazole | ESD-892496-100MG |
| Cas.: 885271-78-3 | Purity: ≥95% | 6-Bromo-3-chloro-1H-indazole | ESD-892496-250MG |
| Cas.: 885271-78-3 | Purity: ≥95% | 6-Bromo-3-chloro-1H-indazole | ESD-892496-1G |
| Cas.: 885271-78-3 | Purity: ≥95% | 6-Bromo-3-chloro-1H-indazole | ESD-892496-5G |
| Cas.: 99910-50-6 | Purity: ≥95% | 4,6-Dibromo-1H-indole | ESD-892497-100MG |
| Cas.: 99910-50-6 | Purity: ≥95% | 4,6-Dibromo-1H-indole | ESD-892497-250MG |
| Cas.: 154593-58-5 | Purity: ≥95% | (S)-2-Amino-3-(5-bromothiophen-2-yl)propanoic acid | ESD-892498-100MG |
| Cas.: 154593-58-5 | Purity: ≥95% | (S)-2-Amino-3-(5-bromothiophen-2-yl)propanoic acid | ESD-892498-250MG |
| Cas.: 154593-58-5 | Purity: ≥95% | (S)-2-Amino-3-(5-bromothiophen-2-yl)propanoic acid | ESD-892498-1G |
| Cas.: 154593-58-5 | Purity: ≥95% | (S)-2-Amino-3-(5-bromothiophen-2-yl)propanoic acid | ESD-892498-5G |
| Cas.: 64198-92-1 | Purity: ≥95% | 2-(3-Benzamidophenyl)acetic acid | ESD-892499-100MG |
| Cas.: 64198-92-1 | Purity: ≥95% | 2-(3-Benzamidophenyl)acetic acid | ESD-892499-250MG |
| Cas.: 64198-92-1 | Purity: ≥95% | 2-(3-Benzamidophenyl)acetic acid | ESD-892499-1G |
| Cas.: 885521-43-7 | Purity: ≥95% | 3-Bromo-5-chloro-1H-indazole | ESD-892500-250MG |
| Cas.: 885521-43-7 | Purity: ≥95% | 3-Bromo-5-chloro-1H-indazole | ESD-892500-1G |
| Cas.: 885521-43-7 | Purity: ≥95% | 3-Bromo-5-chloro-1H-indazole | ESD-892500-5G |
| Cas.: 40615-17-6 | Purity: ≥95% | 3-Amino-3,4-dihydroquinolin-2(1H)-one | ESD-892501-100MG |
| Cas.: 40615-17-6 | Purity: ≥95% | 3-Amino-3,4-dihydroquinolin-2(1H)-one | ESD-892501-250MG |
| Cas.: 1073353-75-9 | Purity: 97% | 5-Bromo-2-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-892502-250MG |
| Cas.: 1073353-75-9 | Purity: 97% | 5-Bromo-2-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-892502-1G |
| Cas.: 1073353-75-9 | Purity: 97% | 5-Bromo-2-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-892502-5G |
| Cas.: 848841-62-3 | Purity: ≥95% | 4-(6-Bromopyrazin-2-yl)morpholine | ESD-892503-250MG |
| Cas.: 848841-62-3 | Purity: ≥95% | 4-(6-Bromopyrazin-2-yl)morpholine | ESD-892503-1G |
| Cas.: 848841-62-3 | Purity: ≥95% | 4-(6-Bromopyrazin-2-yl)morpholine | ESD-892503-5G |
| Cas.: 127356-26-7 | Purity: 97% | 6-Methoxypyridine-3,4-diamine | ESD-892504-100MG |
| Cas.: 127356-26-7 | Purity: 97% | 6-Methoxypyridine-3,4-diamine | ESD-892504-250MG |
| Cas.: 127356-26-7 | Purity: 97% | 6-Methoxypyridine-3,4-diamine | ESD-892504-1G |
| Cas.: 5994-87-6 | Purity: 97% | P,P-Diphenylphosphinic amide | ESD-892505-250MG |
| Cas.: 5994-87-6 | Purity: 97% | P,P-Diphenylphosphinic amide | ESD-892505-1G |
| Cas.: 5994-87-6 | Purity: 97% | P,P-Diphenylphosphinic amide | ESD-892505-5G |
| Cas.: 5994-87-6 | Purity: 97% | P,P-Diphenylphosphinic amide | ESD-892505-25G |
| Cas.: 83823-06-7 | Purity: ≥95% | 6-Chloro-2H-chromene-3-carboxylic acid | ESD-892506-100MG |
| Cas.: 83823-06-7 | Purity: ≥95% | 6-Chloro-2H-chromene-3-carboxylic acid | ESD-892506-250MG |
| Cas.: 83823-06-7 | Purity: ≥95% | 6-Chloro-2H-chromene-3-carboxylic acid | ESD-892506-1G |
| Cas.: 83823-06-7 | Purity: ≥95% | 6-Chloro-2H-chromene-3-carboxylic acid | ESD-892506-5G |
| Cas.: 121936-68-3 | Purity: 98% | 2-Bromo-5-hydroxy-4-methoxybenzoic acid | ESD-892507-250MG |
| Cas.: 121936-68-3 | Purity: 98% | 2-Bromo-5-hydroxy-4-methoxybenzoic acid | ESD-892507-1G |
| Cas.: 121936-68-3 | Purity: 98% | 2-Bromo-5-hydroxy-4-methoxybenzoic acid | ESD-892507-5G |
| Cas.: 121936-68-3 | Purity: 98% | 2-Bromo-5-hydroxy-4-methoxybenzoic acid | ESD-892507-10G |
| Cas.: 352530-22-4 | Purity: 95% | 4-Fluoro-3-nitrophenylboronic acid | ESD-892508-250MG |
| Cas.: 352530-22-4 | Purity: 95% | 4-Fluoro-3-nitrophenylboronic acid | ESD-892508-1G |
| Cas.: 352530-22-4 | Purity: 95% | 4-Fluoro-3-nitrophenylboronic acid | ESD-892508-5G |
| Cas.: 352530-22-4 | Purity: 95% | 4-Fluoro-3-nitrophenylboronic acid | ESD-892508-10G |
| Cas.: 800402-12-4 | Purity: ≥95% | 2-Chloro-5-iodo-4-pyridinamine | ESD-892509-250MG |
| Cas.: 800402-12-4 | Purity: ≥95% | 2-Chloro-5-iodo-4-pyridinamine | ESD-892509-1G |
| Cas.: 800402-12-4 | Purity: ≥95% | 2-Chloro-5-iodo-4-pyridinamine | ESD-892509-5G |
| Cas.: 800402-12-4 | Purity: ≥95% | 2-Chloro-5-iodo-4-pyridinamine | ESD-892509-10G |
| Cas.: 66855-92-3 | Purity: ≥95% | 3-(2-Methoxyphenoxy)benzaldehyde | ESD-892510-100MG |
| Cas.: 1309980-98-0 | Purity: 97% | (3-Bromo-6-ethoxy-2-fluorophenyl)boronic acid | ESD-892511-100MG |
| Cas.: 1309980-98-0 | Purity: 97% | (3-Bromo-6-ethoxy-2-fluorophenyl)boronic acid | ESD-892511-250MG |
| Cas.: 1309980-98-0 | Purity: 97% | (3-Bromo-6-ethoxy-2-fluorophenyl)boronic acid | ESD-892511-1G |
| Cas.: 74431-50-8 | Purity: 97% | 3-(Benzoylthio)-2-methylpropanoic acid | ESD-892512-250MG |
| Cas.: 74431-50-8 | Purity: 97% | 3-(Benzoylthio)-2-methylpropanoic acid | ESD-892512-1G |
| Cas.: 74431-50-8 | Purity: 97% | 3-(Benzoylthio)-2-methylpropanoic acid | ESD-892512-5G |
| Cas.: 36258-82-9 | Purity: 98% | 4-Chloro-3H-[1,2,3]triazolo[4,5-c]pyridine | ESD-892513-250MG |
| Cas.: 36258-82-9 | Purity: 98% | 4-Chloro-3H-[1,2,3]triazolo[4,5-c]pyridine | ESD-892513-1G |
| Cas.: 36258-82-9 | Purity: 98% | 4-Chloro-3H-[1,2,3]triazolo[4,5-c]pyridine | ESD-892513-5G |
| Cas.: 214147-60-1 | Purity: ≥95% | tert-Butyl 2-chloro-1H-benzo[d]imidazole-1-carboxylate | ESD-892514-100MG |
| Cas.: 214147-60-1 | Purity: ≥95% | tert-Butyl 2-chloro-1H-benzo[d]imidazole-1-carboxylate | ESD-892514-250MG |
| Cas.: 633327-11-4 | Purity: ≥95% | 6-Fluoro-1H-indazole-5-carbonitrile | ESD-892515-100MG |
| Cas.: 633327-11-4 | Purity: ≥95% | 6-Fluoro-1H-indazole-5-carbonitrile | ESD-892515-250MG |
| Cas.: 633327-11-4 | Purity: ≥95% | 6-Fluoro-1H-indazole-5-carbonitrile | ESD-892515-1G |
| Cas.: 5181-35-1 | Purity: ≥95% | 2-(2-Bromoethoxy)isoindoline-1,3-dione | ESD-892516-100MG |
| Cas.: 5181-35-1 | Purity: ≥95% | 2-(2-Bromoethoxy)isoindoline-1,3-dione | ESD-892516-250MG |
| Cas.: 5181-35-1 | Purity: ≥95% | 2-(2-Bromoethoxy)isoindoline-1,3-dione | ESD-892516-1G |
| Cas.: 73204-07-6 | Purity: ≥95% | 4-(4-Oxocyclohexyl)benzonitrile | ESD-892517-250MG |
| Cas.: 73204-07-6 | Purity: ≥95% | 4-(4-Oxocyclohexyl)benzonitrile | ESD-892517-1G |
| Cas.: 73204-07-6 | Purity: ≥95% | 4-(4-Oxocyclohexyl)benzonitrile | ESD-892517-5G |
| Cas.: 73204-07-6 | Purity: ≥95% | 4-(4-Oxocyclohexyl)benzonitrile | ESD-892517-10G |
| Cas.: 1044560-96-4 | Purity: 97% | (R)-Benzyl 3-aminopiperidine-1-carboxylate | ESD-892518-100MG |
| Cas.: 1044560-96-4 | Purity: 97% | (R)-Benzyl 3-aminopiperidine-1-carboxylate | ESD-892518-250MG |
| Cas.: 1044560-96-4 | Purity: 97% | (R)-Benzyl 3-aminopiperidine-1-carboxylate | ESD-892518-1G |
| Cas.: 1044560-96-4 | Purity: 97% | (R)-Benzyl 3-aminopiperidine-1-carboxylate | ESD-892518-5G |
| Cas.: 6954-70-7 | Purity: 97% | 2,5-Dimethyl-4-nitrobenzoic acid | ESD-892519-100MG |
| Cas.: 6954-70-7 | Purity: 97% | 2,5-Dimethyl-4-nitrobenzoic acid | ESD-892519-250MG |
| Cas.: 16292-88-9 | Purity: 98% | 3-Methoxy-4-nitroaniline | ESD-892520-250MG |
| Cas.: 16292-88-9 | Purity: 98% | 3-Methoxy-4-nitroaniline | ESD-892520-1G |
| Cas.: 16292-88-9 | Purity: 98% | 3-Methoxy-4-nitroaniline | ESD-892520-5G |
| Cas.: 16292-88-9 | Purity: 98% | 3-Methoxy-4-nitroaniline | ESD-892520-10G |
| Cas.: 1133116-49-0 | Purity: 97% | 3,6-Dibromopicolinic acid | ESD-892521-100MG |
| Cas.: 1133116-49-0 | Purity: 97% | 3,6-Dibromopicolinic acid | ESD-892521-250MG |
| Cas.: 1133116-49-0 | Purity: 97% | 3,6-Dibromopicolinic acid | ESD-892521-1G |
| Cas.: 1133116-49-0 | Purity: 97% | 3,6-Dibromopicolinic acid | ESD-892521-5G |
| Cas.: 6324-10-3 | Purity: 98% | 4,5-Dibromothiophene-2-carboxylic acid | ESD-892522-250MG |
| Cas.: 6324-10-3 | Purity: 98% | 4,5-Dibromothiophene-2-carboxylic acid | ESD-892522-1G |
| Cas.: 40061-21-0 | Purity: 97% | 1-(Pyridin-3-yl)-2-(p-tolyl)ethanone | ESD-892523-100MG |
| Cas.: 40061-21-0 | Purity: 97% | 1-(Pyridin-3-yl)-2-(p-tolyl)ethanone | ESD-892523-250MG |
| Cas.: 139399-61-4 | Purity: ≥95% | 2-Bromoquinolin-8-ol | ESD-892524-100MG |
| Cas.: 139399-61-4 | Purity: ≥95% | 2-Bromoquinolin-8-ol | ESD-892524-250MG |
| Cas.: 139399-61-4 | Purity: ≥95% | 2-Bromoquinolin-8-ol | ESD-892524-1G |
| Cas.: 443956-21-6 | Purity: ≥95% | Methyl 6-amino-3,5-dibromopicolinate | ESD-892525-100MG |
| Cas.: 443956-21-6 | Purity: ≥95% | Methyl 6-amino-3,5-dibromopicolinate | ESD-892525-250MG |
| Cas.: 443956-21-6 | Purity: ≥95% | Methyl 6-amino-3,5-dibromopicolinate | ESD-892525-1G |
| Cas.: 443956-21-6 | Purity: ≥95% | Methyl 6-amino-3,5-dibromopicolinate | ESD-892525-5G |
| Cas.: 1131595-36-2 | Purity: 98% | 3-Methyl-1H-indazol-7-ol | ESD-892526-250MG |
| Cas.: 1131595-36-2 | Purity: 98% | 3-Methyl-1H-indazol-7-ol | ESD-892526-1G |
| Cas.: 77156-85-5 | Purity: ≥95% | Ethyl 4-chloro-7-methoxyquinoline-3-carboxylate | ESD-892527-100MG |
| Cas.: 77156-85-5 | Purity: ≥95% | Ethyl 4-chloro-7-methoxyquinoline-3-carboxylate | ESD-892527-250MG |
| Cas.: 77156-85-5 | Purity: ≥95% | Ethyl 4-chloro-7-methoxyquinoline-3-carboxylate | ESD-892527-1G |
| Cas.: 1217501-08-0 | Purity: 97% | (4-(1-(Methoxycarbonyl)cyclopropyl)phenyl)boronic acid | ESD-892528-100MG |
| Cas.: 1217501-08-0 | Purity: 97% | (4-(1-(Methoxycarbonyl)cyclopropyl)phenyl)boronic acid | ESD-892528-250MG |
| Cas.: 1217501-08-0 | Purity: 97% | (4-(1-(Methoxycarbonyl)cyclopropyl)phenyl)boronic acid | ESD-892528-1G |
| Cas.: 1217501-08-0 | Purity: 97% | (4-(1-(Methoxycarbonyl)cyclopropyl)phenyl)boronic acid | ESD-892528-5G |
| Cas.: 215523-34-5 | Purity: 97% | 1,8-Naphthyridine-2-carboxylic acid | ESD-892529-250MG |
| Cas.: 215523-34-5 | Purity: 97% | 1,8-Naphthyridine-2-carboxylic acid | ESD-892529-1G |
| Cas.: 215523-34-5 | Purity: 97% | 1,8-Naphthyridine-2-carboxylic acid | ESD-892529-5G |
| Cas.: 215523-34-5 | Purity: 97% | 1,8-Naphthyridine-2-carboxylic acid | ESD-892529-10G |
| Cas.: 104866-53-7 | Purity: ≥95% | 1,8-Naphthyridine-3-carboxylic acid | ESD-892530-100MG |
| Cas.: 104866-53-7 | Purity: ≥95% | 1,8-Naphthyridine-3-carboxylic acid | ESD-892530-250MG |
| Cas.: 1260847-61-7 | Purity: ≥95% | 7-Bromo-4,6-dichloroquinazoline | ESD-892531-100MG |
| Cas.: 1260847-61-7 | Purity: ≥95% | 7-Bromo-4,6-dichloroquinazoline | ESD-892531-250MG |
| Cas.: 1260847-61-7 | Purity: ≥95% | 7-Bromo-4,6-dichloroquinazoline | ESD-892531-1G |
| Cas.: 1260847-61-7 | Purity: ≥95% | 7-Bromo-4,6-dichloroquinazoline | ESD-892531-5G |
| Cas.: 1616388-38-5 | Purity: ≥95% | Cyclopropyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridin-1(2H)-yl)methanone | ESD-892532-100MG |
| Cas.: 1616388-38-5 | Purity: ≥95% | Cyclopropyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridin-1(2H)-yl)methanone | ESD-892532-250MG |
| Cas.: 1616388-38-5 | Purity: ≥95% | Cyclopropyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridin-1(2H)-yl)methanone | ESD-892532-1G |
| Cas.: 153203-80-6 | Purity: 97% | 3,5-Dichloro-4-formylbenzoic acid | ESD-892533-250MG |
| Cas.: 153203-80-6 | Purity: 97% | 3,5-Dichloro-4-formylbenzoic acid | ESD-892533-1G |
| Cas.: 153203-80-6 | Purity: 97% | 3,5-Dichloro-4-formylbenzoic acid | ESD-892533-5G |
| Cas.: 153203-80-6 | Purity: 97% | 3,5-Dichloro-4-formylbenzoic acid | ESD-892533-10G |
| Cas.: 1227564-07-9 | Purity: 97% | 2-(2-Fluoro-5-methoxypyridin-3-yl)acetic acid | ESD-892534-100MG |
| Cas.: 1227564-07-9 | Purity: 97% | 2-(2-Fluoro-5-methoxypyridin-3-yl)acetic acid | ESD-892534-250MG |
| Cas.: 1227564-07-9 | Purity: 97% | 2-(2-Fluoro-5-methoxypyridin-3-yl)acetic acid | ESD-892534-1G |
| Cas.: 7574-67-6 | Purity: ≥95% | 3-Chloroisoquinolin-1-amine | ESD-892535-100MG |
| Cas.: 7574-67-6 | Purity: ≥95% | 3-Chloroisoquinolin-1-amine | ESD-892535-250MG |
| Cas.: 6136-66-9 | Purity: ≥95% | (4-Iodophenyl)(phenyl)methanone | ESD-892536-100MG |
| Cas.: 6136-66-9 | Purity: ≥95% | (4-Iodophenyl)(phenyl)methanone | ESD-892536-250MG |
| Cas.: 6136-66-9 | Purity: ≥95% | (4-Iodophenyl)(phenyl)methanone | ESD-892536-1G |
| Cas.: 6136-66-9 | Purity: ≥95% | (4-Iodophenyl)(phenyl)methanone | ESD-892536-5G |
| Cas.: 2510-03-4 | Purity: ≥95% | 2-(3,4-Dihydronaphthalen-1(2H)-ylidene)malononitrile | ESD-892537-250MG |
| Cas.: 2510-03-4 | Purity: ≥95% | 2-(3,4-Dihydronaphthalen-1(2H)-ylidene)malononitrile | ESD-892537-1G |
| Cas.: 126535-26-0 | Purity: 97% | Methyl 2-(chlorosulfonyl)-3-methylbenzoate | ESD-892538-250MG |
| Cas.: 126535-26-0 | Purity: 97% | Methyl 2-(chlorosulfonyl)-3-methylbenzoate | ESD-892538-1G |
| Cas.: 700-47-0 | Purity: 97% | Pteridin-4-ol | ESD-892539-250MG |
| Cas.: 700-47-0 | Purity: 97% | Pteridin-4-ol | ESD-892539-1G |
| Cas.: 130036-17-8 | Purity: 97% | 2-Formylcinnamic acid | ESD-892540-250MG |
| Cas.: 130036-17-8 | Purity: 97% | 2-Formylcinnamic acid | ESD-892540-1G |
| Cas.: 130036-17-8 | Purity: 97% | 2-Formylcinnamic acid | ESD-892540-5G |
| Cas.: 130036-17-8 | Purity: 97% | 2-Formylcinnamic acid | ESD-892540-10G |
| Cas.: 124276-87-5 | Purity: 97% | 1-(2-Bromophenyl)cyclopropanecarboxylic acid | ESD-892541-100MG |
| Cas.: 124276-87-5 | Purity: 97% | 1-(2-Bromophenyl)cyclopropanecarboxylic acid | ESD-892541-250MG |
| Cas.: 124276-87-5 | Purity: 97% | 1-(2-Bromophenyl)cyclopropanecarboxylic acid | ESD-892541-1G |
| Cas.: 124276-87-5 | Purity: 97% | 1-(2-Bromophenyl)cyclopropanecarboxylic acid | ESD-892541-5G |
| Cas.: 39945-54-5 | Purity: 97% | Benzyl (3-bromopropyl)carbamate | ESD-892542-250MG |
| Cas.: 39945-54-5 | Purity: 97% | Benzyl (3-bromopropyl)carbamate | ESD-892542-1G |
| Cas.: 39945-54-5 | Purity: 97% | Benzyl (3-bromopropyl)carbamate | ESD-892542-5G |
| Cas.: 39945-54-5 | Purity: 97% | Benzyl (3-bromopropyl)carbamate | ESD-892542-10G |
| Cas.: 35461-99-5 | Purity: ≥95% | 3-(Furan-2-yl)benzoic acid | ESD-892543-250MG |
| Cas.: 35461-99-5 | Purity: ≥95% | 3-(Furan-2-yl)benzoic acid | ESD-892543-1G |
| Cas.: 35461-99-5 | Purity: ≥95% | 3-(Furan-2-yl)benzoic acid | ESD-892543-5G |
| Cas.: 50739-76-9 | Purity: ≥95% | (2-Amino-3,5-dibromophenyl)methanol | ESD-892544-250MG |
| Cas.: 50739-76-9 | Purity: ≥95% | (2-Amino-3,5-dibromophenyl)methanol | ESD-892544-1G |
| Cas.: 50739-76-9 | Purity: ≥95% | (2-Amino-3,5-dibromophenyl)methanol | ESD-892544-5G |
| Cas.: 50739-76-9 | Purity: ≥95% | (2-Amino-3,5-dibromophenyl)methanol | ESD-892544-25G |
| Cas.: 137045-30-8 | Purity: 95% | 2-Fluoro-[1,1′-biphenyl]-4-carboxylic acid | ESD-892545-100MG |
| Cas.: 137045-30-8 | Purity: 95% | 2-Fluoro-[1,1′-biphenyl]-4-carboxylic acid | ESD-892545-250MG |
| Cas.: 137045-30-8 | Purity: 95% | 2-Fluoro-[1,1′-biphenyl]-4-carboxylic acid | ESD-892545-1G |
| Cas.: 84923-71-7 | Purity: ≥95% | 5-Cyano-2-methoxybenzoic acid | ESD-892546-100MG |
| Cas.: 84923-71-7 | Purity: ≥95% | 5-Cyano-2-methoxybenzoic acid | ESD-892546-250MG |
| Cas.: 84923-71-7 | Purity: ≥95% | 5-Cyano-2-methoxybenzoic acid | ESD-892546-1G |
| Cas.: 1196151-51-5 | Purity: 97% | 5-Fluoropyrimidine-2-carboxylic acid | ESD-892547-100MG |
| Cas.: 1196151-51-5 | Purity: 97% | 5-Fluoropyrimidine-2-carboxylic acid | ESD-892547-250MG |
| Cas.: 1196151-51-5 | Purity: 97% | 5-Fluoropyrimidine-2-carboxylic acid | ESD-892547-1G |
| Cas.: 42728-62-1 | Purity: ≥95% | 4-Chloromethylbenzophenone | ESD-892548-1G |
| Cas.: 42728-62-1 | Purity: ≥95% | 4-Chloromethylbenzophenone | ESD-892548-5G |
| Cas.: 42728-62-1 | Purity: ≥95% | 4-Chloromethylbenzophenone | ESD-892548-10G |
| Cas.: 17061-63-1 | Purity: ≥95% | N-(4-Methoxybenzyl)formamide | ESD-892549-100MG |
| Cas.: 17061-63-1 | Purity: ≥95% | N-(4-Methoxybenzyl)formamide | ESD-892549-250MG |
| Cas.: 120686-00-2 | Purity: ≥95% | Methyl 6-hydroxy-2-methoxy-7,8-dihydroquinoline-5-carboxylate | ESD-892550-250MG |
| Cas.: 120686-00-2 | Purity: ≥95% | Methyl 6-hydroxy-2-methoxy-7,8-dihydroquinoline-5-carboxylate | ESD-892550-1G |
| Cas.: 266690-55-5 | Purity: 97% | tert-Butyl cyclohexyl(3-hydroxypropyl)carbamate | ESD-892551-250MG |
| Cas.: 266690-55-5 | Purity: 97% | tert-Butyl cyclohexyl(3-hydroxypropyl)carbamate | ESD-892551-1G |
| Cas.: 266690-55-5 | Purity: 97% | tert-Butyl cyclohexyl(3-hydroxypropyl)carbamate | ESD-892551-5G |
| Cas.: 55864-87-4 | Purity: ≥95% | Ethyl 4-nitro-1H-pyrazole-3-carboxylate | ESD-892552-250MG |
| Cas.: 55864-87-4 | Purity: ≥95% | Ethyl 4-nitro-1H-pyrazole-3-carboxylate | ESD-892552-1G |
| Cas.: 55864-87-4 | Purity: ≥95% | Ethyl 4-nitro-1H-pyrazole-3-carboxylate | ESD-892552-5G |
| Cas.: 59937-01-8 | Purity: 97% | Ethyl 2-phenylthiazole-4-carboxylate | ESD-892553-1G |
| Cas.: 59937-01-8 | Purity: 97% | Ethyl 2-phenylthiazole-4-carboxylate | ESD-892553-5G |
| Cas.: 59937-01-8 | Purity: 97% | Ethyl 2-phenylthiazole-4-carboxylate | ESD-892553-10G |
| Cas.: 62096-63-3 | Purity: ≥95% | 6-Ethoxy-N2-methyl-1,3,5-triazine-2,4-diamine | ESD-892554-1G |
| Cas.: 62096-63-3 | Purity: ≥95% | 6-Ethoxy-N2-methyl-1,3,5-triazine-2,4-diamine | ESD-892554-5G |
| Cas.: 885280-34-2 | Purity: ≥95% | 6-Fluoro-1H-benzo[d]imidazole-2-carbaldehyde | ESD-892555-100MG |
| Cas.: 885280-34-2 | Purity: ≥95% | 6-Fluoro-1H-benzo[d]imidazole-2-carbaldehyde | ESD-892555-250MG |
| Cas.: 885280-34-2 | Purity: ≥95% | 6-Fluoro-1H-benzo[d]imidazole-2-carbaldehyde | ESD-892555-1G |
| Cas.: 885280-34-2 | Purity: ≥95% | 6-Fluoro-1H-benzo[d]imidazole-2-carbaldehyde | ESD-892555-5G |
| Cas.: 877149-80-9 | Purity: ≥95% | N,N-Dimethyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)ethanamine | ESD-892556-100MG |
| Cas.: 877149-80-9 | Purity: ≥95% | N,N-Dimethyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)ethanamine | ESD-892556-250MG |
| Cas.: 877149-80-9 | Purity: ≥95% | N,N-Dimethyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)ethanamine | ESD-892556-1G |
| Cas.: 877149-80-9 | Purity: ≥95% | N,N-Dimethyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)ethanamine | ESD-892556-5G |
| Cas.: 754971-91-0 | Purity: ≥95% | H-Phe(2,5-DiCl)-OH | ESD-892557-100MG |
| Cas.: 754971-91-0 | Purity: ≥95% | H-Phe(2,5-DiCl)-OH | ESD-892557-250MG |
| Cas.: 754971-91-0 | Purity: ≥95% | H-Phe(2,5-DiCl)-OH | ESD-892557-1G |
| Cas.: 162100-83-6 | Purity: 97% | Methyl 6-chloro-1H-indole-5-carboxylate | ESD-892558-100MG |
| Cas.: 162100-83-6 | Purity: 97% | Methyl 6-chloro-1H-indole-5-carboxylate | ESD-892558-250MG |
| Cas.: 162100-83-6 | Purity: 97% | Methyl 6-chloro-1H-indole-5-carboxylate | ESD-892558-1G |
| Cas.: 1245643-61-1 | Purity: 97% | Methyl 5-chloro-1H-indole-6-carboxylate | ESD-892559-100MG |
| Cas.: 1245643-61-1 | Purity: 97% | Methyl 5-chloro-1H-indole-6-carboxylate | ESD-892559-250MG |
| Cas.: 1245643-61-1 | Purity: 97% | Methyl 5-chloro-1H-indole-6-carboxylate | ESD-892559-1G |
| Cas.: 172595-67-4 | Purity: ≥95% | Methyl 5-chloro-1H-indole-3-carboxylate | ESD-892560-250MG |
| Cas.: 172595-67-4 | Purity: ≥95% | Methyl 5-chloro-1H-indole-3-carboxylate | ESD-892560-1G |
| Cas.: 172595-67-4 | Purity: ≥95% | Methyl 5-chloro-1H-indole-3-carboxylate | ESD-892560-5G |
| Cas.: 912457-18-2 | Purity: 97% | 2-Bromo-6-(methoxycarbonyl)benzoic acid | ESD-892561-100MG |
| Cas.: 912457-18-2 | Purity: 97% | 2-Bromo-6-(methoxycarbonyl)benzoic acid | ESD-892561-250MG |
| Cas.: 912457-18-2 | Purity: 97% | 2-Bromo-6-(methoxycarbonyl)benzoic acid | ESD-892561-1G |
| Cas.: 29269-17-8 | Purity: 95% | Trimethyl 3,3′,3”-phosphinetriyltripropanoate | ESD-892562-100MG |
| Cas.: 29269-17-8 | Purity: 95% | Trimethyl 3,3′,3”-phosphinetriyltripropanoate | ESD-892562-250MG |
| Cas.: 1125828-30-9 | Purity: 97% | 1-(4-Chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethanone | ESD-892563-250MG |
| Cas.: 1125828-30-9 | Purity: 97% | 1-(4-Chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethanone | ESD-892563-1G |
| Cas.: 1125828-30-9 | Purity: 97% | 1-(4-Chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethanone | ESD-892563-5G |
| Cas.: 1125828-30-9 | Purity: 97% | 1-(4-Chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethanone | ESD-892563-10G |
| Cas.: 68282-52-0 | Purity: ≥95% | 2,4-Dimethyl-1H-imidazole-5-carbaldehyde | ESD-892564-100MG |
| Cas.: 68282-52-0 | Purity: ≥95% | 2,4-Dimethyl-1H-imidazole-5-carbaldehyde | ESD-892564-250MG |
| Cas.: 68282-52-0 | Purity: ≥95% | 2,4-Dimethyl-1H-imidazole-5-carbaldehyde | ESD-892564-1G |
| Cas.: 1432323-09-5 | Purity: 97% | 3-Bromo-8-fluoroquinolin-6-amine | ESD-892565-100MG |
| Cas.: 1432323-09-5 | Purity: 97% | 3-Bromo-8-fluoroquinolin-6-amine | ESD-892565-250MG |
| Cas.: 1432323-09-5 | Purity: 97% | 3-Bromo-8-fluoroquinolin-6-amine | ESD-892565-1G |
| Cas.: 18940-57-3 | Purity: ≥95% | 1,1′-(Piperazine-1,4-diyl)diethanone | ESD-892566-1G |
| Cas.: 18940-57-3 | Purity: ≥95% | 1,1′-(Piperazine-1,4-diyl)diethanone | ESD-892566-5G |
| Cas.: 18940-57-3 | Purity: ≥95% | 1,1′-(Piperazine-1,4-diyl)diethanone | ESD-892566-10G |
| Cas.: 79025-82-4 | Purity: 97% | 2-Amino-5-chloro-4-methoxybenzoic acid | ESD-892567-100MG |
| Cas.: 79025-82-4 | Purity: 97% | 2-Amino-5-chloro-4-methoxybenzoic acid | ESD-892567-250MG |
| Cas.: 172678-67-0 | Purity: 97% | Ethyl 2-phenylthiazole-5-carboxylate | ESD-892568-100MG |
| Cas.: 172678-67-0 | Purity: 97% | Ethyl 2-phenylthiazole-5-carboxylate | ESD-892568-250MG |
| Cas.: 1353101-49-1 | Purity: ≥95% | Methyl 1H-pyrrolo[3,2-c]pyridine-3-carboxylate | ESD-892569-100MG |
| Cas.: 1353101-49-1 | Purity: ≥95% | Methyl 1H-pyrrolo[3,2-c]pyridine-3-carboxylate | ESD-892569-250MG |
| Cas.: 1353101-49-1 | Purity: ≥95% | Methyl 1H-pyrrolo[3,2-c]pyridine-3-carboxylate | ESD-892569-1G |
| Cas.: 1353101-49-1 | Purity: ≥95% | Methyl 1H-pyrrolo[3,2-c]pyridine-3-carboxylate | ESD-892569-5G |
| Cas.: 262353-34-4 | Purity: ≥95% | 2,4-Diiodopyrimidine | ESD-892570-100MG |
| Cas.: 262353-34-4 | Purity: ≥95% | 2,4-Diiodopyrimidine | ESD-892570-250MG |
| Cas.: 262353-34-4 | Purity: ≥95% | 2,4-Diiodopyrimidine | ESD-892570-1G |
| Cas.: 848093-29-8 | Purity: 98% | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinaldehyde | ESD-892571-1G |
| Cas.: 354587-63-6 | Purity: ≥95% | 1-tert-Butyl 6-methyl 1H-indole-1,6-dicarboxylate | ESD-892572-250MG |
| Cas.: 354587-63-6 | Purity: ≥95% | 1-tert-Butyl 6-methyl 1H-indole-1,6-dicarboxylate | ESD-892572-1G |
| Cas.: 156047-41-5 | Purity: ≥95% | 2-((tert-Butoxycarbonyl)amino)-4-methylpent-4-enoic acid | ESD-892573-100MG |
| Cas.: 156047-41-5 | Purity: ≥95% | 2-((tert-Butoxycarbonyl)amino)-4-methylpent-4-enoic acid | ESD-892573-250MG |
| Cas.: 342042-82-4 | Purity: 97% | 5-(Benzyloxy)-2-fluoroaniline | ESD-892574-250MG |
| Cas.: 342042-82-4 | Purity: 97% | 5-(Benzyloxy)-2-fluoroaniline | ESD-892574-1G |
| Cas.: 342042-82-4 | Purity: 97% | 5-(Benzyloxy)-2-fluoroaniline | ESD-892574-5G |
| Cas.: 342042-82-4 | Purity: 97% | 5-(Benzyloxy)-2-fluoroaniline | ESD-892574-10G |
| Cas.: 1150114-62-7 | Purity: 97% | (2-(Ethoxycarbonyl)furan-3-yl)boronic acid | ESD-892575-100MG |
| Cas.: 1150114-62-7 | Purity: 97% | (2-(Ethoxycarbonyl)furan-3-yl)boronic acid | ESD-892575-250MG |
| Cas.: 1150114-62-7 | Purity: 97% | (2-(Ethoxycarbonyl)furan-3-yl)boronic acid | ESD-892575-1G |
| Cas.: 26907-54-0 | Purity: ≥95% | 5-(p-Tolyl)-1,3,4-thiadiazol-2-amine | ESD-892576-250MG |
| Cas.: 26907-54-0 | Purity: ≥95% | 5-(p-Tolyl)-1,3,4-thiadiazol-2-amine | ESD-892576-1G |
| Cas.: 26907-54-0 | Purity: ≥95% | 5-(p-Tolyl)-1,3,4-thiadiazol-2-amine | ESD-892576-5G |
| Cas.: 26907-54-0 | Purity: ≥95% | 5-(p-Tolyl)-1,3,4-thiadiazol-2-amine | ESD-892576-10G |
| Cas.: 7770-45-8 | Purity: ≥95% | 4-Hydroxy-1-naphthaldehyde | ESD-892577-250MG |
| Cas.: 7770-45-8 | Purity: ≥95% | 4-Hydroxy-1-naphthaldehyde | ESD-892577-1G |
| Cas.: 7770-45-8 | Purity: ≥95% | 4-Hydroxy-1-naphthaldehyde | ESD-892577-5G |
| Cas.: 51984-61-3 | Purity: 95% | 2-Methyl-5-nitropyridin-3-amine | ESD-892578-100MG |
| Cas.: 51984-61-3 | Purity: 95% | 2-Methyl-5-nitropyridin-3-amine | ESD-892578-250MG |
| Cas.: 51984-61-3 | Purity: 95% | 2-Methyl-5-nitropyridin-3-amine | ESD-892578-1G |
| Cas.: 40525-65-3 | Purity: ≥95% | Methyl 2-(2-(benzyloxy)phenyl)acetate | ESD-892579-100MG |
| Cas.: 40525-65-3 | Purity: ≥95% | Methyl 2-(2-(benzyloxy)phenyl)acetate | ESD-892579-250MG |
| Cas.: 306937-12-2 | Purity: 97% | 3-((tert-Butoxycarbonyl)amino)-4-methoxybenzoic acid | ESD-892580-250MG |
| Cas.: 306937-12-2 | Purity: 97% | 3-((tert-Butoxycarbonyl)amino)-4-methoxybenzoic acid | ESD-892580-1G |
| Cas.: 306937-12-2 | Purity: 97% | 3-((tert-Butoxycarbonyl)amino)-4-methoxybenzoic acid | ESD-892580-5G |
| Cas.: 306937-12-2 | Purity: 97% | 3-((tert-Butoxycarbonyl)amino)-4-methoxybenzoic acid | ESD-892580-10G |
| Cas.: 5059-30-3 | Purity: 97% | 2-Chloro-1H-indole-3-carbaldehyde | ESD-892581-100MG |
| Cas.: 5059-30-3 | Purity: 97% | 2-Chloro-1H-indole-3-carbaldehyde | ESD-892581-250MG |
| Cas.: 5059-30-3 | Purity: 97% | 2-Chloro-1H-indole-3-carbaldehyde | ESD-892581-1G |
| Cas.: 5059-30-3 | Purity: 97% | 2-Chloro-1H-indole-3-carbaldehyde | ESD-892581-5G |
| Cas.: 5543-27-1 | Purity: 97% | (4-Bromophenyl)(pyrrolidin-1-yl)methanone | ESD-892582-250MG |
| Cas.: 5543-27-1 | Purity: 97% | (4-Bromophenyl)(pyrrolidin-1-yl)methanone | ESD-892582-1G |
| Cas.: 5543-27-1 | Purity: 97% | (4-Bromophenyl)(pyrrolidin-1-yl)methanone | ESD-892582-5G |
| Cas.: 5543-27-1 | Purity: 97% | (4-Bromophenyl)(pyrrolidin-1-yl)methanone | ESD-892582-10G |
| Cas.: 131998-24-8 | Purity: ≥95% | 5,7-Dichloro-1,8-naphthyridin-2-amine | ESD-892583-100MG |
| Cas.: 131998-24-8 | Purity: ≥95% | 5,7-Dichloro-1,8-naphthyridin-2-amine | ESD-892583-250MG |
| Cas.: 131998-24-8 | Purity: ≥95% | 5,7-Dichloro-1,8-naphthyridin-2-amine | ESD-892583-1G |
| Cas.: 66217-20-7 | Purity: 97% | 2-Bromo-6-butoxynaphthalene | ESD-892584-1G |
| Cas.: 66217-20-7 | Purity: 97% | 2-Bromo-6-butoxynaphthalene | ESD-892584-5G |
| Cas.: 66217-20-7 | Purity: 97% | 2-Bromo-6-butoxynaphthalene | ESD-892584-25G |
| Cas.: 1240948-77-9 | Purity: ≥95% | 5-(2-Fluorophenyl)-1H-pyrrole-3-carbonitrile | ESD-892585-100MG |
| Cas.: 1240948-77-9 | Purity: ≥95% | 5-(2-Fluorophenyl)-1H-pyrrole-3-carbonitrile | ESD-892585-250MG |
| Cas.: 1240948-77-9 | Purity: ≥95% | 5-(2-Fluorophenyl)-1H-pyrrole-3-carbonitrile | ESD-892585-1G |
| Cas.: 230955-75-6 | Purity: 97% | 4-Chloro-7-methoxyquinazolin-6-yl acetate | ESD-892586-250MG |
| Cas.: 230955-75-6 | Purity: 97% | 4-Chloro-7-methoxyquinazolin-6-yl acetate | ESD-892586-1G |
| Cas.: 230955-75-6 | Purity: 97% | 4-Chloro-7-methoxyquinazolin-6-yl acetate | ESD-892586-5G |
| Cas.: 230955-75-6 | Purity: 97% | 4-Chloro-7-methoxyquinazolin-6-yl acetate | ESD-892586-10G |
| Cas.: 50358-62-8 | Purity: 97% | 8-Chloroquinolin-6-amine | ESD-892587-250MG |
| Cas.: 50358-62-8 | Purity: 97% | 8-Chloroquinolin-6-amine | ESD-892587-1G |
| Cas.: 38469-83-9 | Purity: 95% | 4-Methoxy-2-nitrobenzonitrile | ESD-892588-1G |
| Cas.: 38469-83-9 | Purity: 95% | 4-Methoxy-2-nitrobenzonitrile | ESD-892588-5G |
| Cas.: 38469-83-9 | Purity: 95% | 4-Methoxy-2-nitrobenzonitrile | ESD-892588-10G |
| Cas.: 38469-83-9 | Purity: 95% | 4-Methoxy-2-nitrobenzonitrile | ESD-892588-25G |
| Cas.: 77255-26-6 | Purity: ≥95% | 2-(4-Bromophenyl)cyclopropanecarboxylic acid | ESD-892589-250MG |
| Cas.: 77255-26-6 | Purity: ≥95% | 2-(4-Bromophenyl)cyclopropanecarboxylic acid | ESD-892589-1G |
| Cas.: 1622940-14-0 | Purity: 95% | 1-(((4-Chlorophenoxy)carbonyl)oxy)ethyl isobutyrate | ESD-892590-100MG |
| Cas.: 1622940-14-0 | Purity: 95% | 1-(((4-Chlorophenoxy)carbonyl)oxy)ethyl isobutyrate | ESD-892590-250MG |
| Cas.: 88089-94-5 | Purity: ≥95% | Methyl 4-(bromomethyl)-3-nitrobenzoate | ESD-892591-100MG |
| Cas.: 88089-94-5 | Purity: ≥95% | Methyl 4-(bromomethyl)-3-nitrobenzoate | ESD-892591-250MG |
| Cas.: 88089-94-5 | Purity: ≥95% | Methyl 4-(bromomethyl)-3-nitrobenzoate | ESD-892591-1G |
| Cas.: 88089-94-5 | Purity: ≥95% | Methyl 4-(bromomethyl)-3-nitrobenzoate | ESD-892591-5G |
| Cas.: 76066-07-4 | Purity: ≥95% | 2-Bromo-3-methoxy-6-nitropyridine | ESD-892592-250MG |
| Cas.: 76066-07-4 | Purity: ≥95% | 2-Bromo-3-methoxy-6-nitropyridine | ESD-892592-1G |
| Cas.: 76066-07-4 | Purity: ≥95% | 2-Bromo-3-methoxy-6-nitropyridine | ESD-892592-5G |
| Cas.: 76066-07-4 | Purity: ≥95% | 2-Bromo-3-methoxy-6-nitropyridine | ESD-892592-10G |
| Cas.: 15846-14-7 | Purity: 97% | 4,6-Dimethoxy-5-nitropyrimidine | ESD-892593-1G |
| Cas.: 15846-14-7 | Purity: 97% | 4,6-Dimethoxy-5-nitropyrimidine | ESD-892593-5G |
| Cas.: 15846-14-7 | Purity: 97% | 4,6-Dimethoxy-5-nitropyrimidine | ESD-892593-10G |
| Cas.: 15846-14-7 | Purity: 97% | 4,6-Dimethoxy-5-nitropyrimidine | ESD-892593-25G |
| Cas.: 15384-34-6 | Purity: ≥95% | (3S,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one | ESD-892594-100MG |
| Cas.: 15384-34-6 | Purity: ≥95% | (3S,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one | ESD-892594-250MG |
| Cas.: 15384-34-6 | Purity: ≥95% | (3S,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one | ESD-892594-1G |
| Cas.: 15384-34-6 | Purity: ≥95% | (3S,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one | ESD-892594-5G |
| Cas.: 7021-11-6 | Purity: 98% | 4-(4-Hydroxyphenyl)butanoic acid | ESD-892595-250MG |
| Cas.: 7021-11-6 | Purity: 98% | 4-(4-Hydroxyphenyl)butanoic acid | ESD-892595-1G |
| Cas.: 7021-11-6 | Purity: 98% | 4-(4-Hydroxyphenyl)butanoic acid | ESD-892595-5G |
| Cas.: 7021-11-6 | Purity: 98% | 4-(4-Hydroxyphenyl)butanoic acid | ESD-892595-10G |
| Cas.: 870521-32-7 | Purity: 97% | (2-Isopropoxypyrimidin-5-yl)boronic acid | ESD-892596-100MG |
| Cas.: 870521-32-7 | Purity: 97% | (2-Isopropoxypyrimidin-5-yl)boronic acid | ESD-892596-250MG |
| Cas.: 870521-32-7 | Purity: 97% | (2-Isopropoxypyrimidin-5-yl)boronic acid | ESD-892596-1G |
| Cas.: 870521-32-7 | Purity: 97% | (2-Isopropoxypyrimidin-5-yl)boronic acid | ESD-892596-5G |
| Cas.: 438630-64-9 | Purity: 97% | 1H-Pyrazole-4-sulfonyl chloride | ESD-892597-1G |
| Cas.: 438630-64-9 | Purity: 97% | 1H-Pyrazole-4-sulfonyl chloride | ESD-892597-5G |
| Cas.: 438630-64-9 | Purity: 97% | 1H-Pyrazole-4-sulfonyl chloride | ESD-892597-10G |
| Cas.: 1451393-27-3 | Purity: 97% | 5-Bromo-3-chloro-2-fluorophenylboronic acid | ESD-892598-100MG |
| Cas.: 1451393-27-3 | Purity: 97% | 5-Bromo-3-chloro-2-fluorophenylboronic acid | ESD-892598-250MG |
| Cas.: 1451393-27-3 | Purity: 97% | 5-Bromo-3-chloro-2-fluorophenylboronic acid | ESD-892598-1G |
| Cas.: 1451393-27-3 | Purity: 97% | 5-Bromo-3-chloro-2-fluorophenylboronic acid | ESD-892598-5G |
| Cas.: 34127-22-5 | Purity: ≥95% | Ethyl 3,6-dichloropyridazine-4-carboxylate | ESD-892599-100MG |
| Cas.: 34127-22-5 | Purity: ≥95% | Ethyl 3,6-dichloropyridazine-4-carboxylate | ESD-892599-250MG |
| Cas.: 34127-22-5 | Purity: ≥95% | Ethyl 3,6-dichloropyridazine-4-carboxylate | ESD-892599-1G |
| Cas.: 34127-22-5 | Purity: ≥95% | Ethyl 3,6-dichloropyridazine-4-carboxylate | ESD-892599-5G |
| Cas.: 1072944-15-0 | Purity: 97% | 2,3-Dichloropyridine-5-boronic acid | ESD-892600-1G |
| Cas.: 1072944-15-0 | Purity: 97% | 2,3-Dichloropyridine-5-boronic acid | ESD-892600-5G |
| Cas.: 1072944-15-0 | Purity: 97% | 2,3-Dichloropyridine-5-boronic acid | ESD-892600-10G |
| Cas.: 1072944-15-0 | Purity: 97% | 2,3-Dichloropyridine-5-boronic acid | ESD-892600-25G |
| Cas.: 105544-30-7 | Purity: 98% | Ethyl 2-((5-bromo-3-nitropyridin-2-yl)oxy)acetate | ESD-892601-100MG |
| Cas.: 105544-30-7 | Purity: 98% | Ethyl 2-((5-bromo-3-nitropyridin-2-yl)oxy)acetate | ESD-892601-250MG |
| Cas.: 105544-30-7 | Purity: 98% | Ethyl 2-((5-bromo-3-nitropyridin-2-yl)oxy)acetate | ESD-892601-1G |
| Cas.: 1160994-71-7 | Purity: ≥95% | 4-Amino-2-bromopyrimidine | ESD-892602-250MG |
| Cas.: 1160994-71-7 | Purity: ≥95% | 4-Amino-2-bromopyrimidine | ESD-892602-1G |
| Cas.: 1160994-71-7 | Purity: ≥95% | 4-Amino-2-bromopyrimidine | ESD-892602-5G |
| Cas.: 1160994-71-7 | Purity: ≥95% | 4-Amino-2-bromopyrimidine | ESD-892602-10G |
| Cas.: 30913-86-1 | Purity: 98% | Methyl 4-(4-bromophenyl)-4-oxobutanoate | ESD-892603-250MG |
| Cas.: 30913-86-1 | Purity: 98% | Methyl 4-(4-bromophenyl)-4-oxobutanoate | ESD-892603-1G |
| Cas.: 54109-03-4 | Purity: ≥95% | 5-Chloroisobenzofuran-1(3H)-one | ESD-892604-100MG |
| Cas.: 54109-03-4 | Purity: ≥95% | 5-Chloroisobenzofuran-1(3H)-one | ESD-892604-250MG |
| Cas.: 54109-03-4 | Purity: ≥95% | 5-Chloroisobenzofuran-1(3H)-one | ESD-892604-1G |
| Cas.: 54109-03-4 | Purity: ≥95% | 5-Chloroisobenzofuran-1(3H)-one | ESD-892604-5G |
| Cas.: 41118-21-2 | Purity: 97% | Methyl 4-oxochroman-7-carboxylate | ESD-892605-100MG |
| Cas.: 41118-21-2 | Purity: 97% | Methyl 4-oxochroman-7-carboxylate | ESD-892605-250MG |
| Cas.: 41118-21-2 | Purity: 97% | Methyl 4-oxochroman-7-carboxylate | ESD-892605-1G |
| Cas.: 1082040-89-8 | Purity: 97% | 6-Bromo-7-methyl-1H-pyrrolo[3,2-c]pyridine | ESD-892606-100MG |
| Cas.: 1082040-89-8 | Purity: 97% | 6-Bromo-7-methyl-1H-pyrrolo[3,2-c]pyridine | ESD-892606-250MG |
| Cas.: 5328-76-7 | Purity: 97% | 1-Bromo-5-nitronaphthalene | ESD-892607-100MG |
| Cas.: 5328-76-7 | Purity: 97% | 1-Bromo-5-nitronaphthalene | ESD-892607-250MG |
| Cas.: 5328-76-7 | Purity: 97% | 1-Bromo-5-nitronaphthalene | ESD-892607-1G |
| Cas.: 5328-76-7 | Purity: 97% | 1-Bromo-5-nitronaphthalene | ESD-892607-5G |
| Cas.: 1207175-73-2 | Purity: 97% | tert-Butyl (5-bromo-3-hydroxypyridin-2-yl)carbamate | ESD-892608-100MG |
| Cas.: 1207175-73-2 | Purity: 97% | tert-Butyl (5-bromo-3-hydroxypyridin-2-yl)carbamate | ESD-892608-250MG |
| Cas.: 1207175-73-2 | Purity: 97% | tert-Butyl (5-bromo-3-hydroxypyridin-2-yl)carbamate | ESD-892608-1G |
| Cas.: 1207175-73-2 | Purity: 97% | tert-Butyl (5-bromo-3-hydroxypyridin-2-yl)carbamate | ESD-892608-5G |
| Cas.: 1509899-61-9 | Purity: 97% | (R)-1-(7-Bromoquinolin-2-yl)ethanol | ESD-892609-100MG |
| Cas.: 1509899-61-9 | Purity: 97% | (R)-1-(7-Bromoquinolin-2-yl)ethanol | ESD-892609-250MG |
| Cas.: 1444616-23-2 | Purity: 97% | 4-(4-Propoxyphenyl)cyclohexanone | ESD-892610-100MG |
| Cas.: 1444616-23-2 | Purity: 97% | 4-(4-Propoxyphenyl)cyclohexanone | ESD-892610-250MG |
| Cas.: 27225-00-9 | Purity: ≥95% | 2,7-Naphthyridin-1-amine | ESD-892611-100MG |
| Cas.: 27225-00-9 | Purity: ≥95% | 2,7-Naphthyridin-1-amine | ESD-892611-250MG |
| Cas.: 27225-00-9 | Purity: ≥95% | 2,7-Naphthyridin-1-amine | ESD-892611-1G |
| Cas.: 537712-98-4 | Purity: 97% | 4,4′-Dimethyl-[1,1′-biphenyl]-2-carboxylic acid | ESD-892612-100MG |
| Cas.: 537712-98-4 | Purity: 97% | 4,4′-Dimethyl-[1,1′-biphenyl]-2-carboxylic acid | ESD-892612-250MG |
| Cas.: 292636-13-6 | Purity: ≥95% | 4-Fluoro-1H-indol-7-amine | ESD-892613-100MG |
| Cas.: 292636-13-6 | Purity: ≥95% | 4-Fluoro-1H-indol-7-amine | ESD-892613-250MG |
| Cas.: 955369-43-4 | Purity: 97% | (3-(2-Hydroxypropan-2-yl)phenyl)boronic acid | ESD-892614-100MG |
| Cas.: 955369-43-4 | Purity: 97% | (3-(2-Hydroxypropan-2-yl)phenyl)boronic acid | ESD-892614-250MG |
| Cas.: 955369-43-4 | Purity: 97% | (3-(2-Hydroxypropan-2-yl)phenyl)boronic acid | ESD-892614-1G |
| Cas.: 955369-43-4 | Purity: 97% | (3-(2-Hydroxypropan-2-yl)phenyl)boronic acid | ESD-892614-5G |
| Cas.: 169045-04-9 | Purity: ≥95% | 2-Amino-5-bromo-4-methoxybenzoic acid | ESD-892615-100MG |
| Cas.: 169045-04-9 | Purity: ≥95% | 2-Amino-5-bromo-4-methoxybenzoic acid | ESD-892615-250MG |
| Cas.: 169045-04-9 | Purity: ≥95% | 2-Amino-5-bromo-4-methoxybenzoic acid | ESD-892615-1G |
| Cas.: 169045-04-9 | Purity: ≥95% | 2-Amino-5-bromo-4-methoxybenzoic acid | ESD-892615-5G |
| Cas.: 187392-96-7 | Purity: ≥95% | (5-Phenylpyridin-3-yl)methanol | ESD-892616-100MG |
| Cas.: 187392-96-7 | Purity: ≥95% | (5-Phenylpyridin-3-yl)methanol | ESD-892616-250MG |
| Cas.: 32905-09-2 | Purity: ≥95% | 2,3-Dimethoxy-5-nitrophenol | ESD-892617-100MG |
| Cas.: 32905-09-2 | Purity: ≥95% | 2,3-Dimethoxy-5-nitrophenol | ESD-892617-250MG |
| Cas.: 56734-10-2 | Purity: 97% | 2-(Methylthio)-4-phenylpyrimidine | ESD-892618-100MG |
| Cas.: 56734-10-2 | Purity: 97% | 2-(Methylthio)-4-phenylpyrimidine | ESD-892618-250MG |
| Cas.: 1259318-83-6 | Purity: 97% | (3-Bromo-2,5-dimethylphenyl)boronic acid | ESD-892619-100MG |
| Cas.: 1259318-83-6 | Purity: 97% | (3-Bromo-2,5-dimethylphenyl)boronic acid | ESD-892619-250MG |
| Cas.: 891782-63-1 | Purity: 97% | 5-((tert-Butoxycarbonyl)amino)pyrazine-2-carboxylic acid | ESD-892620-100MG |
| Cas.: 891782-63-1 | Purity: 97% | 5-((tert-Butoxycarbonyl)amino)pyrazine-2-carboxylic acid | ESD-892620-250MG |
| Cas.: 891782-63-1 | Purity: 97% | 5-((tert-Butoxycarbonyl)amino)pyrazine-2-carboxylic acid | ESD-892620-1G |
| Cas.: 651030-55-6 | Purity: ≥95% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzeneethanol | ESD-892621-100MG |
| Cas.: 651030-55-6 | Purity: ≥95% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzeneethanol | ESD-892621-250MG |
| Cas.: 651030-55-6 | Purity: ≥95% | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzeneethanol | ESD-892621-1G |
| Cas.: 1261677-80-8 | Purity: 95% | 7-Bromoquinolin-5-ol | ESD-892622-1G |
| Cas.: 6281-42-1 | Purity: 97% | 1-(2-Aminoethyl)imidazolidin-2-one | ESD-892623-250MG |
| Cas.: 6281-42-1 | Purity: 97% | 1-(2-Aminoethyl)imidazolidin-2-one | ESD-892623-1G |
| Cas.: 6281-42-1 | Purity: 97% | 1-(2-Aminoethyl)imidazolidin-2-one | ESD-892623-5G |
| Cas.: 6281-42-1 | Purity: 97% | 1-(2-Aminoethyl)imidazolidin-2-one | ESD-892623-10G |
| Cas.: 35212-85-2 | Purity: 97% | Methyl 3-aminobenzo[b]thiophene-2-carboxylate | ESD-892624-1G |
| Cas.: 35212-85-2 | Purity: 97% | Methyl 3-aminobenzo[b]thiophene-2-carboxylate | ESD-892624-5G |
| Cas.: 35212-85-2 | Purity: 97% | Methyl 3-aminobenzo[b]thiophene-2-carboxylate | ESD-892624-10G |
| Cas.: 35212-85-2 | Purity: 97% | Methyl 3-aminobenzo[b]thiophene-2-carboxylate | ESD-892624-25G |
| Cas.: 874779-56-3 | Purity: 97% | Ethyl 4-Amino-3-bromo-5-chlorobenzoate | ESD-892625-100MG |
| Cas.: 874779-56-3 | Purity: 97% | Ethyl 4-Amino-3-bromo-5-chlorobenzoate | ESD-892625-250MG |
| Cas.: 874779-56-3 | Purity: 97% | Ethyl 4-Amino-3-bromo-5-chlorobenzoate | ESD-892625-1G |
| Cas.: 36405-01-3 | Purity: 97% | 5-Amino-2-methylthiazole-4-carboxylic acid | ESD-892626-1G |
| Cas.: 36405-01-3 | Purity: 97% | 5-Amino-2-methylthiazole-4-carboxylic acid | ESD-892626-5G |
| Cas.: 76003-30-0 | Purity: ≥95% | 1-Boc-2-methyl-3-oxopiperazine | ESD-892627-250MG |
| Cas.: 76003-30-0 | Purity: ≥95% | 1-Boc-2-methyl-3-oxopiperazine | ESD-892627-1G |
| Cas.: 76003-30-0 | Purity: ≥95% | 1-Boc-2-methyl-3-oxopiperazine | ESD-892627-5G |
| Cas.: 76003-30-0 | Purity: ≥95% | 1-Boc-2-methyl-3-oxopiperazine | ESD-892627-10G |
| Cas.: 959245-12-6 | Purity: 97% | Methyl 6-chloro-1H-pyrrolo[3,2-b]pyridine-3-carboxylate | ESD-892628-100MG |
| Cas.: 959245-12-6 | Purity: 97% | Methyl 6-chloro-1H-pyrrolo[3,2-b]pyridine-3-carboxylate | ESD-892628-250MG |
| Cas.: 54232-43-8 | Purity: ≥95% | 6-Bromo-5-methoxypicolinic acid | ESD-892629-100MG |
| Cas.: 54232-43-8 | Purity: ≥95% | 6-Bromo-5-methoxypicolinic acid | ESD-892629-250MG |
| Cas.: 54232-43-8 | Purity: ≥95% | 6-Bromo-5-methoxypicolinic acid | ESD-892629-1G |
| Cas.: 14686-89-6 | Purity: 98% | 1,2:5,6-Di-O-isopropylidene-α-D-gulofuranose | ESD-892630-100MG |
| Cas.: 14686-89-6 | Purity: 98% | 1,2:5,6-Di-O-isopropylidene-α-D-gulofuranose | ESD-892630-250MG |
| Cas.: 14686-89-6 | Purity: 98% | 1,2:5,6-Di-O-isopropylidene-α-D-gulofuranose | ESD-892630-1G |
| Cas.: 14686-89-6 | Purity: 98% | 1,2:5,6-Di-O-isopropylidene-α-D-gulofuranose | ESD-892630-5G |
| Cas.: 1263280-37-0 | Purity: ≥95% | 3-Chloro-6-hydroxypicolinic acid | ESD-892631-100MG |
| Cas.: 1263280-37-0 | Purity: ≥95% | 3-Chloro-6-hydroxypicolinic acid | ESD-892631-250MG |
| Cas.: 1263280-37-0 | Purity: ≥95% | 3-Chloro-6-hydroxypicolinic acid | ESD-892631-1G |
| Cas.: 16859-59-9 | Purity: 97% | 3-Hydroxyisobenzofuran-1(3H)-one | ESD-892632-250MG |
| Cas.: 16859-59-9 | Purity: 97% | 3-Hydroxyisobenzofuran-1(3H)-one | ESD-892632-1G |
| Cas.: 16859-59-9 | Purity: 97% | 3-Hydroxyisobenzofuran-1(3H)-one | ESD-892632-5G |
| Cas.: 16859-59-9 | Purity: 97% | 3-Hydroxyisobenzofuran-1(3H)-one | ESD-892632-10G |
| Cas.: 77156-75-3 | Purity: ≥95% | Ethyl 8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate | ESD-892633-1G |
| Cas.: 77156-75-3 | Purity: ≥95% | Ethyl 8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate | ESD-892633-5G |
| Cas.: 77156-75-3 | Purity: ≥95% | Ethyl 8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate | ESD-892633-10G |
| Cas.: 77156-75-3 | Purity: ≥95% | Ethyl 8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate | ESD-892633-25G |
| Cas.: 16870-28-3 | Purity: ≥95% | 2-Hydroxy-4-iodobenzoic acid | ESD-892634-1G |
| Cas.: 16870-28-3 | Purity: ≥95% | 2-Hydroxy-4-iodobenzoic acid | ESD-892634-5G |
| Cas.: 16870-28-3 | Purity: ≥95% | 2-Hydroxy-4-iodobenzoic acid | ESD-892634-10G |
| Cas.: 5654-97-7 | Purity: 97% | 1,3-Dihydro-2H-pyrrolo[2,3-b]pyridin-2-one | ESD-892635-250MG |
| Cas.: 5654-97-7 | Purity: 97% | 1,3-Dihydro-2H-pyrrolo[2,3-b]pyridin-2-one | ESD-892635-1G |
| Cas.: 5654-97-7 | Purity: 97% | 1,3-Dihydro-2H-pyrrolo[2,3-b]pyridin-2-one | ESD-892635-5G |
| Cas.: 5654-97-7 | Purity: 97% | 1,3-Dihydro-2H-pyrrolo[2,3-b]pyridin-2-one | ESD-892635-10G |
| Cas.: 915006-52-9 | Purity: 97% | 6-Bromo-2-iodopyridin-3-amine | ESD-892636-100MG |
| Cas.: 915006-52-9 | Purity: 97% | 6-Bromo-2-iodopyridin-3-amine | ESD-892636-250MG |
| Cas.: 323-79-5 | Purity: ≥95% | 2,2′-((3-(Trifluoromethyl)phenyl)azanediyl)diethanol | ESD-892637-100MG |
| Cas.: 323-79-5 | Purity: ≥95% | 2,2′-((3-(Trifluoromethyl)phenyl)azanediyl)diethanol | ESD-892637-250MG |
| Cas.: 1060806-77-0 | Purity: 97% | 6-Amino-2-methoxynicotinic acid | ESD-892638-250MG |
| Cas.: 1060806-77-0 | Purity: 97% | 6-Amino-2-methoxynicotinic acid | ESD-892638-1G |
| Cas.: 116387-40-7 | Purity: 97% | Methyl 5-iodo-2-oxo-1,2-dihydropyridine-3-carboxylate | ESD-892639-100MG |
| Cas.: 116387-40-7 | Purity: 97% | Methyl 5-iodo-2-oxo-1,2-dihydropyridine-3-carboxylate | ESD-892639-250MG |
| Cas.: 116387-40-7 | Purity: 97% | Methyl 5-iodo-2-oxo-1,2-dihydropyridine-3-carboxylate | ESD-892639-1G |
| Cas.: 116387-40-7 | Purity: 97% | Methyl 5-iodo-2-oxo-1,2-dihydropyridine-3-carboxylate | ESD-892639-5G |
| Cas.: 949008-41-7 | Purity: 97% | 6-Bromo-2,2-dimethyl-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-892640-100MG |
| Cas.: 949008-41-7 | Purity: 97% | 6-Bromo-2,2-dimethyl-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-892640-250MG |
| Cas.: 949008-41-7 | Purity: 97% | 6-Bromo-2,2-dimethyl-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-892640-1G |
| Cas.: 52065-78-8 | Purity: ≥95% | Piperidine-2,5-dione | ESD-892641-100MG |
| Cas.: 52065-78-8 | Purity: ≥95% | Piperidine-2,5-dione | ESD-892641-250MG |
| Cas.: 52065-78-8 | Purity: ≥95% | Piperidine-2,5-dione | ESD-892641-1G |
| Cas.: 885518-25-2 | Purity: 97% | 6-Fluoro-1H-indol-4-amine | ESD-892642-100MG |
| Cas.: 885518-25-2 | Purity: 97% | 6-Fluoro-1H-indol-4-amine | ESD-892642-250MG |
| Cas.: 885518-25-2 | Purity: 97% | 6-Fluoro-1H-indol-4-amine | ESD-892642-1G |
| Cas.: 885518-25-2 | Purity: 97% | 6-Fluoro-1H-indol-4-amine | ESD-892642-5G |
| Cas.: 197143-33-2 | Purity: 96% | tert-Butyl 3-cyano-4-hydroxypyrrolidine-1-carboxylate | ESD-892643-1G |
| Cas.: 197143-33-2 | Purity: 96% | tert-Butyl 3-cyano-4-hydroxypyrrolidine-1-carboxylate | ESD-892643-5G |
| Cas.: 25680-54-0 | Purity: 97% | 3-Ethylpyrazin-2(1H)-one | ESD-892644-250MG |
| Cas.: 25680-54-0 | Purity: 97% | 3-Ethylpyrazin-2(1H)-one | ESD-892644-1G |
| Cas.: 72388-15-9 | Purity: 96% (predominantly (S-)) | 2-(4-(Methylsulfonyl)piperazin-1-yl)propan-1-ol | ESD-892645-250MG |
| Cas.: 72388-15-9 | Purity: 96% (predominantly (S-)) | 2-(4-(Methylsulfonyl)piperazin-1-yl)propan-1-ol | ESD-892645-1G |
| Cas.: 72388-15-9 | Purity: 96% (predominantly (S-)) | 2-(4-(Methylsulfonyl)piperazin-1-yl)propan-1-ol | ESD-892645-5G |
| Cas.: 66790-63-4 | Purity: ≥95% | 4-Bromo-5-chloro-2,3-dihydro-1H-inden-1-one | ESD-892646-100MG |
| Cas.: 66790-63-4 | Purity: ≥95% | 4-Bromo-5-chloro-2,3-dihydro-1H-inden-1-one | ESD-892646-250MG |
| Cas.: 66790-63-4 | Purity: ≥95% | 4-Bromo-5-chloro-2,3-dihydro-1H-inden-1-one | ESD-892646-1G |
| Cas.: 86771-76-8 | Purity: ≥95% | 5-Methoxy-4-methyl-2-nitroaniline | ESD-892647-100MG |
| Cas.: 86771-76-8 | Purity: ≥95% | 5-Methoxy-4-methyl-2-nitroaniline | ESD-892647-250MG |
| Cas.: 86771-76-8 | Purity: ≥95% | 5-Methoxy-4-methyl-2-nitroaniline | ESD-892647-1G |
| Cas.: 74386-13-3 | Purity: 97% | 4-Bromo-3-nitrophenylboronic acid | ESD-892648-100MG |
| Cas.: 74386-13-3 | Purity: 97% | 4-Bromo-3-nitrophenylboronic acid | ESD-892648-250MG |
| Cas.: 74386-13-3 | Purity: 97% | 4-Bromo-3-nitrophenylboronic acid | ESD-892648-1G |
| Cas.: 74386-13-3 | Purity: 97% | 4-Bromo-3-nitrophenylboronic acid | ESD-892648-5G |
| Cas.: 878671-94-4 | Purity: 97% | 4-Cyclopropylnaphthalen-1-amine | ESD-892649-250MG |
| Cas.: 878671-94-4 | Purity: 97% | 4-Cyclopropylnaphthalen-1-amine | ESD-892649-1G |
| Cas.: 878671-94-4 | Purity: 97% | 4-Cyclopropylnaphthalen-1-amine | ESD-892649-5G |
| Cas.: 878671-94-4 | Purity: 97% | 4-Cyclopropylnaphthalen-1-amine | ESD-892649-10G |
| Cas.: 137618-48-5 | Purity: ≥95% | tert-Butyl (2,3-dihydroxypropyl)carbamate | ESD-892650-250MG |
| Cas.: 137618-48-5 | Purity: ≥95% | tert-Butyl (2,3-dihydroxypropyl)carbamate | ESD-892650-1G |
| Cas.: 137618-48-5 | Purity: ≥95% | tert-Butyl (2,3-dihydroxypropyl)carbamate | ESD-892650-5G |
| Cas.: 137618-48-5 | Purity: ≥95% | tert-Butyl (2,3-dihydroxypropyl)carbamate | ESD-892650-10G |
| Cas.: 943835-77-6 | Purity: ≥95% | 5-Fluoro-2-(phenylethynyl)benzaldehyde | ESD-892651-100MG |
| Cas.: 943835-77-6 | Purity: ≥95% | 5-Fluoro-2-(phenylethynyl)benzaldehyde | ESD-892651-250MG |
| Cas.: 943835-77-6 | Purity: ≥95% | 5-Fluoro-2-(phenylethynyl)benzaldehyde | ESD-892651-1G |
| Cas.: 65202-52-0 | Purity: ≥95% | Methyl 6-bromopyridazine-3-carboxylate | ESD-892652-250MG |
| Cas.: 65202-52-0 | Purity: ≥95% | Methyl 6-bromopyridazine-3-carboxylate | ESD-892652-1G |
| Cas.: 65202-52-0 | Purity: ≥95% | Methyl 6-bromopyridazine-3-carboxylate | ESD-892652-5G |
| Cas.: 65202-52-0 | Purity: ≥95% | Methyl 6-bromopyridazine-3-carboxylate | ESD-892652-10G |
| Cas.: 850567-56-5 | Purity: 97% | 2-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-892653-100MG |
| Cas.: 850567-56-5 | Purity: 97% | 2-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-892653-250MG |
| Cas.: 850567-56-5 | Purity: 97% | 2-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-892653-1G |
| Cas.: 850567-56-5 | Purity: 97% | 2-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-892653-5G |
| Cas.: 34317-61-8 | Purity: 97% | (R)-2-Amino-3-(phenylthio)propanoic acid | ESD-892654-100MG |
| Cas.: 34317-61-8 | Purity: 97% | (R)-2-Amino-3-(phenylthio)propanoic acid | ESD-892654-250MG |
| Cas.: 34317-61-8 | Purity: 97% | (R)-2-Amino-3-(phenylthio)propanoic acid | ESD-892654-1G |
| Cas.: 259180-79-5 | Purity: 97% | tert-Butyl (1-(2-aminoethyl)piperidin-4-yl)carbamate | ESD-892655-100MG |
| Cas.: 259180-79-5 | Purity: 97% | tert-Butyl (1-(2-aminoethyl)piperidin-4-yl)carbamate | ESD-892655-250MG |
| Cas.: 885520-83-2 | Purity: ≥97% | 4-Bromo-6-methoxy-1H-indazole | ESD-892656-1G |
| Cas.: 868543-19-5 | Purity: ≥95% | 2-Morpholin-4-ylmethylbenzoic acid | ESD-892657-1G |
| Cas.: 868543-19-5 | Purity: ≥95% | 2-Morpholin-4-ylmethylbenzoic acid | ESD-892657-5G |
| Cas.: 868543-19-5 | Purity: ≥95% | 2-Morpholin-4-ylmethylbenzoic acid | ESD-892657-10G |
| Cas.: 52603-48-2 | Purity: 97% | 5-Amino-3-methylthiophene-2,4-dicarbonitrile | ESD-892658-1G |
| Cas.: 52603-48-2 | Purity: 97% | 5-Amino-3-methylthiophene-2,4-dicarbonitrile | ESD-892658-5G |
| Cas.: 132330-98-4 | Purity: ≥95% | 3-(Benzyloxy)-2-bromopyridine | ESD-892659-1G |
| Cas.: 132330-98-4 | Purity: ≥95% | 3-(Benzyloxy)-2-bromopyridine | ESD-892659-5G |
| Cas.: 132330-98-4 | Purity: ≥95% | 3-(Benzyloxy)-2-bromopyridine | ESD-892659-10G |
| Cas.: 1015609-75-2 | Purity: 95% | 6-Iodo-1H-pyrrolo[3,2-b]pyridine | ESD-892660-100MG |
| Cas.: 1015609-75-2 | Purity: 95% | 6-Iodo-1H-pyrrolo[3,2-b]pyridine | ESD-892660-250MG |
| Cas.: 1015609-75-2 | Purity: 95% | 6-Iodo-1H-pyrrolo[3,2-b]pyridine | ESD-892660-1G |
| Cas.: 1015609-75-2 | Purity: 95% | 6-Iodo-1H-pyrrolo[3,2-b]pyridine | ESD-892660-5G |
| Cas.: 3449-63-6 | Purity: ≥95% | 3-(4-Fluorophenyl)pentanedioic acid | ESD-892661-100MG |
| Cas.: 3449-63-6 | Purity: ≥95% | 3-(4-Fluorophenyl)pentanedioic acid | ESD-892661-250MG |
| Cas.: 3449-63-6 | Purity: ≥95% | 3-(4-Fluorophenyl)pentanedioic acid | ESD-892661-1G |
| Cas.: 95104-21-5 | Purity: 95% | 2-Chloroquinoline-3-carbonitrile | ESD-892662-100MG |
| Cas.: 95104-21-5 | Purity: 95% | 2-Chloroquinoline-3-carbonitrile | ESD-892662-250MG |
| Cas.: 95104-21-5 | Purity: 95% | 2-Chloroquinoline-3-carbonitrile | ESD-892662-1G |
| Cas.: 337904-92-4 | Purity: 97% | 5-((tert-Butoxycarbonyl)amino)nicotinic acid | ESD-892663-250MG |
| Cas.: 337904-92-4 | Purity: 97% | 5-((tert-Butoxycarbonyl)amino)nicotinic acid | ESD-892663-1G |
| Cas.: 337904-92-4 | Purity: 97% | 5-((tert-Butoxycarbonyl)amino)nicotinic acid | ESD-892663-5G |
| Cas.: 179412-79-4 | Purity: ≥97% | (S)-3-((tert-Butoxycarbonyl)amino)-4-methylpentanoic acid | ESD-892664-100MG |
| Cas.: 179412-79-4 | Purity: ≥97% | (S)-3-((tert-Butoxycarbonyl)amino)-4-methylpentanoic acid | ESD-892664-250MG |
| Cas.: 179412-79-4 | Purity: ≥97% | (S)-3-((tert-Butoxycarbonyl)amino)-4-methylpentanoic acid | ESD-892664-1G |
| Cas.: 179412-79-4 | Purity: ≥97% | (S)-3-((tert-Butoxycarbonyl)amino)-4-methylpentanoic acid | ESD-892664-5G |
| Cas.: 431888-57-2 | Purity: ≥95% | 2-Chloro-4-(methoxycarbonyl)benzoic acid | ESD-892665-250MG |
| Cas.: 431888-57-2 | Purity: ≥95% | 2-Chloro-4-(methoxycarbonyl)benzoic acid | ESD-892665-1G |
| Cas.: 431888-57-2 | Purity: ≥95% | 2-Chloro-4-(methoxycarbonyl)benzoic acid | ESD-892665-5G |
| Cas.: 52003-20-0 | Purity: ≥95% | 2-Nitrothiophen-3-amine | ESD-892666-50MG |
| Cas.: 879088-40-1 | Purity: 97% | 2-(2-Chloro-5-nitrophenyl)pyridine | ESD-892667-100MG |
| Cas.: 879088-40-1 | Purity: 97% | 2-(2-Chloro-5-nitrophenyl)pyridine | ESD-892667-250MG |
| Cas.: 270596-38-8 | Purity: 97% | (S)-3-Amino-4-(3-chlorophenyl)butanoic acid | ESD-892668-100MG |
| Cas.: 270596-38-8 | Purity: 97% | (S)-3-Amino-4-(3-chlorophenyl)butanoic acid | ESD-892668-250MG |
| Cas.: 1820686-20-1 | Purity: 97% | 8-Bromo-1,6-naphthyridin-5-amine | ESD-892669-100MG |
| Cas.: 1820686-20-1 | Purity: 97% | 8-Bromo-1,6-naphthyridin-5-amine | ESD-892669-250MG |
| Cas.: 1820686-20-1 | Purity: 97% | 8-Bromo-1,6-naphthyridin-5-amine | ESD-892669-1G |
| Cas.: 137756-89-9 | Purity: 97% | (4-(2-Hydroxyethyl)phenyl)boronic acid | ESD-892670-100MG |
| Cas.: 137756-89-9 | Purity: 97% | (4-(2-Hydroxyethyl)phenyl)boronic acid | ESD-892670-250MG |
| Cas.: 137756-89-9 | Purity: 97% | (4-(2-Hydroxyethyl)phenyl)boronic acid | ESD-892670-1G |
| Cas.: 137756-89-9 | Purity: 97% | (4-(2-Hydroxyethyl)phenyl)boronic acid | ESD-892670-5G |
| Cas.: 895577-21-6 | Purity: ≥95% | 4-(1-((tert-Butoxycarbonyl)amino)ethyl)benzoic acid | ESD-892671-100MG |
| Cas.: 895577-21-6 | Purity: ≥95% | 4-(1-((tert-Butoxycarbonyl)amino)ethyl)benzoic acid | ESD-892671-250MG |
| Cas.: 3998-04-7 | Purity: 95% | 9-Allyl-9H-carbazole | ESD-892672-1G |
| Cas.: 3998-04-7 | Purity: 95% | 9-Allyl-9H-carbazole | ESD-892672-5G |
| Cas.: 3998-04-7 | Purity: 95% | 9-Allyl-9H-carbazole | ESD-892672-10G |
| Cas.: 313546-19-9 | Purity: 97% | 3-Cyano-2-methylphenylboronic acid | ESD-892673-250MG |
| Cas.: 313546-19-9 | Purity: 97% | 3-Cyano-2-methylphenylboronic acid | ESD-892673-1G |
| Cas.: 313546-19-9 | Purity: 97% | 3-Cyano-2-methylphenylboronic acid | ESD-892673-5G |
| Cas.: 220247-71-2 | Purity: ≥95% | 1,2,3,4-Tetrahydroisoquinoline-7-carboxylic acid hydrochloride | ESD-892674-100MG |
| Cas.: 220247-71-2 | Purity: ≥95% | 1,2,3,4-Tetrahydroisoquinoline-7-carboxylic acid hydrochloride | ESD-892674-250MG |
| Cas.: 220247-71-2 | Purity: ≥95% | 1,2,3,4-Tetrahydroisoquinoline-7-carboxylic acid hydrochloride | ESD-892674-1G |
| Cas.: 132521-66-5 | Purity: ≥95% | 2,4-Dichloro-3-nitroquinoline | ESD-892675-250MG |
| Cas.: 132521-66-5 | Purity: ≥95% | 2,4-Dichloro-3-nitroquinoline | ESD-892675-1G |
| Cas.: 132521-66-5 | Purity: ≥95% | 2,4-Dichloro-3-nitroquinoline | ESD-892675-5G |
| Cas.: 510729-01-8 | Purity: 97% | Benzyl (4-bromo-3-fluorophenyl)carbamate | ESD-892676-100MG |
| Cas.: 510729-01-8 | Purity: 97% | Benzyl (4-bromo-3-fluorophenyl)carbamate | ESD-892676-250MG |
| Cas.: 510729-01-8 | Purity: 97% | Benzyl (4-bromo-3-fluorophenyl)carbamate | ESD-892676-1G |
| Cas.: 510729-01-8 | Purity: 97% | Benzyl (4-bromo-3-fluorophenyl)carbamate | ESD-892676-5G |
| Cas.: 915201-07-9 | Purity: 97% | 3-Chloro-5-methoxyphenylboronic acid | ESD-892677-250MG |
| Cas.: 915201-07-9 | Purity: 97% | 3-Chloro-5-methoxyphenylboronic acid | ESD-892677-1G |
| Cas.: 915201-07-9 | Purity: 97% | 3-Chloro-5-methoxyphenylboronic acid | ESD-892677-5G |
| Cas.: 915201-07-9 | Purity: 97% | 3-Chloro-5-methoxyphenylboronic acid | ESD-892677-25G |
| Cas.: 144501-28-0 | Purity: ≥95% | Ethyl 2-Phenylpyridine-3-carboxylate | ESD-892678-1G |
| Cas.: 144501-28-0 | Purity: ≥95% | Ethyl 2-Phenylpyridine-3-carboxylate | ESD-892678-5G |
| Cas.: 144501-28-0 | Purity: ≥95% | Ethyl 2-Phenylpyridine-3-carboxylate | ESD-892678-10G |
| Cas.: 1070893-11-6 | Purity: ≥95% | (4,6-Dichloropyridine-3yl)boronic acid | ESD-892679-250MG |
| Cas.: 1070893-11-6 | Purity: ≥95% | (4,6-Dichloropyridine-3yl)boronic acid | ESD-892679-1G |
| Cas.: 1070893-11-6 | Purity: ≥95% | (4,6-Dichloropyridine-3yl)boronic acid | ESD-892679-5G |
| Cas.: 426829-61-0 | Purity: ≥95% | N-Benzyl-6-chloropyrazin-2-amine | ESD-892680-250MG |
| Cas.: 426829-61-0 | Purity: ≥95% | N-Benzyl-6-chloropyrazin-2-amine | ESD-892680-1G |
| Cas.: 190273-94-0 | Purity: 97% | 6-(Trifluoromethyl)quinazolin-2-amine | ESD-892681-100MG |
| Cas.: 190273-94-0 | Purity: 97% | 6-(Trifluoromethyl)quinazolin-2-amine | ESD-892681-250MG |
| Cas.: 190273-94-0 | Purity: 97% | 6-(Trifluoromethyl)quinazolin-2-amine | ESD-892681-1G |
| Cas.: 883-39-6 | Purity: ≥95% | 1-Phenyl-1H-benzo[d][1,2,3]triazole | ESD-892682-250MG |
| Cas.: 883-39-6 | Purity: ≥95% | 1-Phenyl-1H-benzo[d][1,2,3]triazole | ESD-892682-1G |
| Cas.: 115309-58-5 | Purity: 97% | N-(tert-Butyl)-6-chloronicotinamide | ESD-892683-1G |
| Cas.: 115309-58-5 | Purity: 97% | N-(tert-Butyl)-6-chloronicotinamide | ESD-892683-5G |
| Cas.: 115309-58-5 | Purity: 97% | N-(tert-Butyl)-6-chloronicotinamide | ESD-892683-10G |
| Cas.: 115309-58-5 | Purity: 97% | N-(tert-Butyl)-6-chloronicotinamide | ESD-892683-25G |
| Cas.: 178876-82-9 | Purity: 97% | Methyl 6-amino-5-bromopicolinate | ESD-892684-100MG |
| Cas.: 178876-82-9 | Purity: 97% | Methyl 6-amino-5-bromopicolinate | ESD-892684-250MG |
| Cas.: 178876-82-9 | Purity: 97% | Methyl 6-amino-5-bromopicolinate | ESD-892684-1G |
| Cas.: 178876-82-9 | Purity: 97% | Methyl 6-amino-5-bromopicolinate | ESD-892684-5G |
| Cas.: 3847-57-2 | Purity: ≥95% | Sodium 4-nitrobenzoate | ESD-892685-250MG |
| Cas.: 3847-57-2 | Purity: ≥95% | Sodium 4-nitrobenzoate | ESD-892685-1G |
| Cas.: 126533-98-0 | Purity: 97% | Ethyl 2-(pipidin-1-yl)thiazole-4-carboxylate | ESD-892686-250MG |
| Cas.: 126533-98-0 | Purity: 97% | Ethyl 2-(pipidin-1-yl)thiazole-4-carboxylate | ESD-892686-1G |
| Cas.: 126533-98-0 | Purity: 97% | Ethyl 2-(pipidin-1-yl)thiazole-4-carboxylate | ESD-892686-5G |
| Cas.: 105350-49-0 | Purity: ≥95% | 4-(Thiazol-2-yloxy)aniline | ESD-892687-250MG |
| Cas.: 105350-49-0 | Purity: ≥95% | 4-(Thiazol-2-yloxy)aniline | ESD-892687-1G |
| Cas.: 105350-49-0 | Purity: ≥95% | 4-(Thiazol-2-yloxy)aniline | ESD-892687-5G |
| Cas.: 159531-97-2 | Purity: 97% | 2-Methyl-4-phenyl-1H-indene | ESD-892688-250MG |
| Cas.: 159531-97-2 | Purity: 97% | 2-Methyl-4-phenyl-1H-indene | ESD-892688-1G |
| Cas.: 159531-97-2 | Purity: 97% | 2-Methyl-4-phenyl-1H-indene | ESD-892688-5G |
| Cas.: 590418-05-6 | Purity: 97% | 2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-892689-100MG |
| Cas.: 590418-05-6 | Purity: 97% | 2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-892689-250MG |
| Cas.: 590418-05-6 | Purity: 97% | 2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-892689-1G |
| Cas.: 268224-29-9 | Purity: ≥95% | (R)-1-(tert-Butoxycarbonyl)-3,3-dimethyl-1,3-azasirolidine-5-carboxylic acid | ESD-892690-100MG |
| Cas.: 268224-29-9 | Purity: ≥95% | (R)-1-(tert-Butoxycarbonyl)-3,3-dimethyl-1,3-azasirolidine-5-carboxylic acid | ESD-892690-250MG |
| Cas.: 268224-29-9 | Purity: ≥95% | (R)-1-(tert-Butoxycarbonyl)-3,3-dimethyl-1,3-azasirolidine-5-carboxylic acid | ESD-892690-1G |
| Cas.: 762263-66-1 | Purity: 97% | (4-Hydroxy-3-methylphenyl)boronic acid | ESD-892691-100MG |
| Cas.: 762263-66-1 | Purity: 97% | (4-Hydroxy-3-methylphenyl)boronic acid | ESD-892691-250MG |
| Cas.: 762263-66-1 | Purity: 97% | (4-Hydroxy-3-methylphenyl)boronic acid | ESD-892691-1G |
| Cas.: 762263-66-1 | Purity: 97% | (4-Hydroxy-3-methylphenyl)boronic acid | ESD-892691-5G |
| Cas.: 129101-37-7 | Purity: ≥95% | (R)-6-Fluorochroman-2-carboxylic acid | ESD-892692-250MG |
| Cas.: 129101-37-7 | Purity: ≥95% | (R)-6-Fluorochroman-2-carboxylic acid | ESD-892692-1G |
| Cas.: 129101-37-7 | Purity: ≥95% | (R)-6-Fluorochroman-2-carboxylic acid | ESD-892692-5G |
| Cas.: 129101-37-7 | Purity: ≥95% | (R)-6-Fluorochroman-2-carboxylic acid | ESD-892692-10G |
| Cas.: 360576-01-8 | Purity: ≥95% | Methyl 6-bromobenzo[b]thiophene-2-carboxylate | ESD-892693-250MG |
| Cas.: 360576-01-8 | Purity: ≥95% | Methyl 6-bromobenzo[b]thiophene-2-carboxylate | ESD-892693-1G |
| Cas.: 360576-01-8 | Purity: ≥95% | Methyl 6-bromobenzo[b]thiophene-2-carboxylate | ESD-892693-5G |
| Cas.: 360576-01-8 | Purity: ≥95% | Methyl 6-bromobenzo[b]thiophene-2-carboxylate | ESD-892693-10G |
| Cas.: 550998-53-3 | Purity: ≥95% | Methyl 7-bromobenzo[b]thiophene-2-carboxylate | ESD-892694-250MG |
| Cas.: 550998-53-3 | Purity: ≥95% | Methyl 7-bromobenzo[b]thiophene-2-carboxylate | ESD-892694-1G |
| Cas.: 550998-53-3 | Purity: ≥95% | Methyl 7-bromobenzo[b]thiophene-2-carboxylate | ESD-892694-5G |
| Cas.: 25178-38-5 | Purity: ≥95% | 2-Amino-2-(2-hydroxyphenyl)acetic acid | ESD-892695-100MG |
| Cas.: 25178-38-5 | Purity: ≥95% | 2-Amino-2-(2-hydroxyphenyl)acetic acid | ESD-892695-250MG |
| Cas.: 25178-38-5 | Purity: ≥95% | 2-Amino-2-(2-hydroxyphenyl)acetic acid | ESD-892695-1G |
| Cas.: 16313-65-8 | Purity: ≥95% | 2-Amino-5-nitrobenzamide | ESD-892696-250MG |
| Cas.: 16313-65-8 | Purity: ≥95% | 2-Amino-5-nitrobenzamide | ESD-892696-1G |
| Cas.: 16313-65-8 | Purity: ≥95% | 2-Amino-5-nitrobenzamide | ESD-892696-5G |
| Cas.: 1273608-49-3 | Purity: 97% | 5-Bromo-4-chloro-2,3-dihydro-1H-inden-1-one | ESD-892697-100MG |
| Cas.: 1273608-49-3 | Purity: 97% | 5-Bromo-4-chloro-2,3-dihydro-1H-inden-1-one | ESD-892697-250MG |
| Cas.: 1273608-49-3 | Purity: 97% | 5-Bromo-4-chloro-2,3-dihydro-1H-inden-1-one | ESD-892697-1G |
| Cas.: 141943-04-6 | Purity: ≥95% | 1-Benzylpiperidine-3-carboxylic acid | ESD-892698-250MG |
| Cas.: 141943-04-6 | Purity: ≥95% | 1-Benzylpiperidine-3-carboxylic acid | ESD-892698-1G |
| Cas.: 141943-04-6 | Purity: ≥95% | 1-Benzylpiperidine-3-carboxylic acid | ESD-892698-5G |
| Cas.: 683815-49-8 | Purity: 97% | Ethyl 1-ethyl-5-nitro-1H-imidazole-2-carboxylate | ESD-892699-100MG |
| Cas.: 683815-49-8 | Purity: 97% | Ethyl 1-ethyl-5-nitro-1H-imidazole-2-carboxylate | ESD-892699-250MG |
| Cas.: 206055-89-2 | Purity: 97% | (3-(4-Fluorophenyl)isoxazol-5-yl)methanol | ESD-892700-100MG |
| Cas.: 206055-89-2 | Purity: 97% | (3-(4-Fluorophenyl)isoxazol-5-yl)methanol | ESD-892700-250MG |
| Cas.: 206055-89-2 | Purity: 97% | (3-(4-Fluorophenyl)isoxazol-5-yl)methanol | ESD-892700-1G |
| Cas.: 206055-89-2 | Purity: 97% | (3-(4-Fluorophenyl)isoxazol-5-yl)methanol | ESD-892700-5G |
| Cas.: 130371-64-1 | Purity: 98% | 3-(5-Methylisoxazol-3-yl)-3-oxopropanenitrile | ESD-892701-100MG |
| Cas.: 130371-64-1 | Purity: 98% | 3-(5-Methylisoxazol-3-yl)-3-oxopropanenitrile | ESD-892701-250MG |
| Cas.: 312746-72-8 | Purity: ≥95% | 1H-Indazole-7-carbaldehyde | ESD-892702-100MG |
| Cas.: 312746-72-8 | Purity: ≥95% | 1H-Indazole-7-carbaldehyde | ESD-892702-250MG |
| Cas.: 312746-72-8 | Purity: ≥95% | 1H-Indazole-7-carbaldehyde | ESD-892702-1G |
| Cas.: 312746-72-8 | Purity: ≥95% | 1H-Indazole-7-carbaldehyde | ESD-892702-5G |
| Cas.: 13575-75-2 | Purity: 97% | 6,7-Dimethoxy-3,4-dihydronaphthalen-1(2H)-one | ESD-892703-250MG |
| Cas.: 13575-75-2 | Purity: 97% | 6,7-Dimethoxy-3,4-dihydronaphthalen-1(2H)-one | ESD-892703-1G |
| Cas.: 13575-75-2 | Purity: 97% | 6,7-Dimethoxy-3,4-dihydronaphthalen-1(2H)-one | ESD-892703-5G |
| Cas.: 13575-75-2 | Purity: 97% | 6,7-Dimethoxy-3,4-dihydronaphthalen-1(2H)-one | ESD-892703-10G |
| Cas.: 861673-68-9 | Purity: 97% | 2-(2-(tert-Butyl)phenoxy)pyridin-3-amine | ESD-892704-250MG |
| Cas.: 861673-68-9 | Purity: 97% | 2-(2-(tert-Butyl)phenoxy)pyridin-3-amine | ESD-892704-1G |
| Cas.: 56619-93-3 | Purity: 97% | N-(3-Methoxyphenyl)pivalamide | ESD-892705-1G |
| Cas.: 56619-93-3 | Purity: 97% | N-(3-Methoxyphenyl)pivalamide | ESD-892705-5G |
| Cas.: 56619-93-3 | Purity: 97% | N-(3-Methoxyphenyl)pivalamide | ESD-892705-10G |
| Cas.: 56619-93-3 | Purity: 97% | N-(3-Methoxyphenyl)pivalamide | ESD-892705-25G |
| Cas.: 885522-11-2 | Purity: ≥95% | 4-Iodo-1H-indazole | ESD-892706-100MG |
| Cas.: 885522-11-2 | Purity: ≥95% | 4-Iodo-1H-indazole | ESD-892706-250MG |
| Cas.: 885522-11-2 | Purity: ≥95% | 4-Iodo-1H-indazole | ESD-892706-1G |
| Cas.: 1027-35-6 | Purity: 95% | Ethyl 1-benzyl-4-oxopyrrolidine-3-carboxylate | ESD-892707-1G |
| Cas.: 1027-35-6 | Purity: 95% | Ethyl 1-benzyl-4-oxopyrrolidine-3-carboxylate | ESD-892707-5G |
| Cas.: 1027-35-6 | Purity: 95% | Ethyl 1-benzyl-4-oxopyrrolidine-3-carboxylate | ESD-892707-10G |
| Cas.: 1027-35-6 | Purity: 95% | Ethyl 1-benzyl-4-oxopyrrolidine-3-carboxylate | ESD-892707-25G |
| Cas.: 444666-46-0 | Purity: ≥95% | Benzyl 2-methylpiperazine-1-carboxylate | ESD-892708-100MG |
| Cas.: 444666-46-0 | Purity: ≥95% | Benzyl 2-methylpiperazine-1-carboxylate | ESD-892708-250MG |
| Cas.: 444666-46-0 | Purity: ≥95% | Benzyl 2-methylpiperazine-1-carboxylate | ESD-892708-1G |
| Cas.: 84477-85-0 | Purity: ≥95% | Benzyl 3-methylpiperazine-1-carboxylate | ESD-892709-250MG |
| Cas.: 84477-85-0 | Purity: ≥95% | Benzyl 3-methylpiperazine-1-carboxylate | ESD-892709-1G |
| Cas.: 84477-85-0 | Purity: ≥95% | Benzyl 3-methylpiperazine-1-carboxylate | ESD-892709-5G |
| Cas.: 68817-71-0 | Purity: 97% | N1-(4-Chlorophenyl)benzene-1,2-diamine | ESD-892710-250MG |
| Cas.: 68817-71-0 | Purity: 97% | N1-(4-Chlorophenyl)benzene-1,2-diamine | ESD-892710-1G |
| Cas.: 68817-71-0 | Purity: 97% | N1-(4-Chlorophenyl)benzene-1,2-diamine | ESD-892710-5G |
| Cas.: 68817-71-0 | Purity: 97% | N1-(4-Chlorophenyl)benzene-1,2-diamine | ESD-892710-10G |
| Cas.: 216076-11-8 | Purity: ≥95% | 1-(2-Chlorophenyl)-2-(pyridin-4-yl)ethanone | ESD-892711-100MG |
| Cas.: 216076-11-8 | Purity: ≥95% | 1-(2-Chlorophenyl)-2-(pyridin-4-yl)ethanone | ESD-892711-250MG |
| Cas.: 723760-74-5 | Purity: ≥95% | 5-Bromo-6-nitro-2,3-dihydro-1H-inden-1-one | ESD-892712-100MG |
| Cas.: 723760-74-5 | Purity: ≥95% | 5-Bromo-6-nitro-2,3-dihydro-1H-inden-1-one | ESD-892712-250MG |
| Cas.: 53554-20-4 | Purity: ≥95% | 6-Amino-2-chloronicotinonitrile | ESD-892713-100MG |
| Cas.: 53554-20-4 | Purity: ≥95% | 6-Amino-2-chloronicotinonitrile | ESD-892713-250MG |
| Cas.: 5470-75-7 | Purity: ≥95% | 6-Chloroquinolin-8-amine | ESD-892714-100MG |
| Cas.: 5470-75-7 | Purity: ≥95% | 6-Chloroquinolin-8-amine | ESD-892714-250MG |
| Cas.: 5470-75-7 | Purity: ≥95% | 6-Chloroquinolin-8-amine | ESD-892714-1G |
| Cas.: 5470-75-7 | Purity: ≥95% | 6-Chloroquinolin-8-amine | ESD-892714-5G |
| Cas.: 365553-47-5 | Purity: 97% | 4-(4-Isopropoxyphenyl)cyclohexanone | ESD-892715-100MG |
| Cas.: 365553-47-5 | Purity: 97% | 4-(4-Isopropoxyphenyl)cyclohexanone | ESD-892715-250MG |
| Cas.: 1306763-30-3 | Purity: 97% | (R)-tert-Butyl (4-cyano-2,3-dihydro-1H-inden-1-yl)carbamate | ESD-892716-100MG |
| Cas.: 1306763-30-3 | Purity: 97% | (R)-tert-Butyl (4-cyano-2,3-dihydro-1H-inden-1-yl)carbamate | ESD-892716-250MG |
| Cas.: 2922-45-4 | Purity: 98% | Pyridine-3-sulfonamide | ESD-892717-100MG |
| Cas.: 2922-45-4 | Purity: 98% | Pyridine-3-sulfonamide | ESD-892717-250MG |
| Cas.: 2922-45-4 | Purity: 98% | Pyridine-3-sulfonamide | ESD-892717-1G |
| Cas.: 2922-45-4 | Purity: 98% | Pyridine-3-sulfonamide | ESD-892717-5G |
| Cas.: 2912-78-9 | Purity: ≥95% | 2-Hydroxy-5-nitrobenzamide | ESD-892718-250MG |
| Cas.: 2912-78-9 | Purity: ≥95% | 2-Hydroxy-5-nitrobenzamide | ESD-892718-1G |
| Cas.: 2912-78-9 | Purity: ≥95% | 2-Hydroxy-5-nitrobenzamide | ESD-892718-5G |
| Cas.: 40862-88-2 | Purity: ≥95% | Ethyl 5-methoxybenzo[b]thiophene-2-carboxylate | ESD-892719-100MG |
| Cas.: 40862-88-2 | Purity: ≥95% | Ethyl 5-methoxybenzo[b]thiophene-2-carboxylate | ESD-892719-250MG |
| Cas.: 885521-44-8 | Purity: ≥95% | Methyl 4-fluoro-1H-indazole-6-carboxylate | ESD-892720-100MG |
| Cas.: 885521-44-8 | Purity: ≥95% | Methyl 4-fluoro-1H-indazole-6-carboxylate | ESD-892720-250MG |
| Cas.: 885521-44-8 | Purity: ≥95% | Methyl 4-fluoro-1H-indazole-6-carboxylate | ESD-892720-1G |
| Cas.: 885521-44-8 | Purity: ≥95% | Methyl 4-fluoro-1H-indazole-6-carboxylate | ESD-892720-5G |
| Cas.: 181867-18-5 | Purity: ≥98% | (1-Methyl-1H-benzo[d]imidazol-6-yl)methanol | ESD-892721-100MG |
| Cas.: 181867-18-5 | Purity: ≥98% | (1-Methyl-1H-benzo[d]imidazol-6-yl)methanol | ESD-892721-250MG |
| Cas.: 181867-18-5 | Purity: ≥98% | (1-Methyl-1H-benzo[d]imidazol-6-yl)methanol | ESD-892721-1G |
| Cas.: 286946-24-5 | Purity: 97% | Methyl 3,6-dichloropyridazine-4-carboxylate | ESD-892722-250MG |
| Cas.: 286946-24-5 | Purity: 97% | Methyl 3,6-dichloropyridazine-4-carboxylate | ESD-892722-1G |
| Cas.: 286946-24-5 | Purity: 97% | Methyl 3,6-dichloropyridazine-4-carboxylate | ESD-892722-5G |
| Cas.: 286946-24-5 | Purity: 97% | Methyl 3,6-dichloropyridazine-4-carboxylate | ESD-892722-10G |
| Cas.: 175203-85-7 | Purity: ≥95% | Ethyl 4-hydroxy-6-(trifluoromethoxy)quinoline-3-carboxylate | ESD-892723-1G |
| Cas.: 175203-85-7 | Purity: ≥95% | Ethyl 4-hydroxy-6-(trifluoromethoxy)quinoline-3-carboxylate | ESD-892723-5G |
| Cas.: 175203-85-7 | Purity: ≥95% | Ethyl 4-hydroxy-6-(trifluoromethoxy)quinoline-3-carboxylate | ESD-892723-10G |
| Cas.: 175203-85-7 | Purity: ≥95% | Ethyl 4-hydroxy-6-(trifluoromethoxy)quinoline-3-carboxylate | ESD-892723-25G |
| Cas.: 33470-10-9 | Purity: ≥95% | 2′-Methoxy-2-phenylacetophenone | ESD-892724-100MG |
| Cas.: 33470-10-9 | Purity: ≥95% | 2′-Methoxy-2-phenylacetophenone | ESD-892724-250MG |
| Cas.: 33470-10-9 | Purity: ≥95% | 2′-Methoxy-2-phenylacetophenone | ESD-892724-1G |
| Cas.: 13764-20-0 | Purity: ≥95% | 2-(Pyridin-2-yl)benzoic acid | ESD-892725-100MG |
| Cas.: 13764-20-0 | Purity: ≥95% | 2-(Pyridin-2-yl)benzoic acid | ESD-892725-250MG |
| Cas.: 13764-20-0 | Purity: ≥95% | 2-(Pyridin-2-yl)benzoic acid | ESD-892725-1G |
| Cas.: 64224-60-8 | Purity: 97% | 5-Bromo-4-pyrimidinecarboxylic acid | ESD-892726-100MG |
| Cas.: 64224-60-8 | Purity: 97% | 5-Bromo-4-pyrimidinecarboxylic acid | ESD-892726-250MG |
| Cas.: 64224-60-8 | Purity: 97% | 5-Bromo-4-pyrimidinecarboxylic acid | ESD-892726-1G |
| Cas.: 64224-60-8 | Purity: 97% | 5-Bromo-4-pyrimidinecarboxylic acid | ESD-892726-5G |
| Cas.: 1031417-71-6 | Purity: ≥95% | 5-Bromo-3,7-dimethyl-1H-indazole | ESD-892727-100MG |
| Cas.: 1031417-71-6 | Purity: ≥95% | 5-Bromo-3,7-dimethyl-1H-indazole | ESD-892727-250MG |
| Cas.: 1031417-71-6 | Purity: ≥95% | 5-Bromo-3,7-dimethyl-1H-indazole | ESD-892727-1G |
| Cas.: 1190318-93-4 | Purity: ≥95% | 4-Bromo-1H-pyrrolo[2,3-c]pyridin-2(3H)-one | ESD-892728-100MG |
| Cas.: 1190318-93-4 | Purity: ≥95% | 4-Bromo-1H-pyrrolo[2,3-c]pyridin-2(3H)-one | ESD-892728-250MG |
| Cas.: 1190318-93-4 | Purity: ≥95% | 4-Bromo-1H-pyrrolo[2,3-c]pyridin-2(3H)-one | ESD-892728-1G |
| Cas.: 1590-25-6 | Purity: 97% | 1-(6-Bromonaphthalen-2-yl)ethanone | ESD-892729-100MG |
| Cas.: 1590-25-6 | Purity: 97% | 1-(6-Bromonaphthalen-2-yl)ethanone | ESD-892729-250MG |
| Cas.: 1590-25-6 | Purity: 97% | 1-(6-Bromonaphthalen-2-yl)ethanone | ESD-892729-1G |
| Cas.: 1590-25-6 | Purity: 97% | 1-(6-Bromonaphthalen-2-yl)ethanone | ESD-892729-5G |
| Cas.: 5241-56-5 | Purity: 97% | (R)-Benzyl (1-amino-1-oxo-3-phenylpropan-2-yl)carbamate | ESD-892730-250MG |
| Cas.: 5241-56-5 | Purity: 97% | (R)-Benzyl (1-amino-1-oxo-3-phenylpropan-2-yl)carbamate | ESD-892730-1G |
| Cas.: 5241-56-5 | Purity: 97% | (R)-Benzyl (1-amino-1-oxo-3-phenylpropan-2-yl)carbamate | ESD-892730-5G |
| Cas.: 618446-06-3 | Purity: ≥95% | 7-Amino-4,4-dimethyl-3,4-dihydro-1,8-naphthyridin-2(1H)-one | ESD-892731-100MG |
| Cas.: 618446-06-3 | Purity: ≥95% | 7-Amino-4,4-dimethyl-3,4-dihydro-1,8-naphthyridin-2(1H)-one | ESD-892731-250MG |
| Cas.: 179056-04-3 | Purity: 97% | 4-(2H-1,2,3-Triazol-2-yl)benzaldehyde | ESD-892732-100MG |
| Cas.: 179056-04-3 | Purity: 97% | 4-(2H-1,2,3-Triazol-2-yl)benzaldehyde | ESD-892732-250MG |
| Cas.: 179056-04-3 | Purity: 97% | 4-(2H-1,2,3-Triazol-2-yl)benzaldehyde | ESD-892732-1G |
| Cas.: 415912-99-1 | Purity: ≥95% | Ethyl 2-(6-nitropyridin-3-yl)acetate | ESD-892733-100MG |
| Cas.: 415912-99-1 | Purity: ≥95% | Ethyl 2-(6-nitropyridin-3-yl)acetate | ESD-892733-250MG |
| Cas.: 415912-99-1 | Purity: ≥95% | Ethyl 2-(6-nitropyridin-3-yl)acetate | ESD-892733-1G |
| Cas.: 1191076-36-4 | Purity: ≥95% | 2-Amino-4-bromo-6-methylbenzoic acid | ESD-892734-100MG |
| Cas.: 1191076-36-4 | Purity: ≥95% | 2-Amino-4-bromo-6-methylbenzoic acid | ESD-892734-250MG |
| Cas.: 27037-34-9 | Purity: 97% | 4-Hydroxy-7-methoxyquinolin-2(1H)-one | ESD-892735-250MG |
| Cas.: 27037-34-9 | Purity: 97% | 4-Hydroxy-7-methoxyquinolin-2(1H)-one | ESD-892735-1G |
| Cas.: 27037-34-9 | Purity: 97% | 4-Hydroxy-7-methoxyquinolin-2(1H)-one | ESD-892735-5G |
| Cas.: 26095-36-3 | Purity: ≥95% | 5-(Morpholinomethyl)furan-2-carboxylic acid | ESD-892736-1G |
| Cas.: 26095-36-3 | Purity: ≥95% | 5-(Morpholinomethyl)furan-2-carboxylic acid | ESD-892736-5G |
| Cas.: 26095-36-3 | Purity: ≥95% | 5-(Morpholinomethyl)furan-2-carboxylic acid | ESD-892736-10G |
| Cas.: 866775-18-0 | Purity: ≥95% | Methyl 3-amino-6-bromo-5-(trifluoromethyl)picolinate | ESD-892737-100MG |
| Cas.: 866775-18-0 | Purity: ≥95% | Methyl 3-amino-6-bromo-5-(trifluoromethyl)picolinate | ESD-892737-250MG |
| Cas.: 1303972-81-7 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-3,3-difluoropiperidine-4-carboxylic acid | ESD-892738-100MG |
| Cas.: 1303972-81-7 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-3,3-difluoropiperidine-4-carboxylic acid | ESD-892738-250MG |
| Cas.: 1303972-81-7 | Purity: ≥95% | 1-(tert-Butoxycarbonyl)-3,3-difluoropiperidine-4-carboxylic acid | ESD-892738-1G |
| Cas.: 1152441-29-6 | Purity: 97% | 4-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-892739-100MG |
| Cas.: 1152441-29-6 | Purity: 97% | 4-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-892739-250MG |
| Cas.: 1152441-29-6 | Purity: 97% | 4-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-892739-1G |
| Cas.: 1152441-29-6 | Purity: 97% | 4-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-892739-5G |
| Cas.: 88675-31-4 | Purity: ≥95% | 2-Bromo-1-(4-fluorophenyl)-2-phenylethanone | ESD-892740-250MG |
| Cas.: 88675-31-4 | Purity: ≥95% | 2-Bromo-1-(4-fluorophenyl)-2-phenylethanone | ESD-892740-1G |
| Cas.: 88675-31-4 | Purity: ≥95% | 2-Bromo-1-(4-fluorophenyl)-2-phenylethanone | ESD-892740-5G |
| Cas.: 14736-49-3 | Purity: 97% | 2-(2-(Methoxycarbonyl)phenyl)acetic acid | ESD-892741-100MG |
| Cas.: 14736-49-3 | Purity: 97% | 2-(2-(Methoxycarbonyl)phenyl)acetic acid | ESD-892741-250MG |
| Cas.: 14736-49-3 | Purity: 97% | 2-(2-(Methoxycarbonyl)phenyl)acetic acid | ESD-892741-1G |
| Cas.: 88829-82-7 | Purity: 97% | tert-Butyl (8-aminooctyl)carbamate | ESD-892742-100MG |
| Cas.: 88829-82-7 | Purity: 97% | tert-Butyl (8-aminooctyl)carbamate | ESD-892742-250MG |
| Cas.: 88829-82-7 | Purity: 97% | tert-Butyl (8-aminooctyl)carbamate | ESD-892742-1G |
| Cas.: 88829-82-7 | Purity: 97% | tert-Butyl (8-aminooctyl)carbamate | ESD-892742-5G |
| Cas.: 107771-82-4 | Purity: ≥95% | 1-(3-Phenoxyphenyl)guanidine | ESD-892743-100MG |
| Cas.: 107771-82-4 | Purity: ≥95% | 1-(3-Phenoxyphenyl)guanidine | ESD-892743-250MG |
| Cas.: 958649-15-5 | Purity: 97% | 6-Bromo-4-hydroxyquinoline-3-carbonitrile | ESD-892744-100MG |
| Cas.: 958649-15-5 | Purity: 97% | 6-Bromo-4-hydroxyquinoline-3-carbonitrile | ESD-892744-250MG |
| Cas.: 20776-62-9 | Purity: ≥95% | 2-Amino-3,4-dichlorobenzoic acid | ESD-892745-100MG |
| Cas.: 20776-62-9 | Purity: ≥95% | 2-Amino-3,4-dichlorobenzoic acid | ESD-892745-250MG |
| Cas.: 51939-71-0 | Purity: 97% | Chromane-2-carboxylic acid | ESD-892746-250MG |
| Cas.: 51939-71-0 | Purity: 97% | Chromane-2-carboxylic acid | ESD-892746-1G |
| Cas.: 51939-71-0 | Purity: 97% | Chromane-2-carboxylic acid | ESD-892746-5G |
| Cas.: 51939-71-0 | Purity: 97% | Chromane-2-carboxylic acid | ESD-892746-10G |
| Cas.: 73108-76-6 | Purity: ≥95% | 7-Chloro-8-methylquinolin-2(1H)-one | ESD-892747-250MG |
| Cas.: 73108-76-6 | Purity: ≥95% | 7-Chloro-8-methylquinolin-2(1H)-one | ESD-892747-1G |
| Cas.: 113961-88-9 | Purity: 97% | 1-(1,2,3,4-Tetrahydroquinolin-6-yl)ethanone | ESD-892748-100MG |
| Cas.: 113961-88-9 | Purity: 97% | 1-(1,2,3,4-Tetrahydroquinolin-6-yl)ethanone | ESD-892748-250MG |
| Cas.: 113961-88-9 | Purity: 97% | 1-(1,2,3,4-Tetrahydroquinolin-6-yl)ethanone | ESD-892748-1G |
| Cas.: 29449-82-9 | Purity: ≥95% | 2-((6-Chloropyridin-2-yl)amino)ethanol | ESD-892749-250MG |
| Cas.: 29449-82-9 | Purity: ≥95% | 2-((6-Chloropyridin-2-yl)amino)ethanol | ESD-892749-1G |
| Cas.: 850142-72-2 | Purity: ≥95% | 6-Bromo-2-fluoropyridin-3-ol | ESD-892750-100MG |
| Cas.: 850142-72-2 | Purity: ≥95% | 6-Bromo-2-fluoropyridin-3-ol | ESD-892750-250MG |
| Cas.: 850142-72-2 | Purity: ≥95% | 6-Bromo-2-fluoropyridin-3-ol | ESD-892750-1G |
| Cas.: 850142-72-2 | Purity: ≥95% | 6-Bromo-2-fluoropyridin-3-ol | ESD-892750-5G |
| Cas.: 1157012-67-3 | Purity: 97% | 1-(Tetrahydro-2H-pyran-4-yl)-1H-pyrazol-5-amine | ESD-892751-100MG |
| Cas.: 1157012-67-3 | Purity: 97% | 1-(Tetrahydro-2H-pyran-4-yl)-1H-pyrazol-5-amine | ESD-892751-250MG |
| Cas.: 105443-94-5 | Purity: ≥95% | (S)-tert-Butyl 2-carbamoylazetidine-1-carboxylate | ESD-892752-100MG |
| Cas.: 105443-94-5 | Purity: ≥95% | (S)-tert-Butyl 2-carbamoylazetidine-1-carboxylate | ESD-892752-250MG |
| Cas.: 120503-69-7 | Purity: ≥95% | N6-Cyclopropyl-9H-purine-2,6-diamine | ESD-892753-250MG |
| Cas.: 1190318-85-4 | Purity: ≥95% | 3-Iodo-7-methoxy-1H-pyrrolo[3,2-b]pyridine | ESD-892754-100MG |
| Cas.: 1190318-85-4 | Purity: ≥95% | 3-Iodo-7-methoxy-1H-pyrrolo[3,2-b]pyridine | ESD-892754-250MG |
| Cas.: 5548-09-4 | Purity: ≥95% | Methyl 3-(1H-indol-3-yl)propanoate | ESD-892755-100MG |
| Cas.: 5548-09-4 | Purity: ≥95% | Methyl 3-(1H-indol-3-yl)propanoate | ESD-892755-250MG |
| Cas.: 5548-09-4 | Purity: ≥95% | Methyl 3-(1H-indol-3-yl)propanoate | ESD-892755-1G |
| Cas.: 885465-97-4 | Purity: ≥95% | 3-Thiazol-2-yl-benzaldehyde | ESD-892756-1G |
| Cas.: 885465-97-4 | Purity: ≥95% | 3-Thiazol-2-yl-benzaldehyde | ESD-892756-5G |
| Cas.: 885465-97-4 | Purity: ≥95% | 3-Thiazol-2-yl-benzaldehyde | ESD-892756-10G |
| Cas.: 80789-75-9 | Purity: 95% | 1-(p-Tolyl)cyclopentanecarboxylic acid | ESD-892757-1G |
| Cas.: 80789-75-9 | Purity: 95% | 1-(p-Tolyl)cyclopentanecarboxylic acid | ESD-892757-5G |
| Cas.: 80789-75-9 | Purity: 95% | 1-(p-Tolyl)cyclopentanecarboxylic acid | ESD-892757-25G |
| Cas.: 887567-79-5 | Purity: ≥95% | 4,6-Difluoro-3-iodo-1H-indazole | ESD-892758-100MG |
| Cas.: 887567-79-5 | Purity: ≥95% | 4,6-Difluoro-3-iodo-1H-indazole | ESD-892758-250MG |
| Cas.: 757251-62-0 | Purity: 97% | 4-Chloro-N-methoxy-N-methylpyridine-2-carboxamide | ESD-892759-1G |
| Cas.: 757251-62-0 | Purity: 97% | 4-Chloro-N-methoxy-N-methylpyridine-2-carboxamide | ESD-892759-5G |
| Cas.: 757251-62-0 | Purity: 97% | 4-Chloro-N-methoxy-N-methylpyridine-2-carboxamide | ESD-892759-10G |
| Cas.: 757251-62-0 | Purity: 97% | 4-Chloro-N-methoxy-N-methylpyridine-2-carboxamide | ESD-892759-25G |
| Cas.: 135807-51-1 | Purity: 97% | 2-(2-((tert-Butoxycarbonyl)amino)phenyl)acetic acid | ESD-892760-250MG |
| Cas.: 135807-51-1 | Purity: 97% | 2-(2-((tert-Butoxycarbonyl)amino)phenyl)acetic acid | ESD-892760-1G |
| Cas.: 135807-51-1 | Purity: 97% | 2-(2-((tert-Butoxycarbonyl)amino)phenyl)acetic acid | ESD-892760-5G |
| Cas.: 135807-51-1 | Purity: 97% | 2-(2-((tert-Butoxycarbonyl)amino)phenyl)acetic acid | ESD-892760-10G |
| Cas.: 264276-14-4 | Purity: 97% | Dimethyl 2,6-dichloroterephthalate | ESD-892761-100MG |
| Cas.: 264276-14-4 | Purity: 97% | Dimethyl 2,6-dichloroterephthalate | ESD-892761-250MG |
| Cas.: 91940-84-0 | Purity: 96% | 2-(tert-Butyl)isonicotinic acid | ESD-892762-250MG |
| Cas.: 91940-84-0 | Purity: 96% | 2-(tert-Butyl)isonicotinic acid | ESD-892762-1G |
| Cas.: 91940-84-0 | Purity: 96% | 2-(tert-Butyl)isonicotinic acid | ESD-892762-5G |
| Cas.: 32387-83-0 | Purity: 97% | 6-Methoxy-2,3-dimethylquinoxalin-5-amine | ESD-892763-250MG |
| Cas.: 32387-83-0 | Purity: 97% | 6-Methoxy-2,3-dimethylquinoxalin-5-amine | ESD-892763-1G |
| Cas.: 32387-83-0 | Purity: 97% | 6-Methoxy-2,3-dimethylquinoxalin-5-amine | ESD-892763-5G |
| Cas.: 109880-43-5 | Purity: ≥95% | Methyl 4-chloro-6-(hydroxymethyl)picolinate | ESD-892764-100MG |
| Cas.: 109880-43-5 | Purity: ≥95% | Methyl 4-chloro-6-(hydroxymethyl)picolinate | ESD-892764-250MG |
| Cas.: 4298-08-2 | Purity: 97% | (2S,3S)-3-Hydroxypyrrolidine-2-carboxylic acid | ESD-892765-100MG |
| Cas.: 4298-08-2 | Purity: 97% | (2S,3S)-3-Hydroxypyrrolidine-2-carboxylic acid | ESD-892765-250MG |
| Cas.: 4298-08-2 | Purity: 97% | (2S,3S)-3-Hydroxypyrrolidine-2-carboxylic acid | ESD-892765-1G |
| Cas.: 73629-43-3 | Purity: 97% | 2,3-Diaminobenzonitrile | ESD-892766-250MG |
| Cas.: 73629-43-3 | Purity: 97% | 2,3-Diaminobenzonitrile | ESD-892766-1G |
| Cas.: 73629-43-3 | Purity: 97% | 2,3-Diaminobenzonitrile | ESD-892766-5G |
| Cas.: 18213-75-7 | Purity: 96% | 5-Amino-1-methyl-1H-pyrazole-4-carboxamide | ESD-892767-100MG |
| Cas.: 18213-75-7 | Purity: 96% | 5-Amino-1-methyl-1H-pyrazole-4-carboxamide | ESD-892767-250MG |
| Cas.: 18213-75-7 | Purity: 96% | 5-Amino-1-methyl-1H-pyrazole-4-carboxamide | ESD-892767-1G |
| Cas.: 18213-75-7 | Purity: 96% | 5-Amino-1-methyl-1H-pyrazole-4-carboxamide | ESD-892767-5G |
| Cas.: 104619-51-4 | Purity: ≥95% | Di(1H-imidazol-1-yl)methanimine | ESD-892768-100MG |
| Cas.: 104619-51-4 | Purity: ≥95% | Di(1H-imidazol-1-yl)methanimine | ESD-892768-250MG |
| Cas.: 104619-51-4 | Purity: ≥95% | Di(1H-imidazol-1-yl)methanimine | ESD-892768-1G |
| Cas.: 104619-51-4 | Purity: ≥95% | Di(1H-imidazol-1-yl)methanimine | ESD-892768-5G |
| Cas.: 4799-67-1 | Purity: 97% | 3-(Benzyloxy)propane-1,2-diol | ESD-892769-1G |
| Cas.: 4799-67-1 | Purity: 97% | 3-(Benzyloxy)propane-1,2-diol | ESD-892769-5G |
| Cas.: 4799-67-1 | Purity: 97% | 3-(Benzyloxy)propane-1,2-diol | ESD-892769-10G |
| Cas.: 4799-67-1 | Purity: 97% | 3-(Benzyloxy)propane-1,2-diol | ESD-892769-25G |
| Cas.: 28354-20-3 | Purity: 97% | Methyl 2-((cyanomethyl)amino)benzoate | ESD-892770-100MG |
| Cas.: 28354-20-3 | Purity: 97% | Methyl 2-((cyanomethyl)amino)benzoate | ESD-892770-250MG |
| Cas.: 138229-59-1 | Purity: ≥95% | Methyl 3-formyl-2-nitrobenzoate | ESD-892771-1G |
| Cas.: 138229-59-1 | Purity: ≥95% | Methyl 3-formyl-2-nitrobenzoate | ESD-892771-5G |
| Cas.: 138229-59-1 | Purity: ≥95% | Methyl 3-formyl-2-nitrobenzoate | ESD-892771-25G |
| Cas.: 105166-53-8 | Purity: ≥95% | [2,2′-Bipyridin]-3-amine | ESD-892772-100MG |
| Cas.: 105166-53-8 | Purity: ≥95% | [2,2′-Bipyridin]-3-amine | ESD-892772-250MG |
| Cas.: 105166-53-8 | Purity: ≥95% | [2,2′-Bipyridin]-3-amine | ESD-892772-1G |
| Cas.: 10521-08-1 | Purity: 97% | 2H-Pyran-2,4,6(3H,5H)-trione | ESD-892773-100MG |
| Cas.: 10521-08-1 | Purity: 97% | 2H-Pyran-2,4,6(3H,5H)-trione | ESD-892773-250MG |
| Cas.: 55928-90-0 | Purity: 98% | 5-Bromopyridazin-4-amine | ESD-892774-100MG |
| Cas.: 55928-90-0 | Purity: 98% | 5-Bromopyridazin-4-amine | ESD-892774-250MG |
| Cas.: 55928-90-0 | Purity: 98% | 5-Bromopyridazin-4-amine | ESD-892774-1G |
| Cas.: 885277-30-5 | Purity: ≥95% | 1-(4-Chloropyridin-2-yl)piperazine | ESD-892775-250MG |
| Cas.: 885277-30-5 | Purity: ≥95% | 1-(4-Chloropyridin-2-yl)piperazine | ESD-892775-1G |
| Cas.: 63088-78-8 | Purity: ≥95% | (2S,5S)-5-Hydroxypiperidine-2-carboxylic acid | ESD-892776-100MG |
| Cas.: 63088-78-8 | Purity: ≥95% | (2S,5S)-5-Hydroxypiperidine-2-carboxylic acid | ESD-892776-250MG |
| Cas.: 132195-42-7 | Purity: ≥95% | 2,6-Dichloro-5-fluoro-4-methylnicotinic acid | ESD-892777-100MG |
| Cas.: 132195-42-7 | Purity: ≥95% | 2,6-Dichloro-5-fluoro-4-methylnicotinic acid | ESD-892777-250MG |
| Cas.: 909563-22-0 | Purity: 97% | Methyl 4-amino-2-isopropoxybenzoate | ESD-892778-100MG |
| Cas.: 909563-22-0 | Purity: 97% | Methyl 4-amino-2-isopropoxybenzoate | ESD-892778-250MG |
| Cas.: 909563-22-0 | Purity: 97% | Methyl 4-amino-2-isopropoxybenzoate | ESD-892778-1G |
| Cas.: 847727-21-3 | Purity: 97% | 8-Chloro-3-iodoquinoline | ESD-892779-100MG |
| Cas.: 847727-21-3 | Purity: 97% | 8-Chloro-3-iodoquinoline | ESD-892779-250MG |
| Cas.: 847727-21-3 | Purity: 97% | 8-Chloro-3-iodoquinoline | ESD-892779-1G |
| Cas.: 53344-72-2 | Purity: 97% | 6,6′-Dichloro-2,2′-bipyridine | ESD-892780-100MG |
| Cas.: 53344-72-2 | Purity: 97% | 6,6′-Dichloro-2,2′-bipyridine | ESD-892780-250MG |
| Cas.: 53344-72-2 | Purity: 97% | 6,6′-Dichloro-2,2′-bipyridine | ESD-892780-1G |
| Cas.: 53344-72-2 | Purity: 97% | 6,6′-Dichloro-2,2′-bipyridine | ESD-892780-5G |
| Cas.: 29644-97-1 | Purity: ≥95% | 2-(4-Aminophenyl)butanoic acid | ESD-892781-100MG |
| Cas.: 29644-97-1 | Purity: ≥95% | 2-(4-Aminophenyl)butanoic acid | ESD-892781-250MG |
| Cas.: 1086429-88-0 | Purity: ≥95% | 2-Bromo-3-(hydroxymethyl)benzonitrile | ESD-892782-100MG |
| Cas.: 1086429-88-0 | Purity: ≥95% | 2-Bromo-3-(hydroxymethyl)benzonitrile | ESD-892782-250MG |
| Cas.: 200064-11-5 | Purity: 96% | 4-(5-Bromo-2-pyridyl)morpholine | ESD-892783-1G |
| Cas.: 200064-11-5 | Purity: 96% | 4-(5-Bromo-2-pyridyl)morpholine | ESD-892783-5G |
| Cas.: 200064-11-5 | Purity: 96% | 4-(5-Bromo-2-pyridyl)morpholine | ESD-892783-10G |
| Cas.: 200064-11-5 | Purity: 96% | 4-(5-Bromo-2-pyridyl)morpholine | ESD-892783-25G |
| Cas.: 1256346-35-6 | Purity: ≥95% | (4-Chloro-3-isopropoxyphenyl)boronic acid | ESD-892784-250MG |
| Cas.: 1256346-35-6 | Purity: ≥95% | (4-Chloro-3-isopropoxyphenyl)boronic acid | ESD-892784-1G |
| Cas.: 1256346-35-6 | Purity: ≥95% | (4-Chloro-3-isopropoxyphenyl)boronic acid | ESD-892784-5G |
| Cas.: 1256346-35-6 | Purity: ≥95% | (4-Chloro-3-isopropoxyphenyl)boronic acid | ESD-892784-10G |
| Cas.: 96606-95-0 | Purity: 97% | 3-(2-Iodophenyl)propanoic acid | ESD-892785-250MG |
| Cas.: 96606-95-0 | Purity: 97% | 3-(2-Iodophenyl)propanoic acid | ESD-892785-1G |
| Cas.: 96606-95-0 | Purity: 97% | 3-(2-Iodophenyl)propanoic acid | ESD-892785-5G |
| Cas.: 1486470-12-5 | Purity: ≥95% | (1S,2S)-2-((tert-Butoxycarbonyl)amino)cyclopropanecarboxylic acid | ESD-892786-100MG |
| Cas.: 144542-43-8 | Purity: 97% | (R)-Methyl 2-oxooxazolidine-4-carboxylate | ESD-892787-250MG |
| Cas.: 144542-43-8 | Purity: 97% | (R)-Methyl 2-oxooxazolidine-4-carboxylate | ESD-892787-1G |
| Cas.: 144542-43-8 | Purity: 97% | (R)-Methyl 2-oxooxazolidine-4-carboxylate | ESD-892787-5G |
| Cas.: 783-08-4 | Purity: ≥95% | N-Benzylidene-4-methoxyaniline | ESD-892788-250MG |
| Cas.: 783-08-4 | Purity: ≥95% | N-Benzylidene-4-methoxyaniline | ESD-892788-1G |
| Cas.: 74695-25-3 | Purity: 97% | Methyl 2,4-dimethylthieno[3,4-b]pyridine-7-carboxylate | ESD-892789-100MG |
| Cas.: 74695-25-3 | Purity: 97% | Methyl 2,4-dimethylthieno[3,4-b]pyridine-7-carboxylate | ESD-892789-250MG |
| Cas.: 74695-25-3 | Purity: 97% | Methyl 2,4-dimethylthieno[3,4-b]pyridine-7-carboxylate | ESD-892789-1G |
| Cas.: 74695-25-3 | Purity: 97% | Methyl 2,4-dimethylthieno[3,4-b]pyridine-7-carboxylate | ESD-892789-5G |
| Cas.: 307353-32-8 | Purity: ≥95% | Methyl 3-bromo-5-(hydroxymethyl)benzoate | ESD-892790-100MG |
| Cas.: 307353-32-8 | Purity: ≥95% | Methyl 3-bromo-5-(hydroxymethyl)benzoate | ESD-892790-250MG |
| Cas.: 169547-67-5 | Purity: 98% | 3-(4-(Bromomethyl)phenyl)isoxazole | ESD-892791-100MG |
| Cas.: 169547-67-5 | Purity: 98% | 3-(4-(Bromomethyl)phenyl)isoxazole | ESD-892791-250MG |
| Cas.: 169547-67-5 | Purity: 98% | 3-(4-(Bromomethyl)phenyl)isoxazole | ESD-892791-1G |
| Cas.: 1398923-95-9 | Purity: ≥95% | 4-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol | ESD-892792-100MG |
| Cas.: 1398923-95-9 | Purity: ≥95% | 4-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol | ESD-892792-250MG |
| Cas.: 1398923-95-9 | Purity: ≥95% | 4-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol | ESD-892792-1G |
| Cas.: 1398923-95-9 | Purity: ≥95% | 4-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol | ESD-892792-5G |
| Cas.: 1026797-07-8 | Purity: 97% | 4,4,5,5-Tetramethyl-2-(3-((2,2,2-trifluoroethyl)thio)phenyl)-1,3,2-dioxaborolane | ESD-892793-100MG |
| Cas.: 1026797-07-8 | Purity: 97% | 4,4,5,5-Tetramethyl-2-(3-((2,2,2-trifluoroethyl)thio)phenyl)-1,3,2-dioxaborolane | ESD-892793-250MG |
| Cas.: 1184839-78-8 | Purity: 97% | 2-Amino-2-(2,4-dichlorophenyl)ethanol | ESD-892794-250MG |
| Cas.: 1184839-78-8 | Purity: 97% | 2-Amino-2-(2,4-dichlorophenyl)ethanol | ESD-892794-1G |
| Cas.: 188586-38-1 | Purity: 97% | 2-Amino-2-(3,4-dichlorophenyl)ethanol | ESD-892795-100MG |
| Cas.: 188586-38-1 | Purity: 97% | 2-Amino-2-(3,4-dichlorophenyl)ethanol | ESD-892795-250MG |
| Cas.: 518057-74-4 | Purity: 97% | 5-Amino-2-fluorophenylacetic acid | ESD-892796-250MG |
| Cas.: 518057-74-4 | Purity: 97% | 5-Amino-2-fluorophenylacetic acid | ESD-892796-1G |
| Cas.: 518057-74-4 | Purity: 97% | 5-Amino-2-fluorophenylacetic acid | ESD-892796-5G |
| Cas.: 518057-74-4 | Purity: 97% | 5-Amino-2-fluorophenylacetic acid | ESD-892796-10G |
| Cas.: 175277-01-7 | Purity: ≥95% | 4-((5-(Trifluoromethyl)pyridin-2-yl)oxy)benzonitrile | ESD-892797-100MG |
| Cas.: 175277-01-7 | Purity: ≥95% | 4-((5-(Trifluoromethyl)pyridin-2-yl)oxy)benzonitrile | ESD-892797-250MG |
| Cas.: 175277-01-7 | Purity: ≥95% | 4-((5-(Trifluoromethyl)pyridin-2-yl)oxy)benzonitrile | ESD-892797-1G |
| Cas.: 175277-01-7 | Purity: ≥95% | 4-((5-(Trifluoromethyl)pyridin-2-yl)oxy)benzonitrile | ESD-892797-5G |
| Cas.: 205448-31-3 | Purity: ≥95% | 4-Chloro-6-methoxyquinolin-7-ol | ESD-892798-250MG |
| Cas.: 205448-31-3 | Purity: ≥95% | 4-Chloro-6-methoxyquinolin-7-ol | ESD-892798-1G |
| Cas.: 205448-31-3 | Purity: ≥95% | 4-Chloro-6-methoxyquinolin-7-ol | ESD-892798-5G |
| Cas.: 205448-31-3 | Purity: ≥95% | 4-Chloro-6-methoxyquinolin-7-ol | ESD-892798-10G |
| Cas.: 112372-15-3 | Purity: ≥95% | Furo[2,3-c]pyridine-2-carboxylic acid | ESD-892799-100MG |
| Cas.: 112372-15-3 | Purity: ≥95% | Furo[2,3-c]pyridine-2-carboxylic acid | ESD-892799-250MG |
| Cas.: 112372-15-3 | Purity: ≥95% | Furo[2,3-c]pyridine-2-carboxylic acid | ESD-892799-1G |
| Cas.: 605-03-8 | Purity: ≥95% | 4-Phenylquinoline | ESD-892800-100MG |
| Cas.: 605-03-8 | Purity: ≥95% | 4-Phenylquinoline | ESD-892800-250MG |
| Cas.: 130473-26-6 | Purity: 97% | 1H-Pyrrolo[2,3-c]pyridine-5-carbaldehyde | ESD-892801-100MG |
| Cas.: 130473-26-6 | Purity: 97% | 1H-Pyrrolo[2,3-c]pyridine-5-carbaldehyde | ESD-892801-250MG |
| Cas.: 1610527-49-5 | Purity: 98% | (2,4-Dimethylphenyl)(2-nitrophenyl)sulfane | ESD-892802-1G |
| Cas.: 1610527-49-5 | Purity: 98% | (2,4-Dimethylphenyl)(2-nitrophenyl)sulfane | ESD-892802-5G |
| Cas.: 58553-48-3 | Purity: ≥95% | 5-(Hydroxymethyl)picolinonitrile | ESD-892803-250MG |
| Cas.: 58553-48-3 | Purity: ≥95% | 5-(Hydroxymethyl)picolinonitrile | ESD-892803-1G |
| Cas.: 58553-48-3 | Purity: ≥95% | 5-(Hydroxymethyl)picolinonitrile | ESD-892803-5G |
| Cas.: 174349-93-0 | Purity: 97% | 5-Bromo-1H-inden-2(3H)-one | ESD-892804-100MG |
| Cas.: 174349-93-0 | Purity: 97% | 5-Bromo-1H-inden-2(3H)-one | ESD-892804-250MG |
| Cas.: 174349-93-0 | Purity: 97% | 5-Bromo-1H-inden-2(3H)-one | ESD-892804-1G |
| Cas.: 174349-93-0 | Purity: 97% | 5-Bromo-1H-inden-2(3H)-one | ESD-892804-5G |
| Cas.: 1890662-66-4 | Purity: 97% | 4-(4-Isobutylphenyl)cyclohexanone | ESD-892805-100MG |
| Cas.: 1890662-66-4 | Purity: 97% | 4-(4-Isobutylphenyl)cyclohexanone | ESD-892805-250MG |
| Cas.: 1374208-42-0 | Purity: 97% | 2-Amino-4-bromo-5-fluorobenzoic acid | ESD-892806-100MG |
| Cas.: 1374208-42-0 | Purity: 97% | 2-Amino-4-bromo-5-fluorobenzoic acid | ESD-892806-250MG |
| Cas.: 1374208-42-0 | Purity: 97% | 2-Amino-4-bromo-5-fluorobenzoic acid | ESD-892806-1G |
| Cas.: 1374208-42-0 | Purity: 97% | 2-Amino-4-bromo-5-fluorobenzoic acid | ESD-892806-5G |
| Cas.: 72995-94-9 | Purity: ≥95% | 14-Bromotetradecan-1-ol | ESD-892807-100MG |
| Cas.: 72995-94-9 | Purity: ≥95% | 14-Bromotetradecan-1-ol | ESD-892807-250MG |
| Cas.: 72995-94-9 | Purity: ≥95% | 14-Bromotetradecan-1-ol | ESD-892807-1G |
| Cas.: 72995-94-9 | Purity: ≥95% | 14-Bromotetradecan-1-ol | ESD-892807-5G |
| Cas.: 2305-37-5 | Purity: 97% | 3-Amino-5-methylbenzoic acid | ESD-892808-100MG |
| Cas.: 2305-37-5 | Purity: 97% | 3-Amino-5-methylbenzoic acid | ESD-892808-250MG |
| Cas.: 2305-37-5 | Purity: 97% | 3-Amino-5-methylbenzoic acid | ESD-892808-1G |
| Cas.: 115777-72-5 | Purity: 98% | 2-(Methoxycarbonyl)thiophene-3-carboxylic acid | ESD-892809-100MG |
| Cas.: 115777-72-5 | Purity: 98% | 2-(Methoxycarbonyl)thiophene-3-carboxylic acid | ESD-892809-250MG |
| Cas.: 866775-09-9 | Purity: 97% | Methyl 3-amino-6-bromopicolinate | ESD-892810-100MG |
| Cas.: 866775-09-9 | Purity: 97% | Methyl 3-amino-6-bromopicolinate | ESD-892810-250MG |
| Cas.: 866775-09-9 | Purity: 97% | Methyl 3-amino-6-bromopicolinate | ESD-892810-1G |
| Cas.: 289039-83-4 | Purity: ≥95% | Methyl 2-amino-5-bromo-3-iodobenzoate | ESD-892811-100MG |
| Cas.: 1587700-52-4 | Purity: 97% | Methyl 4-amino-3-methyl-1H-pyrazole-5-carboxylate | ESD-892812-100MG |
| Cas.: 1587700-52-4 | Purity: 97% | Methyl 4-amino-3-methyl-1H-pyrazole-5-carboxylate | ESD-892812-250MG |
| Cas.: 53472-18-7 | Purity: 97% | 5-Bromoquinolin-8-amine | ESD-890218-10G |
| Cas.: 749875-02-3 | Purity: ≥95% | 3-Chloro-2-(trifluoromethyl)isonicotinic acid | ESD-892813-100MG |
| Cas.: 749875-02-3 | Purity: ≥95% | 3-Chloro-2-(trifluoromethyl)isonicotinic acid | ESD-892813-250MG |
| Cas.: 749875-02-3 | Purity: ≥95% | 3-Chloro-2-(trifluoromethyl)isonicotinic acid | ESD-892813-1G |
| Cas.: 76535-75-6 | Purity: 97% | Di-tert-butyl piperazine-1,4-dicarboxylate | ESD-892814-250MG |
| Cas.: 76535-75-6 | Purity: 97% | Di-tert-butyl piperazine-1,4-dicarboxylate | ESD-892814-1G |
| Cas.: 76535-75-6 | Purity: 97% | Di-tert-butyl piperazine-1,4-dicarboxylate | ESD-892814-5G |
| Cas.: 76535-75-6 | Purity: 97% | Di-tert-butyl piperazine-1,4-dicarboxylate | ESD-892814-10G |
| Cas.: 273749-25-0 | Purity: 95% | (2,3-Diaminophenyl)methanol | ESD-892815-100MG |
| Cas.: 273749-25-0 | Purity: 95% | (2,3-Diaminophenyl)methanol | ESD-892815-250MG |
| Cas.: 273749-25-0 | Purity: 95% | (2,3-Diaminophenyl)methanol | ESD-892815-1G |
| Cas.: 1107694-98-3 | Purity: ≥95% | 2-Chloro-7-methoxyquinazolin-4-amine | ESD-892816-100MG |
| Cas.: 1107694-98-3 | Purity: ≥95% | 2-Chloro-7-methoxyquinazolin-4-amine | ESD-892816-250MG |
| Cas.: 957065-87-1 | Purity: 97% | (2,6-Difluoro-4-hydroxyphenyl)boronic acid | ESD-892817-250MG |
| Cas.: 957065-87-1 | Purity: 97% | (2,6-Difluoro-4-hydroxyphenyl)boronic acid | ESD-892817-1G |
| Cas.: 957065-87-1 | Purity: 97% | (2,6-Difluoro-4-hydroxyphenyl)boronic acid | ESD-892817-5G |
| Cas.: 957065-87-1 | Purity: 97% | (2,6-Difluoro-4-hydroxyphenyl)boronic acid | ESD-892817-10G |
| Cas.: 1037298-24-0 | Purity: ≥95% | 2-Amino-5-chloro-4-iodophenol | ESD-892818-100MG |
| Cas.: 1037298-24-0 | Purity: ≥95% | 2-Amino-5-chloro-4-iodophenol | ESD-892818-250MG |
| Cas.: 1037298-24-0 | Purity: ≥95% | 2-Amino-5-chloro-4-iodophenol | ESD-892818-1G |
| Cas.: 98484-49-2 | Purity: 96% | 3-(1H-Pyrazol-1-yl)propane-1,2-diol | ESD-892819-250MG |
| Cas.: 98484-49-2 | Purity: 96% | 3-(1H-Pyrazol-1-yl)propane-1,2-diol | ESD-892819-1G |
| Cas.: 185428-55-1 | Purity: 97% | tert-Butyl (5-methoxy-2-nitrophenyl)carbamate | ESD-892820-100MG |
| Cas.: 185428-55-1 | Purity: 97% | tert-Butyl (5-methoxy-2-nitrophenyl)carbamate | ESD-892820-250MG |
| Cas.: 19752-61-5 | Purity: ≥95% | 5-Bromo-2,4-di-tert-butoxypyrimidine | ESD-892821-250MG |
| Cas.: 19752-61-5 | Purity: ≥95% | 5-Bromo-2,4-di-tert-butoxypyrimidine | ESD-892821-1G |
| Cas.: 19752-61-5 | Purity: ≥95% | 5-Bromo-2,4-di-tert-butoxypyrimidine | ESD-892821-5G |
| Cas.: 19752-61-5 | Purity: ≥95% | 5-Bromo-2,4-di-tert-butoxypyrimidine | ESD-892821-10G |
| Cas.: 887568-03-8 | Purity: ≥95% | 4-Fluoro-6-iodo-1H-indazole | ESD-892822-100MG |
| Cas.: 887568-03-8 | Purity: ≥95% | 4-Fluoro-6-iodo-1H-indazole | ESD-892822-250MG |
| Cas.: 173043-61-3 | Purity: 97% | Methyl 2-iodo-4,5-dimethoxybenzoate | ESD-892823-100MG |
| Cas.: 173043-61-3 | Purity: 97% | Methyl 2-iodo-4,5-dimethoxybenzoate | ESD-892823-250MG |
| Cas.: 173043-61-3 | Purity: 97% | Methyl 2-iodo-4,5-dimethoxybenzoate | ESD-892823-1G |
| Cas.: 173043-61-3 | Purity: 97% | Methyl 2-iodo-4,5-dimethoxybenzoate | ESD-892823-5G |
| Cas.: 1844839-22-0 | Purity: 98% | 4-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde | ESD-892824-1G |
| Cas.: 1844839-22-0 | Purity: 98% | 4-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde | ESD-892824-5G |
| Cas.: 1844839-22-0 | Purity: 98% | 4-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde | ESD-892824-10G |
| Cas.: 679433-91-1 | Purity: 97% | 5-Bromo-8-methoxyisoquinoline | ESD-892825-100MG |
| Cas.: 679433-91-1 | Purity: 97% | 5-Bromo-8-methoxyisoquinoline | ESD-892825-250MG |
| Cas.: 329974-09-6 | Purity: 97% | 4-Bromo-2,6-diaminopyridine | ESD-892826-100MG |
| Cas.: 329974-09-6 | Purity: 97% | 4-Bromo-2,6-diaminopyridine | ESD-892826-250MG |
| Cas.: 329974-09-6 | Purity: 97% | 4-Bromo-2,6-diaminopyridine | ESD-892826-1G |
| Cas.: 329974-09-6 | Purity: 97% | 4-Bromo-2,6-diaminopyridine | ESD-892826-5G |
| Cas.: 927801-13-6 | Purity: ≥95% | 4,6-Dibromoquinoline | ESD-892827-100MG |
| Cas.: 927801-13-6 | Purity: ≥95% | 4,6-Dibromoquinoline | ESD-892827-250MG |
| Cas.: 927801-13-6 | Purity: ≥95% | 4,6-Dibromoquinoline | ESD-892827-1G |
| Cas.: 204078-31-9 | Purity: 97% | 3-Morpholinobenzonitrile | ESD-892828-100MG |
| Cas.: 204078-31-9 | Purity: 97% | 3-Morpholinobenzonitrile | ESD-892828-250MG |
| Cas.: 204078-31-9 | Purity: 97% | 3-Morpholinobenzonitrile | ESD-892828-1G |
| Cas.: 204078-31-9 | Purity: 97% | 3-Morpholinobenzonitrile | ESD-892828-5G |
| Cas.: 880-87-5 | Purity: ≥95% | 5,7-Dimethoxyindan-1-one | ESD-892829-100MG |
| Cas.: 880-87-5 | Purity: ≥95% | 5,7-Dimethoxyindan-1-one | ESD-892829-250MG |
| Cas.: 880-87-5 | Purity: ≥95% | 5,7-Dimethoxyindan-1-one | ESD-892829-1G |
| Cas.: 880-87-5 | Purity: ≥95% | 5,7-Dimethoxyindan-1-one | ESD-892829-5G |
| Cas.: 33436-90-7 | Purity: 97% | 2-(Ethylthio)-9H-purin-6-amine | ESD-892830-100MG |
| Cas.: 33436-90-7 | Purity: 97% | 2-(Ethylthio)-9H-purin-6-amine | ESD-892830-250MG |
| Cas.: 33436-90-7 | Purity: 97% | 2-(Ethylthio)-9H-purin-6-amine | ESD-892830-1G |
| Cas.: 196205-06-8 | Purity: ≥95% | 4-Methyl-1H-indol-5-amine | ESD-892831-100MG |
| Cas.: 196205-06-8 | Purity: ≥95% | 4-Methyl-1H-indol-5-amine | ESD-892831-250MG |
| Cas.: 1688656-69-0 | Purity: ≥95% | Ethyl 4-ethoxyquinoline-7-carboxylate | ESD-892832-100MG |
| Cas.: 1688656-69-0 | Purity: ≥95% | Ethyl 4-ethoxyquinoline-7-carboxylate | ESD-892832-250MG |
| Cas.: 1688656-69-0 | Purity: ≥95% | Ethyl 4-ethoxyquinoline-7-carboxylate | ESD-892832-1G |
| Cas.: 73781-74-5 | Purity: ≥95% | 4-Aminothiophene-2-carbonitrile | ESD-892833-100MG |
| Cas.: 73781-74-5 | Purity: ≥95% | 4-Aminothiophene-2-carbonitrile | ESD-892833-250MG |
| Cas.: 73781-74-5 | Purity: ≥95% | 4-Aminothiophene-2-carbonitrile | ESD-892833-1G |
| Cas.: 51206-40-7 | Purity: ≥95% | 1,4-Dibromoisoquinoline | ESD-892834-250MG |
| Cas.: 51206-40-7 | Purity: ≥95% | 1,4-Dibromoisoquinoline | ESD-892834-1G |
| Cas.: 51206-40-7 | Purity: ≥95% | 1,4-Dibromoisoquinoline | ESD-892834-5G |
| Cas.: 51206-40-7 | Purity: ≥95% | 1,4-Dibromoisoquinoline | ESD-892834-10G |
| Cas.: 1307316-83-1 | Purity: 97% | 7-Bromo-6-chloroisoquinoline | ESD-892835-100MG |
| Cas.: 1307316-83-1 | Purity: 97% | 7-Bromo-6-chloroisoquinoline | ESD-892835-250MG |
| Cas.: 1307316-83-1 | Purity: 97% | 7-Bromo-6-chloroisoquinoline | ESD-892835-1G |
| Cas.: 160430-64-8 | Purity: 97% | Acetamiprid | ESD-892836-5G |
| Cas.: 160430-64-8 | Purity: 97% | Acetamiprid | ESD-892836-10G |
| Cas.: 160430-64-8 | Purity: 97% | Acetamiprid | ESD-892836-25G |
| Cas.: 864754-47-2 | Purity: 97% | 2-(4-(2-Fluoroethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-892837-100MG |
| Cas.: 864754-47-2 | Purity: 97% | 2-(4-(2-Fluoroethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-892837-250MG |
| Cas.: 864754-47-2 | Purity: 97% | 2-(4-(2-Fluoroethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-892837-1G |
| Cas.: 864754-47-2 | Purity: 97% | 2-(4-(2-Fluoroethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-892837-5G |
| Cas.: 24526-69-0 | Purity: 97% | 4-Methyl-2-oxo-2H-chromene-3-carbonitrile | ESD-892838-1G |
| Cas.: 24526-69-0 | Purity: 97% | 4-Methyl-2-oxo-2H-chromene-3-carbonitrile | ESD-892838-5G |
| Cas.: 24526-69-0 | Purity: 97% | 4-Methyl-2-oxo-2H-chromene-3-carbonitrile | ESD-892838-10G |
| Cas.: 24526-69-0 | Purity: 97% | 4-Methyl-2-oxo-2H-chromene-3-carbonitrile | ESD-892838-25G |
| Cas.: 175278-21-4 | Purity: ≥95% | 2-(Trifluoromethoxy)terephthalic acid | ESD-892839-250MG |
| Cas.: 175278-21-4 | Purity: ≥95% | 2-(Trifluoromethoxy)terephthalic acid | ESD-892839-1G |
| Cas.: 175278-21-4 | Purity: ≥95% | 2-(Trifluoromethoxy)terephthalic acid | ESD-892839-5G |
| Cas.: 10172-35-7 | Purity: 98% | 2-Bromo-4-methoxy-6-nitroaniline | ESD-892840-1G |
| Cas.: 10172-35-7 | Purity: 98% | 2-Bromo-4-methoxy-6-nitroaniline | ESD-892840-5G |
| Cas.: 10172-35-7 | Purity: 98% | 2-Bromo-4-methoxy-6-nitroaniline | ESD-892840-10G |
| Cas.: 10172-35-7 | Purity: 98% | 2-Bromo-4-methoxy-6-nitroaniline | ESD-892840-25G |
| Cas.: 649736-98-1 | Purity: ≥95% | Methyl 2-amino-5-propylthiazole-4-carboxylate | ESD-892841-250MG |
| Cas.: 649736-98-1 | Purity: ≥95% | Methyl 2-amino-5-propylthiazole-4-carboxylate | ESD-892841-1G |
| Cas.: 649736-98-1 | Purity: ≥95% | Methyl 2-amino-5-propylthiazole-4-carboxylate | ESD-892841-5G |
| Cas.: 1824275-93-5 | Purity: ≥95% | 3-Fluoroquinoline-6-carboxylic acid | ESD-892842-100MG |
| Cas.: 1824275-93-5 | Purity: ≥95% | 3-Fluoroquinoline-6-carboxylic acid | ESD-892842-250MG |
| Cas.: 85003-00-5 | Purity: 97% | 2-(Cyclohexyloxy)-5-nitropyridine | ESD-892843-100MG |
| Cas.: 85003-00-5 | Purity: 97% | 2-(Cyclohexyloxy)-5-nitropyridine | ESD-892843-250MG |
| Cas.: 85003-00-5 | Purity: 97% | 2-(Cyclohexyloxy)-5-nitropyridine | ESD-892843-1G |
| Cas.: 111454-67-2 | Purity: ≥95% | 8-Chloro-6-iodoquinoline | ESD-892844-100MG |
| Cas.: 111454-67-2 | Purity: ≥95% | 8-Chloro-6-iodoquinoline | ESD-892844-250MG |
| Cas.: 74684-38-1 | Purity: 97% | 3,5-Di-tert-butyl-4-methoxybenzaldehyde | ESD-892845-100MG |
| Cas.: 74684-38-1 | Purity: 97% | 3,5-Di-tert-butyl-4-methoxybenzaldehyde | ESD-892845-250MG |
| Cas.: 74684-38-1 | Purity: 97% | 3,5-Di-tert-butyl-4-methoxybenzaldehyde | ESD-892845-1G |
| Cas.: 1273611-01-0 | Purity: 97% | 5-Bromo-7-chloro-2,3-dihydro-1H-inden-1-one | ESD-892846-100MG |
| Cas.: 1273611-01-0 | Purity: 97% | 5-Bromo-7-chloro-2,3-dihydro-1H-inden-1-one | ESD-892846-250MG |
| Cas.: 1000341-27-4 | Purity: 98% | 3-Iodo-6-(trifluoromethyl)-1H-indazole | ESD-892847-100MG |
| Cas.: 1000341-27-4 | Purity: 98% | 3-Iodo-6-(trifluoromethyl)-1H-indazole | ESD-892847-250MG |
| Cas.: 1000341-27-4 | Purity: 98% | 3-Iodo-6-(trifluoromethyl)-1H-indazole | ESD-892847-1G |
| Cas.: 27913-58-2 | Purity: 96% | 4-(4-Iodophenyl)butanoic acid | ESD-892848-250MG |
| Cas.: 27913-58-2 | Purity: 96% | 4-(4-Iodophenyl)butanoic acid | ESD-892848-1G |
| Cas.: 27913-58-2 | Purity: 96% | 4-(4-Iodophenyl)butanoic acid | ESD-892848-5G |
| Cas.: 27913-58-2 | Purity: 96% | 4-(4-Iodophenyl)butanoic acid | ESD-892848-10G |
| Cas.: 33632-74-5 | Purity: 95% | 3,4-Dihydro-2H-benzo[b][1,4]dioxepine-2-carboxylic acid | ESD-892849-250MG |
| Cas.: 33632-74-5 | Purity: 95% | 3,4-Dihydro-2H-benzo[b][1,4]dioxepine-2-carboxylic acid | ESD-892849-1G |
| Cas.: 33632-74-5 | Purity: 95% | 3,4-Dihydro-2H-benzo[b][1,4]dioxepine-2-carboxylic acid | ESD-892849-5G |
| Cas.: 14963-96-3 | Purity: 97% | 4-Methoxyisobenzofuran-1,3-dione | ESD-892850-100MG |
| Cas.: 14963-96-3 | Purity: 97% | 4-Methoxyisobenzofuran-1,3-dione | ESD-892850-250MG |
| Cas.: 14963-96-3 | Purity: 97% | 4-Methoxyisobenzofuran-1,3-dione | ESD-892850-1G |
| Cas.: 20839-78-5 | Purity: 97% | 2-((4-Methoxybenzyl)amino)acetic acid | ESD-892851-250MG |
| Cas.: 20839-78-5 | Purity: 97% | 2-((4-Methoxybenzyl)amino)acetic acid | ESD-892851-1G |
| Cas.: 63746-12-3 | Purity: ≥95% | Dimethyl 4-aminoisophthalate | ESD-892852-100MG |
| Cas.: 63746-12-3 | Purity: ≥95% | Dimethyl 4-aminoisophthalate | ESD-892852-250MG |
| Cas.: 63746-12-3 | Purity: ≥95% | Dimethyl 4-aminoisophthalate | ESD-892852-1G |
| Cas.: 63746-12-3 | Purity: ≥95% | Dimethyl 4-aminoisophthalate | ESD-892852-5G |
| Cas.: 26893-12-9 | Purity: ≥95% | Ethyl 4-hydroxy-6-(trifluoromethyl)quinoline-3-carboxylate | ESD-892853-250MG |
| Cas.: 26893-12-9 | Purity: ≥95% | Ethyl 4-hydroxy-6-(trifluoromethyl)quinoline-3-carboxylate | ESD-892853-1G |
| Cas.: 26893-12-9 | Purity: ≥95% | Ethyl 4-hydroxy-6-(trifluoromethyl)quinoline-3-carboxylate | ESD-892853-5G |
| Cas.: 26893-12-9 | Purity: ≥95% | Ethyl 4-hydroxy-6-(trifluoromethyl)quinoline-3-carboxylate | ESD-892853-10G |
| Cas.: 201811-20-3 | Purity: ≥95% | tert-Butyl (4-hydroxy-2-nitrophenyl)carbamate | ESD-892854-250MG |
| Cas.: 201811-20-3 | Purity: ≥95% | tert-Butyl (4-hydroxy-2-nitrophenyl)carbamate | ESD-892854-1G |
| Cas.: 1227628-78-5 | Purity: ≥95% | 5-Bromo-1H-pyrazolo[4,3-b]pyridine | ESD-892855-250MG |
| Cas.: 1227628-78-5 | Purity: ≥95% | 5-Bromo-1H-pyrazolo[4,3-b]pyridine | ESD-892855-1G |
| Cas.: 1227628-78-5 | Purity: ≥95% | 5-Bromo-1H-pyrazolo[4,3-b]pyridine | ESD-892855-5G |
| Cas.: 1227628-78-5 | Purity: ≥95% | 5-Bromo-1H-pyrazolo[4,3-b]pyridine | ESD-892855-10G |
| Cas.: 1279893-97-8 | Purity: ≥95% | Ethyl 3-oxo-2,3-dihydrofuro[2,3-b]pyridine-2-carboxylate | ESD-892856-250MG |
| Cas.: 1279893-97-8 | Purity: ≥95% | Ethyl 3-oxo-2,3-dihydrofuro[2,3-b]pyridine-2-carboxylate | ESD-892856-1G |
| Cas.: 223131-01-9 | Purity: 97% | tert-Butyl (cis-4-(hydroxymethyl)cyclohexyl)carbamate | ESD-892857-250MG |
| Cas.: 223131-01-9 | Purity: 97% | tert-Butyl (cis-4-(hydroxymethyl)cyclohexyl)carbamate | ESD-892857-1G |
| Cas.: 223131-01-9 | Purity: 97% | tert-Butyl (cis-4-(hydroxymethyl)cyclohexyl)carbamate | ESD-892857-5G |
| Cas.: 22544-07-6 | Purity: ≥95% | 2-Chloro-1-(4-chlorophenoxy)-4-nitrobenzene | ESD-892858-1G |
| Cas.: 22544-07-6 | Purity: ≥95% | 2-Chloro-1-(4-chlorophenoxy)-4-nitrobenzene | ESD-892858-5G |
| Cas.: 22544-07-6 | Purity: ≥95% | 2-Chloro-1-(4-chlorophenoxy)-4-nitrobenzene | ESD-892858-10G |
| Cas.: 128676-85-7 | Purity: ≥95% | 2-Chloro-3-iodoquinoline | ESD-892859-1G |
| Cas.: 128676-85-7 | Purity: ≥95% | 2-Chloro-3-iodoquinoline | ESD-892859-5G |
| Cas.: 79213-60-8 | Purity: 95% | 3-Chloro-[1,1′-biphenyl]-4-carbaldehyde | ESD-892860-100MG |
| Cas.: 79213-60-8 | Purity: 95% | 3-Chloro-[1,1′-biphenyl]-4-carbaldehyde | ESD-892860-250MG |
| Cas.: 1211578-93-6 | Purity: 97% | 6-Chloro-5-(trifluoromethyl)pyridin-3-ol | ESD-892861-100MG |
| Cas.: 1211578-93-6 | Purity: 97% | 6-Chloro-5-(trifluoromethyl)pyridin-3-ol | ESD-892861-250MG |
| Cas.: 189509-22-6 | Purity: 96% | Ethyl 2-(8-hydroxy-1,4-dioxaspiro[4.5]decan-8-yl)acetate | ESD-892862-100MG |
| Cas.: 189509-22-6 | Purity: 96% | Ethyl 2-(8-hydroxy-1,4-dioxaspiro[4.5]decan-8-yl)acetate | ESD-892862-250MG |
| Cas.: 3433-74-7 | Purity: 97% | 5,11-Dihydrodibenzo[b,e][1,4]oxazepine | ESD-892863-100MG |
| Cas.: 3433-74-7 | Purity: 97% | 5,11-Dihydrodibenzo[b,e][1,4]oxazepine | ESD-892863-250MG |
| Cas.: 588-22-7 | Purity: 97% | 2-(3,4-Dichlorophenoxy)acetic acid | ESD-892864-250MG |
| Cas.: 588-22-7 | Purity: 97% | 2-(3,4-Dichlorophenoxy)acetic acid | ESD-892864-1G |
| Cas.: 588-22-7 | Purity: 97% | 2-(3,4-Dichlorophenoxy)acetic acid | ESD-892864-5G |
| Cas.: 588-22-7 | Purity: 97% | 2-(3,4-Dichlorophenoxy)acetic acid | ESD-892864-10G |
| Cas.: 1609402-46-1 | Purity: 97% | tert-Butyl (5-chloro-3-hydroxypyridin-2-yl)carbamate | ESD-892865-1G |
| Cas.: 1609402-46-1 | Purity: 97% | tert-Butyl (5-chloro-3-hydroxypyridin-2-yl)carbamate | ESD-892865-5G |
| Cas.: 1609402-46-1 | Purity: 97% | tert-Butyl (5-chloro-3-hydroxypyridin-2-yl)carbamate | ESD-892865-10G |
| Cas.: 81044-15-7 | Purity: ≥95% | 1-Bromo-2,6-naphthyridine | ESD-892866-1G |
| Cas.: 856169-60-3 | Purity: 97% | 2-Chloro-3,5-diiodopyridine | ESD-892867-100MG |
| Cas.: 856169-60-3 | Purity: 97% | 2-Chloro-3,5-diiodopyridine | ESD-892867-250MG |
| Cas.: 856169-60-3 | Purity: 97% | 2-Chloro-3,5-diiodopyridine | ESD-892867-1G |
| Cas.: 856169-60-3 | Purity: 97% | 2-Chloro-3,5-diiodopyridine | ESD-892867-5G |
| Cas.: 29242-87-3 | Purity: 97% | 2,4-Dichloronaphthalen-1-amine | ESD-892868-250MG |
| Cas.: 29242-87-3 | Purity: 97% | 2,4-Dichloronaphthalen-1-amine | ESD-892868-1G |
| Cas.: 29242-87-3 | Purity: 97% | 2,4-Dichloronaphthalen-1-amine | ESD-892868-5G |
| Cas.: 29242-87-3 | Purity: 97% | 2,4-Dichloronaphthalen-1-amine | ESD-892868-10G |
| Cas.: 222840-95-1 | Purity: 97% | 3-Allyloxyphenylboronic acid | ESD-892869-100MG |
| Cas.: 222840-95-1 | Purity: 97% | 3-Allyloxyphenylboronic acid | ESD-892869-250MG |
| Cas.: 222840-95-1 | Purity: 97% | 3-Allyloxyphenylboronic acid | ESD-892869-1G |
| Cas.: 222840-95-1 | Purity: 97% | 3-Allyloxyphenylboronic acid | ESD-892869-5G |
| Cas.: 32785-40-3 | Purity: 97% | 2-Chloro-4-methyl-6-phenylpyrimidine | ESD-892870-100MG |
| Cas.: 32785-40-3 | Purity: 97% | 2-Chloro-4-methyl-6-phenylpyrimidine | ESD-892870-250MG |
| Cas.: 177985-34-1 | Purity: 98% | 2-(5-Bromo-2-chlorophenyl)acetic acid | ESD-892871-250MG |
| Cas.: 177985-34-1 | Purity: 98% | 2-(5-Bromo-2-chlorophenyl)acetic acid | ESD-892871-1G |
| Cas.: 177985-34-1 | Purity: 98% | 2-(5-Bromo-2-chlorophenyl)acetic acid | ESD-892871-5G |
| Cas.: 177985-34-1 | Purity: 98% | 2-(5-Bromo-2-chlorophenyl)acetic acid | ESD-892871-10G |
| Cas.: 78364-55-3 | Purity: 97% | 6-Fluoro-2-hydrazinylbenzo[d]thiazole | ESD-892872-250MG |
| Cas.: 78364-55-3 | Purity: 97% | 6-Fluoro-2-hydrazinylbenzo[d]thiazole | ESD-892872-1G |
| Cas.: 78364-55-3 | Purity: 97% | 6-Fluoro-2-hydrazinylbenzo[d]thiazole | ESD-892872-5G |
| Cas.: 78364-55-3 | Purity: 97% | 6-Fluoro-2-hydrazinylbenzo[d]thiazole | ESD-892872-10G |
| Cas.: 185256-47-7 | Purity: 97% | tert-Butyl ((1R,2S)-2-phenylcyclopropyl)carbamate | ESD-892873-100MG |
| Cas.: 185256-47-7 | Purity: 97% | tert-Butyl ((1R,2S)-2-phenylcyclopropyl)carbamate | ESD-892873-250MG |
| Cas.: 845655-53-0 | Purity: ≥95% | 6-Methyl-2-oxoindoline-3-carbaldehyde | ESD-892874-100MG |
| Cas.: 845655-53-0 | Purity: ≥95% | 6-Methyl-2-oxoindoline-3-carbaldehyde | ESD-892874-250MG |
| Cas.: 845655-53-0 | Purity: ≥95% | 6-Methyl-2-oxoindoline-3-carbaldehyde | ESD-892874-1G |
| Cas.: 756486-14-3 | Purity: 97% | (S)-1-tert-Butyl 2-methyl 4-oxopiperidine-1,2-dicarboxylate | ESD-892875-250MG |
| Cas.: 756486-14-3 | Purity: 97% | (S)-1-tert-Butyl 2-methyl 4-oxopiperidine-1,2-dicarboxylate | ESD-892875-1G |
| Cas.: 756486-14-3 | Purity: 97% | (S)-1-tert-Butyl 2-methyl 4-oxopiperidine-1,2-dicarboxylate | ESD-892875-5G |
| Cas.: 957065-86-0 | Purity: 97% | (2,6-Difluoro-3-hydroxyphenyl)boronic acid | ESD-892876-250MG |
| Cas.: 957065-86-0 | Purity: 97% | (2,6-Difluoro-3-hydroxyphenyl)boronic acid | ESD-892876-1G |
| Cas.: 957065-86-0 | Purity: 97% | (2,6-Difluoro-3-hydroxyphenyl)boronic acid | ESD-892876-5G |
| Cas.: 848093-36-7 | Purity: 97% | Ethyl 2-amino-5-iodonicotinate | ESD-892877-100MG |
| Cas.: 848093-36-7 | Purity: 97% | Ethyl 2-amino-5-iodonicotinate | ESD-892877-250MG |
| Cas.: 848093-36-7 | Purity: 97% | Ethyl 2-amino-5-iodonicotinate | ESD-892877-1G |
| Cas.: 848093-36-7 | Purity: 97% | Ethyl 2-amino-5-iodonicotinate | ESD-892877-5G |
| Cas.: 872422-15-6 | Purity: 97% | 1-(4-Bromo-2-fluorophenyl)cyclopropanecarboxylic acid | ESD-892878-100MG |
| Cas.: 872422-15-6 | Purity: 97% | 1-(4-Bromo-2-fluorophenyl)cyclopropanecarboxylic acid | ESD-892878-250MG |
| Cas.: 872422-15-6 | Purity: 97% | 1-(4-Bromo-2-fluorophenyl)cyclopropanecarboxylic acid | ESD-892878-1G |
| Cas.: 872422-15-6 | Purity: 97% | 1-(4-Bromo-2-fluorophenyl)cyclopropanecarboxylic acid | ESD-892878-5G |
| Cas.: 52787-19-6 | Purity: ≥95% | 2-(3-(Methoxycarbonyl)phenyl)acetic acid | ESD-892879-50MG |
| Cas.: 52787-19-6 | Purity: ≥95% | 2-(3-(Methoxycarbonyl)phenyl)acetic acid | ESD-892879-100MG |
| Cas.: 52787-19-6 | Purity: ≥95% | 2-(3-(Methoxycarbonyl)phenyl)acetic acid | ESD-892879-250MG |
| Cas.: 52787-19-6 | Purity: ≥95% | 2-(3-(Methoxycarbonyl)phenyl)acetic acid | ESD-892879-1G |
| Cas.: 128651-99-0 | Purity: 95% | 6-Iodochroman-2-one | ESD-892880-100MG |
| Cas.: 128651-99-0 | Purity: 95% | 6-Iodochroman-2-one | ESD-892880-250MG |
| Cas.: 128651-99-0 | Purity: 95% | 6-Iodochroman-2-one | ESD-892880-1G |
| Cas.: 128651-99-0 | Purity: 95% | 6-Iodochroman-2-one | ESD-892880-5G |
| Cas.: 34035-03-5 | Purity: 97% | 5-(4-Chlorophenyl)furan-2-carbaldehyde | ESD-892881-250MG |
| Cas.: 34035-03-5 | Purity: 97% | 5-(4-Chlorophenyl)furan-2-carbaldehyde | ESD-892881-1G |
| Cas.: 34035-03-5 | Purity: 97% | 5-(4-Chlorophenyl)furan-2-carbaldehyde | ESD-892881-5G |
| Cas.: 34035-03-5 | Purity: 97% | 5-(4-Chlorophenyl)furan-2-carbaldehyde | ESD-892881-10G |
| Cas.: 191535-55-4 | Purity: 97% | 2-Isopropylisonicotinic acid | ESD-892882-100MG |
| Cas.: 191535-55-4 | Purity: 97% | 2-Isopropylisonicotinic acid | ESD-892882-250MG |
| Cas.: 191535-55-4 | Purity: 97% | 2-Isopropylisonicotinic acid | ESD-892882-1G |
| Cas.: 1273597-02-6 | Purity: ≥95% | 6-Bromo-7-methyl-3,4-dihydronaphthalen-1(2H)-one | ESD-892883-100MG |
| Cas.: 1273597-02-6 | Purity: ≥95% | 6-Bromo-7-methyl-3,4-dihydronaphthalen-1(2H)-one | ESD-892883-250MG |
| Cas.: 53531-69-4 | Purity: 96% | (4-Bromophenyl)methanesulfonyl chloride | ESD-892884-100MG |
| Cas.: 53531-69-4 | Purity: 96% | (4-Bromophenyl)methanesulfonyl chloride | ESD-892884-250MG |
| Cas.: 53531-69-4 | Purity: 96% | (4-Bromophenyl)methanesulfonyl chloride | ESD-892884-1G |
| Cas.: 53531-69-4 | Purity: 96% | (4-Bromophenyl)methanesulfonyl chloride | ESD-892884-5G |
| Cas.: 19156-54-8 | Purity: 97% | 4,5,6,7-Tetrahydrobenzo[b]thiophene-3-carboxylic acid | ESD-892885-100MG |
| Cas.: 19156-54-8 | Purity: 97% | 4,5,6,7-Tetrahydrobenzo[b]thiophene-3-carboxylic acid | ESD-892885-250MG |
| Cas.: 19156-54-8 | Purity: 97% | 4,5,6,7-Tetrahydrobenzo[b]thiophene-3-carboxylic acid | ESD-892885-1G |
| Cas.: 19156-54-8 | Purity: 97% | 4,5,6,7-Tetrahydrobenzo[b]thiophene-3-carboxylic acid | ESD-892885-5G |
| Cas.: 5350-50-5 | Purity: 97% | 7-Chloro-3-nitroquinolin-4-ol | ESD-892886-250MG |
| Cas.: 5350-50-5 | Purity: 97% | 7-Chloro-3-nitroquinolin-4-ol | ESD-892886-1G |
| Cas.: 5350-50-5 | Purity: 97% | 7-Chloro-3-nitroquinolin-4-ol | ESD-892886-5G |
| Cas.: 5350-50-5 | Purity: 97% | 7-Chloro-3-nitroquinolin-4-ol | ESD-892886-10G |
| Cas.: 81633-29-6 | Purity: 98% | Ethyl 2-amino-4-methylpyrimidine-5-carboxylate | ESD-892887-1G |
| Cas.: 81633-29-6 | Purity: 98% | Ethyl 2-amino-4-methylpyrimidine-5-carboxylate | ESD-892887-5G |
| Cas.: 81633-29-6 | Purity: 98% | Ethyl 2-amino-4-methylpyrimidine-5-carboxylate | ESD-892887-10G |
| Cas.: 351447-07-9 | Purity: ≥95% | 6-Iodo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine | ESD-892888-100MG |
| Cas.: 351447-07-9 | Purity: ≥95% | 6-Iodo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine | ESD-892888-250MG |
| Cas.: 351447-07-9 | Purity: ≥95% | 6-Iodo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine | ESD-892888-1G |
| Cas.: 253677-29-1 | Purity: 97% | 2-((tert-Butoxycarbonyl)amino)-5-chlorobenzoic acid | ESD-892889-250MG |
| Cas.: 253677-29-1 | Purity: 97% | 2-((tert-Butoxycarbonyl)amino)-5-chlorobenzoic acid | ESD-892889-1G |
| Cas.: 253677-29-1 | Purity: 97% | 2-((tert-Butoxycarbonyl)amino)-5-chlorobenzoic acid | ESD-892889-5G |
| Cas.: 253677-29-1 | Purity: 97% | 2-((tert-Butoxycarbonyl)amino)-5-chlorobenzoic acid | ESD-892889-10G |
| Cas.: 45521-09-3 | Purity: ≥95% | (S)-Thiazolidine-4-carboxylic acid | ESD-892890-1G |
| Cas.: 45521-09-3 | Purity: ≥95% | (S)-Thiazolidine-4-carboxylic acid | ESD-892890-5G |
| Cas.: 45521-09-3 | Purity: ≥95% | (S)-Thiazolidine-4-carboxylic acid | ESD-892890-10G |
| Cas.: 130870-00-7 | Purity: 97% | (4-Bromo-2,5-dimethylphenyl)boronic acid | ESD-892891-1G |
| Cas.: 130870-00-7 | Purity: 97% | (4-Bromo-2,5-dimethylphenyl)boronic acid | ESD-892891-5G |
| Cas.: 92807-02-8 | Purity: 97% | Methyl 2-mercapto-1H-benzo[d]imidazole-4-carboxylate | ESD-892892-100MG |
| Cas.: 92807-02-8 | Purity: 97% | Methyl 2-mercapto-1H-benzo[d]imidazole-4-carboxylate | ESD-892892-250MG |
| Cas.: 92807-02-8 | Purity: 97% | Methyl 2-mercapto-1H-benzo[d]imidazole-4-carboxylate | ESD-892892-1G |
| Cas.: 92807-02-8 | Purity: 97% | Methyl 2-mercapto-1H-benzo[d]imidazole-4-carboxylate | ESD-892892-5G |
| Cas.: 351367-77-6 | Purity: 97% | 2-Amino-5-chloro-4-fluorobenzoic acid | ESD-892893-100MG |
| Cas.: 351367-77-6 | Purity: 97% | 2-Amino-5-chloro-4-fluorobenzoic acid | ESD-892893-250MG |
| Cas.: 179055-27-7 | Purity: 96% | 4-(1-Methyl-1H-pyrazol-3-yl)benzaldehyde | ESD-892894-100MG |
| Cas.: 179055-27-7 | Purity: 96% | 4-(1-Methyl-1H-pyrazol-3-yl)benzaldehyde | ESD-892894-250MG |
| Cas.: 179055-27-7 | Purity: 96% | 4-(1-Methyl-1H-pyrazol-3-yl)benzaldehyde | ESD-892894-1G |
| Cas.: 126173-94-2 | Purity: 97% | (S)-Isopropyl 2-amino-3-(4-hydroxyphenyl)propanoate | ESD-892895-250MG |
| Cas.: 126173-94-2 | Purity: 97% | (S)-Isopropyl 2-amino-3-(4-hydroxyphenyl)propanoate | ESD-892895-1G |
| Cas.: 126173-94-2 | Purity: 97% | (S)-Isopropyl 2-amino-3-(4-hydroxyphenyl)propanoate | ESD-892895-5G |
| Cas.: 842965-35-9 | Purity: ≥95% | 3-Chloro-2-(4-methylpiperidin-1-yl)aniline | ESD-892896-1G |
| Cas.: 842965-35-9 | Purity: ≥95% | 3-Chloro-2-(4-methylpiperidin-1-yl)aniline | ESD-892896-5G |
| Cas.: 842965-35-9 | Purity: ≥95% | 3-Chloro-2-(4-methylpiperidin-1-yl)aniline | ESD-892896-25G |
| Cas.: 1615-41-4 | Purity: 96% | 1-Methyl-2-(methylthio)-5-nitro-1H-imidazole | ESD-892897-250MG |
| Cas.: 1615-41-4 | Purity: 96% | 1-Methyl-2-(methylthio)-5-nitro-1H-imidazole | ESD-892897-1G |
| Cas.: 129833-31-4 | Purity: ≥95% | 2-Iodo-3,4-dimethylbenzoic acid | ESD-892898-100MG |
| Cas.: 129833-31-4 | Purity: ≥95% | 2-Iodo-3,4-dimethylbenzoic acid | ESD-892898-250MG |
| Cas.: 863878-22-2 | Purity: ≥95% | 6-Chloro-4-methyl-3-nitropyridin-2-amine | ESD-892899-100MG |
| Cas.: 863878-22-2 | Purity: ≥95% | 6-Chloro-4-methyl-3-nitropyridin-2-amine | ESD-892899-250MG |
| Cas.: 863878-22-2 | Purity: ≥95% | 6-Chloro-4-methyl-3-nitropyridin-2-amine | ESD-892899-1G |
| Cas.: 863878-22-2 | Purity: ≥95% | 6-Chloro-4-methyl-3-nitropyridin-2-amine | ESD-892899-5G |
| Cas.: 68208-19-5 | Purity: ≥95% | 3-Amino-3-(3-methoxyphenyl)propanoic acid | ESD-892900-250MG |
| Cas.: 68208-19-5 | Purity: ≥95% | 3-Amino-3-(3-methoxyphenyl)propanoic acid | ESD-892900-1G |
| Cas.: 68208-19-5 | Purity: ≥95% | 3-Amino-3-(3-methoxyphenyl)propanoic acid | ESD-892900-5G |
| Cas.: 68208-19-5 | Purity: ≥95% | 3-Amino-3-(3-methoxyphenyl)propanoic acid | ESD-892900-10G |
| Cas.: 16323-00-5 | Purity: ≥95% | Ethyl 2-amino-3-(4-hydroxyphenyl)-2-methylpropanoate | ESD-892901-100MG |
| Cas.: 16323-00-5 | Purity: ≥95% | Ethyl 2-amino-3-(4-hydroxyphenyl)-2-methylpropanoate | ESD-892901-250MG |
| Cas.: 16323-00-5 | Purity: ≥95% | Ethyl 2-amino-3-(4-hydroxyphenyl)-2-methylpropanoate | ESD-892901-1G |
| Cas.: 16323-00-5 | Purity: ≥95% | Ethyl 2-amino-3-(4-hydroxyphenyl)-2-methylpropanoate | ESD-892901-5G |
| Cas.: 1451391-50-6 | Purity: 97% | (2-Chloro-3,5-dimethylphenyl)boronic acid | ESD-892902-100MG |
| Cas.: 1451391-50-6 | Purity: 97% | (2-Chloro-3,5-dimethylphenyl)boronic acid | ESD-892902-250MG |
| Cas.: 1451391-50-6 | Purity: 97% | (2-Chloro-3,5-dimethylphenyl)boronic acid | ESD-892902-1G |
| Cas.: 36193-65-4 | Purity: 97% | 1H-Indole-2-carbonitrile | ESD-892903-100MG |
| Cas.: 36193-65-4 | Purity: 97% | 1H-Indole-2-carbonitrile | ESD-892903-250MG |
| Cas.: 36193-65-4 | Purity: 97% | 1H-Indole-2-carbonitrile | ESD-892903-1G |
| Cas.: 36193-65-4 | Purity: 97% | 1H-Indole-2-carbonitrile | ESD-892903-5G |
| Cas.: 1134327-93-7 | Purity: ≥95% | 2-(5-Bromopyrimidin-2-yl)acetic acid | ESD-892904-250MG |
| Cas.: 1134327-93-7 | Purity: ≥95% | 2-(5-Bromopyrimidin-2-yl)acetic acid | ESD-892904-1G |
| Cas.: 1134327-93-7 | Purity: ≥95% | 2-(5-Bromopyrimidin-2-yl)acetic acid | ESD-892904-5G |
| Cas.: 1134327-93-7 | Purity: ≥95% | 2-(5-Bromopyrimidin-2-yl)acetic acid | ESD-892904-10G |
| Cas.: 582-80-9 | Purity: ≥95% | 4-Benzamidobenzoic acid | ESD-892905-100MG |
| Cas.: 582-80-9 | Purity: ≥95% | 4-Benzamidobenzoic acid | ESD-892905-250MG |
| Cas.: 582-80-9 | Purity: ≥95% | 4-Benzamidobenzoic acid | ESD-892905-1G |
| Cas.: 582-80-9 | Purity: ≥95% | 4-Benzamidobenzoic acid | ESD-892905-5G |
| Cas.: 132874-06-7 | Purity: 97% | Methyl 3-(bromomethyl)-2-nitrobenzoate | ESD-892906-100MG |
| Cas.: 132874-06-7 | Purity: 97% | Methyl 3-(bromomethyl)-2-nitrobenzoate | ESD-892906-250MG |
| Cas.: 79670-17-0 | Purity: 95% | Methyl 5-bromo-2-(bromomethyl)benzoate | ESD-892907-250MG |
| Cas.: 79670-17-0 | Purity: 95% | Methyl 5-bromo-2-(bromomethyl)benzoate | ESD-892907-1G |
| Cas.: 79670-17-0 | Purity: 95% | Methyl 5-bromo-2-(bromomethyl)benzoate | ESD-892907-5G |
| Cas.: 79670-17-0 | Purity: 95% | Methyl 5-bromo-2-(bromomethyl)benzoate | ESD-892907-10G |
| Cas.: 57667-50-2 | Purity: ≥95% | 1-Propyl-1H-benzo[d]imidazol-2-amine | ESD-892908-100MG |
| Cas.: 57667-50-2 | Purity: ≥95% | 1-Propyl-1H-benzo[d]imidazol-2-amine | ESD-892908-250MG |
| Cas.: 57667-50-2 | Purity: ≥95% | 1-Propyl-1H-benzo[d]imidazol-2-amine | ESD-892908-1G |
| Cas.: 70969-58-3 | Purity: 96% | Diisobutyl cyclohexane-1,2-dicarboxylate | ESD-892909-1G |
| Cas.: 70969-58-3 | Purity: 96% | Diisobutyl cyclohexane-1,2-dicarboxylate | ESD-892909-5G |
| Cas.: 163671-48-5 | Purity: 97% | 4-(4-Ethoxyphenyl)cyclohexanone | ESD-892910-100MG |
| Cas.: 163671-48-5 | Purity: 97% | 4-(4-Ethoxyphenyl)cyclohexanone | ESD-892910-250MG |
| Cas.: 22744-12-3 | Purity: 98% | 2-(4-(Methoxycarbonyl)phenyl)acetic acid | ESD-892911-250MG |
| Cas.: 22744-12-3 | Purity: 98% | 2-(4-(Methoxycarbonyl)phenyl)acetic acid | ESD-892911-1G |
| Cas.: 22744-12-3 | Purity: 98% | 2-(4-(Methoxycarbonyl)phenyl)acetic acid | ESD-892911-5G |
| Cas.: 22744-12-3 | Purity: 98% | 2-(4-(Methoxycarbonyl)phenyl)acetic acid | ESD-892911-10G |
| Cas.: 1273651-10-7 | Purity: ≥95% | Methyl 6-fluoro-3-oxo-2,3-dihydro-1H-indene-5-carboxylate | ESD-892912-100MG |
| Cas.: 1273651-10-7 | Purity: ≥95% | Methyl 6-fluoro-3-oxo-2,3-dihydro-1H-indene-5-carboxylate | ESD-892912-250MG |
| Cas.: 1273651-10-7 | Purity: ≥95% | Methyl 6-fluoro-3-oxo-2,3-dihydro-1H-indene-5-carboxylate | ESD-892912-1G |
| Cas.: 130200-02-1 | Purity: ≥95% | 2,2-Dimethyl-4-oxochroman-7-carbonitrile | ESD-892913-250MG |
| Cas.: 130200-02-1 | Purity: ≥95% | 2,2-Dimethyl-4-oxochroman-7-carbonitrile | ESD-892913-1G |
| Cas.: 1208657-07-1 | Purity: ≥95% | 6-Bromo-N-methylpyridazin-3-amine | ESD-892914-100MG |
| Cas.: 1208657-07-1 | Purity: ≥95% | 6-Bromo-N-methylpyridazin-3-amine | ESD-892914-250MG |
| Cas.: 1208657-07-1 | Purity: ≥95% | 6-Bromo-N-methylpyridazin-3-amine | ESD-892914-1G |
| Cas.: 499209-19-7 | Purity: ≥95% | Ethyl (2-amino-4-hydroxy-6-methyl-5-pyrimidinyl)acetate | ESD-892915-100MG |
| Cas.: 499209-19-7 | Purity: ≥95% | Ethyl (2-amino-4-hydroxy-6-methyl-5-pyrimidinyl)acetate | ESD-892915-250MG |
| Cas.: 499209-19-7 | Purity: ≥95% | Ethyl (2-amino-4-hydroxy-6-methyl-5-pyrimidinyl)acetate | ESD-892915-1G |
| Cas.: 631909-42-7 | Purity: 97% | 2,2,2-Trifluoro-1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanone | ESD-892916-100MG |
| Cas.: 631909-42-7 | Purity: 97% | 2,2,2-Trifluoro-1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanone | ESD-892916-250MG |
| Cas.: 631909-42-7 | Purity: 97% | 2,2,2-Trifluoro-1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanone | ESD-892916-1G |
| Cas.: 124467-20-5 | Purity: 97% | 2-Chloro-6-iodoquinoline | ESD-892917-100MG |
| Cas.: 124467-20-5 | Purity: 97% | 2-Chloro-6-iodoquinoline | ESD-892917-250MG |
| Cas.: 124467-20-5 | Purity: 97% | 2-Chloro-6-iodoquinoline | ESD-892917-1G |
| Cas.: 124467-20-5 | Purity: 97% | 2-Chloro-6-iodoquinoline | ESD-892917-5G |
| Cas.: 912934-77-1 | Purity: ≥95% | 6-Bromopyridine-2-sulfonyl chloride | ESD-892918-100MG |
| Cas.: 912934-77-1 | Purity: ≥95% | 6-Bromopyridine-2-sulfonyl chloride | ESD-892918-250MG |
| Cas.: 19063-55-9 | Purity: ≥95% | 6-Bromochromen-2-one | ESD-892919-250MG |
| Cas.: 19063-55-9 | Purity: ≥95% | 6-Bromochromen-2-one | ESD-892919-1G |
| Cas.: 19063-55-9 | Purity: ≥95% | 6-Bromochromen-2-one | ESD-892919-5G |
| Cas.: 19063-55-9 | Purity: ≥95% | 6-Bromochromen-2-one | ESD-892919-10G |
| Cas.: 90858-86-9 | Purity: 98% | 4-Bromo-5-methoxy-1H-indole | ESD-892920-100MG |
| Cas.: 90858-86-9 | Purity: 98% | 4-Bromo-5-methoxy-1H-indole | ESD-892920-250MG |
| Cas.: 90858-86-9 | Purity: 98% | 4-Bromo-5-methoxy-1H-indole | ESD-892920-1G |
| Cas.: 34841-47-9 | Purity: 97% | 2-(4-Formylphenyl)acetic acid | ESD-892921-10MG |
| Cas.: 34841-47-9 | Purity: 97% | 2-(4-Formylphenyl)acetic acid | ESD-892921-100MG |
| Cas.: 34841-47-9 | Purity: 97% | 2-(4-Formylphenyl)acetic acid | ESD-892921-250MG |
| Cas.: 57004-60-1 | Purity: 97% | 1-(3-Methoxyphenyl)guanidine | ESD-892922-100MG |
| Cas.: 57004-60-1 | Purity: 97% | 1-(3-Methoxyphenyl)guanidine | ESD-892922-250MG |
| Cas.: 57004-60-1 | Purity: 97% | 1-(3-Methoxyphenyl)guanidine | ESD-892922-1G |
| Cas.: 57004-60-1 | Purity: 97% | 1-(3-Methoxyphenyl)guanidine | ESD-892922-5G |
| Cas.: 1260013-71-5 | Purity: ≥95% | 6-Bromo-5-chloro-2,3-dihydro-1H-inden-1-one | ESD-892923-100MG |
| Cas.: 1260013-71-5 | Purity: ≥95% | 6-Bromo-5-chloro-2,3-dihydro-1H-inden-1-one | ESD-892923-250MG |
| Cas.: 1260013-71-5 | Purity: ≥95% | 6-Bromo-5-chloro-2,3-dihydro-1H-inden-1-one | ESD-892923-1G |
| Cas.: 767359-25-1 | Purity: 95% | 2-(2-Bromophenyl)cyclopropanecarboxylic acid | ESD-892924-250MG |
| Cas.: 767359-25-1 | Purity: 95% | 2-(2-Bromophenyl)cyclopropanecarboxylic acid | ESD-892924-1G |
| Cas.: 767359-25-1 | Purity: 95% | 2-(2-Bromophenyl)cyclopropanecarboxylic acid | ESD-892924-5G |
| Cas.: 29669-41-8 | Purity: 97% | 2-Ethoxy-5-nitrobenzonitrile | ESD-892925-250MG |
| Cas.: 29669-41-8 | Purity: 97% | 2-Ethoxy-5-nitrobenzonitrile | ESD-892925-1G |
| Cas.: 29669-41-8 | Purity: 97% | 2-Ethoxy-5-nitrobenzonitrile | ESD-892925-5G |
| Cas.: 902837-39-2 | Purity: ≥95% | 3-Bromo-5-iodopyridin-4-amine | ESD-892926-100MG |
| Cas.: 902837-39-2 | Purity: ≥95% | 3-Bromo-5-iodopyridin-4-amine | ESD-892926-250MG |
| Cas.: 902837-39-2 | Purity: ≥95% | 3-Bromo-5-iodopyridin-4-amine | ESD-892926-1G |
| Cas.: 902837-39-2 | Purity: ≥95% | 3-Bromo-5-iodopyridin-4-amine | ESD-892926-5G |
| Cas.: 4498-72-0 | Purity: 97% | 1-(1H-Indazol-3-yl)ethanone | ESD-892927-250MG |
| Cas.: 4498-72-0 | Purity: 97% | 1-(1H-Indazol-3-yl)ethanone | ESD-892927-1G |
| Cas.: 681465-85-0 | Purity: 97% | Methyl 4-amino-3-isopropoxybenzoate | ESD-892928-250MG |
| Cas.: 681465-85-0 | Purity: 97% | Methyl 4-amino-3-isopropoxybenzoate | ESD-892928-1G |
| Cas.: 681465-85-0 | Purity: 97% | Methyl 4-amino-3-isopropoxybenzoate | ESD-892928-5G |
| Cas.: 160377-42-4 | Purity: 97% | 5-(4-Bromophenyl)pyrimidine | ESD-892929-100MG |
| Cas.: 160377-42-4 | Purity: 97% | 5-(4-Bromophenyl)pyrimidine | ESD-892929-250MG |
| Cas.: 34545-20-5 | Purity: 97% | 3-Bromo-4-methyl-5-nitrobenzoic acid | ESD-892930-250MG |
| Cas.: 34545-20-5 | Purity: 97% | 3-Bromo-4-methyl-5-nitrobenzoic acid | ESD-892930-1G |
| Cas.: 34545-20-5 | Purity: 97% | 3-Bromo-4-methyl-5-nitrobenzoic acid | ESD-892930-5G |
| Cas.: 34545-20-5 | Purity: 97% | 3-Bromo-4-methyl-5-nitrobenzoic acid | ESD-892930-10G |
| Cas.: 1337850-20-0 | Purity: 97% | 6-Bromo-7-chloro-2,3-dihydro-1H-inden-1-one | ESD-892931-100MG |
| Cas.: 1337850-20-0 | Purity: 97% | 6-Bromo-7-chloro-2,3-dihydro-1H-inden-1-one | ESD-892931-250MG |
| Cas.: 1337850-20-0 | Purity: 97% | 6-Bromo-7-chloro-2,3-dihydro-1H-inden-1-one | ESD-892931-1G |
| Cas.: 116529-61-4 | Purity: ≥95% | 3-Bromo-2-nitrobenzoic acid | ESD-892932-100MG |
| Cas.: 116529-61-4 | Purity: ≥95% | 3-Bromo-2-nitrobenzoic acid | ESD-892932-250MG |
| Cas.: 116529-61-4 | Purity: ≥95% | 3-Bromo-2-nitrobenzoic acid | ESD-892932-1G |
| Cas.: 116529-61-4 | Purity: ≥95% | 3-Bromo-2-nitrobenzoic acid | ESD-892932-5G |
| Cas.: 28281-76-7 | Purity: 97% | 5-Methoxyisobenzofuran-1,3-dione | ESD-892933-100MG |
| Cas.: 28281-76-7 | Purity: 97% | 5-Methoxyisobenzofuran-1,3-dione | ESD-892933-250MG |
| Cas.: 28281-76-7 | Purity: 97% | 5-Methoxyisobenzofuran-1,3-dione | ESD-892933-1G |
| Cas.: 28281-76-7 | Purity: 97% | 5-Methoxyisobenzofuran-1,3-dione | ESD-892933-5G |
| Cas.: 2510-01-2 | Purity: 97% | 2-(2,3-Dihydro-1H-inden-1-ylidene)malononitrile | ESD-892934-250MG |
| Cas.: 2510-01-2 | Purity: 97% | 2-(2,3-Dihydro-1H-inden-1-ylidene)malononitrile | ESD-892934-1G |
| Cas.: 155242-98-1 | Purity: 97% | 1-Methyl-1H-benzo[d]imidazol-4-amine | ESD-892935-100MG |
| Cas.: 155242-98-1 | Purity: 97% | 1-Methyl-1H-benzo[d]imidazol-4-amine | ESD-892935-250MG |
| Cas.: 1017781-60-0 | Purity: 98% | 4-(4-Bromothiazol-2-yl)morpholine | ESD-892936-250MG |
| Cas.: 1017781-60-0 | Purity: 98% | 4-(4-Bromothiazol-2-yl)morpholine | ESD-892936-1G |
| Cas.: 1017781-60-0 | Purity: 98% | 4-(4-Bromothiazol-2-yl)morpholine | ESD-892936-5G |
| Cas.: 1017781-60-0 | Purity: 98% | 4-(4-Bromothiazol-2-yl)morpholine | ESD-892936-10G |
| Cas.: 264927-52-8 | Purity: ≥95% | 2-Chloro-4-fluoro-5-iodobenzoic acid | ESD-892937-100MG |
| Cas.: 264927-52-8 | Purity: ≥95% | 2-Chloro-4-fluoro-5-iodobenzoic acid | ESD-892937-250MG |
| Cas.: 264927-52-8 | Purity: ≥95% | 2-Chloro-4-fluoro-5-iodobenzoic acid | ESD-892937-1G |
| Cas.: 119647-69-7 | Purity: 97% | Ethyl 4-acetyl-1H-pyrrole-2-carboxylate | ESD-892938-50MG |
| Cas.: 73470-46-9 | Purity: ≥95% | tert-Butyl (1-amino-2-methyl-1-oxopropan-2-yl)carbamate | ESD-892939-100MG |
| Cas.: 73470-46-9 | Purity: ≥95% | tert-Butyl (1-amino-2-methyl-1-oxopropan-2-yl)carbamate | ESD-892939-250MG |
| Cas.: 171178-34-0 | Purity: ≥95% | 4-((tert-Butoxycarbonyl)amino)nicotinic acid | ESD-892940-250MG |
| Cas.: 171178-34-0 | Purity: ≥95% | 4-((tert-Butoxycarbonyl)amino)nicotinic acid | ESD-892940-1G |
| Cas.: 171178-34-0 | Purity: ≥95% | 4-((tert-Butoxycarbonyl)amino)nicotinic acid | ESD-892940-5G |
| Cas.: 171178-34-0 | Purity: ≥95% | 4-((tert-Butoxycarbonyl)amino)nicotinic acid | ESD-892940-10G |
| Cas.: 13669-57-3 | Purity: 97% | 3-Bromoquinolin-6-ol | ESD-892941-100MG |
| Cas.: 13669-57-3 | Purity: 97% | 3-Bromoquinolin-6-ol | ESD-892941-250MG |
| Cas.: 13669-57-3 | Purity: 97% | 3-Bromoquinolin-6-ol | ESD-892941-1G |
| Cas.: 73418-88-9 | Purity: ≥95% | Methyl 5-aminopyrimidine-2-carboxylate | ESD-892942-100MG |
| Cas.: 73418-88-9 | Purity: ≥95% | Methyl 5-aminopyrimidine-2-carboxylate | ESD-892942-250MG |
| Cas.: 73418-88-9 | Purity: ≥95% | Methyl 5-aminopyrimidine-2-carboxylate | ESD-892942-1G |
| Cas.: 80900-33-0 | Purity: 97% | 1-Methoxyisoquinolin-3-amine | ESD-892943-100MG |
| Cas.: 80900-33-0 | Purity: 97% | 1-Methoxyisoquinolin-3-amine | ESD-892943-250MG |
| Cas.: 69875-49-6 | Purity: 97% | 4-Chloroquinoline-3-carbonitrile | ESD-892944-250MG |
| Cas.: 69875-49-6 | Purity: 97% | 4-Chloroquinoline-3-carbonitrile | ESD-892944-1G |
| Cas.: 69875-49-6 | Purity: 97% | 4-Chloroquinoline-3-carbonitrile | ESD-892944-5G |
| Cas.: 69875-49-6 | Purity: 97% | 4-Chloroquinoline-3-carbonitrile | ESD-892944-10G |
| Cas.: 72517-23-8 | Purity: ≥95% | 5-Bromo-2,3-dimethoxybenzoic acid | ESD-892945-100MG |
| Cas.: 72517-23-8 | Purity: ≥95% | 5-Bromo-2,3-dimethoxybenzoic acid | ESD-892945-250MG |
| Cas.: 72517-23-8 | Purity: ≥95% | 5-Bromo-2,3-dimethoxybenzoic acid | ESD-892945-1G |
| Cas.: 5337-63-3 | Purity: ≥95% | Ethyl 2-Acetyl-4-phenylbutanoate | ESD-892946-250MG |
| Cas.: 5337-63-3 | Purity: ≥95% | Ethyl 2-Acetyl-4-phenylbutanoate | ESD-892946-1G |
| Cas.: 5337-63-3 | Purity: ≥95% | Ethyl 2-Acetyl-4-phenylbutanoate | ESD-892946-5G |
| Cas.: 406719-77-5 | Purity: 97% | 4-Cyanothiophene-2-carboxylic acid | ESD-892947-100MG |
| Cas.: 406719-77-5 | Purity: 97% | 4-Cyanothiophene-2-carboxylic acid | ESD-892947-250MG |
| Cas.: 406719-77-5 | Purity: 97% | 4-Cyanothiophene-2-carboxylic acid | ESD-892947-1G |
| Cas.: 406719-77-5 | Purity: 97% | 4-Cyanothiophene-2-carboxylic acid | ESD-892947-5G |
| Cas.: 1283176-56-6 | Purity: 97% | tert-Butyl (2-methoxy-6-nitrophenyl)carbamate | ESD-892948-250MG |
| Cas.: 1283176-56-6 | Purity: 97% | tert-Butyl (2-methoxy-6-nitrophenyl)carbamate | ESD-892948-1G |
| Cas.: 1283176-56-6 | Purity: 97% | tert-Butyl (2-methoxy-6-nitrophenyl)carbamate | ESD-892948-5G |
| Cas.: 360056-45-7 | Purity: ≥95% | Methyl 4-amino-1H-pyrazole-3-carboxylate | ESD-892949-250MG |
| Cas.: 360056-45-7 | Purity: ≥95% | Methyl 4-amino-1H-pyrazole-3-carboxylate | ESD-892949-1G |
| Cas.: 360056-45-7 | Purity: ≥95% | Methyl 4-amino-1H-pyrazole-3-carboxylate | ESD-892949-5G |
| Cas.: 360056-45-7 | Purity: ≥95% | Methyl 4-amino-1H-pyrazole-3-carboxylate | ESD-892949-10G |
| Cas.: 288385-99-9 | Purity: 97% | 1-(2-Fluoro-3-methoxy-6-nitrophenyl)propan-2-one | ESD-892950-100MG |
| Cas.: 288385-99-9 | Purity: 97% | 1-(2-Fluoro-3-methoxy-6-nitrophenyl)propan-2-one | ESD-892950-250MG |
| Cas.: 288385-99-9 | Purity: 97% | 1-(2-Fluoro-3-methoxy-6-nitrophenyl)propan-2-one | ESD-892950-1G |
| Cas.: 40371-63-9 | Purity: 97% | 5-Bromo-4-methyl-2-nitroaniline | ESD-892951-100MG |
| Cas.: 40371-63-9 | Purity: 97% | 5-Bromo-4-methyl-2-nitroaniline | ESD-892951-250MG |
| Cas.: 40371-63-9 | Purity: 97% | 5-Bromo-4-methyl-2-nitroaniline | ESD-892951-1G |
| Cas.: 40371-63-9 | Purity: 97% | 5-Bromo-4-methyl-2-nitroaniline | ESD-892951-5G |
| Cas.: 206548-13-2 | Purity: 97% | 2-Amino-5-bromo-3-methylbenzoic acid | ESD-892952-250MG |
| Cas.: 206548-13-2 | Purity: 97% | 2-Amino-5-bromo-3-methylbenzoic acid | ESD-892952-1G |
| Cas.: 206548-13-2 | Purity: 97% | 2-Amino-5-bromo-3-methylbenzoic acid | ESD-892952-5G |
| Cas.: 206548-13-2 | Purity: 97% | 2-Amino-5-bromo-3-methylbenzoic acid | ESD-892952-10G |
| Cas.: 51988-36-4 | Purity: 97% | 3-(Propionyloxy)benzoic acid | ESD-892953-100MG |
| Cas.: 51988-36-4 | Purity: 97% | 3-(Propionyloxy)benzoic acid | ESD-892953-250MG |
| Cas.: 51988-36-4 | Purity: 97% | 3-(Propionyloxy)benzoic acid | ESD-892953-1G |
| Cas.: 528882-16-8 | Purity: 97% | 3-(N-Tert-butoxycarbonyl-N-methylamino)aniline | ESD-892954-250MG |
| Cas.: 528882-16-8 | Purity: 97% | 3-(N-Tert-butoxycarbonyl-N-methylamino)aniline | ESD-892954-1G |
| Cas.: 528882-16-8 | Purity: 97% | 3-(N-Tert-butoxycarbonyl-N-methylamino)aniline | ESD-892954-5G |
| Cas.: 528882-16-8 | Purity: 97% | 3-(N-Tert-butoxycarbonyl-N-methylamino)aniline | ESD-892954-10G |
| Cas.: 16110-98-8 | Purity: 97% | 2-Phenylmaleic acid | ESD-892955-100MG |
| Cas.: 16110-98-8 | Purity: 97% | 2-Phenylmaleic acid | ESD-892955-250MG |
| Cas.: 16110-98-8 | Purity: 97% | 2-Phenylmaleic acid | ESD-892955-1G |
| Cas.: 889858-34-8 | Purity: ≥95% | tert-Butyl 4-amino-2-hydroxybenzoate | ESD-892956-250MG |
| Cas.: 889858-34-8 | Purity: ≥95% | tert-Butyl 4-amino-2-hydroxybenzoate | ESD-892956-1G |
| Cas.: 3913-19-7 | Purity: ≥95% | 6-Bromo-2-chloro-4-methylquinoline | ESD-892957-100MG |
| Cas.: 3913-19-7 | Purity: ≥95% | 6-Bromo-2-chloro-4-methylquinoline | ESD-892957-250MG |
| Cas.: 3913-19-7 | Purity: ≥95% | 6-Bromo-2-chloro-4-methylquinoline | ESD-892957-1G |
| Cas.: 885532-41-2 | Purity: 97% | 4-Bromo-2,5-dichlorobenzoic acid | ESD-892958-250MG |
| Cas.: 885532-41-2 | Purity: 97% | 4-Bromo-2,5-dichlorobenzoic acid | ESD-892958-1G |
| Cas.: 885532-41-2 | Purity: 97% | 4-Bromo-2,5-dichlorobenzoic acid | ESD-892958-5G |
| Cas.: 22300-52-3 | Purity: 98% | 4,5-Dibromo-2H-1,2,3-triazole | ESD-892959-250MG |
| Cas.: 22300-52-3 | Purity: 98% | 4,5-Dibromo-2H-1,2,3-triazole | ESD-892959-1G |
| Cas.: 22300-52-3 | Purity: 98% | 4,5-Dibromo-2H-1,2,3-triazole | ESD-892959-5G |
| Cas.: 22300-52-3 | Purity: 98% | 4,5-Dibromo-2H-1,2,3-triazole | ESD-892959-10G |
| Cas.: 84547-86-4 | Purity: ≥95% | 4-Bromo-1-methyl-1H-pyrazole-3-carboxylic acid | ESD-892960-250MG |
| Cas.: 84547-86-4 | Purity: ≥95% | 4-Bromo-1-methyl-1H-pyrazole-3-carboxylic acid | ESD-892960-1G |
| Cas.: 84547-86-4 | Purity: ≥95% | 4-Bromo-1-methyl-1H-pyrazole-3-carboxylic acid | ESD-892960-5G |
| Cas.: 84547-86-4 | Purity: ≥95% | 4-Bromo-1-methyl-1H-pyrazole-3-carboxylic acid | ESD-892960-10G |
| Cas.: 2896-98-2 | Purity: ≥95% | Tetrahydro-1,4-thiazepan-5-one | ESD-892961-100MG |
| Cas.: 2896-98-2 | Purity: ≥95% | Tetrahydro-1,4-thiazepan-5-one | ESD-892961-250MG |
| Cas.: 2896-98-2 | Purity: ≥95% | Tetrahydro-1,4-thiazepan-5-one | ESD-892961-1G |
| Cas.: 4640-29-3 | Purity: 97% | 2,5-Dihydroxybenzonitrile | ESD-892962-100MG |
| Cas.: 4640-29-3 | Purity: 97% | 2,5-Dihydroxybenzonitrile | ESD-892962-250MG |
| Cas.: 124691-76-5 | Purity: 97% | 5,6-Dichloro-1H-indazole | ESD-892963-100MG |
| Cas.: 124691-76-5 | Purity: 97% | 5,6-Dichloro-1H-indazole | ESD-892963-250MG |
| Cas.: 124691-76-5 | Purity: 97% | 5,6-Dichloro-1H-indazole | ESD-892963-1G |
| Cas.: 1269292-28-5 | Purity: ≥95% | Ethyl 4-hydroxy-6-(trifluoromethyl)nicotinate | ESD-892964-100MG |
| Cas.: 1269292-28-5 | Purity: ≥95% | Ethyl 4-hydroxy-6-(trifluoromethyl)nicotinate | ESD-892964-250MG |
| Cas.: 15467-31-9 | Purity: ≥95% | 2-(1H-Indol-3-yl)-2-methylpropan-1-amine | ESD-892965-50MG |
| Cas.: 1093879-46-9 | Purity: 97% | 2-(6-Bromopyridin-2-yl)acetic acid | ESD-892966-100MG |
| Cas.: 1093879-46-9 | Purity: 97% | 2-(6-Bromopyridin-2-yl)acetic acid | ESD-892966-250MG |
| Cas.: 77972-87-3 | Purity: ≥95% | Cyclopropyl(naphthalen-1-yl)methanone | ESD-892967-100MG |
| Cas.: 77972-87-3 | Purity: ≥95% | Cyclopropyl(naphthalen-1-yl)methanone | ESD-892967-250MG |
| Cas.: 175277-80-2 | Purity: 98% | 1-(3,5-Dichloropyridin-4-yl)piperazine | ESD-892968-250MG |
| Cas.: 175277-80-2 | Purity: 98% | 1-(3,5-Dichloropyridin-4-yl)piperazine | ESD-892968-1G |
| Cas.: 175277-80-2 | Purity: 98% | 1-(3,5-Dichloropyridin-4-yl)piperazine | ESD-892968-5G |
| Cas.: 175277-80-2 | Purity: 98% | 1-(3,5-Dichloropyridin-4-yl)piperazine | ESD-892968-10G |
| Cas.: 90940-40-2 | Purity: ≥95% | 2-(4-Chlorophenyl)cyclopropanecarboxylic acid | ESD-892969-100MG |
| Cas.: 90940-40-2 | Purity: ≥95% | 2-(4-Chlorophenyl)cyclopropanecarboxylic acid | ESD-892969-250MG |
| Cas.: 90940-40-2 | Purity: ≥95% | 2-(4-Chlorophenyl)cyclopropanecarboxylic acid | ESD-892969-1G |
| Cas.: 90940-40-2 | Purity: ≥95% | 2-(4-Chlorophenyl)cyclopropanecarboxylic acid | ESD-892969-5G |
| Cas.: 77166-01-9 | Purity: ≥95% | 4-Methyl-2-(methylsulfonyl)pyrimidine | ESD-892970-250MG |
| Cas.: 77166-01-9 | Purity: ≥95% | 4-Methyl-2-(methylsulfonyl)pyrimidine | ESD-892970-1G |
| Cas.: 14080-56-9 | Purity: 97% | Thieno[2,3-d]pyrimidin-4-amine | ESD-892971-100MG |
| Cas.: 14080-56-9 | Purity: 97% | Thieno[2,3-d]pyrimidin-4-amine | ESD-892971-250MG |
| Cas.: 14080-56-9 | Purity: 97% | Thieno[2,3-d]pyrimidin-4-amine | ESD-892971-1G |
| Cas.: 14080-56-9 | Purity: 97% | Thieno[2,3-d]pyrimidin-4-amine | ESD-892971-5G |
| Cas.: 35779-35-2 | Purity: 98% | Di(pyridin-3-yl)methanone | ESD-892972-100MG |
| Cas.: 35779-35-2 | Purity: 98% | Di(pyridin-3-yl)methanone | ESD-892972-250MG |
| Cas.: 35779-35-2 | Purity: 98% | Di(pyridin-3-yl)methanone | ESD-892972-1G |
| Cas.: 864754-48-3 | Purity: ≥95% | 2-(4-(2,2-Difluoroethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-892973-100MG |
| Cas.: 864754-48-3 | Purity: ≥95% | 2-(4-(2,2-Difluoroethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-892973-250MG |
| Cas.: 864754-48-3 | Purity: ≥95% | 2-(4-(2,2-Difluoroethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-892973-1G |
| Cas.: 19282-45-2 | Purity: ≥95% | Ethyl 4,5,6,7-tetrahydrobenzo[b]thiophene-2-carboxylate | ESD-892974-250MG |
| Cas.: 19282-45-2 | Purity: ≥95% | Ethyl 4,5,6,7-tetrahydrobenzo[b]thiophene-2-carboxylate | ESD-892974-1G |
| Cas.: 19282-45-2 | Purity: ≥95% | Ethyl 4,5,6,7-tetrahydrobenzo[b]thiophene-2-carboxylate | ESD-892974-5G |
| Cas.: 758699-74-0 | Purity: 98% | 4-Methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-892975-50MG |
| Cas.: 758699-74-0 | Purity: 98% | 4-Methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-892975-100MG |
| Cas.: 758699-74-0 | Purity: 98% | 4-Methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-892975-250MG |
| Cas.: 1260178-71-9 | Purity: ≥95% | 8-Methoxypyrido[3,4-d]pyrimidin-4(3H)-one | ESD-892976-100MG |
| Cas.: 1260178-71-9 | Purity: ≥95% | 8-Methoxypyrido[3,4-d]pyrimidin-4(3H)-one | ESD-892976-250MG |
| Cas.: 799293-73-5 | Purity: 97% | 3-Bromofuro[3,2-c]pyridin-4-amine | ESD-892977-100MG |
| Cas.: 799293-73-5 | Purity: 97% | 3-Bromofuro[3,2-c]pyridin-4-amine | ESD-892977-250MG |
| Cas.: 148018-34-2 | Purity: 97% | Ethyl 4-chloroquinoline-6-carboxylate | ESD-892978-100MG |
| Cas.: 148018-34-2 | Purity: 97% | Ethyl 4-chloroquinoline-6-carboxylate | ESD-892978-250MG |
| Cas.: 3823-19-6 | Purity: ≥95% | 2-Bromo-N-(4-(trifluoromethyl)phenyl)acetamide | ESD-892979-100MG |
| Cas.: 3823-19-6 | Purity: ≥95% | 2-Bromo-N-(4-(trifluoromethyl)phenyl)acetamide | ESD-892979-250MG |
| Cas.: 3823-19-6 | Purity: ≥95% | 2-Bromo-N-(4-(trifluoromethyl)phenyl)acetamide | ESD-892979-1G |
| Cas.: 870238-67-8 | Purity: 97% | 2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile | ESD-892980-250MG |
| Cas.: 870238-67-8 | Purity: 97% | 2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile | ESD-892980-1G |
| Cas.: 870238-67-8 | Purity: 97% | 2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile | ESD-892980-5G |
| Cas.: 870238-67-8 | Purity: 97% | 2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile | ESD-892980-10G |
| Cas.: 66315-16-0 | Purity: 96% | Methyl 3-amino-4-(methylamino)benzoate | ESD-892981-250MG |
| Cas.: 66315-16-0 | Purity: 96% | Methyl 3-amino-4-(methylamino)benzoate | ESD-892981-1G |
| Cas.: 66315-16-0 | Purity: 96% | Methyl 3-amino-4-(methylamino)benzoate | ESD-892981-5G |
| Cas.: 66315-16-0 | Purity: 96% | Methyl 3-amino-4-(methylamino)benzoate | ESD-892981-10G |
| Cas.: 1857-56-3 | Purity: ≥95% | 3-(3-Chloro-4-methoxyphenyl)propanoic acid | ESD-892982-250MG |
| Cas.: 1857-56-3 | Purity: ≥95% | 3-(3-Chloro-4-methoxyphenyl)propanoic acid | ESD-892982-1G |
| Cas.: 1857-56-3 | Purity: ≥95% | 3-(3-Chloro-4-methoxyphenyl)propanoic acid | ESD-892982-5G |
| Cas.: 886370-89-4 | Purity: ≥95% | 2-Bromo-4-(pyridin-2-yl)thiazole | ESD-892983-1G |
| Cas.: 1223434-15-8 | Purity: ≥95% | Methyl 4-bromo-2-cyanobenzoate | ESD-892984-100MG |
| Cas.: 1223434-15-8 | Purity: ≥95% | Methyl 4-bromo-2-cyanobenzoate | ESD-892984-250MG |
| Cas.: 1223434-15-8 | Purity: ≥95% | Methyl 4-bromo-2-cyanobenzoate | ESD-892984-1G |
| Cas.: 1223434-15-8 | Purity: ≥95% | Methyl 4-bromo-2-cyanobenzoate | ESD-892984-5G |
| Cas.: 1092522-02-5 | Purity: 97% | tert-Butyl (4-aminophenyl)(methyl)carbamate | ESD-892985-250MG |
| Cas.: 1092522-02-5 | Purity: 97% | tert-Butyl (4-aminophenyl)(methyl)carbamate | ESD-892985-1G |
| Cas.: 1092522-02-5 | Purity: 97% | tert-Butyl (4-aminophenyl)(methyl)carbamate | ESD-892985-5G |
| Cas.: 618-76-8 | Purity: 97% | 4-Hydroxy-3,5-diiodobenzoic acid | ESD-892986-10G |
| Cas.: 618-76-8 | Purity: 97% | 4-Hydroxy-3,5-diiodobenzoic acid | ESD-892986-25G |
| Cas.: 618-76-8 | Purity: 97% | 4-Hydroxy-3,5-diiodobenzoic acid | ESD-892986-100G |
| Cas.: 124341-06-6 | Purity: ≥95% | 6-Amino-3-bromo-2-methylbenzoic acid | ESD-892987-100MG |
| Cas.: 124341-06-6 | Purity: ≥95% | 6-Amino-3-bromo-2-methylbenzoic acid | ESD-892987-250MG |
| Cas.: 53611-47-5 | Purity: ≥95% | 4-(Hydroxymethyl)piperidin-2-one | ESD-892988-100MG |
| Cas.: 499214-11-8 | Purity: ≥95% | 6-Formylpicolinic acid | ESD-892989-100MG |
| Cas.: 499214-11-8 | Purity: ≥95% | 6-Formylpicolinic acid | ESD-892989-250MG |
| Cas.: 37538-67-3 | Purity: 98% | Pyrido[3,2-d]pyrimidin-4(3H)-one | ESD-892990-100MG |
| Cas.: 37538-67-3 | Purity: 98% | Pyrido[3,2-d]pyrimidin-4(3H)-one | ESD-892990-250MG |
| Cas.: 37538-67-3 | Purity: 98% | Pyrido[3,2-d]pyrimidin-4(3H)-one | ESD-892990-1G |
| Cas.: 37538-67-3 | Purity: 98% | Pyrido[3,2-d]pyrimidin-4(3H)-one | ESD-892990-5G |
| Cas.: 1073353-50-0 | Purity: 97% | 5-Bromo-2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-892991-250MG |
| Cas.: 1073353-50-0 | Purity: 97% | 5-Bromo-2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-892991-1G |
| Cas.: 1073353-50-0 | Purity: 97% | 5-Bromo-2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-892991-5G |
| Cas.: 1073353-50-0 | Purity: 97% | 5-Bromo-2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-892991-10G |
| Cas.: 1356109-81-3 | Purity: ≥95% | tert-Butyl 3-(6-fluoropyridin-2-yl)azetidine-1-carboxylate | ESD-892992-100MG |
| Cas.: 1356109-81-3 | Purity: ≥95% | tert-Butyl 3-(6-fluoropyridin-2-yl)azetidine-1-carboxylate | ESD-892992-250MG |
| Cas.: 42381-05-5 | Purity: ≥95% | 2-Aminoadamantane-2-carboxylic acid | ESD-892993-100MG |
| Cas.: 42381-05-5 | Purity: ≥95% | 2-Aminoadamantane-2-carboxylic acid | ESD-892993-250MG |
| Cas.: 42381-05-5 | Purity: ≥95% | 2-Aminoadamantane-2-carboxylic acid | ESD-892993-1G |
| Cas.: 68634-02-6 | Purity: ≥95% | Methyl 1-oxo-2,3-dihydro-1H-indene-5-carboxylate | ESD-892994-100MG |
| Cas.: 68634-02-6 | Purity: ≥95% | Methyl 1-oxo-2,3-dihydro-1H-indene-5-carboxylate | ESD-892994-250MG |
| Cas.: 68634-02-6 | Purity: ≥95% | Methyl 1-oxo-2,3-dihydro-1H-indene-5-carboxylate | ESD-892994-1G |
| Cas.: 55934-10-6 | Purity: ≥95% | Methyl 1-oxo-2,3-dihydro-1H-indene-4-carboxylate | ESD-892995-100MG |
| Cas.: 55934-10-6 | Purity: ≥95% | Methyl 1-oxo-2,3-dihydro-1H-indene-4-carboxylate | ESD-892995-250MG |
| Cas.: 55934-10-6 | Purity: ≥95% | Methyl 1-oxo-2,3-dihydro-1H-indene-4-carboxylate | ESD-892995-1G |
| Cas.: 1315340-56-7 | Purity: ≥95% | (4-Bromo-2-ethoxy-6-fluorophenyl)boronic acid | ESD-892996-1G |
| Cas.: 1315340-56-7 | Purity: ≥95% | (4-Bromo-2-ethoxy-6-fluorophenyl)boronic acid | ESD-892996-5G |
| Cas.: 62400-75-3 | Purity: 95% | 5-(Hydroxymethyl)pyrrolidin-2-one | ESD-892997-250MG |
| Cas.: 62400-75-3 | Purity: 95% | 5-(Hydroxymethyl)pyrrolidin-2-one | ESD-892997-1G |
| Cas.: 62400-75-3 | Purity: 95% | 5-(Hydroxymethyl)pyrrolidin-2-one | ESD-892997-5G |
| Cas.: 62400-75-3 | Purity: 95% | 5-(Hydroxymethyl)pyrrolidin-2-one | ESD-892997-25G |
| Cas.: 169770-25-6 | Purity: 98% | Methyl 1-methyl-4-nitro-1H-imidazole-2-carboxylate | ESD-892998-100MG |
| Cas.: 169770-25-6 | Purity: 98% | Methyl 1-methyl-4-nitro-1H-imidazole-2-carboxylate | ESD-892998-250MG |
| Cas.: 169770-25-6 | Purity: 98% | Methyl 1-methyl-4-nitro-1H-imidazole-2-carboxylate | ESD-892998-1G |
| Cas.: 169770-25-6 | Purity: 98% | Methyl 1-methyl-4-nitro-1H-imidazole-2-carboxylate | ESD-892998-5G |
| Cas.: 21617-20-9 | Purity: 97% | 6-Chloro-2,3-dihydroquinolin-4(1H)-one | ESD-892999-100MG |
| Cas.: 21617-20-9 | Purity: 97% | 6-Chloro-2,3-dihydroquinolin-4(1H)-one | ESD-892999-250MG |
| Cas.: 21617-20-9 | Purity: 97% | 6-Chloro-2,3-dihydroquinolin-4(1H)-one | ESD-892999-1G |
| Cas.: 21617-20-9 | Purity: 97% | 6-Chloro-2,3-dihydroquinolin-4(1H)-one | ESD-892999-5G |
| Cas.: 16492-75-4 | Purity: ≥95% | 5-Bromobenzene-1,2,3-triol | ESD-893000-100MG |
| Cas.: 16492-75-4 | Purity: ≥95% | 5-Bromobenzene-1,2,3-triol | ESD-893000-250MG |
| Cas.: 16492-75-4 | Purity: ≥95% | 5-Bromobenzene-1,2,3-triol | ESD-893000-1G |
| Cas.: 16492-75-4 | Purity: ≥95% | 5-Bromobenzene-1,2,3-triol | ESD-893000-5G |
| Cas.: 348-32-3 | Purity: 97% | Ethyl 4-fluoro-1H-indole-2-carboxylate | ESD-893001-100MG |
| Cas.: 348-32-3 | Purity: 97% | Ethyl 4-fluoro-1H-indole-2-carboxylate | ESD-893001-250MG |
| Cas.: 348-32-3 | Purity: 97% | Ethyl 4-fluoro-1H-indole-2-carboxylate | ESD-893001-1G |
| Cas.: 348-32-3 | Purity: 97% | Ethyl 4-fluoro-1H-indole-2-carboxylate | ESD-893001-5G |
| Cas.: 27330-35-4 | Purity: ≥95% | Ethyl 3-amino-5-chloropicolinate | ESD-893002-100MG |
| Cas.: 27330-35-4 | Purity: ≥95% | Ethyl 3-amino-5-chloropicolinate | ESD-893002-250MG |
| Cas.: 27330-35-4 | Purity: ≥95% | Ethyl 3-amino-5-chloropicolinate | ESD-893002-1G |
| Cas.: 771-84-6 | Purity: 98% | 2-Cyano-2-phenylacetamide | ESD-893003-100MG |
| Cas.: 771-84-6 | Purity: 98% | 2-Cyano-2-phenylacetamide | ESD-893003-250MG |
| Cas.: 91552-11-3 | Purity: 97% | 2-(3-Chlorophenyl)cyclopropanecarboxylic acid | ESD-893004-100MG |
| Cas.: 91552-11-3 | Purity: 97% | 2-(3-Chlorophenyl)cyclopropanecarboxylic acid | ESD-893004-250MG |
| Cas.: 91552-11-3 | Purity: 97% | 2-(3-Chlorophenyl)cyclopropanecarboxylic acid | ESD-893004-1G |
| Cas.: 706789-07-3 | Purity: 97% | 2-Chlorooxazole-4-carboxylic acid | ESD-893005-100MG |
| Cas.: 706789-07-3 | Purity: 97% | 2-Chlorooxazole-4-carboxylic acid | ESD-893005-250MG |
| Cas.: 706789-07-3 | Purity: 97% | 2-Chlorooxazole-4-carboxylic acid | ESD-893005-1G |
| Cas.: 706789-07-3 | Purity: 97% | 2-Chlorooxazole-4-carboxylic acid | ESD-893005-5G |
| Cas.: 61727-34-2 | Purity: 97% | Ethyl 2-(4-chloro-2-(methylthio)pyrimidin-5-yl)acetate | ESD-893006-250MG |
| Cas.: 61727-34-2 | Purity: 97% | Ethyl 2-(4-chloro-2-(methylthio)pyrimidin-5-yl)acetate | ESD-893006-1G |
| Cas.: 61727-34-2 | Purity: 97% | Ethyl 2-(4-chloro-2-(methylthio)pyrimidin-5-yl)acetate | ESD-893006-5G |
| Cas.: 61727-34-2 | Purity: 97% | Ethyl 2-(4-chloro-2-(methylthio)pyrimidin-5-yl)acetate | ESD-893006-10G |
| Cas.: 957120-61-5 | Purity: 98% | (5-Bromo-2-fluoro-3-methylphenyl)boronic acid | ESD-893007-250MG |
| Cas.: 957120-61-5 | Purity: 98% | (5-Bromo-2-fluoro-3-methylphenyl)boronic acid | ESD-893007-1G |
| Cas.: 957120-61-5 | Purity: 98% | (5-Bromo-2-fluoro-3-methylphenyl)boronic acid | ESD-893007-5G |
| Cas.: 957120-61-5 | Purity: 98% | (5-Bromo-2-fluoro-3-methylphenyl)boronic acid | ESD-893007-10G |
| Cas.: 857429-79-9 | Purity: 97% | 2,5-Dibromopyridin-3-ol | ESD-893008-100MG |
| Cas.: 857429-79-9 | Purity: 97% | 2,5-Dibromopyridin-3-ol | ESD-893008-250MG |
| Cas.: 857429-79-9 | Purity: 97% | 2,5-Dibromopyridin-3-ol | ESD-893008-1G |
| Cas.: 126811-29-8 | Purity: ≥95% | 7-Bromo-4-chloro-1H-indole | ESD-893009-100MG |
| Cas.: 126811-29-8 | Purity: ≥95% | 7-Bromo-4-chloro-1H-indole | ESD-893009-250MG |
| Cas.: 126811-29-8 | Purity: ≥95% | 7-Bromo-4-chloro-1H-indole | ESD-893009-1G |
| Cas.: 126811-29-8 | Purity: ≥95% | 7-Bromo-4-chloro-1H-indole | ESD-893009-5G |
| Cas.: 78610-70-5 | Purity: 97% | 2-Oxoindoline-3-carbaldehyde | ESD-893010-250MG |
| Cas.: 78610-70-5 | Purity: 97% | 2-Oxoindoline-3-carbaldehyde | ESD-893010-1G |
| Cas.: 78610-70-5 | Purity: 97% | 2-Oxoindoline-3-carbaldehyde | ESD-893010-5G |
| Cas.: 78610-70-5 | Purity: 97% | 2-Oxoindoline-3-carbaldehyde | ESD-893010-10G |
| Cas.: 19230-58-1 | Purity: 98% | 2-Bromo-5-methylpyridine 1-oxide | ESD-893011-250MG |
| Cas.: 19230-58-1 | Purity: 98% | 2-Bromo-5-methylpyridine 1-oxide | ESD-893011-1G |
| Cas.: 19230-58-1 | Purity: 98% | 2-Bromo-5-methylpyridine 1-oxide | ESD-893011-5G |
| Cas.: 127168-90-5 | Purity: ≥97% | Methyl isoindoline-4-carboxylate hydrochloride | ESD-893012-100MG |
| Cas.: 127168-90-5 | Purity: ≥97% | Methyl isoindoline-4-carboxylate hydrochloride | ESD-893012-250MG |
| Cas.: 127168-90-5 | Purity: ≥97% | Methyl isoindoline-4-carboxylate hydrochloride | ESD-893012-1G |
| Cas.: 187732-95-2 | Purity: ≥95% | Ethyl 7-aminofuro[2,3-b]pyrazine-6-carboxylate | ESD-893013-250MG |
| Cas.: 187732-95-2 | Purity: ≥95% | Ethyl 7-aminofuro[2,3-b]pyrazine-6-carboxylate | ESD-893013-1G |
| Cas.: 187732-95-2 | Purity: ≥95% | Ethyl 7-aminofuro[2,3-b]pyrazine-6-carboxylate | ESD-893013-5G |
| Cas.: 179692-08-1 | Purity: 98% | Ethyl 4-iodo-1H-pyrazole-5-carboxylate | ESD-893014-250MG |
| Cas.: 179692-08-1 | Purity: 98% | Ethyl 4-iodo-1H-pyrazole-5-carboxylate | ESD-893014-1G |
| Cas.: 179692-08-1 | Purity: 98% | Ethyl 4-iodo-1H-pyrazole-5-carboxylate | ESD-893014-5G |
| Cas.: 179692-08-1 | Purity: 98% | Ethyl 4-iodo-1H-pyrazole-5-carboxylate | ESD-893014-10G |
| Cas.: 29913-51-7 | Purity: 97% | 2-(4-Hydroxyphenyl)-2-methylpropanoic acid | ESD-893015-100MG |
| Cas.: 29913-51-7 | Purity: 97% | 2-(4-Hydroxyphenyl)-2-methylpropanoic acid | ESD-893015-250MG |
| Cas.: 29913-51-7 | Purity: 97% | 2-(4-Hydroxyphenyl)-2-methylpropanoic acid | ESD-893015-1G |
| Cas.: 29913-51-7 | Purity: 97% | 2-(4-Hydroxyphenyl)-2-methylpropanoic acid | ESD-893015-5G |
| Cas.: 107818-55-3 | Purity: 97% | Methyl 3-amino-5-bromothiophene-2-carboxylate | ESD-893016-100MG |
| Cas.: 107818-55-3 | Purity: 97% | Methyl 3-amino-5-bromothiophene-2-carboxylate | ESD-893016-250MG |
| Cas.: 107818-55-3 | Purity: 97% | Methyl 3-amino-5-bromothiophene-2-carboxylate | ESD-893016-1G |
| Cas.: 107818-55-3 | Purity: 97% | Methyl 3-amino-5-bromothiophene-2-carboxylate | ESD-893016-5G |
| Cas.: 4410-31-5 | Purity: ≥95% | 2-Hydroxy-2-phenylacetamide | ESD-893017-250MG |
| Cas.: 4410-31-5 | Purity: ≥95% | 2-Hydroxy-2-phenylacetamide | ESD-893017-1G |
| Cas.: 4410-31-5 | Purity: ≥95% | 2-Hydroxy-2-phenylacetamide | ESD-893017-5G |
| Cas.: 4923-01-7 | Purity: 98% | 5-Methyl-4H-1,2,4-triazol-3-amine | ESD-893018-5G |
| Cas.: 4923-01-7 | Purity: 98% | 5-Methyl-4H-1,2,4-triazol-3-amine | ESD-893018-10G |
| Cas.: 4923-01-7 | Purity: 98% | 5-Methyl-4H-1,2,4-triazol-3-amine | ESD-893018-25G |
| Cas.: 662117-20-6 | Purity: ≥95% | 5-Chloro-4-methylpyridine-2,3-diamine | ESD-893019-100MG |
| Cas.: 662117-20-6 | Purity: ≥95% | 5-Chloro-4-methylpyridine-2,3-diamine | ESD-893019-250MG |
| Cas.: 1191616-45-1 | Purity: 97% | 4-(4-Bromophenyl)-1-methyl-1H-pyrazole | ESD-893020-100MG |
| Cas.: 1191616-45-1 | Purity: 97% | 4-(4-Bromophenyl)-1-methyl-1H-pyrazole | ESD-893020-250MG |
| Cas.: 372118-01-9 | Purity: 98% | Methyl 4,6-dichloropyridazine-3-carboxylate | ESD-893021-250MG |
| Cas.: 372118-01-9 | Purity: 98% | Methyl 4,6-dichloropyridazine-3-carboxylate | ESD-893021-1G |
| Cas.: 372118-01-9 | Purity: 98% | Methyl 4,6-dichloropyridazine-3-carboxylate | ESD-893021-5G |
| Cas.: 372118-01-9 | Purity: 98% | Methyl 4,6-dichloropyridazine-3-carboxylate | ESD-893021-10G |
| Cas.: 19840-44-9 | Purity: ≥95% | 5-Bromo-6-oxo-1,6-dihydropyridine-3-carbonitrile | ESD-893022-100MG |
| Cas.: 19840-44-9 | Purity: ≥95% | 5-Bromo-6-oxo-1,6-dihydropyridine-3-carbonitrile | ESD-893022-250MG |
| Cas.: 19840-44-9 | Purity: ≥95% | 5-Bromo-6-oxo-1,6-dihydropyridine-3-carbonitrile | ESD-893022-1G |
| Cas.: 227960-12-5 | Purity: 98% | Methyl 5-methylindole-3-carboxylate | ESD-893023-250MG |
| Cas.: 227960-12-5 | Purity: 98% | Methyl 5-methylindole-3-carboxylate | ESD-893023-1G |
| Cas.: 227960-12-5 | Purity: 98% | Methyl 5-methylindole-3-carboxylate | ESD-893023-5G |
| Cas.: 143946-49-0 | Purity: 97% | 4-Chloro-5,7-dimethoxyquinoline | ESD-893024-100MG |
| Cas.: 143946-49-0 | Purity: 97% | 4-Chloro-5,7-dimethoxyquinoline | ESD-893024-250MG |
| Cas.: 143946-49-0 | Purity: 97% | 4-Chloro-5,7-dimethoxyquinoline | ESD-893024-1G |
| Cas.: 1249581-67-6 | Purity: 97% | 3-Cyclopropyl-4-nitro-1H-pyrazole | ESD-893025-250MG |
| Cas.: 1249581-67-6 | Purity: 97% | 3-Cyclopropyl-4-nitro-1H-pyrazole | ESD-893025-1G |
| Cas.: 188347-48-0 | Purity: 97% | 3,5-Dibromobenzylcyanide | ESD-893026-100MG |
| Cas.: 188347-48-0 | Purity: 97% | 3,5-Dibromobenzylcyanide | ESD-893026-250MG |
| Cas.: 188347-48-0 | Purity: 97% | 3,5-Dibromobenzylcyanide | ESD-893026-1G |
| Cas.: 188347-48-0 | Purity: 97% | 3,5-Dibromobenzylcyanide | ESD-893026-5G |
| Cas.: 20101-92-2 | Purity: ≥95% | 2-(4-Chlorophenyl)acetamide | ESD-893027-100MG |
| Cas.: 20101-92-2 | Purity: ≥95% | 2-(4-Chlorophenyl)acetamide | ESD-893027-250MG |
| Cas.: 20101-92-2 | Purity: ≥95% | 2-(4-Chlorophenyl)acetamide | ESD-893027-1G |
| Cas.: 1092350-87-2 | Purity: 97% | 8-Bromo-6-fluorochroman-4-one | ESD-893028-100MG |
| Cas.: 1092350-87-2 | Purity: 97% | 8-Bromo-6-fluorochroman-4-one | ESD-893028-250MG |
| Cas.: 1092350-87-2 | Purity: 97% | 8-Bromo-6-fluorochroman-4-one | ESD-893028-1G |
| Cas.: 40707-01-5 | Purity: 97% | 5-Chloro-1-methyl-1H-benzo[d][1,3]oxazine-2,4-dione | ESD-893029-250MG |
| Cas.: 40707-01-5 | Purity: 97% | 5-Chloro-1-methyl-1H-benzo[d][1,3]oxazine-2,4-dione | ESD-893029-1G |
| Cas.: 40707-01-5 | Purity: 97% | 5-Chloro-1-methyl-1H-benzo[d][1,3]oxazine-2,4-dione | ESD-893029-5G |
| Cas.: 1092062-74-2 | Purity: ≥95% | 6-Chloro-3-methyl-1H-pyrazolo[4,3-c]pyridine | ESD-893030-100MG |
| Cas.: 1092062-74-2 | Purity: ≥95% | 6-Chloro-3-methyl-1H-pyrazolo[4,3-c]pyridine | ESD-893030-250MG |
| Cas.: 1260008-29-4 | Purity: ≥95% | 5-Bromo-7-fluorochroman-4-one | ESD-893031-100MG |
| Cas.: 1260008-29-4 | Purity: ≥95% | 5-Bromo-7-fluorochroman-4-one | ESD-893031-250MG |
| Cas.: 1260008-29-4 | Purity: ≥95% | 5-Bromo-7-fluorochroman-4-one | ESD-893031-1G |
| Cas.: 1125828-26-3 | Purity: ≥95% | 1-(2-Bromo-5-chlorophenyl)-3-methyl-1H-pyrazole | ESD-893032-1G |
| Cas.: 1125828-26-3 | Purity: ≥95% | 1-(2-Bromo-5-chlorophenyl)-3-methyl-1H-pyrazole | ESD-893032-5G |
| Cas.: 1125828-26-3 | Purity: ≥95% | 1-(2-Bromo-5-chlorophenyl)-3-methyl-1H-pyrazole | ESD-893032-10G |
| Cas.: 1082041-58-4 | Purity: ≥95% | 5-Chloro-6-methoxy-1H-indazole | ESD-893033-100MG |
| Cas.: 1082041-58-4 | Purity: ≥95% | 5-Chloro-6-methoxy-1H-indazole | ESD-893033-250MG |
| Cas.: 1082041-58-4 | Purity: ≥95% | 5-Chloro-6-methoxy-1H-indazole | ESD-893033-1G |
| Cas.: 223519-11-7 | Purity: 97% | Methyl 3-amino-5-bromo-4-methylbenzoate | ESD-893034-100MG |
| Cas.: 223519-11-7 | Purity: 97% | Methyl 3-amino-5-bromo-4-methylbenzoate | ESD-893034-250MG |
| Cas.: 223519-11-7 | Purity: 97% | Methyl 3-amino-5-bromo-4-methylbenzoate | ESD-893034-1G |
| Cas.: 223519-11-7 | Purity: 97% | Methyl 3-amino-5-bromo-4-methylbenzoate | ESD-893034-5G |
| Cas.: 22306-30-5 | Purity: 97% | 1,1,4,4,5,5,8,8-Octamethyl-1,2,3,4,5,6,7,8-octahydroanthracene | ESD-893035-250MG |
| Cas.: 22306-30-5 | Purity: 97% | 1,1,4,4,5,5,8,8-Octamethyl-1,2,3,4,5,6,7,8-octahydroanthracene | ESD-893035-1G |
| Cas.: 22306-30-5 | Purity: 97% | 1,1,4,4,5,5,8,8-Octamethyl-1,2,3,4,5,6,7,8-octahydroanthracene | ESD-893035-5G |
| Cas.: 22306-30-5 | Purity: 97% | 1,1,4,4,5,5,8,8-Octamethyl-1,2,3,4,5,6,7,8-octahydroanthracene | ESD-893035-10G |
| Cas.: 7255-28-9 | Purity: ≥99% | Hexaketocyclohexane octahydrate | ESD-893036-1G |
| Cas.: 7255-28-9 | Purity: ≥99% | Hexaketocyclohexane octahydrate | ESD-893036-5G |
| Cas.: 7255-28-9 | Purity: ≥99% | Hexaketocyclohexane octahydrate | ESD-893036-10G |
| Cas.: 877624-40-3 | Purity: 98% | Methyl 3-bromo-5-(bromomethyl)benzoate | ESD-893037-250MG |
| Cas.: 877624-40-3 | Purity: 98% | Methyl 3-bromo-5-(bromomethyl)benzoate | ESD-893037-1G |
| Cas.: 877624-40-3 | Purity: 98% | Methyl 3-bromo-5-(bromomethyl)benzoate | ESD-893037-5G |
| Cas.: 877624-40-3 | Purity: 98% | Methyl 3-bromo-5-(bromomethyl)benzoate | ESD-893037-10G |
| Cas.: 337958-60-8 | Purity: ≥97% | 5,7-Dichloro-1,6-naphthyridine | ESD-893038-100MG |
| Cas.: 337958-60-8 | Purity: ≥97% | 5,7-Dichloro-1,6-naphthyridine | ESD-893038-250MG |
| Cas.: 337958-60-8 | Purity: ≥97% | 5,7-Dichloro-1,6-naphthyridine | ESD-893038-1G |
| Cas.: 337958-60-8 | Purity: ≥97% | 5,7-Dichloro-1,6-naphthyridine | ESD-893038-5G |
| Cas.: 660398-06-1 | Purity: 97% | 8-Bromoisoquinolin-7-ol | ESD-893039-100MG |
| Cas.: 660398-06-1 | Purity: 97% | 8-Bromoisoquinolin-7-ol | ESD-893039-250MG |
| Cas.: 38070-80-3 | Purity: 97% | Pyridine-3,4-diyldimethanol | ESD-893040-250MG |
| Cas.: 38070-80-3 | Purity: 97% | Pyridine-3,4-diyldimethanol | ESD-893040-1G |
| Cas.: 38070-80-3 | Purity: 97% | Pyridine-3,4-diyldimethanol | ESD-893040-5G |
| Cas.: 803700-29-0 | Purity: ≥95% | 3-(3-Fluoro-5-nitrophenoxy)pyridine | ESD-893041-100MG |
| Cas.: 803700-29-0 | Purity: ≥95% | 3-(3-Fluoro-5-nitrophenoxy)pyridine | ESD-893041-250MG |
| Cas.: 5556-20-7 | Purity: ≥95% | Ethyl 3-hydroxybenzo[b]thiophene-2-carboxylate | ESD-893042-100MG |
| Cas.: 5556-20-7 | Purity: ≥95% | Ethyl 3-hydroxybenzo[b]thiophene-2-carboxylate | ESD-893042-250MG |
| Cas.: 20151-40-0 | Purity: 96% | 2,4-Dibromoquinoline | ESD-893043-250MG |
| Cas.: 20151-40-0 | Purity: 96% | 2,4-Dibromoquinoline | ESD-893043-1G |
| Cas.: 24127-59-1 | Purity: 97% | Methyl 2-((1H-1,2,4-triazol-5-yl)thio)acetate | ESD-893044-100MG |
| Cas.: 24127-59-1 | Purity: 97% | Methyl 2-((1H-1,2,4-triazol-5-yl)thio)acetate | ESD-893044-250MG |
| Cas.: 98232-51-0 | Purity: ≥95% | 8-Methoxy-3,4-dihydrobenzo[b]oxepin-5(2H)-one | ESD-893045-250MG |
| Cas.: 98232-51-0 | Purity: ≥95% | 8-Methoxy-3,4-dihydrobenzo[b]oxepin-5(2H)-one | ESD-893045-1G |
| Cas.: 98232-51-0 | Purity: ≥95% | 8-Methoxy-3,4-dihydrobenzo[b]oxepin-5(2H)-one | ESD-893045-5G |
| Cas.: 98232-51-0 | Purity: ≥95% | 8-Methoxy-3,4-dihydrobenzo[b]oxepin-5(2H)-one | ESD-893045-10G |
| Cas.: 1198-83-0 | Purity: 97% | 2-(Methylthio)-9H-purin-6-amine | ESD-893046-100MG |
| Cas.: 1198-83-0 | Purity: 97% | 2-(Methylthio)-9H-purin-6-amine | ESD-893046-250MG |
| Cas.: 1198-83-0 | Purity: 97% | 2-(Methylthio)-9H-purin-6-amine | ESD-893046-1G |
| Cas.: 1198-83-0 | Purity: 97% | 2-(Methylthio)-9H-purin-6-amine | ESD-893046-5G |
| Cas.: 120-13-8 | Purity: 97% | 4-Ethoxy-3-methoxyphenylacetic acid | ESD-893047-1G |
| Cas.: 120-13-8 | Purity: 97% | 4-Ethoxy-3-methoxyphenylacetic acid | ESD-893047-5G |
| Cas.: 120-13-8 | Purity: 97% | 4-Ethoxy-3-methoxyphenylacetic acid | ESD-893047-10G |
| Cas.: 1269291-10-2 | Purity: ≥95% | 4-Bromo-1-(tert-butyl)-5-phenyl-1H-pyrazole | ESD-893048-100MG |
| Cas.: 1269291-10-2 | Purity: ≥95% | 4-Bromo-1-(tert-butyl)-5-phenyl-1H-pyrazole | ESD-893048-250MG |
| Cas.: 1269291-10-2 | Purity: ≥95% | 4-Bromo-1-(tert-butyl)-5-phenyl-1H-pyrazole | ESD-893048-1G |
| Cas.: 446-18-4 | Purity: 97% | 4-Fluoro-2-methyl-5-nitroaniline | ESD-893049-100MG |
| Cas.: 446-18-4 | Purity: 97% | 4-Fluoro-2-methyl-5-nitroaniline | ESD-893049-250MG |
| Cas.: 446-18-4 | Purity: 97% | 4-Fluoro-2-methyl-5-nitroaniline | ESD-893049-1G |
| Cas.: 446-18-4 | Purity: 97% | 4-Fluoro-2-methyl-5-nitroaniline | ESD-893049-5G |
| Cas.: 5912-34-5 | Purity: 97% | 3-(Cyanomethyl)picolinonitrile | ESD-893050-100MG |
| Cas.: 5912-34-5 | Purity: 97% | 3-(Cyanomethyl)picolinonitrile | ESD-893050-250MG |
| Cas.: 5912-34-5 | Purity: 97% | 3-(Cyanomethyl)picolinonitrile | ESD-893050-1G |
| Cas.: 5912-34-5 | Purity: 97% | 3-(Cyanomethyl)picolinonitrile | ESD-893050-5G |
| Cas.: 54329-54-3 | Purity: ≥95% | 2-Methyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | ESD-893051-100MG |
| Cas.: 54329-54-3 | Purity: ≥95% | 2-Methyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | ESD-893051-250MG |
| Cas.: 54329-54-3 | Purity: ≥95% | 2-Methyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | ESD-893051-1G |
| Cas.: 54329-54-3 | Purity: ≥95% | 2-Methyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | ESD-893051-5G |
| Cas.: 920313-61-7 | Purity: 97% | Thiazolo[5,4-d]pyrimidin-2-amine | ESD-893052-100MG |
| Cas.: 180976-94-7 | Purity: 97% | 4-((tert-Butoxycarbonyl)amino)-3-methylbenzoic acid | ESD-893053-250MG |
| Cas.: 180976-94-7 | Purity: 97% | 4-((tert-Butoxycarbonyl)amino)-3-methylbenzoic acid | ESD-893053-1G |
| Cas.: 503176-50-9 | Purity: ≥95% | 2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde | ESD-893054-100MG |
| Cas.: 503176-50-9 | Purity: ≥95% | 2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde | ESD-893054-250MG |
| Cas.: 503176-50-9 | Purity: ≥95% | 2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde | ESD-893054-1G |
| Cas.: 503176-50-9 | Purity: ≥95% | 2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde | ESD-893054-5G |
| Cas.: 65128-66-7 | Purity: 97% | Thiazolo[4,5-c]pyridine-2(3H)-thione | ESD-893055-100MG |
| Cas.: 60781-83-1 | Purity: ≥95% | 4-Phenylpyridin-2-amine | ESD-893057-250MG |
| Cas.: 60781-83-1 | Purity: ≥95% | 4-Phenylpyridin-2-amine | ESD-893057-1G |
| Cas.: 60781-83-1 | Purity: ≥95% | 4-Phenylpyridin-2-amine | ESD-893057-5G |
| Cas.: 60781-83-1 | Purity: ≥95% | 4-Phenylpyridin-2-amine | ESD-893057-10G |
| Cas.: 24782-43-2 | Purity: ≥95% | Ethyl 4-hydroxyquinoline-2-carboxylate | ESD-893058-250MG |
| Cas.: 24782-43-2 | Purity: ≥95% | Ethyl 4-hydroxyquinoline-2-carboxylate | ESD-893058-1G |
| Cas.: 24782-43-2 | Purity: ≥95% | Ethyl 4-hydroxyquinoline-2-carboxylate | ESD-893058-5G |
| Cas.: 24782-43-2 | Purity: ≥95% | Ethyl 4-hydroxyquinoline-2-carboxylate | ESD-893058-10G |
| Cas.: 143945-65-7 | Purity: 97% | 2-Amino-5-bromo-4-fluorobenzoic acid | ESD-893059-250MG |
| Cas.: 143945-65-7 | Purity: 97% | 2-Amino-5-bromo-4-fluorobenzoic acid | ESD-893059-1G |
| Cas.: 143945-65-7 | Purity: 97% | 2-Amino-5-bromo-4-fluorobenzoic acid | ESD-893059-5G |
| Cas.: 143945-65-7 | Purity: 97% | 2-Amino-5-bromo-4-fluorobenzoic acid | ESD-893059-10G |
| Cas.: 182692-69-9 | Purity: 97% | 5-Bromo-2-nitrothiazole | ESD-893060-100MG |
| Cas.: 182692-69-9 | Purity: 97% | 5-Bromo-2-nitrothiazole | ESD-893060-250MG |
| Cas.: 1824282-29-2 | Purity: ≥95% | tert-Butyl (2-methylquinolin-3-yl)carbamate | ESD-893061-100MG |
| Cas.: 1824282-29-2 | Purity: ≥95% | tert-Butyl (2-methylquinolin-3-yl)carbamate | ESD-893061-250MG |
| Cas.: 1824282-29-2 | Purity: ≥95% | tert-Butyl (2-methylquinolin-3-yl)carbamate | ESD-893061-1G |
| Cas.: 1824282-29-2 | Purity: ≥95% | tert-Butyl (2-methylquinolin-3-yl)carbamate | ESD-893061-5G |
| Cas.: 262368-47-8 | Purity: 97% | 4-(2-Morpholinoethyl)aniline | ESD-893062-250MG |
| Cas.: 262368-47-8 | Purity: 97% | 4-(2-Morpholinoethyl)aniline | ESD-893062-1G |
| Cas.: 262368-47-8 | Purity: 97% | 4-(2-Morpholinoethyl)aniline | ESD-893062-5G |
| Cas.: 262368-47-8 | Purity: 97% | 4-(2-Morpholinoethyl)aniline | ESD-893062-10G |
| Cas.: 957121-09-4 | Purity: 97% | (2-Bromo-6-fluoro-3-methylphenyl)boronic acid | ESD-893063-250MG |
| Cas.: 957121-09-4 | Purity: 97% | (2-Bromo-6-fluoro-3-methylphenyl)boronic acid | ESD-893063-1G |
| Cas.: 957121-09-4 | Purity: 97% | (2-Bromo-6-fluoro-3-methylphenyl)boronic acid | ESD-893063-5G |
| Cas.: 957121-09-4 | Purity: 97% | (2-Bromo-6-fluoro-3-methylphenyl)boronic acid | ESD-893063-10G |
| Cas.: 622864-56-6 | Purity: 97% | 5-Methoxybenzo[b]thiophene-2-carbaldehyde | ESD-893064-1G |
| Cas.: 139297-51-1 | Purity: ≥95% | 5-Methoxy-1-methyl-1H-pyrazole-3-carboxylic acid | ESD-893065-100MG |
| Cas.: 139297-51-1 | Purity: ≥95% | 5-Methoxy-1-methyl-1H-pyrazole-3-carboxylic acid | ESD-893065-250MG |
| Cas.: 139297-51-1 | Purity: ≥95% | 5-Methoxy-1-methyl-1H-pyrazole-3-carboxylic acid | ESD-893065-1G |
| Cas.: 791626-59-0 | Purity: 97% | 2-Chloroquinoline-6-carbaldehyde | ESD-893066-100MG |
| Cas.: 791626-59-0 | Purity: 97% | 2-Chloroquinoline-6-carbaldehyde | ESD-893066-250MG |
| Cas.: 17965-82-1 | Purity: 95% | 1,7-Naphthyridin-8-amine | ESD-893067-100MG |
| Cas.: 17965-82-1 | Purity: 95% | 1,7-Naphthyridin-8-amine | ESD-893067-250MG |
| Cas.: 17965-82-1 | Purity: 95% | 1,7-Naphthyridin-8-amine | ESD-893067-1G |
| Cas.: 17965-82-1 | Purity: 95% | 1,7-Naphthyridin-8-amine | ESD-893067-5G |
| Cas.: 55570-60-0 | Purity: ≥95% | 1,6-Naphthyridin-5-amine | ESD-893068-100MG |
| Cas.: 55570-60-0 | Purity: ≥95% | 1,6-Naphthyridin-5-amine | ESD-893068-250MG |
| Cas.: 55570-60-0 | Purity: ≥95% | 1,6-Naphthyridin-5-amine | ESD-893068-1G |
| Cas.: 916766-83-1 | Purity: 97% | 3-(4-(Chloromethyl)phenyl)-1-methyl-1H-pyrazole | ESD-893069-1G |
| Cas.: 916766-83-1 | Purity: 97% | 3-(4-(Chloromethyl)phenyl)-1-methyl-1H-pyrazole | ESD-893069-5G |
| Cas.: 916766-83-1 | Purity: 97% | 3-(4-(Chloromethyl)phenyl)-1-methyl-1H-pyrazole | ESD-893069-10G |
| Cas.: 1150632-93-1 | Purity: 98% | 2-(Dimethoxymethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-893070-250MG |
| Cas.: 1150632-93-1 | Purity: 98% | 2-(Dimethoxymethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | ESD-893070-1G |
| Cas.: 334769-80-1 | Purity: 97% | (2S,5S)-1-(tert-Butoxycarbonyl)-5-methylpyrrolidine-2-carboxylic acid | ESD-893071-250MG |
| Cas.: 334769-80-1 | Purity: 97% | (2S,5S)-1-(tert-Butoxycarbonyl)-5-methylpyrrolidine-2-carboxylic acid | ESD-893071-1G |
| Cas.: 334769-80-1 | Purity: 97% | (2S,5S)-1-(tert-Butoxycarbonyl)-5-methylpyrrolidine-2-carboxylic acid | ESD-893071-5G |
| Cas.: 334769-80-1 | Purity: 97% | (2S,5S)-1-(tert-Butoxycarbonyl)-5-methylpyrrolidine-2-carboxylic acid | ESD-893071-10G |
| Cas.: 85642-13-3 | Purity: ≥95% | Boc-Ala-NH2 | ESD-893072-1G |
| Cas.: 85642-13-3 | Purity: ≥95% | Boc-Ala-NH2 | ESD-893072-5G |
| Cas.: 85642-13-3 | Purity: ≥95% | Boc-Ala-NH2 | ESD-893072-10G |
| Cas.: 85642-13-3 | Purity: ≥95% | Boc-Ala-NH2 | ESD-893072-25G |
| Cas.: 56080-99-0 | Purity: 97% | (R)-1-Benzylpyrrolidine-2-carboxylic acid | ESD-893073-250MG |
| Cas.: 56080-99-0 | Purity: 97% | (R)-1-Benzylpyrrolidine-2-carboxylic acid | ESD-893073-1G |
| Cas.: 56080-99-0 | Purity: 97% | (R)-1-Benzylpyrrolidine-2-carboxylic acid | ESD-893073-5G |
| Cas.: 56080-99-0 | Purity: 97% | (R)-1-Benzylpyrrolidine-2-carboxylic acid | ESD-893073-10G |
| Cas.: 6076-14-8 | Purity: ≥95% | Ethyl 4-bromo-5-methyl-1H-pyrazole-3-carboxylate | ESD-893074-100MG |
| Cas.: 6076-14-8 | Purity: ≥95% | Ethyl 4-bromo-5-methyl-1H-pyrazole-3-carboxylate | ESD-893074-250MG |
| Cas.: 6076-14-8 | Purity: ≥95% | Ethyl 4-bromo-5-methyl-1H-pyrazole-3-carboxylate | ESD-893074-1G |
| Cas.: 713-57-5 | Purity: ≥95% | 4-(Ethoxycarbonyl)benzoic acid | ESD-893075-250MG |
| Cas.: 713-57-5 | Purity: ≥95% | 4-(Ethoxycarbonyl)benzoic acid | ESD-893075-1G |
| Cas.: 713-57-5 | Purity: ≥95% | 4-(Ethoxycarbonyl)benzoic acid | ESD-893075-5G |
| Cas.: 5334-49-6 | Purity: ≥95% | N,1-Dimethyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | ESD-893076-100MG |
| Cas.: 5334-49-6 | Purity: ≥95% | N,1-Dimethyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | ESD-893076-250MG |
| Cas.: 863578-24-9 | Purity: ≥95% | 4-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-893077-100MG |
| Cas.: 863578-24-9 | Purity: ≥95% | 4-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | ESD-893077-250MG |
| Cas.: 176526-00-4 | Purity: 97% | 2-(Pyridin-4-yl)benzaldehyde | ESD-893078-100MG |
| Cas.: 176526-00-4 | Purity: 97% | 2-(Pyridin-4-yl)benzaldehyde | ESD-893078-250MG |
| Cas.: 176526-00-4 | Purity: 97% | 2-(Pyridin-4-yl)benzaldehyde | ESD-893078-1G |
| Cas.: 176526-00-4 | Purity: 97% | 2-(Pyridin-4-yl)benzaldehyde | ESD-893078-5G |
| Cas.: 1092350-30-5 | Purity: ≥95% | 6-Bromo-7-fluorochroman-4-one | ESD-893079-100MG |
| Cas.: 1092350-30-5 | Purity: ≥95% | 6-Bromo-7-fluorochroman-4-one | ESD-893079-250MG |
| Cas.: 1092350-30-5 | Purity: ≥95% | 6-Bromo-7-fluorochroman-4-one | ESD-893079-1G |
| Cas.: 1513119-35-1 | Purity: 97% | 2-Amino-6-bromo-3-chloro-5-fluorobenzoic acid | ESD-893080-100MG |
| Cas.: 1513119-35-1 | Purity: 97% | 2-Amino-6-bromo-3-chloro-5-fluorobenzoic acid | ESD-893080-250MG |
| Cas.: 1513119-35-1 | Purity: 97% | 2-Amino-6-bromo-3-chloro-5-fluorobenzoic acid | ESD-893080-1G |
| Cas.: 56893-25-5 | Purity: 97% | Methyl 4-(2-bromoacetyl)benzoate | ESD-893081-250MG |
| Cas.: 56893-25-5 | Purity: 97% | Methyl 4-(2-bromoacetyl)benzoate | ESD-893081-1G |
| Cas.: 56893-25-5 | Purity: 97% | Methyl 4-(2-bromoacetyl)benzoate | ESD-893081-5G |
| Cas.: 56893-25-5 | Purity: 97% | Methyl 4-(2-bromoacetyl)benzoate | ESD-893081-10G |
| Cas.: 88947-28-8 | Purity: 97% | 4-Amino-1,2,5-thiadiazole-3-carboxamide | ESD-893082-100MG |
| Cas.: 88947-28-8 | Purity: 97% | 4-Amino-1,2,5-thiadiazole-3-carboxamide | ESD-893082-250MG |
| Cas.: 88947-28-8 | Purity: 97% | 4-Amino-1,2,5-thiadiazole-3-carboxamide | ESD-893082-1G |
| Cas.: 496-42-4 | Purity: ≥95% | 2-(1H-Indol-2-yl)ethanamine | ESD-893083-250MG |
| Cas.: 364793-93-1 | Purity: ≥95% | 4-((6-Bromopyridin-3-yl)methyl)morpholine | ESD-893084-100MG |
| Cas.: 364793-93-1 | Purity: ≥95% | 4-((6-Bromopyridin-3-yl)methyl)morpholine | ESD-893084-250MG |
| Cas.: 177583-27-6 | Purity: ≥95% | tert-Butyl (trans-4-(aminomethyl)cyclohexyl)carbamate | ESD-893085-250MG |
| Cas.: 177583-27-6 | Purity: ≥95% | tert-Butyl (trans-4-(aminomethyl)cyclohexyl)carbamate | ESD-893085-1G |
| Cas.: 177583-27-6 | Purity: ≥95% | tert-Butyl (trans-4-(aminomethyl)cyclohexyl)carbamate | ESD-893085-5G |
| Cas.: 177583-27-6 | Purity: ≥95% | tert-Butyl (trans-4-(aminomethyl)cyclohexyl)carbamate | ESD-893085-10G |
| Cas.: 15520-05-5 | Purity: 95% | 2,2′-(Octylazanediyl)diethanol | ESD-893086-250MG |
| Cas.: 15520-05-5 | Purity: 95% | 2,2′-(Octylazanediyl)diethanol | ESD-893086-1G |
| Cas.: 519059-11-1 | Purity: ≥95% | 2-(3-Cyano-4-fluorophenyl)acetic acid | ESD-893087-100MG |
| Cas.: 519059-11-1 | Purity: ≥95% | 2-(3-Cyano-4-fluorophenyl)acetic acid | ESD-893087-250MG |
| Cas.: 519059-11-1 | Purity: ≥95% | 2-(3-Cyano-4-fluorophenyl)acetic acid | ESD-893087-1G |
| Cas.: 519059-11-1 | Purity: ≥95% | 2-(3-Cyano-4-fluorophenyl)acetic acid | ESD-893087-5G |
| Cas.: 132118-47-9 | Purity: 97% | 7-Bromo-2-chloro-3-methylquinoline | ESD-893088-250MG |
| Cas.: 132118-47-9 | Purity: 97% | 7-Bromo-2-chloro-3-methylquinoline | ESD-893088-1G |
| Cas.: 132118-47-9 | Purity: 97% | 7-Bromo-2-chloro-3-methylquinoline | ESD-893088-5G |
| Cas.: 132118-47-9 | Purity: 97% | 7-Bromo-2-chloro-3-methylquinoline | ESD-893088-10G |
| Cas.: 99070-18-5 | Purity: 97% | 2-(4-Bromophenyl)butanoic acid | ESD-893089-100MG |
| Cas.: 99070-18-5 | Purity: 97% | 2-(4-Bromophenyl)butanoic acid | ESD-893089-250MG |
| Cas.: 99070-18-5 | Purity: 97% | 2-(4-Bromophenyl)butanoic acid | ESD-893089-1G |
| Cas.: 99070-18-5 | Purity: 97% | 2-(4-Bromophenyl)butanoic acid | ESD-893089-5G |
| Cas.: 31568-91-9 | Purity: 97% | 2-Chloroquinolin-8-ol | ESD-893090-100MG |
| Cas.: 31568-91-9 | Purity: 97% | 2-Chloroquinolin-8-ol | ESD-893090-250MG |
| Cas.: 31568-91-9 | Purity: 97% | 2-Chloroquinolin-8-ol | ESD-893090-1G |
| Cas.: 1202858-68-1 | Purity: 98% | 1-Bromo-5-isopropoxy-2-methyl-4-nitrobenzene | ESD-893091-1G |
| Cas.: 1202858-68-1 | Purity: 98% | 1-Bromo-5-isopropoxy-2-methyl-4-nitrobenzene | ESD-893091-5G |
| Cas.: 1202858-68-1 | Purity: 98% | 1-Bromo-5-isopropoxy-2-methyl-4-nitrobenzene | ESD-893091-10G |
| Cas.: 1202858-68-1 | Purity: 98% | 1-Bromo-5-isopropoxy-2-methyl-4-nitrobenzene | ESD-893091-25G |
| Cas.: 577967-89-6 | Purity: 97% | 2-Chloroquinolin-6-ol | ESD-893092-250MG |
| Cas.: 577967-89-6 | Purity: 97% | 2-Chloroquinolin-6-ol | ESD-893092-1G |
| Cas.: 577967-89-6 | Purity: 97% | 2-Chloroquinolin-6-ol | ESD-893092-5G |
| Cas.: 577967-89-6 | Purity: 97% | 2-Chloroquinolin-6-ol | ESD-893092-10G |
| Cas.: 25934-52-5 | Purity: ≥95% | 3-(Cyclopropylmethoxy)-4-hydroxybenzaldehyde | ESD-893093-250MG |
| Cas.: 25934-52-5 | Purity: ≥95% | 3-(Cyclopropylmethoxy)-4-hydroxybenzaldehyde | ESD-893093-1G |
| Cas.: 392331-66-7 | Purity: ≥95% | 1-Boc-4-(Aminomethyl)-4-hydroxypiperidine | ESD-893094-250MG |
| Cas.: 392331-66-7 | Purity: ≥95% | 1-Boc-4-(Aminomethyl)-4-hydroxypiperidine | ESD-893094-1G |
| Cas.: 392331-66-7 | Purity: ≥95% | 1-Boc-4-(Aminomethyl)-4-hydroxypiperidine | ESD-893094-5G |
| Cas.: 88661-56-7 | Purity: ≥95% | 1-(3-Bromopropyl)pyrrolidine-2,5-dione | ESD-893095-100MG |
| Cas.: 88661-56-7 | Purity: ≥95% | 1-(3-Bromopropyl)pyrrolidine-2,5-dione | ESD-893095-250MG |
| Cas.: 905856-70-4 | Purity: ≥95% | 2-Bromo-5-iodopyrimidine | ESD-893096-100MG |
| Cas.: 905856-70-4 | Purity: ≥95% | 2-Bromo-5-iodopyrimidine | ESD-893096-250MG |
| Cas.: 1046816-75-4 | Purity: 97% | (2-Chloropyrimdin-5-yl)methanol | ESD-893097-100MG |
| Cas.: 1046816-75-4 | Purity: 97% | (2-Chloropyrimdin-5-yl)methanol | ESD-893097-250MG |
| Cas.: 1046816-75-4 | Purity: 97% | (2-Chloropyrimdin-5-yl)methanol | ESD-893097-1G |
| Cas.: 407623-83-0 | Purity: 97% | Ethyl isoquinoline-7-carboxylate | ESD-893098-100MG |
| Cas.: 407623-83-0 | Purity: 97% | Ethyl isoquinoline-7-carboxylate | ESD-893098-250MG |
| Cas.: 26340-49-8 | Purity: ≥95% | 2-Iodo-1H-indole | ESD-893099-100MG |
| Cas.: 115666-47-2 | Purity: 97% | 6-Iodo-1H-indole | ESD-893100-100MG |
| Cas.: 115666-47-2 | Purity: 97% | 6-Iodo-1H-indole | ESD-893100-250MG |
| Cas.: 115666-47-2 | Purity: 97% | 6-Iodo-1H-indole | ESD-893100-1G |
| Cas.: 115666-47-2 | Purity: 97% | 6-Iodo-1H-indole | ESD-893100-5G |
| Cas.: 5866-98-8 | Purity: 98% | 2,6-Dichloro-3-nitrobenzonitrile | ESD-893101-250MG |
| Cas.: 5866-98-8 | Purity: 98% | 2,6-Dichloro-3-nitrobenzonitrile | ESD-893101-1G |
| Cas.: 5866-98-8 | Purity: 98% | 2,6-Dichloro-3-nitrobenzonitrile | ESD-893101-5G |
| Cas.: 5866-98-8 | Purity: 98% | 2,6-Dichloro-3-nitrobenzonitrile | ESD-893101-10G |
| Cas.: 42822-57-1 | Purity: ≥95% | Diethyl (4-aminophenyl)phosphonate | ESD-893102-100MG |
| Cas.: 42822-57-1 | Purity: ≥95% | Diethyl (4-aminophenyl)phosphonate | ESD-893102-250MG |
| Cas.: 42822-57-1 | Purity: ≥95% | Diethyl (4-aminophenyl)phosphonate | ESD-893102-1G |
| Cas.: 912444-90-7 | Purity: 95% | 1-tert-Butyl 4-ethyl azepane-1,4-dicarboxylate | ESD-893103-100MG |
| Cas.: 912444-90-7 | Purity: 95% | 1-tert-Butyl 4-ethyl azepane-1,4-dicarboxylate | ESD-893103-250MG |
| Cas.: 912444-90-7 | Purity: 95% | 1-tert-Butyl 4-ethyl azepane-1,4-dicarboxylate | ESD-893103-1G |
| Cas.: 149682-82-6 | Purity: ≥95% | (S)-tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolidine-1-carboxylate | ESD-893104-50MG |
| Cas.: 354153-65-4 | Purity: 97% | (S)-2-Amino-2-(4-bromophenyl)ethanol | ESD-893105-100MG |
| Cas.: 354153-65-4 | Purity: 97% | (S)-2-Amino-2-(4-bromophenyl)ethanol | ESD-893105-250MG |
| Cas.: 354153-64-3 | Purity: ≥95% | (R)-2-Amino-2-(4-bromophenyl)ethanol | ESD-893106-100MG |
| Cas.: 354153-64-3 | Purity: ≥95% | (R)-2-Amino-2-(4-bromophenyl)ethanol | ESD-893106-250MG |
| Cas.: 223671-92-9 | Purity: 97% | Isoquinoline-7-carbonitrile | ESD-893107-100MG |
| Cas.: 223671-92-9 | Purity: 97% | Isoquinoline-7-carbonitrile | ESD-893107-250MG |
| Cas.: 223671-92-9 | Purity: 97% | Isoquinoline-7-carbonitrile | ESD-893107-1G |
| Cas.: 223671-92-9 | Purity: 97% | Isoquinoline-7-carbonitrile | ESD-893107-5G |
| Cas.: 21339-73-1 | Purity: ≥95% | 4-Amino-2,5-dimethylbenzoic acid | ESD-893108-100MG |
| Cas.: 21339-73-1 | Purity: ≥95% | 4-Amino-2,5-dimethylbenzoic acid | ESD-893108-250MG |
| Cas.: 21339-73-1 | Purity: ≥95% | 4-Amino-2,5-dimethylbenzoic acid | ESD-893108-1G |
| Cas.: 21339-73-1 | Purity: ≥95% | 4-Amino-2,5-dimethylbenzoic acid | ESD-893108-5G |
| Cas.: 59608-01-4 | Purity: ≥95% | 3-(Pyridin-3-yl)propiolic acid | ESD-893109-100MG |
| Cas.: 59608-01-4 | Purity: ≥95% | 3-(Pyridin-3-yl)propiolic acid | ESD-893109-250MG |
| Cas.: 59608-01-4 | Purity: ≥95% | 3-(Pyridin-3-yl)propiolic acid | ESD-893109-1G |
| Cas.: 59608-01-4 | Purity: ≥95% | 3-(Pyridin-3-yl)propiolic acid | ESD-893109-5G |
| Cas.: 138799-95-8 | Purity: ≥95% | (1H-Imidazol-2-yl)methanamine hydrochloride | ESD-893110-250MG |
| Cas.: 138799-95-8 | Purity: ≥95% | (1H-Imidazol-2-yl)methanamine hydrochloride | ESD-893110-1G |
| Cas.: 1256345-66-0 | Purity: 98% | (6-Chloro-2-fluoropyridin-3-yl)boronic acid | ESD-893111-250MG |
| Cas.: 1256345-66-0 | Purity: 98% | (6-Chloro-2-fluoropyridin-3-yl)boronic acid | ESD-893111-1G |
| Cas.: 1256345-66-0 | Purity: 98% | (6-Chloro-2-fluoropyridin-3-yl)boronic acid | ESD-893111-5G |
| Cas.: 115955-48-1 | Purity: ≥95% | 3-(Dimethylamino)-1-(3-nitrophenyl)prop-2-en-1-one | ESD-893112-1G |
| Cas.: 115955-48-1 | Purity: ≥95% | 3-(Dimethylamino)-1-(3-nitrophenyl)prop-2-en-1-one | ESD-893112-5G |
| Cas.: 1159511-73-5 | Purity: ≥95% | 4-Bromo-3-methyl-1H-indazole | ESD-893113-250MG |
| Cas.: 1159511-73-5 | Purity: ≥95% | 4-Bromo-3-methyl-1H-indazole | ESD-893113-1G |
| Cas.: 1159511-73-5 | Purity: ≥95% | 4-Bromo-3-methyl-1H-indazole | ESD-893113-5G |
| Cas.: 1159511-73-5 | Purity: ≥95% | 4-Bromo-3-methyl-1H-indazole | ESD-893113-25G |
| Cas.: 31825-95-3 | Purity: 97% | 2-Methylthiazole-4-carboxamide | ESD-893114-100MG |
| Cas.: 31825-95-3 | Purity: 97% | 2-Methylthiazole-4-carboxamide | ESD-893114-250MG |
| Cas.: 31825-95-3 | Purity: 97% | 2-Methylthiazole-4-carboxamide | ESD-893114-1G |
| Cas.: 31825-95-3 | Purity: 97% | 2-Methylthiazole-4-carboxamide | ESD-893114-5G |
| Cas.: 1019453-85-0 | Purity: 97% | 2-((2,4-Dimethylphenyl)thio)aniline | ESD-893115-1G |
| Cas.: 1019453-85-0 | Purity: 97% | 2-((2,4-Dimethylphenyl)thio)aniline | ESD-893115-5G |
| Cas.: 118853-60-4 | Purity: ≥95% | Methyl 6-aminopyrazine-2-carboxylate | ESD-893116-100MG |
| Cas.: 118853-60-4 | Purity: ≥95% | Methyl 6-aminopyrazine-2-carboxylate | ESD-893116-250MG |
| Cas.: 118853-60-4 | Purity: ≥95% | Methyl 6-aminopyrazine-2-carboxylate | ESD-893116-1G |
| Cas.: 118853-60-4 | Purity: ≥95% | Methyl 6-aminopyrazine-2-carboxylate | ESD-893116-5G |
| Cas.: 1421602-80-3 | Purity: ≥95% | 2,4-Dibromo-6-fluoropyridin-3-ol | ESD-893117-250MG |
| Cas.: 1421602-80-3 | Purity: ≥95% | 2,4-Dibromo-6-fluoropyridin-3-ol | ESD-893117-1G |
| Cas.: 100644-67-5 | Purity: ≥95% | 4-Methoxy-1H-pyrazolo[3,4-d]pyrimidin-6-amine | ESD-893118-20MG |
| Cas.: 230646-11-4 | Purity: 97% | Ethyl 3-amino-4,5-dimethyl-1H-pyrrole-2-carboxylate | ESD-893119-100MG |
| Cas.: 230646-11-4 | Purity: 97% | Ethyl 3-amino-4,5-dimethyl-1H-pyrrole-2-carboxylate | ESD-893119-250MG |
| Cas.: 934240-59-2 | Purity: 97% | 1-((4-Bromophenoxy)methyl)-2-fluorobenzene | ESD-893120-100MG |
| Cas.: 934240-59-2 | Purity: 97% | 1-((4-Bromophenoxy)methyl)-2-fluorobenzene | ESD-893120-250MG |
| Cas.: 934240-59-2 | Purity: 97% | 1-((4-Bromophenoxy)methyl)-2-fluorobenzene | ESD-893120-1G |
| Cas.: 934240-59-2 | Purity: 97% | 1-((4-Bromophenoxy)methyl)-2-fluorobenzene | ESD-893120-5G |
| Cas.: 1257856-32-8 | Purity: 97% | (R)-tert-Butyl 3-cyanomorpholine-4-carboxylate | ESD-893121-100MG |
| Cas.: 1257856-32-8 | Purity: 97% | (R)-tert-Butyl 3-cyanomorpholine-4-carboxylate | ESD-893121-250MG |
| Cas.: 1257856-32-8 | Purity: 97% | (R)-tert-Butyl 3-cyanomorpholine-4-carboxylate | ESD-893121-1G |
| Cas.: 1257856-32-8 | Purity: 97% | (R)-tert-Butyl 3-cyanomorpholine-4-carboxylate | ESD-893121-5G |
| Cas.: 58577-87-0 | Purity: 97% | H-Serinol(Bzl) | ESD-893122-250MG |
| Cas.: 58577-87-0 | Purity: 97% | H-Serinol(Bzl) | ESD-893122-1G |
| Cas.: 58577-87-0 | Purity: 97% | H-Serinol(Bzl) | ESD-893122-5G |
| Cas.: 289039-48-1 | Purity: ≥95% | 4,5-Dibromo-2-fluorobenzoic acid | ESD-893123-100MG |
| Cas.: 289039-48-1 | Purity: ≥95% | 4,5-Dibromo-2-fluorobenzoic acid | ESD-893123-250MG |
| Cas.: 1003843-30-8 | Purity: 97% | (2R,6S)-rel-tert-Butyl 2,6-diethyl-4-oxopiperidine-1-carboxylate | ESD-893124-1G |
| Cas.: 1003843-30-8 | Purity: 97% | (2R,6S)-rel-tert-Butyl 2,6-diethyl-4-oxopiperidine-1-carboxylate | ESD-893124-5G |
| Cas.: 1003843-30-8 | Purity: 97% | (2R,6S)-rel-tert-Butyl 2,6-diethyl-4-oxopiperidine-1-carboxylate | ESD-893124-10G |
| Cas.: 1003843-30-8 | Purity: 97% | (2R,6S)-rel-tert-Butyl 2,6-diethyl-4-oxopiperidine-1-carboxylate | ESD-893124-25G |
| Cas.: 10199-68-5 | Purity: ≥95% | 4-Phenyl-1H-pyrazole | ESD-893125-100MG |
| Cas.: 10199-68-5 | Purity: ≥95% | 4-Phenyl-1H-pyrazole | ESD-893125-250MG |
| Cas.: 10199-68-5 | Purity: ≥95% | 4-Phenyl-1H-pyrazole | ESD-893125-1G |
| Cas.: 10199-68-5 | Purity: ≥95% | 4-Phenyl-1H-pyrazole | ESD-893125-5G |
| Cas.: 1235450-86-8 | Purity: 97% | 5-Bromo-2-ethylpyrimidine-4-carboxylic acid | ESD-893126-100MG |
| Cas.: 1235450-86-8 | Purity: 97% | 5-Bromo-2-ethylpyrimidine-4-carboxylic acid | ESD-893126-250MG |
| Cas.: 61545-41-3 | Purity: ≥95% | 6-Methyl-1H-indol-4-ol | ESD-893127-100MG |
| Cas.: 61545-41-3 | Purity: ≥95% | 6-Methyl-1H-indol-4-ol | ESD-893127-250MG |
| Cas.: 61545-41-3 | Purity: ≥95% | 6-Methyl-1H-indol-4-ol | ESD-893127-1G |
| Cas.: 21617-15-2 | Purity: ≥95% | 7-Chloro-2,3-dihydroquinolin-4(1H)-one | ESD-893128-100MG |
| Cas.: 21617-15-2 | Purity: ≥95% | 7-Chloro-2,3-dihydroquinolin-4(1H)-one | ESD-893128-250MG |
| Cas.: 21617-15-2 | Purity: ≥95% | 7-Chloro-2,3-dihydroquinolin-4(1H)-one | ESD-893128-1G |
| Cas.: 909391-56-6 | Purity: ≥95% | N,N-Dimethyl-1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine | ESD-893129-250MG |
| Cas.: 909391-56-6 | Purity: ≥95% | N,N-Dimethyl-1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine | ESD-893129-1G |
| Cas.: 909391-56-6 | Purity: ≥95% | N,N-Dimethyl-1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine | ESD-893129-5G |
| Cas.: 909391-56-6 | Purity: ≥95% | N,N-Dimethyl-1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine | ESD-893129-10G |
| Cas.: 131184-73-1 | Purity: 97% | (2-Aminothiazol-5-yl)methanol | ESD-893130-100MG |
| Cas.: 131184-73-1 | Purity: 97% | (2-Aminothiazol-5-yl)methanol | ESD-893130-250MG |
| Cas.: 131184-73-1 | Purity: 97% | (2-Aminothiazol-5-yl)methanol | ESD-893130-1G |
| Cas.: 130658-65-0 | Purity: 97% | 1-(Pyridin-4-yl)piperidin-4-ol | ESD-893131-250MG |
| Cas.: 130658-65-0 | Purity: 97% | 1-(Pyridin-4-yl)piperidin-4-ol | ESD-893131-1G |
| Cas.: 130658-65-0 | Purity: 97% | 1-(Pyridin-4-yl)piperidin-4-ol | ESD-893131-5G |
| Cas.: 264903-54-0 | Purity: 97% | (R)-2-Amino-3-(5-bromothiophen-2-yl)propanoic acid | ESD-893132-100MG |
| Cas.: 264903-54-0 | Purity: 97% | (R)-2-Amino-3-(5-bromothiophen-2-yl)propanoic acid | ESD-893132-250MG |
| Cas.: 264903-54-0 | Purity: 97% | (R)-2-Amino-3-(5-bromothiophen-2-yl)propanoic acid | ESD-893132-1G |
| Cas.: 116530-60-0 | Purity: ≥97% | 5-Nitro-1H-inden-2(3H)-one | ESD-893133-250MG |
| Cas.: 116530-60-0 | Purity: ≥97% | 5-Nitro-1H-inden-2(3H)-one | ESD-893133-1G |
| Cas.: 116530-60-0 | Purity: ≥97% | 5-Nitro-1H-inden-2(3H)-one | ESD-893133-5G |
| Cas.: 116530-60-0 | Purity: ≥97% | 5-Nitro-1H-inden-2(3H)-one | ESD-893133-10G |
| Cas.: 6414-58-0 | Purity: ≥95% | Diethyl 2-(phenylamino)malonate | ESD-893134-100MG |
| Cas.: 6414-58-0 | Purity: ≥95% | Diethyl 2-(phenylamino)malonate | ESD-893134-250MG |
| Cas.: 6414-58-0 | Purity: ≥95% | Diethyl 2-(phenylamino)malonate | ESD-893134-1G |
| Cas.: 5432-53-1 | Purity: 97% | 4-(4-(Dimethylamino)phenyl)but-3-en-2-one | ESD-893135-250MG |
| Cas.: 5432-53-1 | Purity: 97% | 4-(4-(Dimethylamino)phenyl)but-3-en-2-one | ESD-893135-1G |
| Cas.: 5432-53-1 | Purity: 97% | 4-(4-(Dimethylamino)phenyl)but-3-en-2-one | ESD-893135-5G |
| Cas.: 15174-02-4 | Purity: 97% | 4-Methoxy-3-nitrophenol | ESD-893136-250MG |
| Cas.: 15174-02-4 | Purity: 97% | 4-Methoxy-3-nitrophenol | ESD-893136-1G |
| Cas.: 15174-02-4 | Purity: 97% | 4-Methoxy-3-nitrophenol | ESD-893136-5G |
| Cas.: 15174-02-4 | Purity: 97% | 4-Methoxy-3-nitrophenol | ESD-893136-10G |
| Cas.: 6281-32-9 | Purity: 95% | 4-(Hydroxymethyl)quinoline | ESD-893137-1G |
| Cas.: 145742-50-3 | Purity: ≥95% | 4-Amino-5-chloro-2-methoxybenzaldehyde | ESD-893138-100MG |
| Cas.: 145742-50-3 | Purity: ≥95% | 4-Amino-5-chloro-2-methoxybenzaldehyde | ESD-893138-250MG |
| Cas.: 145742-50-3 | Purity: ≥95% | 4-Amino-5-chloro-2-methoxybenzaldehyde | ESD-893138-1G |
| Cas.: 1260017-94-4 | Purity: 95% | 4-Bromo-6-chloro-2,3-dihydro-1H-inden-1-one | ESD-893139-100MG |
| Cas.: 1260017-94-4 | Purity: 95% | 4-Bromo-6-chloro-2,3-dihydro-1H-inden-1-one | ESD-893139-250MG |
| Cas.: 63056-20-2 | Purity: ≥95% | 6-Phenylnicotinaldehyde | ESD-893140-100MG |
| Cas.: 63056-20-2 | Purity: ≥95% | 6-Phenylnicotinaldehyde | ESD-893140-250MG |
| Cas.: 63056-20-2 | Purity: ≥95% | 6-Phenylnicotinaldehyde | ESD-893140-1G |
| Cas.: 63056-20-2 | Purity: ≥95% | 6-Phenylnicotinaldehyde | ESD-893140-5G |
| Cas.: 73290-32-1 | Purity: ≥95% | 5-Ethylpiperidine-2,4-dione | ESD-893141-100MG |
| Cas.: 73290-32-1 | Purity: ≥95% | 5-Ethylpiperidine-2,4-dione | ESD-893141-250MG |
| Cas.: 73290-32-1 | Purity: ≥95% | 5-Ethylpiperidine-2,4-dione | ESD-893141-1G |
| Cas.: 2047-89-4 | Purity: ≥95% | 5,6,7,8,9,10-Hexahydrocyclohepta[b]indole | ESD-893142-250MG |
| Cas.: 2047-89-4 | Purity: ≥95% | 5,6,7,8,9,10-Hexahydrocyclohepta[b]indole | ESD-893142-1G |
| Cas.: 67706-68-7 | Purity: ≥95% | Ethyl 4-((tert-butoxycarbonyl)amino)-3-oxobutanoate | ESD-893143-250MG |
| Cas.: 67706-68-7 | Purity: ≥95% | Ethyl 4-((tert-butoxycarbonyl)amino)-3-oxobutanoate | ESD-893143-1G |
| Cas.: 1221398-11-3 | Purity: 96% | 6-Chloro-5-iodopyridin-2-amine | ESD-893144-100MG |
| Cas.: 1221398-11-3 | Purity: 96% | 6-Chloro-5-iodopyridin-2-amine | ESD-893144-250MG |
| Cas.: 1221398-11-3 | Purity: 96% | 6-Chloro-5-iodopyridin-2-amine | ESD-893144-1G |
| Cas.: 1221398-11-3 | Purity: 96% | 6-Chloro-5-iodopyridin-2-amine | ESD-893144-5G |
| Cas.: 479411-93-3 | Purity: 97% | 2-(3-Methoxy-5-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-893145-1G |
| Cas.: 479411-93-3 | Purity: 97% | 2-(3-Methoxy-5-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-893145-5G |
| Cas.: 479411-93-3 | Purity: 97% | 2-(3-Methoxy-5-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-893145-10G |
| Cas.: 883028-23-7 | Purity: 97% | N-(4-Methyl-3-nitrophenyl)-4-(trifluoromethyl)benzamide | ESD-893146-100MG |
| Cas.: 883028-23-7 | Purity: 97% | N-(4-Methyl-3-nitrophenyl)-4-(trifluoromethyl)benzamide | ESD-893146-250MG |
| Cas.: 1394120-64-9 | Purity: 96% | 6-Bromo-5-fluoro-3-methyl-1H-indazole | ESD-893147-100MG |
| Cas.: 1394120-64-9 | Purity: 96% | 6-Bromo-5-fluoro-3-methyl-1H-indazole | ESD-893147-250MG |
| Cas.: 1394120-64-9 | Purity: 96% | 6-Bromo-5-fluoro-3-methyl-1H-indazole | ESD-893147-1G |
| Cas.: 1806340-56-6 | Purity: ≥95% | 4-Bromobenzo[d]oxazol-2-amine | ESD-893148-100MG |
| Cas.: 1806340-56-6 | Purity: ≥95% | 4-Bromobenzo[d]oxazol-2-amine | ESD-893148-250MG |
| Cas.: 128577-48-0 | Purity: 95% | Methyl 2-bromo-4-(bromomethyl)benzoate | ESD-893149-100MG |
| Cas.: 128577-48-0 | Purity: 95% | Methyl 2-bromo-4-(bromomethyl)benzoate | ESD-893149-250MG |
| Cas.: 128577-48-0 | Purity: 95% | Methyl 2-bromo-4-(bromomethyl)benzoate | ESD-893149-1G |
| Cas.: 128577-48-0 | Purity: 95% | Methyl 2-bromo-4-(bromomethyl)benzoate | ESD-893149-5G |
| Cas.: 219763-83-4 | Purity: 95% | 4-Chloroquinoline-6-carbonitrile | ESD-893150-100MG |
| Cas.: 219763-83-4 | Purity: 95% | 4-Chloroquinoline-6-carbonitrile | ESD-893150-250MG |
| Cas.: 219763-83-4 | Purity: 95% | 4-Chloroquinoline-6-carbonitrile | ESD-893150-1G |
| Cas.: 1211592-70-9 | Purity: 98% | tert-Butyl 2-cyanomorpholine-4-carboxylate | ESD-893151-100MG |
| Cas.: 1211592-70-9 | Purity: 98% | tert-Butyl 2-cyanomorpholine-4-carboxylate | ESD-893151-250MG |
| Cas.: 1211592-70-9 | Purity: 98% | tert-Butyl 2-cyanomorpholine-4-carboxylate | ESD-893151-1G |
| Cas.: 1211592-70-9 | Purity: 98% | tert-Butyl 2-cyanomorpholine-4-carboxylate | ESD-893151-5G |
| Cas.: 849935-87-1 | Purity: 97% | (3S,4S)-tert-Butyl 3-hydroxy-4-(hydroxymethyl)pyrrolidine-1-carboxylate | ESD-893152-100MG |
| Cas.: 849935-87-1 | Purity: 97% | (3S,4S)-tert-Butyl 3-hydroxy-4-(hydroxymethyl)pyrrolidine-1-carboxylate | ESD-893152-250MG |
| Cas.: 849935-87-1 | Purity: 97% | (3S,4S)-tert-Butyl 3-hydroxy-4-(hydroxymethyl)pyrrolidine-1-carboxylate | ESD-893152-1G |
| Cas.: 4427-97-8 | Purity: ≥95% | Dicyclohexyl carbonate | ESD-893153-100MG |
| Cas.: 4427-97-8 | Purity: ≥95% | Dicyclohexyl carbonate | ESD-893153-250MG |
| Cas.: 4427-97-8 | Purity: ≥95% | Dicyclohexyl carbonate | ESD-893153-1G |
| Cas.: 283608-37-7 | Purity: 97% | 3-(1-Hydroxyethyl)benzoic acid | ESD-893154-100MG |
| Cas.: 283608-37-7 | Purity: 97% | 3-(1-Hydroxyethyl)benzoic acid | ESD-893154-250MG |
| Cas.: 1426566-90-6 | Purity: 97% | 4-Bromo-3-chloro-2-iodoaniline | ESD-893155-100MG |
| Cas.: 1426566-90-6 | Purity: 97% | 4-Bromo-3-chloro-2-iodoaniline | ESD-893155-250MG |
| Cas.: 1426566-90-6 | Purity: 97% | 4-Bromo-3-chloro-2-iodoaniline | ESD-893155-1G |
| Cas.: 1426566-90-6 | Purity: 97% | 4-Bromo-3-chloro-2-iodoaniline | ESD-893155-5G |
| Cas.: 36194-82-8 | Purity: 98% | 5-Bromo-2-hydroxy-3-methylbenzoic acid | ESD-893156-250MG |
| Cas.: 36194-82-8 | Purity: 98% | 5-Bromo-2-hydroxy-3-methylbenzoic acid | ESD-893156-1G |
| Cas.: 36194-82-8 | Purity: 98% | 5-Bromo-2-hydroxy-3-methylbenzoic acid | ESD-893156-5G |
| Cas.: 113124-06-4 | Purity: ≥95% | 2-Bromo-5,6-dimethylnicotinonitrile | ESD-893157-100MG |
| Cas.: 113124-06-4 | Purity: ≥95% | 2-Bromo-5,6-dimethylnicotinonitrile | ESD-893157-250MG |
| Cas.: 113124-06-4 | Purity: ≥95% | 2-Bromo-5,6-dimethylnicotinonitrile | ESD-893157-1G |
| Cas.: 113124-06-4 | Purity: ≥95% | 2-Bromo-5,6-dimethylnicotinonitrile | ESD-893157-5G |
| Cas.: 318276-74-3 | Purity: ≥95% | Methyl cinnoline-6-carboxylate | ESD-893158-100MG |
| Cas.: 318276-74-3 | Purity: ≥95% | Methyl cinnoline-6-carboxylate | ESD-893158-250MG |
| Cas.: 162709-20-8 | Purity: ≥95% | tert-Butyl (4-iodo-2-methoxypyridin-3-yl)carbamate | ESD-893159-100MG |
| Cas.: 162709-20-8 | Purity: ≥95% | tert-Butyl (4-iodo-2-methoxypyridin-3-yl)carbamate | ESD-893159-250MG |
| Cas.: 442150-49-4 | Purity: ≥95% | 6-Bromo-1-fluoronaphthalen-2-ol | ESD-893160-100MG |
| Cas.: 442150-49-4 | Purity: ≥95% | 6-Bromo-1-fluoronaphthalen-2-ol | ESD-893160-250MG |
| Cas.: 442150-49-4 | Purity: ≥95% | 6-Bromo-1-fluoronaphthalen-2-ol | ESD-893160-1G |
| Cas.: 887582-19-6 | Purity: 97% | (6-Fluoro-1H-indol-3-yl)methanamine | ESD-893161-100MG |
| Cas.: 15965-57-8 | Purity: ≥95% | 2-Chloro-7-methyl-1H-benzo[d]imidazole | ESD-893162-100MG |
| Cas.: 15965-57-8 | Purity: ≥95% | 2-Chloro-7-methyl-1H-benzo[d]imidazole | ESD-893162-250MG |
| Cas.: 15965-57-8 | Purity: ≥95% | 2-Chloro-7-methyl-1H-benzo[d]imidazole | ESD-893162-1G |
| Cas.: 15965-57-8 | Purity: ≥95% | 2-Chloro-7-methyl-1H-benzo[d]imidazole | ESD-893162-5G |
| Cas.: 23833-99-0 | Purity: 97% | 4-Chloro-8-nitroquinoline | ESD-893163-250MG |
| Cas.: 23833-99-0 | Purity: 97% | 4-Chloro-8-nitroquinoline | ESD-893163-1G |
| Cas.: 23833-99-0 | Purity: 97% | 4-Chloro-8-nitroquinoline | ESD-893163-5G |
| Cas.: 23833-99-0 | Purity: 97% | 4-Chloro-8-nitroquinoline | ESD-893163-10G |
| Cas.: 40106-98-7 | Purity: 97% | 4-Chloro-5-nitroquinoline | ESD-893164-100MG |
| Cas.: 40106-98-7 | Purity: 97% | 4-Chloro-5-nitroquinoline | ESD-893164-250MG |
| Cas.: 73006-78-7 | Purity: 97% | 5-Chloro-[1,1′-biphenyl]-2-amine | ESD-893165-100MG |
| Cas.: 73006-78-7 | Purity: 97% | 5-Chloro-[1,1′-biphenyl]-2-amine | ESD-893165-250MG |
| Cas.: 926663-00-5 | Purity: 97% | Ethyl 5-oxo-4,5-dihydropyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-893166-100MG |
| Cas.: 926663-00-5 | Purity: 97% | Ethyl 5-oxo-4,5-dihydropyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-893166-250MG |
| Cas.: 926663-00-5 | Purity: 97% | Ethyl 5-oxo-4,5-dihydropyrazolo[1,5-a]pyrimidine-3-carboxylate | ESD-893166-1G |
| Cas.: 1121057-77-9 | Purity: ≥95% | tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydropyridine-1(2H)-carboxylate | ESD-893167-100MG |
| Cas.: 1121057-77-9 | Purity: ≥95% | tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydropyridine-1(2H)-carboxylate | ESD-893167-250MG |
| Cas.: 1121057-77-9 | Purity: ≥95% | tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydropyridine-1(2H)-carboxylate | ESD-893167-1G |
| Cas.: 1070879-31-0 | Purity: 97% | 4,8-Dibromoquinoline | ESD-893168-100MG |
| Cas.: 1070879-31-0 | Purity: 97% | 4,8-Dibromoquinoline | ESD-893168-250MG |
| Cas.: 1070879-31-0 | Purity: 97% | 4,8-Dibromoquinoline | ESD-893168-1G |
| Cas.: 1070879-31-0 | Purity: 97% | 4,8-Dibromoquinoline | ESD-893168-5G |
| Cas.: 116548-04-0 | Purity: ≥95% | 2-Oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carbonitrile | ESD-893169-100MG |
| Cas.: 116548-04-0 | Purity: ≥95% | 2-Oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carbonitrile | ESD-893169-250MG |
| Cas.: 116548-04-0 | Purity: ≥95% | 2-Oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carbonitrile | ESD-893169-1G |
| Cas.: 1199782-67-6 | Purity: 97% | 5-Bromochroman-4-one | ESD-893170-100MG |
| Cas.: 1199782-67-6 | Purity: 97% | 5-Bromochroman-4-one | ESD-893170-250MG |
| Cas.: 1199782-67-6 | Purity: 97% | 5-Bromochroman-4-one | ESD-893170-1G |
| Cas.: 5835-28-9 | Purity: 98% | 2-((2-Hydroxyethyl)amino)acetic acid | ESD-893171-100MG |
| Cas.: 5835-28-9 | Purity: 98% | 2-((2-Hydroxyethyl)amino)acetic acid | ESD-893171-250MG |
| Cas.: 5835-28-9 | Purity: 98% | 2-((2-Hydroxyethyl)amino)acetic acid | ESD-893171-1G |
| Cas.: 53946-87-5 | Purity: ≥95% | 2-Bromo-1-(4-hydroxyphenyl)propan-1-one | ESD-893172-250MG |
| Cas.: 53946-87-5 | Purity: ≥95% | 2-Bromo-1-(4-hydroxyphenyl)propan-1-one | ESD-893172-1G |
| Cas.: 53946-87-5 | Purity: ≥95% | 2-Bromo-1-(4-hydroxyphenyl)propan-1-one | ESD-893172-5G |
| Cas.: 31872-64-7 | Purity: ≥95% | 3-Chloro-5-nitropyridin-4-ol | ESD-893173-250MG |
| Cas.: 31872-64-7 | Purity: ≥95% | 3-Chloro-5-nitropyridin-4-ol | ESD-893173-1G |
| Cas.: 31872-64-7 | Purity: ≥95% | 3-Chloro-5-nitropyridin-4-ol | ESD-893173-5G |
| Cas.: 31872-64-7 | Purity: ≥95% | 3-Chloro-5-nitropyridin-4-ol | ESD-893173-10G |
| Cas.: 25173-68-6 | Purity: 95% | 3-(3,4-Dichlorophenyl)propanoic acid | ESD-893174-250MG |
| Cas.: 25173-68-6 | Purity: 95% | 3-(3,4-Dichlorophenyl)propanoic acid | ESD-893174-1G |
| Cas.: 25173-68-6 | Purity: 95% | 3-(3,4-Dichlorophenyl)propanoic acid | ESD-893174-5G |
| Cas.: 25173-68-6 | Purity: 95% | 3-(3,4-Dichlorophenyl)propanoic acid | ESD-893174-10G |
| Cas.: 57915-79-4 | Purity: 97% | 3-(2,3-Dichlorophenyl)propanoic acid | ESD-893175-250MG |
| Cas.: 57915-79-4 | Purity: 97% | 3-(2,3-Dichlorophenyl)propanoic acid | ESD-893175-1G |
| Cas.: 57915-79-4 | Purity: 97% | 3-(2,3-Dichlorophenyl)propanoic acid | ESD-893175-5G |
| Cas.: 57915-79-4 | Purity: 97% | 3-(2,3-Dichlorophenyl)propanoic acid | ESD-893175-10G |
| Cas.: 169448-17-3 | Purity: ≥95% | (S)-tert-Butyl 2-(2-hydroxyethyl)piperazine-1-carboxylate | ESD-893176-100MG |
| Cas.: 169448-17-3 | Purity: ≥95% | (S)-tert-Butyl 2-(2-hydroxyethyl)piperazine-1-carboxylate | ESD-893176-250MG |
| Cas.: 169448-17-3 | Purity: ≥95% | (S)-tert-Butyl 2-(2-hydroxyethyl)piperazine-1-carboxylate | ESD-893176-1G |
| Cas.: 588702-65-2 | Purity: ≥95% | 3-(Trifluoromethyl)quinoline-4-carboxylic acid | ESD-893177-100MG |
| Cas.: 588702-65-2 | Purity: ≥95% | 3-(Trifluoromethyl)quinoline-4-carboxylic acid | ESD-893177-250MG |
| Cas.: 588702-65-2 | Purity: ≥95% | 3-(Trifluoromethyl)quinoline-4-carboxylic acid | ESD-893177-1G |
| Cas.: 10496-75-0 | Purity: 98% | 2-Methoxy-5-nitrobenzonitrile | ESD-893178-250MG |
| Cas.: 10496-75-0 | Purity: 98% | 2-Methoxy-5-nitrobenzonitrile | ESD-893178-1G |
| Cas.: 10496-75-0 | Purity: 98% | 2-Methoxy-5-nitrobenzonitrile | ESD-893178-5G |
| Cas.: 55860-22-5 | Purity: ≥95% | 2-Chloro-N-(2-methoxyphenyl)acetamide | ESD-893179-250MG |
| Cas.: 55860-22-5 | Purity: ≥95% | 2-Chloro-N-(2-methoxyphenyl)acetamide | ESD-893179-1G |
| Cas.: 55860-22-5 | Purity: ≥95% | 2-Chloro-N-(2-methoxyphenyl)acetamide | ESD-893179-5G |
| Cas.: 55860-22-5 | Purity: ≥95% | 2-Chloro-N-(2-methoxyphenyl)acetamide | ESD-893179-10G |
| Cas.: 78441-62-0 | Purity: 97% | 2-(((2-((Dimethylamino)methyl)thiazol-4-yl)methyl)thio)ethanamine | ESD-893180-250MG |
| Cas.: 78441-62-0 | Purity: 97% | 2-(((2-((Dimethylamino)methyl)thiazol-4-yl)methyl)thio)ethanamine | ESD-893180-1G |
| Cas.: 78441-62-0 | Purity: 97% | 2-(((2-((Dimethylamino)methyl)thiazol-4-yl)methyl)thio)ethanamine | ESD-893180-5G |
| Cas.: 78441-62-0 | Purity: 97% | 2-(((2-((Dimethylamino)methyl)thiazol-4-yl)methyl)thio)ethanamine | ESD-893180-10G |
| Cas.: 123770-62-7 | Purity: ≥95% | Ethyl 5-(hydroxymethyl)isoxazole-3-carboxylate | ESD-893181-100MG |
| Cas.: 123770-62-7 | Purity: ≥95% | Ethyl 5-(hydroxymethyl)isoxazole-3-carboxylate | ESD-893181-250MG |
| Cas.: 123770-62-7 | Purity: ≥95% | Ethyl 5-(hydroxymethyl)isoxazole-3-carboxylate | ESD-893181-1G |
| Cas.: 123770-62-7 | Purity: ≥95% | Ethyl 5-(hydroxymethyl)isoxazole-3-carboxylate | ESD-893181-5G |
| Cas.: 16064-24-7 | Purity: ≥95% | 7-Methoxyquinazolin-4(1H)-one | ESD-893182-100MG |
| Cas.: 16064-24-7 | Purity: ≥95% | 7-Methoxyquinazolin-4(1H)-one | ESD-893182-250MG |
| Cas.: 16064-24-7 | Purity: ≥95% | 7-Methoxyquinazolin-4(1H)-one | ESD-893182-1G |
| Cas.: 16064-24-7 | Purity: ≥95% | 7-Methoxyquinazolin-4(1H)-one | ESD-893182-5G |
| Cas.: 104795-85-9 | Purity: ≥95% | Methyl 6-chlorobenzo[b]thiophene-2-carboxylate | ESD-893183-250MG |
| Cas.: 104795-85-9 | Purity: ≥95% | Methyl 6-chlorobenzo[b]thiophene-2-carboxylate | ESD-893183-1G |
| Cas.: 104795-85-9 | Purity: ≥95% | Methyl 6-chlorobenzo[b]thiophene-2-carboxylate | ESD-893183-5G |
| Cas.: 104795-85-9 | Purity: ≥95% | Methyl 6-chlorobenzo[b]thiophene-2-carboxylate | ESD-893183-10G |
| Cas.: 765-01-5 | Purity: ≥98% | 10-Hydroxydec-2-enoic acid | ESD-893184-1G |
| Cas.: 765-01-5 | Purity: ≥98% | 10-Hydroxydec-2-enoic acid | ESD-893184-5G |
| Cas.: 106047-28-3 | Purity: ≥95% | 6-Bromo-2,3′-bipyridine | ESD-893185-100MG |
| Cas.: 106047-28-3 | Purity: ≥95% | 6-Bromo-2,3′-bipyridine | ESD-893185-250MG |
| Cas.: 1263774-42-0 | Purity: 97% | (7aR)-3-(Trichloromethyl)tetrahydropyrrolo[1,2-c]oxazol-1(3H)-one | ESD-893186-250MG |
| Cas.: 1263774-42-0 | Purity: 97% | (7aR)-3-(Trichloromethyl)tetrahydropyrrolo[1,2-c]oxazol-1(3H)-one | ESD-893186-1G |
| Cas.: 22996-19-6 | Purity: ≥95% | 4-Bromo-2-nitrobenzylalcohol | ESD-893187-250MG |
| Cas.: 22996-19-6 | Purity: ≥95% | 4-Bromo-2-nitrobenzylalcohol | ESD-893187-1G |
| Cas.: 22996-19-6 | Purity: ≥95% | 4-Bromo-2-nitrobenzylalcohol | ESD-893187-5G |
| Cas.: 22996-19-6 | Purity: ≥95% | 4-Bromo-2-nitrobenzylalcohol | ESD-893187-10G |
| Cas.: 4390-92-5 | Purity: ≥95% | 1-(2,4-Dihydroxyphenyl)butan-1-one | ESD-893188-250MG |
| Cas.: 4390-92-5 | Purity: ≥95% | 1-(2,4-Dihydroxyphenyl)butan-1-one | ESD-893188-1G |
| Cas.: 4390-92-5 | Purity: ≥95% | 1-(2,4-Dihydroxyphenyl)butan-1-one | ESD-893188-5G |
| Cas.: 136944-79-1 | Purity: ≥95% | Methyl 4-iodo-1H-pyrazole-3-carboxylate | ESD-893189-100MG |
| Cas.: 136944-79-1 | Purity: ≥95% | Methyl 4-iodo-1H-pyrazole-3-carboxylate | ESD-893189-250MG |
| Cas.: 136944-79-1 | Purity: ≥95% | Methyl 4-iodo-1H-pyrazole-3-carboxylate | ESD-893189-1G |
| Cas.: 22200-50-6 | Purity: 97% | 7-Iodo-4-chloroquinoline | ESD-893190-250MG |
| Cas.: 22200-50-6 | Purity: 97% | 7-Iodo-4-chloroquinoline | ESD-893190-1G |
| Cas.: 1059630-12-4 | Purity: 97% | 6-Bromo-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole | ESD-893191-100MG |
| Cas.: 1059630-12-4 | Purity: 97% | 6-Bromo-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole | ESD-893191-250MG |
| Cas.: 1059630-12-4 | Purity: 97% | 6-Bromo-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole | ESD-893191-1G |
| Cas.: 1059630-12-4 | Purity: 97% | 6-Bromo-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole | ESD-893191-5G |
| Cas.: 221136-66-9 | Purity: 95% | Ethyl 2-(3-bromo-6-methyl-2-oxopyrazin-1(2H)-yl)acetate | ESD-893192-100MG |
| Cas.: 221136-66-9 | Purity: 95% | Ethyl 2-(3-bromo-6-methyl-2-oxopyrazin-1(2H)-yl)acetate | ESD-893192-250MG |
| Cas.: 1029439-87-9 | Purity: 97% | 3,5-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol | ESD-893193-250MG |
| Cas.: 1029439-87-9 | Purity: 97% | 3,5-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol | ESD-893193-1G |
| Cas.: 1029439-87-9 | Purity: 97% | 3,5-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol | ESD-893193-5G |
| Cas.: 850568-09-1 | Purity: 98% | 4-Isopropoxy-3-methylphenylboronic acid | ESD-893194-250MG |
| Cas.: 850568-09-1 | Purity: 98% | 4-Isopropoxy-3-methylphenylboronic acid | ESD-893194-1G |
| Cas.: 850568-09-1 | Purity: 98% | 4-Isopropoxy-3-methylphenylboronic acid | ESD-893194-5G |
| Cas.: 850568-09-1 | Purity: 98% | 4-Isopropoxy-3-methylphenylboronic acid | ESD-893194-10G |
| Cas.: 52498-32-5 | Purity: 95% | (2S,3S)-2-((tert-Butoxycarbonyl)(methyl)amino)-3-methylpentanoic acid | ESD-893195-1G |
| Cas.: 52498-32-5 | Purity: 95% | (2S,3S)-2-((tert-Butoxycarbonyl)(methyl)amino)-3-methylpentanoic acid | ESD-893195-5G |
| Cas.: 52498-32-5 | Purity: 95% | (2S,3S)-2-((tert-Butoxycarbonyl)(methyl)amino)-3-methylpentanoic acid | ESD-893195-10G |
| Cas.: 1206248-47-6 | Purity: 95% | Methyl 4,6-dibromopicolinate | ESD-893196-100MG |
| Cas.: 1206248-47-6 | Purity: 95% | Methyl 4,6-dibromopicolinate | ESD-893196-250MG |
| Cas.: 1146290-36-9 | Purity: 97% | 2-Fluoro-4-nitrobenzene-1-sulfonyl chloride | ESD-893197-100MG |
| Cas.: 1146290-36-9 | Purity: 97% | 2-Fluoro-4-nitrobenzene-1-sulfonyl chloride | ESD-893197-250MG |
| Cas.: 1146290-36-9 | Purity: 97% | 2-Fluoro-4-nitrobenzene-1-sulfonyl chloride | ESD-893197-1G |
| Cas.: 1146290-36-9 | Purity: 97% | 2-Fluoro-4-nitrobenzene-1-sulfonyl chloride | ESD-893197-5G |
| Cas.: 120703-45-9 | Purity: 97% | 4-Propanoylphenyl 2,2-dimethylpropanoate | ESD-893198-250MG |
| Cas.: 120703-45-9 | Purity: 97% | 4-Propanoylphenyl 2,2-dimethylpropanoate | ESD-893198-1G |
| Cas.: 120703-45-9 | Purity: 97% | 4-Propanoylphenyl 2,2-dimethylpropanoate | ESD-893198-5G |
| Cas.: 896160-69-3 | Purity: ≥95% | 3-Bromopyridine-2,5-diamine | ESD-893199-100MG |
| Cas.: 896160-69-3 | Purity: ≥95% | 3-Bromopyridine-2,5-diamine | ESD-893199-250MG |
| Cas.: 896160-69-3 | Purity: ≥95% | 3-Bromopyridine-2,5-diamine | ESD-893199-1G |
| Cas.: 896160-69-3 | Purity: ≥95% | 3-Bromopyridine-2,5-diamine | ESD-893199-5G |
| Cas.: 774608-88-7 | Purity: ≥95% | Ethyl 5-chloro-1H-1,2,4-triazole-3-carboxylate | ESD-893200-250MG |
| Cas.: 774608-88-7 | Purity: ≥95% | Ethyl 5-chloro-1H-1,2,4-triazole-3-carboxylate | ESD-893200-1G |
| Cas.: 774608-88-7 | Purity: ≥95% | Ethyl 5-chloro-1H-1,2,4-triazole-3-carboxylate | ESD-893200-5G |
| Cas.: 774608-88-7 | Purity: ≥95% | Ethyl 5-chloro-1H-1,2,4-triazole-3-carboxylate | ESD-893200-10G |
| Cas.: 118263-96-0 | Purity: ≥95% | 5-Methylpiperidine-2,4-dione | ESD-893201-100MG |
| Cas.: 118263-96-0 | Purity: ≥95% | 5-Methylpiperidine-2,4-dione | ESD-893201-250MG |
| Cas.: 118263-96-0 | Purity: ≥95% | 5-Methylpiperidine-2,4-dione | ESD-893201-1G |
| Cas.: 1373333-62-0 | Purity: ≥95% | 7-Chloro-2-methyl-2H-pyrazolo[3,4-c]pyridine | ESD-893202-100MG |
| Cas.: 1373333-62-0 | Purity: ≥95% | 7-Chloro-2-methyl-2H-pyrazolo[3,4-c]pyridine | ESD-893202-250MG |
| Cas.: 1373333-62-0 | Purity: ≥95% | 7-Chloro-2-methyl-2H-pyrazolo[3,4-c]pyridine | ESD-893202-1G |
| Cas.: 2423-65-6 | Purity: ≥95% | Pyrazine 1-oxide | ESD-893203-250MG |
| Cas.: 2423-65-6 | Purity: ≥95% | Pyrazine 1-oxide | ESD-893203-1G |
| Cas.: 2423-65-6 | Purity: ≥95% | Pyrazine 1-oxide | ESD-893203-5G |
| Cas.: 887587-09-9 | Purity: 90% | 1-(tert-Butoxycarbonyl)-3-methylpyrrolidine-3-carboxylic acid | ESD-893204-100MG |
| Cas.: 887587-09-9 | Purity: 90% | 1-(tert-Butoxycarbonyl)-3-methylpyrrolidine-3-carboxylic acid | ESD-893204-250MG |
| Cas.: 887587-09-9 | Purity: 90% | 1-(tert-Butoxycarbonyl)-3-methylpyrrolidine-3-carboxylic acid | ESD-893204-1G |
| Cas.: 1036724-54-5 | Purity: 97% | 2-(Benzyloxy)-4-bromo-1-fluorobenzene | ESD-893205-250MG |
| Cas.: 1036724-54-5 | Purity: 97% | 2-(Benzyloxy)-4-bromo-1-fluorobenzene | ESD-893205-1G |
| Cas.: 1036724-54-5 | Purity: 97% | 2-(Benzyloxy)-4-bromo-1-fluorobenzene | ESD-893205-5G |
| Cas.: 223519-08-2 | Purity: 97% | Methyl 3-bromo-4-methyl-5-nitrobenzoate | ESD-893206-250MG |
| Cas.: 223519-08-2 | Purity: 97% | Methyl 3-bromo-4-methyl-5-nitrobenzoate | ESD-893206-1G |
| Cas.: 223519-08-2 | Purity: 97% | Methyl 3-bromo-4-methyl-5-nitrobenzoate | ESD-893206-5G |
| Cas.: 223519-08-2 | Purity: 97% | Methyl 3-bromo-4-methyl-5-nitrobenzoate | ESD-893206-10G |
| Cas.: 50591-22-5 | Purity: 97% | 1-Methyl-1H-benzo[d]imidazol-5-ol | ESD-893207-250MG |
| Cas.: 50591-22-5 | Purity: 97% | 1-Methyl-1H-benzo[d]imidazol-5-ol | ESD-893207-1G |
| Cas.: 50591-22-5 | Purity: 97% | 1-Methyl-1H-benzo[d]imidazol-5-ol | ESD-893207-5G |
| Cas.: 50591-22-5 | Purity: 97% | 1-Methyl-1H-benzo[d]imidazol-5-ol | ESD-893207-10G |
| Cas.: 885681-96-9 | Purity: 97% | 4-Bromo-1-(bromomethyl)-2-iodobenzene | ESD-893208-100MG |
| Cas.: 885681-96-9 | Purity: 97% | 4-Bromo-1-(bromomethyl)-2-iodobenzene | ESD-893208-250MG |
| Cas.: 885681-96-9 | Purity: 97% | 4-Bromo-1-(bromomethyl)-2-iodobenzene | ESD-893208-1G |
| Cas.: 214679-17-1 | Purity: 97% | tert-Butyl ((1S,2R)-2-hydroxycyclohexyl)carbamate | ESD-893209-100MG |
| Cas.: 214679-17-1 | Purity: 97% | tert-Butyl ((1S,2R)-2-hydroxycyclohexyl)carbamate | ESD-893209-250MG |
| Cas.: 214679-17-1 | Purity: 97% | tert-Butyl ((1S,2R)-2-hydroxycyclohexyl)carbamate | ESD-893209-1G |
| Cas.: 714237-95-3 | Purity: ≥95% | Methyl 5-bromo-2-cyanobenzoate | ESD-893210-100MG |
| Cas.: 714237-95-3 | Purity: ≥95% | Methyl 5-bromo-2-cyanobenzoate | ESD-893210-250MG |
| Cas.: 1135437-92-1 | Purity: 97% | 1-Methyl-5-nitro-1H-pyrrolo[2,3-b]pyridine | ESD-893211-250MG |
| Cas.: 1135437-92-1 | Purity: 97% | 1-Methyl-5-nitro-1H-pyrrolo[2,3-b]pyridine | ESD-893211-1G |
| Cas.: 1135437-92-1 | Purity: 97% | 1-Methyl-5-nitro-1H-pyrrolo[2,3-b]pyridine | ESD-893211-5G |
| Cas.: 710972-40-0 | Purity: 97% | tert-Butyl 4-((2-methoxyethyl)amino)piperidine-1-carboxylate | ESD-893212-100MG |
| Cas.: 710972-40-0 | Purity: 97% | tert-Butyl 4-((2-methoxyethyl)amino)piperidine-1-carboxylate | ESD-893212-250MG |
| Cas.: 710972-40-0 | Purity: 97% | tert-Butyl 4-((2-methoxyethyl)amino)piperidine-1-carboxylate | ESD-893212-1G |
| Cas.: 710972-40-0 | Purity: 97% | tert-Butyl 4-((2-methoxyethyl)amino)piperidine-1-carboxylate | ESD-893212-5G |
| Cas.: 61830-40-8 | Purity: 98% | 3,5-Dibromopicolinic acid | ESD-893213-250MG |
| Cas.: 61830-40-8 | Purity: 98% | 3,5-Dibromopicolinic acid | ESD-893213-1G |
| Cas.: 61830-40-8 | Purity: 98% | 3,5-Dibromopicolinic acid | ESD-893213-5G |
| Cas.: 61830-40-8 | Purity: 98% | 3,5-Dibromopicolinic acid | ESD-893213-10G |
| Cas.: 677304-78-8 | Purity: 97% | 5-Bromobenzo[d]isothiazole-3-carboxylic acid | ESD-893214-100MG |
| Cas.: 677304-78-8 | Purity: 97% | 5-Bromobenzo[d]isothiazole-3-carboxylic acid | ESD-893214-250MG |
| Cas.: 677304-78-8 | Purity: 97% | 5-Bromobenzo[d]isothiazole-3-carboxylic acid | ESD-893214-1G |
| Cas.: 216443-78-6 | Purity: 95% | 3′-Methyl-[1,1′-biphenyl]-3-carbaldehyde | ESD-893215-1G |
| Cas.: 216443-78-6 | Purity: 95% | 3′-Methyl-[1,1′-biphenyl]-3-carbaldehyde | ESD-893215-5G |
| Cas.: 1017782-09-0 | Purity: 97% | 5-Bromo-6-methoxy-3-nitropyridin-2-amine | ESD-893216-100MG |
| Cas.: 1017782-09-0 | Purity: 97% | 5-Bromo-6-methoxy-3-nitropyridin-2-amine | ESD-893216-250MG |
| Cas.: 24507-29-7 | Purity: ≥95% | 3-Bromo-4-ethoxybenzoic acid | ESD-893217-100MG |
| Cas.: 24507-29-7 | Purity: ≥95% | 3-Bromo-4-ethoxybenzoic acid | ESD-893217-250MG |
| Cas.: 24507-29-7 | Purity: ≥95% | 3-Bromo-4-ethoxybenzoic acid | ESD-893217-1G |
| Cas.: 24507-29-7 | Purity: ≥95% | 3-Bromo-4-ethoxybenzoic acid | ESD-893217-5G |
| Cas.: 120715-49-3 | Purity: 97% | 4,5-Dichloro-3-methoxythiophene-2-carboxylic acid | ESD-893218-100MG |
| Cas.: 120715-49-3 | Purity: 97% | 4,5-Dichloro-3-methoxythiophene-2-carboxylic acid | ESD-893218-250MG |
| Cas.: 31558-41-5 | Purity: ≥95% | 4-Bromo-2,5-dimethoxybenzaldehyde | ESD-893219-250MG |
| Cas.: 31558-41-5 | Purity: ≥95% | 4-Bromo-2,5-dimethoxybenzaldehyde | ESD-893219-1G |
| Cas.: 31558-41-5 | Purity: ≥95% | 4-Bromo-2,5-dimethoxybenzaldehyde | ESD-893219-5G |
| Cas.: 31558-41-5 | Purity: ≥95% | 4-Bromo-2,5-dimethoxybenzaldehyde | ESD-893219-10G |
| Cas.: 85686-97-1 | Purity: 98% | 1,2-Difluoro-4,5-dinitrobenzene | ESD-893220-1G |
| Cas.: 85686-97-1 | Purity: 98% | 1,2-Difluoro-4,5-dinitrobenzene | ESD-893220-5G |
| Cas.: 85686-97-1 | Purity: 98% | 1,2-Difluoro-4,5-dinitrobenzene | ESD-893220-10G |
| Cas.: 85686-97-1 | Purity: 98% | 1,2-Difluoro-4,5-dinitrobenzene | ESD-893220-25G |
| Cas.: 101421-73-2 | Purity: 98% | Quinazolin-7-amine | ESD-893221-100MG |
| Cas.: 101421-73-2 | Purity: 98% | Quinazolin-7-amine | ESD-893221-250MG |
| Cas.: 101421-73-2 | Purity: 98% | Quinazolin-7-amine | ESD-893221-1G |
| Cas.: 608-32-2 | Purity: 97% | Benzene-1,2,3-triamine | ESD-893222-100MG |
| Cas.: 608-32-2 | Purity: 97% | Benzene-1,2,3-triamine | ESD-893222-250MG |
| Cas.: 32501-05-6 | Purity: ≥95% | 1H-Pyrrolo[3,2-b]pyridin-2(3H)-one | ESD-893223-100MG |
| Cas.: 32501-05-6 | Purity: ≥95% | 1H-Pyrrolo[3,2-b]pyridin-2(3H)-one | ESD-893223-250MG |
| Cas.: 32501-05-6 | Purity: ≥95% | 1H-Pyrrolo[3,2-b]pyridin-2(3H)-one | ESD-893223-1G |
| Cas.: 32501-05-6 | Purity: ≥95% | 1H-Pyrrolo[3,2-b]pyridin-2(3H)-one | ESD-893223-5G |
| Cas.: 426831-08-5 | Purity: 97% | (4-(3-(Dimethylamino)propoxy)phenyl)methanol | ESD-893224-250MG |
| Cas.: 426831-08-5 | Purity: 97% | (4-(3-(Dimethylamino)propoxy)phenyl)methanol | ESD-893224-1G |
| Cas.: 426831-08-5 | Purity: 97% | (4-(3-(Dimethylamino)propoxy)phenyl)methanol | ESD-893224-5G |
| Cas.: 426831-08-5 | Purity: 97% | (4-(3-(Dimethylamino)propoxy)phenyl)methanol | ESD-893224-10G |
| Cas.: 145903-31-7 | Purity: ≥95% | 7-Methoxy-2,3,4,5-tetrahydrobenzo[f][1,4]thiazepine | ESD-893225-100MG |
| Cas.: 145903-31-7 | Purity: ≥95% | 7-Methoxy-2,3,4,5-tetrahydrobenzo[f][1,4]thiazepine | ESD-893225-250MG |
| Cas.: 145903-31-7 | Purity: ≥95% | 7-Methoxy-2,3,4,5-tetrahydrobenzo[f][1,4]thiazepine | ESD-893225-1G |
| Cas.: 181867-19-6 | Purity: ≥95% | 1-Methyl-1H-benzo[d]imidazole-6-carbaldehyde | ESD-893226-1G |
| Cas.: 149739-36-6 | Purity: 95% | 3-(m-Tolyl)-1H-pyrazole | ESD-893227-100MG |
| Cas.: 149739-36-6 | Purity: 95% | 3-(m-Tolyl)-1H-pyrazole | ESD-893227-250MG |
| Cas.: 149739-36-6 | Purity: 95% | 3-(m-Tolyl)-1H-pyrazole | ESD-893227-1G |
| Cas.: 908494-87-1 | Purity: ≥95% | 5-Bromo-N-isopropylthiophene-2-carboxamide | ESD-893228-5G |
| Cas.: 908494-87-1 | Purity: ≥95% | 5-Bromo-N-isopropylthiophene-2-carboxamide | ESD-893228-10G |
| Cas.: 908494-87-1 | Purity: ≥95% | 5-Bromo-N-isopropylthiophene-2-carboxamide | ESD-893228-25G |
| Cas.: 33469-36-2 | Purity: 97% | 2-Phenyl-4-(trifluoromethyl)-1H-imidazole | ESD-893229-100MG |
| Cas.: 33469-36-2 | Purity: 97% | 2-Phenyl-4-(trifluoromethyl)-1H-imidazole | ESD-893229-250MG |
| Cas.: 33469-36-2 | Purity: 97% | 2-Phenyl-4-(trifluoromethyl)-1H-imidazole | ESD-893229-1G |
| Cas.: 33469-36-2 | Purity: 97% | 2-Phenyl-4-(trifluoromethyl)-1H-imidazole | ESD-893229-5G |
| Cas.: 669713-59-1 | Purity: ≥95% | 2-tert-Butoxycarbonylamino-3-methylbenzoic acid | ESD-893230-1G |
| Cas.: 669713-59-1 | Purity: ≥95% | 2-tert-Butoxycarbonylamino-3-methylbenzoic acid | ESD-893230-5G |
| Cas.: 314250-03-8 | Purity: ≥95% | N,N-Diethylpyridine-2-sulfonamide | ESD-893231-100MG |
| Cas.: 314250-03-8 | Purity: ≥95% | N,N-Diethylpyridine-2-sulfonamide | ESD-893231-250MG |
| Cas.: 938439-54-4 | Purity: ≥95% | Methyl 3-amino-6-methoxypicolinate | ESD-893232-100MG |
| Cas.: 938439-54-4 | Purity: ≥95% | Methyl 3-amino-6-methoxypicolinate | ESD-893232-250MG |
| Cas.: 938439-54-4 | Purity: ≥95% | Methyl 3-amino-6-methoxypicolinate | ESD-893232-1G |
| Cas.: 938439-54-4 | Purity: ≥95% | Methyl 3-amino-6-methoxypicolinate | ESD-893232-5G |
| Cas.: 102169-99-3 | Purity: ≥95% | 2-Bromo-4-methyl-5-nitroaniline | ESD-893233-250MG |
| Cas.: 102169-99-3 | Purity: ≥95% | 2-Bromo-4-methyl-5-nitroaniline | ESD-893233-1G |
| Cas.: 102169-99-3 | Purity: ≥95% | 2-Bromo-4-methyl-5-nitroaniline | ESD-893233-5G |
| Cas.: 102169-99-3 | Purity: ≥95% | 2-Bromo-4-methyl-5-nitroaniline | ESD-893233-10G |
| Cas.: 1052686-50-6 | Purity: 97% | 5-Bromo-4-fluoro-2-nitroaniline | ESD-893234-100MG |
| Cas.: 1052686-50-6 | Purity: 97% | 5-Bromo-4-fluoro-2-nitroaniline | ESD-893234-250MG |
| Cas.: 1052686-50-6 | Purity: 97% | 5-Bromo-4-fluoro-2-nitroaniline | ESD-893234-1G |
| Cas.: 1052686-50-6 | Purity: 97% | 5-Bromo-4-fluoro-2-nitroaniline | ESD-893234-5G |
| Cas.: 92914-74-4 | Purity: 98% | Isoxazolo[5,4-b]pyridin-3-amine | ESD-893235-100MG |
| Cas.: 92914-74-4 | Purity: 98% | Isoxazolo[5,4-b]pyridin-3-amine | ESD-893235-250MG |
| Cas.: 92914-74-4 | Purity: 98% | Isoxazolo[5,4-b]pyridin-3-amine | ESD-893235-1G |
| Cas.: 92914-74-4 | Purity: 98% | Isoxazolo[5,4-b]pyridin-3-amine | ESD-893235-5G |
| Cas.: 145508-94-7 | Purity: ≥95% | tert-Butyl 4-(iodomethyl)piperidine-1-carboxylate | ESD-893236-100MG |
| Cas.: 145508-94-7 | Purity: ≥95% | tert-Butyl 4-(iodomethyl)piperidine-1-carboxylate | ESD-893236-250MG |
| Cas.: 145508-94-7 | Purity: ≥95% | tert-Butyl 4-(iodomethyl)piperidine-1-carboxylate | ESD-893236-1G |
| Cas.: 145508-94-7 | Purity: ≥95% | tert-Butyl 4-(iodomethyl)piperidine-1-carboxylate | ESD-893236-5G |
| Cas.: 253177-03-6 | Purity: ≥95% | tert-Butyl 3-(iodomethyl)piperidine-1-carboxylate | ESD-893237-1G |
| Cas.: 253177-03-6 | Purity: ≥95% | tert-Butyl 3-(iodomethyl)piperidine-1-carboxylate | ESD-893237-5G |
| Cas.: 253177-03-6 | Purity: ≥95% | tert-Butyl 3-(iodomethyl)piperidine-1-carboxylate | ESD-893237-25G |
| Cas.: 1206248-77-2 | Purity: 97% | 5-Fluorothiazolo[4,5-b]pyridin-2-amine | ESD-893238-100MG |
| Cas.: 1206248-77-2 | Purity: 97% | 5-Fluorothiazolo[4,5-b]pyridin-2-amine | ESD-893238-250MG |
| Cas.: 1131614-23-7 | Purity: 98% | Methyl 4-(difluoromethoxy)-3-iodobenzoate | ESD-893239-100MG |
| Cas.: 1131614-23-7 | Purity: 98% | Methyl 4-(difluoromethoxy)-3-iodobenzoate | ESD-893239-250MG |
| Cas.: 1131614-23-7 | Purity: 98% | Methyl 4-(difluoromethoxy)-3-iodobenzoate | ESD-893239-1G |
| Cas.: 448964-30-5 | Purity: 97% | 5,6-Dihydro-2H-indeno[5,6-b]furan-7(3H)-one | ESD-893240-100MG |
| Cas.: 448964-30-5 | Purity: 97% | 5,6-Dihydro-2H-indeno[5,6-b]furan-7(3H)-one | ESD-893240-250MG |
| Cas.: 1123169-39-0 | Purity: ≥95% | 1-Ethyl-2-oxo-1,2-dihydropyridine-4-carboxylic acid | ESD-893241-100MG |
| Cas.: 1123169-39-0 | Purity: ≥95% | 1-Ethyl-2-oxo-1,2-dihydropyridine-4-carboxylic acid | ESD-893241-250MG |
| Cas.: 1123169-39-0 | Purity: ≥95% | 1-Ethyl-2-oxo-1,2-dihydropyridine-4-carboxylic acid | ESD-893241-1G |
| Cas.: 362489-56-3 | Purity: 95% | trans-1-tert-Butyl 3-ethyl 4-aminopyrrolidine-1,3-dicarboxylate | ESD-893242-50MG |
| Cas.: 362489-56-3 | Purity: 95% | trans-1-tert-Butyl 3-ethyl 4-aminopyrrolidine-1,3-dicarboxylate | ESD-893242-100MG |
| Cas.: 362489-56-3 | Purity: 95% | trans-1-tert-Butyl 3-ethyl 4-aminopyrrolidine-1,3-dicarboxylate | ESD-893242-250MG |
| Cas.: 137105-52-3 | Purity: 97% | (2-Bromophenyl)(2,2-diethoxyethyl)sulfane | ESD-893243-1G |
| Cas.: 137105-52-3 | Purity: 97% | (2-Bromophenyl)(2,2-diethoxyethyl)sulfane | ESD-893243-5G |
| Cas.: 740794-79-0 | Purity: 97% | (R)-3-Amino-3-(2-chlorophenyl)propanoic acid | ESD-893244-250MG |
| Cas.: 740794-79-0 | Purity: 97% | (R)-3-Amino-3-(2-chlorophenyl)propanoic acid | ESD-893244-1G |
| Cas.: 51154-06-4 | Purity: 98% | (S)-1-(tert-Butoxycarbonyl)-2,5-dihydro-1H-pyrrole-2-carboxylic acid | ESD-893245-100MG |
| Cas.: 51154-06-4 | Purity: 98% | (S)-1-(tert-Butoxycarbonyl)-2,5-dihydro-1H-pyrrole-2-carboxylic acid | ESD-893245-250MG |
| Cas.: 51154-06-4 | Purity: 98% | (S)-1-(tert-Butoxycarbonyl)-2,5-dihydro-1H-pyrrole-2-carboxylic acid | ESD-893245-1G |
| Cas.: 51154-06-4 | Purity: 98% | (S)-1-(tert-Butoxycarbonyl)-2,5-dihydro-1H-pyrrole-2-carboxylic acid | ESD-893245-5G |
| Cas.: 62595-74-8 | Purity: 97% | 3-Bromopiperidine-2,6-dione | ESD-893246-250MG |
| Cas.: 62595-74-8 | Purity: 97% | 3-Bromopiperidine-2,6-dione | ESD-893246-1G |
| Cas.: 62595-74-8 | Purity: 97% | 3-Bromopiperidine-2,6-dione | ESD-893246-5G |
| Cas.: 1137664-24-4 | Purity: ≥95% | Ethyl 6-phenylpiperidine-2-carboxylate | ESD-893247-100MG |
| Cas.: 1137664-24-4 | Purity: ≥95% | Ethyl 6-phenylpiperidine-2-carboxylate | ESD-893247-250MG |
| Cas.: 14248-50-1 | Purity: 98% | 4-Bromopyridine 1-oxide | ESD-893248-100MG |
| Cas.: 14248-50-1 | Purity: 98% | 4-Bromopyridine 1-oxide | ESD-893248-250MG |
| Cas.: 14248-50-1 | Purity: 98% | 4-Bromopyridine 1-oxide | ESD-893248-1G |
| Cas.: 14248-50-1 | Purity: 98% | 4-Bromopyridine 1-oxide | ESD-893248-5G |
| Cas.: 777009-05-9 | Purity: 97% | 1-(3-Chloropyridin-2-yl)piperidin-4-amine | ESD-893249-100MG |
| Cas.: 777009-05-9 | Purity: 97% | 1-(3-Chloropyridin-2-yl)piperidin-4-amine | ESD-893249-250MG |
| Cas.: 777009-05-9 | Purity: 97% | 1-(3-Chloropyridin-2-yl)piperidin-4-amine | ESD-893249-1G |
| Cas.: 33786-90-2 | Purity: ≥95% | 5-Bromobenzene-1,3-diamine | ESD-893250-250MG |
| Cas.: 33786-90-2 | Purity: ≥95% | 5-Bromobenzene-1,3-diamine | ESD-893250-1G |
| Cas.: 33786-90-2 | Purity: ≥95% | 5-Bromobenzene-1,3-diamine | ESD-893250-5G |
| Cas.: 33786-90-2 | Purity: ≥95% | 5-Bromobenzene-1,3-diamine | ESD-893250-10G |
| Cas.: 6642-34-8 | Purity: 95% | (6-Bromobenzo[d][1,3]dioxol-5-yl)methanol | ESD-893251-250MG |
| Cas.: 6642-34-8 | Purity: 95% | (6-Bromobenzo[d][1,3]dioxol-5-yl)methanol | ESD-893251-1G |
| Cas.: 6642-34-8 | Purity: 95% | (6-Bromobenzo[d][1,3]dioxol-5-yl)methanol | ESD-893251-5G |
| Cas.: 221006-67-3 | Purity: 97% | (4-Bromo-3-methylphenyl)boronic acid | ESD-893252-100MG |
| Cas.: 221006-67-3 | Purity: 97% | (4-Bromo-3-methylphenyl)boronic acid | ESD-893252-250MG |
| Cas.: 221006-67-3 | Purity: 97% | (4-Bromo-3-methylphenyl)boronic acid | ESD-893252-1G |
| Cas.: 1054484-40-0 | Purity: ≥95% | 3,5-Dibromo-2-chloropyridin-4-amine | ESD-893253-100MG |
| Cas.: 1054484-40-0 | Purity: ≥95% | 3,5-Dibromo-2-chloropyridin-4-amine | ESD-893253-250MG |
| Cas.: 1260787-67-4 | Purity: ≥95% | 6-Bromo-4-chloropteridine | ESD-893254-50MG |
| Cas.: 136992-21-7 | Purity: 97% | (R)-tert-Butyl 2-(2-hydroxyethyl)morpholine-4-carboxylate | ESD-893255-100MG |
| Cas.: 136992-21-7 | Purity: 97% | (R)-tert-Butyl 2-(2-hydroxyethyl)morpholine-4-carboxylate | ESD-893255-250MG |
| Cas.: 136992-21-7 | Purity: 97% | (R)-tert-Butyl 2-(2-hydroxyethyl)morpholine-4-carboxylate | ESD-893255-1G |
| Cas.: 2503-44-8 | Purity: ≥95% | 1-(3,4-Dihydroxyphenyl)propan-2-one | ESD-893256-100MG |
| Cas.: 2503-44-8 | Purity: ≥95% | 1-(3,4-Dihydroxyphenyl)propan-2-one | ESD-893256-250MG |
| Cas.: 380626-81-3 | Purity: ≥95% | Ethyl 4-amino-6-chloronicotinate | ESD-893257-250MG |
| Cas.: 380626-81-3 | Purity: ≥95% | Ethyl 4-amino-6-chloronicotinate | ESD-893257-1G |
| Cas.: 380626-81-3 | Purity: ≥95% | Ethyl 4-amino-6-chloronicotinate | ESD-893257-5G |
| Cas.: 380626-81-3 | Purity: ≥95% | Ethyl 4-amino-6-chloronicotinate | ESD-893257-10G |
| Cas.: 97271-97-1 | Purity: 98% | 2-Amino-3-nitrobenzaldehyde | ESD-893258-1G |
| Cas.: 14161-09-2 | Purity: 95% | 2-(Methylsulfonyl)pyrimidine | ESD-893259-250MG |
| Cas.: 14161-09-2 | Purity: 95% | 2-(Methylsulfonyl)pyrimidine | ESD-893259-1G |
| Cas.: 14161-09-2 | Purity: 95% | 2-(Methylsulfonyl)pyrimidine | ESD-893259-5G |
| Cas.: 14161-09-2 | Purity: 95% | 2-(Methylsulfonyl)pyrimidine | ESD-893259-10G |
| Cas.: 854267-89-3 | Purity: ≥95% | 1-(6-Chloropyridin-3-yl)cyclopropanecarbonitrile | ESD-893260-250MG |
| Cas.: 3468-17-5 | Purity: 98% | (1H-Indol-6-yl)methanamine | ESD-893261-100MG |
| Cas.: 3468-17-5 | Purity: 98% | (1H-Indol-6-yl)methanamine | ESD-893261-250MG |
| Cas.: 3468-17-5 | Purity: 98% | (1H-Indol-6-yl)methanamine | ESD-893261-1G |
| Cas.: 97602-72-7 | Purity: 95% | Methyl 2-methyl-1H-imidazole-5-carboxylate | ESD-893262-100MG |
| Cas.: 97602-72-7 | Purity: 95% | Methyl 2-methyl-1H-imidazole-5-carboxylate | ESD-893262-250MG |
| Cas.: 97602-72-7 | Purity: 95% | Methyl 2-methyl-1H-imidazole-5-carboxylate | ESD-893262-1G |
| Cas.: 1003298-72-3 | Purity: 97% | (3-Chloro-5-fluoro-4-hydroxyphenyl)boronic acid | ESD-893263-100MG |
| Cas.: 1003298-72-3 | Purity: 97% | (3-Chloro-5-fluoro-4-hydroxyphenyl)boronic acid | ESD-893263-250MG |
| Cas.: 1003298-72-3 | Purity: 97% | (3-Chloro-5-fluoro-4-hydroxyphenyl)boronic acid | ESD-893263-1G |
| Cas.: 1003298-72-3 | Purity: 97% | (3-Chloro-5-fluoro-4-hydroxyphenyl)boronic acid | ESD-893263-5G |
| Cas.: 1129278-73-4 | Purity: 97% | 4-Phenyl-3,4-dihydro-2H-benzo[e][1,3]oxazin-2-one | ESD-893264-100MG |
| Cas.: 1129278-73-4 | Purity: 97% | 4-Phenyl-3,4-dihydro-2H-benzo[e][1,3]oxazin-2-one | ESD-893264-250MG |
| Cas.: 230618-42-5 | Purity: 97% | 2-Bromo-4-(pyrrolidin-1-yl)pyridine | ESD-893265-100MG |
| Cas.: 230618-42-5 | Purity: 97% | 2-Bromo-4-(pyrrolidin-1-yl)pyridine | ESD-893265-250MG |
| Cas.: 230618-42-5 | Purity: 97% | 2-Bromo-4-(pyrrolidin-1-yl)pyridine | ESD-893265-1G |
| Cas.: 230618-42-5 | Purity: 97% | 2-Bromo-4-(pyrrolidin-1-yl)pyridine | ESD-893265-5G |
| Cas.: 58088-57-6 | Purity: ≥95% | Phenyl(pyridin-4-yl)methanamine | ESD-893266-100MG |
| Cas.: 58088-57-6 | Purity: ≥95% | Phenyl(pyridin-4-yl)methanamine | ESD-893266-250MG |
| Cas.: 58088-57-6 | Purity: ≥95% | Phenyl(pyridin-4-yl)methanamine | ESD-893266-1G |
| Cas.: 16293-12-2 | Purity: ≥95% | N1,N1-Dimethyl-3-nitrobenzene-1,4-diamine | ESD-893267-100MG |
| Cas.: 16293-12-2 | Purity: ≥95% | N1,N1-Dimethyl-3-nitrobenzene-1,4-diamine | ESD-893267-250MG |
| Cas.: 16293-12-2 | Purity: ≥95% | N1,N1-Dimethyl-3-nitrobenzene-1,4-diamine | ESD-893267-1G |
| Cas.: 1260666-60-1 | Purity: 96% | Methyl 6-amino-4-chloronicotinate | ESD-893268-100MG |
| Cas.: 1260666-60-1 | Purity: 96% | Methyl 6-amino-4-chloronicotinate | ESD-893268-250MG |
| Cas.: 167631-84-7 | Purity: ≥95% | Methyl 5-fluoro-1H-indole-2-carboxylate | ESD-893269-100MG |
| Cas.: 167631-84-7 | Purity: ≥95% | Methyl 5-fluoro-1H-indole-2-carboxylate | ESD-893269-250MG |
| Cas.: 167631-84-7 | Purity: ≥95% | Methyl 5-fluoro-1H-indole-2-carboxylate | ESD-893269-1G |
| Cas.: 167631-84-7 | Purity: ≥95% | Methyl 5-fluoro-1H-indole-2-carboxylate | ESD-893269-5G |
| Cas.: 2125-51-1 | Purity: ≥95% | 3-(Dimethylamino)-1-(4-hydroxyphenyl)propan-1-one hydrochloride | ESD-893270-250MG |
| Cas.: 2125-51-1 | Purity: ≥95% | 3-(Dimethylamino)-1-(4-hydroxyphenyl)propan-1-one hydrochloride | ESD-893270-1G |
| Cas.: 1802180-16-0 | Purity: 97% | tert-Butyl 3-hydroxy-5-oxo-5,6-dihydropyridine-1(2H)-carboxylate | ESD-893271-100MG |
| Cas.: 7126-57-0 | Purity: 97% | Ethyl 4-formyl-1H-pyrrole-2-carboxylate | ESD-893272-100MG |
| Cas.: 7126-57-0 | Purity: 97% | Ethyl 4-formyl-1H-pyrrole-2-carboxylate | ESD-893272-250MG |
| Cas.: 7126-57-0 | Purity: 97% | Ethyl 4-formyl-1H-pyrrole-2-carboxylate | ESD-893272-1G |
| Cas.: 7126-57-0 | Purity: 97% | Ethyl 4-formyl-1H-pyrrole-2-carboxylate | ESD-893272-5G |
| Cas.: 100707-39-9 | Purity: ≥95% | 2-Methyl-5-bromopyrimidine-4-carboxylic acid | ESD-893273-250MG |
| Cas.: 100707-39-9 | Purity: ≥95% | 2-Methyl-5-bromopyrimidine-4-carboxylic acid | ESD-893273-1G |
| Cas.: 100707-39-9 | Purity: ≥95% | 2-Methyl-5-bromopyrimidine-4-carboxylic acid | ESD-893273-5G |
| Cas.: 1240390-36-6 | Purity: ≥95% | tert-Butyl ((3R,4R)-4-aminotetrahydro-2H-pyran-3-yl)carbamate | ESD-893274-100MG |
| Cas.: 1240390-36-6 | Purity: ≥95% | tert-Butyl ((3R,4R)-4-aminotetrahydro-2H-pyran-3-yl)carbamate | ESD-893274-250MG |
| Cas.: 1240390-36-6 | Purity: ≥95% | tert-Butyl ((3R,4R)-4-aminotetrahydro-2H-pyran-3-yl)carbamate | ESD-893274-1G |
| Cas.: 1240390-36-6 | Purity: ≥95% | tert-Butyl ((3R,4R)-4-aminotetrahydro-2H-pyran-3-yl)carbamate | ESD-893274-5G |
| Cas.: 98453-60-2 | Purity: 97% | 6-Bromo-4,4-dimethyl-3,4-dihydronaphthalen-1(2H)-one | ESD-893275-100MG |
| Cas.: 98453-60-2 | Purity: 97% | 6-Bromo-4,4-dimethyl-3,4-dihydronaphthalen-1(2H)-one | ESD-893275-250MG |
| Cas.: 169750-75-8 | Purity: 95% | tert-Butyl (morpholin-3-ylmethyl)carbamate | ESD-893276-100MG |
| Cas.: 169750-75-8 | Purity: 95% | tert-Butyl (morpholin-3-ylmethyl)carbamate | ESD-893276-250MG |
| Cas.: 169750-75-8 | Purity: 95% | tert-Butyl (morpholin-3-ylmethyl)carbamate | ESD-893276-1G |
| Cas.: 850589-57-0 | Purity: 98% | 3-Fluoro-5-(isobutoxy)benzeneboronicacid | ESD-893277-250MG |
| Cas.: 850589-57-0 | Purity: 98% | 3-Fluoro-5-(isobutoxy)benzeneboronicacid | ESD-893277-1G |
| Cas.: 850589-57-0 | Purity: 98% | 3-Fluoro-5-(isobutoxy)benzeneboronicacid | ESD-893277-5G |
| Cas.: 850589-57-0 | Purity: 98% | 3-Fluoro-5-(isobutoxy)benzeneboronicacid | ESD-893277-10G |
| Cas.: 80410-57-7 | Purity: ≥95% | 3-Methoxy-4-nitrobenzaldehyde | ESD-893278-250MG |
| Cas.: 80410-57-7 | Purity: ≥95% | 3-Methoxy-4-nitrobenzaldehyde | ESD-893278-1G |
| Cas.: 80410-57-7 | Purity: ≥95% | 3-Methoxy-4-nitrobenzaldehyde | ESD-893278-5G |
| Cas.: 59237-50-2 | Purity: ≥95% | Methyl 5-amino-6-methoxynicotinate | ESD-893280-100MG |
| Cas.: 59237-50-2 | Purity: ≥95% | Methyl 5-amino-6-methoxynicotinate | ESD-893280-250MG |
| Cas.: 59237-50-2 | Purity: ≥95% | Methyl 5-amino-6-methoxynicotinate | ESD-893280-1G |
| Cas.: 59237-50-2 | Purity: ≥95% | Methyl 5-amino-6-methoxynicotinate | ESD-893280-5G |
| Cas.: 50-82-8 | Purity: ≥95% | 2,4,5-Trichlorobenzoic acid | ESD-893281-100MG |
| Cas.: 50-82-8 | Purity: ≥95% | 2,4,5-Trichlorobenzoic acid | ESD-893281-250MG |
| Cas.: 50-82-8 | Purity: ≥95% | 2,4,5-Trichlorobenzoic acid | ESD-893281-1G |
| Cas.: 50-82-8 | Purity: ≥95% | 2,4,5-Trichlorobenzoic acid | ESD-893281-5G |
| Cas.: 15128-85-5 | Purity: 97% | 2-Chloro-4-nitropyridin-3-ol | ESD-893282-100MG |
| Cas.: 15128-85-5 | Purity: 97% | 2-Chloro-4-nitropyridin-3-ol | ESD-893282-250MG |
| Cas.: 15128-85-5 | Purity: 97% | 2-Chloro-4-nitropyridin-3-ol | ESD-893282-1G |
| Cas.: 1211540-74-7 | Purity: ≥95% | Ethyl 2-(5-bromo-3-nitropyridin-2-yl)acetate | ESD-893283-100MG |
| Cas.: 1211540-74-7 | Purity: ≥95% | Ethyl 2-(5-bromo-3-nitropyridin-2-yl)acetate | ESD-893283-250MG |
| Cas.: 1211540-74-7 | Purity: ≥95% | Ethyl 2-(5-bromo-3-nitropyridin-2-yl)acetate | ESD-893283-1G |
| Cas.: 89891-83-8 | Purity: ≥95% | 2-Chloro-5-cyanobenzoic acid | ESD-893284-250MG |
| Cas.: 89891-83-8 | Purity: ≥95% | 2-Chloro-5-cyanobenzoic acid | ESD-893284-1G |
| Cas.: 89891-83-8 | Purity: ≥95% | 2-Chloro-5-cyanobenzoic acid | ESD-893284-5G |
| Cas.: 5622-50-4 | Purity: 97% | Methyl 2-(1,2,3,4-tetrahydroquinolin-6-yl)acetate | ESD-893285-100MG |
| Cas.: 5622-50-4 | Purity: 97% | Methyl 2-(1,2,3,4-tetrahydroquinolin-6-yl)acetate | ESD-893285-250MG |
| Cas.: 1121586-37-5 | Purity: 97% | 4-Bromo-2,6-dichloropyridin-3-amine | ESD-893286-100MG |
| Cas.: 1121586-37-5 | Purity: 97% | 4-Bromo-2,6-dichloropyridin-3-amine | ESD-893286-250MG |
| Cas.: 1121586-37-5 | Purity: 97% | 4-Bromo-2,6-dichloropyridin-3-amine | ESD-893286-1G |
| Cas.: 1121586-37-5 | Purity: 97% | 4-Bromo-2,6-dichloropyridin-3-amine | ESD-893286-5G |
| Cas.: 2327-45-9 | Purity: ≥95% | Methyl 5-methoxy-2-nitrobenzoate | ESD-893287-1G |
| Cas.: 2327-45-9 | Purity: ≥95% | Methyl 5-methoxy-2-nitrobenzoate | ESD-893287-5G |
| Cas.: 2327-45-9 | Purity: ≥95% | Methyl 5-methoxy-2-nitrobenzoate | ESD-893287-10G |
| Cas.: 2327-45-9 | Purity: ≥95% | Methyl 5-methoxy-2-nitrobenzoate | ESD-893287-25G |
| Cas.: 49592-84-9 | Purity: ≥95% | Methyl 2,5-Diaminobenzoate | ESD-893288-100MG |
| Cas.: 49592-84-9 | Purity: ≥95% | Methyl 2,5-Diaminobenzoate | ESD-893288-250MG |
| Cas.: 49592-84-9 | Purity: ≥95% | Methyl 2,5-Diaminobenzoate | ESD-893288-1G |
| Cas.: 75711-01-2 | Purity: ≥95% | 6-Chloro-5-methoxypyridin-3-amine | ESD-893289-100MG |
| Cas.: 75711-01-2 | Purity: ≥95% | 6-Chloro-5-methoxypyridin-3-amine | ESD-893289-250MG |
| Cas.: 75711-01-2 | Purity: ≥95% | 6-Chloro-5-methoxypyridin-3-amine | ESD-893289-1G |
| Cas.: 75711-01-2 | Purity: ≥95% | 6-Chloro-5-methoxypyridin-3-amine | ESD-893289-5G |
| Cas.: 98953-72-1 | Purity: 97% | 2,6-Dimethylbenzo[d]thiazol-5-amine | ESD-893290-100MG |
| Cas.: 98953-72-1 | Purity: 97% | 2,6-Dimethylbenzo[d]thiazol-5-amine | ESD-893290-250MG |
| Cas.: 855763-77-8 | Purity: 97% | Ethyl 2-methylquinoline-6-carboxylate | ESD-893291-250MG |
| Cas.: 855763-77-8 | Purity: 97% | Ethyl 2-methylquinoline-6-carboxylate | ESD-893291-1G |
| Cas.: 855763-77-8 | Purity: 97% | Ethyl 2-methylquinoline-6-carboxylate | ESD-893291-5G |
| Cas.: 855763-77-8 | Purity: 97% | Ethyl 2-methylquinoline-6-carboxylate | ESD-893291-10G |
| Cas.: 612834-90-9 | Purity: ≥95% | Ethyl 6-chloropyridazine-4-carboxylate | ESD-893292-250MG |
| Cas.: 612834-90-9 | Purity: ≥95% | Ethyl 6-chloropyridazine-4-carboxylate | ESD-893292-1G |
| Cas.: 612834-90-9 | Purity: ≥95% | Ethyl 6-chloropyridazine-4-carboxylate | ESD-893292-5G |
| Cas.: 612834-90-9 | Purity: ≥95% | Ethyl 6-chloropyridazine-4-carboxylate | ESD-893292-10G |
| Cas.: 5653-46-3 | Purity: ≥95% | 2-Hydroxy-3,4-dimethoxybenzoic acid | ESD-893293-100MG |
| Cas.: 5653-46-3 | Purity: ≥95% | 2-Hydroxy-3,4-dimethoxybenzoic acid | ESD-893293-250MG |
| Cas.: 5653-46-3 | Purity: ≥95% | 2-Hydroxy-3,4-dimethoxybenzoic acid | ESD-893293-1G |
| Cas.: 5653-46-3 | Purity: ≥95% | 2-Hydroxy-3,4-dimethoxybenzoic acid | ESD-893293-5G |
| Cas.: 54535-22-7 | Purity: ≥95% | Diethyl 2-((phenylamino)methylene)malonate | ESD-893294-1G |
| Cas.: 54535-22-7 | Purity: ≥95% | Diethyl 2-((phenylamino)methylene)malonate | ESD-893294-5G |
| Cas.: 54535-22-7 | Purity: ≥95% | Diethyl 2-((phenylamino)methylene)malonate | ESD-893294-10G |
| Cas.: 131020-36-5 | Purity: 97% | Methyl 1-methyl-1H-benzo[d]imidazole-5-carboxylate | ESD-893295-250MG |
| Cas.: 131020-36-5 | Purity: 97% | Methyl 1-methyl-1H-benzo[d]imidazole-5-carboxylate | ESD-893295-1G |
| Cas.: 131020-36-5 | Purity: 97% | Methyl 1-methyl-1H-benzo[d]imidazole-5-carboxylate | ESD-893295-5G |
| Cas.: 131020-36-5 | Purity: 97% | Methyl 1-methyl-1H-benzo[d]imidazole-5-carboxylate | ESD-893295-10G |
| Cas.: 41280-55-1 | Purity: ≥95% | 4-(2,6-Dimethylphenoxy)aniline | ESD-893296-250MG |
| Cas.: 41280-55-1 | Purity: ≥95% | 4-(2,6-Dimethylphenoxy)aniline | ESD-893296-1G |
| Cas.: 41280-55-1 | Purity: ≥95% | 4-(2,6-Dimethylphenoxy)aniline | ESD-893296-5G |
| Cas.: 3347-62-4 | Purity: ≥95% | 3-Methyl-5-phenyl-1H-pyrazole | ESD-893297-250MG |
| Cas.: 3347-62-4 | Purity: ≥95% | 3-Methyl-5-phenyl-1H-pyrazole | ESD-893297-1G |
| Cas.: 3347-62-4 | Purity: ≥95% | 3-Methyl-5-phenyl-1H-pyrazole | ESD-893297-5G |
| Cas.: 4264-35-1 | Purity: 98% | 1-(1H-Indol-2-yl)ethanone | ESD-893298-250MG |
| Cas.: 4264-35-1 | Purity: 98% | 1-(1H-Indol-2-yl)ethanone | ESD-893298-1G |
| Cas.: 4264-35-1 | Purity: 98% | 1-(1H-Indol-2-yl)ethanone | ESD-893298-5G |
| Cas.: 4264-35-1 | Purity: 98% | 1-(1H-Indol-2-yl)ethanone | ESD-893298-10G |
| Cas.: 612-20-4 | Purity: 97% | 2-(Hydroxymethyl)benzoic acid | ESD-893299-1G |
| Cas.: 612-20-4 | Purity: 97% | 2-(Hydroxymethyl)benzoic acid | ESD-893299-5G |
| Cas.: 612-20-4 | Purity: 97% | 2-(Hydroxymethyl)benzoic acid | ESD-893299-10G |
| Cas.: 612-20-4 | Purity: 97% | 2-(Hydroxymethyl)benzoic acid | ESD-893299-25G |
| Cas.: 877149-08-1 | Purity: ≥95% | 4-Bromo-2-methoxy-6-methylbenzoic acid | ESD-893300-100MG |
| Cas.: 877149-08-1 | Purity: ≥95% | 4-Bromo-2-methoxy-6-methylbenzoic acid | ESD-893300-250MG |
| Cas.: 1227489-68-0 | Purity: 95% | 2-Amino-4-(trifluoromethyl)nicotinic acid | ESD-893301-100MG |
| Cas.: 1227489-68-0 | Purity: 95% | 2-Amino-4-(trifluoromethyl)nicotinic acid | ESD-893301-250MG |
| Cas.: 81223-73-6 | Purity: 95% | 1-(1H-Indol-6-yl)ethanone | ESD-893302-250MG |
| Cas.: 81223-73-6 | Purity: 95% | 1-(1H-Indol-6-yl)ethanone | ESD-893302-1G |
| Cas.: 81223-73-6 | Purity: 95% | 1-(1H-Indol-6-yl)ethanone | ESD-893302-5G |
| Cas.: 5154-01-8 | Purity: 98% | 5-Hydroxypyridin-2(1H)-one | ESD-893303-100MG |
| Cas.: 5154-01-8 | Purity: 98% | 5-Hydroxypyridin-2(1H)-one | ESD-893303-250MG |
| Cas.: 5154-01-8 | Purity: 98% | 5-Hydroxypyridin-2(1H)-one | ESD-893303-1G |
| Cas.: 5154-01-8 | Purity: 98% | 5-Hydroxypyridin-2(1H)-one | ESD-893303-5G |
| Cas.: 40877-09-6 | Purity: 95% | 4-Chloro-1-(4-chlorophenyl)butan-1-one | ESD-893304-250MG |
| Cas.: 40877-09-6 | Purity: 95% | 4-Chloro-1-(4-chlorophenyl)butan-1-one | ESD-893304-1G |
| Cas.: 40877-09-6 | Purity: 95% | 4-Chloro-1-(4-chlorophenyl)butan-1-one | ESD-893304-5G |
| Cas.: 1196152-90-5 | Purity: 94% | 5-Bromo-1H-pyrazolo[3,4-b]pyrazine | ESD-893305-100MG |
| Cas.: 1196152-90-5 | Purity: 94% | 5-Bromo-1H-pyrazolo[3,4-b]pyrazine | ESD-893305-250MG |
| Cas.: 876-91-5 | Purity: ≥95% | 4-Bromo-6-methyl-2,3-dihydro-1H-inden-1-one | ESD-893306-100MG |
| Cas.: 876-91-5 | Purity: ≥95% | 4-Bromo-6-methyl-2,3-dihydro-1H-inden-1-one | ESD-893306-250MG |
| Cas.: 1365939-36-1 | Purity: 97% | 5-Ethoxy-1-methyl-1H-pyrazole-4-carboxylic acid | ESD-893307-100MG |
| Cas.: 1365939-36-1 | Purity: 97% | 5-Ethoxy-1-methyl-1H-pyrazole-4-carboxylic acid | ESD-893307-250MG |
| Cas.: 188554-13-4 | Purity: ≥95% | 2-Hydroxyisonicotinaldehyde | ESD-893308-100MG |
| Cas.: 188554-13-4 | Purity: ≥95% | 2-Hydroxyisonicotinaldehyde | ESD-893308-250MG |
| Cas.: 188554-13-4 | Purity: ≥95% | 2-Hydroxyisonicotinaldehyde | ESD-893308-1G |
| Cas.: 188554-13-4 | Purity: ≥95% | 2-Hydroxyisonicotinaldehyde | ESD-893308-5G |
| Cas.: 944742-29-4 | Purity: 97% | 5-Fluoro-7-methoxyquinazolin-4(3H)-one | ESD-893309-100MG |
| Cas.: 944742-29-4 | Purity: 97% | 5-Fluoro-7-methoxyquinazolin-4(3H)-one | ESD-893309-250MG |
| Cas.: 944742-29-4 | Purity: 97% | 5-Fluoro-7-methoxyquinazolin-4(3H)-one | ESD-893309-1G |
| Cas.: 149554-06-3 | Purity: ≥95% | 4-(Piperidin-4-yl)benzonitrile | ESD-893310-100MG |
| Cas.: 149554-06-3 | Purity: ≥95% | 4-(Piperidin-4-yl)benzonitrile | ESD-893310-250MG |
| Cas.: 149554-06-3 | Purity: ≥95% | 4-(Piperidin-4-yl)benzonitrile | ESD-893310-1G |
| Cas.: 10470-83-4 | Purity: 97% | 5,8-Quinolinequinone | ESD-893311-100MG |
| Cas.: 10470-83-4 | Purity: 97% | 5,8-Quinolinequinone | ESD-893311-250MG |
| Cas.: 10470-83-4 | Purity: 97% | 5,8-Quinolinequinone | ESD-893311-1G |
| Cas.: 374794-96-4 | Purity: 95% | tert-Butyl 2-oxa-8-azaspiro[4.5]decane-8-carboxylate | ESD-893312-100MG |
| Cas.: 374794-96-4 | Purity: 95% | tert-Butyl 2-oxa-8-azaspiro[4.5]decane-8-carboxylate | ESD-893312-250MG |
| Cas.: 62777-25-7 | Purity: 97% | (S)-2-Amino-5-phenylpentanoic acid | ESD-893313-250MG |
| Cas.: 62777-25-7 | Purity: 97% | (S)-2-Amino-5-phenylpentanoic acid | ESD-893313-1G |
| Cas.: 178876-83-0 | Purity: 97% | Methyl 6-amino-3-bromopicolinate | ESD-893314-250MG |
| Cas.: 178876-83-0 | Purity: 97% | Methyl 6-amino-3-bromopicolinate | ESD-893314-1G |
| Cas.: 178876-83-0 | Purity: 97% | Methyl 6-amino-3-bromopicolinate | ESD-893314-5G |
| Cas.: 178876-83-0 | Purity: 97% | Methyl 6-amino-3-bromopicolinate | ESD-893314-25G |
| Cas.: 1135916-70-9 | Purity: ≥95% | tert-Butyl 3-(1-amino-2-methoxy-2-oxoethyl)pyrrolidine-1-carboxylate | ESD-893315-100MG |
| Cas.: 1135916-70-9 | Purity: ≥95% | tert-Butyl 3-(1-amino-2-methoxy-2-oxoethyl)pyrrolidine-1-carboxylate | ESD-893315-250MG |
| Cas.: 1135916-70-9 | Purity: ≥95% | tert-Butyl 3-(1-amino-2-methoxy-2-oxoethyl)pyrrolidine-1-carboxylate | ESD-893315-1G |
| Cas.: 1214375-85-5 | Purity: ≥95% | Ethyl 3,6-dibromopicolinate | ESD-893316-100MG |
| Cas.: 1214375-85-5 | Purity: ≥95% | Ethyl 3,6-dibromopicolinate | ESD-893316-250MG |
| Cas.: 1214375-85-5 | Purity: ≥95% | Ethyl 3,6-dibromopicolinate | ESD-893316-1G |
| Cas.: 1214375-85-5 | Purity: ≥95% | Ethyl 3,6-dibromopicolinate | ESD-893316-5G |
| Cas.: 72965-16-3 | Purity: 97% | Ethyl 2-amino-4-isopropylthiophene-3-carboxylate | ESD-893317-100MG |
| Cas.: 72965-16-3 | Purity: 97% | Ethyl 2-amino-4-isopropylthiophene-3-carboxylate | ESD-893317-250MG |
| Cas.: 72965-16-3 | Purity: 97% | Ethyl 2-amino-4-isopropylthiophene-3-carboxylate | ESD-893317-1G |
| Cas.: 72965-16-3 | Purity: 97% | Ethyl 2-amino-4-isopropylthiophene-3-carboxylate | ESD-893317-5G |
| Cas.: 104-27-8 | Purity: 97% | 1-(4-Methoxyphenyl)pent-1-en-3-one | ESD-893318-100MG |
| Cas.: 104-27-8 | Purity: 97% | 1-(4-Methoxyphenyl)pent-1-en-3-one | ESD-893318-250MG |
| Cas.: 3336-60-5 | Purity: 97% | 1-Chloro-4-methoxyisoquinoline | ESD-893319-100MG |
| Cas.: 3336-60-5 | Purity: 97% | 1-Chloro-4-methoxyisoquinoline | ESD-893319-250MG |
| Cas.: 3336-60-5 | Purity: 97% | 1-Chloro-4-methoxyisoquinoline | ESD-893319-1G |
| Cas.: 3336-60-5 | Purity: 97% | 1-Chloro-4-methoxyisoquinoline | ESD-893319-5G |
| Cas.: 850568-08-0 | Purity: 97% | 4-Ethoxy-3-methylphenylboronic acid | ESD-893320-250MG |
| Cas.: 850568-08-0 | Purity: 97% | 4-Ethoxy-3-methylphenylboronic acid | ESD-893320-1G |
| Cas.: 850568-08-0 | Purity: 97% | 4-Ethoxy-3-methylphenylboronic acid | ESD-893320-5G |
| Cas.: 850568-08-0 | Purity: 97% | 4-Ethoxy-3-methylphenylboronic acid | ESD-893320-10G |
| Cas.: 1190862-72-6 | Purity: 98% | 5-Bromo-6-methylnicotinic acid | ESD-893321-250MG |
| Cas.: 1190862-72-6 | Purity: 98% | 5-Bromo-6-methylnicotinic acid | ESD-893321-1G |
| Cas.: 1190862-72-6 | Purity: 98% | 5-Bromo-6-methylnicotinic acid | ESD-893321-5G |
| Cas.: 58665-00-2 | Purity: ≥95% | Methyl 2-(1-methyl-1H-indol-3-yl)acetate | ESD-893322-100MG |
| Cas.: 58665-00-2 | Purity: ≥95% | Methyl 2-(1-methyl-1H-indol-3-yl)acetate | ESD-893322-250MG |
| Cas.: 32580-41-9 | Purity: ≥95% | 1-(2-Amino-5-nitrophenyl)ethanone | ESD-893323-100MG |
| Cas.: 32580-41-9 | Purity: ≥95% | 1-(2-Amino-5-nitrophenyl)ethanone | ESD-893323-250MG |
| Cas.: 32580-41-9 | Purity: ≥95% | 1-(2-Amino-5-nitrophenyl)ethanone | ESD-893323-1G |
| Cas.: 218770-02-6 | Purity: 98% | 6-Chloro-2-methylpyridin-3-ol | ESD-893324-250MG |
| Cas.: 218770-02-6 | Purity: 98% | 6-Chloro-2-methylpyridin-3-ol | ESD-893324-1G |
| Cas.: 218770-02-6 | Purity: 98% | 6-Chloro-2-methylpyridin-3-ol | ESD-893324-5G |
| Cas.: 218770-02-6 | Purity: 98% | 6-Chloro-2-methylpyridin-3-ol | ESD-893324-10G |
| Cas.: 94805-51-3 | Purity: ≥95% | 2-Oxo-1,2-dihydropyridine-4-carbonitrile | ESD-893325-100MG |
| Cas.: 94805-51-3 | Purity: ≥95% | 2-Oxo-1,2-dihydropyridine-4-carbonitrile | ESD-893325-250MG |
| Cas.: 94805-51-3 | Purity: ≥95% | 2-Oxo-1,2-dihydropyridine-4-carbonitrile | ESD-893325-1G |
| Cas.: 94805-51-3 | Purity: ≥95% | 2-Oxo-1,2-dihydropyridine-4-carbonitrile | ESD-893325-5G |
| Cas.: 3012-80-4 | Purity: 95% | 1-Methyl-1H-benzo[d]imidazole-2-carbaldehyde | ESD-893326-250MG |
| Cas.: 3012-80-4 | Purity: 95% | 1-Methyl-1H-benzo[d]imidazole-2-carbaldehyde | ESD-893326-1G |
| Cas.: 3012-80-4 | Purity: 95% | 1-Methyl-1H-benzo[d]imidazole-2-carbaldehyde | ESD-893326-5G |
| Cas.: 3012-80-4 | Purity: 95% | 1-Methyl-1H-benzo[d]imidazole-2-carbaldehyde | ESD-893326-10G |
| Cas.: 130200-01-0 | Purity: 97% | 7-Bromo-2,2-dimethylchroman-4-one | ESD-893327-250MG |
| Cas.: 130200-01-0 | Purity: 97% | 7-Bromo-2,2-dimethylchroman-4-one | ESD-893327-1G |
| Cas.: 130200-01-0 | Purity: 97% | 7-Bromo-2,2-dimethylchroman-4-one | ESD-893327-5G |
| Cas.: 72985-23-0 | Purity: ≥95% | 6-Methylisobenzofuran-1(3H)-one | ESD-893328-100MG |
| Cas.: 72985-23-0 | Purity: ≥95% | 6-Methylisobenzofuran-1(3H)-one | ESD-893328-250MG |
| Cas.: 72985-23-0 | Purity: ≥95% | 6-Methylisobenzofuran-1(3H)-one | ESD-893328-1G |
| Cas.: 13721-00-1 | Purity: 98% | 2,3-Dibromoquinoline | ESD-893329-250MG |
| Cas.: 13721-00-1 | Purity: 98% | 2,3-Dibromoquinoline | ESD-893329-1G |
| Cas.: 13721-00-1 | Purity: 98% | 2,3-Dibromoquinoline | ESD-893329-5G |
| Cas.: 129844-69-5 | Purity: 97% | 6-Methylquinolin-7-amine | ESD-893330-100MG |
| Cas.: 129844-69-5 | Purity: 97% | 6-Methylquinolin-7-amine | ESD-893330-250MG |
| Cas.: 141940-32-1 | Purity: ≥95% | 5-((tert-Butoxycarbonyl)amino)-2-fluorobenzoic acid | ESD-893331-100MG |
| Cas.: 141940-32-1 | Purity: ≥95% | 5-((tert-Butoxycarbonyl)amino)-2-fluorobenzoic acid | ESD-893331-250MG |
| Cas.: 141940-32-1 | Purity: ≥95% | 5-((tert-Butoxycarbonyl)amino)-2-fluorobenzoic acid | ESD-893331-1G |
| Cas.: 141940-32-1 | Purity: ≥95% | 5-((tert-Butoxycarbonyl)amino)-2-fluorobenzoic acid | ESD-893331-5G |
| Cas.: 64119-42-2 | Purity: 95% | Ethyl 6-chloro-5-cyano-2-methylpyridine-3-carboxylate | ESD-893332-100MG |
| Cas.: 64119-42-2 | Purity: 95% | Ethyl 6-chloro-5-cyano-2-methylpyridine-3-carboxylate | ESD-893332-250MG |
| Cas.: 64119-42-2 | Purity: 95% | Ethyl 6-chloro-5-cyano-2-methylpyridine-3-carboxylate | ESD-893332-1G |
| Cas.: 64119-42-2 | Purity: 95% | Ethyl 6-chloro-5-cyano-2-methylpyridine-3-carboxylate | ESD-893332-5G |
| Cas.: 19828-20-7 | Purity: ≥95% | 2-Amino-5-acetylpyridine | ESD-893333-100MG |
| Cas.: 19828-20-7 | Purity: ≥95% | 2-Amino-5-acetylpyridine | ESD-893333-250MG |
| Cas.: 19828-20-7 | Purity: ≥95% | 2-Amino-5-acetylpyridine | ESD-893333-1G |
| Cas.: 19828-20-7 | Purity: ≥95% | 2-Amino-5-acetylpyridine | ESD-893333-5G |
| Cas.: 941294-25-3 | Purity: ≥95% | 1,3-Dichloro-7-fluoroisoquinoline | ESD-893334-100MG |
| Cas.: 941294-25-3 | Purity: ≥95% | 1,3-Dichloro-7-fluoroisoquinoline | ESD-893334-250MG |
| Cas.: 941294-25-3 | Purity: ≥95% | 1,3-Dichloro-7-fluoroisoquinoline | ESD-893334-1G |
| Cas.: 941294-25-3 | Purity: ≥95% | 1,3-Dichloro-7-fluoroisoquinoline | ESD-893334-5G |
| Cas.: 70817-26-4 | Purity: 97% | (1-Phenyl-1H-pyrazol-4-yl)methanol | ESD-893335-250MG |
| Cas.: 1309980-95-7 | Purity: 97% | (6-Ethoxy-2,3-difluorophenyl)boronic acid | ESD-893336-100MG |
| Cas.: 1309980-95-7 | Purity: 97% | (6-Ethoxy-2,3-difluorophenyl)boronic acid | ESD-893336-250MG |
| Cas.: 1309980-95-7 | Purity: 97% | (6-Ethoxy-2,3-difluorophenyl)boronic acid | ESD-893336-1G |
| Cas.: 1057961-75-7 | Purity: 98% | tert-Butyl 4-bromo-3-fluorobenzoate | ESD-893337-1G |
| Cas.: 1057961-75-7 | Purity: 98% | tert-Butyl 4-bromo-3-fluorobenzoate | ESD-893337-5G |
| Cas.: 5252-98-2 | Purity: 97% | 4,5-Dichloro-2-methylbenzoic acid | ESD-893338-100MG |
| Cas.: 5252-98-2 | Purity: 97% | 4,5-Dichloro-2-methylbenzoic acid | ESD-893338-250MG |
| Cas.: 5252-98-2 | Purity: 97% | 4,5-Dichloro-2-methylbenzoic acid | ESD-893338-1G |
| Cas.: 1082041-85-7 | Purity: ≥95% | 5-Bromo-4-fluoro-1H-indazole | ESD-893339-100MG |
| Cas.: 1082041-85-7 | Purity: ≥95% | 5-Bromo-4-fluoro-1H-indazole | ESD-893339-250MG |
| Cas.: 1082041-85-7 | Purity: ≥95% | 5-Bromo-4-fluoro-1H-indazole | ESD-893339-1G |
| Cas.: 1082041-85-7 | Purity: ≥95% | 5-Bromo-4-fluoro-1H-indazole | ESD-893339-5G |
| Cas.: 457889-46-2 | Purity: 97% | (4′-(Trifluoromethyl)-[1,1′-biphenyl]-4-yl)methanol | ESD-893340-100MG |
| Cas.: 457889-46-2 | Purity: 97% | (4′-(Trifluoromethyl)-[1,1′-biphenyl]-4-yl)methanol | ESD-893340-250MG |
| Cas.: 457889-46-2 | Purity: 97% | (4′-(Trifluoromethyl)-[1,1′-biphenyl]-4-yl)methanol | ESD-893340-1G |
| Cas.: 457889-46-2 | Purity: 97% | (4′-(Trifluoromethyl)-[1,1′-biphenyl]-4-yl)methanol | ESD-893340-5G |
| Cas.: 957061-14-2 | Purity: 98% | 5-Bromo-2-fluoro-4-methylphenylboronic acid | ESD-893341-100MG |
| Cas.: 957061-14-2 | Purity: 98% | 5-Bromo-2-fluoro-4-methylphenylboronic acid | ESD-893341-250MG |
| Cas.: 957061-14-2 | Purity: 98% | 5-Bromo-2-fluoro-4-methylphenylboronic acid | ESD-893341-1G |
| Cas.: 957061-14-2 | Purity: 98% | 5-Bromo-2-fluoro-4-methylphenylboronic acid | ESD-893341-5G |
| Cas.: 221241-37-8 | Purity: ≥95% | 2,5-Dibromopyridin-4-amine | ESD-893342-100MG |
| Cas.: 221241-37-8 | Purity: ≥95% | 2,5-Dibromopyridin-4-amine | ESD-893342-250MG |
| Cas.: 221241-37-8 | Purity: ≥95% | 2,5-Dibromopyridin-4-amine | ESD-893342-1G |
| Cas.: 1416013-62-1 | Purity: 97% | 2-Amino-4-bromo-3-fluorobenzoic acid | ESD-893343-100MG |
| Cas.: 1416013-62-1 | Purity: 97% | 2-Amino-4-bromo-3-fluorobenzoic acid | ESD-893343-250MG |
| Cas.: 1416013-62-1 | Purity: 97% | 2-Amino-4-bromo-3-fluorobenzoic acid | ESD-893343-1G |
| Cas.: 1416013-62-1 | Purity: 97% | 2-Amino-4-bromo-3-fluorobenzoic acid | ESD-893343-5G |
| Cas.: 108940-96-1 | Purity: 97% | 3,5-Dibromo-4-methoxybenzaldehyde | ESD-893344-100MG |
| Cas.: 108940-96-1 | Purity: 97% | 3,5-Dibromo-4-methoxybenzaldehyde | ESD-893344-250MG |
| Cas.: 108940-96-1 | Purity: 97% | 3,5-Dibromo-4-methoxybenzaldehyde | ESD-893344-1G |
| Cas.: 108940-96-1 | Purity: 97% | 3,5-Dibromo-4-methoxybenzaldehyde | ESD-893344-5G |
| Cas.: 1381861-91-1 | Purity: 97% | tert-Butyl 3-(2-(2-bromoethoxy)ethoxy)propanoate | ESD-893345-100MG |
| Cas.: 1381861-91-1 | Purity: 97% | tert-Butyl 3-(2-(2-bromoethoxy)ethoxy)propanoate | ESD-893345-250MG |
| Cas.: 1381861-91-1 | Purity: 97% | tert-Butyl 3-(2-(2-bromoethoxy)ethoxy)propanoate | ESD-893345-1G |
| Cas.: 42327-52-6 | Purity: 98% | 7-Methoxychroman-4-one | ESD-893346-100MG |
| Cas.: 42327-52-6 | Purity: 98% | 7-Methoxychroman-4-one | ESD-893346-250MG |
| Cas.: 42327-52-6 | Purity: 98% | 7-Methoxychroman-4-one | ESD-893346-1G |
| Cas.: 42327-52-6 | Purity: 98% | 7-Methoxychroman-4-one | ESD-893346-5G |
| Cas.: 106131-61-7 | Purity: 97% | 3,6-Dichloro-1,2,4,5-tetrazine | ESD-893347-100MG |
| Cas.: 106131-61-7 | Purity: 97% | 3,6-Dichloro-1,2,4,5-tetrazine | ESD-893347-250MG |
| Cas.: 106131-61-7 | Purity: 97% | 3,6-Dichloro-1,2,4,5-tetrazine | ESD-893347-1G |
| Cas.: 106131-61-7 | Purity: 97% | 3,6-Dichloro-1,2,4,5-tetrazine | ESD-893347-5G |
| Cas.: 501-60-0 | Purity: ≥95% | 1,2-Di-p-tolyldiazene | ESD-893348-250MG |
| Cas.: 501-60-0 | Purity: ≥95% | 1,2-Di-p-tolyldiazene | ESD-893348-1G |
| Cas.: 33852-43-6 | Purity: 97% | 3′-Methoxy-2′-nitroacetophenone | ESD-893349-100MG |
| Cas.: 33852-43-6 | Purity: 97% | 3′-Methoxy-2′-nitroacetophenone | ESD-893349-250MG |
| Cas.: 33852-43-6 | Purity: 97% | 3′-Methoxy-2′-nitroacetophenone | ESD-893349-1G |
| Cas.: 33852-43-6 | Purity: 97% | 3′-Methoxy-2′-nitroacetophenone | ESD-893349-5G |
| Cas.: 1136-52-3 | Purity: 97% | (2,2,8-Trimethyl-4H-[1,3]dioxino[4,5-c]pyridin-5-yl)methanol | ESD-893350-100MG |
| Cas.: 1136-52-3 | Purity: 97% | (2,2,8-Trimethyl-4H-[1,3]dioxino[4,5-c]pyridin-5-yl)methanol | ESD-893350-250MG |
| Cas.: 70951-96-1 | Purity: 97% | 4-Bromo-5-methyl-3-nitro-1H-pyrazole | ESD-893351-100MG |
| Cas.: 70951-96-1 | Purity: 97% | 4-Bromo-5-methyl-3-nitro-1H-pyrazole | ESD-893351-250MG |
| Cas.: 70951-96-1 | Purity: 97% | 4-Bromo-5-methyl-3-nitro-1H-pyrazole | ESD-893351-1G |
| Cas.: 70951-96-1 | Purity: 97% | 4-Bromo-5-methyl-3-nitro-1H-pyrazole | ESD-893351-5G |
| Cas.: 29958-12-1 | Purity: ≥95% | 5-Amino-2-iodopyridine | ESD-893352-250MG |
| Cas.: 29958-12-1 | Purity: ≥95% | 5-Amino-2-iodopyridine | ESD-893352-1G |
| Cas.: 29958-12-1 | Purity: ≥95% | 5-Amino-2-iodopyridine | ESD-893352-5G |
| Cas.: 7205-46-1 | Purity: 97% | 6-Chloro-1-methyl-1H-imidazo[4,5-c]pyridine | ESD-893353-100MG |
| Cas.: 7205-46-1 | Purity: 97% | 6-Chloro-1-methyl-1H-imidazo[4,5-c]pyridine | ESD-893353-250MG |
| Cas.: 7205-46-1 | Purity: 97% | 6-Chloro-1-methyl-1H-imidazo[4,5-c]pyridine | ESD-893353-1G |
| Cas.: 7205-46-1 | Purity: 97% | 6-Chloro-1-methyl-1H-imidazo[4,5-c]pyridine | ESD-893353-5G |
| Cas.: 55304-83-1 | Purity: ≥95% | 2,6-Dibromonicotinaldehyde | ESD-893354-250MG |
| Cas.: 55304-83-1 | Purity: ≥95% | 2,6-Dibromonicotinaldehyde | ESD-893354-1G |
| Cas.: 55304-83-1 | Purity: ≥95% | 2,6-Dibromonicotinaldehyde | ESD-893354-5G |
| Cas.: 55304-83-1 | Purity: ≥95% | 2,6-Dibromonicotinaldehyde | ESD-893354-10G |
| Cas.: 63920-73-0 | Purity: 97% | 2-Amino-4,6-dimethoxybenzamide | ESD-893355-250MG |
| Cas.: 63920-73-0 | Purity: 97% | 2-Amino-4,6-dimethoxybenzamide | ESD-893355-1G |
| Cas.: 63920-73-0 | Purity: 97% | 2-Amino-4,6-dimethoxybenzamide | ESD-893355-5G |
| Cas.: 78502-81-5 | Purity: ≥95% | 5-Bromo-2-methyl-4-phenylthiazole | ESD-893356-100MG |
| Cas.: 78502-81-5 | Purity: ≥95% | 5-Bromo-2-methyl-4-phenylthiazole | ESD-893356-250MG |
| Cas.: 884-33-3 | Purity: 95% | 2-Benzylsuccinic acid | ESD-893357-250MG |
| Cas.: 884-33-3 | Purity: 95% | 2-Benzylsuccinic acid | ESD-893357-1G |
| Cas.: 884-33-3 | Purity: 95% | 2-Benzylsuccinic acid | ESD-893357-5G |
| Cas.: 2805-84-7 | Purity: 98% | 6-(Trifluoromethyl)-2,3,4,9-tetrahydro-1H-carbazole | ESD-893358-100MG |
| Cas.: 2805-84-7 | Purity: 98% | 6-(Trifluoromethyl)-2,3,4,9-tetrahydro-1H-carbazole | ESD-893358-250MG |
| Cas.: 174603-55-5 | Purity: 97% | 3-(2-Bromo-4-fluorophenyl)propionic acid | ESD-893359-100MG |
| Cas.: 174603-55-5 | Purity: 97% | 3-(2-Bromo-4-fluorophenyl)propionic acid | ESD-893359-250MG |
| Cas.: 174603-55-5 | Purity: 97% | 3-(2-Bromo-4-fluorophenyl)propionic acid | ESD-893359-1G |
| Cas.: 21279-64-1 | Purity: 97% | 5-Chloropyrazine-2-carboxamide | ESD-893360-100MG |
| Cas.: 21279-64-1 | Purity: 97% | 5-Chloropyrazine-2-carboxamide | ESD-893360-250MG |
| Cas.: 21279-64-1 | Purity: 97% | 5-Chloropyrazine-2-carboxamide | ESD-893360-1G |
| Cas.: 21279-64-1 | Purity: 97% | 5-Chloropyrazine-2-carboxamide | ESD-893360-5G |
| Cas.: 6541-19-1 | Purity: 98% | 6,7-Dichloroquinoline-5,8-dione | ESD-893361-100MG |
| Cas.: 6541-19-1 | Purity: 98% | 6,7-Dichloroquinoline-5,8-dione | ESD-893361-250MG |
| Cas.: 6541-19-1 | Purity: 98% | 6,7-Dichloroquinoline-5,8-dione | ESD-893361-1G |
| Cas.: 6541-19-1 | Purity: 98% | 6,7-Dichloroquinoline-5,8-dione | ESD-893361-5G |
| Cas.: 51632-16-7 | Purity: 97% | 1-(Bromomethyl)-3-phenoxybenzene | ESD-893362-100MG |
| Cas.: 51632-16-7 | Purity: 97% | 1-(Bromomethyl)-3-phenoxybenzene | ESD-893362-250MG |
| Cas.: 51632-16-7 | Purity: 97% | 1-(Bromomethyl)-3-phenoxybenzene | ESD-893362-1G |
| Cas.: 51632-16-7 | Purity: 97% | 1-(Bromomethyl)-3-phenoxybenzene | ESD-893362-5G |
| Cas.: 525-03-1 | Purity: 97% | 9-Aminofluorene | ESD-893363-250MG |
| Cas.: 525-03-1 | Purity: 97% | 9-Aminofluorene | ESD-893363-1G |
| Cas.: 525-03-1 | Purity: 97% | 9-Aminofluorene | ESD-893363-5G |
| Cas.: 525-03-1 | Purity: 97% | 9-Aminofluorene | ESD-893363-10G |
| Cas.: 3792-04-9 | Purity: 97% | 2-Chloro-N-(2-(trifluoromethyl)phenyl)acetamide | ESD-893364-1G |
| Cas.: 3792-04-9 | Purity: 97% | 2-Chloro-N-(2-(trifluoromethyl)phenyl)acetamide | ESD-893364-5G |
| Cas.: 3792-04-9 | Purity: 97% | 2-Chloro-N-(2-(trifluoromethyl)phenyl)acetamide | ESD-893364-10G |
| Cas.: 3792-04-9 | Purity: 97% | 2-Chloro-N-(2-(trifluoromethyl)phenyl)acetamide | ESD-893364-25G |
| Cas.: 71887-28-0 | Purity: ≥95% | Methyl 2-(bromomethyl)-3-methoxybenzoate | ESD-893365-250MG |
| Cas.: 71887-28-0 | Purity: ≥95% | Methyl 2-(bromomethyl)-3-methoxybenzoate | ESD-893365-1G |
| Cas.: 119515-38-7 | Purity: 98% | Icaridin | ESD-893366-1G |
| Cas.: 119515-38-7 | Purity: 98% | Icaridin | ESD-893366-5G |
| Cas.: 119515-38-7 | Purity: 98% | Icaridin | ESD-893366-10G |
| Cas.: 119515-38-7 | Purity: 98% | Icaridin | ESD-893366-25G |
| Cas.: 1352397-22-8 | Purity: ≥95% | 6-Chloro-4-methyl-1H-pyrrolo[3,2-c]pyridine | ESD-893367-100MG |
| Cas.: 1352397-22-8 | Purity: ≥95% | 6-Chloro-4-methyl-1H-pyrrolo[3,2-c]pyridine | ESD-893367-250MG |
| Cas.: 1352397-22-8 | Purity: ≥95% | 6-Chloro-4-methyl-1H-pyrrolo[3,2-c]pyridine | ESD-893367-1G |
| Cas.: 6640-47-7 | Purity: 97% | Quinoxaline-2,3-diamine | ESD-893368-100MG |
| Cas.: 6640-47-7 | Purity: 97% | Quinoxaline-2,3-diamine | ESD-893368-250MG |
| Cas.: 6640-47-7 | Purity: 97% | Quinoxaline-2,3-diamine | ESD-893368-1G |
| Cas.: 6640-47-7 | Purity: 97% | Quinoxaline-2,3-diamine | ESD-893368-5G |
| Cas.: 2632-65-7 | Purity: 97% | 4-(Pyrrolidin-1-yl)aniline | ESD-893369-100MG |
| Cas.: 2632-65-7 | Purity: 97% | 4-(Pyrrolidin-1-yl)aniline | ESD-893369-250MG |
| Cas.: 2632-65-7 | Purity: 97% | 4-(Pyrrolidin-1-yl)aniline | ESD-893369-1G |
| Cas.: 2632-65-7 | Purity: 97% | 4-(Pyrrolidin-1-yl)aniline | ESD-893369-5G |
| Cas.: 321533-62-4 | Purity: 98% | Methyl 6-(1H-pyrazol-1-yl)nicotinate | ESD-893370-100MG |
| Cas.: 321533-62-4 | Purity: 98% | Methyl 6-(1H-pyrazol-1-yl)nicotinate | ESD-893370-250MG |
| Cas.: 321533-62-4 | Purity: 98% | Methyl 6-(1H-pyrazol-1-yl)nicotinate | ESD-893370-1G |
| Cas.: 321533-62-4 | Purity: 98% | Methyl 6-(1H-pyrazol-1-yl)nicotinate | ESD-893370-5G |
| Cas.: 55218-73-0 | Purity: ≥95% | (4-Phenylpyridin-2-yl)methanol | ESD-893371-100MG |
| Cas.: 55218-73-0 | Purity: ≥95% | (4-Phenylpyridin-2-yl)methanol | ESD-893371-250MG |
| Cas.: 165669-07-8 | Purity: 97% | 7-Bromo-4-methyl-1H-indole | ESD-893372-100MG |
| Cas.: 165669-07-8 | Purity: 97% | 7-Bromo-4-methyl-1H-indole | ESD-893372-250MG |
| Cas.: 165669-07-8 | Purity: 97% | 7-Bromo-4-methyl-1H-indole | ESD-893372-1G |
| Cas.: 165669-07-8 | Purity: 97% | 7-Bromo-4-methyl-1H-indole | ESD-893372-5G |
| Cas.: 52867-42-2 | Purity: 95% | Methyl 2-methyl-5-oxo-2,5-dihydro-1H-pyrazole-3-carboxylate | ESD-893373-100MG |
| Cas.: 52867-42-2 | Purity: 95% | Methyl 2-methyl-5-oxo-2,5-dihydro-1H-pyrazole-3-carboxylate | ESD-893373-250MG |
| Cas.: 52867-42-2 | Purity: 95% | Methyl 2-methyl-5-oxo-2,5-dihydro-1H-pyrazole-3-carboxylate | ESD-893373-1G |
| Cas.: 52867-42-2 | Purity: 95% | Methyl 2-methyl-5-oxo-2,5-dihydro-1H-pyrazole-3-carboxylate | ESD-893373-5G |
| Cas.: 397323-70-5 | Purity: ≥95% | (2-Amino-3-bromophenyl)methanol | ESD-893374-100MG |
| Cas.: 397323-70-5 | Purity: ≥95% | (2-Amino-3-bromophenyl)methanol | ESD-893374-250MG |
| Cas.: 397323-70-5 | Purity: ≥95% | (2-Amino-3-bromophenyl)methanol | ESD-893374-1G |
| Cas.: 397323-70-5 | Purity: ≥95% | (2-Amino-3-bromophenyl)methanol | ESD-893374-5G |
| Cas.: 63037-63-8 | Purity: ≥95% | 4-Bromo-3-iodonitrobenzene | ESD-893375-100MG |
| Cas.: 63037-63-8 | Purity: ≥95% | 4-Bromo-3-iodonitrobenzene | ESD-893375-250MG |
| Cas.: 63037-63-8 | Purity: ≥95% | 4-Bromo-3-iodonitrobenzene | ESD-893375-1G |
| Cas.: 71825-51-9 | Purity: 98% | 2-Methyl-2-(4-nitrophenyl)propanenitrile | ESD-893376-100MG |
| Cas.: 71825-51-9 | Purity: 98% | 2-Methyl-2-(4-nitrophenyl)propanenitrile | ESD-893376-250MG |
| Cas.: 71825-51-9 | Purity: 98% | 2-Methyl-2-(4-nitrophenyl)propanenitrile | ESD-893376-1G |
| Cas.: 71825-51-9 | Purity: 98% | 2-Methyl-2-(4-nitrophenyl)propanenitrile | ESD-893376-5G |
| Cas.: 886365-79-3 | Purity: 97% | 5-Bromo-2-(2-methoxyethylamino)pyrimidine | ESD-893377-250MG |
| Cas.: 886365-79-3 | Purity: 97% | 5-Bromo-2-(2-methoxyethylamino)pyrimidine | ESD-893377-1G |
| Cas.: 886365-79-3 | Purity: 97% | 5-Bromo-2-(2-methoxyethylamino)pyrimidine | ESD-893377-5G |
| Cas.: 886365-79-3 | Purity: 97% | 5-Bromo-2-(2-methoxyethylamino)pyrimidine | ESD-893377-10G |
| Cas.: 21744-83-2 | Purity: 97% | 2-Methyl-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-893378-250MG |
| Cas.: 21744-83-2 | Purity: 97% | 2-Methyl-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-893378-1G |
| Cas.: 21744-83-2 | Purity: 97% | 2-Methyl-2H-benzo[b][1,4]oxazin-3(4H)-one | ESD-893378-5G |
| Cas.: 2941-56-2 | Purity: 97% | 2-Bromo-5-chlorobenzo[d]thiazole | ESD-893379-100MG |
| Cas.: 2941-56-2 | Purity: 97% | 2-Bromo-5-chlorobenzo[d]thiazole | ESD-893379-250MG |
| Cas.: 2941-56-2 | Purity: 97% | 2-Bromo-5-chlorobenzo[d]thiazole | ESD-893379-1G |
| Cas.: 2941-56-2 | Purity: 97% | 2-Bromo-5-chlorobenzo[d]thiazole | ESD-893379-5G |
| Cas.: 947-65-9 | Purity: ≥95% | Methyl 2-hydroxy-1-naphthoate | ESD-893380-1G |
| Cas.: 947-65-9 | Purity: ≥95% | Methyl 2-hydroxy-1-naphthoate | ESD-893380-5G |
| Cas.: 947-65-9 | Purity: ≥95% | Methyl 2-hydroxy-1-naphthoate | ESD-893380-10G |
| Cas.: 947-65-9 | Purity: ≥95% | Methyl 2-hydroxy-1-naphthoate | ESD-893380-25G |
| Cas.: 1030832-75-7 | Purity: 97% | 2-(4-Chloro-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-893381-250MG |
| Cas.: 1030832-75-7 | Purity: 97% | 2-(4-Chloro-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-893381-1G |
| Cas.: 1030832-75-7 | Purity: 97% | 2-(4-Chloro-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-893381-5G |
| Cas.: 1030832-75-7 | Purity: 97% | 2-(4-Chloro-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | ESD-893381-10G |
| Cas.: 954239-61-3 | Purity: 97% | Methyl 5-bromobenzo[d]oxazole-2-carboxylate | ESD-893382-100MG |
| Cas.: 954239-61-3 | Purity: 97% | Methyl 5-bromobenzo[d]oxazole-2-carboxylate | ESD-893382-250MG |
| Cas.: 1195684-52-6 | Purity: 97% | (3-(Benzylamino)oxetan-3-yl)methanol | ESD-893383-100MG |
| Cas.: 1195684-52-6 | Purity: 97% | (3-(Benzylamino)oxetan-3-yl)methanol | ESD-893383-250MG |
| Cas.: 1195684-52-6 | Purity: 97% | (3-(Benzylamino)oxetan-3-yl)methanol | ESD-893383-1G |
| Cas.: 22530-98-9 | Purity: 98% | 4-Benzyldihydrofuran-2(3H)-one | ESD-893384-250MG |
| Cas.: 22530-98-9 | Purity: 98% | 4-Benzyldihydrofuran-2(3H)-one | ESD-893384-1G |
| Cas.: 22530-98-9 | Purity: 98% | 4-Benzyldihydrofuran-2(3H)-one | ESD-893384-5G |
| Cas.: 36405-91-1 | Purity: 95% | 6-Oxo-3,6-dihydropyridazine-3-carboxylic acid | ESD-893385-1G |
| Cas.: 36405-91-1 | Purity: 95% | 6-Oxo-3,6-dihydropyridazine-3-carboxylic acid | ESD-893385-5G |
| Cas.: 139755-99-0 | Purity: ≥95% | 1-Methyl-3-propyl-1H-pyrazole-5-carboxylic acid | ESD-893386-250MG |
| Cas.: 139755-99-0 | Purity: ≥95% | 1-Methyl-3-propyl-1H-pyrazole-5-carboxylic acid | ESD-893386-1G |
| Cas.: 139755-99-0 | Purity: ≥95% | 1-Methyl-3-propyl-1H-pyrazole-5-carboxylic acid | ESD-893386-5G |
| Cas.: 703-12-8 | Purity: 98% | 4-Bromo-N-methylbenzenesulfonamide | ESD-893387-1G |
| Cas.: 703-12-8 | Purity: 98% | 4-Bromo-N-methylbenzenesulfonamide | ESD-893387-5G |
| Cas.: 703-12-8 | Purity: 98% | 4-Bromo-N-methylbenzenesulfonamide | ESD-893387-25G |
| Cas.: 703-12-8 | Purity: 98% | 4-Bromo-N-methylbenzenesulfonamide | ESD-893387-100G |
| Cas.: 1050501-88-6 | Purity: 97% | 2-Bromo-6-chloropyridin-3-amine | ESD-893388-1G |
| Cas.: 1050501-88-6 | Purity: 97% | 2-Bromo-6-chloropyridin-3-amine | ESD-893388-5G |
| Cas.: 1050501-88-6 | Purity: 97% | 2-Bromo-6-chloropyridin-3-amine | ESD-893388-25G |
| Cas.: 3240-10-6 | Purity: 98% | 3-(4-Chlorophenyl)propiolic acid | ESD-893389-250MG |
| Cas.: 3240-10-6 | Purity: 98% | 3-(4-Chlorophenyl)propiolic acid | ESD-893389-1G |
| Cas.: 3240-10-6 | Purity: 98% | 3-(4-Chlorophenyl)propiolic acid | ESD-893389-5G |
| Cas.: 3240-10-6 | Purity: 98% | 3-(4-Chlorophenyl)propiolic acid | ESD-893389-10G |
| Cas.: 37904-72-6 | Purity: ≥95% | 2-Bromo-1-(4-(dimethylamino)phenyl)ethanone | ESD-893390-250MG |
| Cas.: 37904-72-6 | Purity: ≥95% | 2-Bromo-1-(4-(dimethylamino)phenyl)ethanone | ESD-893390-1G |
| Cas.: 37904-72-6 | Purity: ≥95% | 2-Bromo-1-(4-(dimethylamino)phenyl)ethanone | ESD-893390-5G |
| Cas.: 1188232-19-0 | Purity: ≥95% | 4-Chlorobenzo[d]thiazole-2-carbonitrile | ESD-893391-100MG |
| Cas.: 1188232-19-0 | Purity: ≥95% | 4-Chlorobenzo[d]thiazole-2-carbonitrile | ESD-893391-250MG |
| Cas.: 21224-16-8 | Purity: ≥95% | 6-Ethyl-1,3-benzothiazol-2-amine | ESD-893392-100MG |
| Cas.: 21224-16-8 | Purity: ≥95% | 6-Ethyl-1,3-benzothiazol-2-amine | ESD-893392-250MG |
| Cas.: 21224-16-8 | Purity: ≥95% | 6-Ethyl-1,3-benzothiazol-2-amine | ESD-893392-1G |
| Cas.: 98910-61-3 | Purity: ≥95% | 5-Methoxy-2,2-dimethylchroman-4-one | ESD-893393-100MG |
| Cas.: 98910-61-3 | Purity: ≥95% | 5-Methoxy-2,2-dimethylchroman-4-one | ESD-893393-250MG |
| Cas.: 98910-61-3 | Purity: ≥95% | 5-Methoxy-2,2-dimethylchroman-4-one | ESD-893393-1G |
| Cas.: 75844-41-6 | Purity: 97% | 5-Methylquinazolin-4(1H)-one | ESD-893394-250MG |
| Cas.: 75844-41-6 | Purity: 97% | 5-Methylquinazolin-4(1H)-one | ESD-893394-1G |
| Cas.: 75844-41-6 | Purity: 97% | 5-Methylquinazolin-4(1H)-one | ESD-893394-5G |
| Cas.: 97483-79-9 | Purity: ≥95% | Ethyl 6-cyanopicolinate | ESD-893395-100MG |
| Cas.: 97483-79-9 | Purity: ≥95% | Ethyl 6-cyanopicolinate | ESD-893395-250MG |
| Cas.: 97483-79-9 | Purity: ≥95% | Ethyl 6-cyanopicolinate | ESD-893395-1G |
| Cas.: 97483-79-9 | Purity: ≥95% | Ethyl 6-cyanopicolinate | ESD-893395-5G |
| Cas.: 13575-41-2 | Purity: 97% | Thiazolo[4,5-b]pyridin-2-amine | ESD-893396-100MG |
| Cas.: 13575-41-2 | Purity: 97% | Thiazolo[4,5-b]pyridin-2-amine | ESD-893396-250MG |
| Cas.: 13575-41-2 | Purity: 97% | Thiazolo[4,5-b]pyridin-2-amine | ESD-893396-1G |
| Cas.: 13575-41-2 | Purity: 97% | Thiazolo[4,5-b]pyridin-2-amine | ESD-893396-5G |
| Cas.: 50488-36-3 | Purity: 97% | 8-Bromo-6-methoxyquinoline | ESD-893397-250MG |
| Cas.: 50488-36-3 | Purity: 97% | 8-Bromo-6-methoxyquinoline | ESD-893397-1G |
| Cas.: 6270-57-1 | Purity: ≥95% | Diethyl 3,4-dihydroxyfuran-2,5-dicarboxylate | ESD-893398-250MG |
| Cas.: 6270-57-1 | Purity: ≥95% | Diethyl 3,4-dihydroxyfuran-2,5-dicarboxylate | ESD-893398-1G |
| Cas.: 723294-74-4 | Purity: ≥95% | 5-Fluoro-3-iodobenzoic acid | ESD-893399-100MG |
| Cas.: 723294-74-4 | Purity: ≥95% | 5-Fluoro-3-iodobenzoic acid | ESD-893399-250MG |
| Cas.: 723294-74-4 | Purity: ≥95% | 5-Fluoro-3-iodobenzoic acid | ESD-893399-1G |
| Cas.: 723294-74-4 | Purity: ≥95% | 5-Fluoro-3-iodobenzoic acid | ESD-893399-5G |
| Cas.: 66790-62-3 | Purity: 97% | 4-Bromo-5-methyl-2,3-dihydro-1H-inden-1-one | ESD-893400-100MG |
| Cas.: 66790-62-3 | Purity: 97% | 4-Bromo-5-methyl-2,3-dihydro-1H-inden-1-one | ESD-893400-250MG |
| Cas.: 32260-73-4 | Purity: ≥95% | 7-Methoxy-8-methyl-3,4-dihydronaphthalen-1(2H)-one | ESD-893402-100MG |
| Cas.: 32260-73-4 | Purity: ≥95% | 7-Methoxy-8-methyl-3,4-dihydronaphthalen-1(2H)-one | ESD-893402-250MG |
| Cas.: 13669-51-7 | Purity: ≥95% | Quinolin-3-ylmethanol | ESD-893403-100MG |
| Cas.: 13669-51-7 | Purity: ≥95% | Quinolin-3-ylmethanol | ESD-893403-250MG |
| Cas.: 13669-51-7 | Purity: ≥95% | Quinolin-3-ylmethanol | ESD-893403-1G |
| Cas.: 7146-26-1 | Purity: ≥95% | 2-Aminothiazol-4-ol | ESD-893404-1G |
| Cas.: 7146-26-1 | Purity: ≥95% | 2-Aminothiazol-4-ol | ESD-893404-5G |
| Cas.: 7146-26-1 | Purity: ≥95% | 2-Aminothiazol-4-ol | ESD-893404-10G |
| Cas.: 856972-65-1 | Purity: ≥95% | 4-Chloro-6-(methoxymethyl)pyrimidin-2-amine | ESD-893405-100MG |
| Cas.: 856972-65-1 | Purity: ≥95% | 4-Chloro-6-(methoxymethyl)pyrimidin-2-amine | ESD-893405-250MG |
| Cas.: 39905-48-1 | Purity: ≥95% | 4-(Cyclohexyloxy)aniline | ESD-893406-100MG |
| Cas.: 39905-48-1 | Purity: ≥95% | 4-(Cyclohexyloxy)aniline | ESD-893406-250MG |
| Cas.: 39905-48-1 | Purity: ≥95% | 4-(Cyclohexyloxy)aniline | ESD-893406-1G |
| Cas.: 39905-48-1 | Purity: ≥95% | 4-(Cyclohexyloxy)aniline | ESD-893406-5G |
| Cas.: 3719-45-7 | Purity: 97% | 1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid | ESD-893407-250MG |
| Cas.: 3719-45-7 | Purity: 97% | 1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid | ESD-893407-1G |
| Cas.: 3719-45-7 | Purity: 97% | 1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid | ESD-893407-5G |
| Cas.: 3719-45-7 | Purity: 97% | 1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid | ESD-893407-10G |
| Cas.: 20921-00-0 | Purity: 97% | 6-Bromochroman-2-one | ESD-893408-250MG |
| Cas.: 20921-00-0 | Purity: 97% | 6-Bromochroman-2-one | ESD-893408-1G |
| Cas.: 20921-00-0 | Purity: 97% | 6-Bromochroman-2-one | ESD-893408-5G |
| Cas.: 20921-00-0 | Purity: 97% | 6-Bromochroman-2-one | ESD-893408-10G |
| Cas.: 338454-02-7 | Purity: ≥95% | Methyl 3,5-dihydroxy-4-iodobenzoate | ESD-893409-100MG |
| Cas.: 338454-02-7 | Purity: ≥95% | Methyl 3,5-dihydroxy-4-iodobenzoate | ESD-893409-250MG |
| Cas.: 338454-02-7 | Purity: ≥95% | Methyl 3,5-dihydroxy-4-iodobenzoate | ESD-893409-1G |
| Cas.: 175277-67-5 | Purity: 98% | 2,6-Dichloro-4-(trifluoromethyl)pyridin-3-amine | ESD-893410-250MG |
| Cas.: 175277-67-5 | Purity: 98% | 2,6-Dichloro-4-(trifluoromethyl)pyridin-3-amine | ESD-893410-1G |
| Cas.: 175277-67-5 | Purity: 98% | 2,6-Dichloro-4-(trifluoromethyl)pyridin-3-amine | ESD-893410-5G |
| Cas.: 175277-67-5 | Purity: 98% | 2,6-Dichloro-4-(trifluoromethyl)pyridin-3-amine | ESD-893410-10G |
| Cas.: 89380-77-8 | Purity: ≥95% | Methyl 3-hydroxy-5-nitrothiophene-2-carboxylate | ESD-893411-100MG |
| Cas.: 89380-77-8 | Purity: ≥95% | Methyl 3-hydroxy-5-nitrothiophene-2-carboxylate | ESD-893411-250MG |
| Cas.: 89380-77-8 | Purity: ≥95% | Methyl 3-hydroxy-5-nitrothiophene-2-carboxylate | ESD-893411-1G |
| Cas.: 89380-77-8 | Purity: ≥95% | Methyl 3-hydroxy-5-nitrothiophene-2-carboxylate | ESD-893411-5G |
| Cas.: 181950-57-2 | Purity: 98% | 4-Chloro-7-hydroxyquinoline | ESD-893412-250MG |
| Cas.: 181950-57-2 | Purity: 98% | 4-Chloro-7-hydroxyquinoline | ESD-893412-1G |
| Cas.: 181950-57-2 | Purity: 98% | 4-Chloro-7-hydroxyquinoline | ESD-893412-5G |
| Cas.: 1273653-86-3 | Purity: 97% | 5-Chloro-8-fluorochroman-4-one | ESD-893413-100MG |
| Cas.: 1273653-86-3 | Purity: 97% | 5-Chloro-8-fluorochroman-4-one | ESD-893413-250MG |
| Cas.: 1432323-27-7 | Purity: 97% | 4-Bromo-8-methyl-1,5-naphthyridine | ESD-893414-100MG |
| Cas.: 1432323-27-7 | Purity: 97% | 4-Bromo-8-methyl-1,5-naphthyridine | ESD-893414-250MG |
| Cas.: 1432323-27-7 | Purity: 97% | 4-Bromo-8-methyl-1,5-naphthyridine | ESD-893414-1G |
| Cas.: 1432323-27-7 | Purity: 97% | 4-Bromo-8-methyl-1,5-naphthyridine | ESD-893414-5G |
| Cas.: 1260883-24-6 | Purity: ≥95% | 4-Aminopipidin-2-one hydrochloride | ESD-893415-100MG |
| Cas.: 1260883-24-6 | Purity: ≥95% | 4-Aminopipidin-2-one hydrochloride | ESD-893415-250MG |
| Cas.: 1260883-24-6 | Purity: ≥95% | 4-Aminopipidin-2-one hydrochloride | ESD-893415-1G |
| Cas.: 762263-64-9 | Purity: ≥95% | Pyrazin-2-ylboronic acid | ESD-893416-25MG |
| Cas.: 762263-64-9 | Purity: ≥95% | Pyrazin-2-ylboronic acid | ESD-893416-100MG |
| Cas.: 762263-64-9 | Purity: ≥95% | Pyrazin-2-ylboronic acid | ESD-893416-250MG |
| Cas.: 960203-41-2 | Purity: 97% | (2-Bromophenyl)(2,4-dimethylphenyl)sulfane | ESD-893417-1G |
| Cas.: 960203-41-2 | Purity: 97% | (2-Bromophenyl)(2,4-dimethylphenyl)sulfane | ESD-893417-5G |
| Cas.: 848841-54-3 | Purity: 98% | 6-Iodoquinazoline | ESD-893418-100MG |
| Cas.: 848841-54-3 | Purity: 98% | 6-Iodoquinazoline | ESD-893418-250MG |
| Cas.: 65001-21-0 | Purity: 98% | 5-Bromopyridine-3-sulfonyl chloride | ESD-893419-100MG |
| Cas.: 65001-21-0 | Purity: 98% | 5-Bromopyridine-3-sulfonyl chloride | ESD-893419-250MG |
| Cas.: 65001-21-0 | Purity: 98% | 5-Bromopyridine-3-sulfonyl chloride | ESD-893419-1G |
| Cas.: 65001-21-0 | Purity: 98% | 5-Bromopyridine-3-sulfonyl chloride | ESD-893419-5G |
| Cas.: 715-11-7 | Purity: ≥95% | sec-Butyl 4-methylbenzenesulfonate | ESD-893420-250MG |
| Cas.: 715-11-7 | Purity: ≥95% | sec-Butyl 4-methylbenzenesulfonate | ESD-893420-1G |
| Cas.: 715-11-7 | Purity: ≥95% | sec-Butyl 4-methylbenzenesulfonate | ESD-893420-5G |
| Cas.: 715-11-7 | Purity: ≥95% | sec-Butyl 4-methylbenzenesulfonate | ESD-893420-10G |
| Cas.: 134419-59-3 | Purity: 97% | Tetrahydro-2H-pyran-4-yl methanesulfonate | ESD-893421-1G |
| Cas.: 134419-59-3 | Purity: 97% | Tetrahydro-2H-pyran-4-yl methanesulfonate | ESD-893421-5G |
| Cas.: 134419-59-3 | Purity: 97% | Tetrahydro-2H-pyran-4-yl methanesulfonate | ESD-893421-10G |
| Cas.: 134419-59-3 | Purity: 97% | Tetrahydro-2H-pyran-4-yl methanesulfonate | ESD-893421-25G |
| Cas.: 90178-82-8 | Purity: 97% | 3-Formyl-4-nitrobenzonitrile | ESD-893422-100MG |
| Cas.: 90178-82-8 | Purity: 97% | 3-Formyl-4-nitrobenzonitrile | ESD-893422-250MG |
| Cas.: 90178-82-8 | Purity: 97% | 3-Formyl-4-nitrobenzonitrile | ESD-893422-1G |
| Cas.: 90178-82-8 | Purity: 97% | 3-Formyl-4-nitrobenzonitrile | ESD-893422-5G |
| Cas.: 147937-36-8 | Purity: 98% | 3-(Chloromethyl)isoquinoline | ESD-893423-100MG |
| Cas.: 147937-36-8 | Purity: 98% | 3-(Chloromethyl)isoquinoline | ESD-893423-250MG |
| Cas.: 147937-36-8 | Purity: 98% | 3-(Chloromethyl)isoquinoline | ESD-893423-1G |
| Cas.: 78686-83-6 | Purity: 97% | Methyl 2-chloro-5-iodonicotinate | ESD-893424-250MG |
| Cas.: 78686-83-6 | Purity: 97% | Methyl 2-chloro-5-iodonicotinate | ESD-893424-1G |
| Cas.: 78686-83-6 | Purity: 97% | Methyl 2-chloro-5-iodonicotinate | ESD-893424-5G |
| Cas.: 78686-83-6 | Purity: 97% | Methyl 2-chloro-5-iodonicotinate | ESD-893424-10G |
| Cas.: 37908-97-7 | Purity: 97% | 3,5-Dichloro-4-methoxybenzoic acid | ESD-893425-250MG |
| Cas.: 37908-97-7 | Purity: 97% | 3,5-Dichloro-4-methoxybenzoic acid | ESD-893425-1G |
| Cas.: 37908-97-7 | Purity: 97% | 3,5-Dichloro-4-methoxybenzoic acid | ESD-893425-5G |
| Cas.: 37908-97-7 | Purity: 97% | 3,5-Dichloro-4-methoxybenzoic acid | ESD-893425-10G |
| Cas.: 18514-76-6 | Purity: ≥95% | 5-Nitroquinoxaline | ESD-893426-100MG |
| Cas.: 18514-76-6 | Purity: ≥95% | 5-Nitroquinoxaline | ESD-893426-250MG |
| Cas.: 18514-76-6 | Purity: ≥95% | 5-Nitroquinoxaline | ESD-893426-1G |
| Cas.: 18514-76-6 | Purity: ≥95% | 5-Nitroquinoxaline | ESD-893426-5G |
| Cas.: 21575-91-7 | Purity: 95% | Ethyl 3-(3-bromophenyl)-3-oxopropanoate | ESD-893427-100MG |
| Cas.: 21575-91-7 | Purity: 95% | Ethyl 3-(3-bromophenyl)-3-oxopropanoate | ESD-893427-250MG |
| Cas.: 21575-91-7 | Purity: 95% | Ethyl 3-(3-bromophenyl)-3-oxopropanoate | ESD-893427-1G |
| Cas.: 21575-91-7 | Purity: 95% | Ethyl 3-(3-bromophenyl)-3-oxopropanoate | ESD-893427-5G |
| Cas.: 31827-94-8 | Purity: ≥95% | 2-Bromo-1-(4-iodophenyl)ethanone | ESD-893428-250MG |
| Cas.: 31827-94-8 | Purity: ≥95% | 2-Bromo-1-(4-iodophenyl)ethanone | ESD-893428-1G |
| Cas.: 31827-94-8 | Purity: ≥95% | 2-Bromo-1-(4-iodophenyl)ethanone | ESD-893428-5G |
| Cas.: 31827-94-8 | Purity: ≥95% | 2-Bromo-1-(4-iodophenyl)ethanone | ESD-893428-10G |
| Cas.: 421553-62-0 | Purity: 97% | 2′-Methoxy-[1,1′-biphenyl]-4-carbaldehyde | ESD-893429-250MG |
| Cas.: 421553-62-0 | Purity: 97% | 2′-Methoxy-[1,1′-biphenyl]-4-carbaldehyde | ESD-893429-1G |
| Cas.: 421553-62-0 | Purity: 97% | 2′-Methoxy-[1,1′-biphenyl]-4-carbaldehyde | ESD-893429-5G |
| Cas.: 421553-62-0 | Purity: 97% | 2′-Methoxy-[1,1′-biphenyl]-4-carbaldehyde | ESD-893429-10G |
| Cas.: 94-31-5 | Purity: 98% | 4-((2-Chloroethyl)(methyl)amino)benzaldehyde | ESD-893430-250MG |
| Cas.: 94-31-5 | Purity: 98% | 4-((2-Chloroethyl)(methyl)amino)benzaldehyde | ESD-893430-1G |
| Cas.: 94-31-5 | Purity: 98% | 4-((2-Chloroethyl)(methyl)amino)benzaldehyde | ESD-893430-5G |
| Cas.: 114969-66-3 | Purity: ≥95% | 5-Bromo-4-cyanopyrimidine | ESD-893431-100MG |
| Cas.: 114969-66-3 | Purity: ≥95% | 5-Bromo-4-cyanopyrimidine | ESD-893431-250MG |
| Cas.: 114969-66-3 | Purity: ≥95% | 5-Bromo-4-cyanopyrimidine | ESD-893431-1G |
| Cas.: 114969-66-3 | Purity: ≥95% | 5-Bromo-4-cyanopyrimidine | ESD-893431-5G |
| Cas.: 1211533-09-3 | Purity: 97% | 5-Cyanopyrazine-2-carboxylic acid | ESD-893432-100MG |
| Cas.: 1211533-09-3 | Purity: 97% | 5-Cyanopyrazine-2-carboxylic acid | ESD-893432-250MG |
| Cas.: 1211533-09-3 | Purity: 97% | 5-Cyanopyrazine-2-carboxylic acid | ESD-893432-1G |
| Cas.: 236406-33-0 | Purity: 97% | tert-Butyl 4-(2-hydroxyethyl)-4-methylpiperidine-1-carboxylate | ESD-893433-100MG |
| Cas.: 236406-33-0 | Purity: 97% | tert-Butyl 4-(2-hydroxyethyl)-4-methylpiperidine-1-carboxylate | ESD-893433-250MG |
| Cas.: 195730-31-5 | Purity: 98% | Bicyclo[4.2.0]octa-1,3,5-trien-3-ylboronic acid | ESD-893434-100MG |
| Cas.: 195730-31-5 | Purity: 98% | Bicyclo[4.2.0]octa-1,3,5-trien-3-ylboronic acid | ESD-893434-250MG |
| Cas.: 195730-31-5 | Purity: 98% | Bicyclo[4.2.0]octa-1,3,5-trien-3-ylboronic acid | ESD-893434-1G |
| Cas.: 134896-35-8 | Purity: ≥95% | 3-Nitro-2-phenylpyridine | ESD-893435-1G |
| Cas.: 134896-35-8 | Purity: ≥95% | 3-Nitro-2-phenylpyridine | ESD-893435-5G |
| Cas.: 137736-63-1 | Purity: 97% | 2-(4-Bromophenoxy)-5-(trifluoromethyl)pyridine | ESD-893436-100MG |
| Cas.: 137736-63-1 | Purity: 97% | 2-(4-Bromophenoxy)-5-(trifluoromethyl)pyridine | ESD-893436-250MG |
| Cas.: 137736-63-1 | Purity: 97% | 2-(4-Bromophenoxy)-5-(trifluoromethyl)pyridine | ESD-893436-1G |
| Cas.: 137736-63-1 | Purity: 97% | 2-(4-Bromophenoxy)-5-(trifluoromethyl)pyridine | ESD-893436-5G |
| Cas.: 474330-54-6 | Purity: 97% | Methyl 5-amino-2-bromo-4-methylbenzoate | ESD-893437-250MG |
| Cas.: 474330-54-6 | Purity: 97% | Methyl 5-amino-2-bromo-4-methylbenzoate | ESD-893437-1G |
| Cas.: 474330-54-6 | Purity: 97% | Methyl 5-amino-2-bromo-4-methylbenzoate | ESD-893437-5G |
| Cas.: 474330-54-6 | Purity: 97% | Methyl 5-amino-2-bromo-4-methylbenzoate | ESD-893437-10G |
| Cas.: 113310-52-4 | Purity: 97% | 4-(Piperidin-4-yl)aniline | ESD-893438-250MG |
| Cas.: 113310-52-4 | Purity: 97% | 4-(Piperidin-4-yl)aniline | ESD-893438-1G |
| Cas.: 113310-52-4 | Purity: 97% | 4-(Piperidin-4-yl)aniline | ESD-893438-5G |
| Cas.: 113310-52-4 | Purity: 97% | 4-(Piperidin-4-yl)aniline | ESD-893438-10G |
| Cas.: 220185-63-7 | Purity: 97% | 4,5-Dichloro-2-iodoaniline | ESD-893439-100MG |
| Cas.: 220185-63-7 | Purity: 97% | 4,5-Dichloro-2-iodoaniline | ESD-893439-250MG |
| Cas.: 220185-63-7 | Purity: 97% | 4,5-Dichloro-2-iodoaniline | ESD-893439-1G |
| Cas.: 83179-01-5 | Purity: ≥95% | Ethyl 7-chlorothieno[3,2-b]pyridine-6-carboxylate | ESD-893440-100MG |
| Cas.: 83179-01-5 | Purity: ≥95% | Ethyl 7-chlorothieno[3,2-b]pyridine-6-carboxylate | ESD-893440-250MG |
| Cas.: 83179-01-5 | Purity: ≥95% | Ethyl 7-chlorothieno[3,2-b]pyridine-6-carboxylate | ESD-893440-1G |
| Cas.: 59713-58-5 | Purity: ≥95% | Ethyl 4-chlorothieno[2,3-b]pyridine-5-carboxylate | ESD-893441-100MG |
| Cas.: 59713-58-5 | Purity: ≥95% | Ethyl 4-chlorothieno[2,3-b]pyridine-5-carboxylate | ESD-893441-250MG |
| Cas.: 59713-58-5 | Purity: ≥95% | Ethyl 4-chlorothieno[2,3-b]pyridine-5-carboxylate | ESD-893441-1G |
| Cas.: 79965-62-1 | Purity: ≥95% | 4-Methyl-3-nitroquinoline | ESD-893442-100MG |
| Cas.: 79965-62-1 | Purity: ≥95% | 4-Methyl-3-nitroquinoline | ESD-893442-250MG |
| Cas.: 79965-62-1 | Purity: ≥95% | 4-Methyl-3-nitroquinoline | ESD-893442-1G |
| Cas.: 211915-96-7 | Purity: ≥95% | Methyl 5-amino-6-chloronicotinate | ESD-893443-100MG |
| Cas.: 211915-96-7 | Purity: ≥95% | Methyl 5-amino-6-chloronicotinate | ESD-893443-250MG |
| Cas.: 211915-96-7 | Purity: ≥95% | Methyl 5-amino-6-chloronicotinate | ESD-893443-1G |
| Cas.: 211915-96-7 | Purity: ≥95% | Methyl 5-amino-6-chloronicotinate | ESD-893443-5G |
| Cas.: 1452574-71-8 | Purity: 97% | (5-Bromo-2-chloro-4-(trifluoromethyl)phenyl)boronic acid | ESD-893444-100MG |
| Cas.: 1452574-71-8 | Purity: 97% | (5-Bromo-2-chloro-4-(trifluoromethyl)phenyl)boronic acid | ESD-893444-250MG |
| Cas.: 1452574-71-8 | Purity: 97% | (5-Bromo-2-chloro-4-(trifluoromethyl)phenyl)boronic acid | ESD-893444-1G |
| Cas.: 1452574-71-8 | Purity: 97% | (5-Bromo-2-chloro-4-(trifluoromethyl)phenyl)boronic acid | ESD-893444-5G |
| Cas.: 1033202-51-5 | Purity: 97% | 5-Fluoro-3-nitropicolinonitrile | ESD-893445-100MG |
| Cas.: 1033202-51-5 | Purity: 97% | 5-Fluoro-3-nitropicolinonitrile | ESD-893445-250MG |
| Cas.: 1033202-51-5 | Purity: 97% | 5-Fluoro-3-nitropicolinonitrile | ESD-893445-1G |
| Cas.: 1033202-51-5 | Purity: 97% | 5-Fluoro-3-nitropicolinonitrile | ESD-893445-5G |
| Cas.: 1374258-63-5 | Purity: ≥95% | 6-Bromo-3-(trifluoromethyl)-1H-indazole | ESD-893446-100MG |
| Cas.: 1374258-63-5 | Purity: ≥95% | 6-Bromo-3-(trifluoromethyl)-1H-indazole | ESD-893446-250MG |
| Cas.: 1374258-63-5 | Purity: ≥95% | 6-Bromo-3-(trifluoromethyl)-1H-indazole | ESD-893446-1G |
| Cas.: 55414-72-7 | Purity: 97% | (2-Amino-5-methoxyphenyl)methanol | ESD-893447-100MG |
| Cas.: 55414-72-7 | Purity: 97% | (2-Amino-5-methoxyphenyl)methanol | ESD-893447-250MG |
| Cas.: 55414-72-7 | Purity: 97% | (2-Amino-5-methoxyphenyl)methanol | ESD-893447-1G |
| Cas.: 55414-72-7 | Purity: 97% | (2-Amino-5-methoxyphenyl)methanol | ESD-893447-5G |
| Cas.: 1196147-56-4 | Purity: ≥95% | 3-Bromo-6-methoxypicolinic acid | ESD-893448-100MG |
| Cas.: 1196147-56-4 | Purity: ≥95% | 3-Bromo-6-methoxypicolinic acid | ESD-893448-250MG |
| Cas.: 1196147-56-4 | Purity: ≥95% | 3-Bromo-6-methoxypicolinic acid | ESD-893448-1G |
| Cas.: 52191-15-8 | Purity: 95% | 4-(2-Bromoethoxy)benzaldehyde | ESD-893449-100MG |
| Cas.: 52191-15-8 | Purity: 95% | 4-(2-Bromoethoxy)benzaldehyde | ESD-893449-250MG |
| Cas.: 52191-15-8 | Purity: 95% | 4-(2-Bromoethoxy)benzaldehyde | ESD-893449-1G |
| Cas.: 52191-15-8 | Purity: 95% | 4-(2-Bromoethoxy)benzaldehyde | ESD-893449-5G |
| Cas.: 54582-35-3 | Purity: 97% | 1-(4-Methoxybenzyl)urea | ESD-893450-250MG |
| Cas.: 54582-35-3 | Purity: 97% | 1-(4-Methoxybenzyl)urea | ESD-893450-1G |
| Cas.: 54582-35-3 | Purity: 97% | 1-(4-Methoxybenzyl)urea | ESD-893450-5G |
| Cas.: 54582-35-3 | Purity: 97% | 1-(4-Methoxybenzyl)urea | ESD-893450-10G |
| Cas.: 17945-54-9 | Purity: ≥95% | Ethyl 3-(benzylamino)-3-methylbutanoate | ESD-893451-100MG |
| Cas.: 17945-54-9 | Purity: ≥95% | Ethyl 3-(benzylamino)-3-methylbutanoate | ESD-893451-250MG |
| Cas.: 20996-87-6 | Purity: 97% | 1-Methyl-1H-indole-6-carbonitrile | ESD-893452-100MG |
| Cas.: 20996-87-6 | Purity: 97% | 1-Methyl-1H-indole-6-carbonitrile | ESD-893452-250MG |
| Cas.: 20996-87-6 | Purity: 97% | 1-Methyl-1H-indole-6-carbonitrile | ESD-893452-1G |
| Cas.: 20996-87-6 | Purity: 97% | 1-Methyl-1H-indole-6-carbonitrile | ESD-893452-5G |
| Cas.: 70810-23-0 | Purity: 97% | 1,5-Dichloroisoquinoline | ESD-893453-100MG |
| Cas.: 70810-23-0 | Purity: 97% | 1,5-Dichloroisoquinoline | ESD-893453-250MG |
| Cas.: 70810-23-0 | Purity: 97% | 1,5-Dichloroisoquinoline | ESD-893453-1G |
| Cas.: 3441-01-8 | Purity: 97% | 3-Cyanobenzamide | ESD-893454-1G |
| Cas.: 3441-01-8 | Purity: 97% | 3-Cyanobenzamide | ESD-893454-5G |
| Cas.: 3441-01-8 | Purity: 97% | 3-Cyanobenzamide | ESD-893454-10G |
| Cas.: 894852-86-9 | Purity: ≥95% | 1-Ethyl-1H-indole-4-carbaldehyde | ESD-893455-100MG |
| Cas.: 25617-34-9 | Purity: 98% | N-(4-(Trifluoromethyl)phenyl)pivalamide | ESD-893456-250MG |
| Cas.: 25617-34-9 | Purity: 98% | N-(4-(Trifluoromethyl)phenyl)pivalamide | ESD-893456-1G |
| Cas.: 25617-34-9 | Purity: 98% | N-(4-(Trifluoromethyl)phenyl)pivalamide | ESD-893456-5G |
| Cas.: 1189757-62-7 | Purity: 97% | 5-Bromo-3-methoxypyridin-2(1H)-one | ESD-893457-100MG |
| Cas.: 1189757-62-7 | Purity: 97% | 5-Bromo-3-methoxypyridin-2(1H)-one | ESD-893457-250MG |
| Cas.: 74733-90-7 | Purity: ≥95% | 2-(4-Bromophenyl)-2H-1,2,3-triazole | ESD-893458-100MG |
| Cas.: 74733-90-7 | Purity: ≥95% | 2-(4-Bromophenyl)-2H-1,2,3-triazole | ESD-893458-250MG |
| Cas.: 74733-90-7 | Purity: ≥95% | 2-(4-Bromophenyl)-2H-1,2,3-triazole | ESD-893458-1G |
| Cas.: 2521-91-7 | Purity: ≥95% | Ethyl 2-((3-bromophenyl)amino)acetate | ESD-893459-250MG |
| Cas.: 2521-91-7 | Purity: ≥95% | Ethyl 2-((3-bromophenyl)amino)acetate | ESD-893459-1G |
| Cas.: 2521-91-7 | Purity: ≥95% | Ethyl 2-((3-bromophenyl)amino)acetate | ESD-893459-5G |
| Cas.: 1451391-83-5 | Purity: 97% | 4,6-Dichloropyrimidine-2-carbonitrile | ESD-893460-100MG |
| Cas.: 1451391-83-5 | Purity: 97% | 4,6-Dichloropyrimidine-2-carbonitrile | ESD-893460-250MG |
| Cas.: 199522-66-2 | Purity: 96% | N1-(5-Bromopyrid-2-yl)ethane-1,2-diamine | ESD-893461-1G |
| Cas.: 199522-66-2 | Purity: 96% | N1-(5-Bromopyrid-2-yl)ethane-1,2-diamine | ESD-893461-5G |
| Cas.: 65343-67-1 | Purity: 95% | Ethyl 2-(4-hydroxyphenoxy)propanoate | ESD-893462-5G |
| Cas.: 65343-67-1 | Purity: 95% | Ethyl 2-(4-hydroxyphenoxy)propanoate | ESD-893462-10G |
| Cas.: 65343-67-1 | Purity: 95% | Ethyl 2-(4-hydroxyphenoxy)propanoate | ESD-893462-25G |
| Cas.: 101494-95-5 | Purity: 95% | 8-Chloroquinazolin-4-ol | ESD-893463-1G |
| Cas.: 101494-95-5 | Purity: 95% | 8-Chloroquinazolin-4-ol | ESD-893463-5G |
| Cas.: 1209459-78-8 | Purity: ≥95% | Methyl 2-bromopyrimidine-4-carboxylate | ESD-893464-100MG |
| Cas.: 1209459-78-8 | Purity: ≥95% | Methyl 2-bromopyrimidine-4-carboxylate | ESD-893464-250MG |
| Cas.: 1209459-78-8 | Purity: ≥95% | Methyl 2-bromopyrimidine-4-carboxylate | ESD-893464-1G |
| Cas.: 1209459-78-8 | Purity: ≥95% | Methyl 2-bromopyrimidine-4-carboxylate | ESD-893464-5G |
| Cas.: 142253-50-7 | Purity: 97% | (S)-tert-Butyl 2-(cyanomethyl)pyrrolidine-1-carboxylate | ESD-893465-100MG |
| Cas.: 142253-50-7 | Purity: 97% | (S)-tert-Butyl 2-(cyanomethyl)pyrrolidine-1-carboxylate | ESD-893465-250MG |
| Cas.: 142253-50-7 | Purity: 97% | (S)-tert-Butyl 2-(cyanomethyl)pyrrolidine-1-carboxylate | ESD-893465-1G |
| Cas.: 183182-07-2 | Purity: 98% | (R)-3-Amino-2-benzylpropanoic acid | ESD-893466-100MG |
| Cas.: 183182-07-2 | Purity: 98% | (R)-3-Amino-2-benzylpropanoic acid | ESD-893466-250MG |
| Cas.: 929277-63-4 | Purity: 98% | (2-((tert-Butyldimethylsilyl)oxy)phenyl)boronic acid | ESD-893467-100MG |
| Cas.: 929277-63-4 | Purity: 98% | (2-((tert-Butyldimethylsilyl)oxy)phenyl)boronic acid | ESD-893467-250MG |
| Cas.: 929277-63-4 | Purity: 98% | (2-((tert-Butyldimethylsilyl)oxy)phenyl)boronic acid | ESD-893467-1G |
| Cas.: 100487-74-9 | Purity: 97% | 6-Chloro-5-fluoroindolin-2-one | ESD-893468-100MG |
| Cas.: 100487-74-9 | Purity: 97% | 6-Chloro-5-fluoroindolin-2-one | ESD-893468-250MG |
| Cas.: 100487-74-9 | Purity: 97% | 6-Chloro-5-fluoroindolin-2-one | ESD-893468-1G |
| Cas.: 100487-74-9 | Purity: 97% | 6-Chloro-5-fluoroindolin-2-one | ESD-893468-5G |
| Cas.: 6301-54-8 | Purity: ≥95% | 2-(Naphthalen-1-yl)propan-2-ol | ESD-893469-100MG |
| Cas.: 6301-54-8 | Purity: ≥95% | 2-(Naphthalen-1-yl)propan-2-ol | ESD-893469-250MG |
| Cas.: 6301-54-8 | Purity: ≥95% | 2-(Naphthalen-1-yl)propan-2-ol | ESD-893469-1G |
| Cas.: 6301-54-8 | Purity: ≥95% | 2-(Naphthalen-1-yl)propan-2-ol | ESD-893469-5G |
| Cas.: 145485-58-1 | Purity: 97% | 6-Fluoro-4,5-dihydro-1H-benzo[b]azepin-2(3H)-one | ESD-893470-100MG |
| Cas.: 145485-58-1 | Purity: 97% | 6-Fluoro-4,5-dihydro-1H-benzo[b]azepin-2(3H)-one | ESD-893470-250MG |
| Cas.: 145485-58-1 | Purity: 97% | 6-Fluoro-4,5-dihydro-1H-benzo[b]azepin-2(3H)-one | ESD-893470-1G |
| Cas.: 313545-39-0 | Purity: 97% | (4-Ethoxy-2-(trifluoromethyl)phenyl)boronic acid | ESD-893471-100MG |
| Cas.: 313545-39-0 | Purity: 97% | (4-Ethoxy-2-(trifluoromethyl)phenyl)boronic acid | ESD-893471-250MG |
| Cas.: 313545-39-0 | Purity: 97% | (4-Ethoxy-2-(trifluoromethyl)phenyl)boronic acid | ESD-893471-1G |
| Cas.: 52397-81-6 | Purity: 97% | 4,6-Dichloro-2,3-dihydro-1H-inden-1-one | ESD-893472-100MG |
| Cas.: 52397-81-6 | Purity: 97% | 4,6-Dichloro-2,3-dihydro-1H-inden-1-one | ESD-893472-250MG |
| Cas.: 52397-81-6 | Purity: 97% | 4,6-Dichloro-2,3-dihydro-1H-inden-1-one | ESD-893472-1G |
| Cas.: 52397-81-6 | Purity: 97% | 4,6-Dichloro-2,3-dihydro-1H-inden-1-one | ESD-893472-5G |
| Cas.: 24566-95-8 | Purity: 95% | 1-(3-Aminopropyl)azepan-2-one | ESD-893473-100MG |
| Cas.: 24566-95-8 | Purity: 95% | 1-(3-Aminopropyl)azepan-2-one | ESD-893473-250MG |
| Cas.: 24566-95-8 | Purity: 95% | 1-(3-Aminopropyl)azepan-2-one | ESD-893473-1G |
| Cas.: 212555-23-2 | Purity: 98% | (2,4,6-Trimethoxyphenyl)methanethiol | ESD-893474-250MG |
| Cas.: 212555-23-2 | Purity: 98% | (2,4,6-Trimethoxyphenyl)methanethiol | ESD-893474-1G |
| Cas.: 212555-23-2 | Purity: 98% | (2,4,6-Trimethoxyphenyl)methanethiol | ESD-893474-5G |
| Cas.: 13785-48-3 | Purity: ≥95% | 2,6-Dichloro-3-nitroaniline | ESD-893475-20MG |
| Cas.: 959996-48-6 | Purity: 98% | (2-Bromo-5-fluorophenyl)boronic acid | ESD-893476-100MG |
| Cas.: 959996-48-6 | Purity: 98% | (2-Bromo-5-fluorophenyl)boronic acid | ESD-893476-250MG |
| Cas.: 959996-48-6 | Purity: 98% | (2-Bromo-5-fluorophenyl)boronic acid | ESD-893476-1G |
| Cas.: 57775-08-3 | Purity: 95% | 3-(4-Bromophenyl)propanenitrile | ESD-893477-250MG |
| Cas.: 57775-08-3 | Purity: 95% | 3-(4-Bromophenyl)propanenitrile | ESD-893477-1G |
| Cas.: 57775-08-3 | Purity: 95% | 3-(4-Bromophenyl)propanenitrile | ESD-893477-5G |
| Cas.: 433980-62-2 | Purity: ≥95% | 3-(Methylsulfonyl)pyrrolidine | ESD-893478-1G |
| Cas.: 23432-44-2 | Purity: 95% | 8-Methylquinolin-4(1H)-one | ESD-893479-100MG |
| Cas.: 23432-44-2 | Purity: 95% | 8-Methylquinolin-4(1H)-one | ESD-893479-250MG |
| Cas.: 23432-44-2 | Purity: 95% | 8-Methylquinolin-4(1H)-one | ESD-893479-1G |
| Cas.: 23432-44-2 | Purity: 95% | 8-Methylquinolin-4(1H)-one | ESD-893479-5G |
| Cas.: 1551-45-7 | Purity: 97% | Ethyl 4-oxo-4H-pyran-2-carboxylate | ESD-893480-100MG |
| Cas.: 1551-45-7 | Purity: 97% | Ethyl 4-oxo-4H-pyran-2-carboxylate | ESD-893480-250MG |
| Cas.: 1256804-49-5 | Purity: ≥95% | 4-(Difluoromethyl)picolinic acid | ESD-893481-100MG |
| Cas.: 1256804-49-5 | Purity: ≥95% | 4-(Difluoromethyl)picolinic acid | ESD-893481-250MG |
| Cas.: 936630-57-8 | Purity: ≥95% | (R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid | ESD-893482-250MG |
| Cas.: 936630-57-8 | Purity: ≥95% | (R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid | ESD-893482-1G |
| Cas.: 936630-57-8 | Purity: ≥95% | (R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid | ESD-893482-5G |
| Cas.: 1613329-94-4 | Purity: 97% | (6-Fluoro-2-methyl-3-nitrophenyl)methanol | ESD-893483-250MG |
| Cas.: 1613329-94-4 | Purity: 97% | (6-Fluoro-2-methyl-3-nitrophenyl)methanol | ESD-893483-1G |
| Cas.: 119138-29-3 | Purity: ≥95% | 4-(Hydroxymethyl)-3-methoxyphenol | ESD-893484-100MG |
| Cas.: 119138-29-3 | Purity: ≥95% | 4-(Hydroxymethyl)-3-methoxyphenol | ESD-893484-250MG |
| Cas.: 119138-29-3 | Purity: ≥95% | 4-(Hydroxymethyl)-3-methoxyphenol | ESD-893484-1G |
| Cas.: 119138-29-3 | Purity: ≥95% | 4-(Hydroxymethyl)-3-methoxyphenol | ESD-893484-5G |
| Cas.: 354512-22-4 | Purity: ≥95% | 3-Methoxy-5-nitrobenzaldehyde | ESD-893485-100MG |
| Cas.: 354512-22-4 | Purity: ≥95% | 3-Methoxy-5-nitrobenzaldehyde | ESD-893485-250MG |
| Cas.: 354512-22-4 | Purity: ≥95% | 3-Methoxy-5-nitrobenzaldehyde | ESD-893485-1G |
| Cas.: 99799-09-4 | Purity: ≥95% | 2-(4-Hydroxycyclohexyl)acetic acid | ESD-893486-100MG |
| Cas.: 99799-09-4 | Purity: ≥95% | 2-(4-Hydroxycyclohexyl)acetic acid | ESD-893486-250MG |
| Cas.: 99799-09-4 | Purity: ≥95% | 2-(4-Hydroxycyclohexyl)acetic acid | ESD-893486-1G |
| Cas.: 99799-09-4 | Purity: ≥95% | 2-(4-Hydroxycyclohexyl)acetic acid | ESD-893486-5G |
| Cas.: 97231-90-8 | Purity: ≥95% | Benzyl piperidine-3-carboxylate | ESD-893487-250MG |
| Cas.: 97231-90-8 | Purity: ≥95% | Benzyl piperidine-3-carboxylate | ESD-893487-1G |
| Cas.: 97231-90-8 | Purity: ≥95% | Benzyl piperidine-3-carboxylate | ESD-893487-5G |
| Cas.: 5118-07-0 | Purity: ≥95% | 3-Hydroxythiophene-2-carboxylic acid | ESD-893488-100MG |
| Cas.: 5118-07-0 | Purity: ≥95% | 3-Hydroxythiophene-2-carboxylic acid | ESD-893488-250MG |
| Cas.: 5118-07-0 | Purity: ≥95% | 3-Hydroxythiophene-2-carboxylic acid | ESD-893488-1G |
| Cas.: 100047-52-7 | Purity: ≥95% | 5-Methyl-1H-pyrrole-3-carboxylic acid | ESD-893489-100MG |
| Cas.: 100047-52-7 | Purity: ≥95% | 5-Methyl-1H-pyrrole-3-carboxylic acid | ESD-893489-250MG |
| Cas.: 100047-52-7 | Purity: ≥95% | 5-Methyl-1H-pyrrole-3-carboxylic acid | ESD-893489-1G |
| Cas.: 100047-52-7 | Purity: ≥95% | 5-Methyl-1H-pyrrole-3-carboxylic acid | ESD-893489-5G |
| Cas.: 2221-13-8 | Purity: ≥95% | 3-Phenylimidazolidine-2,4-dione | ESD-893490-100MG |
| Cas.: 2221-13-8 | Purity: ≥95% | 3-Phenylimidazolidine-2,4-dione | ESD-893490-250MG |
| Cas.: 2221-13-8 | Purity: ≥95% | 3-Phenylimidazolidine-2,4-dione | ESD-893490-1G |
| Cas.: 752198-38-2 | Purity: ≥95% | (R)-3-Amino-3-(o-tolyl)propanoic acid | ESD-893491-250MG |
| Cas.: 752198-38-2 | Purity: ≥95% | (R)-3-Amino-3-(o-tolyl)propanoic acid | ESD-893491-1G |
| Cas.: 752198-38-2 | Purity: ≥95% | (R)-3-Amino-3-(o-tolyl)propanoic acid | ESD-893491-5G |
| Cas.: 80126-54-1 | Purity: 97% | (R)-2-Amino-3-(o-tolyl)propanoic acid | ESD-893492-250MG |
| Cas.: 80126-54-1 | Purity: 97% | (R)-2-Amino-3-(o-tolyl)propanoic acid | ESD-893492-1G |
| Cas.: 80126-54-1 | Purity: 97% | (R)-2-Amino-3-(o-tolyl)propanoic acid | ESD-893492-5G |
| Cas.: 80126-54-1 | Purity: 97% | (R)-2-Amino-3-(o-tolyl)propanoic acid | ESD-893492-10G |
| Cas.: 6948-34-1 | Purity: 97% | 6-Methylthiochroman-4-one | ESD-893493-1G |
| Cas.: 6948-34-1 | Purity: 97% | 6-Methylthiochroman-4-one | ESD-893493-5G |
| Cas.: 22888-51-3 | Purity: 97% | 2-Amino-3-(o-tolyl)propanoic acid | ESD-893494-250MG |
| Cas.: 22888-51-3 | Purity: 97% | 2-Amino-3-(o-tolyl)propanoic acid | ESD-893494-1G |
| Cas.: 22888-51-3 | Purity: 97% | 2-Amino-3-(o-tolyl)propanoic acid | ESD-893494-5G |
| Cas.: 51068-78-1 | Purity: 97% | 2-Hydroxy-1-morpholinoethanone | ESD-893495-250MG |
| Cas.: 51068-78-1 | Purity: 97% | 2-Hydroxy-1-morpholinoethanone | ESD-893495-1G |
| Cas.: 51068-78-1 | Purity: 97% | 2-Hydroxy-1-morpholinoethanone | ESD-893495-5G |
| Cas.: 51068-78-1 | Purity: 97% | 2-Hydroxy-1-morpholinoethanone | ESD-893495-10G |
| Cas.: 155814-22-5 | Purity: 97% | 3-Chloro-4-fluorocinnamic acid | ESD-893496-1G |
| Cas.: 155814-22-5 | Purity: 97% | 3-Chloro-4-fluorocinnamic acid | ESD-893496-5G |
| Cas.: 155814-22-5 | Purity: 97% | 3-Chloro-4-fluorocinnamic acid | ESD-893496-10G |
| Cas.: 155814-22-5 | Purity: 97% | 3-Chloro-4-fluorocinnamic acid | ESD-893496-25G |
| Cas.: 261762-62-3 | Purity: ≥95% | 3-(3-Chloro-2-fluorophenyl)acrylic acid | ESD-893497-1G |
| Cas.: 261762-62-3 | Purity: ≥95% | 3-(3-Chloro-2-fluorophenyl)acrylic acid | ESD-893497-5G |
| Cas.: 885521-74-4 | Purity: ≥95% | 4-Chloro-6-methyl-1H-indazole | ESD-893498-100MG |
| Cas.: 885521-74-4 | Purity: ≥95% | 4-Chloro-6-methyl-1H-indazole | ESD-893498-250MG |
| Cas.: 443955-98-4 | Purity: ≥95% | (3R,4R)-rel-tert-Butyl 4-amino-3-hydroxypiperidine-1-carboxylate | ESD-893499-100MG |
| Cas.: 443955-98-4 | Purity: ≥95% | (3R,4R)-rel-tert-Butyl 4-amino-3-hydroxypiperidine-1-carboxylate | ESD-893499-250MG |
| Cas.: 443955-98-4 | Purity: ≥95% | (3R,4R)-rel-tert-Butyl 4-amino-3-hydroxypiperidine-1-carboxylate | ESD-893499-1G |
| Cas.: 936092-87-4 | Purity: ≥95% | 4-Bromo-7-methyl-1H-indole | ESD-893500-100MG |
| Cas.: 936092-87-4 | Purity: ≥95% | 4-Bromo-7-methyl-1H-indole | ESD-893500-250MG |
| Cas.: 936092-87-4 | Purity: ≥95% | 4-Bromo-7-methyl-1H-indole | ESD-893500-1G |
| Cas.: 936092-87-4 | Purity: ≥95% | 4-Bromo-7-methyl-1H-indole | ESD-893500-5G |
| Cas.: 351329-88-9 | Purity: 98% | N-(3,5-Dimethyladamantan-1-yl)formamide | ESD-893501-100MG |
| Cas.: 351329-88-9 | Purity: 98% | N-(3,5-Dimethyladamantan-1-yl)formamide | ESD-893501-250MG |
| Cas.: 1313617-76-3 | Purity: 97% | (3-Methoxy-2-methylphenyl)boronic acid | ESD-893502-100MG |
| Cas.: 1313617-76-3 | Purity: 97% | (3-Methoxy-2-methylphenyl)boronic acid | ESD-893502-250MG |
| Cas.: 1313617-76-3 | Purity: 97% | (3-Methoxy-2-methylphenyl)boronic acid | ESD-893502-1G |
| Cas.: 78920-10-2 | Purity: ≥98% | 5-Hydroxy-4-propylfuran-2(5H)-one | ESD-893503-1G |
| Cas.: 78920-10-2 | Purity: ≥98% | 5-Hydroxy-4-propylfuran-2(5H)-one | ESD-893503-5G |
| Cas.: 78920-10-2 | Purity: ≥98% | 5-Hydroxy-4-propylfuran-2(5H)-one | ESD-893503-10G |
| Cas.: 78920-10-2 | Purity: ≥98% | 5-Hydroxy-4-propylfuran-2(5H)-one | ESD-893503-25G |
| Cas.: 57478-19-0 | Purity: 98% | 4-(4-(Trifluoromethyl)phenoxy)aniline | ESD-893504-250MG |
| Cas.: 57478-19-0 | Purity: 98% | 4-(4-(Trifluoromethyl)phenoxy)aniline | ESD-893504-1G |
| Cas.: 57478-19-0 | Purity: 98% | 4-(4-(Trifluoromethyl)phenoxy)aniline | ESD-893504-5G |
| Cas.: 53967-21-8 | Purity: 97% | 6-(Bromomethyl)quinoxaline | ESD-893505-100MG |
| Cas.: 166599-84-4 | Purity: 97% | Benzofuran-4-carboxylic acid | ESD-893506-100MG |
| Cas.: 166599-84-4 | Purity: 97% | Benzofuran-4-carboxylic acid | ESD-893506-250MG |
| Cas.: 166599-84-4 | Purity: 97% | Benzofuran-4-carboxylic acid | ESD-893506-1G |
| Cas.: 26537-68-8 | Purity: 95% | Benzofuran-3-carboxylic acid | ESD-893507-250MG |
| Cas.: 26537-68-8 | Purity: 95% | Benzofuran-3-carboxylic acid | ESD-893507-1G |
| Cas.: 26537-68-8 | Purity: 95% | Benzofuran-3-carboxylic acid | ESD-893507-5G |
| Cas.: 98895-60-4 | Purity: 97% | 2-Cyano-3-cyclopropylacrylic acid | ESD-893508-100MG |
| Cas.: 98895-60-4 | Purity: 97% | 2-Cyano-3-cyclopropylacrylic acid | ESD-893508-250MG |
| Cas.: 90484-22-3 | Purity: ≥95% | Benzofuran-7-carboxylic acid | ESD-893509-100MG |
| Cas.: 90484-22-3 | Purity: ≥95% | Benzofuran-7-carboxylic acid | ESD-893509-250MG |
| Cas.: 90484-22-3 | Purity: ≥95% | Benzofuran-7-carboxylic acid | ESD-893509-1G |
| Cas.: 1213016-49-9 | Purity: 97% | (S)-2-Amino-2-(3-methoxyphenyl)ethanol | ESD-893510-250MG |
| Cas.: 1213016-49-9 | Purity: 97% | (S)-2-Amino-2-(3-methoxyphenyl)ethanol | ESD-893510-1G |
| Cas.: 915226-44-7 | Purity: 95% | 1-N-Boc-3-(R)-Cyanopiperidine | ESD-893511-250MG |
| Cas.: 915226-44-7 | Purity: 95% | 1-N-Boc-3-(R)-Cyanopiperidine | ESD-893511-1G |
| Cas.: 915226-44-7 | Purity: 95% | 1-N-Boc-3-(R)-Cyanopiperidine | ESD-893511-5G |
| Cas.: 915226-44-7 | Purity: 95% | 1-N-Boc-3-(R)-Cyanopiperidine | ESD-893511-10G |
| Cas.: 940000-26-0 | Purity: 97% | (R)-1-Boc-2-Cyanopiperidine | ESD-893512-1G |
| Cas.: 940000-26-0 | Purity: 97% | (R)-1-Boc-2-Cyanopiperidine | ESD-893512-5G |
| Cas.: 940000-26-0 | Purity: 97% | (R)-1-Boc-2-Cyanopiperidine | ESD-893512-10G |
| Cas.: 940000-26-0 | Purity: 97% | (R)-1-Boc-2-Cyanopiperidine | ESD-893512-25G |
| Cas.: 30448-43-2 | Purity: 97% | Di-tert-butyl phthalate | ESD-893513-250MG |
| Cas.: 30448-43-2 | Purity: 97% | Di-tert-butyl phthalate | ESD-893513-1G |
| Cas.: 30448-43-2 | Purity: 97% | Di-tert-butyl phthalate | ESD-893513-5G |
| Cas.: 482578-63-2 | Purity: ≥95% | Methyl 2-(bromomethyl)-6-chlorobenzoate | ESD-893514-100MG |
| Cas.: 482578-63-2 | Purity: ≥95% | Methyl 2-(bromomethyl)-6-chlorobenzoate | ESD-893514-250MG |
| Cas.: 75833-63-5 | Purity: 97% | 2-Iodo-1-methyl-1H-indole | ESD-893515-100MG |
| Cas.: 75833-63-5 | Purity: 97% | 2-Iodo-1-methyl-1H-indole | ESD-893515-250MG |
| Cas.: 20730-07-8 | Purity: ≥95% | Pyridine-2,5-dicarbonitrile | ESD-893516-100MG |
| Cas.: 20730-07-8 | Purity: ≥95% | Pyridine-2,5-dicarbonitrile | ESD-893516-250MG |
| Cas.: 20730-07-8 | Purity: ≥95% | Pyridine-2,5-dicarbonitrile | ESD-893516-1G |
| Cas.: 930766-09-9 | Purity: ≥95% | 4-(4-Chlorophenyl)cyclohexanol | ESD-893517-250MG |
| Cas.: 930766-09-9 | Purity: ≥95% | 4-(4-Chlorophenyl)cyclohexanol | ESD-893517-1G |
| Cas.: 161117-88-0 | Purity: ≥95% | tert-Butyl (5-nitropyridin-2-yl)carbamate | ESD-893518-100MG |
| Cas.: 114498-55-4 | Purity: 98% | Oxazolo[4,5-c]pyridin-2-amine | ESD-893519-100MG |
| Cas.: 114498-55-4 | Purity: 98% | Oxazolo[4,5-c]pyridin-2-amine | ESD-893519-250MG |
| Cas.: 114498-55-4 | Purity: 98% | Oxazolo[4,5-c]pyridin-2-amine | ESD-893519-1G |
| Cas.: 50878-90-5 | Purity: ≥95% | 4-Methylquinolin-3-amine | ESD-893520-100MG |
| Cas.: 50878-90-5 | Purity: ≥95% | 4-Methylquinolin-3-amine | ESD-893520-250MG |
| Cas.: 38993-84-9 | Purity: 97% | (1-Methyl-1H-imidazol-5-yl)methanol | ESD-893521-250MG |
